Citrus Sinensis ID: 006777
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 631 | 2.2.26 [Sep-21-2011] | |||||||
| Q944Q0 | 563 | Serine/threonine-protein | yes | no | 0.819 | 0.918 | 0.538 | 1e-161 | |
| Q6EU49 | 612 | Probable serine/threonine | yes | no | 0.927 | 0.955 | 0.500 | 1e-154 | |
| Q8S8Y8 | 567 | Probable serine/threonine | no | no | 0.624 | 0.694 | 0.617 | 1e-142 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.606 | 0.687 | 0.632 | 1e-141 | |
| Q8RXE5 | 524 | Probable serine/threonine | no | no | 0.613 | 0.738 | 0.659 | 1e-139 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.649 | 0.582 | 0.549 | 1e-127 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.649 | 0.582 | 0.549 | 1e-127 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.619 | 0.558 | 0.522 | 1e-124 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.618 | 0.628 | 0.537 | 1e-122 | |
| Q2V338 | 492 | Probable serine/threonine | no | no | 0.618 | 0.792 | 0.522 | 1e-120 |
| >sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 568 bits (1463), Expect = e-161, Method: Compositional matrix adjust.
Identities = 328/609 (53%), Positives = 397/609 (65%), Gaps = 92/609 (15%)
Query: 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
V+ F YK FDEVDGIEVAWN V+IEDVMQ P QLERLYSEVHLLK+LKHENIIK
Sbjct: 34 VLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSEVHLLKALKHENIIKL 93
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
+ SWVD+ N+TINMITELFTSGSLR YRKKH+ VD KAIKNWARQIL+GL+YLHS NPP+
Sbjct: 94 FYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPV 153
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDI 211
IHRDLKCDNIFVNGN GEVKIGDLGLA V+QQPTARSVIGTPEFMAPELYEEEYNELVDI
Sbjct: 154 IHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEYNELVDI 213
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
YSFGMC+LEMVTCEYPYNEC+N AQIYKKVTS IKP SL KV DPQV+QFIEKC++PAS
Sbjct: 214 YSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASS 273
Query: 272 RLPALELLKDPFLVTDNPKDLVCDP--------LRLPNLVPEVMNLAHSEPHPMDIDLNH 323
R ALEL KDPFL D KD +R P L E PMD+D N
Sbjct: 274 RPTALELSKDPFLARDGGKDSALLASSSTSSKYVRPPQL----------EHLPMDVDHNE 323
Query: 324 KKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIH 383
K S + + W T+ELQR+ EN EF LRGE++DD T S+ LRI D SG +H
Sbjct: 324 NK----SVSSNEDYPWSQTIELQRIAENKEFRLRGERSDDVTASMVLRIADPSGKCRIVH 379
Query: 384 FVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGL 443
F FYL +DTA +IAEEMVE+L L+ ++VV IA++ID+ IM+L+ T+S N
Sbjct: 380 FAFYLESDTATAIAEEMVEELHLTSQEVVVIADMIDDFIMQLLSD------RTSSHHN-- 431
Query: 444 LKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLS--ELASGKYQYNQESSDSDISAE 501
P + EA +QQ V S E A+G +S SDISA+
Sbjct: 432 ----------------QNSPRLTHEDHEAANQQTVNSKDEEAAG------QSMKSDISAD 469
Query: 502 FDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFID 561
+ P + DG +A A D ES+ +S++D
Sbjct: 470 YYFPYSAN---------DGNAAMEAGRD-------------AESM----------SSYLD 497
Query: 562 SCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKR 621
SCS M S+I +LS++D ++ + LK EL+ I S++ Q FQ+LL+ +ED +ENA+++
Sbjct: 498 SCSMM------STIYNLSISDNDYPEDLKTELNLIESQFNQSFQDLLKLKEDAIENAKRK 551
Query: 622 WLAGSNVSV 630
W+ +V
Sbjct: 552 WITKKQKAV 560
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 544 bits (1401), Expect = e-154, Method: Compositional matrix adjust.
Identities = 311/621 (50%), Positives = 404/621 (65%), Gaps = 36/621 (5%)
Query: 13 CMSLEPISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER 72
C+ ++P + Y V+ YK FDEV+GIEVAW+QV I++VMQSPD LER
Sbjct: 15 CVEVDPTRRYIRYNE----VLGRGAMKTVYKAFDEVEGIEVAWSQVEIDEVMQSPDNLER 70
Query: 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKN 132
LYSEVHLLKSLKHEN++KFYN WVDD +TIN+ITELFTSGSLRQYR+KH VD+KAIKN
Sbjct: 71 LYSEVHLLKSLKHENVMKFYNYWVDDQKKTINVITELFTSGSLRQYRQKHPRVDLKAIKN 130
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
WARQ+LRGL YLH+H PPIIHRDLKCDNIFVNGN+GEVKIGDLGLA VM P A+SVIGT
Sbjct: 131 WARQVLRGLDYLHTHQPPIIHRDLKCDNIFVNGNHGEVKIGDLGLATVMLTPRAKSVIGT 190
Query: 193 PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
PEFMAPELY+E Y+ELVDIYSFGMC+LEM T EYPY+EC N AQI+KKV+ G+KPA+L+K
Sbjct: 191 PEFMAPELYDENYDELVDIYSFGMCMLEMFTLEYPYSECTNAAQIFKKVSKGVKPAALAK 250
Query: 253 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 312
+T+ Q KQFI+KC+VPAS RL A ELL+DPFL +DN LV + P+ +P+ ++++
Sbjct: 251 ITNIQAKQFIDKCLVPASERLSAKELLQDPFLCSDNSSVLV--GTKFPSSLPKSVDVSLE 308
Query: 313 EPHPMDIDLNHKKVSADSCAKSNTGTWFLT-LELQRLTENNEFTLRGEKNDDDTVSLTLR 371
H MD+D N ++ +C +++ G + LE R +N E L GEK DD++VSL LR
Sbjct: 309 ALH-MDVDTNESMCTS-TCKRNDLGGPHRSVLEFTRTNKNTELKLTGEKLDDNSVSLVLR 366
Query: 372 IGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPS--- 428
I D GH NIHF+FYL++DTA+S+A EMVEQL+L+ DV IA+ ID LI+ LVP
Sbjct: 367 IADLCGHARNIHFLFYLDSDTAMSVAAEMVEQLELADCDVTFIADFIDLLIVNLVPGQQL 426
Query: 429 WNPSLGSTASQQN-GLLKGSPVSQGNSISLK---CPGEPGSNNAFAEAVSQQGVLSELAS 484
N ++ ST+S+ G + SQ + L E ++ A A + S L +
Sbjct: 427 MNDAVMSTSSESKMGESEHVITSQQHPSELTHDYVLVEGMMHSKEANASPSDYIDSLLNA 486
Query: 485 GKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVS--L 542
S SDIS + D KSL + Y V ++ E A + + L
Sbjct: 487 TNLGGPNSSEGSDISVQLDGS-------SKSL------SEYGVDEYRTLECGAYKGTDKL 533
Query: 543 GESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQ 602
G + + N +D S S+ + +S+S E+ D L EL I ++Y+Q
Sbjct: 534 GCRHPLSNGSSNFAIFQMDQASHHSELVIGASVSI-----TENRDVLNGELGLIEAQYEQ 588
Query: 603 CFQELLRQREDEMENARKRWL 623
F+EL R RE+ +E ARK+WL
Sbjct: 589 WFRELTRMREEALEGARKKWL 609
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 506 bits (1304), Expect = e-142, Method: Compositional matrix adjust.
Identities = 253/410 (61%), Positives = 310/410 (75%), Gaps = 16/410 (3%)
Query: 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
V+ F YK FDEVDGIEVAWNQV I+DV+QSP+ LERLYSEV LLKSLKH NII+F
Sbjct: 33 VIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRF 92
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
YNSW+DD N+T+N+ITELFTSGSLR YRKKH+ V+MKA+KNWARQIL GL YLH PPI
Sbjct: 93 YNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPI 152
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDI 211
IHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q A+SVIGTPEFMAPELY+E YNEL DI
Sbjct: 153 IHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADI 212
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
YSFGMC+LEMVT +YPY ECKN AQIYKKV+SGIKPASLS+V DP+VKQFIEKC++PAS
Sbjct: 213 YSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASE 272
Query: 272 RLPALELLKDPFLVTDNPKDLVCDPLRLPNLV-PE--------VMNLAHSEPHP---MDI 319
RL A ELL DPFL + + +PL LP++V P+ +M+ P + I
Sbjct: 273 RLSAKELLLDPFLQLNGLT--MNNPLPLPDIVMPKEGAFGDRCLMSEGPPTTRPSKTLSI 330
Query: 320 DLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHV 379
DL+ N+G+ +E++R N F L+GE+ND+ +VSL LRI D++G V
Sbjct: 331 DLDEDSNLPIVTFSDNSGSR--CIEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRV 388
Query: 380 SNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSW 429
NIHF+FY DTA ++ EMVEQL+L+ ++V IAELID L++ ++P+W
Sbjct: 389 RNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTW 438
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 503 bits (1296), Expect = e-141, Method: Compositional matrix adjust.
Identities = 253/400 (63%), Positives = 314/400 (78%), Gaps = 17/400 (4%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+KGFDEVDGIEVAWNQV I+D++QSPD LERLYSEV LLKSLKH+NII+FYNSW+DD N+
Sbjct: 43 FKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNK 102
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
T+N+ITELFTSGSLRQYRKKH+ V+MKA+K WARQIL GL YLHS +PPIIHRD+KCDNI
Sbjct: 103 TVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNI 162
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 221
F+NGN+GEVKIGDLGLA VM+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
VT EYPY EC+N AQIYKKV+SGIKPASLSKV DP+V +FIEKC++PAS RL A ELL D
Sbjct: 223 VTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLD 282
Query: 282 PFLVTDNPKDLVC-DPLRLPNLV-PEVMNLAH----SEPHP------MDIDLNHKKVSAD 329
FL N LV +PL LP++V P+ + SE P M ++L+
Sbjct: 283 SFL---NVNGLVMNNPLPLPDIVMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDNNLPI 339
Query: 330 SCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLN 389
+ +N+GT +E++R N F L+GE+ND+++VSL LRI D++G V NIHF+F+
Sbjct: 340 VISSNNSGTN--CIEVRRAKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQE 397
Query: 390 ADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSW 429
DTA +++ EMVEQL+L+ ++V IAELID L++ L+P+W
Sbjct: 398 GDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNW 437
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXE5|WNK10_ARATH Probable serine/threonine-protein kinase WNK10 OS=Arabidopsis thaliana GN=WNK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 494 bits (1272), Expect = e-139, Method: Compositional matrix adjust.
Identities = 258/391 (65%), Positives = 292/391 (74%), Gaps = 4/391 (1%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F YK FDEV+GIEVAWN ++IEDV+Q P QL+RLYSEVHLL SLKH+NIIK + SWV
Sbjct: 26 AFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSEVHLLNSLKHDNIIKLFYSWV 85
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
DD N++INMITELFTSGSL YRKKH+ VD KAI NWARQIL+GLHYLHS PP+IHRDL
Sbjct: 86 DDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDL 145
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 216
KCDNIFVNGN G+VKIGDLGLA VMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM
Sbjct: 146 KCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 205
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
C+LEMVTCEYPY EC+N AQIYKKVTSGIKP SLSKV DPQVKQFIEKC++PA R AL
Sbjct: 206 CMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTAL 265
Query: 277 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDL-NHKKVSADSCAKSN 335
ELLKD L D KD P + E PMD++ + VS S AKS+
Sbjct: 266 ELLKDQLLAVDGAKDSTLTASSNTTFKPAMP--PQCEYRPMDVEYKKNTSVSICSSAKSS 323
Query: 336 TGTWFL-TLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAI 394
L T+E+QR+ E+ EF L GE+ DD S+ LRI SG + F F L DTA
Sbjct: 324 QECALLQTMEVQRVAESTEFKLSGERRDDVAASMALRIAGSSGQARKVDFDFNLKTDTAR 383
Query: 395 SIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 425
++ EMVE+LDLS +V IAE+ID LIMKL
Sbjct: 384 AVTGEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1174), Expect = e-127, Method: Compositional matrix adjust.
Identities = 237/431 (54%), Positives = 291/431 (67%), Gaps = 21/431 (4%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+ FDE G+EVAWNQV + D +QSP+ LERLY E+HLLK+LKH NI+KFY SWVD + R
Sbjct: 42 YRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRR 101
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
IN ITE+FTSG+LRQYR+KH V++ A+K+W RQIL GL YLHSH+PPIIHRDLKCDNI
Sbjct: 102 NINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNI 161
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 221
FVNGN GEVKIGDLGLA ++++ A +GTPEFMAPE+YEEEYNELVDIYSFGMC+LEM
Sbjct: 162 FVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEM 221
Query: 222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
VT EYPY+EC +P QIYKKV SG KP +L KV DP V+QF+EKC+ AS RL A ELLKD
Sbjct: 222 VTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKD 281
Query: 282 PFLVTDNPKDLVCDP----------LRLPNLVPEVMNLAH-----SEPHPMDIDLNHKKV 326
PFL D DLV P LR P L N++ SE D +
Sbjct: 282 PFLQVD---DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWD 338
Query: 327 SADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVF 386
D K++ F E + L N + T++G K++D ++ L LRI D GHV NI+F F
Sbjct: 339 CEDDDIKADGIDLFNGHEDEPLG-NVDITIKGRKSEDGSIFLRLRIADNDGHVRNIYFPF 397
Query: 387 YLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLK- 445
+ ADTA+S+A EMV +LD++ +V IAE+ID + LVP W P G SQ
Sbjct: 398 DIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRPGPGIEESQDTTYCHN 457
Query: 446 -GSPVSQGNSI 455
GS VS S+
Sbjct: 458 CGSNVSSCGSL 468
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 456 bits (1173), Expect = e-127, Method: Compositional matrix adjust.
Identities = 237/431 (54%), Positives = 291/431 (67%), Gaps = 21/431 (4%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+ FDE G+EVAWNQV + D +QSP+ LERLY E+HLLK+LKH NI+KFY SWVD + R
Sbjct: 42 YRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRR 101
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
IN ITE+FTSG+LRQYR+KH V++ A+K+W RQIL GL YLHSH+PPIIHRDLKCDNI
Sbjct: 102 NINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNI 161
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 221
FVNGN GEVKIGDLGLA ++++ A +GTPEFMAPE+YEEEYNELVDIYSFGMC+LEM
Sbjct: 162 FVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEM 221
Query: 222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
VT EYPY+EC +P QIYKKV SG KP +L KV DP V+QF+EKC+ AS RL A ELLKD
Sbjct: 222 VTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKD 281
Query: 282 PFLVTDNPKDLVCDP----------LRLPNLVPEVMNLAH-----SEPHPMDIDLNHKKV 326
PFL D DLV P LR P L N++ SE D +
Sbjct: 282 PFLQVD---DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWD 338
Query: 327 SADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVF 386
D K++ F E + L N + T++G K++D ++ L LRI D GHV NI+F F
Sbjct: 339 CEDDDIKADGIDLFNGHEDEPLG-NVDITIKGRKSEDGSIFLRLRIADNDGHVRNIYFPF 397
Query: 387 YLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLK- 445
+ ADTA+S+A EMV +LD++ +V IAE+ID + LVP W P G SQ
Sbjct: 398 DIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRPGPGIEESQDTTYCHN 457
Query: 446 -GSPVSQGNSI 455
GS VS S+
Sbjct: 458 CGSNVSSCGSL 468
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1147), Expect = e-124, Method: Compositional matrix adjust.
Identities = 225/431 (52%), Positives = 284/431 (65%), Gaps = 40/431 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+ FDE +GIEVAWNQV + D +QSP+ LERLY E+HLLK+LKH+NI+KFY SWVD NR
Sbjct: 39 YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
IN +TELFTSG+LRQYR +HK V+++A+K+W RQILRGLHYLHSH+PP+IHRDLKCDNI
Sbjct: 99 NINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNI 158
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 221
FVNGN GEVKIGDLGLA ++++ A +GTPEFMAPE+YEE YNELVDIYSFGMCILEM
Sbjct: 159 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEM 218
Query: 222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
VT +YPY+EC +PAQIYKKV SG KP +L KV DP+VK FIEKC+ SLR+ A ELL D
Sbjct: 219 VTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDD 278
Query: 282 PFLVTDNP---------KDLVCDPLRLPNLVPEVMNLAHSEP----------HPMD-IDL 321
PFL D+ +D V R P+ +P+ N + +P + L
Sbjct: 279 PFLRIDDGEFDLRSVDMEDSVGPLYRQPHHLPDYYNYPSNSSSLNRQYSNGNYPSNSSSL 338
Query: 322 NHKKVSADSCAKSNTGTWFLT--------------------LELQRLTENNEFTLRGEKN 361
N + + + W E ++ + N + T++G++
Sbjct: 339 NRQYSNGYNSHHEYQNGWAYNPAETEETHGIELFESRNNDDQEEEKKSGNVDITIKGKRR 398
Query: 362 DDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNL 421
DD + L LRI DK G V NI+F F + DTA+S+A EMV +LD+ V IA +ID
Sbjct: 399 DDGGLFLRLRIADKEGRVRNIYFPFDIETDTALSVATEMVAELDMDDHGVTKIANMIDGE 458
Query: 422 IMKLVPSWNPS 432
I LVPSW P
Sbjct: 459 ISSLVPSWRPG 469
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1127), Expect = e-122, Method: Compositional matrix adjust.
Identities = 220/409 (53%), Positives = 285/409 (69%), Gaps = 19/409 (4%)
Query: 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
V+ F YK FD+++G+EVAWNQ+ + D++++ D LERL SEV LLK+LKH+NIIKF
Sbjct: 33 VLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLERLRSEVRLLKTLKHKNIIKF 92
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
YNSW+D N IN ITE+FTSG+LRQYR KHK VD++A+K W+RQIL GL YLHSH+PP+
Sbjct: 93 YNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALKKWSRQILSGLVYLHSHDPPV 152
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVD 210
IHRDLKCDNIFVNGN GEVKIGDLGLA ++ +A S+IGTPEFMAPELY+EEYNELVD
Sbjct: 153 IHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSIIGTPEFMAPELYDEEYNELVD 212
Query: 211 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPAS 270
IY+FGMC+LE+VT EYPY EC N AQIYKKV+ G KP+SL+K+ DP+V+ FIEKCI AS
Sbjct: 213 IYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSLAKIEDPEVRFFIEKCIAKAS 272
Query: 271 LRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADS 330
RL A ELL DPFL D K + PL+ + ++S + + + ++
Sbjct: 273 QRLSAQELLMDPFLRDDGEK--IFYPLQSNTKASDGAGSSNSS-----MGYKYDRDASSM 325
Query: 331 CAKSNTGTW----------FLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVS 380
+ +TG++ T++ Q T+ + D +T+ L LRI D +GH
Sbjct: 326 AIREHTGSFAEEHPSDRYIHSTMDPQ-AAAGRIITVESQMKDLNTIFLKLRIADSTGHAQ 384
Query: 381 NIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSW 429
NIHF F + ADT+IS+A EMV QLDL+ +DV +IAE+ID I +P W
Sbjct: 385 NIHFPFDIEADTSISVATEMVVQLDLTDQDVTAIAEMIDAEIRAHIPDW 433
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V338|WNK9_ARATH Probable serine/threonine-protein kinase WNK9 OS=Arabidopsis thaliana GN=WNK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 432 bits (1112), Expect = e-120, Method: Compositional matrix adjust.
Identities = 219/419 (52%), Positives = 281/419 (67%), Gaps = 29/419 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+GFDE GIEVAWNQV + D +QSP +LERLY E+HLLK+LKH++I+KFY SWVD NR
Sbjct: 40 YRGFDEYQGIEVAWNQVKLYDFLQSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNR 99
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
IN +TE+FTSG+LRQYR KHK V+++A+KNW RQILRGL+YLH+H+PP+IHRDLKCDNI
Sbjct: 100 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNI 159
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 221
F+NGN GEVKIGDLGLA +Q A +GTPEFMAPE+Y+EEYN+LVDIYSFGMC+LEM
Sbjct: 160 FINGNQGEVKIGDLGLAACLQHSHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEM 219
Query: 222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
VT +YPY+EC +PAQIYK+V SG KP L KV DP+V+ FIEKC+ SLRL A ELL D
Sbjct: 220 VTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDD 279
Query: 282 PFLVTDNPK-----------DLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADS 330
FL D D PLR +P N +S + D N D
Sbjct: 280 HFLCIDESDMRRVESEKGLIDEAGTPLRHSYHIPHYSNGYYSLYNQNQWDYN-----GDE 334
Query: 331 CAKSNTGTWFLTLELQRLTENN---------EFTLRGEKNDD-DTVSLTLRIGDKSGHVS 380
+S+ LE Q + + +++G++ D+ D + L L+ +K G V
Sbjct: 335 TVESHE---IDLLEFQNDDDEEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVR 391
Query: 381 NIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQ 439
NI+F F + DTAIS+A EMVE+L++ DV IA +ID I LVP+W+ S +++
Sbjct: 392 NIYFPFDIETDTAISVAREMVEELEMDDRDVTKIANMIDGEIASLVPNWSIFCSSESNR 450
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 631 | ||||||
| 224072272 | 596 | predicted protein [Populus trichocarpa] | 0.881 | 0.932 | 0.651 | 0.0 | |
| 255555709 | 585 | kinase, putative [Ricinus communis] gi|2 | 0.873 | 0.941 | 0.629 | 0.0 | |
| 359474135 | 645 | PREDICTED: serine/threonine-protein kina | 0.933 | 0.913 | 0.631 | 0.0 | |
| 224058021 | 571 | predicted protein [Populus trichocarpa] | 0.841 | 0.929 | 0.635 | 0.0 | |
| 357462359 | 614 | Serine/threonine protein kinase WNK8 [Me | 0.923 | 0.949 | 0.606 | 0.0 | |
| 449452398 | 679 | PREDICTED: serine/threonine-protein kina | 0.914 | 0.849 | 0.581 | 0.0 | |
| 351724041 | 618 | with no lysine kinase 8 [Glycine max] gi | 0.912 | 0.932 | 0.584 | 1e-178 | |
| 356547519 | 618 | PREDICTED: serine/threonine-protein kina | 0.920 | 0.940 | 0.583 | 1e-176 | |
| 225470964 | 625 | PREDICTED: probable serine/threonine-pro | 0.916 | 0.924 | 0.558 | 1e-168 | |
| 255564615 | 693 | kinase, putative [Ricinus communis] gi|2 | 0.942 | 0.858 | 0.530 | 1e-166 |
| >gi|224072272|ref|XP_002303683.1| predicted protein [Populus trichocarpa] gi|222841115|gb|EEE78662.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1821), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/589 (65%), Positives = 442/589 (75%), Gaps = 33/589 (5%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F YK FDEVDGIEVAWNQVNIEDV+QS QLERLYSEVHLLKSLKHENIIKFY+SWV
Sbjct: 34 AFKTVYKAFDEVDGIEVAWNQVNIEDVLQSSQQLERLYSEVHLLKSLKHENIIKFYSSWV 93
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
DD N+TIN+ITELFTSGS+RQYRKKHK VDMKAIKNWARQILRGLHYLH+H+PPIIHRDL
Sbjct: 94 DDKNKTINIITELFTSGSMRQYRKKHKTVDMKAIKNWARQILRGLHYLHTHSPPIIHRDL 153
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 216
KCDNIFVNGN GEVKIGDLGLAIVMQQP ARSVIGTPEFMAPELYEEEYNELVDIYSFGM
Sbjct: 154 KCDNIFVNGNTGEVKIGDLGLAIVMQQPIARSVIGTPEFMAPELYEEEYNELVDIYSFGM 213
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
C+LEMVTCEYPY+ECKNPAQIYKKV+SGIKPASL KV+D QVK FIEKC+VPAS RLPA+
Sbjct: 214 CMLEMVTCEYPYSECKNPAQIYKKVSSGIKPASLGKVSDHQVKVFIEKCLVPASTRLPAI 273
Query: 277 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKS-N 335
ELLKDPFL T+N K+LV L+LPNL+ ++L SE H MDID KK+S SC KS N
Sbjct: 274 ELLKDPFLATENSKELVSSSLQLPNLISRQVHLLQSESHLMDIDC--KKLSVGSCTKSIN 331
Query: 336 TGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAIS 395
F TLEL R TENNEF LRG KN+D+TVSLTLRI D G NIHF FYL++DTA+
Sbjct: 332 ESPQFSTLELSRFTENNEFRLRGAKNNDNTVSLTLRIADPCGRARNIHFTFYLDSDTAVL 391
Query: 396 IAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSI 455
IAEEMVEQLDL EDV IAELIDNLI KLVPSWN SP + S
Sbjct: 392 IAEEMVEQLDLLTEDVAVIAELIDNLIAKLVPSWNT---------------SPSVRNGSS 436
Query: 456 SLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKS 515
L+ N++ +EAV + L L + ++S +SDISAE+++ + D+ +KS
Sbjct: 437 ELE-------NHSTSEAVKKPDFLP-LTNMTDLETKQSVNSDISAEYNMAIASDSGTNKS 488
Query: 516 LVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSI 575
L +YD E E + + N+ST+NS S+I S SGMS+N S SSI
Sbjct: 489 LGSSDCCLQSNMYD---LEFGMLEDGISK---HNKSTRNSNDSYIGSFSGMSRNASMSSI 542
Query: 576 SSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLA 624
SLSLADK+ S+ LK ELD+I+S Y QC QEL++ RE+ +ENA+KR +
Sbjct: 543 CSLSLADKDGSE-LKQELDSIDSHYNQCLQELMKMREEAIENAKKRGIT 590
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555709|ref|XP_002518890.1| kinase, putative [Ricinus communis] gi|223541877|gb|EEF43423.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 693 bits (1789), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/597 (62%), Positives = 435/597 (72%), Gaps = 46/597 (7%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F YK FDE++GIEVAWNQV++EDV+QSPDQLERLYSEVHLLKSLKHENI+KFYNSWV
Sbjct: 33 AFKTVYKAFDEINGIEVAWNQVSVEDVLQSPDQLERLYSEVHLLKSLKHENIMKFYNSWV 92
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
DD N+TINMITELFTSGSLR+YRKKHKNVD+KAIKNWARQILRGLHYLHSHNPPIIHRDL
Sbjct: 93 DDNNKTINMITELFTSGSLRKYRKKHKNVDIKAIKNWARQILRGLHYLHSHNPPIIHRDL 152
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 216
KCDN+FVNGNNGEVKIGDLGLA VMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM
Sbjct: 153 KCDNVFVNGNNGEVKIGDLGLATVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 212
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
CILEMVTCEYPY+ECKNPAQIYKKVTSGIKPASL KV DP VK+FIEKCIVPAS+RLPAL
Sbjct: 213 CILEMVTCEYPYSECKNPAQIYKKVTSGIKPASLCKVNDPLVKRFIEKCIVPASMRLPAL 272
Query: 277 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKS-N 335
ELLKDPFL T+NPK+LV L LP+L+ + ++ SE +PMDID NHKK+S SC KS +
Sbjct: 273 ELLKDPFLATENPKELVFASLHLPDLMLKQVSRGQSESYPMDIDSNHKKLSVGSCTKSMD 332
Query: 336 TGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAIS 395
F T E QRLT NEF LRGEKNDD+T+SLTLRI D+ G V NIHF FYL++DT +S
Sbjct: 333 ESLHFSTSEFQRLTVKNEFRLRGEKNDDNTISLTLRIVDRCGGVKNIHFTFYLDSDTTLS 392
Query: 396 IAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSI 455
IAEEMVEQLDLS+EDV IAELID LI+KLVP + S GST+S NG
Sbjct: 393 IAEEMVEQLDLSNEDVAIIAELIDALILKLVPHLSQS-GSTSSMPNGF------------ 439
Query: 456 SLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKS 515
N+A + S+ L LA K Q Q+S S++S E + V DA +K
Sbjct: 440 ------SELHNDATFKVASKHDFLP-LADLKGQETQDSLLSELSTELPLTVASDASTNKP 492
Query: 516 LVPDGYSAHYAVYDHGGHEVKADEVSLGESIL-FNESTQNSETSFIDSCSGMSKNLSFSS 574
L Y+ + Y+ G +D + G+ + + T++SE
Sbjct: 493 LGSSDYTIDFNTYEFG-----SDFMMHGDGTFKYGKYTKHSE------------------ 529
Query: 575 ISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSVI 631
L A E D LKLELDAI+ +Y QCF+EL RE+ +ENA+K+W+ V I
Sbjct: 530 -KHLPSAKGEVQDDLKLELDAIDMQYNQCFRELSMMREEAIENAKKKWITRKKVPAI 585
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474135|ref|XP_002273005.2| PREDICTED: serine/threonine-protein kinase WNK8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1786), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/608 (63%), Positives = 454/608 (74%), Gaps = 19/608 (3%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F YK FDEVDGIEVAW QV IED++QSP QLERLYSEVHLLKSLKH+NIIKFYNSWV
Sbjct: 33 AFKTVYKAFDEVDGIEVAWGQVEIEDLLQSPQQLERLYSEVHLLKSLKHDNIIKFYNSWV 92
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
DDTN+TIN+ITELFTSGSLRQYRKKHKNVD+KAIKNWA+QILRGLHYLHSHNPPIIHRDL
Sbjct: 93 DDTNKTINLITELFTSGSLRQYRKKHKNVDLKAIKNWAKQILRGLHYLHSHNPPIIHRDL 152
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 216
KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM
Sbjct: 153 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 212
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
CILE+VTCEYPYNECKNPAQIYKKV+SGIKPASL KV+DPQVKQFIEKC+VPASLRL A
Sbjct: 213 CILELVTCEYPYNECKNPAQIYKKVSSGIKPASLGKVSDPQVKQFIEKCLVPASLRLSAQ 272
Query: 277 ELLKDPFLVTDNPKDLVC------DPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADS 330
ELLKD F T+N K+ V D L+ N +P +MNL E PMD+D N+KK+S +
Sbjct: 273 ELLKDAFFATENSKEPVYNHMHVDDSLQSSNFMPNLMNLPKPELQPMDMDPNYKKLSVST 332
Query: 331 CAKSNTGT-WFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLN 389
KS +GT F L+ +R +NN F LRGEK DD+++S+TL I D G NIHF FYL+
Sbjct: 333 HMKSISGTPHFRALQFERFNKNNLFKLRGEKIDDNSISMTLHIADPCGRAKNIHFAFYLD 392
Query: 390 ADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPV 449
+DTA+SIA EMVEQLDL +EDV IAELID +I +LVP+W P+ S N + S V
Sbjct: 393 SDTALSIAGEMVEQLDLYNEDVAVIAELIDVMISELVPTWKPAFESMLCGANSSCEDSLV 452
Query: 450 SQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILD 509
SL+ P + GS ++AV++ ++S A+G+ Q ES+ S +S + D V D
Sbjct: 453 LHNGGTSLRHPSDSGSAKGTSDAVTEH-LISLSANGEEQSTVESALSGMSTKDDATVASD 511
Query: 510 AHIDKSL-VPDG----------YSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETS 558
A+ KSL PD ++ V DH H+ ++GE + N T++ E S
Sbjct: 512 ANDIKSLECPDDECYEASDRCCFNGDRQVLDHERHKEGRYNGNIGEPVAMNGFTKDWEIS 571
Query: 559 FIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENA 618
I+SCSGMS +LS SSI SLSLADK+ SD LKLE+D I+++Y QCFQELLR RE+ +E A
Sbjct: 572 CIESCSGMSNSLSLSSICSLSLADKDPSDELKLEVDTIDTQYHQCFQELLRMREEAIEKA 631
Query: 619 RKRWLAGS 626
+ RW+ S
Sbjct: 632 KNRWITKS 639
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224058021|ref|XP_002299436.1| predicted protein [Populus trichocarpa] gi|222846694|gb|EEE84241.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 685 bits (1768), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/590 (63%), Positives = 431/590 (73%), Gaps = 59/590 (10%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F YK FDEVDGIEVAWNQV+IEDV+QS QLERLYSEVHLLKSLKHENIIKFYNSWV
Sbjct: 34 AFKTVYKAFDEVDGIEVAWNQVDIEDVLQSSQQLERLYSEVHLLKSLKHENIIKFYNSWV 93
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
DD N+TINMITEL TSG+LRQYRKKHK VDMKAIKNWARQILRGL YLH+ +P IIHRDL
Sbjct: 94 DDKNKTINMITELLTSGNLRQYRKKHKTVDMKAIKNWARQILRGLQYLHTRSPRIIHRDL 153
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 216
KCDNI VNGNNGEVKIGDLGLAIVMQQP ARSVIGTPEFMAPELYEEEYNELVDIYSFGM
Sbjct: 154 KCDNILVNGNNGEVKIGDLGLAIVMQQPIARSVIGTPEFMAPELYEEEYNELVDIYSFGM 213
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
C+LEMVTCEYPY+ECKNPAQIYKKVTSGIKPASL KV D QVK+FIEKC+VPAS+RL A+
Sbjct: 214 CMLEMVTCEYPYSECKNPAQIYKKVTSGIKPASLVKVNDLQVKEFIEKCLVPASVRLSAI 273
Query: 277 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKS-N 335
+LLKDPFL T+N K++V +LPN++ + ++L SE H MDID K +S SC KS N
Sbjct: 274 DLLKDPFLATENSKEVVSSLSQLPNVICKQVHLPQSESHHMDIDC--KMLSLGSCPKSIN 331
Query: 336 TGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAIS 395
FLTLEL+R TENNEF LR EKNDD+TVSLTLRI D G NIHF FYLN+DTA+S
Sbjct: 332 ESPQFLTLELRRFTENNEFRLRAEKNDDNTVSLTLRIADPCGRARNIHFTFYLNSDTAVS 391
Query: 396 IAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSI 455
IAEEMVEQLDLS EDV IAELID+LI+KLVP WN S +S +NG + S
Sbjct: 392 IAEEMVEQLDLSSEDVAVIAELIDSLIVKLVPCWNTS----SSVRNG--SSELENHATSE 445
Query: 456 SLKCPG-EPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDK 514
+ K P P +N EA+ +S +SDISAE+++ + DA +K
Sbjct: 446 TGKTPDFSPLTNITDHEAL------------------QSVNSDISAEYNMAIASDASTNK 487
Query: 515 SLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSS 574
SL S V+ IDSCSGMS+N S S
Sbjct: 488 SLGSSSCSLQSNVF------------------------------HIDSCSGMSRNASLSI 517
Query: 575 ISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLA 624
I SL LADK+ S+ LKLELD+I+S Y QCFQEL++ RE+ +ENA++RW++
Sbjct: 518 ICSLFLADKDGSE-LKLELDSIDSHYNQCFQELMKTREEAIENAKRRWIS 566
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357462359|ref|XP_003601461.1| Serine/threonine protein kinase WNK8 [Medicago truncatula] gi|355490509|gb|AES71712.1| Serine/threonine protein kinase WNK8 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 663 bits (1711), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/597 (60%), Positives = 434/597 (72%), Gaps = 14/597 (2%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F YK FDEVDGIEVAWNQ++IEDVMQSP LE+LYSEVHLLKSLKHENIIK Y+SWV
Sbjct: 30 AFKTVYKAFDEVDGIEVAWNQISIEDVMQSPQNLEKLYSEVHLLKSLKHENIIKMYSSWV 89
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
D+ + INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL +LHSHNPP+IHRDL
Sbjct: 90 DEKSSNINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLCFLHSHNPPVIHRDL 149
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 216
KCDNIFVNGNNG+VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVD+YSFGM
Sbjct: 150 KCDNIFVNGNNGQVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDVYSFGM 209
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
CILEM+TCEYPY+ECKNPAQIYKKVTSGIKPASL++V DP+VKQFIEKC+VPAS+RLPA
Sbjct: 210 CILEMITCEYPYSECKNPAQIYKKVTSGIKPASLARVNDPEVKQFIEKCLVPASMRLPAS 269
Query: 277 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNT 336
ELLKDPFL T N K++ D L LPN + +N EPHPM+ID N K S S + +
Sbjct: 270 ELLKDPFLATGNTKEIYHDNLLLPNPPSKSLNPPTCEPHPMEIDSNVKHTSPASTVERDK 329
Query: 337 GTWFLTL--ELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAI 394
T ++ ++ R TENNEF LRGEKN D T+SLTLRI D +G NIHF FY+++DT I
Sbjct: 330 ETSQVSSNHDILRKTENNEFRLRGEKNADRTISLTLRIADANGGARNIHFPFYIDSDTTI 389
Query: 395 SIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNS 454
SIAEEMVE L+L EDV IAELI N+I KLVP W P L +S + L + P+ N
Sbjct: 390 SIAEEMVEHLELKDEDVAVIAELIHNMIFKLVPDWKP-LCENSSGTDNLYR--PLEPQNE 446
Query: 455 ISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDK 514
L C GSNN +++ + S+L G+ Q QES SDISAE+ + DA K
Sbjct: 447 -QLNCHWTLGSNNFDMKSMYEDLGHSQL-DGEDQDKQESVSSDISAEYGTVIATDA---K 501
Query: 515 SLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSS 574
+ + + H G D G+ + ++ SE S + SC S+NL S
Sbjct: 502 GVEQNCFILHECCKGSNGLNTNPDVRICGQE---DGNSNQSENSVV-SCCSPSENLDRLS 557
Query: 575 ISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSVI 631
SL+ D++H D L+LE++AI +YQQ F+EL++ RE+ +EN +KRW + N+SV+
Sbjct: 558 KCSLTALDQDHLDELQLEIEAIEIQYQQSFRELMKMREEAIENVKKRWTSKKNISVM 614
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452398|ref|XP_004143946.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus] gi|449529646|ref|XP_004171809.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/612 (58%), Positives = 429/612 (70%), Gaps = 35/612 (5%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F YK FDEV GIEVAW+QV+IEDV+QSP+QL+RLYSEVHLLKSLKHENIIKFY+ WV
Sbjct: 86 AFKTVYKAFDEVGGIEVAWSQVDIEDVLQSPEQLQRLYSEVHLLKSLKHENIIKFYSYWV 145
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
DD ++TINMITELFTSGSLRQYRKKH+ VD+KA KNWARQILRGL YLH HNPPIIHRDL
Sbjct: 146 DDKHKTINMITELFTSGSLRQYRKKHRKVDLKAFKNWARQILRGLTYLHGHNPPIIHRDL 205
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 216
KCDNIFVNGN GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY+E+YNELVDIYSFGM
Sbjct: 206 KCDNIFVNGNTGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYDEDYNELVDIYSFGM 265
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
C+LE+VTCEYPYNECKN AQI+KKVTSGIKPASL KV DPQVKQFIEKC+VPAS RLPA
Sbjct: 266 CMLEIVTCEYPYNECKNSAQIFKKVTSGIKPASLEKVLDPQVKQFIEKCLVPASTRLPAS 325
Query: 277 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD--SCAKS 334
ELLKDPFL ++PKD + R N + +N HPM+ D N K+S S KS
Sbjct: 326 ELLKDPFLAAESPKDNSSELSRSLNEHFKSVNPPLLGSHPMETDHNCTKLSGSVASSVKS 385
Query: 335 NTG-TWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTA 393
N G + F T ELQRLTENNE TL+G+ D +T+S LRI + G NIHF FYL++DT+
Sbjct: 386 NNGISHFSTQELQRLTENNELTLKGDMTDHNTMSFHLRIAELYGKSRNIHFAFYLDSDTS 445
Query: 394 ISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGN 453
++IA EMVEQL+LS+ED IA+LID LI K VPSW P QQ SP +Q +
Sbjct: 446 LAIALEMVEQLELSNEDATIIAKLIDELIAKFVPSWKPCPNYCEEQQQN-TPHSPEAQED 504
Query: 454 SISLKCPGEPGSNNAFAEAV-------SQQGVLSELASGKYQYNQESSDSDISAEFDVPV 506
+ + F+E V + + L+ LA + Q NQ+S S S E+
Sbjct: 505 KTFI--------SPFFSELVLSSPMVAAARNNLTGLAKVEDQENQQSIISCASVEYIYST 556
Query: 507 ILDAHIDKSLV------PDGYSAHYAVYDHGGHEVKADEV-SLGESILFNESTQNSETSF 559
+ D I K PD A+ + G ++ A+ V SL +I F ++ S
Sbjct: 557 VSDYSIGKGSECGEFGHPDCEKAYIS---SGTIDLDAEAVGSLSTTIDF------AKPSL 607
Query: 560 IDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENAR 619
I SCS MSK LS SS S+LS+ +++H D LK+E+DAI+ +Y QC EL R RE+ +E+A+
Sbjct: 608 ISSCSEMSKELSLSSFSTLSMEERDHQDELKMEIDAIDLQYHQCLCELSRMREEAIESAK 667
Query: 620 KRWLAGSNVSVI 631
KRW++ + I
Sbjct: 668 KRWMSKKKATGI 679
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351724041|ref|NP_001236020.1| with no lysine kinase 8 [Glycine max] gi|225348645|gb|ACN87284.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1626), Expect = e-178, Method: Compositional matrix adjust.
Identities = 344/589 (58%), Positives = 428/589 (72%), Gaps = 13/589 (2%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F YK FDEVDGIEVAWN++ +EDV+Q+P QL +LYSEVHLLKSLKH+N+IK YNSWV
Sbjct: 26 AFKTVYKAFDEVDGIEVAWNRIGVEDVVQTPQQLGKLYSEVHLLKSLKHDNVIKLYNSWV 85
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
DDT TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL +LHS +PPI+HRDL
Sbjct: 86 DDTAGTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLCFLHSQSPPIVHRDL 145
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 216
KCDNIFVNGN+G VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM
Sbjct: 146 KCDNIFVNGNSGLVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 205
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
CILEMVTCEYPY+ECKNPAQIYKKVTSGIKPA+L+KV DP+VKQFIEKC+VPAS+RL A
Sbjct: 206 CILEMVTCEYPYSECKNPAQIYKKVTSGIKPAALAKVNDPEVKQFIEKCLVPASMRLSAS 265
Query: 277 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVS-ADSCAKSN 335
ELLKDPFL T+N K++ D L+LPN +++NL EPHPM+ID ++ S S +
Sbjct: 266 ELLKDPFLATENTKEINHDTLQLPNPHIKLVNLPKCEPHPMEIDSYSRRTSPGSSMGRIE 325
Query: 336 TGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAIS 395
+ +L R+T+NN+ LRGEKN + T+SLTLRI D G NIHF FY+++DTAIS
Sbjct: 326 ETSQVSFFDLVRMTDNNKLMLRGEKNAESTISLTLRIPDACGGARNIHFPFYMDSDTAIS 385
Query: 396 IAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSI 455
IAEEMVE L+L++EDV IAELI+++I KLVP+ P +S+ N L + S Q N
Sbjct: 386 IAEEMVEHLELTNEDVSVIAELINDMIAKLVPNSKPLCEKLSSETNLLYRPSSEVQ-NGE 444
Query: 456 SLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKS 515
C S++ +A+ + V S G Q QES SDISA + + D+ K
Sbjct: 445 QFNCHWPLQSSDYDMKAMYKDLVHSRPVDGDDQEKQESVMSDISAACGITIASDS---KV 501
Query: 516 LVPDGYSAHYAVYD---HGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSF 572
+ PD + ++D G +D G+ ++NS S I+SC KN
Sbjct: 502 VEPDIF-----IFDEFWEGFFNSTSDIRFCGQEDGHKNQSENSVGSLINSCCCPFKNFDM 556
Query: 573 SSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKR 621
SSI SL+LADK+ S+GL+L+++AI++ + + F EL R++ +++A++R
Sbjct: 557 SSICSLTLADKDPSEGLRLDIEAIDTYFDRRFLELEMMRQEAIKSAKRR 605
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547519|ref|XP_003542159.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 626 bits (1614), Expect = e-176, Method: Compositional matrix adjust.
Identities = 342/586 (58%), Positives = 418/586 (71%), Gaps = 5/586 (0%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F YK FDEVDGIEVAWN +++EDV+Q+P QLE+LYSE+HLLKSLKH+N+IK YNSWV
Sbjct: 26 AFKTVYKAFDEVDGIEVAWNMISVEDVVQTPQQLEKLYSEIHLLKSLKHDNVIKLYNSWV 85
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
DDT TINMITELFTSGSLRQYR KHKNVDMKAIKNWARQILRGL +LH H+PPI+HRDL
Sbjct: 86 DDTTGTINMITELFTSGSLRQYRNKHKNVDMKAIKNWARQILRGLCFLHCHSPPIVHRDL 145
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 216
KCDNIFVNGN+G VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM
Sbjct: 146 KCDNIFVNGNSGLVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 205
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
CILEMVTCEYPY+EC NPAQIYKKVTSGIKPA+L+KV DP+VKQFIEKC+VPAS+RL A
Sbjct: 206 CILEMVTCEYPYSECNNPAQIYKKVTSGIKPAALAKVNDPEVKQFIEKCLVPASMRLSAS 265
Query: 277 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVS-ADSCAKSN 335
ELLKDPFL T+N K++ D L LPN +++N EPHPM+ID ++ S S +
Sbjct: 266 ELLKDPFLATENTKEINHDILELPNPHTKLVNPPTCEPHPMEIDSKSRRTSPGSSMGRIE 325
Query: 336 TGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAIS 395
+ +L R+TENN+F LRGEKN + T+SLTLRI + G NIHF FY+N+DTAIS
Sbjct: 326 ETSQVSFFDLVRMTENNKFMLRGEKNAESTISLTLRIANACGGARNIHFPFYINSDTAIS 385
Query: 396 IAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSI 455
IAEEMVE L+L++EDV IAELI+++I KLVP+ P +S + L + S Q N
Sbjct: 386 IAEEMVEHLELTNEDVSVIAELINDMIAKLVPNLKPLSEKLSSGTDQLYRPSSEVQ-NGE 444
Query: 456 SLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKS 515
C S++ + V + V S G QES SDIS E + V D+ K
Sbjct: 445 QFNCHWPLQSSDYDMKPVFKDLVHSWPVDGDDLEKQESVMSDISVECGITVASDS---KV 501
Query: 516 LVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSI 575
+ PD + +D G+ ++NS S I+SC KN SSI
Sbjct: 502 VEPDIFIFDEFWEGFDAFNSTSDVRFCGQEDGHKNQSENSSGSLINSCCCPFKNFDISSI 561
Query: 576 SSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKR 621
SL+LADK+ S+GL+LE++AI++ ++Q F+EL R +E+ ++R
Sbjct: 562 CSLTLADKDPSEGLRLEIEAIDTYFEQRFRELEMMRVAAIESLKRR 607
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470964|ref|XP_002266888.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 598 bits (1541), Expect = e-168, Method: Compositional matrix adjust.
Identities = 340/609 (55%), Positives = 415/609 (68%), Gaps = 31/609 (5%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F YK FDEVDGIE+AWNQV I+DV++SP+ LE+LYSEVHLLKSLKHENIIKFYNSWV
Sbjct: 32 AFKTVYKAFDEVDGIEIAWNQVKIDDVLRSPEDLEKLYSEVHLLKSLKHENIIKFYNSWV 91
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
DD +T+NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ+LRGL YLHSHNPPIIHRDL
Sbjct: 92 DDKKKTVNMITELFTSGSLRQYRKKHKNVDMKAIKNWARQVLRGLVYLHSHNPPIIHRDL 151
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 216
KCDNIFVNGN+GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM
Sbjct: 152 KCDNIFVNGNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 211
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
C+LEMVT EYPYNECKNPAQIYKKVTSGIKPASL KVTD Q+K+FI KC+ PAS RLPA
Sbjct: 212 CMLEMVTFEYPYNECKNPAQIYKKVTSGIKPASLCKVTDLQIKEFIVKCLAPASERLPAK 271
Query: 277 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNT 336
ELLKDPF ++NPK+ + PL+LP+ P+ + L+ S P MDID +H ++S+ + ++N
Sbjct: 272 ELLKDPFFQSENPKEPIRVPLQLPSRSPKSIILSKSGPFSMDIDPDHPQLSSSTSTENNG 331
Query: 337 GTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISI 396
F LE QR+ +++EF LR +K +D+++SLTLR D G V NIHF F L+ DT S+
Sbjct: 332 SPDFPVLEFQRMYKSSEFRLRAKKINDNSISLTLRTVDSYGPVKNIHFPFSLDTDTVHSV 391
Query: 397 AEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNP----SLGSTASQQNGLLKGSPVSQG 452
EMVEQL+L+ +V IA+ ID +IM+L+P W P LG S P G
Sbjct: 392 VGEMVEQLELAEHEVAFIADFIDYVIMRLLPGWKPPRDDPLGGARSPN-----AEPPVLG 446
Query: 453 NSISLKCPGEPGSNNA---FAEAVSQQGV-------LSELASGKYQYNQESSDSDISAEF 502
N + C G N+ A A Q + L+ AS K D +I +
Sbjct: 447 NGNNHDCTISHGDGNSSPNLANAEDQDSLASAGLVTLTVDASKKNDKTVGFGDYNIGGNY 506
Query: 503 DVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDS 562
H + D Y H ++++ + S+ E N+ +++ SF D
Sbjct: 507 KGSN--GGHASEQESRDPY--------HEDYKLQRNNSSIEEFTPMNKFQKSTVLSF-DD 555
Query: 563 CSGMSK-NLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKR 621
SG+S S SSLSLAD + GLK ELDAI+ +YQ FQEL R R + +E +KR
Sbjct: 556 LSGLSNVRSLTCSCSSLSLADIDQDPGLKQELDAIDLQYQHWFQELSRMRVEALEATKKR 615
Query: 622 WLAGSNVSV 630
W+ ++V
Sbjct: 616 WMTKKKLAV 624
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255564615|ref|XP_002523302.1| kinase, putative [Ricinus communis] gi|223537390|gb|EEF39018.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1526), Expect = e-166, Method: Compositional matrix adjust.
Identities = 342/645 (53%), Positives = 428/645 (66%), Gaps = 50/645 (7%)
Query: 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKF 91
V+ F YKGFDEVDGIEVAWNQV I DV++SP LE+L+SEVHLL+SLKHENI++
Sbjct: 46 VLGKGAFKTVYKGFDEVDGIEVAWNQVRIADVLRSPKDLEKLHSEVHLLRSLKHENIMEL 105
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
NSWVDD +TINMITELFTSG+LRQYRKKHKNVDMKAIKNWARQIL+GL YLH HNPPI
Sbjct: 106 CNSWVDDKKKTINMITELFTSGNLRQYRKKHKNVDMKAIKNWARQILQGLVYLHGHNPPI 165
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDI 211
IHRDLKCDNIFVNG+NG VKIGDLGLAI+MQQPTA SVIGTPEFMA ELYEEEYNEL+DI
Sbjct: 166 IHRDLKCDNIFVNGHNGVVKIGDLGLAIIMQQPTATSVIGTPEFMATELYEEEYNELIDI 225
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL 271
YSFGMC+LEMVT EYPY+EC+NPAQIYKKVTSGIKPASL V+DPQVK+FI KC+VPAS
Sbjct: 226 YSFGMCMLEMVTFEYPYSECRNPAQIYKKVTSGIKPASLGNVSDPQVKEFILKCLVPASE 285
Query: 272 RLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSC 331
RL A ELLKDPFL N + V DPL LPN P+ + S P MDID ++K++S+ +C
Sbjct: 286 RLSAKELLKDPFLQPQNLVEPVRDPLLLPNQYPKSSSATKSGPLSMDIDADYKQISSSTC 345
Query: 332 AKSNT-GTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNA 390
SN GT F E QR +N F L+G+++DD++VSLTLRI D SG V NIHF+FYL++
Sbjct: 346 TGSNNEGTRFPVPEYQREHKNKVFKLKGKESDDNSVSLTLRIADSSGRVWNIHFLFYLDS 405
Query: 391 DTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVS 450
DTA+S+A EMV+QL+L+ DV IAE ID+LIMKL P W S + ++ S
Sbjct: 406 DTALSVASEMVDQLELADHDVAFIAEFIDHLIMKLSPGWKLSSNYSLNELTSFYTASAAL 465
Query: 451 QGNSISLKCPGEPGSNNAFAEAVSQQGVLS---------ELASGKYQYNQ---------- 491
+ S+ CP + ++ +Q LS L + + YN
Sbjct: 466 EN---SVACPWDSVLTTVLSQPAVEQEALSGMTTTPPEGSLQADDFNYNDNRDGAVFHIN 522
Query: 492 ----------ESSDSDISAEFDVPVILDAHIDKSL--VPD-----------GYSAHYAVY 528
E DS S ++ V + D + +PD GY++ +
Sbjct: 523 YHSSPSFGYMEDQDSQTSGVSEILVEDVSSKDDRISELPDYNTDGNCKYLNGYTSEPELR 582
Query: 529 D-HGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKN--LSFSSISSLSLADKEH 585
D + +++ ++ +GE I NE+ + SET F SG + ++ SS SSL L K
Sbjct: 583 DSYSLRKLERNDSGVGECIPMNENAKVSETPF-PKLSGAPNDMSMTSSSSSSLYLVGKSM 641
Query: 586 SDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSV 630
LKLELDAI ++YQ F++L R+RE+ +E+ +KRW A + V
Sbjct: 642 DTELKLELDAIEAQYQNWFRDLSRRREEALESTKKRWTAKKKLPV 686
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 631 | ||||||
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.606 | 0.680 | 0.691 | 9.9e-154 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.614 | 0.684 | 0.623 | 5.2e-134 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.729 | 0.877 | 0.582 | 1.9e-131 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.606 | 0.687 | 0.632 | 8.4e-129 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.397 | 0.358 | 0.702 | 2.8e-119 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.385 | 0.470 | 0.713 | 2.1e-113 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.621 | 0.796 | 0.524 | 2.6e-109 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.421 | 0.484 | 0.638 | 3.1e-106 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.389 | 0.430 | 0.631 | 1.8e-97 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.396 | 0.796 | 0.594 | 1.1e-80 |
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1370 (487.3 bits), Expect = 9.9e-154, Sum P(3) = 9.9e-154
Identities = 269/389 (69%), Positives = 307/389 (78%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
F YK FDEVDGIEVAWN V+IEDVMQ P QLERLYSEVHLLK+LKHENIIK + SWVD
Sbjct: 40 FKTVYKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVD 99
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+ N+TINMITELFTSGSLR YRKKH+ VD KAIKNWARQIL+GL+YLHS NPP+IHRDLK
Sbjct: 100 EKNKTINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLK 159
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC 217
CDNIFVNGN GEVKIGDLGLA V+QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC
Sbjct: 160 CDNIFVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC 219
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALE 277
+LEMVTCEYPYNEC+N AQIYKKVTS IKP SL KV DPQV+QFIEKC++PAS R ALE
Sbjct: 220 MLEMVTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALE 279
Query: 278 LLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTG 337
L KDPFL D KD L + + + E PMD+D N K S + +
Sbjct: 280 LSKDPFLARDGGKDSAL--LASSSTSSKYVRPPQLEHLPMDVDHNENK----SVSSNEDY 333
Query: 338 TWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIA 397
W T+ELQR+ EN EF LRGE++DD T S+ LRI D SG +HF FYL +DTA +IA
Sbjct: 334 PWSQTIELQRIAENKEFRLRGERSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIA 393
Query: 398 EEMVEQLDLSHEDVVSIAELIDNLIMKLV 426
EEMVE+L L+ ++VV IA++ID+ IM+L+
Sbjct: 394 EEMVEELHLTSQEVVVIADMIDDFIMQLL 422
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1268 (451.4 bits), Expect = 5.2e-134, Sum P(2) = 5.2e-134
Identities = 252/404 (62%), Positives = 308/404 (76%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
F YK FDEVDGIEVAWNQV I+DV+QSP+ LERLYSEV LLKSLKH NII+FYNSW+D
Sbjct: 39 FKTVYKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWID 98
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
D N+T+N+ITELFTSGSLR YRKKH+ V+MKA+KNWARQIL GL YLH PPIIHRDLK
Sbjct: 99 DKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLK 158
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC 217
CDNIF+NGN+GEVKIGDLGLA VM+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC
Sbjct: 159 CDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMC 218
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALE 277
+LEMVT +YPY ECKN AQIYKKV+SGIKPASLS+V DP+VKQFIEKC++PAS RL A E
Sbjct: 219 MLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKE 278
Query: 278 LLKDPFLVTDNPKDLVCDPLRLPNLV-PE--------VMNLAHSEPHP---MDIDLNHKK 325
LL DPFL + + +PL LP++V P+ +M+ P + IDL+
Sbjct: 279 LLLDPFLQLNGLT--MNNPLPLPDIVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDS 336
Query: 326 VSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFV 385
N+G+ +E++R N F L+GE+ND+ +VSL LRI D++G V NIHF+
Sbjct: 337 NLPIVTFSDNSGS--RCIEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFL 394
Query: 386 FYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSW 429
FY DTA ++ EMVEQL+L+ ++V IAELID L++ ++P+W
Sbjct: 395 FYQEGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTW 438
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1289 (458.8 bits), Expect = 1.9e-131, P = 1.9e-131
Identities = 276/474 (58%), Positives = 322/474 (67%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
F YK FDEV+GIEVAWN ++IEDV+Q P QL+RLYSEVHLL SLKH+NIIK + SWVD
Sbjct: 27 FKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSEVHLLNSLKHDNIIKLFYSWVD 86
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
D N++INMITELFTSGSL YRKKH+ VD KAI NWARQIL+GLHYLHS PP+IHRDLK
Sbjct: 87 DHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLK 146
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC 217
CDNIFVNGN G+VKIGDLGLA VMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC
Sbjct: 147 CDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC 206
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALE 277
+LEMVTCEYPY EC+N AQIYKKVTSGIKP SLSKV DPQVKQFIEKC++PA R ALE
Sbjct: 207 MLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALE 266
Query: 278 LLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLN-HKKVSADSCAKSNT 336
LLKD L D KD P + E PMD++ + VS S AKS+
Sbjct: 267 LLKDQLLAVDGAKDSTLTASSNTTFKPAMP--PQCEYRPMDVEYKKNTSVSICSSAKSSQ 324
Query: 337 GTWFL-TLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAIS 395
L T+E+QR+ E+ EF L GE+ DD S+ LRI SG + F F L DTA +
Sbjct: 325 ECALLQTMEVQRVAESTEFKLSGERRDDVAASMALRIAGSSGQARKVDFDFNLKTDTARA 384
Query: 396 IAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSI 455
+ EMVE+LDLS +V IAE+ID LIMKL N SL + S + + S + I
Sbjct: 385 VTGEMVEELDLSSHEVTVIAEMIDELIMKLKA--NRSLPNANSVYQSKDEEAGESMKSEI 442
Query: 456 SL----KCPGEPGSN-NAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDV 504
S + GS EAV + +LS + + S+ D+ E +V
Sbjct: 443 SADYYHRVSSNEGSRLGCCCEAV--ESLLSSFLDSCSMVSNKQSE-DLKTELNV 493
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1264 (450.0 bits), Expect = 8.4e-129, P = 8.4e-129
Identities = 253/400 (63%), Positives = 314/400 (78%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+KGFDEVDGIEVAWNQV I+D++QSPD LERLYSEV LLKSLKH+NII+FYNSW+DD N+
Sbjct: 43 FKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNK 102
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
T+N+ITELFTSGSLRQYRKKH+ V+MKA+K WARQIL GL YLHS +PPIIHRD+KCDNI
Sbjct: 103 TVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNI 162
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 221
F+NGN+GEVKIGDLGLA VM+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
VT EYPY EC+N AQIYKKV+SGIKPASLSKV DP+V +FIEKC++PAS RL A ELL D
Sbjct: 223 VTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLD 282
Query: 282 PFLVTDNPKDLVCD-PLRLPNLV-PEVMNLAH----SEPHP------MDIDLNHKKVSAD 329
FL N LV + PL LP++V P+ + SE P M ++L+
Sbjct: 283 SFL---NVNGLVMNNPLPLPDIVMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDNNLPI 339
Query: 330 SCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLN 389
+ +N+GT +E++R N F L+GE+ND+++VSL LRI D++G V NIHF+F+
Sbjct: 340 VISSNNSGT--NCIEVRRAKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQE 397
Query: 390 ADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSW 429
DTA +++ EMVEQL+L+ ++V IAELID L++ L+P+W
Sbjct: 398 GDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNW 437
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 968 (345.8 bits), Expect = 2.8e-119, Sum P(3) = 2.8e-119
Identities = 177/252 (70%), Positives = 210/252 (83%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+ FDE +GIEVAWNQV + D +QSP+ LERLY E+HLLK+LKH+NI+KFY SWVD NR
Sbjct: 39 YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
IN +TELFTSG+LRQYR +HK V+++A+K+W RQILRGLHYLHSH+PP+IHRDLKCDNI
Sbjct: 99 NINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNI 158
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 221
FVNGN GEVKIGDLGLA ++++ A +GTPEFMAPE+YEE YNELVDIYSFGMCILEM
Sbjct: 159 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEM 218
Query: 222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
VT +YPY+EC +PAQIYKKV SG KP +L KV DP+VK FIEKC+ SLR+ A ELL D
Sbjct: 219 VTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDD 278
Query: 282 PFL-VTDNPKDL 292
PFL + D DL
Sbjct: 279 PFLRIDDGEFDL 290
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 951 (339.8 bits), Expect = 2.1e-113, Sum P(2) = 2.1e-113
Identities = 174/244 (71%), Positives = 209/244 (85%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+ FD+++GIEVAWNQV ++D S + L+RLYSEVHLLK+LKH++IIKFY SW+D +
Sbjct: 37 YRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHM 96
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
TIN+ITE+FTSG+LRQYRKKHK VD++A+K W+RQIL GL YLHSH+PP+IHRDLKCDNI
Sbjct: 97 TINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNI 156
Query: 162 FVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 220
F+NGN GEVKIGDLGLA ++ + +A SVIGTPEFMAPELYEE+YN LVDIY+FGMC+LE
Sbjct: 157 FINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLE 216
Query: 221 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 280
+VT EYPY+EC N AQIY+KVTSGIKPA+L VTDPQV+ FIEKCI S RL A ELL
Sbjct: 217 LVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLD 276
Query: 281 DPFL 284
DPFL
Sbjct: 277 DPFL 280
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1080 (385.2 bits), Expect = 2.6e-109, P = 2.6e-109
Identities = 221/421 (52%), Positives = 286/421 (67%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+GFDE GIEVAWNQV + D +QSP +LERLY E+HLLK+LKH++I+KFY SWVD NR
Sbjct: 40 YRGFDEYQGIEVAWNQVKLYDFLQSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNR 99
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
IN +TE+FTSG+LRQYR KHK V+++A+KNW RQILRGL+YLH+H+PP+IHRDLKCDNI
Sbjct: 100 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNI 159
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 221
F+NGN GEVKIGDLGLA +Q A +GTPEFMAPE+Y+EEYN+LVDIYSFGMC+LEM
Sbjct: 160 FINGNQGEVKIGDLGLAACLQHSHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEM 219
Query: 222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
VT +YPY+EC +PAQIYK+V SG KP L KV DP+V+ FIEKC+ SLRL A ELL D
Sbjct: 220 VTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDD 279
Query: 282 PFLVTD--------NPKDLVCD---PLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADS 330
FL D + K L+ + PLR +P N +S + D N D
Sbjct: 280 HFLCIDESDMRRVESEKGLIDEAGTPLRHSYHIPHYSNGYYSLYNQNQWDYN-----GDE 334
Query: 331 CAKSNTGTWFLTLELQRLTENNE---------FTLRGEKNDD-DTVSLTLRIGDKSGHVS 380
+S+ LE Q + E +++G++ D+ D + L L+ +K G V
Sbjct: 335 TVESHE---IDLLEFQNDDDEEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVR 391
Query: 381 NIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQ 440
NI+F F + DTAIS+A EMVE+L++ DV IA +ID I LVP+W+ S +++
Sbjct: 392 NIYFPFDIETDTAISVAREMVEELEMDDRDVTKIANMIDGEIASLVPNWSIFCSSESNRS 451
Query: 441 N 441
+
Sbjct: 452 S 452
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 913 (326.5 bits), Expect = 3.1e-106, Sum P(2) = 3.1e-106
Identities = 173/271 (63%), Positives = 214/271 (78%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK FD+V G+EVAWNQV + +V +SP+ L+RLYSEVHLLK+L HE+II++ SW+D R
Sbjct: 40 YKAFDQVLGMEVAWNQVKLNEVFRSPEPLQRLYSEVHLLKNLNHESIIRYCTSWIDVNRR 99
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
T N ITELFTSG+LR+YR+K++ VD++AIK+WARQIL GL YLH H+PP+IHRDLKCDNI
Sbjct: 100 TFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNI 159
Query: 162 FVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 220
FVNG+ G+VKIGDLGLA +++ A SVIGTPEFMAPELYEE+YNELVDIYSFGMC+LE
Sbjct: 160 FVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLE 219
Query: 221 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 280
M+T EYPY+EC NPAQIYKKVTSG P S + + ++F+ KC+ S RLPA ELL
Sbjct: 220 MLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLA 279
Query: 281 DPFLVTDNPKDLVCDPL-RLPNLVPEVMNLA 310
DPFL + +DL PL RLP + + NLA
Sbjct: 280 DPFLAATDERDLA--PLFRLPQQLA-IQNLA 307
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 857 (306.7 bits), Expect = 1.8e-97, Sum P(2) = 1.8e-97
Identities = 156/247 (63%), Positives = 200/247 (80%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK DE GIEVAW+QV +++V++S L+RLYSEVHLL +L H++II+FY SW+D N
Sbjct: 34 YKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYSEVHLLSTLNHKSIIRFYTSWIDVHNH 93
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
T+N ITELFTSG+LRQY+ K+ +D++AIK+WARQIL GL YLH H+PP+IHRDLKCDNI
Sbjct: 94 TLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLVYLHEHDPPVIHRDLKCDNI 153
Query: 162 FVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 220
FVNG+ G+VKIGDLGLA +++ +A S+IGTPEFMAPELYEE YNEL+D+YSFGMC LE
Sbjct: 154 FVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELYEENYNELIDVYSFGMCFLE 213
Query: 221 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 280
M+T E+PY+EC +PAQIYKKV G P + +V D + ++FI KC+V AS R+ A ELL+
Sbjct: 214 MITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRFIGKCLVSASKRVSAKELLQ 273
Query: 281 DPFLVTD 287
DPFL +D
Sbjct: 274 DPFLASD 280
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 810 (290.2 bits), Expect = 1.1e-80, P = 1.1e-80
Identities = 151/254 (59%), Positives = 193/254 (75%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+ FD+ +GIEVAWNQV + P ERLYSEV LLK+LK+ NII Y W D+ N
Sbjct: 46 YRAFDQEEGIEVAWNQVKLRCFSDDPAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNN 105
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
T+N ITE+ TSG+LR+YRKKH++V M+A+K W++QIL+GL YLH+H+P IIHRDL C NI
Sbjct: 106 TLNFITEICTSGNLREYRKKHRHVSMRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNI 165
Query: 162 FVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 220
FVNGN G+VKIGDLGLA IV + A S++GTPEFMAPELYEE Y E+VDIYS+GMC+LE
Sbjct: 166 FVNGNIGQVKIGDLGLAAIVGKNHLAHSILGTPEFMAPELYEENYTEMVDIYSYGMCVLE 225
Query: 221 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 280
+V+ E PY+EC + A+IYK+V+ G+KP +L+KV DP+ K FIEKCI R A ELL
Sbjct: 226 LVSLEIPYSECDSVAKIYKRVSKGLKPEALNKVNDPEAKAFIEKCIAQPRARPSAAELLC 285
Query: 281 DPF---LVTDNPKD 291
DPF ++ D+ +D
Sbjct: 286 DPFFDGILDDDDED 299
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6EU49 | WNK4_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5008 | 0.9270 | 0.9558 | yes | no |
| Q944Q0 | WNK8_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5385 | 0.8193 | 0.9182 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 631 | |||
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-64 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-63 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-51 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-49 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-48 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-38 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-37 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-35 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-35 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-33 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-32 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-31 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-29 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-29 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-27 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-26 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-25 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-24 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-24 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-17 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 4e-64
Identities = 90/249 (36%), Positives = 131/249 (52%), Gaps = 11/249 (4%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y D+ G +A V + S ++LE L E+ +L SL+H NI+++Y S D+
Sbjct: 17 YLALDKDTGELMAVKSVELSG--DSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
T+N+ E + GSL KK + I+ + RQIL GL YLHS+ I+HRD+K NI
Sbjct: 75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANI 132
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGM 216
V ++G VK+ D G A + SV GTP +MAPE+ EEY DI+S G
Sbjct: 133 LV-DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGC 191
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 275
++EM T + P++E NP K+ S +P + + + K F+ KC+ R A
Sbjct: 192 TVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTA 251
Query: 276 LELLKDPFL 284
ELL+ PFL
Sbjct: 252 DELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 209 bits (535), Expect = 2e-63
Identities = 81/248 (32%), Positives = 124/248 (50%), Gaps = 14/248 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y D+ G VA + + + ER+ E+ +LK LKH NI++ Y+ + D+
Sbjct: 16 YLARDKKTGKLVAIKVIKKKKI---KKDRERILREIKILKKLKHPNIVRLYDVFEDEDK- 71
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ ++ E G L KK + + + RQIL L YLHS I+HRDLK +NI
Sbjct: 72 -LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG--IVHRDLKPENI 128
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 219
++ +G VK+ D GLA + + +GTPE+MAPE L + Y + VDI+S G IL
Sbjct: 129 LLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLG-VIL 186
Query: 220 -EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCIVP-ASLRLPAL 276
E++T + P+ +++KK+ P + P+ K I K +V RL A
Sbjct: 187 YELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAE 246
Query: 277 ELLKDPFL 284
E L+ PF
Sbjct: 247 EALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 3e-56
Identities = 74/252 (29%), Positives = 121/252 (48%), Gaps = 16/252 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK + G VA + + + + E+ +L+ L H NI++ +++ D +
Sbjct: 16 YKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH- 72
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ ++ E G L Y + + K A QILRGL YLHS+ IIHRDLK +NI
Sbjct: 73 -LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPENI 129
Query: 162 FVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMC 217
++ NG VKI D GLA + + + +GTP +MAPE L Y VD++S G+
Sbjct: 130 LLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVI 188
Query: 218 ILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASLSKVTD--PQVKQFIEKCIVP-ASLR 272
+ E++T + P++ Q+ ++ K + + K I+KC+ S R
Sbjct: 189 LYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKR 248
Query: 273 LPALELLKDPFL 284
A E+L+ P+
Sbjct: 249 PTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 3e-51
Identities = 73/247 (29%), Positives = 115/247 (46%), Gaps = 47/247 (19%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y D+ G +VA + ED S LE L E+ +LK L H NI+K Y + D+ +
Sbjct: 10 YLARDKKTGKKVAIKIIKKED---SSSLLEELLREIEILKKLNHPNIVKLYGVFEDENH- 65
Query: 102 TINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ ++ E GSL+ ++ + I QIL GL YLHS+ IIHRDLK +N
Sbjct: 66 -LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPEN 122
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGM 216
I ++ +NG+VK+ D GL+ ++ ++++GTP +MAPE+ Y+E DI+S G+
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGV 182
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 275
+ E+ P++K I K + R A
Sbjct: 183 ILYEL----------------------------------PELKDLIRKMLQKDPEKRPSA 208
Query: 276 LELLKDP 282
E+L+
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 8e-49
Identities = 89/256 (34%), Positives = 140/256 (54%), Gaps = 17/256 (6%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLKHENIIKFYNSW 95
+F Y+G + DG A +V++ D Q+ + +++L E+ LL L+H NI+++ +
Sbjct: 12 SFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71
Query: 96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
++ N + + EL GSL + KK+ + I+ + RQIL GL YLH N +HRD
Sbjct: 72 REEDN--LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRD 127
Query: 156 LKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIY 212
+K NI V+ NG VK+ D G+A V++ A+S G+P +MAPE+ + Y DI+
Sbjct: 128 IKGANILVD-TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIW 186
Query: 213 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIEKCI-VP 268
S G +LEM T + P+++ + A ++K S P LS + K FI KC+
Sbjct: 187 SLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS----DEAKDFILKCLQRD 242
Query: 269 ASLRLPALELLKDPFL 284
SLR A ELL+ PF+
Sbjct: 243 PSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 5e-48
Identities = 85/258 (32%), Positives = 134/258 (51%), Gaps = 23/258 (8%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK D G EVA ++ + E + +E+ ++K KH NI+ +Y+S++
Sbjct: 36 YKATDRATGKEVAIKKMRLRK-----QNKELIINEILIMKDCKHPNIVDYYDSYLVG--D 88
Query: 102 TINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+ ++ E GSL Q + + + R++L+GL YLHS N +IHRD+K
Sbjct: 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV---CREVLQGLEYLHSQN--VIHRDIK 143
Query: 158 CDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 214
DNI ++ +G VK+ D G A + ++ SV+GTP +MAPE+ + ++Y VDI+S
Sbjct: 144 SDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL 202
Query: 215 GMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLR 272
G+ +EM E PY + P + ++ T GI P + P+ K F+ KC+V R
Sbjct: 203 GIMCIEMAEGEPPYLR-EPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKR 261
Query: 273 LPALELLKDPFLVTDNPK 290
A ELL+ PFL PK
Sbjct: 262 PSAEELLQHPFLKKACPK 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 6e-46
Identities = 72/244 (29%), Positives = 126/244 (51%), Gaps = 17/244 (6%)
Query: 49 DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108
DG ++++ + S + E +EV +LK L H NIIK+Y S+ + + ++ E
Sbjct: 24 DGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGK--LCIVME 79
Query: 109 LFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164
G L Q KK K + I +W Q+ L YLHS I+HRD+K NIF+
Sbjct: 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT 137
Query: 165 GNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEM 221
+NG VK+GD G++ V+ A++V+GTP +++PEL + + YN DI+S G + E+
Sbjct: 138 -SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYEL 196
Query: 222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
T ++P+ E +N ++ K+ G + + +++ + + R ++L+
Sbjct: 197 CTLKHPF-EGENLLELALKILKG-QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
Query: 281 DPFL 284
PF+
Sbjct: 255 SPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 82/247 (33%), Positives = 136/247 (55%), Gaps = 15/247 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK + G EVA + +E S ++ E++ +E+ +LK KH NI+K+Y S++
Sbjct: 17 YKARHKRTGKEVAIKVIKLE----SKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL 72
Query: 102 TINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
I M E + GSL+ + ++ + I +++L+GL YLHS+ IIHRD+K N
Sbjct: 73 WIVM--EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAAN 128
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 218
I + ++GEVK+ D GL+ + AR +++GTP +MAPE + + Y+ DI+S G+
Sbjct: 129 ILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITA 187
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIVPA-SLRLPAL 276
+E+ + PY+E ++K T+G + K +D K F++KC+ R A
Sbjct: 188 IELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDE-FKDFLKKCLQKNPEKRPTAE 246
Query: 277 ELLKDPF 283
+LLK PF
Sbjct: 247 QLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 84/251 (33%), Positives = 134/251 (53%), Gaps = 13/251 (5%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
F YKG + G VA Q+++E + + L+ + E+ LLK+LKH NI+K+ S
Sbjct: 13 FGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSI-- 68
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+T+ ++ +I E +GSLRQ KK + + Q+L+GL YLH +IHRD+K
Sbjct: 69 ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIK 126
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYEEE-YNELVDIYSF 214
NI +G VK+ D G+A + SV+GTP +MAPE+ E + DI+S
Sbjct: 127 AANILTTK-DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSL 185
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRL 273
G ++E++T PY + A +++ V P L + P++K F+ +C +LR
Sbjct: 186 GCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQKDPNLRP 243
Query: 274 PALELLKDPFL 284
A +LLK P++
Sbjct: 244 TAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 86/258 (33%), Positives = 136/258 (52%), Gaps = 25/258 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y + G +A ++ I+D P ++ + E+ +L+ LKH N++K+Y V
Sbjct: 17 YTAVNLDTGELMAVKEIRIQD--NDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV 74
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
I M E + G+L + + + +D I+ + Q+L GL YLHSH I+HRD+K NI
Sbjct: 75 YIFM--EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANI 130
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTAR------SVIGTPEFMAPELY----EEEYNELVDI 211
F+ +NG +K+GD G A+ ++ T S+ GTP +MAPE+ + + DI
Sbjct: 131 FL-DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADI 189
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIEKCIV- 267
+S G +LEM T + P++E N QI V +G KP SL P+ K F+++C+
Sbjct: 190 WSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL--SPEGKDFLDRCLES 247
Query: 268 -PASLRLPALELLKDPFL 284
P R A ELL+ PF+
Sbjct: 248 DP-KKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 74/247 (29%), Positives = 135/247 (54%), Gaps = 16/247 (6%)
Query: 49 DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108
DG + W +++ + M ++ ++L SEV++L+ LKH NI+++Y+ +D +N+T+ ++ E
Sbjct: 24 DGKILVWKEIDYGN-MTEKEK-QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81
Query: 109 LFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP---IIHRDLKCDNI 161
G L ++ +K+ K ++ + I Q+L L+ H+ + P ++HRDLK NI
Sbjct: 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANI 141
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 218
F++ NN VK+GD GLA ++ + A++ +GTP +M+PE L Y+E DI+S G I
Sbjct: 142 FLDANN-NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLI 200
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALE 277
E+ P+ +N Q+ K+ G + ++ + I+ + V R E
Sbjct: 201 YELCALSPPF-TARNQLQLASKIKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258
Query: 278 LLKDPFL 284
LL+ P +
Sbjct: 259 LLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 7e-38
Identities = 83/250 (33%), Positives = 130/250 (52%), Gaps = 14/250 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
Y +D G E+A QV + D ++ ++ L E+ LLK+L+HE I+++Y DD
Sbjct: 19 YLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET 78
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+I M E GS++ K + + + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 79 LSIFM--EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGAN 134
Query: 161 IFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 214
I + + G VK+GD G + I +SV GTP +M+PE+ E Y D++S
Sbjct: 135 I-LRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSV 193
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP 274
G ++EM+T + P+ E + A I+K T P S V P + F+ + V + + P
Sbjct: 194 GCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARNFLRRTFVENAKKRP 252
Query: 275 -ALELLKDPF 283
A ELL+ F
Sbjct: 253 SAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 70/250 (28%), Positives = 127/250 (50%), Gaps = 15/250 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK + G A +++++ + ++L E+ L+S + ++K Y ++
Sbjct: 18 YKVRHKPTGKIYALKKIHVDG---DEEFRKQLLRELKTLRSCESPYVVKCYGAF--YKEG 72
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDN 160
I+++ E GSL KK + + ARQIL+GL YLH+ + IIHRD+K N
Sbjct: 73 EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSN 130
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 217
+ +N + GEVKI D G++ V++ + +GT +M+PE + E Y+ DI+S G+
Sbjct: 131 LLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189
Query: 218 ILEMVTCEYPY--NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+LE ++P+ + ++ + + G P+ ++ P+ + FI C+ R
Sbjct: 190 LLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPS 249
Query: 275 ALELLKDPFL 284
A ELL+ PF+
Sbjct: 250 AAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 73/235 (31%), Positives = 122/235 (51%), Gaps = 14/235 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK +DG VA +V I ++M + E+ LLK L H N+IK+ S+++ N
Sbjct: 19 YKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NN 75
Query: 102 TINMITELFTSGSLRQ----YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+N++ EL +G L + ++K+ + + + I + Q+ L ++HS I+HRD+K
Sbjct: 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIK 133
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSF 214
N+F+ G VK+GDLGL T A S++GTP +M+PE ++E YN DI+S
Sbjct: 134 PANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192
Query: 215 GMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268
G + EM + P Y + N + KK+ P + +++ + +CI P
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 79/266 (29%), Positives = 127/266 (47%), Gaps = 30/266 (11%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK D+ VA +++E+ + D++E + E+ L + I K+Y S++ +
Sbjct: 18 YKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL 74
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
I M E GS K K +D I R++L GL YLH IHRD+K NI
Sbjct: 75 WIIM--EYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEGK--IHRDIKAANI 129
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 218
++ G+VK+ D G++ + ++ + +GTP +MAPE+ + Y+E DI+S G+
Sbjct: 130 LLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITA 188
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGI---KPASL--SKVTDPQVKQFIEKCIV--PASL 271
+E+ E P ++ +P +V I P SL +K + P K F+ C+ P
Sbjct: 189 IELAKGEPPLSD-LHPM----RVLFLIPKNNPPSLEGNKFSKP-FKDFVSLCLNKDPKE- 241
Query: 272 RLPALELLKDPFL----VTDNPKDLV 293
R A ELLK F+ T L+
Sbjct: 242 RPSAKELLKHKFIKKAKKTSYLTLLI 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 8e-35
Identities = 83/250 (33%), Positives = 133/250 (53%), Gaps = 11/250 (4%)
Query: 42 YKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
Y +D G E+A QV + + ++ ++ L E+ LLK+L HE I+++Y D
Sbjct: 19 YLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
RT+++ E GS++ K + + + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGAN 136
Query: 161 IFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 214
I + + G VK+GD G + I + +SV GTP +M+PE+ E Y DI+S
Sbjct: 137 ILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSV 195
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP 274
G ++EM+T + P+ E + A I+K T P V+D + F+++ V A LR
Sbjct: 196 GCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRDFLKRIFVEAKLRPS 254
Query: 275 ALELLKDPFL 284
A ELL+ F+
Sbjct: 255 ADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 1e-34
Identities = 82/249 (32%), Positives = 131/249 (52%), Gaps = 11/249 (4%)
Query: 42 YKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
Y +D G E+A QV + + ++ ++ L E+ LLK+L+HE I+++Y D
Sbjct: 19 YLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+T+ + E GS++ K + + + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGAN 136
Query: 161 IFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 214
I + + G VK+GD G + I M RSV GTP +M+PE+ E Y D++S
Sbjct: 137 ILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSL 195
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP 274
G ++EM+T + P+ E + A I+K T P S +++ + F+ V A R
Sbjct: 196 GCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARDFLGCIFVEARHRPS 254
Query: 275 ALELLKDPF 283
A ELL+ PF
Sbjct: 255 AEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 9e-34
Identities = 74/249 (29%), Positives = 136/249 (54%), Gaps = 15/249 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+K + D A Q+++ M ++ E + E +L L II++Y S++D
Sbjct: 17 FKVVRKADKRVYAMKQIDLSK-MNRREREEAI-DEARVLAKLDSSYIIRYYESFLDK--G 72
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR--QILRGLHYLHSHNPPIIHRDLKCD 159
+N++ E +G L + K + + + W QIL GL +LHS I+HRD+K
Sbjct: 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSL 130
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGM 216
N+F++ + VKIGDLG+A ++ T A +++GTP +++PEL E++ YNE D+++ G+
Sbjct: 131 NLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGV 189
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-A 275
+ E T ++P+ + N + K+ G+ P +S++ Q+ Q I++C+ + P
Sbjct: 190 VLYECCTGKHPF-DANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQCLTKDYRQRPDT 247
Query: 276 LELLKDPFL 284
+LL++P L
Sbjct: 248 FQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 18/215 (8%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ KG E +VA + S ++ E E ++K L H NI++
Sbjct: 16 YKGTLKGDGEGTETKVAVKTLKEGA---SEEEREEFLEEASIMKKLSHPNIVRLLGVCTQ 72
Query: 98 DTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
+ ++TE G L + +KH + +K + A QI +G+ YL S N +HRDL
Sbjct: 73 G--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN--FVHRDL 128
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF-----MAPELYEE-EYNELVD 210
N V N VKI D GL+ + MAPE ++ ++ D
Sbjct: 129 AARNCLV-TENLVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSD 186
Query: 211 IYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
++SFG+ + E+ T E PY N ++ + + G
Sbjct: 187 VWSFGVLLWEIFTLGEQPYPGMSN-EEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 16/234 (6%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ + KG +EVA V S Q+E E +++ L H N++K +
Sbjct: 16 YKGKLKGKGGKKKVEVA---VKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE 72
Query: 98 DTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
+ + ++ E G L Y RK + + + ++A QI RG+ YL S N IHRDL
Sbjct: 73 EEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN--FIHRDL 128
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE---FMAPE-LYEEEYNELVDIY 212
N V G N VKI D GL+ + G +MAPE L E ++ D++
Sbjct: 129 AARNCLV-GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVW 187
Query: 213 SFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
SFG+ + E+ T E PY N ++ + + +G + + + +C
Sbjct: 188 SFGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYRLPQPPNCPPE-LYDLMLQC 239
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 87/273 (31%), Positives = 141/273 (51%), Gaps = 22/273 (8%)
Query: 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQ-----LERLYSEVHLLK 81
WI ++ + +F Y G + G +A QV + V S L+ L E+ LLK
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 82 SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGL 141
L+HENI+++ S +D + +N+ E GS+ + + ++N+ RQIL+GL
Sbjct: 62 ELQHENIVQYLGSSLDADH--LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGL 119
Query: 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTAR-SVIGTP 193
+YLH+ IIHRD+K NI V+ N G +KI D G++ + + AR S+ G+
Sbjct: 120 NYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 194 EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
+MAPE+ ++ Y DI+S G ++EM+T ++P+ +C I+ K+ P S
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASPEIPSN 235
Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
++ + F+EK + R A ELLK PFL
Sbjct: 236 ISS-EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 6e-33
Identities = 79/249 (31%), Positives = 131/249 (52%), Gaps = 11/249 (4%)
Query: 42 YKGFDEVDGIEVAWNQVNIE-DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
Y +D G E+A QV + D ++ ++ L E+ LLK+L+H+ I+++Y D
Sbjct: 19 YLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ +++ E GS++ K + + + + RQIL+G+ YLHS+ I+HRD+K N
Sbjct: 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGAN 136
Query: 161 IFVNGNNGEVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 214
I + + G VK+GD G + I M +SV GTP +M+PE+ E Y D++S
Sbjct: 137 ILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSV 195
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP 274
++EM+T + P+ E + A I+K T KP V+D + F+++ V R
Sbjct: 196 ACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRDFLKQIFVEEKRRPT 254
Query: 275 ALELLKDPF 283
A LL+ PF
Sbjct: 255 AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 17/235 (7%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ KG + +EVA V S Q+E E +++ L H NI+K +
Sbjct: 16 YKGTLKGKGDGKEVEVA---VKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE 72
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK--NWARQILRGLHYLHSHNPPIIHRD 155
+ + ++ E G L Y +K++ ++ ++A QI RG+ YL S N IHRD
Sbjct: 73 EEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRD 128
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE---FMAPE-LYEEEYNELVDI 211
L N V G N VKI D GL+ + V G +MAPE L E ++ D+
Sbjct: 129 LAARNCLV-GENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDV 187
Query: 212 YSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
+SFG+ + E+ T E PY N A++ + + G + + + + +C
Sbjct: 188 WSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLKKGYRLPKPPNCPPE-LYKLMLQC 240
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 7e-32
Identities = 81/253 (32%), Positives = 128/253 (50%), Gaps = 26/253 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK + G VA V +E+ +Q + E+ +LK I+K+Y S+ +T+
Sbjct: 20 YKAIHKETGQVVAIKVVPVEEDLQE------IIKEISILKQCDSPYIVKYYGSYFKNTDL 73
Query: 102 TINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
I M E +GS+ K +K + + I Q L+GL YLHS+ IHRD+K N
Sbjct: 74 WIVM--EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGN 129
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE-YNELVDIYSFGMC 217
I +N G+ K+ D G++ + A+ +VIGTP +MAPE+ +E YN DI+S G+
Sbjct: 130 ILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGIT 188
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASLSKVTD--PQVKQFIEKCIV-PASL 271
+EM + PY++ I+ I P +LS P+ F++KC+V
Sbjct: 189 AIEMAEGKPPYSDIHPMRAIFM-----IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEE 243
Query: 272 RLPALELLKDPFL 284
R A++LL+ PF+
Sbjct: 244 RPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 73/250 (29%), Positives = 120/250 (48%), Gaps = 29/250 (11%)
Query: 52 EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT 111
+VA ++++E + ++ L EV + H N++K+Y S+V + M +
Sbjct: 28 KVAIKRIDLE---KCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM--PYLS 82
Query: 112 SGSLR---QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168
GSL + +D I +++L+GL YLHS+ IHRD+K NI + G +G
Sbjct: 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILL-GEDG 139
Query: 169 EVKIGDLGLAIVMQQPTARS------VIGTPEFMAPELYEEE--YNELVDIYSFGMCILE 220
VKI D G++ + R+ +GTP +MAPE+ E+ Y+ DI+SFG+ +E
Sbjct: 140 SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIE 199
Query: 221 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV-----KQFIEKCIV--PASLRL 273
+ T PY++ P ++ P SL D + ++ I C+ P+ R
Sbjct: 200 LATGAAPYSKYP-PMKVLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSK-RP 256
Query: 274 PALELLKDPF 283
A ELLK F
Sbjct: 257 TAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 76/234 (32%), Positives = 127/234 (54%), Gaps = 20/234 (8%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSW-VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA 129
E L++EV +++ +H NI++ Y+S+ V D + ++ E G+L H ++ +
Sbjct: 61 ELLFNEVVIMRDYQHPNIVEMYSSYLVGDE---LWVVMEFLEGGALTDI-VTHTRMNEEQ 116
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 187
I +L+ L +LH+ +IHRD+K D+I + ++G VK+ D G + + P +
Sbjct: 117 IATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRK 173
Query: 188 SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGI 245
S++GTP +MAPE+ Y VDI+S G+ ++EMV E PY NE P Q K++ +
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE--PPLQAMKRIRDNL 231
Query: 246 KPAS--LSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 295
P L KV+ P+++ F+++ +V PA R A ELL PFL P +
Sbjct: 232 PPKLKNLHKVS-PRLRSFLDRMLVRDPAQ-RATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-31
Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 20/232 (8%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
E+V+++ L E+ L+ L H +II+ + +D++ N+ E GS+
Sbjct: 44 EEVVEA------LRKEIRLMARLNHPHIIRMLGATCEDSH--FNLFVEWMAGGSVSHLLS 95
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
K+ I N+ Q+LRGL YLH + IIHRD+K N+ ++ ++I D G A
Sbjct: 96 KYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153
Query: 181 MQQPTARS------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYN--EC 231
+ + ++GT FMAPE L E+Y D++S G I+EM T + P+N +
Sbjct: 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213
Query: 232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDP 282
N + K+ S S+ + P ++ +C+ + R P+ ELLK P
Sbjct: 214 SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 79/251 (31%), Positives = 123/251 (49%), Gaps = 19/251 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--EVHLLKSLKHENIIKFYNSWVDDT 99
YK D A +V++ S Q ER + E+ +L S+ H NII + +++D
Sbjct: 17 YKVKRLSDNQFYALKEVDL----GSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN 72
Query: 100 NRTINMITELFTSGSLRQY---RKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
I M E G L + RKK + + + I Q+LRGL LH I+HRD
Sbjct: 73 KLCIVM--EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRD 128
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSF 214
LK NI + N VKIGDLG++ V+++ A++ IGTP +MAPE+++ Y+ DI+S
Sbjct: 129 LKSANILLV-ANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSL 187
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRL 273
G + EM T P+ E ++ + KV G P + + ++ FI + LR
Sbjct: 188 GCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPP-IPPIYSQDLQNFIRSMLQVKPKLRP 245
Query: 274 PALELLKDPFL 284
++L P +
Sbjct: 246 NCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 89/270 (32%), Positives = 129/270 (47%), Gaps = 31/270 (11%)
Query: 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
VV+ T+ Y D + +A ++ D + L+ E+ L LKH NI++
Sbjct: 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV----QPLHEEIALHSYLKHRNIVQ 69
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMK--AIKNWARQILRGLHYLHSH 147
+ S D N + E GSL R K + I + +QIL GL YLH +
Sbjct: 70 YLGS--DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLG----LAIVMQQPTARSVIGTPEFMAPELYEE 203
I+HRD+K DN+ VN +G VKI D G LA + P + GT ++MAPE+ ++
Sbjct: 128 Q--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDK 183
Query: 204 ---EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYK----KVTSGIKPASLSKVTD 255
Y DI+S G I+EM T + P+ E P A ++K K+ I P SLS
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI-PESLSA--- 239
Query: 256 PQVKQFIEKCIVPASLRLP-ALELLKDPFL 284
+ K FI +C P + A +LL+DPFL
Sbjct: 240 -EAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 1e-30
Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 11/203 (5%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
++E +E ++L + H I+K + ++ + + ++ E G L + K
Sbjct: 35 KEVEHTLTERNILSRINHPFIVKLHYAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSE 92
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPT 185
+ + +A +I+ L YLHS II+RDLK +NI ++ +G +K+ D GLA + +
Sbjct: 93 ERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSR 149
Query: 186 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
+ GTPE++APE L + Y + VD +S G+ + EM+T + P+ ++ +IY+K+
Sbjct: 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK- 207
Query: 245 IKPASLSKVTDPQVKQFIEKCIV 267
P + P+ + I +
Sbjct: 208 -DPLRFPEFLSPEARDLISGLLQ 229
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 89/284 (31%), Positives = 127/284 (44%), Gaps = 58/284 (20%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----EVHLLKSLKHENIIKFYNSWVD 97
YK D+ G VA ++ +++ + E + S E+ LLK LKH NI+K + V
Sbjct: 16 YKARDKKTGEIVALKKIRLDN------EEEGIPSTALREISLLKELKHPNIVKLLD--VI 67
Query: 98 DTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
T R + ++ E + L++Y K+ + IK+ Q+LRGL Y HSH I+HRDL
Sbjct: 68 HTERKLYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDL 124
Query: 157 KCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPELY--EEEYNELVD 210
K NI +N +G +K+ D GLA I ++ T V T + APE+ + Y+ VD
Sbjct: 125 KPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSKHYSTAVD 181
Query: 211 IYSFGMCILEMVT--------CE------------YPYNE-----CKNPAQIYKKVTSGI 245
I+S G EM+T E P E K P YK
Sbjct: 182 IWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD--YKPTFPKF 239
Query: 246 KPASLSKVT---DPQVKQFIEK--CIVPASLRLPALELLKDPFL 284
P L KV DP+ + K PA R+ A E LK P+
Sbjct: 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAK-RISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 81/254 (31%), Positives = 121/254 (47%), Gaps = 24/254 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLKH---ENIIKFYNSWVD 97
Y+G G VA +N++ +P D + + EV LL L+ NI K+Y S++
Sbjct: 18 YRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK 73
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
I M E GS+R K + K I R++L L Y+H +IHRD+K
Sbjct: 74 GPRLWIIM--EYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALKYIHKV--GVIHRDIK 128
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEE--EYNELVDIYS 213
NI V N G VK+ D G+A ++ Q +++ + +GTP +MAPE+ E Y+ DI+S
Sbjct: 129 AANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWS 187
Query: 214 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-KVTDPQVKQFIEKCI--VPAS 270
G+ I EM T PY A + KP L +++F+ C+ P
Sbjct: 188 LGITIYEMATGNPPY--SDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKE 245
Query: 271 LRLPALELLKDPFL 284
RL A ELLK ++
Sbjct: 246 -RLSAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 1e-29
Identities = 74/338 (21%), Positives = 123/338 (36%), Gaps = 34/338 (10%)
Query: 62 DVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
+ ++ER E+ +L SL H NI+K Y+ + D+ + + M E GSL K
Sbjct: 33 KLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM--EYVDGGSLEDLLK 90
Query: 121 KH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177
K + QIL L YLHS IIHRD+K +NI ++ + VK+ D GL
Sbjct: 91 KIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGL 148
Query: 178 AIVM--------QQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCE 225
A ++ + +GTP +MAPE+ + DI+S G+ + E++T
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
Query: 226 YPY---NECKNPAQIYKKVTSGIKPASLSKV-------TDPQVKQFIEKCIVP-ASLRLP 274
P+ +Q K + P+ S + ++K + RL
Sbjct: 209 PPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
Query: 275 ALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKS 334
+ L L L L + L S P ++ ++ A S +
Sbjct: 269 SSSDLSHDLL---AHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDL 325
Query: 335 NTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRI 372
+ EL ++ S +
Sbjct: 326 KLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSSL 363
|
Length = 384 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 75/253 (29%), Positives = 119/253 (47%), Gaps = 21/253 (8%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK D G VA + +E D E + E+ +LK +H NI+ ++ S++
Sbjct: 20 YKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKL 75
Query: 102 TINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
I M E GSL+ Y+ + I R+ L+GL YLH IHRD+K N
Sbjct: 76 WIVM--EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGAN 131
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE----YNELVDIYSF 214
I + +G+VK+ D G++ + A+ S IGTP +MAPE+ E Y+ DI++
Sbjct: 132 ILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWAL 190
Query: 215 GMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVT--DPQVKQFIEKCIVPASL 271
G+ +E+ + P + +P + ++ S P L P FI+KC+
Sbjct: 191 GITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPK 249
Query: 272 RLP-ALELLKDPF 283
+ P A +LL+ PF
Sbjct: 250 KRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 77/248 (31%), Positives = 132/248 (53%), Gaps = 14/248 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+ +DG+ VA +V I D+M + + + + E+ LLK L H N+IK+Y S+++D
Sbjct: 19 YRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPNVIKYYASFIEDNE- 76
Query: 102 TINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+N++ EL +G L + ++K+ + + K + + Q+ L ++HS ++HRD+K
Sbjct: 77 -LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIK 133
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSF 214
N+F+ G VK+GDLGL T A S++GTP +M+PE ++E YN DI+S
Sbjct: 134 PANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192
Query: 215 GMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRL 273
G + EM + P Y + N + KK+ P S +++Q + CI P +
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
Query: 274 PALELLKD 281
P + + D
Sbjct: 253 PDITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 77/250 (30%), Positives = 132/250 (52%), Gaps = 17/250 (6%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+CR K D V Q+ +E + + D+ +E +LK L H NII++Y ++++
Sbjct: 17 HLCRRKA----DQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEYYENFLE 70
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
D I M E G+L +Y +K N +D I ++ QIL LH++H+ I+HRD
Sbjct: 71 DKALMIVM--EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRD 126
Query: 156 LKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYS 213
LK NI ++ + VKIGD G++ I+ + A +V+GTP +++PEL E + YN+ DI++
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWA 186
Query: 214 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLR 272
G + E+ + + + PA + K+ SG A +S P ++Q I + + S R
Sbjct: 187 LGCVLYELASLKRAFEAANLPA-LVLKIMSG-TFAPISDRYSPDLRQLILSMLNLDPSKR 244
Query: 273 LPALELLKDP 282
+++ P
Sbjct: 245 PQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 37/215 (17%)
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
L + H IIK Y ++ D+ N + + E +G L QY +K+ ++D K + +A +IL
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----------------- 181
L YLHS IIHRDLK +NI ++ + +KI D G A V+
Sbjct: 113 LALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 182 -----QQPTARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCIL-EMVTCEYPYNECKNP 234
+ S +GT E+++PEL E+ + D+++ G CI+ +M+T + P+ N
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFR-GSNE 227
Query: 235 AQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIV 267
++K I S P K IEK +V
Sbjct: 228 YLTFQK----ILKLEYSFPPNFPPDAKDLIEKLLV 258
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 22/215 (10%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
S ++ + E ++K L H N+++ V + ++ E G L Y +K + V
Sbjct: 36 SEEERKDFLKEARVMKKLGHPNVVRLLG--VCTEEEPLYLVLEYMEGGDLLDYLRKSRPV 93
Query: 126 DMKAIKN---------WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
K+ +A QI +G+ YL S +HRDL N V G + VKI D G
Sbjct: 94 FPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLV-GEDLVVKISDFG 150
Query: 177 LAIVMQQPT-ARSVIGTPE---FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNE 230
L+ + R G +MAPE L + + D++SFG+ + E+ T PY
Sbjct: 151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210
Query: 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
N ++ + + G + D ++ + + C
Sbjct: 211 LSN-EEVLEYLRKGYRLPKPEYCPD-ELYELMLSC 243
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 75/247 (30%), Positives = 125/247 (50%), Gaps = 23/247 (9%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HK 123
+S ++LE E+ +L KH NI+ Y ++ + ++ E G+L + +
Sbjct: 41 ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW--ILIEFCDGGALDSIMLELER 98
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+ I+ RQ+L L++LHSH +IHRDLK NI + +G+VK+ D G++ +
Sbjct: 99 GLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKS 155
Query: 184 PTAR--SVIGTPEFMAPELYEEE------YNELVDIYSFGMCILEMVTCEYPYNECKNPA 235
+ + IGTP +MAPE+ E Y+ DI+S G+ ++E+ E P++E NP
Sbjct: 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPM 214
Query: 236 QIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL--VTDNP- 289
++ K+ P SK + F++ C+V R A ELLK PF+ +DN
Sbjct: 215 RVLLKILKSEPPTLDQPSKWSS-SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKA 273
Query: 290 -KDLVCD 295
KDL+ +
Sbjct: 274 IKDLLAE 280
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 68/242 (28%), Positives = 121/242 (50%), Gaps = 15/242 (6%)
Query: 49 DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108
D V W +VN+ + S + +E+ +L L+H NII +YN ++DD I M E
Sbjct: 24 DDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM--E 79
Query: 109 LFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166
G+L R+K + + + + + QI+ + Y+H I+HRD+K NIF+
Sbjct: 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-K 136
Query: 167 NGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 223
G +K+GD G++ ++ A +V+GTP +M+PEL + +YN DI++ G + E++T
Sbjct: 137 AGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
Query: 224 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDP 282
+ + + NP + K+ G +S + ++ + + R A E+L P
Sbjct: 197 LKRTF-DATNPLNLVVKIVQGNYTPVVSVYSS-ELISLVHSLLQQDPEKRPTADEVLDQP 254
Query: 283 FL 284
L
Sbjct: 255 LL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 78/236 (33%), Positives = 128/236 (54%), Gaps = 18/236 (7%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
E L++EV +++ +HEN+++ YNS++ + ++ E G+L H ++ + I
Sbjct: 62 ELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 118
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS 188
+L+ L LH+ +IHRD+K D+I + ++G VK+ D G + + P +S
Sbjct: 119 AAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKS 175
Query: 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 246
++GTP +MAPEL Y VDI+S G+ ++EMV E PY NE P + K + +
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLP 233
Query: 247 P--ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
P +L KV+ P +K F+++ +V PA R A ELLK PFL P + +R
Sbjct: 234 PKLKNLHKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPSCIVPLMR 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 59/221 (26%), Positives = 111/221 (50%), Gaps = 11/221 (4%)
Query: 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAI 130
++ E+ +L I+ FY ++ ++ + I++ E GSL + K+ + + +
Sbjct: 45 QILRELDILHKCNSPYIVGFYGAFYNNGD--ISICMEYMDGGSLDKILKEVQGRIPERIL 102
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
A +L+GL YLH IIHRD+K NI VN + G++K+ D G++ + A++ +
Sbjct: 103 GKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFV 160
Query: 191 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGI 245
GT +MAPE + +Y+ DI+S G+ ++E+ T +PY ++ + + +
Sbjct: 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP 220
Query: 246 KPASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLV 285
P S P + F+ C++ P+ ELL+ PF+
Sbjct: 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
Q E ++SE +L+ H I+K Y ++ D + I M+ E G L + D
Sbjct: 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDE 92
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-A 186
+ + ++ YLH+ II+RDLK +N+ ++ +NG VK+ D G A ++
Sbjct: 93 YTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKT 149
Query: 187 RSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSG 244
+ GTPE++APE+ + Y+ VD +S G+ + E++T P+ E +P +IY + G
Sbjct: 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG 209
Query: 245 IKPASLSKVTDPQVKQFIEK 264
D K I++
Sbjct: 210 NGKLEFPNYIDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 82/254 (32%), Positives = 131/254 (51%), Gaps = 18/254 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y D G EVA Q+N++ Q P + E + +E+ +++ KH NI+ + +S++
Sbjct: 36 YTAIDVATGQEVAIKQMNLQ---QQPKK-ELIINEILVMRENKHPNIVNYLDSYL--VGD 89
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ ++ E GSL + +D I R+ L+ L +LHS+ +IHRD+K DNI
Sbjct: 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 146
Query: 162 FVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 218
+ G +G VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+
Sbjct: 147 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 219 LEMVTCEYPY-NECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPA 275
+EMV E PY NE NP + +Y T+G + + F+ +C+ + R A
Sbjct: 206 IEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSA 263
Query: 276 LELLKDPFLVTDNP 289
ELL+ PFL P
Sbjct: 264 KELLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 74/245 (30%), Positives = 118/245 (48%), Gaps = 19/245 (7%)
Query: 53 VAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110
+A QV ++ +V+ + + E+L EV LLKSLKH NI+++ + +DD TI++ E
Sbjct: 27 IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN--TISIFMEFV 84
Query: 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170
GS+ + + + +QIL G+ YLH++ ++HRD+K +N+ + NG +
Sbjct: 85 PGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGII 141
Query: 171 KIGDLGLAI--------VMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEM 221
K+ D G A +S+ GTP +MAPE+ E Y DI+S G + EM
Sbjct: 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201
Query: 222 VTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELL 279
T + P A + Y G+ P L F+ C+ P AL+LL
Sbjct: 202 ATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260
Query: 280 KDPFL 284
+ FL
Sbjct: 261 RHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 53/158 (33%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT---SGSLRQYRKKHKNVDMKAIKN 132
E+ LL+ L+H NI++ +I M+ E +G L K IK
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKC 104
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---- 188
+ +Q+L GL YLHS+ I+HRD+K NI +N N+G +K+ D GLA + +
Sbjct: 105 YMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 189 VIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 223
VI T + PEL Y VD++S G CIL E+
Sbjct: 162 VI-TLWYRPPELLLGATRYGPEVDMWSVG-CILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 7e-26
Identities = 69/241 (28%), Positives = 127/241 (52%), Gaps = 14/241 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+ +D VA +V I ++M + + + E+ LLK L H N+IK+ +S+++D
Sbjct: 19 YRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVIKYLDSFIEDNE- 76
Query: 102 TINMITELFTSGSLRQ----YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+N++ EL +G L Q ++K+ + + + + + Q+ + ++HS ++HRD+K
Sbjct: 77 -LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIK 133
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSF 214
N+F+ G VK+GDLGL T A S++GTP +M+PE ++E YN DI+S
Sbjct: 134 PANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192
Query: 215 GMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRL 273
G + EM + P Y + N + +K+ P ++ ++++ + CI P +
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
Query: 274 P 274
P
Sbjct: 253 P 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 60/238 (25%), Positives = 112/238 (47%), Gaps = 21/238 (8%)
Query: 62 DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK 121
M +Q++++ +E +L + ++K Y S+ N + ++ E G L +
Sbjct: 29 ADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKN--LYLVMEYLPGGDLASLLEN 86
Query: 122 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL---- 177
++D + + +I+ L YLHS+ IIHRDLK DNI ++ +NG +K+ D GL
Sbjct: 87 VGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVG 143
Query: 178 ----AIVMQQPTARS--VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 230
I + ++GTP+++APE + + +++ VD +S G + E + P++
Sbjct: 144 LVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203
Query: 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL-RLPAL---ELLKDPFL 284
+ P +I++ + +G + I K +VP RL A E+ PF
Sbjct: 204 -ETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 64/197 (32%), Positives = 93/197 (47%), Gaps = 28/197 (14%)
Query: 43 KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100
D+ G +VA I +V +R+ E+ LL+ L+HENII + +
Sbjct: 18 SAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75
Query: 101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ ++TEL + L + K + + I+ + QILRGL YLHS N +IHRDLK
Sbjct: 76 FNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPS 132
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----------APE--LYEEEYNE 207
NI VN N ++KI D GLA + F+ APE L Y +
Sbjct: 133 NILVNSNC-DLKICDFGLARGVDPDED-----EKGFLTEYVVTRWYRAPELLLSSSRYTK 186
Query: 208 LVDIYSFGMCIL-EMVT 223
+DI+S G CI E++T
Sbjct: 187 AIDIWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 65/238 (27%), Positives = 120/238 (50%), Gaps = 18/238 (7%)
Query: 63 VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQY 118
+PD +++ E+ + KS K I+K+Y +++D+++ +I + E GSL ++
Sbjct: 36 TDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKV 95
Query: 119 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
+K+ + K + A +L+GL YLHS IIHRD+K NI + G+VK+ D G++
Sbjct: 96 KKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVS 152
Query: 179 IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237
+ A + GT +MAPE + + Y+ D++S G+ +LE+ +P+ P
Sbjct: 153 GELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG 212
Query: 238 YKKVTSGIKPASLSKVTD-PQV--------KQFIEKCIVPASLRLPA-LELLKDPFLV 285
++ S I ++ D P K FI++C+ R P ++L+ P++
Sbjct: 213 PIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 70/245 (28%), Positives = 126/245 (51%), Gaps = 30/245 (12%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ R+KG + A ++ +++ Q+E + +E +L+S++H ++ Y S+ D
Sbjct: 18 MLVRHKGSGKY----YALKILSKAKIVKL-KQVEHVLNEKRILQSIRHPFLVNLYGSFQD 72
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
D+N + ++ E G L + +K + +A Q++ L YLHS + I++RDLK
Sbjct: 73 DSN--LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLK 128
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGM 216
+N+ + ++G +KI D G A ++ T ++ GTPE++APE+ + Y + VD ++ G+
Sbjct: 129 PENLLL-DSDGYIKITDFGFAKRVKGRT-YTLCGTPEYLAPEIILSKGYGKAVDWWALGI 186
Query: 217 CILEMVTCEYP--YNECKNPAQIYKKVTSGIKPASLSKVT-----DPQVKQFIEK-CIVP 268
I EM+ YP +++ NP QIY+K+ G KV P K I V
Sbjct: 187 LIYEML-AGYPPFFDD--NPIQIYEKILEG-------KVRFPSFFSPDAKDLIRNLLQVD 236
Query: 269 ASLRL 273
+ RL
Sbjct: 237 LTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 72/235 (30%), Positives = 123/235 (52%), Gaps = 16/235 (6%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
E L++EV +++ HEN++ YNS++ + ++ E G+L H ++ + I
Sbjct: 64 ELLFNEVVIMRDYHHENVVDMYNSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQI 120
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS 188
+LR L YLH+ +IHRD+K D+I + ++G +K+ D G + + P +S
Sbjct: 121 ATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKS 177
Query: 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIK 246
++GTP +MAPE+ Y VDI+S G+ ++EM+ E PY NE P Q +++ +
Sbjct: 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE--PPLQAMRRIRDNLP 235
Query: 247 P--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
P KV+ ++ F++ +V S R A ELL+ PFL P + +R
Sbjct: 236 PRVKDSHKVSS-VLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVPLMR 289
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 80/246 (32%), Positives = 129/246 (52%), Gaps = 18/246 (7%)
Query: 50 GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109
G EVA Q+N +Q + E + +E+ ++K LK+ NI+ F +S++ + ++ E
Sbjct: 44 GQEVAIKQIN----LQKQPKKELIINEILVMKELKNPNIVNFLDSFL--VGDELFVVMEY 97
Query: 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
GSL + +D I R+ L+ L +LH++ +IHRD+K DN+ + G +G
Sbjct: 98 LAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLL-GMDGS 153
Query: 170 VKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEY 226
VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+ +EMV E
Sbjct: 154 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
Query: 227 PY-NECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPF 283
PY NE NP + +Y T+G + P + F+ +C+ + R A ELL+ PF
Sbjct: 214 PYLNE--NPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271
Query: 284 LVTDNP 289
L P
Sbjct: 272 LKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 63/190 (33%), Positives = 96/190 (50%), Gaps = 15/190 (7%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHENIIKFYNSW 95
T+ YK D+ G VA ++ + + ++ D + E+ LL+ LKH NII + +
Sbjct: 12 TYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71
Query: 96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA-IKNWARQILRGLHYLHSHNPPIIHR 154
+N IN++ E F L + K V A IK++ LRGL YLHS+ I+HR
Sbjct: 72 GHKSN--INLVFE-FMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHR 126
Query: 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELY--EEEYNELV 209
DLK +N+ + ++G +K+ D GLA P + V+ T + APEL Y V
Sbjct: 127 DLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGARHYGVGV 184
Query: 210 DIYSFGMCIL 219
D++S G CI
Sbjct: 185 DMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 64/215 (29%), Positives = 113/215 (52%), Gaps = 12/215 (5%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNW 133
E LL LKH NI+ + SW + + + ++ G L K+ K + + W
Sbjct: 49 EAQLLSQLKHPNIVAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIG 191
QI L YLH + I+HRDLK N+F+ N +K+GDLG+A V+ Q A ++IG
Sbjct: 108 FVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIG 164
Query: 192 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
TP +M+PEL+ + YN D+++ G C+ EM T ++ +N + +Y+ + + P +
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--M 222
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFL 284
K P++ + I + + P+++ +L+ P++
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 64/217 (29%), Positives = 113/217 (52%), Gaps = 15/217 (6%)
Query: 54 AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSG 113
A + I +V+ Q + +++E +LK + H II+ + + D + M+ E G
Sbjct: 30 ALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF--LYMLMEYVPGG 86
Query: 114 SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173
L Y + +A +I+ L YLHS I++RDLK +NI ++ G +K+
Sbjct: 87 ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLT 143
Query: 174 DLGLAIVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 232
D G A ++ T ++ GTPE++APE+ + + +N+ VD ++ G+ I EM+ P+ +
Sbjct: 144 DFGFAKKLRDRTW-TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-D 201
Query: 233 NPAQIYKKVTSG-IK-PASLSKVTDPQVKQFIEKCIV 267
NP IY+K+ +G ++ P L D K I+K +V
Sbjct: 202 NPFGIYEKILAGKLEFPRHL----DLYAKDLIKKLLV 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 61/192 (31%), Positives = 103/192 (53%), Gaps = 13/192 (6%)
Query: 39 MCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98
+CRY + G +VA + E + + L E+ +L++L HENI+K+ +D
Sbjct: 22 LCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTED 78
Query: 99 TNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
I +I E SGSL++Y ++KN +++K +A QI +G+ YL S +HRDL
Sbjct: 79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLA 136
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDI 211
N+ V + +VKIGD GL ++ T + + +P F APE L + ++ D+
Sbjct: 137 ARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDV 195
Query: 212 YSFGMCILEMVT 223
+SFG+ + E++T
Sbjct: 196 WSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 18/228 (7%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
D ++ L SE+ LK L H NI+++ + T +++ E GS+ + + +
Sbjct: 50 DMVKALRSEIETLKDLDHLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE 107
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----AIVMQQ 183
+ ++ + Q+L GL YLHS I+HRDLK DN+ V+ +G KI D G+ +
Sbjct: 108 QLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDN 164
Query: 184 PTARSVIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK- 239
S+ G+ +MAPE Y + Y+ VDI+S G +LEM P+++ + A ++K
Sbjct: 165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL 224
Query: 240 ---KVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPF 283
+ I P ++ P F+ C P A ELL+ PF
Sbjct: 225 GNKRSAPPIPPDVSMNLS-PVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 85/258 (32%), Positives = 134/258 (51%), Gaps = 26/258 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y D G EVA Q+N++ Q P + E + +E+ +++ K+ NI+ + +S++
Sbjct: 36 YTAIDIATGQEVAIKQMNLQ---QQPKK-ELIINEILVMRENKNPNIVNYLDSYL--VGD 89
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ ++ E GSL + +D I R+ L+ L +LHS+ +IHRD+K DNI
Sbjct: 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNI 146
Query: 162 FVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 218
+ G +G VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+
Sbjct: 147 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 219 LEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPASLSKVTDPQVKQFIEKCI-VPASL 271
+EMV E PY NE NP + +Y T+G P LS V + F+ +C+ +
Sbjct: 206 IEMVEGEPPYLNE--NPLRALYLIATNGTPELQNPERLSAV----FRDFLNRCLEMDVDR 259
Query: 272 RLPALELLKDPFLVTDNP 289
R A ELL+ PFL P
Sbjct: 260 RGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 50/156 (32%), Positives = 79/156 (50%), Gaps = 7/156 (4%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E +L+ L H ++ + S+ D+ N + ++ +L G LR + + + +K W
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC 107
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPE 194
+I+ L YLHS IIHRD+K DNI ++ G V I D +A V S GTP
Sbjct: 108 EIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPG 164
Query: 195 FMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYN 229
+MAPE+ + Y+ VD +S G+ E + + PY
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 71/229 (31%), Positives = 120/229 (52%), Gaps = 13/229 (5%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
E L++EV +++ +H+N+++ Y S++ + ++ E G+L + + ++ + I
Sbjct: 63 ELLFNEVVIMRDYQHQNVVEMYKSYL--VGEELWVLMEFLQGGALTDIVSQTR-LNEEQI 119
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS 188
+L+ L YLHS +IHRD+K D+I + +G VK+ D G I P +S
Sbjct: 120 ATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKS 176
Query: 189 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
++GTP +MAPE+ Y VDI+S G+ ++EMV E PY +P Q K++ P
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPP 235
Query: 248 -ASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 293
+ P ++ F+E+ + R A ELL PFL+ T P+ LV
Sbjct: 236 KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLV 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 3e-23
Identities = 79/253 (31%), Positives = 128/253 (50%), Gaps = 15/253 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+KG D VA + I D+ ++ D++E + E+ +L + K+Y S++ DT
Sbjct: 21 FKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 77
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
I I E GS + +D I R+IL+GL YLHS IHRD+K N+
Sbjct: 78 WI--IMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKK--IHRDIKAANV 132
Query: 162 FVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 218
++ +GEVK+ D G+A + Q + +GTP +MAPE+ ++ Y+ DI+S G+
Sbjct: 133 LLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 191
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALE 277
+E+ E P++E +P ++ + P + P +K+F+E C+ S R A E
Sbjct: 192 IELAKGEPPHSEL-HPMKVLFLIPKNNPPTLEGNYSKP-LKEFVEACLNKEPSFRPTAKE 249
Query: 278 LLKDPFLVTDNPK 290
LLK F+V K
Sbjct: 250 LLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 69/228 (30%), Positives = 115/228 (50%), Gaps = 18/228 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSG-----SLRQYRK 120
+P++ + E LL L H I+KF+ S+++ I ITE + G L + +
Sbjct: 42 NPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI--ITE-YCEGRDLDCKLEELKH 98
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
K + + W Q+L G+HY+H I+HRDLK NIF+ N +KIGD G++ +
Sbjct: 99 TGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKNN--LLKIGDFGVSRL 154
Query: 181 MQQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237
+ A + GTP +M+PE L + Y+ DI+S G + EM + + E +N +
Sbjct: 155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSV 213
Query: 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
++ G P SL + Q+ ++ + SLR A E+L++PF+
Sbjct: 214 VLRIVEGPTP-SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-23
Identities = 73/253 (28%), Positives = 125/253 (49%), Gaps = 18/253 (7%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT-SGSLRQYRKKHK 123
QS ++ + + EV L+ L+H N I++ ++ + + M L + S L ++K +
Sbjct: 54 QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQ 113
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
V++ AI L+GL YLHSH IHRD+K NI + G VK+ D G A ++
Sbjct: 114 EVEIAAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVS- 166
Query: 184 PTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 239
A S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P + +Y
Sbjct: 167 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
Query: 240 KVTSGIKPASLSKVTDPQ-VKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPL 297
+ +LS + F++ C+ R + ELLK F++ + P ++ D +
Sbjct: 226 IAQN--DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLI 283
Query: 298 -RLPNLVPEVMNL 309
R + V E+ NL
Sbjct: 284 QRTKDAVRELDNL 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 73/267 (27%), Positives = 124/267 (46%), Gaps = 38/267 (14%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV--DD 98
YK + G VA + I D++ D+ E + E ++L+ H NI FY +++ +
Sbjct: 23 YKARHKKTGQLVA---IKIMDII--EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77
Query: 99 TNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNW----ARQILRGLHYLHSHNPPII 152
+ ++ EL GS+ K + + + W R+ LRGL YLH + +I
Sbjct: 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VI 135
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL------YEEE 204
HRD+K NI + N EVK+ D G++ + R + IGTP +MAPE+ +
Sbjct: 136 HRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDAS 194
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPA-----QIYKKVTSGIK-PASLSKVTDPQV 258
Y+ D++S G+ +E+ + P C +I + +K P + SK +
Sbjct: 195 YDARSDVWSLGITAIELADGKPPL--CDMHPMRALFKIPRNPPPTLKSPENWSK----KF 248
Query: 259 KQFIEKCIVPASLRLP-ALELLKDPFL 284
FI +C++ + P ELL+ PF+
Sbjct: 249 NDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 12/215 (5%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMKAIKNW 133
EV LL +KH NI+ F+ S+ ++ I M E G L + + + V I +W
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVM--EYCDGGDLMKRINRQRGVLFSEDQILSW 106
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIG 191
QI GL H H+ I+HRD+K NIF++ N K+GD G+A + A + +G
Sbjct: 107 FVQISLGLK--HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164
Query: 192 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
TP +++PE+ + YN DI+S G + E+ T ++P+ E N Q+ K+ G A +
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQG-YFAPI 222
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFL 284
S ++ I + + P++ +LK PFL
Sbjct: 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 5e-22
Identities = 82/258 (31%), Positives = 133/258 (51%), Gaps = 26/258 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y D G EVA Q+N++ Q P + E + +E+ +++ K+ NI+ + +S++
Sbjct: 37 YTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVMRENKNPNIVNYLDSYL--VGD 90
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ ++ E GSL + +D I R+ L+ L +LHS+ +IHRD+K DNI
Sbjct: 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 147
Query: 162 FVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 218
+ G +G VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+
Sbjct: 148 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 219 LEMVTCEYPY-NECKNPAQ-IYKKVTSGI----KPASLSKVTDPQVKQFIEKCI-VPASL 271
+EM+ E PY NE NP + +Y T+G P LS + + F+ +C+ +
Sbjct: 207 IEMIEGEPPYLNE--NPLRALYLIATNGTPELQNPEKLSAI----FRDFLNRCLDMDVEK 260
Query: 272 RLPALELLKDPFLVTDNP 289
R A ELL+ FL P
Sbjct: 261 RGSAKELLQHQFLKIAKP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 15/193 (7%)
Query: 39 MCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98
+CRY + G +VA +N Q ER E+ +L++L HENI+K Y +
Sbjct: 22 LCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEILRTLDHENIVK-YKGVCEK 77
Query: 99 TN-RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
R++ +I E SGSLR Y ++H+ +++K + ++ QI +G+ YL S IHRDL
Sbjct: 78 PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDL 135
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVD 210
NI V + VKI D GLA V+ + + +P F APE L +++ D
Sbjct: 136 AARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASD 194
Query: 211 IYSFGMCILEMVT 223
++SFG+ + E+ T
Sbjct: 195 VWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 62/192 (32%), Positives = 97/192 (50%), Gaps = 14/192 (7%)
Query: 39 MCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98
+CRY + G VA ++ + + L E+ +LKSL+H+NI+K+
Sbjct: 22 LCRYDPLQDNTGEVVAVKKLQ----HSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 77
Query: 99 TNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
R + ++ E GSLR Y +KH+ +D + + +A QI +G+ YL S +HRDL
Sbjct: 78 GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLA 135
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDI 211
NI V N VKIGD GL V+ Q + P + APE L E +++ D+
Sbjct: 136 TRNILVESEN-RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDV 194
Query: 212 YSFGMCILEMVT 223
+SFG+ + E+ T
Sbjct: 195 WSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 76 EVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKN 132
EV L+ L H NI+K + + N + + E + G+L Q K K I++
Sbjct: 47 EVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRS 103
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 191
QIL+GL ++H H HRDLK +N+ V+G VKI D GLA + +P +
Sbjct: 104 IIYQILQGLAHIHKHG--FFHRDLKPENLLVSG-PEVVKIADFGLAREIRSRPPYTDYVS 160
Query: 192 TPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCE 225
T + APE L Y+ VDI++ G CI+ E+ T
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALG-CIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 56/166 (33%), Positives = 89/166 (53%), Gaps = 20/166 (12%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ-----YRKKHKNVDMKAI 130
E+ LL+ LKHEN++ +++ ++++ ++ + + L Q + K ++ +
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP--- 184
K+ QIL G+HYLHS+ ++HRDLK NI V G G VKIGDLGLA + P
Sbjct: 111 KSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 185 --TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE 225
V+ T + APEL Y + +DI++ G CI E++T E
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 82/269 (30%), Positives = 131/269 (48%), Gaps = 25/269 (9%)
Query: 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIK 90
VV N T+ YKG G A + + DV + D+ E + E+++LK H NI
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTE--DEEEEIKLEINMLKKYSHHRNIAT 77
Query: 91 FYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHYL 144
+Y +++ + + + ++ E +GS+ K K +K I R+ILRGL +L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY- 201
H+H +IHRD+K N+ + N EVK+ D G++ + + R + IGTP +MAPE+
Sbjct: 138 HAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194
Query: 202 -----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256
+ Y+ DI+S G+ +EM P + +P + + P SK
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLKSKKWSK 253
Query: 257 QVKQFIEKCIVPASLRLPALE-LLKDPFL 284
+ FIE C+V L P+ E LLK PF+
Sbjct: 254 KFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 67/194 (34%), Positives = 96/194 (49%), Gaps = 24/194 (12%)
Query: 42 YKGFDEVDGIEVAWNQVNI---EDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYN-- 93
YK D G VA +V + E+ + P R E+ LLK L+ H NI++ +
Sbjct: 16 YKARDLNTGRFVALKKVRVPLSEEGI--PLSTLR---EIALLKQLESFEHPNIVRLLDVC 70
Query: 94 -SWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPP 150
D + ++ E L Y K + + IK+ RQ+LRG+ +LHSH
Sbjct: 71 HGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR-- 127
Query: 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE-LYEEEYNEL 208
I+HRDLK NI V ++G+VKI D GLA + A SV+ T + APE L + Y
Sbjct: 128 IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATP 186
Query: 209 VDIYSFGMCIL-EM 221
VD++S G CI E+
Sbjct: 187 VDMWSVG-CIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 68/240 (28%), Positives = 124/240 (51%), Gaps = 19/240 (7%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYR-KKHK 123
+S ++LE E+ +L S H NI+K +++ + N I + E G++ + +
Sbjct: 41 KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI--LIEFCAGGAVDAVMLELER 98
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+ I+ +Q L L+YLH + IIHRDLK NI +G++K+ D G++ +
Sbjct: 99 PLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTR 155
Query: 184 PTAR--SVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 235
R S IGTP +MAPE+ + Y+ D++S G+ ++EM E P++E NP
Sbjct: 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPM 214
Query: 236 QIYKKVTSGIKPASLSKVT--DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
++ K+ +P +L++ + + K F++KC+ R +LL+ PF+ ++ K +
Sbjct: 215 RVLLKIAKS-EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 74/248 (29%), Positives = 122/248 (49%), Gaps = 15/248 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YKG D VA + I D+ ++ D++E + E+ +L I ++Y S++ T
Sbjct: 21 YKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL 77
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
I I E GS K ++ I R+IL+GL YLHS IHRD+K N+
Sbjct: 78 WI--IMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSERK--IHRDIKAANV 132
Query: 162 FVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 218
++ G+VK+ D G+A + Q + +GTP +MAPE+ ++ Y+ DI+S G+
Sbjct: 133 LLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITA 191
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALE 277
+E+ E P ++ +P ++ + P + + P K+F+E C+ R A E
Sbjct: 192 IELAKGEPPNSDL-HPMRVLFLIPKNSPPTLEGQYSKP-FKEFVEACLNKDPRFRPTAKE 249
Query: 278 LLKDPFLV 285
LLK F+
Sbjct: 250 LLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 7e-21
Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 16/254 (6%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-K 123
Q+ ++ + + EV L+ LKH N I++ ++ + + M L ++ L + KK +
Sbjct: 60 QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ 119
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
V++ AI + A L+GL YLHSHN +IHRD+K NI + G+VK+ D G A
Sbjct: 120 EVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSS- 172
Query: 184 PTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 239
A S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P + +Y
Sbjct: 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY- 230
Query: 240 KVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDPL- 297
+ P S + F++ C+ PA ELL+ F+ D P ++ D +
Sbjct: 231 HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQ 290
Query: 298 RLPNLVPEVMNLAH 311
R + V E+ NL +
Sbjct: 291 RTKDAVRELDNLQY 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 75/253 (29%), Positives = 123/253 (48%), Gaps = 15/253 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+KG D VA + I D+ ++ D++E + E+ +L + K+Y S++ T
Sbjct: 21 FKGIDNRTQQVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL 77
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
I I E GS + D I ++IL+GL YLHS IHRD+K N+
Sbjct: 78 WI--IMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKK--IHRDIKAANV 132
Query: 162 FVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 218
++ G+VK+ D G+A + Q + +GTP +MAPE+ ++ Y+ DI+S G+
Sbjct: 133 LLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITA 191
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALE 277
+E+ E P N +P ++ + P + + K+FI+ C+ S R A E
Sbjct: 192 IELAKGE-PPNSDMHPMRVLFLIPKNNPPTLTGEFSK-PFKEFIDACLNKDPSFRPTAKE 249
Query: 278 LLKDPFLVTDNPK 290
LLK F+V + K
Sbjct: 250 LLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 1e-20
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 25/269 (9%)
Query: 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIK 90
+V N T+ YKG G A + + DV + D+ E + E+++LK H NI
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAA---IKVMDV--TGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 91 FYNSWVDDT----NRTINMITELFTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHYL 144
+Y +++ + + ++ E +GS+ K K +K I R+ILRGL +L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY- 201
H H +IHRD+K N+ + N EVK+ D G++ + + R + IGTP +MAPE+
Sbjct: 128 HQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 202 -----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256
+ Y+ D++S G+ +EM P + +P + + P SK
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWSK 243
Query: 257 QVKQFIEKCIVPASLRLPALE-LLKDPFL 284
+ + FIE C+V + P E L+K PF+
Sbjct: 244 KFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 64/169 (37%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRK 120
QS +R Y E+ LLK + HEN+I + + ++ + + ++T L + L K
Sbjct: 53 QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK 111
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
K D I+ QILRGL Y+HS IIHRDLK NI VN + E+KI D GLA
Sbjct: 112 CQKLSDDH-IQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA-- 165
Query: 181 MQQPTARSVIG---TPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 223
+ T + G T + APE L YN+ VDI+S G CI+ E++T
Sbjct: 166 --RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 69/231 (29%), Positives = 115/231 (49%), Gaps = 17/231 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
+ + +++ SE+ +L II FY ++ + NR I++ TE GSL YRK ++V
Sbjct: 39 TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-NR-ISICTEFMDGGSLDVYRKIPEHV 96
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185
+ A +++GL YL S I+HRD+K N+ VN G+VK+ D G++ +
Sbjct: 97 ----LGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSI 149
Query: 186 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY-----NECK-NPAQIY 238
A++ +GT +MAPE + E+Y D++S G+ +E+ +PY N+ P Q+
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209
Query: 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD-PFLVTDN 288
+ + P + FI +C+ PA E L D PF+V N
Sbjct: 210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 64/182 (35%), Positives = 98/182 (53%), Gaps = 17/182 (9%)
Query: 46 DEVDGIEVAWNQVNIEDVMQ---SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102
D++ G VA I+ +M+ +P +R Y E+ LLK L+HENII + ++
Sbjct: 31 DQLTGQNVA-----IKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE-D 84
Query: 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 162
I +TEL + R + ++ + I+ + QILRGL Y+HS ++HRDLK NI
Sbjct: 85 IYFVTELLGTDLHRLL--TSRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNIL 140
Query: 163 VNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILE 220
+N N ++KI D GLA + Q P + T + APE L ++Y+ VDI+S G E
Sbjct: 141 IN-ENCDLKICDFGLARI-QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAE 198
Query: 221 MV 222
M+
Sbjct: 199 ML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 4e-20
Identities = 76/255 (29%), Positives = 132/255 (51%), Gaps = 18/255 (7%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-K 123
QS ++ + + EV L+ +KH N I++ ++ + + M L ++ L + KK +
Sbjct: 64 QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ 123
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
V++ AI + A L+GL YLHSHN +IHRD+K NI + G+VK+ D G A +
Sbjct: 124 EVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIAS- 176
Query: 184 PTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 239
A S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P + +Y
Sbjct: 177 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY- 234
Query: 240 KVTSGIKPASLSKVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPL 297
+ P S + F++ C+ +P R + ELLK F++ + P+ ++ D +
Sbjct: 235 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQD-RPTSEELLKHMFVLRERPETVLIDLI 293
Query: 298 -RLPNLVPEVMNLAH 311
R + V E+ NL +
Sbjct: 294 QRTKDAVRELDNLQY 308
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 4e-20
Identities = 76/254 (29%), Positives = 130/254 (51%), Gaps = 16/254 (6%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-K 123
QS ++ + + EV L+ L+H N I++ ++ + + M L ++ L + KK +
Sbjct: 54 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ 113
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
V++ A+ + A L+GL YLHSHN +IHRD+K NI ++ G VK+GD G A +M
Sbjct: 114 EVEIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA- 166
Query: 184 PTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 239
A +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P + +Y
Sbjct: 167 -PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY- 224
Query: 240 KVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKDLVCDPL- 297
+ PA S + F++ C+ P E LLK F++ + P ++ D +
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284
Query: 298 RLPNLVPEVMNLAH 311
R + V E+ NL +
Sbjct: 285 RTKDAVRELDNLQY 298
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 49 DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108
DG + ++NI + SP + E EV +L ++KH NI+++ S+ ++ N I M +
Sbjct: 24 DGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM--D 79
Query: 109 LFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166
G L + + V I +W QI L H H+ I+HRD+K NIF+
Sbjct: 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--HVHDRKILHRDIKSQNIFLT-K 136
Query: 167 NGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVT 223
+G +K+GD G+A V+ AR+ IGTP +++PE+ E YN DI++ G + EM T
Sbjct: 137 DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
Query: 224 CEYPYNECKNPAQIYKKVTSGIKP 247
++ + E N + K+ G P
Sbjct: 197 LKHAF-EAGNMKNLVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 56/187 (29%), Positives = 94/187 (50%), Gaps = 13/187 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK D++ G VA ++ + +S + E+ LLK L H NIIK + V
Sbjct: 16 YKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLLD--VFRHKG 71
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ ++ E + + + + + + IK++ Q+L+GL + HSH I+HRDLK +N+
Sbjct: 72 DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENL 129
Query: 162 FVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMC 217
+N G +K+ D GLA + T + APEL ++ Y+ VDI+S G C
Sbjct: 130 LINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVG-C 187
Query: 218 IL-EMVT 223
I E+++
Sbjct: 188 IFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 18/195 (9%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
T+ YKG + G VA +++++ +P R E+ L+K LKHENI++ ++ V
Sbjct: 12 TYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVRLHD--V 66
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIH 153
T + ++ E + L++Y H +D +K++ Q+L+G+ + H + ++H
Sbjct: 67 IHTENKLMLVFE-YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLH 123
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEYNELV 209
RDLK N+ +N GE+K+ D GLA P T + + T + AP+ L Y+ +
Sbjct: 124 RDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI 182
Query: 210 DIYSFGMCIL-EMVT 223
DI+S G CI+ EM+T
Sbjct: 183 DIWSVG-CIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 9/177 (5%)
Query: 116 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175
++ K + + A I++ L YLHS +IHRD+K N+ +N NG+VK+ D
Sbjct: 91 KKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLIN-RNGQVKLCDF 148
Query: 176 GLAIVMQQPTARSV-IGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYN 229
G++ + A+++ G +MAPE E Y+ D++S G+ ++E+ T +PY+
Sbjct: 149 GISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
Query: 230 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLV 285
K P Q K+V P ++ P+ + F+ KC+ P ELL+ PF
Sbjct: 209 SWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 59/177 (33%), Positives = 86/177 (48%), Gaps = 10/177 (5%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNW 133
E LL +KH NI+ F S+ D + I M E G L Q K + I W
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVM--EYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--IG 191
Q+ G+ H H ++HRD+K NIF+ NG+VK+GD G A ++ P A + +G
Sbjct: 106 FVQMCLGVQ--HIHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVG 162
Query: 192 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
TP ++ PE++E YN DI+S G + E+ T ++P+ I K KP
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 61 EDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY- 118
+D + + + SEV ++K L+H NI+++Y ++++ N + ++ +L L ++
Sbjct: 43 KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHF 100
Query: 119 ---RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175
++K + + I N Q++ L YLH I+HRDL +NI + G + +V I D
Sbjct: 101 NSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR-IVHRDLTPNNIML-GEDDKVTITDF 158
Query: 176 GLAIVMQQPTAR--SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 232
GLA +QP ++ SV+GT + PE+ + E Y E D+++FG + +M T + P+
Sbjct: 159 GLA-KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-T 216
Query: 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268
N + K+ + + V I C+ P
Sbjct: 217 NMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTP 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 57/236 (24%), Positives = 110/236 (46%), Gaps = 21/236 (8%)
Query: 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIK 131
++ E+ ++ + I+ FY +++++ N I M E GSL + KK + ++ +
Sbjct: 49 QILRELQIMHECRSPYIVSFYGAFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILG 106
Query: 132 NWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
A ++ GL YL++ H I+HRD+K NI VN G++K+ D G++ + A + +
Sbjct: 107 KIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFV 163
Query: 191 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---- 245
GT +M+PE + +Y D++S G+ I+E+ ++P+ N + GI
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLL 222
Query: 246 ------KPASLSKVTDPQV-KQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDL 292
P L P+ + F++ C++ P P PF+ ++
Sbjct: 223 QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 16/218 (7%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E+ ++K KH NI+ ++ S++ I M E GSL+ + I +R
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICM--EFCGGGSLQDIYHVTGPLSESQIAYVSR 113
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTP 193
+ L+GL+YLHS +HRD+K NI + +NG VK+ D G++ + A+ S IGTP
Sbjct: 114 ETLQGLYYLHSKGK--MHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTP 170
Query: 194 EFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249
+MAPE+ E YN+L DI++ G+ +E+ + P + ++ S +P
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK 230
Query: 250 LS---KVTDPQVKQFIEKCIVPASLRLPALE-LLKDPF 283
L K ++ F++ + + P E LL+ PF
Sbjct: 231 LKDKMKWSN-SFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 68/232 (29%), Positives = 118/232 (50%), Gaps = 19/232 (8%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HK 123
+S ++LE E+ +L + H I+K ++ D I MI E G++ + +
Sbjct: 48 KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI-MI-EFCPGGAVDAIMLELDR 105
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+ I+ RQ+L L YLHS IIHRDLK N+ + +G++K+ D G++ +
Sbjct: 106 GLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVK 162
Query: 184 PTAR--SVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 235
R S IGTP +MAPE + + Y+ DI+S G+ ++EM E P++E NP
Sbjct: 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPM 221
Query: 236 QIYKKVTSGIKPASLSKVT--DPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
++ K+ +P +LS+ + + + F++ + R A +LL+ PF+
Sbjct: 222 RVLLKIAKS-EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 55/166 (33%), Positives = 88/166 (53%), Gaps = 14/166 (8%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
E+++LK+L HENI+K+ + + + +I E GSLR Y KH +
Sbjct: 46 GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KL 104
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185
++ + +A+QI G+ YLHS + IHRDL N+ ++ N+ VKIGD GLA + P
Sbjct: 105 NLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAV--PE 159
Query: 186 A------RSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
R +P F A E L E +++ D++SFG+ + E++T
Sbjct: 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 13/224 (5%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
++ D + E+ ++K KH NI+ ++ S++ I M E GSL+
Sbjct: 44 LEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM--EYCGGGSLQDIYHVTG 101
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+ I R+ L+GL YLHS +HRD+K NI + +NG+VK+ D G+A +
Sbjct: 102 PLSELQIAYVCRETLQGLAYLHSKGK--MHRDIKGANILLT-DNGDVKLADFGVAAKITA 158
Query: 184 PTAR--SVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237
A+ S IGTP +MAPE+ E YN+L DI++ G+ +E+ + P + +
Sbjct: 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
Query: 238 YKKVTSGIKPASLSKVT--DPQVKQFIEKCIVPASLRLPALELL 279
+ S +P L T F++ + + P E L
Sbjct: 219 FLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 50/141 (35%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
I+ FY ++ D +I M E GSL Q KK + + + +LRGL YL
Sbjct: 61 IVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE- 117
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYN 206
I+HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y
Sbjct: 118 KHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYT 176
Query: 207 ELVDIYSFGMCILEMVTCEYP 227
DI+S G+ ++EM YP
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-18
Identities = 64/223 (28%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E+ +L+ + H N++K ++ + D N I ++ E GSL + + + + AR
Sbjct: 122 EIEILRDVNHPNVVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADE----QFLADVAR 175
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---PTARSVIGT 192
QIL G+ YLH + I+HRD+K N+ +N VKI D G++ ++ Q P SV GT
Sbjct: 176 QILSGIAYLHRRH--IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSV-GT 231
Query: 193 PEFMAPELYEEEYNELV------DIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSG 244
+M+PE + N DI+S G+ ILE +P+ + A + +
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS 291
Query: 245 IKPASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLV 285
P + + + + + FI C+ PA R A++LL+ PF++
Sbjct: 292 QPPEAPATAS-REFRHFISCCLQREPAK-RWSAMQLLQHPFIL 332
|
Length = 353 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 41/99 (41%), Positives = 63/99 (63%), Gaps = 6/99 (6%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 190
+ QI+ GL +LH II+RDLK +N+ ++ N+G V+I DLGLA+ ++ Q +
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 191 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPY 228
GTP FMAPEL + EEY+ VD ++ G+ + EM+ P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 36/197 (18%)
Query: 66 SPDQLERLYS----EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK 121
D+L + E ++ SL HEN+I+ Y + + M+TEL GSL +K
Sbjct: 32 KSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTH---PLMMVTELAPLGSLLDRLRK 88
Query: 122 HKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA- 178
+ + ++A QI G+ YL S IHRDL NI + ++ +VKIGD GL
Sbjct: 89 DALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDD-KVKIGDFGLMR 145
Query: 179 --------IVMQQ----PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C 224
VM++ P A + APE L ++ D++ FG+ + EM T
Sbjct: 146 ALPQNEDHYVMEEHLKVPFA--------WCAPESLRTRTFSHASDVWMFGVTLWEMFTYG 197
Query: 225 EYPYNECKNPAQIYKKV 241
E P+ + +QI KK+
Sbjct: 198 EEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 43/164 (26%), Positives = 83/164 (50%), Gaps = 15/164 (9%)
Query: 67 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 126
P+Q R E+ L++ +H ++K + + + ++ E S R + + +
Sbjct: 43 PNQALR---EIKALQACQHPYVVKLLDVFPHGSG--FVLVMEYMPSDLSEVLRDEERPLP 97
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
+K++ R +L+G+ Y+H++ I+HRDLK N+ + +G +KI D GLA + +
Sbjct: 98 EAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEP 154
Query: 187 RSV---IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTC 224
R + T + APEL +Y+ VD+++ G CI E++
Sbjct: 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVG-CIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 12/154 (7%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
EV +L+ L+HENI+ ++ + ++ E L + A++++
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRK--GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW 107
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGT 192
Q+L+ + Y HSHN IIHRD+K +NI V+ +G +K+ D G A ++ A + T
Sbjct: 108 QLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVAT 164
Query: 193 PEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 223
+ APEL + Y + VD+++ G CI+ E++
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIG-CIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNW 133
E ++K L+H +I+ Y V I ++TEL GSL +Y + + + + +
Sbjct: 51 EAQIMKKLRHPKLIQLYA--VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM 108
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIG 191
A Q+ G+ YL + N IHRDL N+ V G N K+ D GLA V+++ AR
Sbjct: 109 AAQVASGMAYLEAQN--YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAK 165
Query: 192 TP-EFMAPELYEEEYNELV---DIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246
P ++ APE YN D++SFG+ + E+VT PY N A++ ++V G +
Sbjct: 166 FPIKWTAPE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQGYR 222
Query: 247 ---PASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 280
P ++ + C P E L+
Sbjct: 223 MPCPPG----CPKELYDIMLDCWKEDPDDRPTFETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 49/175 (28%), Positives = 92/175 (52%), Gaps = 9/175 (5%)
Query: 61 EDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYR 119
+DV+ D +E E +L + +H + + ++ T + + E G L +
Sbjct: 30 KDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF--QTKEHLFFVMEYLNGGDLMFHI 87
Query: 120 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179
+ D + +A +I+ GL +LH II+RDLK DN+ ++ +G +KI D G+
Sbjct: 88 QSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCK 144
Query: 180 --VMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC 231
+ + A + GTP+++APE+ + ++YNE VD +SFG+ + EM+ + P++
Sbjct: 145 ENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 55/218 (25%), Positives = 106/218 (48%), Gaps = 13/218 (5%)
Query: 70 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK--KHKNVDM 127
+ EV LK L+H+++I + V + +ITEL GSL + + + + + +
Sbjct: 46 QQDFQKEVQALKRLRHKHLISLFA--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV 103
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 185
++ + A Q+ G+ YL N IHRDL NI V G + K+ D GLA ++++
Sbjct: 104 ASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYL 160
Query: 186 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 243
+ ++ APE ++ D++SFG+ + EM T + PY N ++Y ++T+
Sbjct: 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITA 219
Query: 244 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
G + +K ++ + + +C P+ + L++
Sbjct: 220 GYRMPCPAKCP-QEIYKIMLECWAAEPEDRPSFKALRE 256
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK G+ +A ++ +E + ++ E+ +L I+ FY ++ +
Sbjct: 18 YKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-- 72
Query: 102 TINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLK 157
+ M E +GSL + + + ++ +++GL +L HN IIHRD+K
Sbjct: 73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVK 130
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-------YNELVD 210
N+ VNGN G+VK+ D G++ + A++ IG +MAPE + Y D
Sbjct: 131 PTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSD 189
Query: 211 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------PASLSKVTDPQVKQFIEK 264
++S G+ ILEM YPY P + Y + + + P +L + F+ K
Sbjct: 190 VWSLGLSILEMALGRYPY-----PPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAK 244
Query: 265 CI--VPASLRLPALELLKDPFLVTDNPKD 291
C+ +P + R +LL+ P+LV D
Sbjct: 245 CLNKIP-NRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 58/189 (30%), Positives = 105/189 (55%), Gaps = 21/189 (11%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
+K + VA +V ++D + P R E+ LLK LKH+NI++ Y+ V ++
Sbjct: 17 FKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIVRLYD--VLHSD 71
Query: 101 RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ + ++ E + L++Y + ++D + +K++ Q+L+GL + HSHN ++HRDLK
Sbjct: 72 KKLTLVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQ 128
Query: 160 NIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYS 213
N+ +N NGE+K+ D GLA I ++ +A V T + P+ + Y+ +D++S
Sbjct: 129 NLLINK-NGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTSIDMWS 185
Query: 214 FGMCIL-EM 221
G CI E+
Sbjct: 186 AG-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 8e-17
Identities = 58/202 (28%), Positives = 108/202 (53%), Gaps = 29/202 (14%)
Query: 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RQYRKKHK---NVDM 127
+L EV++++ LKH+NI+++ + +++ N+ + ++ E +G L R +K +K ++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 128 KAIKNWARQILRGLHYLHS-----HNPPIIHRDLKCDNIFV--------------NGNNG 168
AI + RQ+L L Y H+ + ++HRDLK NIF+ N NG
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 169 E--VKIGDLGLAI-VMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMV 222
KIGD GL+ + + A S +GTP + +PEL E Y++ D+++ G I E+
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 223 TCEYPYNECKNPAQIYKKVTSG 244
+ + P+++ N +Q+ ++ G
Sbjct: 238 SGKTPFHKANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 40/99 (40%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VI 190
+A ++ GL YLH + I++RDLK DN+ ++ G VKI D GL R+
Sbjct: 106 YAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFC 162
Query: 191 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 228
GTPEF+APE L E Y VD + G+ I EM+ E P+
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 62/192 (32%), Positives = 97/192 (50%), Gaps = 14/192 (7%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
T+ +KG ++ VA ++ +E +P R EV LLK+LKH NI+ ++ +
Sbjct: 17 TYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVTLHD--I 71
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
T R + ++ E S L+QY N+ M +K + Q+LRGL Y H I+HRD
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRD 128
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEYNELVDI 211
LK N+ +N GE+K+ D GLA PT + + T + P+ L EY+ +D+
Sbjct: 129 LKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDM 187
Query: 212 YSFGMCILEMVT 223
+ G + EM T
Sbjct: 188 WGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 61/192 (31%), Positives = 97/192 (50%), Gaps = 22/192 (11%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
YK D++ G VA ++ +E + P R E+ LLK L H NI++ + +
Sbjct: 16 YKARDKLTGEIVALKKIRLETEDEGVPSTAIR---EISLLKELNHPNIVRLLDVVHSENK 72
Query: 101 RTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
+ ++ E F L++Y +D IK++ Q+L+G+ Y HSH ++HRDLK
Sbjct: 73 --LYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKP 127
Query: 159 DNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIY 212
N+ ++ G +K+ D GLA + ++ T V T + APE L +Y+ VDI+
Sbjct: 128 QNLLID-REGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQYSTPVDIW 184
Query: 213 SFGMCIL-EMVT 223
S G CI EMV
Sbjct: 185 SIG-CIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 61/194 (31%), Positives = 97/194 (50%), Gaps = 16/194 (8%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSW 95
T+ YK +++ G VA ++ ++ + P R E+ LLK L H NI+K +
Sbjct: 12 TYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIVKLLD-- 66
Query: 96 VDDTNRTINMITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
V T + ++ E F L+++ + + IK++ Q+L+GL + HSH ++H
Sbjct: 67 VIHTENKLYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLH 123
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEYNELV 209
RDLK N+ +N G +K+ D GLA P T + T + APE L + Y+ V
Sbjct: 124 RDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 182
Query: 210 DIYSFGMCILEMVT 223
DI+S G EMVT
Sbjct: 183 DIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 46/209 (22%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 87 NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS 146
+ K Y + + + ++ E G K + K + +++ G+ LH
Sbjct: 58 YVAKLY--YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ 115
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEY 205
IIHRD+K +N+ ++ G +K+ D GL+ + + +GTP+++APE
Sbjct: 116 RG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETILGVGD 170
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIE 263
+++ D +S G I E + YP + P ++ + S P + + P+ I
Sbjct: 171 DKMSDWWSLGCVIFEFLF-GYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229
Query: 264 KCIVP-ASLRLPA---LELLKDPFLVTDN 288
+ + + RL A E+ PF + N
Sbjct: 230 RLLCMDPAKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 59/192 (30%), Positives = 98/192 (51%), Gaps = 14/192 (7%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
T+ YKG ++ VA ++ +E +P R EV LLK LKH NI+ ++ +
Sbjct: 18 TYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLHD--I 72
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
T +++ ++ E + L+QY N ++M +K + Q+LRGL+Y H ++HRD
Sbjct: 73 IHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRD 129
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEYNELVDI 211
LK N+ +N GE+K+ D GLA PT + + T + P+ L +Y+ +D+
Sbjct: 130 LKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188
Query: 212 YSFGMCILEMVT 223
+ G EM T
Sbjct: 189 WGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 67/302 (22%), Positives = 127/302 (42%), Gaps = 52/302 (17%)
Query: 63 VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD---DTNRTINMITELFTSGSLRQYR 119
V+ P ++ E+ +++ L H+NI+K Y D + +TEL + +++Y
Sbjct: 39 VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM 98
Query: 120 K-------KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172
+ + + + + + Q+LRGL Y+HS N ++HRDLK N+F+N + +KI
Sbjct: 99 ETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKI 156
Query: 173 GDLGLAIVMQQPTARS-----VIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTC 224
GD GLA ++ + + T + +P L Y + +D+++ G CI EM+T
Sbjct: 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTG 215
Query: 225 ------------------------EYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQ 257
E NE N + + G L + +P+
Sbjct: 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPE 275
Query: 258 VKQFIEKCIVPASL-RLPALELLKDPFL-VTDNPKD--LVCDPLRLPNLVPEVMNLAHSE 313
F+E+ + + RL A E L P++ P D + P + + + +++ +
Sbjct: 276 ALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIH 335
Query: 314 PH 315
Sbjct: 336 SI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 54/165 (32%), Positives = 86/165 (52%), Gaps = 17/165 (10%)
Query: 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMK 128
R E+ +L+ KHENII + + + N ++ EL + + + +H + D
Sbjct: 49 RTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH- 107
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
I+ + QILRGL Y+HS N ++HRDLK N+ +N N ++KI D GLA + +
Sbjct: 108 -IQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHT 163
Query: 189 -----VIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCE 225
+ T + APE L + Y + +DI+S G CIL EM++
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 57/187 (30%), Positives = 93/187 (49%), Gaps = 14/187 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YKG ++ G VA ++ +E +P R E LLK LKH NI+ ++ + T +
Sbjct: 22 YKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVTLHD--IIHTKK 76
Query: 102 TINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
T+ ++ E + L+QY + M ++ + Q+LRGL Y H ++HRDLK N
Sbjct: 77 TLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQN 133
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIYSFGM 216
+ ++ GE+K+ D GLA P T + + T + P+ L EY+ +D++ G
Sbjct: 134 LLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGC 192
Query: 217 CILEMVT 223
EM T
Sbjct: 193 IFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 32/173 (18%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT---------SGSLRQYRKKHKNVD 126
E+ +LK LKH N++ + V+ +++ ++ SG L K +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LT 113
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----Q 182
IK + Q+L G++YLH ++ I+HRD+K NI ++ N G +KI D GLA
Sbjct: 114 ESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPP 170
Query: 183 QPTARSVIGTPEFM---------APELY--EEEYNELVDIYSFGMCIL-EMVT 223
P GT ++ PEL E Y VDI+ G C+ EM T
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 69/230 (30%), Positives = 111/230 (48%), Gaps = 22/230 (9%)
Query: 45 FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---- 100
FD G+ VA +++ QS +R Y E+ LLK +KHEN+I + + +
Sbjct: 37 FDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ ++T L L K K D ++ QILRGL Y+HS + IIHRDLK N
Sbjct: 95 NDVYLVTHLM-GADLNNIVKCQKLTD-DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSN 150
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAPELYEE--EYNELVDIYSFG 215
+ VN + E+KI D GLA + T + G T + APE+ YN+ VDI+S G
Sbjct: 151 LAVN-EDCELKILDFGLA----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 205
Query: 216 MCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
+ E++T +P + + ++ ++ L K++ + +I+
Sbjct: 206 CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 9e-16
Identities = 52/162 (32%), Positives = 84/162 (51%), Gaps = 5/162 (3%)
Query: 67 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 126
P ++ E+ +L I+ FY ++ D +I M E GSL Q K+ K +
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKEAKRIP 101
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
+ + + +LRGL YL + I+HRD+K NI VN + GE+K+ D G++ + A
Sbjct: 102 EEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
S +GT +M+PE L Y+ DI+S G+ ++E+ YP
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 70/289 (24%), Positives = 122/289 (42%), Gaps = 47/289 (16%)
Query: 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMK 128
R E+ LL+ L HEN+I + N ++ EL + L Q + + +
Sbjct: 50 RTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDD 108
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
+ + Q+LRGL Y+HS N ++HRDLK N+ +N N ++KI D GL AR+
Sbjct: 109 HCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANC-DLKICDFGL--------ART 157
Query: 189 VIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKN 233
+FM APEL EY +D++S G CI E++ + +P + +
Sbjct: 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVH 216
Query: 234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-----------ALELLKDP 282
++ ++ L + + + +++I +P + R A++LL +
Sbjct: 217 QLKLITELLGSPSEEDLGFIRNEKARRYIRS--LPYTPRQSFARLFPHANPLAIDLL-EK 273
Query: 283 FLVTDNPKDL-VCDPLRLPNLVP-EVMNLAHSEPHPMDIDLNHKKVSAD 329
LV D K + V + L P L + P D ++ +
Sbjct: 274 MLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTEE 322
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 9e-16
Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 9/154 (5%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E LL+++ H ++I+ ++ V + M+ ++S K+ + + + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPE 194
QIL GL YLH+ IIHRD+K +NIF+N + +V IGDLG A + P + GT E
Sbjct: 165 QILEGLRYLHAQR--IIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 195 FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
APE L ++YN DI+S G+ + EM+ YP
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLA--YP 253
|
Length = 357 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 9/154 (5%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E+ +LK L+HEN++ V + + ++ E L K +D ++ +
Sbjct: 50 EIRMLKQLRHENLVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF 107
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP 193
QILRG+ + HSHN IIHRD+K +NI V+ +G VK+ D G A + P + T
Sbjct: 108 QILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATR 164
Query: 194 EFMAPELY--EEEYNELVDIYSFGMCILEMVTCE 225
+ APEL + +Y VDI++ G + EM+T E
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWV 96
+ KG DE+ ++V V ++D D +E +E +L + KH + + ++ +
Sbjct: 12 LLAELKGTDELYAVKVLKKDVILQD-----DDVECTMTEKRVLALAGKHPFLTQLHSCF- 65
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
T + + E G L + ++ D + +A +I+ GL +LH II+RDL
Sbjct: 66 -QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDL 122
Query: 157 KCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYS 213
K DN+ ++ G +KI D G+ ++ T + GTP+++APE L + Y VD ++
Sbjct: 123 KLDNVLLDS-EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWA 181
Query: 214 FGMCILEMVTCEYPY 228
G+ + EM+ + P+
Sbjct: 182 LGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
E+ +LK LKH N++ V R ++++ E L + K + V IK
Sbjct: 50 EIRMLKQLKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIW 107
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTP 193
Q L+ +++ H HN IHRD+K +NI + G++K+ D G A ++ P + T
Sbjct: 108 QTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 194 EFMAPELY--EEEYNELVDIYSFGMCILEMVT 223
+ APEL + +Y VD+++ G E++T
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 38/103 (36%), Positives = 61/103 (59%), Gaps = 7/103 (6%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVI 190
+A QI+ GL +LH I++RDLK +N+ ++ ++G V+I DLGLA+ + +
Sbjct: 100 YAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRA- 155
Query: 191 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
GTP +MAPE L E Y+ VD ++ G + EM+ P+ + K
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 13/165 (7%)
Query: 65 QSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
+S +Q+ L E+ L+ L H NI++ D + ++ EL +L + K K
Sbjct: 37 KSLEQVNNL-REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRK 94
Query: 124 N-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IV 180
+ K +K++ Q+L+ L ++H + I HRD+K +NI + + +K+ D G I
Sbjct: 95 RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKDDI--LKLADFGSCRGIY 150
Query: 181 MQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 223
+ P I T + APE L + Y +DI++ G E+++
Sbjct: 151 SKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 35/166 (21%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA------ 129
E+++L L+H NI+ V I M+ E +H D+K+
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV----------EH---DLKSLMETMK 100
Query: 130 -------IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
+K Q+L G+ +LH + I+HRDLK N+ +N N G +KI D GLA
Sbjct: 101 QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYG 157
Query: 183 QPTAR--SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 223
P ++ T + APEL +EY+ +D++S G CI E++T
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 21/193 (10%)
Query: 42 YKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
YKG +G I VA + E SP + + E +++ S+ H ++++ +
Sbjct: 24 YKGVWIPEGEKVKIPVAIKVLREE---TSPKANKEILDEAYVMASVDHPHVVRLLGICL- 79
Query: 98 DTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
+ + +IT+L G L Y + HK N+ + + NW QI +G+ YL ++HRDL
Sbjct: 80 --SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDL 135
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT----P-EFMAPE-LYEEEYNELVD 210
N+ V VKI D GLA + + P ++MA E + Y D
Sbjct: 136 AARNVLVKTPQ-HVKITDFGLA-KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSD 193
Query: 211 IYSFGMCILEMVT 223
++S+G+ + E++T
Sbjct: 194 VWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 137 ILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPE 194
I++ LHYL H +IHRD+K NI ++ +G VK+ D G++ + A++ G
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 195 FMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA- 248
+MAPE + +Y+ D++S G+ ++E+ T ++PY CK ++ K+ P+
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 249 SLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKD 291
++ P F++ C+ + P ELL+ PF+ +
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 14/192 (7%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
T+ +KG ++ VA ++ +E +P R EV LLK LKH NI+ ++ +
Sbjct: 18 TYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLHD--I 72
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
T++++ ++ E + L+QY N+ M +K + QILRGL Y H ++HRD
Sbjct: 73 VHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRD 129
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPE--LYEEEYNELVDI 211
LK N+ +N GE+K+ D GLA PT + + T + P+ L EY+ +D+
Sbjct: 130 LKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188
Query: 212 YSFGMCILEMVT 223
+ G EM +
Sbjct: 189 WGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 57/185 (30%), Positives = 91/185 (49%), Gaps = 29/185 (15%)
Query: 57 QVNIEDVMQSPDQL---ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT-------INMI 106
+V I+ + + D +R E+ +L+ KH+NII + D R + ++
Sbjct: 32 KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIA-----IRDILRPPGADFKDVYVV 86
Query: 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166
+L S L + + + I+ + Q+LRGL Y+HS N +IHRDLK N+ VN
Sbjct: 87 MDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNE- 142
Query: 167 NGEVKIGDLGLA-IVMQQPTARSV-----IGTPEFMAPELY--EEEYNELVDIYSFGMCI 218
+ E++IGD G+A + PT + T + APEL EY +D++S G CI
Sbjct: 143 DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG-CI 201
Query: 219 L-EMV 222
EM+
Sbjct: 202 FAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 5/162 (3%)
Query: 67 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD 126
P ++ E+ +L I+ FY ++ D +I M E GSL Q KK +
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIP 101
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
+ + + +++GL YL + I+HRD+K NI VN + GE+K+ D G++ + A
Sbjct: 102 EQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
S +GT +M+PE L Y+ DI+S G+ ++EM YP
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 60/238 (25%), Positives = 109/238 (45%), Gaps = 24/238 (10%)
Query: 51 IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110
I+VA + E M D +E E ++ L H N+++ Y V R I ++TE
Sbjct: 29 IDVAIKMIR-EGAMSEDDFIE----EAKVMMKLSHPNLVQLYG--VCTKQRPIFIVTEYM 81
Query: 111 TSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
+G L Y ++ K + + + + + YL S+ IHRDL N V G +
Sbjct: 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNV 138
Query: 170 VKIGDLGLA--IVMQQPTARSVIGTP-EFMAPELYE-EEYNELVDIYSFGMCILEMVTC- 224
VK+ D GLA ++ Q T+ P ++ PE+++ ++ D++SFG+ + E+ +
Sbjct: 139 VKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEG 198
Query: 225 EYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVPASLRLPALELL 279
+ PY N +++ + V++G +P K+ +V + C PA + L
Sbjct: 199 KMPYERFSN-SEVVESVSAGYRLYRP----KLAPTEVYTIMYSCWHEKPEDRPAFKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 49/177 (27%), Positives = 92/177 (51%), Gaps = 8/177 (4%)
Query: 69 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
Q++ + E +L L H I+ S+ D+ + + E G L + +K
Sbjct: 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPND 118
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
K + +++ YLHS + II+RDLK +N+ ++ N G VK+ D G A + T +
Sbjct: 119 VAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTF-T 174
Query: 189 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
+ GTPE++APE+ + + + + VD ++ G+ + E + P+ + P +IY+K+ +G
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG 230
|
Length = 329 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 61/185 (32%), Positives = 94/185 (50%), Gaps = 23/185 (12%)
Query: 46 DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD-------D 98
D DG VA + + +V Q+ +R++ E+ +L KH+N++ S +D D
Sbjct: 21 DPRDGKRVALKK--MPNVFQNLVSCKRVFRELKMLCFFKHDNVL----SALDILQPPHID 74
Query: 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
I ++TEL S L + + + +K + QILRGL YLHS I+HRD+K
Sbjct: 75 PFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKP 131
Query: 159 DNIFVNGNNGEVKIGDLGLAIVMQQPTARSV---IGTPEFMAPELY--EEEYNELVDIYS 213
N+ VN +N +KI D GLA V + ++ + + T + APE+ Y VDI+S
Sbjct: 132 GNLLVN-SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWS 190
Query: 214 FGMCI 218
G CI
Sbjct: 191 VG-CI 194
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 78/269 (28%), Positives = 131/269 (48%), Gaps = 32/269 (11%)
Query: 46 DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT--- 102
D G +VA ++N DV + R+ E+ LL+ L+H +I++ + + + R
Sbjct: 21 DTHTGEKVAIKKIN--DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78
Query: 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 162
I ++ EL S L Q K + ++ + + + Q+LR L Y+H+ N + HRDLK NI
Sbjct: 79 IYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNIL 135
Query: 163 VNGNNGEVKIGDLGLAIVMQQPTARSV-----IGTPEFMAPEL---YEEEYNELVDIYSF 214
N + ++KI D GLA V T ++ + T + APEL + +Y +DI+S
Sbjct: 136 ANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 194
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFI----EKCIV 267
G CI V P KN +T + P ++S+V + + ++++ +K V
Sbjct: 195 G-CIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPV 253
Query: 268 PASLRLP-----ALELLKDPFLVTDNPKD 291
P S + P AL LL+ L+ +PKD
Sbjct: 254 PFSQKFPNADPLALRLLER--LLAFDPKD 280
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 40/206 (19%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
YK D+ G VA +V +++ + P R E+ +L+ L H NI+ D +
Sbjct: 24 YKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIVNLKEIVTDKQD 80
Query: 101 --------RTINMITE--------LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144
++ E L SG L + + H IK++ +Q+L GL+Y
Sbjct: 81 ALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDH-------IKSFMKQLLEGLNYC 132
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPEL 200
H N +HRD+KC NI +N N G++K+ D GLA + +P VI T + PEL
Sbjct: 133 HKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPPEL 188
Query: 201 Y--EEEYNELVDIYSFGMCIL-EMVT 223
EE Y +D++S G CIL E+ T
Sbjct: 189 LLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 53 VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112
VA ++N++ S + L+ L E+ + L+H NI+ + S++ D+ + +++ L
Sbjct: 28 VAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAY 83
Query: 113 GSLRQYRKKHKNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170
GS K H + AI + +L L Y+HS IHR +K +I ++G +G+V
Sbjct: 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSG-DGKV 140
Query: 171 KIGDLGLAIVM--QQPTARSVIGTPEF-------MAPELYEEE---YNELVDIYSFGMCI 218
+ L ++ M R V P+ ++PE+ ++ YNE DIYS G+
Sbjct: 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITA 200
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258
E+ P+ + Q+ + G P L K T P
Sbjct: 201 CELANGHVPFKDMP-ATQMLLEKVRGTVPCLLDKSTYPLY 239
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 23/198 (11%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSW 95
T+ YK D V +A ++ +E + P R E+ LLK ++H NI++ +
Sbjct: 14 TYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR---EISLLKEMQHGNIVRLQD-- 68
Query: 96 VDDTNRTINMITELFTSGSLRQYRKKHKNV------DMKAIKNWARQILRGLHYLHSHNP 149
V + + + ++ E L KKH + + + IK + QILRG+ Y HSH
Sbjct: 69 VVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR- 122
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEY 205
++HRDLK N+ ++ +K+ D GLA P T + T + APE L Y
Sbjct: 123 -VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181
Query: 206 NELVDIYSFGMCILEMVT 223
+ VDI+S G EMV
Sbjct: 182 STPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 55/162 (33%), Positives = 82/162 (50%), Gaps = 16/162 (9%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNW 133
E ++K L+H+ +++ Y V I ++TE + GSL + K K + + + +
Sbjct: 51 EAQIMKKLRHDKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM 108
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIG 191
A QI G+ YL S N IHRDL NI V G N KI D GLA +++ TAR
Sbjct: 109 AAQIAEGMAYLESRN--YIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAK 165
Query: 192 TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT---CEYP 227
P ++ APE Y + D++SFG+ + E+VT YP
Sbjct: 166 FPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 62/228 (27%), Positives = 109/228 (47%), Gaps = 17/228 (7%)
Query: 43 KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWVDDTNR 101
KG DEV I+V V ++D D ++ +E +L + KH + + + T
Sbjct: 17 KGTDEVYAIKVLKKDVILQD-----DDVDCTMTEKRILALAAKHPFLTALHCCF--QTKD 69
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ + E G L ++ + D + +A ++ L +LH H +I+RDLK DNI
Sbjct: 70 RLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNI 127
Query: 162 FVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 218
++ G K+ D G+ ++ T + GTP+++APE L E EY VD ++ G+ +
Sbjct: 128 LLDA-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLM 186
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEK 264
EM+ + P+ E N +++ + + P LSK +K F+ K
Sbjct: 187 YEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 12/159 (7%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT----SGSLRQYRKKHKNVD 126
+R Y E+ LLK +KHEN+I + + D + ++ + + G+ KH+ +
Sbjct: 59 KRAYRELRLLKHMKHENVIGLLDVFTPDLS--LDRFHDFYLVMPFMGTDLGKLMKHEKLS 116
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
I+ Q+L+GL Y+H+ IIHRDLK N+ VN + E+KI D GLA
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEMT 173
Query: 187 RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 223
V+ T + APE L Y + VDI+S G + EM+T
Sbjct: 174 GYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 59/191 (30%), Positives = 99/191 (51%), Gaps = 14/191 (7%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
++ YKG +V+G VA + +++ +P R E LLK LKH NI+ ++ +
Sbjct: 17 SYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLKGLKHANIVLLHD--I 71
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
T T+ ++ E + L QY KH + + +K + Q+LRGL Y+H I+HRD
Sbjct: 72 IHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRD 128
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDI 211
LK N+ ++ + GE+K+ D GLA P T + + T + P+ L EY+ +D+
Sbjct: 129 LKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187
Query: 212 YSFGMCILEMV 222
+ G +EM+
Sbjct: 188 WGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 69 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
Q++ ++SE +L + H + Y S+ D++ + ++ E G + +++K
Sbjct: 74 QVDHVFSERKILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRNKRFPND 131
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
+A QI+ YL S N I++RDLK +N+ ++ +G +K+ D G A V+ T +
Sbjct: 132 VGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDTRT-YT 187
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
+ GTPE++APE L + + D ++ G+ I E++ P+ P IY+K+ GI
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF-YANEPLLIYQKILEGI-- 244
Query: 248 ASLSKVTDPQVKQFIEKCI 266
K D K ++K +
Sbjct: 245 IYFPKFLDNNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 22/175 (12%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT---SGSLRQ 117
E V+ Q +E H+L+++ H +II+ ++ T N T L L
Sbjct: 118 EHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTF------TYNKFTCLILPRYKTDLYC 171
Query: 118 YRKKHKNV---DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174
Y +N+ D+ AI+ R +LR + YLH IIHRD+K +NIF+N + G+V +GD
Sbjct: 172 YLAAKRNIAICDILAIE---RSVLRAIQYLH--ENRIIHRDIKAENIFIN-HPGDVCLGD 225
Query: 175 LGLA---IVMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCE 225
G A + + GT APEL + Y VDI+S G+ + EM TC
Sbjct: 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 21/178 (11%)
Query: 60 IEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQY 118
I D ++ +R + E+ L+ L H NI+K N + ++ I ++ E + L
Sbjct: 40 IFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAV 98
Query: 119 RKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
+ + ++V + I Q+L+ L Y+HS N +IHRDLK NI +N ++ VK+ D G
Sbjct: 99 IRANILEDVHKRYI---MYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFG 152
Query: 177 LA-------IVMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTC 224
LA + P + T + APE L Y + VD++S G CIL EM+
Sbjct: 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVG-CILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 14/187 (7%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
+ E ++ L H I++ + + ++ EL G L +Y KK +
Sbjct: 35 HIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP---LMLVMELAPLGPLLKYLKKRRE 91
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--- 181
+ + +K A Q+ G+ YL S + +HRDL N+ + N + KI D G++ +
Sbjct: 92 IPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAG 148
Query: 182 -QQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
A + P ++ APE + +++ D++S+G+ + E + PY E K ++
Sbjct: 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EV 207
Query: 238 YKKVTSG 244
+ SG
Sbjct: 208 IAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 63/192 (32%), Positives = 99/192 (51%), Gaps = 21/192 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
YKG ++ G VA ++ +E + P R E+ LLK L+H NI+ + + + +
Sbjct: 17 YKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---EISLLKELQHPNIVCLQDVLMQE-S 72
Query: 101 RTINMITELFTSGSLRQYR---KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
R + +I E F S L++Y K + +D + +K++ QIL+G+ + HS ++HRDLK
Sbjct: 73 R-LYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLK 128
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPE--LYEEEYNELVDI 211
N+ ++ N G +K+ D GLA P T V T + APE L Y+ VDI
Sbjct: 129 PQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSPRYSTPVDI 185
Query: 212 YSFGMCILEMVT 223
+S G EM T
Sbjct: 186 WSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 59/194 (30%), Positives = 86/194 (44%), Gaps = 34/194 (17%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS--EVHLLKSLKHENIIKFYNSWVDDT 99
Y+ D G VA +V ++ D + + S E+ LL +L+H NI++ V
Sbjct: 24 YRARDTTSGEIVALKKVRMD---NERDGIP-ISSLREITLLLNLRHPNIVELKEVVVGKH 79
Query: 100 NRTINMITELFTS--GSLRQYRKKHKNVDMKA------IKNWARQILRGLHYLHSHNPPI 151
+I ++ E SL +M +K Q+LRGL YLH + I
Sbjct: 80 LDSIFLVMEYCEQDLASLLD--------NMPTPFSESQVKCLMLQLLRGLQYLHENF--I 129
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY--EEEY 205
IHRDLK N+ + G +KI D GLA P T + V T + APEL Y
Sbjct: 130 IHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGCTTY 186
Query: 206 NELVDIYSFGMCIL 219
+D+++ G CIL
Sbjct: 187 TTAIDMWAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-14
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRK 120
QS R Y E+ LLK +KHEN+I + + T+ + ++T L L K
Sbjct: 53 QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK 111
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
K D + ++ Q+LRGL Y+HS IIHRDLK N+ VN + E++I D GLA
Sbjct: 112 CQKLSD-EHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQ 167
Query: 181 MQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQ 236
+ T + APE L YN+ VDI+S G + E++ + +P N+ + +
Sbjct: 168 ADDEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK 226
Query: 237 IYKKVTSGIKPASLSKVTDPQVKQFIE 263
+V P L K++ +++I+
Sbjct: 227 RIMEVVGTPSPEVLKKISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 35/265 (13%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100
YK ++ DG A V I D + D E + +E ++L+SL H N++KFY +
Sbjct: 39 YKVTNKKDGSLAA---VKILDPISDVD--EEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93
Query: 101 RT---INMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
+ ++ EL GS+ + K + +D I L GL +LH N IIH
Sbjct: 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIH 151
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL------YEEEY 205
RD+K +NI + G VK+ D G++ + R + +GTP +MAPE+ Y+ Y
Sbjct: 152 RDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSY 210
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ-----VKQ 260
+ D++S G+ +E+ + P + +P + K+ P L P+
Sbjct: 211 DARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKIPRNPPPTLL----HPEKWCRSFNH 265
Query: 261 FIEKCIVPASLRLPAL-ELLKDPFL 284
FI +C++ P++ LL+ PF+
Sbjct: 266 FISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 44/138 (31%), Positives = 77/138 (55%), Gaps = 11/138 (7%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 190
+A +I GL +LHS II+RDLK DN+ ++ G +KI D G+ + T R+
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFC 162
Query: 191 GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SGIK 246
GTP+++APE Y + Y + VD ++FG+ + EM+ + P+ + ++ ++++ + +
Sbjct: 163 GTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSY 220
Query: 247 PASLSKVTDPQVKQFIEK 264
P SLSK K + K
Sbjct: 221 PKSLSKEAVSICKGLLTK 238
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 35/205 (17%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYS----------EVHLLKSLKHENIIKF 91
K +D + G VA +V I ++ + +L E+ ++ +KHENI+
Sbjct: 26 EKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85
Query: 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151
+ +V+ IN++ ++ + L++ + + +K QIL GL+ LH
Sbjct: 86 VDVYVEGD--FINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--F 140
Query: 152 IHRDLKCDNIFVNGNNGEVKIGDLGLA-----------IVMQQPTARSVIGTPE-----F 195
+HRDL NIF+N + G KI D GLA + + R T + +
Sbjct: 141 MHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWY 199
Query: 196 MAPELY--EEEYNELVDIYSFGMCI 218
APEL E+Y+ VD++S G CI
Sbjct: 200 RAPELLMGAEKYHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 59/188 (31%), Positives = 91/188 (48%), Gaps = 13/188 (6%)
Query: 57 QVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR 116
+V I+ + Q E +E +L+K L+H +++ Y T I +ITE +GSL
Sbjct: 32 KVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV---TQEPIYIITEYMENGSLV 88
Query: 117 QYRKKHKNVDMKAIK--NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174
+ K + + + K + A QI G+ ++ N IHRDL+ NI V+ KI D
Sbjct: 89 DFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIAD 145
Query: 175 LGLA--IVMQQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYN 229
GLA I + TAR P ++ APE + + D++SFG+ + E+VT PY
Sbjct: 146 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP 205
Query: 230 ECKNPAQI 237
NP I
Sbjct: 206 GMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 43/174 (24%), Positives = 91/174 (52%), Gaps = 9/174 (5%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
++V+ + D++ +E +L++ +H + + T+ + + E G L +
Sbjct: 30 KEVIIAKDEVAHTVTESRVLQNTRHPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLS 87
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI- 179
+ + + + + +I+ L YLHS + +++RD+K +N+ ++ +G +KI D GL
Sbjct: 88 RERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKE 144
Query: 180 -VMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP-YNE 230
+ T ++ GTPE++APE+ E+ +Y VD + G+ + EM+ P YN+
Sbjct: 145 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 47/174 (27%), Positives = 89/174 (51%), Gaps = 9/174 (5%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
++V+ + D++ +E +LK+ +H + S+ T + + E G L +
Sbjct: 30 KEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF--QTKDRLCFVMEYVNGGELFFHLS 87
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI- 179
+ + + + +I+ L YLHS I++RDLK +N+ ++ +G +KI D GL
Sbjct: 88 RERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKE 144
Query: 180 -VMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP-YNE 230
+ T ++ GTPE++APE+ E+ +Y VD + G+ + EM+ P YN+
Sbjct: 145 GITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 55 WN---QVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT 111
WN +V ++ + E E ++K L+H+ +++ Y + I ++TE +
Sbjct: 27 WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV---SEEPIYIVTEYMS 83
Query: 112 SGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
GSL + K + + + + + + A Q+ G+ Y+ N IHRDL+ NI V G+
Sbjct: 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILV-GDGLV 140
Query: 170 VKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT- 223
KI D GLA +++ + TAR P ++ APE LY + D++SFG+ + E+VT
Sbjct: 141 CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTK 199
Query: 224 CEYPYNECKNPAQIYKKVTSGIK-------PASLSKV 253
PY N ++ ++V G + P SL ++
Sbjct: 200 GRVPYPGMNN-REVLEQVERGYRMPCPQDCPISLHEL 235
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITE--------LFTSGSLRQYRKKHKNVDM 127
E+ LL+ LKH N+I ++ ++R + ++ + + + KK +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP 184
+K+ QIL G+HYLH++ ++HRDLK NI V G G VKI D+G A + P
Sbjct: 108 SMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 185 TA-----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
V+ T + APEL Y + +DI++ G E++T E P C+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 53/149 (35%), Positives = 80/149 (53%), Gaps = 11/149 (7%)
Query: 80 LKSLKHENIIKFYN-SWVDDTNRTINMITELF--TSGSLRQYRKK--HKNVDMKAIKNWA 134
L++ +H N+++ ++ V T+R + T +F L Y K V + IK+
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTP 193
Q+LRGL +LHSH ++HRDLK NI V ++G++K+ D GLA I Q SV+ T
Sbjct: 117 FQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTL 173
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEM 221
+ APE L + Y VD++S G EM
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWV 96
F+ KG ++ I+ +DV+ D +E E +L + +H + Y ++
Sbjct: 12 FLAELKGTNQFFAIKAL-----KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF- 65
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
T + + E G L + + D+ +A +I+ GL +LHS I++RDL
Sbjct: 66 -QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDL 122
Query: 157 KCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYS 213
K DNI ++ +G +KI D G+ ++ + GTP+++APE L ++YN VD +S
Sbjct: 123 KLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWS 181
Query: 214 FGMCILEMVTCEYPYN 229
FG+ + EM+ + P++
Sbjct: 182 FGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 14/186 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YKG ++G VA ++++ P R E LLK LKH NI+ ++ + T
Sbjct: 22 YKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVLLHD--IIHTKE 76
Query: 102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
T+ + E + L QY +H + ++ + Q+LRGL Y+H + I+HRDLK N
Sbjct: 77 TLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQN 133
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIYSFGM 216
+ ++ GE+K+ D GLA P T S + T + P+ L +Y+ +DI+ G
Sbjct: 134 LLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGC 192
Query: 217 CILEMV 222
+EM+
Sbjct: 193 IFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 84/294 (28%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWV-----DDTNRTINMITELFTSGSLRQYR 119
QS +R Y E+ LLK ++HEN+I + + D+ ++ + T L++
Sbjct: 53 QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIM 110
Query: 120 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179
+ D ++ Q+L GL Y+HS IIHRDLK N+ VN + E+KI D GLA
Sbjct: 111 GHPLSED--KVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLAR 165
Query: 180 VMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237
V+ T + APE L YN+ VDI+S G + EM+T + + Q+
Sbjct: 166 HADAEMTGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 224
Query: 238 YK--KVTSGIKPASLSKVTDPQVKQFIEKCIVPA------SLRLP-----ALELLKDPFL 284
+ KVT P + K+ D K +I+ +P S P A++LL + L
Sbjct: 225 TQILKVTGVPGPEFVQKLEDKAAKSYIKS--LPKYPRKDFSTLFPKASPQAVDLL-EKML 281
Query: 285 VTDNPKDLVC---------DPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD 329
D K L D R + E P D L ++K+S D
Sbjct: 282 ELDVDKRLTATEALEHPYFDSFRDADEET--------EQQPYDDSLENEKLSVD 327
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 14/178 (7%)
Query: 49 DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108
+ I VA SP E+ E ++++ H +I+K ++ + ++ E
Sbjct: 33 EKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PVWIVME 86
Query: 109 LFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167
L G LR Y + +K +D+ ++ ++ Q+ L YL S +HRD+ N+ V+ +
Sbjct: 87 LAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPD 144
Query: 168 GEVKIGDLGLAIVMQQPT--ARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEM 221
VK+GD GL+ ++ + S P ++MAPE + + D++ FG+C+ E+
Sbjct: 145 C-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 66/265 (24%), Positives = 123/265 (46%), Gaps = 35/265 (13%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN 100
+K ++ +G + A V I D + D E + +E ++LK+L H N++KFY +
Sbjct: 35 FKVLNKKNGSKAA---VKILDPIHDID--EEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89
Query: 101 RT---INMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
+ + ++ EL GS+ + + K+ + ++ I + L GL +LH IH
Sbjct: 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--VNKTIH 147
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPEL------YEEEY 205
RD+K +NI + G VK+ D G++ + R + +GTP +MAPE+ + Y
Sbjct: 148 RDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTY 206
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV-----KQ 260
+ D++S G+ +E+ + P + +P + K+ P + P++
Sbjct: 207 DARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRNPPP----TLHQPELWSNEFND 261
Query: 261 FIEKCIVPA-SLRLPALELLKDPFL 284
FI KC+ R +LL+ F+
Sbjct: 262 FIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 41/127 (32%), Positives = 70/127 (55%), Gaps = 6/127 (4%)
Query: 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165
+ E G L + + D+ +A +I+ GL +LHS II+RDLK DN+ ++
Sbjct: 74 VMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDR 131
Query: 166 NNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 222
+G +KI D G+ V A + GTP+++APE+ + +Y VD +SFG+ + EM+
Sbjct: 132 -DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
Query: 223 TCEYPYN 229
+ P++
Sbjct: 191 IGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 47/182 (25%), Positives = 88/182 (48%), Gaps = 12/182 (6%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKA 129
+ E ++ L HE +++ Y V R I ++TE ++G L Y ++H K
Sbjct: 44 DEFIEEAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ 101
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
+ + + G+ YL S IHRDL N V+ + G VK+ D GL+ + S
Sbjct: 102 LLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSS 158
Query: 190 IGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+G+ + PE L +++ D+++FG+ + E+ + + PY N ++ +KV+ G
Sbjct: 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQG 217
Query: 245 IK 246
++
Sbjct: 218 LR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 7e-13
Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 23/197 (11%)
Query: 77 VHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQ 136
VH L + N IK Y S T + +I + G L KK + +K RQ
Sbjct: 61 VHQLMK-DNPNFIKLYYSV--TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ 117
Query: 137 ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 196
++ L+ LH HN IIH D+K +N+ + + + D GL ++ P+ GT ++
Sbjct: 118 LVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--GTLDYF 173
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPY----NECKNPAQ----IYKKVTSGIKP 247
+PE + Y+ D ++ G+ E++T ++P+ +E + KK+
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP----- 228
Query: 248 ASLSKVTDPQVKQFIEK 264
K F++
Sbjct: 229 --FIKNVSKNANDFVQS 243
|
Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 44 GFDEVDGIEVAWNQVNIEDVMQSPDQLE--RLYSEVHLLKSLKHENIIKFYNS------- 94
GF EV + QV M + +L+ RL + +L + I++ NS
Sbjct: 5 GFGEVCAV-----QVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 95 WVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
+ ++ + ++ L G L+ Y + ++M+ + +++ QI G+ LH H+ I+
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI--LHLHSMDIV 117
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE-LYEEEYNELV 209
+RD+K +N+ ++ + G ++ DLGLA+ ++ + + GT +MAPE L EE Y+ V
Sbjct: 118 YRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPEILKEEPYSYPV 175
Query: 210 DIYSFGMCILEMVTCEYPYNECK 232
D ++ G I EMV P+ + K
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 14/160 (8%)
Query: 76 EVHLLKSLKHEN-IIKFYN-SWVDDTNRTINM-ITELFTSGSLRQY-----RKKHKNVDM 127
E+ LL+ L I++ + V++ N ++ + + L+++ R + +
Sbjct: 50 EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPA 109
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
K IK++ Q+L+G+ + H H ++HRDLK N+ V+ G +KI DLGL P
Sbjct: 110 KTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 188 SV--IGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 223
I T + APE L Y+ VDI+S G EM
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 52/175 (29%), Positives = 83/175 (47%), Gaps = 21/175 (12%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITE--------LFTSGSLRQYRKKHKNVDM 127
E+ LL+ LKH N+I ++ +R + ++ + + + KK +
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP 184
+K+ QIL G+HYLH++ ++HRDLK NI V G G VKI D+G A + P
Sbjct: 108 GMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 185 TA-----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
V+ T + APEL Y + +DI++ G E++T E P C+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 60/157 (38%), Positives = 83/157 (52%), Gaps = 16/157 (10%)
Query: 76 EVHLLKSLK---HENIIKFYNSWVDDTNRTIN--MITELF--TSGSLRQYRKK--HKNVD 126
EV LLK L+ H NI++ + V T+RT +T +F LR Y K +
Sbjct: 49 EVALLKRLEAFDHPNIVRLMD--VCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLP 106
Query: 127 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPT 185
+ IK+ RQ LRGL +LH++ I+HRDLK +NI V + G+VK+ D GLA I Q
Sbjct: 107 AETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMA 163
Query: 186 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 221
V+ T + APE L + Y VD++S G EM
Sbjct: 164 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 42/207 (20%)
Query: 49 DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV--DDTN----RT 102
DG A V++E + S R +EV L + +I+K + + D N
Sbjct: 56 DGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM 113
Query: 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWAR---------------QILRGLHYLHSH 147
I ++ + +G LRQ IK+ A+ Q+L +H++HS
Sbjct: 114 IALVLDYANAGDLRQ-----------EIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK 162
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----AIVMQQPTARSVIGTPEFMAPELYEE 203
+ +IHRD+K NI + +NG VK+GD G A + R+ GTP ++APE++
Sbjct: 163 H--MIHRDIKSANILL-CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219
Query: 204 E-YNELVDIYSFGMCILEMVTCEYPYN 229
+ Y++ D++S G+ + E++T + P++
Sbjct: 220 KPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 56/181 (30%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRKKHKNVDMKAI 130
SE+H L + H I+K ++ + D + +I E + G L +Q K+H +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----A 186
QI+ L +HS ++HRDLK NIF+ G +K+GD G + A
Sbjct: 172 GLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 187 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ--IYKKVTS 243
S GTP ++APEL+E + Y++ D++S G+ + E++T P+ K P+Q I ++V
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLY 285
Query: 244 G 244
G
Sbjct: 286 G 286
|
Length = 478 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-----RQYRKKHKNVDMKAIKNWAR 135
+S I+KFY + + + I M EL SL Y + + + A
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICM--ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAV 114
Query: 136 QILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTP 193
++ L+YL IIHRD+K NI ++ NG +K+ D G++ + A++ G
Sbjct: 115 ATVKALNYLKEELK--IIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIAKTRDAGCR 171
Query: 194 EFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IK 246
+MAPE + Y+ D++S G+ + E+ T ++PY + + +V G I
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL 231
Query: 247 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPF 283
S + P FI C++ S R ELL+ PF
Sbjct: 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 17/179 (9%)
Query: 55 WN---QVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT 111
WN +V I+ + E E ++K L+HE +++ Y ++ I ++TE +
Sbjct: 27 WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMS 83
Query: 112 SGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
GSL + K K + + + + A QI G+ Y+ N +HRDL+ NI V G N
Sbjct: 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV-GENLV 140
Query: 170 VKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 223
K+ D GLA +++ + TAR P ++ APE LY + D++SFG+ + E+ T
Sbjct: 141 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 70/247 (28%)
Query: 76 EVHLLKSLKHENIIKFY---NSWVDDTNR---TINMITELFT---SGSLRQYRKKHKNVD 126
E+ +L+ LKHEN++ + NR + ++ E +G L KNV
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN-----KNVK 115
Query: 127 MK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
IK + +L GL+Y+H + I+HRD+K NI + +G +K+ D GLA
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLARAFSLS 172
Query: 185 --------TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT---------- 223
T R V T + PEL E +Y +D++ G CI+ EM T
Sbjct: 173 KNSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWTRSPIMQGNTE 229
Query: 224 ----------C------------EYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260
C + + + + P +KV +KP V DP
Sbjct: 230 QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKDPHALD 285
Query: 261 FIEKCIV 267
I+K +V
Sbjct: 286 LIDKLLV 292
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 48/166 (28%), Positives = 89/166 (53%), Gaps = 9/166 (5%)
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
LLK++KH ++ + S+ T + + + G L + ++ ++ + +A +I
Sbjct: 49 LLKNVKHPFLVGLHYSF--QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFM 196
L YLHS N I++RDLK +NI ++ + G V + D GL + Q T + GTPE++
Sbjct: 107 SALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYL 163
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
APE + ++ Y+ VD + G + EM+ P+ C++ A++Y +
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 51/188 (27%), Positives = 94/188 (50%), Gaps = 11/188 (5%)
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
LLK++KH ++ + S+ T + + + G L + ++ + + +A +I
Sbjct: 49 LLKNVKHPFLVGLHFSF--QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 106
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFM 196
L YLHS N I++RDLK +NI ++ + G + + D GL + T + GTPE++
Sbjct: 107 SALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYL 163
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
APE L+++ Y+ VD + G + EM+ P+ +N A++Y + + KP L
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILN--KPLQLKPNIT 220
Query: 256 PQVKQFIE 263
+ +E
Sbjct: 221 NSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 45/174 (25%), Positives = 90/174 (51%), Gaps = 8/174 (4%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
++V+ + D++ +E +L++ +H + S+ T+ + + E G L +
Sbjct: 30 KEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYANGGELFFHLS 87
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI- 179
+ + + + +I+ L YLHS +++RDLK +N+ ++ +G +KI D GL
Sbjct: 88 RERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLD-KDGHIKITDFGLCKE 145
Query: 180 -VMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP-YNE 230
+ T ++ GTPE++APE+ E+ +Y VD + G+ + EM+ P YN+
Sbjct: 146 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 59/224 (26%), Positives = 108/224 (48%), Gaps = 15/224 (6%)
Query: 61 EDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYR 119
+DV+ D +E +E +L + H + + Y + T + + E G L +
Sbjct: 30 KDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF--QTPDRLFFVMEFVNGGDLMFHI 87
Query: 120 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179
+K + D + +A +I L +LH II+RDLK DN+ ++ + G K+ D G+
Sbjct: 88 QKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCK 144
Query: 180 --VMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 236
+ T + GTP+++APE L E Y VD ++ G+ + EM+ P+ E +N
Sbjct: 145 EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF-EAENEDD 203
Query: 237 IYKKVTSG--IKPASLSKVTDPQVKQFIEKCIVPASLRLPALEL 278
+++ + + + P LS+ +K F+ K ++RL +L L
Sbjct: 204 LFEAILNDEVVYPTWLSQDAVDILKAFMTK---NPTMRLGSLTL 244
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 39/129 (30%), Positives = 69/129 (53%), Gaps = 5/129 (3%)
Query: 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165
I +L G L + +H K ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 166 NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 223
+G V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191
Query: 224 CEYPYNECK 232
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 49/168 (29%), Positives = 87/168 (51%), Gaps = 9/168 (5%)
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
LLK+LKH ++ + S+ T + + + G L + ++ + + +A ++
Sbjct: 49 LLKNLKHPFLVGLHYSF--QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA 106
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFM 196
+ YLHS N II+RDLK +NI ++ + G V + D GL +P T + GTPE++
Sbjct: 107 SAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYL 163
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243
APE L +E Y+ VD + G + EM+ P+ ++ +Q+Y +
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 34/187 (18%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
S +L L SE +LLK + H ++IK Y + D + +I E GSLR + ++ + V
Sbjct: 43 SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRSFLRESRKV 100
Query: 126 D------------------------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
M + ++A QI RG+ YL ++HRDL N+
Sbjct: 101 GPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNV 158
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGM 216
V ++KI D GL+ + + + RS P ++MA E L++ Y D++SFG+
Sbjct: 159 LV-AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 217 CILEMVT 223
+ E+VT
Sbjct: 218 LLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 64/286 (22%), Positives = 111/286 (38%), Gaps = 57/286 (19%)
Query: 44 GFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F EV G A + D+++ Q+ + +E +L I+K Y S+
Sbjct: 13 AFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN-QIAHVRAERDILADADSPWIVKLYYSFQ 71
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
D+ + + ++ E G L + + + + +++ L +H IHRD+
Sbjct: 72 DEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDI 127
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVM-----------------------------QQPT-- 185
K DNI + +G +K+ D GL M +Q
Sbjct: 128 KPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR 186
Query: 186 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVT 242
A S +GTP+++APE L Y D +S G+ + EM+ +P Y++ + Y K+
Sbjct: 187 ANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY-GFPPFYSD--TLQETYNKII 243
Query: 243 SGIKPASLSKVTDPQV----KQFIEKCIVPASLRL-PALELLKDPF 283
+ + SL DP V I + + RL E+ PF
Sbjct: 244 NWKE--SLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 5/102 (4%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 191
+A +I GL LH I++RDLK +NI ++ + G ++I DLGLA+ + + T R +G
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVG 163
Query: 192 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK 232
T +MAPE+ + E Y D + G I EM+ + P+ + K
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 28/176 (15%)
Query: 63 VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM--------ITELFTSGS 114
++ +++ + +E +L + K E ++K ++ DD + M T L G
Sbjct: 38 LLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV 97
Query: 115 LRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174
L + + +M + LH L IHRDLK +N F+ +G +K+ D
Sbjct: 98 LSEDHARFYMAEMFEAVD-------ALHELG-----YIHRDLKPEN-FLIDASGHIKLTD 144
Query: 175 LGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
GL+ IV A SV+G+P++MAPE L + Y+ VD +S G C+L C +P
Sbjct: 145 FGLSKGIVTY---ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLG-CMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 8e-12
Identities = 56/179 (31%), Positives = 91/179 (50%), Gaps = 17/179 (9%)
Query: 55 WN---QVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT 111
WN +V I+ + E E ++K L+H+ ++ Y ++ I ++TE
Sbjct: 27 WNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEP---IYIVTEFMG 83
Query: 112 SGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
GSL + K+ K + + + + A QI G+ Y+ N IHRDL+ NI V G+N
Sbjct: 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILV-GDNLV 140
Query: 170 VKIGDLGLAIVMQ--QPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 223
KI D GLA +++ + TAR P ++ APE LY + D++SFG+ + E+VT
Sbjct: 141 CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 43/171 (25%), Positives = 89/171 (52%), Gaps = 8/171 (4%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
++V+ + D++ +E +L++ +H + S+ T+ + + E G L +
Sbjct: 30 KEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF--QTHDRLCFVMEYANGGELFFHLS 87
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI- 179
+ + + + +I+ L YLHS + +++RDLK +N+ ++ +G +KI D GL
Sbjct: 88 RERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKE 144
Query: 180 -VMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 228
+ T ++ GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 145 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 63/267 (23%), Positives = 124/267 (46%), Gaps = 34/267 (12%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWV 96
+ R K + + ++V ++ +D + ++ + +E H+ ++ H ++ ++ +
Sbjct: 12 LLVRLKKTERIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHPFLVGLHSCF- 65
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
T + + E G L + ++ + + + + ++ +I L+YLH II+RDL
Sbjct: 66 -QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDL 122
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYS 213
K DN+ ++ + G +K+ D G+ +P T + GTP ++APE+ E+Y VD ++
Sbjct: 123 KLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181
Query: 214 FGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPA 269
G+ + EM+ P++ NP Q D + +EK I +P
Sbjct: 182 LGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDYLFQVILEKQIRIPR 226
Query: 270 SLRLPALELLKDPFLVTDNPKDLVCDP 296
SL + A +LK FL D + L C P
Sbjct: 227 SLSVKAASVLKS-FLNKDPKERLGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 55/169 (32%), Positives = 86/169 (50%), Gaps = 22/169 (13%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRK 120
Q+ +R Y E+ L+K + H+NII N + + + + ++ EL + +L Q
Sbjct: 54 QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQV-- 110
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
++D + + Q+L G+ +LHS IIHRDLK NI V ++ +KI D GLA
Sbjct: 111 IQMDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA-- 165
Query: 181 MQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCIL-EMV 222
+ S + TP + APE + Y E VDI+S G CI+ EM+
Sbjct: 166 --RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 38/129 (29%), Positives = 68/129 (52%), Gaps = 5/129 (3%)
Query: 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165
I +L G L + +H ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 166 NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 223
+G V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 224 CEYPYNECK 232
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/177 (31%), Positives = 85/177 (48%), Gaps = 29/177 (16%)
Query: 70 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
L L SE+ ++K + KH+NII + D + +I E + G+LR+Y + + M+
Sbjct: 64 LSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGME 121
Query: 129 AIKNWAR----------------QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172
+ AR Q+ RG+ YL S IHRDL N+ V NN +KI
Sbjct: 122 YSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN-VMKI 178
Query: 173 GDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 179 ADFGLARDVNNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 76 EVHLLKSLKHENIIKFYNSWVD--DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNW 133
E+ L+ + NI+K Y +D D +++I E T G LR+ K K++ K +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 134 ARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
A +GL+ L+ N P +++L + V N ++KI GL ++ P ++V
Sbjct: 128 AIDCCKGLYNLYKYTNKP--YKNLTSVSFLVT-ENYKLKIICHGLEKILSSPPFKNV--- 181
Query: 193 PEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
FM Y+ EY DIYS G+ + E+ T + P+ +IY + +
Sbjct: 182 -NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNN 239
Query: 247 PASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
L ++K +E C S++ P +
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
|
Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 33/210 (15%)
Query: 42 YKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
Y+G VA VN M+ +++E +E ++K ++++ V
Sbjct: 23 YEGLAKGVVKGEPETRVAIKTVNENASMR--ERIE-FLNEASVMKEFNCHHVVRLLGV-V 78
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKA----------IKNWARQILRGLHYLHS 146
T+ ++ EL G L+ Y + + A +I G+ YL +
Sbjct: 79 STGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA 137
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ---QPTARSVIGTP-EFMAPE- 199
+HRDL N V + VKIGD G+ I + + ++ P +MAPE
Sbjct: 138 KK--FVHRDLAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLL--PVRWMAPES 192
Query: 200 LYEEEYNELVDIYSFGMCILEMVT-CEYPY 228
L + + D++SFG+ + EM T E PY
Sbjct: 193 LKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 69/247 (27%), Positives = 118/247 (47%), Gaps = 20/247 (8%)
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
LLK++KH ++ + S+ T + + + G L + ++ ++ + +A +I
Sbjct: 49 LLKNVKHPFLVGLHYSF--QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFM 196
L YLHS N II+RDLK +NI ++ + G V + D GL + T + GTPE++
Sbjct: 107 SALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYL 163
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255
APE L ++ Y+ VD + G + EM+ P+ ++ A++Y + + KP L
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDTAEMYDNILN--KPLRLKPNIS 220
Query: 256 PQVKQFIEKCIVP-ASLRLPA----LELLKDPFLVTDNPKDLVCDPLRLPNLVPEV---M 307
+ +E + + RL A LE+ F + N DLV + P P V M
Sbjct: 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPP-FNPNVSGPM 279
Query: 308 NLAHSEP 314
+L H +P
Sbjct: 280 DLKHFDP 286
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 51/180 (28%), Positives = 93/180 (51%), Gaps = 17/180 (9%)
Query: 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT-----ELFTSGSLRQYRKKHKNVDM 127
L +E+ L L HENI+K + N MIT +L++ + K + + +
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTY--MITQKYDFDLYSFMYDEAFDWKDRPL-L 266
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TA 186
K + +Q+L + Y+H +IHRD+K +NIF+N +G++ +GD G A+ ++ A
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC-DGKIVLGDFGTAMPFEKEREA 323
Query: 187 RSV--IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY-PYNE-CKNPAQIYKKV 241
+GT +PE L + Y E+ DI+S G+ +L+M++ ++ P + P + K+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383
|
Length = 501 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 80/315 (25%), Positives = 134/315 (42%), Gaps = 56/315 (17%)
Query: 57 QVNIEDVMQSPDQLERLYSEVHLLKSLKHENII----KFYNSWV--DDTNRTINMITELF 110
+V I+ V+Q P R E+ ++K+L H NII +Y ++ N +N++ E
Sbjct: 93 KVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI 149
Query: 111 ---TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167
++ Y + + + + +K ++ Q+ R L Y+HS I HRDLK N+ ++ N
Sbjct: 150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNT 207
Query: 168 GEVKIGDLGLAI-VMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTC 224
+K+ D G A ++ + S I + + APEL Y +D++S G I EM+
Sbjct: 208 HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL- 266
Query: 225 EYPYNECKN--------------PAQIYKKVTS---------GIKPASLSKV----TDPQ 257
YP ++ P + K + +KP L KV T
Sbjct: 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDD 326
Query: 258 VKQFIEKCIVPASL-RLPALELLKDPFLVTDNPKDLVCDP-LRLPNLV---PEVMNLAHS 312
FI + + L RL +E L DPF D + DP ++LP + P++ N +
Sbjct: 327 AINFISQFLKYEPLKRLNPIEALADPFF------DDLRDPCIKLPKYIDKLPDLFNFCDA 380
Query: 313 EPHPMDIDLNHKKVS 327
E M K +
Sbjct: 381 EIKEMSDACRRKIIP 395
|
Length = 440 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA------IVMQQ 183
+++ QIL GL Y+HS N ++HRDLK N+ VN + E+KI D GLA
Sbjct: 107 FQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNA-DCELKICDFGLARGFSENPGENA 163
Query: 184 PTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL 219
+ T + APE L + Y + +D++S G CIL
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 51/190 (26%), Positives = 93/190 (48%), Gaps = 12/190 (6%)
Query: 43 KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102
KG DE+ I++ V I+D D +E E +L + +S +R
Sbjct: 22 KGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR- 75
Query: 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 162
+ + E G L + ++ +A +I GL +LH II+RDLK DN+
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVM 133
Query: 163 VNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL 219
++ + G +KI D G+ ++ T R+ GTP+++APE+ + Y + VD +++G+ +
Sbjct: 134 LD-SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLY 192
Query: 220 EMVTCEYPYN 229
EM+ + P++
Sbjct: 193 EMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 22/197 (11%)
Query: 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164
+ E + G L + ++ + + + + ++ +I L++LH II+RDLK DN+ ++
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD 130
Query: 165 GNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 221
G +K+ D G+ +P T + GTP ++APE L E+Y VD ++ G+ + EM
Sbjct: 131 A-EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 222 VTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLK 280
+ P++ G+ D + +EK I +P SL + A +LK
Sbjct: 190 MAGRSPFD------------IVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 281 DPFLVTDNPKD-LVCDP 296
FL +PK+ L C P
Sbjct: 238 G-FL-NKDPKERLGCHP 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 44/154 (28%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWA 134
E ++ S+ H ++++ + + TI ++T+L G L Y +HK N+ + + NW
Sbjct: 59 EALIMASMDHPHLVRLLGVCL---SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC 115
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVI 190
QI +G+ YL ++HRDL N+ V N VKI D GLA +++ + A
Sbjct: 116 VQIAKGMMYLEERR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGK 172
Query: 191 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
++MA E ++ ++ D++S+G+ I E++T
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
T+ + ++T+ + G L + +K K + +++ L +LH ++ I++RDLK
Sbjct: 67 TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKP 124
Query: 159 DNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSF 214
+NI ++ G + + D GL A + T + GT E++APE+ +E Y + VD +S
Sbjct: 125 ENILLDA-TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL 183
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSG 244
G+ + EM P+ ++ Q+Y+ + G
Sbjct: 184 GVLVFEMCCGWSPF-YAEDTQQMYRNIAFG 212
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 11/160 (6%)
Query: 70 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDM 127
++ E +L+K+L+H+ +++ Y V I +ITE GSL + K + V +
Sbjct: 45 VQAFLEEANLMKTLQHDKLVRLYA--VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL 102
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPT 185
+ +++ QI G+ Y+ N IHRDL+ N+ V+ + KI D GLA V++ + T
Sbjct: 103 PKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYT 159
Query: 186 ARSVIGTP-EFMAPELYE-EEYNELVDIYSFGMCILEMVT 223
AR P ++ APE + D++SFG+ + E+VT
Sbjct: 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 64/264 (24%), Positives = 120/264 (45%), Gaps = 30/264 (11%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ R K D++ ++V ++ +D + ++ + +E H+ + + +S
Sbjct: 12 LLVRLKKNDQIYAMKVVKKELVHDD-----EDIDWVQTEKHVFEQASSNPFLVGLHSCFQ 66
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
T+R ++ E G L + ++ + + + + +A +I L++LH II+RDLK
Sbjct: 67 TTSRLF-LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLK 123
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSF 214
DN+ ++ +G +K+ D G+ P T + GTP ++APE+ EEY VD ++
Sbjct: 124 LDNVLLDA-DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 182
Query: 215 GMCILEMVTCEYPYN-ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLR 272
G+ + EM+ P++ NP D + +EK I +P L
Sbjct: 183 GVLMFEMMAGRSPFDIITDNPDM---------------NTEDYLFQVILEKPIRIPRFLS 227
Query: 273 LPALELLKDPFLVTDNPKDLVCDP 296
+ A +LK FL D + L C P
Sbjct: 228 VKASHVLKG-FLNKDPKERLGCQP 250
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 16/152 (10%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 191
+A +I GL LH I++RDLK +NI ++ ++G ++I DLGLA+ V + T + +G
Sbjct: 107 YAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 163
Query: 192 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250
T +MAPE+ + E Y D ++ G + EM+ + P+ + K KK IK +
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK------KK----IKREEV 213
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKDP 282
++ +++ EK P + L + L KDP
Sbjct: 214 ERLVKEVQEEYSEK-FSPDARSLCKMLLCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 40/125 (32%), Positives = 74/125 (59%), Gaps = 9/125 (7%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 190
+A +I GL +LHS II+RDLK DN+ ++ + G +KI D G+ + T ++
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFC 162
Query: 191 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP 247
GTP+++APE+ + Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYP 221
Query: 248 ASLSK 252
S+SK
Sbjct: 222 KSMSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 22/190 (11%)
Query: 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN------- 124
E HL+ + H NI+K + N +I EL G L Y + +
Sbjct: 45 EFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPPL 102
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIV 180
+ +K + + + +G YL + IHRDL N V+ + VKIGD GLA
Sbjct: 103 LTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160
Query: 181 MQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNP 234
+ + G +MAPE L + ++ D++SFG+ + E++T + PY N
Sbjct: 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN- 219
Query: 235 AQIYKKVTSG 244
++ + VT+G
Sbjct: 220 QEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 54/175 (30%), Positives = 93/175 (53%), Gaps = 13/175 (7%)
Query: 70 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDM 127
+E +E +++K+L+H+ ++K ++ V T I +ITE GSL + K + +
Sbjct: 45 VEAFLAEANVMKTLQHDKLVKL-HAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL 101
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPT 185
+ +++ QI G+ ++ N IHRDL+ NI V+ + KI D GLA V++ + T
Sbjct: 102 PKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT 158
Query: 186 ARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
AR P ++ APE + + D++SFG+ ++E+VT PY NP I
Sbjct: 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 21/195 (10%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-- 118
ED M+ +E E ++K +KH N+++ V +ITE T G+L Y
Sbjct: 41 EDTME----VEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLR 94
Query: 119 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
+ V+ + A QI + YL N IHRDL N V G N VK+ D GL+
Sbjct: 95 ECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV-GENHLVKVADFGLS 151
Query: 179 IVMQQPTARSVIGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVT---CEYPYNEC 231
+M T + G ++ APE L +++ D+++FG+ + E+ T YP +
Sbjct: 152 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 211
Query: 232 KNPAQIYKKVTSGIK 246
+Q+Y+ + G +
Sbjct: 212 ---SQVYELLEKGYR 223
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 72/259 (27%), Positives = 114/259 (44%), Gaps = 25/259 (9%)
Query: 44 GFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 100
FD V GI VA +++ Q+ +R Y E+ LLK + H+NII N + +
Sbjct: 40 AFDTVLGINVAVKKLS--RPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97
Query: 101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ + ++ EL + + H +D + + Q+L G+ +LHS IIHRDLK
Sbjct: 98 FQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 152
Query: 160 NIFVNGNNGEVKIGDLGLAIV-----MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYS 213
NI V ++ +KI D GLA M P + T + APE + Y E VDI+S
Sbjct: 153 NIVVK-SDCTLKILDFGLARTACTNFMMTP----YVVTRYYRAPEVILGMGYKENVDIWS 207
Query: 214 FGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVTDPQVKQFIEKCIVPASLR 272
G + E+V + + Q K + G A P V+ ++E P
Sbjct: 208 VGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN--RPQYPG 265
Query: 273 LPALELLKDPFLVTDNPKD 291
+ EL D +++ +D
Sbjct: 266 ISFEELFPDWIFPSESERD 284
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 52/192 (27%), Positives = 94/192 (48%), Gaps = 16/192 (8%)
Query: 68 DQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKN 124
+ E L SE+ ++ L HENI+ + I +ITE G L + RK+
Sbjct: 80 SEREALMSELKIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESF 137
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV-KIGDLGLAIVMQQ 183
+ ++ + +++ Q+ +G+ +L S N IHRDL N+ + +G++ KI D GLA +
Sbjct: 138 LTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLL--THGKIVKICDFGLARDIMN 193
Query: 184 PTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
+ V G ++MAPE ++ Y D++S+G+ + E+ + PY ++
Sbjct: 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253
Query: 238 YKKVTSGIKPAS 249
YK + G + A
Sbjct: 254 YKLIKEGYRMAQ 265
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 29/181 (16%)
Query: 66 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK- 123
+ L L SE+ ++K + KH+NII + D + +I E + G+LR+Y + +
Sbjct: 63 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRP 120
Query: 124 ---------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168
+ K + + A Q+ RG+ YL S IHRDL N+ V +N
Sbjct: 121 PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN- 177
Query: 169 EVKIGDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 222
+KI D GLA I + T + ++MAPE L++ Y D++SFG+ + E+
Sbjct: 178 VMKIADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
Query: 223 T 223
T
Sbjct: 237 T 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 36/98 (36%), Positives = 57/98 (58%), Gaps = 5/98 (5%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 191
+A +IL GL LH N ++RDLK +NI ++ + G ++I DLGLA+ + + + R +G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 228
T +MAPE L + Y D + G I EM+ + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167
ELFT R++ + ++ + +I+ L +LH II+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTES------EVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDS-E 141
Query: 168 GEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 221
G V + D GL+ A S GT E+MAPE+ +++ VD +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 222 VTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
+T P+ E + ++I +++ P K + + FI+K
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQK 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 29/177 (16%)
Query: 70 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---------- 118
L L SE+ L+K + KH+NII + + +I E G+LR++
Sbjct: 61 LADLISEMELMKLIGKHKNIINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPD 118
Query: 119 ------RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172
+ + + K + + A Q+ RG+ YL S IHRDL N+ V +N +KI
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMKI 175
Query: 173 GDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
D GLA I + T+ + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 176 ADFGLARGVHDIDYYKKTSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 44/164 (26%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 124
SP + + E +++ S+ + ++ + + T+ +IT+L G L Y ++HK N
Sbjct: 49 SPKANKEILDEAYVMASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDN 105
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--- 181
+ + + NW QI +G++YL ++HRDL N+ V VKI D GLA ++
Sbjct: 106 IGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAD 162
Query: 182 -QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
++ A ++MA E + Y D++S+G+ + E++T
Sbjct: 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 24/114 (21%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----------PT 185
+I + Y+HS ++HRDLK DNI + G GEV I D G AI +
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 186 ARS----------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 228
++GTP++MAPE L +E DIY+ G+ + +M+T +PY
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 70 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM- 127
L L SE+ ++K + KH+NII V + ++ E G+LR + + +
Sbjct: 59 LSDLVSEMEMMKMIGKHKNIINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEY 116
Query: 128 ---------------KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172
K + ++A Q+ RG+ +L S IHRDL N+ V ++ +KI
Sbjct: 117 ASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDH-VMKI 173
Query: 173 GDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 37/128 (28%), Positives = 74/128 (57%), Gaps = 9/128 (7%)
Query: 102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
++ ++T+L GSL + ++H+ ++D + + NW QI +G++YL H ++HR+L N
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARN 139
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTP-EFMAPE-LYEEEYNELVDIYSFG 215
I + ++ V+I D G+A ++ + S TP ++MA E + Y D++S+G
Sbjct: 140 ILLK-SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 216 MCILEMVT 223
+ + EM++
Sbjct: 199 VTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSV 189
ARQ+L + Y+H IIHRD+K +N+ VNG ++ +GD G A + P +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGI 322
Query: 190 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 220
GT + APE L + Y VDI+S G+ I E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 38/132 (28%), Positives = 72/132 (54%), Gaps = 7/132 (5%)
Query: 113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172
G L + ++ D+ + + ++L L LH N +I+RDLK +NI ++ G + +
Sbjct: 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134
Query: 173 GDLGLAIVMQQPTARS--VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 229
D GL + + ++ GTPE++APEL Y + VD ++ G+ + EM+T P+
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
Query: 230 ECKNPAQIYKKV 241
+ +N ++Y+K+
Sbjct: 195 D-ENVNEMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167
ELFT S R+ K+ + ++ ++ +I+ L +LH II+RD+K +NI ++ +N
Sbjct: 91 ELFTHLSQRERFKEQE------VQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SN 141
Query: 168 GEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 221
G V + D GL+ + A S GT E+MAP++ + +++ VD +S G+ + E+
Sbjct: 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201
Query: 222 VTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRL---- 273
+T P+ E + A+I +++ P + K I++ ++ RL
Sbjct: 202 LTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDIIQRLLMKDPKKRLGCGP 259
Query: 274 -PALELLKDPFLVTDNPKDLVCDPLRLP 300
A E+ K PF N DL + P
Sbjct: 260 SDADEIKKHPFFQKINWDDLAAKKVPAP 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 29/177 (16%)
Query: 70 LERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM- 127
L L SE+ ++K + KH+NII + D + ++ E + G+LR+Y + + M
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 128 ---------------KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172
K + + A Q+ RG+ YL S IHRDL N+ V +N +KI
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDN-VMKI 175
Query: 173 GDLGLA-----IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 67 PDQLE-RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 124
P +L+ + SE +LK H NI+K V + I ++ EL G + RKK
Sbjct: 32 PQELKIKFLSEARILKQYDHPNIVKLIG--VCTQRQPIYIVMELVPGGDFLSFLRKKKDE 89
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
+ K + +A G+ YL S N IHRDL N V G N +KI D G++ +
Sbjct: 90 LKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLV-GENNVLKISDFGMS-RQEDD 145
Query: 185 TARSVIGTPE----FMAPE-LYEEEYNELVDIYSFGMCILEMVT---CEYPYNECKNPAQ 236
S G + + APE L Y+ D++S+G+ + E + C YP Q
Sbjct: 146 GIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYP---GMTNQQ 202
Query: 237 IYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
++V G + + K D V + +++C
Sbjct: 203 AREQVEKGYRMSCPQKCPD-DVYKVMQRC 230
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 26/169 (15%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------------- 122
E LL +L+HE+I+KFY D + M+ E G L ++ + H
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 114
Query: 123 ---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179
+ + + + A QI G+ YL S + +HRDL N V G N VKIGD G++
Sbjct: 115 QAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSR 171
Query: 180 VMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 223
+ V G +M PE + ++ D++SFG+ + E+ T
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 4/87 (4%)
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE 202
H H+ II+RDLK +NI ++ G +K+ D GL+ + + A S GT E+MAPE+
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 203 EE-YNELVDIYSFGMCILEMVTCEYPY 228
+ + D +SFG+ + EM+T P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 52/192 (27%), Positives = 91/192 (47%), Gaps = 17/192 (8%)
Query: 69 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMK 128
Q + SE ++ H NII+ V + +ITE +G+L +Y + H +
Sbjct: 49 QRQDFLSEASIMGQFSHHNIIRLEG--VVTKFKPAMIITEYMENGALDKYLRDHDG-EFS 105
Query: 129 AIK--NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
+ + R I G+ YL N +HRDL NI VN +N E K+ D GL+ V++
Sbjct: 106 SYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPE 162
Query: 187 RSVIGTP-----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 239
+ + + APE + ++ D++SFG+ + E+++ E PY + N ++ K
Sbjct: 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMK 221
Query: 240 KVTSGIK-PASL 250
+ G + PA +
Sbjct: 222 AINDGFRLPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 49/215 (22%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV-DMKAIKN 132
+E ++ L+H N+++ V++ + ++TE GSL Y R + ++V +
Sbjct: 48 AEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 106
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVI 190
++ + + YL ++N +HRDL N+ V+ +N K+ D GL Q T + +
Sbjct: 107 FSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPV 163
Query: 191 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249
++ APE L E++++ D++SFG+ + E+ Y + P K V ++
Sbjct: 164 ---KWTAPEALREKKFSTKSDVWSFGILLWEI----YSFGRVPYPRIPLKDVVPRVEKGY 216
Query: 250 LSKVTD---PQVKQFIEKCIVPASLRLPALELLKD 281
D P V +++C + P+ L++
Sbjct: 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 53/188 (28%), Positives = 77/188 (40%), Gaps = 17/188 (9%)
Query: 49 DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108
EVA PD + E +LK H NI+K V + I ++ E
Sbjct: 18 GNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVME 72
Query: 109 LFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167
L GSL + RKK + +K + + G+ YL S N IHRDL N V G N
Sbjct: 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLV-GEN 129
Query: 168 GEVKIGDLGLAIVMQQPTARSVIGTPE----FMAPE-LYEEEYNELVDIYSFGMCILEMV 222
+KI D G++ + G + + APE L Y D++S+G+ + E
Sbjct: 130 NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETF 189
Query: 223 T---CEYP 227
+ YP
Sbjct: 190 SLGDTPYP 197
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA 134
E+ +LK++ H II +++ T+ M+ + L Y + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAY--RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQ 191
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVI 190
R++L L YLH IIHRD+K +NIF++ +GD G A + P
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 191 GTPEFMAPELYE-EEYNELVDIYSFGMCILEM 221
GT E +PEL + Y DI+S G+ + EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 28/203 (13%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
S D + E LL + +HENI+KFY + M+ E G L ++ + H
Sbjct: 46 TASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD--PPIMVFEYMEHGDLNKFLRSHG 103
Query: 124 NVDMKAIKN--------------WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
A QI G+ YL S + +HRDL N V G +
Sbjct: 104 PDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLV 160
Query: 170 VKIGDLGLAIVMQQPTARSVIGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 223
VKIGD G++ + V G +M PE +Y + E D++SFG+ + E+ T
Sbjct: 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFT 219
Query: 224 C-EYPYNECKNPAQIYKKVTSGI 245
+ P+ N ++ + +T G
Sbjct: 220 YGKQPWYGLSN-EEVIECITQGR 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 5/102 (4%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 191
+A ++ GL L I++RDLK +NI ++ + G ++I DLGLA+ + + T R +G
Sbjct: 107 YAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVG 163
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 232
T +MAPE + E+Y D + G I EM+ + P+ + K
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 49/192 (25%), Positives = 74/192 (38%), Gaps = 16/192 (8%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
D + Q R E L L H NI+ +S + E +LR+
Sbjct: 13 TDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLF-AVFEYVPGRTLREVLA 71
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGL- 177
+ Q+L L +HN I+HRDLK NI V+ K+ D G+
Sbjct: 72 ADGALPAGETGRLMLQVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129
Query: 178 --------AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 228
A V V+GTP + APE L E D+Y++G+ LE +T +
Sbjct: 130 TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RV 188
Query: 229 NECKNPAQIYKK 240
+ + A+I +
Sbjct: 189 VQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 44/216 (20%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
M +Q+ + +E +L ++K + S+ D R + +I E G + K
Sbjct: 39 MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKD 96
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+ +A + + + + + +H IHRD+K DN+ ++ G VK+ D GL +++
Sbjct: 97 TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKK 153
Query: 184 --------------PT-----------------------ARSVIGTPEFMAPELYEEE-Y 205
P+ A S +GTP+++APE++ + Y
Sbjct: 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY 213
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
N+L D +S G+ + EM+ YP + P + Y+KV
Sbjct: 214 NKLCDWWSLGVIMYEMLI-GYPPFCSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 50/200 (25%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 51 IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110
I+VA +N E M D +E E ++ L H +++ Y V + + ++TE
Sbjct: 29 IKVAIKAIN-EGAMSEEDFIE----EAKVMMKLSHPKLVQLYG--VCTQQKPLYIVTEFM 81
Query: 111 TSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
+G L Y R++ + + + + + G+ YL ++ IHRDL N V+ + G
Sbjct: 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGV 138
Query: 170 VKIGDLGLA--IVMQQPTARSVIGTP-EFMAPELYE-EEYNELVDIYSFGMCILEMVT-C 224
VK+ D G+ ++ + T+ S P ++ PE++ +Y+ D++SFG+ + E+ T
Sbjct: 139 VKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198
Query: 225 EYPYNECKNPAQIYKKVTSG 244
+ P+ E K+ ++ + ++ G
Sbjct: 199 KMPF-EKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 44/216 (20%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
M +Q+ + +E +L ++K + S+ D N + +I E G + K
Sbjct: 39 MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKD 96
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+ + + + + + + +H IHRD+K DN+ ++ + G VK+ D GL +++
Sbjct: 97 TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKK 153
Query: 184 --------------PT-----------------------ARSVIGTPEFMAPELYEEE-Y 205
P+ A S +GTP+++APE++ + Y
Sbjct: 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY 213
Query: 206 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
N+L D +S G+ + EM+ YP + P + YKKV
Sbjct: 214 NKLCDWWSLGVIMYEMLI-GYPPFCSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 45/196 (22%), Positives = 96/196 (48%), Gaps = 26/196 (13%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
+Q+++++ E +L ++ ++ + S+ +T R + M+ E G K + +
Sbjct: 43 NQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLCMVMEYVEGGDCATLLKNIGALPV 100
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV------- 180
+ + + + L YLH++ I+HRDLK DN+ + + G +K+ D GL+ +
Sbjct: 101 DMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTT 157
Query: 181 ----------MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPY 228
++ + V GTPE++APE + + Y + VD ++ G+ + E +V C +
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217
Query: 229 NECKNPAQIYKKVTSG 244
+ P +++ +V S
Sbjct: 218 GD--TPEELFGQVISD 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 41/146 (28%), Positives = 77/146 (52%), Gaps = 21/146 (14%)
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 197
+H LH +HRD+K DNI ++ NG +++ D G + +M+ T +S +GTP++++
Sbjct: 118 VHQLH-----YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 198 PELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----P 247
PE+ + +Y D +S G+C+ EM+ E P+ ++ + Y K+ + + P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFP 230
Query: 248 ASLSKVTDPQVKQFIEKCIVPASLRL 273
A ++ V++ K I + I RL
Sbjct: 231 AQVTDVSE-DAKDLIRRLICSREHRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYR 119
Q+ +R Y E+ L+K + H+NII N + + + + ++ EL + + +
Sbjct: 54 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ 113
Query: 120 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179
+ +D + + Q+L G+ +LHS IIHRDLK NI V ++ +KI D GLA
Sbjct: 114 ME---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA- 166
Query: 180 VMQQPTARSVIGTP-----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKN 233
+ S + TP + APE + Y E VDI+S G + EMV + + ++
Sbjct: 167 ---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRD 222
Query: 234 PAQIYKKVTS--GIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 276
+ KV G K P V+ ++E A L P L
Sbjct: 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 35/135 (25%), Positives = 72/135 (53%), Gaps = 8/135 (5%)
Query: 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
T +++I + + G + + + N ++ ++ +I+ L +LH I++RD+K
Sbjct: 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKL 133
Query: 159 DNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYS 213
+NI ++ + G V + D GL+ + ++ S GT E+MAPE+ + + + VD +S
Sbjct: 134 ENILLD-SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWS 192
Query: 214 FGMCILEMVTCEYPY 228
G+ I E++T P+
Sbjct: 193 LGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 25/191 (13%)
Query: 73 LYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH---------- 122
+ E LL +L+HE+I+KFY V+ + M+ E G L ++ + H
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111
Query: 123 ---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179
+ + + A+QI G+ YL S + +HRDL N V G N VKIGD G++
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSR 168
Query: 180 VMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKN 233
+ V G +M PE + ++ D++S G+ + E+ T + P+ + N
Sbjct: 169 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
Query: 234 PAQIYKKVTSG 244
++ + +T G
Sbjct: 229 -NEVIECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 43/197 (21%), Positives = 87/197 (44%), Gaps = 43/197 (21%)
Query: 62 DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSG----SLRQ 117
M ++++R+ +E +L +L H + Y T + ++ + + G L Q
Sbjct: 37 KEMIKRNKVKRVLTEQEILATLDHPFLPTLY--ASFQTETYLCLVMD-YCPGGELFRLLQ 93
Query: 118 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177
R+ K + + + +A ++L L YLH I++RDLK +NI ++ +G + + D L
Sbjct: 94 -RQPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHE-SGHIMLSDFDL 149
Query: 178 A-----------------------------IVMQQPTAR--SVIGTPEFMAPELYEEE-Y 205
+ ++P+ R S +GT E++APE+ + +
Sbjct: 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209
Query: 206 NELVDIYSFGMCILEMV 222
VD ++ G+ + EM+
Sbjct: 210 GSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 40/144 (27%), Positives = 78/144 (54%), Gaps = 17/144 (11%)
Query: 144 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS--VIGTPEFMAPE 199
+HS H +HRD+K DN+ ++ NG +++ D G + M Q T +S +GTP++++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 200 LYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----PAS 249
+ + +Y D +S G+C+ EM+ E P+ ++ + Y K+ + + P+
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHEERFQFPSH 232
Query: 250 LSKVTDPQVKQFIEKCIVPASLRL 273
++ V++ + K I++ I RL
Sbjct: 233 ITDVSE-EAKDLIQRLICSRERRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 51/179 (28%), Positives = 77/179 (43%), Gaps = 23/179 (12%)
Query: 70 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------- 122
E EV +L L NI + D + MI E +G L Q+ +KH
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 123 ----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
K++ + A QI G+ YL S N +HRDL N V G N +KI D G++
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLV-GKNYTIKIADFGMS 177
Query: 179 IVMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 230
+ V G +MA E + ++ D+++FG+ + E++T C E PY
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 20/168 (11%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----RTINMITELFTSGSLRQYRK 120
Q+ +R Y E+ L+K + H+NII N + + + + ++ EL + + +
Sbjct: 62 QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 121
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
+ +D + + Q+L G+ +LHS IIHRDLK NI V ++ +KI D GLA
Sbjct: 122 E---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA-- 173
Query: 181 MQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMV 222
+ S + TP + APE + Y E VDI+S G + EM+
Sbjct: 174 --RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 38/128 (29%), Positives = 67/128 (52%), Gaps = 9/128 (7%)
Query: 102 TINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
T+ ++T+L G L Y +++K+ + + + NW QI +G+ YL ++HRDL N
Sbjct: 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARN 139
Query: 161 IFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTP---EFMAPE-LYEEEYNELVDIYSFG 215
+ V N VKI D GLA ++ T G ++MA E + + D++S+G
Sbjct: 140 VLVKSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYG 198
Query: 216 MCILEMVT 223
+ + E++T
Sbjct: 199 VTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 55/184 (29%), Positives = 84/184 (45%), Gaps = 22/184 (11%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL---AIVMQQPTARSVIGT 192
+I L +LH II+RDLK +NI ++ G VK+ D GL +I T + GT
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVT-HTFCGT 163
Query: 193 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPAS 249
E+MAPE L + + VD +S G + +M+T P+ +N + K+ G P
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPY 222
Query: 250 LSKVTDPQVKQFIEKCIVPASLRL-----PALELLKDPFLVTDNPKDLVC---DPLRLPN 301
L+ +K+ +++ S RL A E+ PF N DL+ +P P
Sbjct: 223 LTPEARDLLKKLLKR---NPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPL 279
Query: 302 LVPE 305
L E
Sbjct: 280 LQSE 283
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 36/149 (24%), Positives = 77/149 (51%), Gaps = 14/149 (9%)
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+++ + ++ DD + + M+ E G L + +V K K + +++ L +HS
Sbjct: 105 VVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM 161
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEEE 204
+IHRD+K DN+ ++ +G +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 162 G--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 205 -----YNELVDIYSFGMCILEMVTCEYPY 228
Y D +S G+ + EM+ + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 47/219 (21%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
M +Q+ + +E +L + ++K Y S+ D+ + +I E G + K
Sbjct: 39 MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY--LYLIMEYLPGGDMMTLLMKKD 96
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL------ 177
+ + + + + + +H IHRD+K DN+ ++ G +K+ D GL
Sbjct: 97 TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKK 153
Query: 178 ------------------AIVMQQPT----------------ARSVIGTPEFMAPELYEE 203
+ +P A S +GTP+++APE++ +
Sbjct: 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ 213
Query: 204 E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
YN+ D +S G+ + EM+ YP NP + Y+K+
Sbjct: 214 TGYNKECDWWSLGVIMYEMLV-GYPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 23/173 (13%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------N 124
E+ ++ LK NII+ + + MITE +G L Q+ +H+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
+ + A QI G+ YL S N +HRDL N V G N +KI D G++ +
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLYSG 183
Query: 185 -----TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 230
R+V+ + ++ D+++FG+ + E++T C E PY++
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 27/169 (15%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH------------- 122
E LL L+H++I++FY + R + M+ E G L ++ + H
Sbjct: 57 EAELLTVLQHQHIVRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDV 114
Query: 123 --KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
+ + + A QI G+ YL S + +HRDL N V G VKIGD G++
Sbjct: 115 APGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRD 171
Query: 181 MQQPTARSVIGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 223
+ V G +M PE LY + E DI+SFG+ + E+ T
Sbjct: 172 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 69 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDM 127
Q SE ++ H NII V +R + +ITE +G+L + R+ +
Sbjct: 48 QRRDFLSEASIMGQFDHPNIIHLEG--VVTKSRPVMIITEFMENGALDSFLRQNDGQFTV 105
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---- 183
+ R I G+ YL N +HRDL NI VN +N K+ D GL+ ++
Sbjct: 106 IQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSD 162
Query: 184 PTARSVIGTP---EFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 233
PT S +G + APE + ++ D++S+G+ + E M E PY + N
Sbjct: 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 48/212 (22%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLYSEVHLLKSLKHENIIKFYNSW 95
F+ + KG +E G + V ++ + ++ D+ E+ + + L H+N+++
Sbjct: 22 FLAKAKGIEEEGGETL----VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC 77
Query: 96 VDDTNRTINMITELFTSGSLRQY---------RKKHKNVDMKAIKNWARQILRGLHYLHS 146
+ MI E G L+Q+ + K + K QI G+ +L +
Sbjct: 78 REAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN 135
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQP--TARSVIGTPEFMAPE-LYE 202
+HRDL N V+ EVK+ L L+ V R+ + ++APE + E
Sbjct: 136 AR--FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE 192
Query: 203 EEYNELVDIYSFGMCILEMVTC-EYPYNECKN 233
++++ D++SFG+ + E+ T E P+ +
Sbjct: 193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 64/273 (23%), Positives = 94/273 (34%), Gaps = 79/273 (28%)
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------------------------- 181
H IHRD+K DNI ++ +G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 182 --------------------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 220
Q+ A S++GTP ++APE+ Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 221 MVTCEYPYNECKNPAQIYKKV-----TSGIKP-ASLSKVTDPQVKQFIEKCIVPASLRL- 273
M+ + P+ PA+ KV T I A LS + I + A RL
Sbjct: 237 MLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLS----REASDLILRLCCGAEDRLG 291
Query: 274 --PALELLKDPFLVTDNPKDLVCDPLRLP-NLVPEVMNLAHSEPHPMDIDLNHKKVSADS 330
A E+ PF D R +P++ HP D N V +
Sbjct: 292 KNGADEIKAHPFFKG---IDFASLIRRQKAPYIPKIT-------HPTDTS-NFDPVDPEK 340
Query: 331 CAKSNTG---TWFLTLELQR-LTENN--EFTLR 357
++G R TE+ EFT R
Sbjct: 341 LRSDDSGESSPDRNVKPNNRKRTEHAFYEFTFR 373
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 16/184 (8%)
Query: 56 NQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL 115
+V I+ + + E E ++ L H +++ Y V I ++ E G L
Sbjct: 29 RKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG--VCTERSPICLVFEFMEHGCL 86
Query: 116 RQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174
Y R + + + + G+ YL S N +IHRDL N V G N VK+ D
Sbjct: 87 SDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLV-GENQVVKVSD 143
Query: 175 LGLAIVMQQPTARSVIGTP---EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNE 230
G+ + S GT ++ +PE++ +Y+ D++SFG+ + E+ ++E
Sbjct: 144 FGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV------FSE 197
Query: 231 CKNP 234
K P
Sbjct: 198 GKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 36/149 (24%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+++ + ++ DD R + M+ E G L + +V K + + +++ L +HS
Sbjct: 105 VVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM 161
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEEE 204
IHRD+K DN+ ++ +G +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 162 G--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 205 -----YNELVDIYSFGMCILEMVTCEYPY 228
Y D +S G+ + EM+ + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 24/173 (13%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK---------NVD 126
E+ ++ LK+ NII+ V D + MITE +G L Q+ + + N+
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 127 MKAIKN---WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+I N A QI G+ YL S N +HRDL N V GN+ +KI D G++ +
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV-GNHYTIKIADFGMSRNLYS 181
Query: 184 PTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYN 229
+ G +MA E + ++ D+++FG+ + EM T C E PY+
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 70 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMK 128
+ +E ++ +L+H N+++ + + ++TE GSL Y R + + V
Sbjct: 44 AQAFLAEASVMTTLRHPNLVQLLGVVLQGNP--LYIVTEYMAKGSLVDYLRSRGRAVITL 101
Query: 129 A-IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPT 185
A +A + G+ YL N +HRDL N+ V+ + K+ D GLA Q +
Sbjct: 102 AQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQDS 158
Query: 186 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 221
+ + ++ APE L E++++ D++SFG+ + E+
Sbjct: 159 GKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 50 GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109
G V ++E+ + + L+ L +EV L +H NI+ + V T + +I+
Sbjct: 25 GTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWT--VFTTGSWLWVISPF 80
Query: 110 FTSGSLRQYRKKHKNVDMKA--IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167
GS K + M I N LRGL+YLH + IHR++K +I ++G+
Sbjct: 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGD- 137
Query: 168 GEVKIGDLG--LAIVMQQPTARSVIGTPEF-------MAPELYEEE---YNELVDIYSFG 215
G V + L ++V A+ V P+F ++PEL ++ YN DIYS G
Sbjct: 138 GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVG 197
Query: 216 MCILEMVTCEYPYNE 230
+ E+ T P+ +
Sbjct: 198 ITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 33/182 (18%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVD--------- 126
EV +L LK NII+ VD+ + MITE +G L Q+ H D
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 127 ----------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
++ + A QI G+ YL S N +HRDL N V G N +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLV-GENLTIKIADFG 183
Query: 177 LAIVM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE--MVTCEYPY 228
++ + + R+V+ +MA E + ++ D+++FG+ + E M+ E PY
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPI-RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 229 NE 230
E
Sbjct: 243 GE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 22/181 (12%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS-GSLRQYRKKHKN 124
S Q+ L E LL L H+NI+ + ++D + + + G+L+ + ++ +
Sbjct: 48 SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP--FVLYPYMNWGNLKLFLQQCRL 105
Query: 125 VDM---KAIK-----NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
+ +A+ + A QI G+ YLH +IH+D+ N ++ +VKI D
Sbjct: 106 GEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNA 162
Query: 177 LAIVMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYN 229
L+ + P +G E +MA E L +EY+ D++SFG+ + E++T + PY
Sbjct: 163 LSRDLF-PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221
Query: 230 E 230
E
Sbjct: 222 E 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 13/177 (7%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNW 133
+E ++ H NII+ V +R + +ITE +GSL ++ R+ + +
Sbjct: 54 TEASIMGQFDHPNIIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM 111
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSV 189
R I G+ YL N +HRDL NI VN +N K+ D GL+ ++ T +
Sbjct: 112 LRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGG 168
Query: 190 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKNPAQIYKKVTSG 244
+ APE + ++ D++SFG+ + E M E PY + N + K V G
Sbjct: 169 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 43/184 (23%), Positives = 93/184 (50%), Gaps = 16/184 (8%)
Query: 40 CRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99
CR+K E+ I+ +D ++ + E E+ +L++LK ENI++ ++
Sbjct: 20 CRHKETKEIVAIK------KFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF--RR 71
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ ++ E L + V + ++++ Q+++ +H+ H ++ I+HRD+K +
Sbjct: 72 RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPE 129
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGTPEFMAPE-LYEEEYNELVDIYSFG 215
N+ ++ N+ +K+ D G A + + + + + T + +PE L Y + VD++S G
Sbjct: 130 NLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVG 188
Query: 216 MCIL 219
CIL
Sbjct: 189 -CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 15/108 (13%)
Query: 133 WAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ---QPT 185
WAR +++ L +HS IHRD+K DN+ ++ +G +K+ D G + M
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVR 199
Query: 186 ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPY 228
+ +GTP++++PE+ + Y D +S G+ + EM+ + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 13/167 (7%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNW 133
SE ++ H NII V ++ + ++TE +GSL + +KH + +
Sbjct: 54 SEASIMGQFDHPNIIHLEG--VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM 111
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARS 188
R I G+ YL +HRDL NI VN +N K+ D GL+ V++ T R
Sbjct: 112 LRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRG 168
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 233
+ APE + ++ D++S+G+ + E M E PY E N
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 19/155 (12%)
Query: 144 LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTPEFMAPE 199
+HS H +HRD+K +N+ ++ G +K+ D G A + + ++ +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 200 LYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
+ Y D +S G+ EM+ P++E A+ Y + + L
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMN--FQRFLKF 230
Query: 253 VTDPQV----KQFIEKCIVPASLRLPALELLKDPF 283
DP+V I+ + RL L PF
Sbjct: 231 PEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 43/136 (31%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGT-- 192
Q+ G+ +L S N +HRDL N+ + VKI D GLA +M+ S T
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 193 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 249
P ++MAPE ++ Y L D++SFG+ + E+ T PY E Q Y + G + A
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK 363
Query: 250 LSKVTDPQVKQFIEKC 265
+ +D ++ + ++KC
Sbjct: 364 PAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 21/146 (14%)
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 197
+H L +HRD+K DN+ ++ NG +++ D G + ++ T +S +GTP++++
Sbjct: 118 VHQLG-----YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 198 PELYEE------EYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASL 250
PE+ + Y D +S G+C+ EM+ E P Y E + + Y K+ + +
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQF 229
Query: 251 -SKVTD--PQVKQFIEKCIVPASLRL 273
VTD + K I + I RL
Sbjct: 230 PPDVTDVSEEAKDLIRRLICSPETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 49/178 (27%), Positives = 70/178 (39%), Gaps = 28/178 (15%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKH 122
P + E L+ L+H NI+ V + M+ E G L ++ H
Sbjct: 48 EPKVQQEFRQEAELMSDLQHPNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPH 105
Query: 123 KNV-------------DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
+V D + A QI G+ YL SH+ +HRDL N V G
Sbjct: 106 SDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLT 162
Query: 170 VKIGDLGLAIVMQQPTARSVIGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEM 221
VKI D GL+ + V +M PE LY + E DI+SFG+ + E+
Sbjct: 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 44/192 (22%), Positives = 81/192 (42%), Gaps = 36/192 (18%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-------VDMK 128
E ++ H+NI++ + R I + EL G L+ + ++++ + MK
Sbjct: 59 EALIMSKFNHQNIVRLIGVSFERLPRFI--LLELMAGGDLKSFLRENRPRPERPSSLTMK 116
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTA 186
+ AR + +G YL ++ IHRD+ N + G KI D G+A
Sbjct: 117 DLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMA-------- 166
Query: 187 RSVIGTP------------EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEY-PYNECK 232
R + ++M PE + + + D++SFG+ + E+ + Y PY
Sbjct: 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
Query: 233 NPAQIYKKVTSG 244
N ++ + VT G
Sbjct: 227 N-QEVMEFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 48/187 (25%), Positives = 78/187 (41%), Gaps = 13/187 (6%)
Query: 67 PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNV 125
PD + E +LK H NI++ V + I ++ EL G + R + +
Sbjct: 34 PDLKAKFLQEARILKQYSHPNIVRLIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGPRL 91
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185
+K + G+ YL S + IHRDL N V N +KI D G++ +
Sbjct: 92 KVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNV-LKISDFGMSREEEDGV 148
Query: 186 ARSVIGTPE----FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 239
S G + + APE L Y+ D++SFG+ + E + PY N Q +
Sbjct: 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-QQTRE 207
Query: 240 KVTSGIK 246
+ G++
Sbjct: 208 AIEQGVR 214
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 40/175 (22%), Positives = 83/175 (47%), Gaps = 14/175 (8%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKN 132
E ++ L H+N+++ + + + ++ EL + G+L + + V + +
Sbjct: 48 EETAVMTKLHHKNLVRLLGVIL---HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ 104
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
++ + G+ YL S ++HRDL NI V+ +G K+ D GLA V S +
Sbjct: 105 FSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPV 161
Query: 193 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
++ APE L ++++ D++S+G+ + E+ + Y P K+V ++
Sbjct: 162 -KWTAPEALKHKKFSSKSDVWSYGVLLWEV----FSYGRAPYPKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
Q+ RG+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 229
Query: 196 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
MAPE ++++ Y D++SFG+ + E+ +
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 193
Q+ RG+ +L S N +HRDL N+ + VKI D GLA + + G+
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 194 --EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 249
++MAPE +++ Y L D++S+G+ + E+ + PY + Y K+ SG + A
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK 361
Query: 250 LSKVTDPQVKQFIEKCIVPASLRLPALELLKD 281
T +V + KC + P+ L D
Sbjct: 362 PDHATQ-EVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
Q+ RG+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 230
Query: 196 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 223
MAPE ++++ Y D++SFG+ + E+ +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 39/173 (22%), Positives = 62/173 (35%), Gaps = 22/173 (12%)
Query: 133 WA--RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190
WA Q L L LH L + + +G V + +S
Sbjct: 20 WAVCLQCLGALRELHRQAKS--GNILLTWDGLLK-LDGSV----------AFKTPEQS-R 65
Query: 191 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249
P FMAPE+ + Y E DIYS G+ + E + E PYNE + + I + + +G +
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG--MPA 123
Query: 250 LSKVTDPQVKQFIEKCIVPASLRLPALELLK---DPFLVTDNPKDLVCDPLRL 299
++ +RL A L + + + L + L L
Sbjct: 124 DDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 26/144 (18%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195
Q+ +G+ +L S IHRDL NI ++ NN VKI D GL AR + P++
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 235
Query: 196 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 241
MAPE +++ Y D++SFG+ + E+ + PY K + +++
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295
Query: 242 TSGIKPASLSKVTDPQVKQFIEKC 265
G + + T P++ Q + C
Sbjct: 296 KEGTRMRA-PDYTTPEMYQTMLDC 318
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 25/56 (44%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181
D+ IK RQ+L GL LH I+HRD+K +N+ V +G+VKI D G A+ M
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 26/201 (12%)
Query: 38 FMCRYKG-FDEVDGIEV--AWNQVN-IEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN 93
F C Y G + DG ++ A +N I D+ +++E+ E ++K H N++
Sbjct: 8 FGCVYHGTLIDSDGQKIHCAVKSLNRITDL----EEVEQFLKEGIIMKDFSHPNVLSLLG 63
Query: 94 SWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
+ + ++ G LR + R + N +K + + Q+ +G+ YL S +
Sbjct: 64 ICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FV 120
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLA---------IVMQQPTARSVIGTPEFMAPE-LYE 202
HRDL N ++ + VK+ D GLA V A+ + ++MA E L
Sbjct: 121 HRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQT 176
Query: 203 EEYNELVDIYSFGMCILEMVT 223
+++ D++SFG+ + E++T
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 17/143 (11%)
Query: 134 ARQILR-------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
++Q+L+ G+ YL IHRDL N+ V G N KI D GL+ +
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVK 174
Query: 187 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVT 242
+++ P +MA E L Y D++SFG+ + E+V+ PY C A++Y+K+
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY--CGMTCAELYEKLP 232
Query: 243 SGIKPASLSKVTDPQVKQFIEKC 265
G + + D +V + + +C
Sbjct: 233 QGYR-MEKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 24/194 (12%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 124
+PD+ EV + L H N+++ ++ ++ E G L+ Y R
Sbjct: 35 TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--PYLLVLEFCPLGDLKNYLRSNRGM 92
Query: 125 VDMKA----IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
V A ++ A ++ GL +LH + IH DL N + + VKIGD GLA+
Sbjct: 93 VAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALE 149
Query: 181 MQQP----TARSVIGTPEFMAPELYEEEYNELV--------DIYSFGMCILEMVT-CEYP 227
T ++APEL E +L+ +I+S G+ + E+ T + P
Sbjct: 150 QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
Query: 228 YNECKNPAQIYKKV 241
Y + + Q+ K+V
Sbjct: 210 YPDLSD-EQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 24/184 (13%)
Query: 57 QVNIEDVMQSPDQLERLY--SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGS 114
QV ++++ S E++ E +SL+H N+++ + T + M E G
Sbjct: 24 QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVM--EFCPLGD 81
Query: 115 LRQYRKKHKNV-----DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
L+ Y + + D ++ A +I GL +LH +N IH DL N + +
Sbjct: 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADL-T 138
Query: 170 VKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEEEYNELV--------DIYSFGMC 217
VKIGD GL+ + T + ++APEL +E + L+ +++S G+
Sbjct: 139 VKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT 198
Query: 218 ILEM 221
I E+
Sbjct: 199 IWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 36/129 (27%), Positives = 67/129 (51%), Gaps = 11/129 (8%)
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV-KIGDLGLAIVMQQ 183
+D + + +++ Q+ +G+ +L S N IHRDL NI + +G + KI D GLA ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRN 266
Query: 184 PTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
+ V G ++MAPE ++ Y D++S+G+ + E+ + PY ++
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
Query: 238 YKKVTSGIK 246
YK + G +
Sbjct: 327 YKMIKEGYR 335
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 9/122 (7%)
Query: 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164
++ EL G L ++ +K+K+V K I Q+ G+ YL N +HRDL N+ +
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV 129
Query: 165 GNNGEVKIGDLGLAIVMQQP----TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 218
+ KI D GL+ + A++ P ++ APE + +++ D++SFG+ +
Sbjct: 130 TQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
Query: 219 LE 220
E
Sbjct: 189 WE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 37/123 (30%), Positives = 52/123 (42%), Gaps = 32/123 (26%)
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----- 182
K I+ RQIL L LHS I+HRD+K NI + +G KI DLG A ++
Sbjct: 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY 312
Query: 183 QPTARSVIGTPEFMAPE-----------------------LYEEEYNELVDIYSFGMCIL 219
P + + P + APE L++ + DIYS G+ L
Sbjct: 313 IP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 220 EMV 222
+M
Sbjct: 371 QMA 373
|
Length = 566 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 17/143 (11%)
Query: 134 ARQILR-------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186
++Q+L G+ YL IHRDL NI V G N KI D GL+ +
Sbjct: 111 SQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVK 167
Query: 187 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVT 242
+++ P +MA E L Y D++S+G+ + E+V+ PY C A++Y+K+
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLP 225
Query: 243 SGIKPASLSKVTDPQVKQFIEKC 265
G + D +V + +C
Sbjct: 226 QGYR-LEKPLNCDDEVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 21/40 (52%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
L YLH H IIHRDLK DN+ ++ N G +K+ D GL+ V
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 33/132 (25%), Positives = 51/132 (38%), Gaps = 51/132 (38%)
Query: 147 HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----------------------------- 177
H IHRD+K DNI ++ +G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 178 --------------------AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 216
A Q+ A S++GTP ++APE L Y +L D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 217 CILEMVTCEYPY 228
+ EM+ + P+
Sbjct: 237 ILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 55/233 (23%), Positives = 103/233 (44%), Gaps = 28/233 (12%)
Query: 39 MCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98
+ RYK G V ++N+E + + + L E+H+ K H NI+ + +++ D
Sbjct: 18 LARYKP----TGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 71
Query: 99 TNRTINMITELFTSGSLRQYRKKHKNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDL 156
+ ++T GS + H M AI + +L+ L Y+H +HR +
Sbjct: 72 NE--LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSV 127
Query: 157 KCDNIFVNGNNGEVKIGDL--GLAIVMQQPTARSVIGTPEF-------MAPELYEEE--- 204
K +I ++ +G+V + L L+++ R V P++ ++PE+ ++
Sbjct: 128 KASHILISV-DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQG 186
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSGIKPASLSKVTDP 256
Y+ DIYS G+ E+ P+ + PA Q+ + +G P L T P
Sbjct: 187 YDAKSDIYSVGITACELANGHVPFKDM--PATQMLLEKLNGTVPCLLDTTTIP 237
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 78/360 (21%), Positives = 138/360 (38%), Gaps = 81/360 (22%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
+DV+ +Q+ + +E +L +E ++K Y S+ D N + + + G +
Sbjct: 37 KDVLNR-NQVAHVKAERDILAEADNEWVVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLI 93
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
+ + + + ++ + +H IHRD+K DNI ++ +G +K+ D GL
Sbjct: 94 RMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTG 150
Query: 181 MQ-------------------QPT------------------------------ARSVIG 191
+ +P+ A S++G
Sbjct: 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVG 210
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT---SGIKP 247
TP ++APE L + Y +L D +S G+ + EM+ + P+ P + KV + +
Sbjct: 211 TPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF-LAPTPTETQLKVINWENTLHI 269
Query: 248 ASLSKVTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKDLVCDPLRLPNLVP 304
K++ P+ I K A RL A ++ PF + D D P P
Sbjct: 270 PPQVKLS-PEAVDLITKLCCSAEERLGRNGADDIKAHPFF---SEVDFSSDIRTQP--AP 323
Query: 305 EVMNLAHSEPHPMDIDLNHKKVSADS----CAKSNTGTW-FLTLELQRLTENN--EFTLR 357
V ++ HPMD N V +S + +T TW L + E+ EFT R
Sbjct: 324 YVPKIS----HPMDTS-NFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFR 378
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 16/140 (11%)
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 192
+A + RG+ YL IHRDL NI V G N KI D GL+ + +++
Sbjct: 129 FAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGRL 185
Query: 193 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGI--- 245
P +MA E L Y D++S+G+ + E+V+ PY C A++Y+K+ G
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYRLE 243
Query: 246 KPASLSKVTDPQVKQFIEKC 265
KP + D +V + +C
Sbjct: 244 KPLN----CDDEVYDLMRQC 259
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 9e-04
Identities = 60/244 (24%), Positives = 103/244 (42%), Gaps = 38/244 (15%)
Query: 62 DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT-----INMITELFTS-GSL 115
D+ S D +E E +K H N+IK V +R I M+ F G L
Sbjct: 38 DIFSSSD-IEEFLREAACMKEFDHPNVIKLIG--VSLRSRAKGRLPIPMVILPFMKHGDL 94
Query: 116 RQYRKKHK------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
+ + + ++ + + I G+ YL S N IHRDL N +N N
Sbjct: 95 HTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMT 151
Query: 170 VKIGDLGLAIVM------QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 222
V + D GL+ + +Q A + +++A E L + Y D+++FG+ + E++
Sbjct: 152 VCVADFGLSKKIYSGDYYRQGCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIM 209
Query: 223 T-CEYPYNECKNPAQIYKKVTSGIK----PASLSKVTDPQVKQFIEKCIVPASLRLPALE 277
T + PY +N ++IY + G + P L V + + +C P P+ +
Sbjct: 210 TRGQTPYAGVEN-SEIYNYLIKGNRLKQPPDCLEDVYE-----LMCQCWSPEPKCRPSFQ 263
Query: 278 LLKD 281
L+D
Sbjct: 264 HLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 37/168 (22%), Positives = 72/168 (42%), Gaps = 22/168 (13%)
Query: 83 LKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQIL 138
L+H NI++ V+ ++ E G L+ Y + +N + ++ A +I
Sbjct: 52 LQHPNILQCLGQCVEAI--PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIA 109
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPE 194
G+ ++H HN +H DL N F+ + VK+GD G+ + T
Sbjct: 110 AGVTHMHKHN--FLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 195 FMAPELYEEEYNELV--------DIYSFGMCILEMVTC-EYPYNECKN 233
++APEL E + L+ ++++ G+ + E+ PY+ +
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 45/228 (19%), Positives = 88/228 (38%), Gaps = 56/228 (24%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
M DQL + +E +L ++ Y S+ D + + +I E G L K+
Sbjct: 39 MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYD 96
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI---- 179
+ + + + + +H IHRD+K DNI ++ G +K+ D GL+
Sbjct: 97 TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHK 153
Query: 180 ---------VMQQPTAR------------------------------------SVIGTPE 194
++Q + + S +GTP+
Sbjct: 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213
Query: 195 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241
++APE++ ++ Y + D +S G + E + +P +N + Y+K+
Sbjct: 214 YIAPEIFLQQGYGQECDWWSLGAIMFECL-IGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 631 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.63 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.62 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 98.38 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.37 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.29 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.25 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.09 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.08 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.02 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.01 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.84 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.78 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.74 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.73 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.55 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.38 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.33 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.29 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.27 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.21 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.2 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.87 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.7 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.44 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.36 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.27 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.23 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.21 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.16 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.11 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 95.99 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.92 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.87 | |
| PLN02236 | 344 | choline kinase | 95.82 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.55 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.53 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.09 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.7 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.01 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.41 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.85 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 92.46 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 90.84 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 89.69 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 89.62 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 87.54 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-88 Score=732.31 Aligned_cols=409 Identities=58% Similarity=0.934 Sum_probs=352.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
+...++.++||+|+|.+||+|+|..+|.+|||+++++.++.+++..+++|+.|+++|+.|+|||||+||++|++..+.++
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 33446678999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||+|++++|+|+.|++++++++.+.++.|++||+.||.|||++.||||||||||+||||+|+.|.|||||+|||+..+.
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006777 184 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 184 ~~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~ 263 (631)
..+..++|||.|||||+++..|++.+||||||||++||+|+++||++|.+++++|+++.+|++|..+.++.+|++++||.
T Consensus 199 s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe 278 (632)
T KOG0584|consen 199 SHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE 278 (632)
T ss_pred cccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCHHHHhcCCCccCCCCCc-------cccCC--CCCCCCchhhhccCCCCCCCCCcccccccccccccc--
Q 006777 264 KCIVPASLRLPALELLKDPFLVTDNPKD-------LVCDP--LRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCA-- 332 (631)
Q Consensus 264 kcL~~p~~Rpta~elL~hpff~~~~~~~-------~~~~~--l~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 332 (631)
+||...+.|+||.|||+||||....... ..... +.+.................++.+... +.+...+-
T Consensus 279 kCl~~~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~-D~~e~v~~em 357 (632)
T KOG0584|consen 279 KCLATKSERLSAKELLKDPFFDEDGGIVELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNLNT-DESEEVAQEM 357 (632)
T ss_pred HHhcCchhccCHHHHhhChhhccccccccccchhhcccccccccccccchhhcCCcccccccceeecCC-CchhHHHHHH
Confidence 9999999999999999999999864421 00000 011111111111111111122221111 00000000
Q ss_pred -cCCCCCcchhHHHHhhccccceeeccccCCCC-ceEEEEEecCCCCCceeeeeeeecCCCCHHHHHHHHHHccCCCccc
Q 006777 333 -KSNTGTWFLTLELQRLTENNEFTLRGEKNDDD-TVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHED 410 (631)
Q Consensus 333 -~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~-~i~L~Lri~d~~~~~~~i~f~f~~~~Dta~~va~EmV~~~~i~~~d 410 (631)
....-......+.+|...++.+.++|+++++. .++|.|||+|.+|+.|||+|+|++..|||.+||.|||+++.+++++
T Consensus 358 ~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~el~~~dq~ 437 (632)
T KOG0584|consen 358 VEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHEMVEELEITDQP 437 (632)
T ss_pred HHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHHHHhhcCCcccc
Confidence 00111222345677888889999999999877 9999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCCCC
Q 006777 411 VVSIAELIDNLIMKLVPSWNPSL 433 (631)
Q Consensus 411 ~~~ia~~i~~~i~~~~~~~~~~~ 433 (631)
+..||+|||.+|.+|+|.|+...
T Consensus 438 v~~ia~mid~~i~~L~p~~~~~~ 460 (632)
T KOG0584|consen 438 VVNIAEMIDGEISALVPNWKAST 460 (632)
T ss_pred hhhHHHHHhchhhhcCCccCCCC
Confidence 99999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=444.32 Aligned_cols=265 Identities=24% Similarity=0.346 Sum_probs=231.6
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCH---HHHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSP---DQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~ 96 (631)
.....+.|.+.+.||+|+||.|-+|+.+.+|+.||||+++........ .....+.+|+++|++|+|||||+++++|.
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 445789999999999999999999999999999999999876543321 13344679999999999999999999887
Q ss_pred cCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEEcc
Q 006777 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGD 174 (631)
Q Consensus 97 ~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI~D 174 (631)
.++ +.||||||++||+|.+.+-.++.+.+...+.+++|++.||.|||++| |+||||||+|||++. ++-.+||.|
T Consensus 247 ~~d--s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 247 VPD--SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred cCC--ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecc
Confidence 655 68999999999999999999999999999999999999999999999 999999999999972 225799999
Q ss_pred ccchhhccC-CCCccccCCCCCCCccccccc----cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-
Q 006777 175 LGLAIVMQQ-PTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA- 248 (631)
Q Consensus 175 FGlA~~~~~-~~~~~~~GTp~y~APE~l~~~----y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~- 248 (631)
||+|+.... ...++.||||.|.|||++... |..++|||||||++|-+++|.+||++......+.+.|..|..+.
T Consensus 323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 999987754 357899999999999998642 55699999999999999999999999777777889999986543
Q ss_pred -CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 249 -SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 249 -~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
..+..++.++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 403 PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 2345578999999999997 999999999999999998643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-52 Score=434.18 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=234.0
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
..+.+..||+|+.|+||++.++.+++.+|+|+|... ..+....++.+|+++++.++|||||++|+.|+.+.. .+.+
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 566789999999999999999999999999999543 245667889999999999999999999999988765 6999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||+||+|.+++++.++++|..+..++++++.||.|||. ++ ||||||||+|||++ ..|+|||||||.+..+.+.
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVN-SKGEVKICDFGVSGILVNS 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeec-cCCCEEeccccccHHhhhh
Confidence 99999999999999999999999999999999999999995 77 99999999999999 7999999999999988888
Q ss_pred CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCC----CCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~----~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
.+.+++||..|||||.+.+ .|+.++||||||+.++||++|++||... .+..+++..|..+.+|......++++++
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~ 312 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFR 312 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence 8899999999999999876 5999999999999999999999999873 4678888888888776655556999999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+||..||+ +|++||++.|||.|||++...
T Consensus 313 ~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 313 SFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 99999998 899999999999999998754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=447.42 Aligned_cols=257 Identities=32% Similarity=0.483 Sum_probs=232.8
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
+....+|..++.||+|||+.||.|.+..+|..||+|+|....+ ......+++.+||+++++|+|||||+||++|.|.+
T Consensus 14 D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l-~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~- 91 (592)
T KOG0575|consen 14 DPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL-KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN- 91 (592)
T ss_pred cCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh-cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-
Confidence 3334689999999999999999999999999999999998765 34567789999999999999999999999997665
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
++|||.|+|..|+|..++++.+.++|.+++.+++||+.||.|||+++ |||||||..|+|++ .+.+|||||||||..
T Consensus 92 -nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~-~~~~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 92 -NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLN-ENMNVKIGDFGLATQ 167 (592)
T ss_pred -ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeec-CcCcEEecccceeee
Confidence 79999999999999999999999999999999999999999999999 99999999999998 788999999999987
Q ss_pred ccCC--CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 181 MQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
...+ ...+.||||.|.|||++. .+++..+||||+||+||-||+|++||.. .+..+.+.+|..... .+|...+.+
T Consensus 168 le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y--~~P~~ls~~ 244 (592)
T KOG0575|consen 168 LEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEY--SMPSHLSAE 244 (592)
T ss_pred ecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCc--ccccccCHH
Confidence 7644 456889999999999875 5699999999999999999999999976 678899999987643 244467899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
+++||.++|. +|.+|||++++|.|+||..
T Consensus 245 A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 245 AKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 9999999998 8999999999999999954
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=422.42 Aligned_cols=273 Identities=23% Similarity=0.374 Sum_probs=243.5
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
..-+.|.++++||+|+||+||.++.+.+|+.+|+|++++..+.. ..+......|..+|..++||.||+++.+|.+..
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~-- 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE-- 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC--
Confidence 34678999999999999999999999999999999999887644 356788999999999999999999999997665
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+|||+||+.||.|+.++++.+.++|..++.|+..|+.||.|||++| ||||||||+|||++ .+|+|+|+|||+++..
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKED 175 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhc
Confidence 79999999999999999999999999999999999999999999999 99999999999998 8999999999999854
Q ss_pred c--CCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 182 Q--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~--~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
- .....++|||++|||||++. .+|+.++|+||||+++|||++|.+||.+ .+....+++|..+.. ..++...+.++
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~-~~~p~~ls~~a 253 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKL-PLPPGYLSEEA 253 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcC-CCCCccCCHHH
Confidence 3 33567789999999999764 5799999999999999999999999987 678888888888752 33455678999
Q ss_pred HHHHHHhcC-CCCCCC----CHHHHhcCCCccCCCCCccccCCCCCCCC
Q 006777 259 KQFIEKCIV-PASLRL----PALELLKDPFLVTDNPKDLVCDPLRLPNL 302 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rp----ta~elL~hpff~~~~~~~~~~~~l~~p~~ 302 (631)
++||.++|. +|.+|. .+.++-.||||...+|+.+....+..|..
T Consensus 254 rdll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~ 302 (357)
T KOG0598|consen 254 RDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFK 302 (357)
T ss_pred HHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCee
Confidence 999999998 899995 68899999999999999987766655443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=422.76 Aligned_cols=266 Identities=25% Similarity=0.382 Sum_probs=227.5
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
........|++.++||.|..++||+|++..+++.||||++++++.. ..++.+.+|++.|+.++||||+++|.+|+.+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 3445577899999999999999999999999999999999998763 3478899999999999999999999999987
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
. .+|+||.||.+|++.++++.. ..++|..|..++++++.||.|||++| .||||||+.||||+ .+|.|||+|||
T Consensus 97 ~--~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLadFg 171 (516)
T KOG0582|consen 97 S--ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLADFG 171 (516)
T ss_pred c--eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEcCce
Confidence 6 799999999999999999875 45999999999999999999999999 99999999999997 89999999999
Q ss_pred chhhccCC-----CC-ccccCCCCCCCccccc---cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-
Q 006777 177 LAIVMQQP-----TA-RSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK- 246 (631)
Q Consensus 177 lA~~~~~~-----~~-~~~~GTp~y~APE~l~---~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~- 246 (631)
.+..+... .. .+++|||+|||||++. .+|+.|+||||||+++.||++|..||........+..++....+
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~ 251 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT 251 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence 87544221 11 5679999999999954 36999999999999999999999999986555555555544322
Q ss_pred ------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCcc
Q 006777 247 ------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 247 ------p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~~ 292 (631)
+..-.+..+..++.+|..||+ ||.+||||.+||+|+||+....+..
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~ 304 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY 304 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence 111123356789999999998 9999999999999999998766553
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-50 Score=401.16 Aligned_cols=274 Identities=25% Similarity=0.412 Sum_probs=247.8
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
...++|++.+.||.|+||.|.+++++.+|..+|+|++++.++.+ .++.+...+|.++|+.+.||+++++++.|.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~-- 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS-- 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEeeccCC--
Confidence 56778999999999999999999999999999999999887643 567788999999999999999999999887654
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+||||||++||.|..++++.++|++..++.++.||+.||+|||+++ |++|||||+|||++ .+|.+||.|||+|+..
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRV 194 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEe
Confidence 79999999999999999999999999999999999999999999999 99999999999998 8999999999999876
Q ss_pred cCCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 182 QQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
... ..+.||||.|+|||++. .+|+.++|+||||+++|||+.|.+||.. .++.++|++|..+. ..+|...++++++
T Consensus 195 ~~r-T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~--v~fP~~fs~~~kd 270 (355)
T KOG0616|consen 195 SGR-TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGK--VKFPSYFSSDAKD 270 (355)
T ss_pred cCc-EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCc--ccCCcccCHHHHH
Confidence 654 67889999999999875 5799999999999999999999999987 67799999999873 3466677899999
Q ss_pred HHHHhcC-CCCCC-----CCHHHHhcCCCccCCCCCccccCCCCCCCCchh
Q 006777 261 FIEKCIV-PASLR-----LPALELLKDPFLVTDNPKDLVCDPLRLPNLVPE 305 (631)
Q Consensus 261 lI~kcL~-~p~~R-----pta~elL~hpff~~~~~~~~~~~~l~~p~~~~~ 305 (631)
||.++|+ |-.+| ....++..||||+...|.++....+..|..+|.
T Consensus 271 Ll~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~ 321 (355)
T KOG0616|consen 271 LLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPN 321 (355)
T ss_pred HHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCcc
Confidence 9999997 87777 357899999999999999988877777776644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=409.94 Aligned_cols=261 Identities=26% Similarity=0.461 Sum_probs=230.0
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
....+.|.+.+.||.|+|++||+|+++.+|.+||||.|....+ .++..+.+..|+.+|+.++|||||.+++...+++
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~- 82 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD- 82 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-
Confidence 3456789999999999999999999999999999999988765 5677788999999999999999999999876554
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC--C---CcEEEccc
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--N---GEVKIGDL 175 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~---g~vKI~DF 175 (631)
++|||||||.||+|.+|+++++.+++..++.++.||+.||++||+++ ||||||||+|||++.. + -.+||+||
T Consensus 83 -~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 83 -FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred -eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 89999999999999999999999999999999999999999999999 9999999999999842 1 35899999
Q ss_pred cchhhccCC-CCccccCCCCCCCcccc-ccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Q 006777 176 GLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSK 252 (631)
Q Consensus 176 GlA~~~~~~-~~~~~~GTp~y~APE~l-~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-p~~l~~ 252 (631)
|+|+.++.. ...+.||+|-|||||++ .++|+.|+|+||+|+++|+|++|+.||.. .++.++...+..+.. .+.++.
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhh
Confidence 999988755 46789999999999988 57899999999999999999999999987 567777778877644 344555
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
..++...+++-..|. +|..|.+..+-+.|+|+....
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 566677788888887 899999999999999997643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-51 Score=407.22 Aligned_cols=251 Identities=29% Similarity=0.433 Sum_probs=224.3
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
......|+|+++||+|.||.||++.+..+|..||+|.|+.... +.+..+.+..|+.+|++|+|||||++|+.-+.+++
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 3344579999999999999999999999999999999997654 45677889999999999999999999994444555
Q ss_pred ceEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eEecCCCCCceEEeCCCCcEEEcc
Q 006777 101 RTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPP--IIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~--IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
..+++|||||.+|+|.+.++. ++.++|+.+|.++.|++.||..+|++-|+ |+||||||.|||++ .+|.|||||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGD 171 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGD 171 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeecc
Confidence 579999999999999998864 45799999999999999999999996555 99999999999998 899999999
Q ss_pred ccchhhccCC--CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006777 175 LGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 175 FGlA~~~~~~--~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~ 251 (631)
||+++.+... .+.+.+|||+||+||.+. .+|+.++||||+||++|||+..+.||.+ .+..++.++|..+..|+.+.
T Consensus 172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred chhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcH
Confidence 9999988765 367899999999999875 5799999999999999999999999998 58999999999997776666
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCH
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPA 275 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta 275 (631)
..++..++.+|..|++ +|..||+.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc
Confidence 7889999999999998 99999997
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=412.06 Aligned_cols=259 Identities=25% Similarity=0.472 Sum_probs=226.8
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCH-HHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLK-HENIIKFYNSWVDDT 99 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~-~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~ 99 (631)
...+.|.+.+.||+|+||+||+|.+..+|..||+|+++........ ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567999999999999999999999999999999987765332222 34566779999999999 999999999887665
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+|+||||+.||+|.+++.+.+++.|..++.+++||++|++|||++| |+||||||+|||++.+.+.+||+|||++.
T Consensus 94 --~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 --KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred --eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 59999999999999999999999999999999999999999999999 99999999999998433999999999998
Q ss_pred hc--cCCCCccccCCCCCCCcccccc-c-c-CccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006777 180 VM--QQPTARSVIGTPEFMAPELYEE-E-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~--~~~~~~~~~GTp~y~APE~l~~-~-y-~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~ 254 (631)
.. ......+.+|||.|+|||++.+ . | +.++||||+|+++|.|++|..||.. .+...++.+|..+.. .++...
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~--~~p~~~ 246 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEF--KIPSYL 246 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCc--cCCCCc
Confidence 77 3446788999999999999875 4 6 5799999999999999999999988 666777777777633 233344
Q ss_pred -cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 255 -DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 255 -~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+++++.||.+||+ +|.+|+++.+++.||||+..
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 8999999999998 99999999999999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=415.56 Aligned_cols=262 Identities=24% Similarity=0.406 Sum_probs=230.6
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
--..|.+++.||.|+|++||+|.++.++++||||++.++-+.+ ....+-+..|-..|.+| .||.|+++|..|.|+.
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-- 147 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-- 147 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--
Confidence 3568999999999999999999999999999999988665433 23334567788899999 8999999999998776
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+|||+||+++|+|.+++++.+.|++...+.++.||+.||+|||++| ||||||||+|||++ .+|++||.|||.|+.+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd-~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLD-KDGHIKITDFGSAKIL 224 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEc-CCCcEEEeeccccccC
Confidence 69999999999999999999999999999999999999999999999 99999999999998 7999999999999765
Q ss_pred cCC-------------C--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006777 182 QQP-------------T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 182 ~~~-------------~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~ 245 (631)
... . ..+++||..|.+||++.. ..+..+|||+||||+|+|+.|.+||.+ .|.-.++++|..-
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l- 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQAL- 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHh-
Confidence 321 1 145899999999999875 478999999999999999999999988 6777777887764
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCccc
Q 006777 246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 246 ~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~~~ 293 (631)
.-.++...++.+++||+++|+ +|++|+|+.+|..||||...+|..+.
T Consensus 303 -~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw 350 (604)
T KOG0592|consen 303 -DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW 350 (604)
T ss_pred -cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence 334556677999999999998 99999999999999999999998854
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=403.29 Aligned_cols=259 Identities=32% Similarity=0.504 Sum_probs=219.3
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
..+|...+.||+|+||+||+|.+..+|...|+|.+.... ... .+.+.+|+++|++|+|||||++++.........+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 456889999999999999999999999999999998763 222 6778999999999999999999996322222478
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+++|||+++|+|.+++++.+ .+++..++.+.+||+.||.|||++| |+||||||+|||++..+|.+||+|||++....
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999999999987 7999999999999999999999999 99999999999998327999999999997665
Q ss_pred C-----CCCccccCCCCCCCccccccccC--ccceEeehhhHHHHHhhcCCCCCCC-CCHHHHHHHHHcCCCCCCCCCCC
Q 006777 183 Q-----PTARSVIGTPEFMAPELYEEEYN--ELVDIYSFGMCILEMVTCEYPYNEC-KNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 183 ~-----~~~~~~~GTp~y~APE~l~~~y~--~~sDIwSLG~il~emltG~~Pf~~~-~~~~~~~~~i~~~~~p~~l~~~~ 254 (631)
. .....+.|||.|||||++...+. .++|||||||++.||+||..||.+. .....++........| .++...
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~l 248 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSL 248 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCccc
Confidence 2 22446889999999999885433 4999999999999999999999873 3333444444444334 777788
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
++++++||.+|++ +|..||||.+||.|||++....
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999999998 9999999999999999987543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=410.77 Aligned_cols=266 Identities=21% Similarity=0.352 Sum_probs=233.3
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
-.+.|.++.+||+||||.||+|+-+.+|..+|+|.++..... ...+.+.+..|-.+|...++|+||++|.+|.+.. +
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~--~ 215 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE--Y 215 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC--e
Confidence 456799999999999999999999999999999999987653 3567888999999999999999999999997765 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+||||||++||++..+|.+.+.|++..++.++.+++.|++.||++| +|||||||+|+||+ ..|++||.||||+..+.
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLD 292 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhh
Confidence 9999999999999999999999999999999999999999999999 99999999999998 89999999999984210
Q ss_pred C-------------------------CC------------------------CccccCCCCCCCcccccc-ccCccceEe
Q 006777 183 Q-------------------------PT------------------------ARSVIGTPEFMAPELYEE-EYNELVDIY 212 (631)
Q Consensus 183 ~-------------------------~~------------------------~~~~~GTp~y~APE~l~~-~y~~~sDIw 212 (631)
. .. +.+.+|||.|||||++.+ +|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 0 00 114679999999998764 699999999
Q ss_pred ehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCccCC
Q 006777 213 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTD 287 (631)
Q Consensus 213 SLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~--~~~~~lk~lI~kcL~~p~~Rpt---a~elL~hpff~~~ 287 (631)
|||||+||||.|.+||.+ .++.+.+++|........++. ..++++++||.+||.+|..|.. +.||-+||||+..
T Consensus 373 SLG~ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccC
Confidence 999999999999999998 788999998877543222222 2468999999999999999986 8899999999999
Q ss_pred CCCccccC
Q 006777 288 NPKDLVCD 295 (631)
Q Consensus 288 ~~~~~~~~ 295 (631)
+|..+...
T Consensus 452 ~W~~l~~~ 459 (550)
T KOG0605|consen 452 DWDHLREM 459 (550)
T ss_pred CcchhhcC
Confidence 99887543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=415.22 Aligned_cols=257 Identities=30% Similarity=0.510 Sum_probs=227.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
....|...++||+|+.|.||.|....+++.||||++.+... ...+-+.+|+.+|+.++|+|||.|+++|...+ .
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d--e 344 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVGD--E 344 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcccc--e
Confidence 45688999999999999999999999999999999997643 33456899999999999999999999998764 6
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+|+||||++||+|.+.+.... ++|.+|+.++++++.||+|||.+| |||||||.+|||++ .+|.|||+|||++....
T Consensus 345 LWVVMEym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eEEEEeecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeeeeccc
Confidence 999999999999999987654 999999999999999999999999 99999999999997 89999999999997665
Q ss_pred CC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 183 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 ~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
.. ...+.+|||+|||||++.. .|++++||||||++++||+-|++||...+....++..-..|.+....+...+++++
T Consensus 421 ~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~k 500 (550)
T KOG0578|consen 421 EEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELK 500 (550)
T ss_pred cccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHH
Confidence 43 4567899999999998864 69999999999999999999999998745455556555666666667778899999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
+|+.+||+ ++.+|++|.|||.||||+...+
T Consensus 501 dFL~~cL~~dv~~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 501 DFLDRCLVVDVEQRASAKELLEHPFLKMAKP 531 (550)
T ss_pred HHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence 99999998 9999999999999999966543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=382.75 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=214.8
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|+.+.++|+|+||+||+++++.+|+.||||.+.-.+ .++.-.+-..+||++|++|+|||+|.+.++|. .++.+++
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--rkrklhL 78 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVFR--RKRKLHL 78 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHHH--hcceeEE
Confidence 5788899999999999999999999999999987553 34555667889999999999999999999884 4458999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC-
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~- 184 (631)
|+|||+..-|.++-.....++++.++.+++|++.|+.|||+++ ||||||||+|||++ .+|.+||||||+|+.+..+
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcCCc
Confidence 9999997666555444456999999999999999999999999 99999999999998 8999999999999987643
Q ss_pred -CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc------------------
Q 006777 185 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------------ 243 (631)
Q Consensus 185 -~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~------------------ 243 (631)
....++.|.+|+|||++-+ +|+.++||||+||++.||++|++.|.+..+.++++.....
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 2355788999999998765 6999999999999999999999999999999998765532
Q ss_pred -CCC---C---CCCC---CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 244 -GIK---P---ASLS---KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 244 -~~~---p---~~l~---~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
|.. | ..+. ...+..+.+|+.+||. ||.+|++.+++|.||||.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 111 1 1111 1235678999999998 999999999999999993
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=408.51 Aligned_cols=256 Identities=23% Similarity=0.428 Sum_probs=229.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+-|.+++.||.|+.|.|.+|++.+||+.+|||+|.... ..+......+.+||-+|+.+.||||+++|++|... ..+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~--~~ly 88 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK--QHLY 88 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCCeeeeeeeeccC--ceEE
Confidence 45999999999999999999999999999999998763 22344566788999999999999999999999554 5899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc-C
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-Q 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~-~ 183 (631)
+|.||++||-|++|+.+++++++.+++.+++||+.|+.|||..+ |+||||||+|+|++ ..+.|||+|||+|..-. .
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd-~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLD-VKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhh-cccCEeeeccceeecccCC
Confidence 99999999999999999999999999999999999999999999 99999999999998 66679999999997544 3
Q ss_pred CCCccccCCCCCCCccccccc-c-CccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 184 PTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 184 ~~~~~~~GTp~y~APE~l~~~-y-~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
....+.||+|+|.|||++.+. | +.++||||.|||+|.||||..||.+ .|...++.++..|... ++..+++++++|
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~eaQdL 242 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISSEAQDL 242 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCHHHHHH
Confidence 456788999999999988764 5 6899999999999999999999986 7899999999998653 457789999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 262 IEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
|.+||. ||.+|.|..|+++|||+.....
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHhccCccccccHHHHhhCchhhcCCC
Confidence 999997 9999999999999999987543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=389.43 Aligned_cols=262 Identities=22% Similarity=0.354 Sum_probs=227.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
.-+.|.+.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+.+|+.+|++++||||++++++|.+.+ .
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~ 92 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN--R 92 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC--E
Confidence 357899999999999999999999999999999999865432 2344577889999999999999999999887654 7
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcC
Confidence 9999999999999999999889999999999999999999999999 99999999999998 78999999999997654
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
.. ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+....++.+..+.. .++...++.+++|
T Consensus 170 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~l 245 (329)
T PTZ00263 170 DR-TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDL 245 (329)
T ss_pred CC-cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCc--CCCCCCCHHHHHH
Confidence 32 335689999999998764 588999999999999999999999986 566677777776633 3455678899999
Q ss_pred HHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCcccc
Q 006777 262 IEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVC 294 (631)
Q Consensus 262 I~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~ 294 (631)
|.+||. +|.+|++ +.+++.||||...++..+..
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~ 284 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYA 284 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence 999998 8999997 79999999999877766543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=384.65 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=223.4
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+.+|+.+|+.++||||+++++++.+. ..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--CeEE
Confidence 4799999999999999999999999999999999765431 234456788999999999999999999977654 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC
Confidence 99999999999999999889999999999999999999999999 99999999999997 7899999999999765432
Q ss_pred CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006777 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~ 263 (631)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...++..+..+. ..++...++.+++||.
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~ 230 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGK--LEFPRHLDLYAKDLIK 230 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--cCCCccCCHHHHHHHH
Confidence 335679999999998764 588999999999999999999999987 56667777776653 2345556899999999
Q ss_pred HhcC-CCCCCCC-----HHHHhcCCCccCCCCCcc
Q 006777 264 KCIV-PASLRLP-----ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 264 kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~ 292 (631)
+||+ +|.+|++ +.+++.||||....+...
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 265 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDV 265 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCCCHHHH
Confidence 9998 8999995 999999999988766543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=407.25 Aligned_cols=271 Identities=22% Similarity=0.370 Sum_probs=238.6
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~ 101 (631)
--++|.++++||+|.||+|++|..+.+++.+|||++++..+.+ .++.+....|.+++.... ||.++.+|..|...+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~-- 442 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE-- 442 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccCC--
Confidence 3578999999999999999999999999999999999888765 467788899999988885 999999999997655
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++|+||||+.||++..+ .+.+.|++..++.|+..|+.||.|||++| |||||||.+|||++ ..|++||+|||+++..
T Consensus 443 ~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEG 518 (694)
T ss_pred eEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEeccccccccc
Confidence 89999999999995433 44477999999999999999999999999 99999999999998 8999999999999754
Q ss_pred --cCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 182 --QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 --~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
....+.++||||.|||||++.+ .|+.++|+|||||+|||||+|+.||.+ .+.++++..|... ...+|...+.++
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d--~~~yP~~ls~ea 595 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVND--EVRYPRFLSKEA 595 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC--CCCCCCcccHHH
Confidence 3445778999999999998865 699999999999999999999999998 6788888888764 344566678999
Q ss_pred HHHHHHhcC-CCCCCCCH-----HHHhcCCCccCCCCCccccCCCCCCCCc
Q 006777 259 KQFIEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLRLPNLV 303 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta-----~elL~hpff~~~~~~~~~~~~l~~p~~~ 303 (631)
.++++++|. +|.+|..+ .+|.+||||+..+|.++....++.|..+
T Consensus 596 ~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P 646 (694)
T KOG0694|consen 596 IAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVP 646 (694)
T ss_pred HHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCc
Confidence 999999998 89999974 7899999999999999887777666554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=393.33 Aligned_cols=263 Identities=24% Similarity=0.292 Sum_probs=220.5
Q ss_pred ccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 18 PISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 18 ~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
.+.....+.|+.+++||+|+||.||+|++..+|+.||+|.|.++.. .+.......+||.+|++|+|||||++.+..++
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTS 187 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence 4455567789999999999999999999999999999999998752 23344557789999999999999999998888
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
...+.+|||+|||++ +|.-++... -.|++.+|+.+++||+.||+|||++| |+|||||+.||||| ++|.+||+|||
T Consensus 188 ~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFG 263 (560)
T KOG0600|consen 188 KLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFG 263 (560)
T ss_pred cCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEecccc
Confidence 767799999999985 888887764 36999999999999999999999999 99999999999998 89999999999
Q ss_pred chhhccCCC---CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC-CCC
Q 006777 177 LAIVMQQPT---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-PAS 249 (631)
Q Consensus 177 lA~~~~~~~---~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-~~~-p~~ 249 (631)
||+.+.... ....+-|.+|+|||++-+ .|+.++|+||.|||+.||++|++.|.+....+|+-+...- |.+ +..
T Consensus 264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 999765443 345677999999998754 5999999999999999999999999986665555443321 111 111
Q ss_pred C------------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 250 L------------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 250 l------------------------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
| .+..++.+.+|+.++|. +|.+|.||.++|.|+||..
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 1 12347789999999998 9999999999999999944
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=385.52 Aligned_cols=258 Identities=22% Similarity=0.389 Sum_probs=220.3
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEecc
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~ 110 (631)
++||+|+||.||+|.++.+|+.||+|+++.... .......++.+|+.+++.++||||++++++|...+ .+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEEEeCC
Confidence 479999999999999999999999999986532 22345567889999999999999999999886544 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCcc
Q 006777 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARS 188 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~~ 188 (631)
++|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++.... ......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccc
Confidence 99999999998889999999999999999999999999 99999999999998 78999999999986432 223345
Q ss_pred ccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006777 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 189 ~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~ 267 (631)
.+||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+.......+..+. ..++...++++++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 689999999998864 589999999999999999999999976 45555666665442 33455678999999999998
Q ss_pred -CCCCCC-----CHHHHhcCCCccCCCCCccccCCC
Q 006777 268 -PASLRL-----PALELLKDPFLVTDNPKDLVCDPL 297 (631)
Q Consensus 268 -~p~~Rp-----ta~elL~hpff~~~~~~~~~~~~l 297 (631)
+|.+|| ++.++++||||...++..+....+
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~ 267 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKL 267 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 899999 899999999999988776554333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=390.44 Aligned_cols=264 Identities=22% Similarity=0.338 Sum_probs=221.0
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+|+.++++++||||+++++.|.+.. .+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~--~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL--NLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--eEE
Confidence 3689999999999999999999999999999999765331 2344567889999999999999999999887654 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCccccccc
Confidence 99999999999999998889999999999999999999999999 99999999999998 7899999999998643211
Q ss_pred -------------------------------------CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCC
Q 006777 185 -------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEY 226 (631)
Q Consensus 185 -------------------------------------~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~ 226 (631)
.....+||+.|+|||++. ..|+.++|||||||++|||++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 012458999999999875 458999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHHHHhcCC---CCCCCCHHHHhcCCCccCCCCCccccC
Q 006777 227 PYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKDLVCD 295 (631)
Q Consensus 227 Pf~~~~~~~~~~~~i~~~~~p~~l~~--~~~~~lk~lI~kcL~~---p~~Rpta~elL~hpff~~~~~~~~~~~ 295 (631)
||.+ .+....+..+........++. ..++++++||.+++.+ +..||++.|+++||||+..+|..+...
T Consensus 235 Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~ 307 (363)
T cd05628 235 PFCS-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRER 307 (363)
T ss_pred CCCC-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHhC
Confidence 9986 456667777765432222222 3578999999997764 346789999999999999888765443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=400.35 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=225.3
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
.+|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. ...+++..+.+|+++++.|+|||||.++++|... ..+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~--~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFETS--AHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc--ceEE
Confidence 46888999999999999999999999999999998664 3567888899999999999999999999988544 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+|+|||.| +|+.++...+.++|+.++.++.|++.||.|||+++ |+|||+||.|||+. .+|.+|+||||+|+.+...
T Consensus 78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccC
Confidence 99999986 99999999999999999999999999999999999 99999999999997 7999999999999877654
Q ss_pred C--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 185 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 ~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
+ ..++.|||.|||||++++ .|+..+|.|||||++|||.+|++||.. ....++.+.|... |..++...+..+++|
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~nf 230 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVNF 230 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHHH
Confidence 3 456789999999998875 599999999999999999999999986 4566677777664 445556788999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 262 IEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
|..+|. ||..|.+..+|+.|||.+.
T Consensus 231 l~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 231 LQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHHHhhcChhhcccHHHHhcChHHhh
Confidence 999998 8999999999999999975
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=399.37 Aligned_cols=255 Identities=29% Similarity=0.492 Sum_probs=226.6
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|...+.||+|+||.||+|++..+++.||+|++..+. ..+..+.+.+|+.+|.+++++||.++|++|+... .+
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~g~--~L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT--KL 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheeecc--cH
Confidence 457888899999999999999999999999999999775 3567788999999999999999999999998765 69
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+++||||.||++.+.++....+++..+..++++++.||.|||.++ .+|||||+.|||+. .+|.||++|||++..+..
T Consensus 87 wiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s-~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLS-ESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEe-ccCcEEEEecceeeeeec
Confidence 999999999999999999888899999999999999999999999 99999999999998 679999999999987665
Q ss_pred C--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 184 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
. ...+++|||.|||||++.+ .|+.++||||||++++||++|++|+...... . +..+.....|+.+...+++.+++
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-r-vlflIpk~~PP~L~~~~S~~~kE 241 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-R-VLFLIPKSAPPRLDGDFSPPFKE 241 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-e-EEEeccCCCCCccccccCHHHHH
Confidence 4 3468999999999999876 6999999999999999999999999885431 1 11222334566777788999999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
||+.||. +|..||+|.+||+|+|++...
T Consensus 242 FV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 242 FVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 9999998 899999999999999998844
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=385.92 Aligned_cols=267 Identities=22% Similarity=0.369 Sum_probs=227.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g-~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
..+.|.+.+.||+|+||.||+|.+..++ ..||+|++...... .....+.+.+|+.+++.++||||++++++|.+..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-- 104 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDES-- 104 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC--
Confidence 3568999999999999999999876655 78999998765432 2345567889999999999999999999986654
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeec
Confidence 79999999999999999999889999999999999999999999999 99999999999997 7899999999999765
Q ss_pred cCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 182 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+....++.+..+.. .++...++.+++
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 257 (340)
T PTZ00426 182 DT-RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKH 257 (340)
T ss_pred CC-CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHH
Confidence 43 2345689999999998764 588999999999999999999999986 566667777776533 345567889999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHhcCCCccCCCCCccccCCCCC
Q 006777 261 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRL 299 (631)
Q Consensus 261 lI~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~~~l~~ 299 (631)
+|++||. +|.+|+ ++.++++||||...+|..+....+..
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~ 302 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEV 302 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCC
Confidence 9999998 899995 89999999999987776654444433
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=386.53 Aligned_cols=260 Identities=22% Similarity=0.384 Sum_probs=219.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+|+.+|+.++||||++++++|.+.. .+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN--YLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--eEE
Confidence 4799999999999999999999999999999999865432 2344567888999999999999999999887654 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceecccc
Confidence 99999999999999998888999999999999999999999999 99999999999997 7899999999998643211
Q ss_pred ----------------------------------------CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh
Q 006777 185 ----------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 223 (631)
Q Consensus 185 ----------------------------------------~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt 223 (631)
.....+||+.|+|||++. ..++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 111357999999999875 468999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCccCCCCCc
Q 006777 224 CEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 224 G~~Pf~~~~~~~~~~~~i~~~~~p~~l~--~~~~~~lk~lI~kcL~~p~~Rpt---a~elL~hpff~~~~~~~ 291 (631)
|..||.. .+....+..+........++ ...++.+++||.+||.+|.+|++ +.++|.||||+...+..
T Consensus 235 G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~ 306 (364)
T cd05599 235 GYPPFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEH 306 (364)
T ss_pred CCCCCCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 9999987 45556666665543322222 24578999999999998989997 99999999999876654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=381.74 Aligned_cols=259 Identities=20% Similarity=0.312 Sum_probs=220.4
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+.|.+.+.||+|+||.||+|.+..+|+.||+|++..... ........+.+|+.+++.++||||+++++++.+.. .+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE--YLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC--EEE
Confidence 369999999999999999999999999999999986532 22345567889999999999999999999886544 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||++||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc-
Confidence 99999999999999998889999999999999999999999999 99999999999997 789999999999975543
Q ss_pred CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC---C---CCCCcHH
Q 006777 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---L---SKVTDPQ 257 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~---l---~~~~~~~ 257 (631)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+.+..+........ . ....+++
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 3456689999999998764 589999999999999999999999986 456666555544321111 1 1235789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCc
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~ 291 (631)
+++||.+||. +|.+||++.++++||||....+..
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~ 267 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNE 267 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence 9999999998 789999999999999999866544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=395.51 Aligned_cols=260 Identities=26% Similarity=0.349 Sum_probs=220.3
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~ 100 (631)
++-++|.+.++||.|+||.||+|..+.+|..||||.++.+-. +-++. --.||++.|++|+ |||||++++++.+.++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~--s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY--SWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc--cHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 345789999999999999999999999999999999886532 22222 2357999999998 9999999999887765
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+|||||||+ .+|.++++.+ +.|++..|+.|++||+.||+|+|.+| +.||||||+|||+.+ +..|||+|||+|+
T Consensus 84 -~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~-~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 84 -ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISG-NDVIKIADFGLAR 158 (538)
T ss_pred -eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecc-cceeEeccccccc
Confidence 8999999997 6999998865 56999999999999999999999999 999999999999984 6689999999998
Q ss_pred hccCC-CCccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-------------
Q 006777 180 VMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------- 243 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~------------- 243 (631)
..... ....++.|.+|+|||++- +-|+.++|||++|||++|+.+.++.|.|....+++++...-
T Consensus 159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 77654 456678999999999763 45999999999999999999999999998888888875431
Q ss_pred ------CCC-----CC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 244 ------GIK-----PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 244 ------~~~-----p~---~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
+.. +. .+-...++++.++|.+||. ||.+||||.++|+||||+....
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 000 11 1122367899999999999 9999999999999999987543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=387.18 Aligned_cols=261 Identities=21% Similarity=0.333 Sum_probs=217.4
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
.+|.+.+.||+|+||.||+|.++.+|+.||+|++...... .....+++.+|++++++++||||++++++|.+.. .+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ--YLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--eeE
Confidence 3699999999999999999999999999999998765431 2345677889999999999999999999987644 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||++||+|.+++...+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+++.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeecccccccccc
Confidence 99999999999999998889999999999999999999999999 99999999999997 7899999999998532110
Q ss_pred -------------------------------------------------CCccccCCCCCCCcccccc-ccCccceEeeh
Q 006777 185 -------------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSF 214 (631)
Q Consensus 185 -------------------------------------------------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSL 214 (631)
.....+||+.|+|||++.+ .|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0013579999999998754 58999999999
Q ss_pred hhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHHHHhcCCCCC---CCCHHHHhcCCCccCCCC
Q 006777 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNP 289 (631)
Q Consensus 215 G~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~--~~~~~lk~lI~kcL~~p~~---Rpta~elL~hpff~~~~~ 289 (631)
||++|||+||..||.+ .+....+..+........++. ..++++++||.+||.+|.+ |+++.+++.||||...++
T Consensus 235 Gvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 235 GAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred chhhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999999986 445555666654332222222 4678999999999986544 569999999999987665
Q ss_pred Ccc
Q 006777 290 KDL 292 (631)
Q Consensus 290 ~~~ 292 (631)
..+
T Consensus 314 ~~~ 316 (377)
T cd05629 314 DTI 316 (377)
T ss_pred HHH
Confidence 443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=384.93 Aligned_cols=265 Identities=23% Similarity=0.371 Sum_probs=221.9
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+.|.+.+.||+|+||.||+|.++.+|+.||+|++..... ........+.+|+.++.+++||||++++++|.+. ..+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEE
Confidence 468999999999999999999999999999999975433 2234567788999999999999999999988654 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCcccccc
Confidence 99999999999999998889999999999999999999999999 99999999999997 7899999999998643211
Q ss_pred -------------------------------------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCC
Q 006777 185 -------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEY 226 (631)
Q Consensus 185 -------------------------------------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~ 226 (631)
.....+||+.|+|||++.+ .|+.++|||||||++|||+||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 0124579999999998754 58999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCC--CCcHHHHHHHHHhcCCCCCCC---CHHHHhcCCCccCCCCCccccCC
Q 006777 227 PYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKDLVCDP 296 (631)
Q Consensus 227 Pf~~~~~~~~~~~~i~~~~~p~~l~~--~~~~~lk~lI~kcL~~p~~Rp---ta~elL~hpff~~~~~~~~~~~~ 296 (631)
||.+ .++...+..+........++. ..++++++||.+|+.+|.+|+ ++.++++||||...+|..+...+
T Consensus 235 Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~ 308 (360)
T cd05627 235 PFCS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRERP 308 (360)
T ss_pred CCCC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCC
Confidence 9986 556666666654322222222 357899999999888888888 48999999999998887764433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=381.19 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=220.9
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+|+.+++.++||||++++++|.+.. .++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDEE--HLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecCC--eEE
Confidence 3799999999999999999999999999999999865432 2244567889999999999999999999886544 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCccc
Confidence 99999999999999998888999999999999999999999998 99999999999998 7899999999999754432
Q ss_pred C-------------------------------CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCC
Q 006777 185 T-------------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK 232 (631)
Q Consensus 185 ~-------------------------------~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~ 232 (631)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~- 233 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD- 233 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC-
Confidence 2 234579999999998764 5899999999999999999999999874
Q ss_pred CHHHHHHHHHcCCCCCCCC--CCCcHHHHHHHHHhcCCCCCCCC-HHHHhcCCCccCCCCCc
Q 006777 233 NPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 233 ~~~~~~~~i~~~~~p~~l~--~~~~~~lk~lI~kcL~~p~~Rpt-a~elL~hpff~~~~~~~ 291 (631)
+....+..+........++ ...++.+++||.+||.+|.+||+ +.++|+||||....+..
T Consensus 234 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~~ 295 (350)
T cd05573 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWEN 295 (350)
T ss_pred CHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHHH
Confidence 4555556665522222222 22589999999999999999999 99999999998866544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=383.22 Aligned_cols=259 Identities=20% Similarity=0.329 Sum_probs=215.1
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|++++.||+|+||+||+|.+..+|+.||+|++...... .....+.+.+|+.+|+.++||||++++++|.+.. .+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--EEEE
Confidence 689999999999999999999999999999999865432 2345677899999999999999999999987644 7999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC-
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~- 184 (631)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCccccccc
Confidence 9999999999999999889999999999999999999999999 99999999999997 7899999999997532100
Q ss_pred ------------------------------------------------CCccccCCCCCCCccccc-cccCccceEeehh
Q 006777 185 ------------------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFG 215 (631)
Q Consensus 185 ------------------------------------------------~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG 215 (631)
...+.+||+.|+|||++. ..|+.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 012467999999999875 4589999999999
Q ss_pred hHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcHHHHHHHHHhcC---CCCCCCCHHHHhcCCCccCCCCC
Q 006777 216 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV---PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 216 ~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l--~~~~~~~lk~lI~kcL~---~p~~Rpta~elL~hpff~~~~~~ 290 (631)
|++|||+||..||.... .......+........+ ....++++++||.+|+. ++..|+++.+++.||||....+.
T Consensus 236 ~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 236 VILFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred hHHHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 99999999999998744 44433444332211112 22468999999999664 45569999999999999987665
Q ss_pred c
Q 006777 291 D 291 (631)
Q Consensus 291 ~ 291 (631)
.
T Consensus 315 ~ 315 (381)
T cd05626 315 S 315 (381)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=376.23 Aligned_cols=251 Identities=22% Similarity=0.366 Sum_probs=215.6
Q ss_pred EeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCC
Q 006777 33 VLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~g 112 (631)
||+|+||.||+|.+..+|+.||+|+++.... ........+.+|+.+|++++||||++++++|.+. ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence 6999999999999999999999999875432 2344567788999999999999999999988654 479999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC--CCCcccc
Q 006777 113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVI 190 (631)
Q Consensus 113 GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~--~~~~~~~ 190 (631)
|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ......+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCcccccc
Confidence 999999998888999999999999999999999999 99999999999997 789999999999875322 2234567
Q ss_pred CCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-C
Q 006777 191 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 268 (631)
Q Consensus 191 GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~ 268 (631)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+.++.+..+ +..++...++.+++||.+||. +
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCC
Confidence 9999999998764 589999999999999999999999987 4556666666554 344556678999999999998 8
Q ss_pred CCCCC---CHHHHhcCCCccCCCCCcc
Q 006777 269 ASLRL---PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 269 p~~Rp---ta~elL~hpff~~~~~~~~ 292 (631)
|.+|| ++.++|+||||...++...
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~~~~~ 258 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLSWKKL 258 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCCHHHH
Confidence 99997 5899999999998765543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=359.45 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=214.7
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|...++||+|.||.||+|.|..+|+.||||.|+..+.... -.....+||+.|+.++||||+.+.++|...+ .+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG--i~~talREIK~Lqel~h~nIi~LiD~F~~~~--~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG--INRTALREIKLLQELKHPNIIELIDVFPHKS--NLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC--ccHHHHHHHHHHHHccCcchhhhhhhccCCC--ceE
Confidence 578899999999999999999999999999999998754321 1234789999999999999999999996654 688
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+|+||++ .+|...++.. ..++...++.|+.|++.||+|||++. |+||||||.|+|++ .+|.+||+|||+|+.+..
T Consensus 78 lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 78 LVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccCC
Confidence 9999998 6999988765 46999999999999999999999999 99999999999997 899999999999998765
Q ss_pred CCC--ccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCCCCCC-------
Q 006777 184 PTA--RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPASL------- 250 (631)
Q Consensus 184 ~~~--~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--~~~p~~l------- 250 (631)
+.. ...+-|.+|+|||++-+ .|+..+||||.|||+.||+.|.+-|.+.++.+|+...... ...+..|
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 432 22367999999997754 6999999999999999999999888887777776554432 1111111
Q ss_pred ----------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 251 ----------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 251 ----------------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
....+.++.+|+.+++. +|-+|++|.|+|+||||+.
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 12245678999999999 9999999999999999986
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=370.04 Aligned_cols=265 Identities=20% Similarity=0.313 Sum_probs=218.9
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|.+.+.||+|+||.||+|.+..+|+.||+|.+....... ......+.+|+.++++++||||++++++|.+.+ .+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~--~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETKD--ALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--eEEE
Confidence 4889999999999999999999999999999987654322 233456788999999999999999999886554 7999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCC
Confidence 99999999999887653 36899999999999999999999999 99999999999997 789999999999976433
Q ss_pred C-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 184 P-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~---~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
. ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...... ..+...+.. .+..++...++.+
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~ 232 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDA 232 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHH
Confidence 2 2345679999999998864 6899999999999999999999999864332 222222222 2233455678999
Q ss_pred HHHHHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCccccCCCC
Q 006777 259 KQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLR 298 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~~~l~ 298 (631)
++||.+||. +|.+||+ +.++++||||...+++.+....+.
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~ 278 (285)
T cd05631 233 KSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLE 278 (285)
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCC
Confidence 999999998 8999997 899999999999888776544333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=383.74 Aligned_cols=259 Identities=21% Similarity=0.323 Sum_probs=216.7
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|.+.++||+|+||.||+|.+..+++.||+|++..... ........+.+|+.++++++|||||++++.|.+.. .+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~--~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--EEEE
Confidence 68999999999999999999999999999999876543 12345677889999999999999999999987654 7999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC--
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-- 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~-- 183 (631)
||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCccccccc
Confidence 9999999999999998888999999999999999999999999 99999999999997 789999999999743210
Q ss_pred -----------------------------------------------CCCccccCCCCCCCccccc-cccCccceEeehh
Q 006777 184 -----------------------------------------------PTARSVIGTPEFMAPELYE-EEYNELVDIYSFG 215 (631)
Q Consensus 184 -----------------------------------------------~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG 215 (631)
....+.+||+.|+|||++. ..|+.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0012357999999999875 4699999999999
Q ss_pred hHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCccCCCCC
Q 006777 216 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPK 290 (631)
Q Consensus 216 ~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l--~~~~~~~lk~lI~kcL~~p~~Rpt---a~elL~hpff~~~~~~ 290 (631)
|++|||++|+.||.+. ++.+....+........+ ....+++++++|.+|+.+|.+|++ +.++++||||+...+.
T Consensus 236 vil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 236 VILYEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHHHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 9999999999999874 444444444432222222 234688999999998889999987 9999999999886654
Q ss_pred c
Q 006777 291 D 291 (631)
Q Consensus 291 ~ 291 (631)
.
T Consensus 315 ~ 315 (382)
T cd05625 315 S 315 (382)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=383.68 Aligned_cols=260 Identities=21% Similarity=0.309 Sum_probs=216.1
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
..|++.+.||+|+||.||+|.+..+|+.||+|++...... .......+.+|+.+|+.++||||+++++.|.+. ..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEE
Confidence 3699999999999999999999999999999998754331 123456788999999999999999999988764 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC-
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~- 183 (631)
+||||+++|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|.....
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCcccccc
Confidence 99999999999999998888999999999999999999999999 99999999999997 789999999999742210
Q ss_pred --------------------------------------------CCCccccCCCCCCCcccccc-ccCccceEeehhhHH
Q 006777 184 --------------------------------------------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCI 218 (631)
Q Consensus 184 --------------------------------------------~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il 218 (631)
......+||+.|+|||++.+ .++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00123579999999998764 589999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCcHHHHHHHHHhcCCCCCCC---CHHHHhcCCCccCCCCCc
Q 006777 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKD 291 (631)
Q Consensus 219 ~emltG~~Pf~~~~~~~~~~~~i~~~~~p~--~l~~~~~~~lk~lI~kcL~~p~~Rp---ta~elL~hpff~~~~~~~ 291 (631)
|+|++|+.||.+. ++......+....... ......++++++||.+|+.+|.+|+ ++.++++||||+...+..
T Consensus 235 yell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~ 311 (376)
T cd05598 235 YEMLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFAS 311 (376)
T ss_pred eehhhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHH
Confidence 9999999999874 4444444444322211 1223467899999999888999999 999999999998765544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=367.07 Aligned_cols=258 Identities=24% Similarity=0.417 Sum_probs=227.4
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..+.|.+.++||+|+|+.||++.+..+|+.+|+|.|+...+... ..+++.+|++|-+.|+|||||++++.... ..+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~ 84 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQE--ESF 84 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhcc--cce
Confidence 46789999999999999999999999999999999988776433 56789999999999999999999997643 458
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC--CCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKI~DFGlA~~ 180 (631)
.|+|+|+++||+|..-+-++..++|..+-.+++||+.||.|+|.++ |+|||+||+|+++..+ ..-|||+|||+|..
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999999999887777778899999999999999999999999 9999999999999632 33699999999987
Q ss_pred ccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcH
Q 006777 181 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDP 256 (631)
Q Consensus 181 ~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l~~~~~~ 256 (631)
.+.. ....++|||.|||||+++. +|+..+|||+.|+++|-|+.|.+||.+ .+...+++.|..+.. |......+++
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCH
Confidence 7643 3567899999999998865 699999999999999999999999997 578889999998854 3434556789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
++++||++||. +|.+|.|+.|.|+|||+...
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 99999999997 99999999999999999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=389.64 Aligned_cols=256 Identities=29% Similarity=0.511 Sum_probs=229.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.|..++++|+|+||.+++.+++.++..||+|.|..... +........+|+.++++++|||||.++++|++++ ..+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l 79 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLL 79 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceE
Confidence 3579999999999999999999999999999999998865 3344457889999999999999999999998765 369
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++||+||+||+|.+.+++.+ .++++.+..|+.||+.||.|||+++ |+||||||.|||++ .++.|||+|||+|+.+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLT-KDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcc-ccCceeecchhhhhhc
Confidence 99999999999999998754 5999999999999999999999988 99999999999998 7888999999999988
Q ss_pred cCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 182 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
+.. .+.+++|||.||.||++.+ +|+.++||||||||+|||++-+.+|.. .+...+..+|..+. -..++..++.++
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~-~~Plp~~ys~el 234 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL-YSPLPSMYSSEL 234 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc-CCCCCccccHHH
Confidence 776 5778999999999999976 699999999999999999999999987 67777877887775 334566788999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 259 KQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+.+|..||. +|..||+|.+||.+|.++..
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 999999998 89999999999999988754
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=376.03 Aligned_cols=254 Identities=22% Similarity=0.396 Sum_probs=216.8
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEecc
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~ 110 (631)
++||+|+||.||+|.+..+|..||+|++..... .......++.+|+.+|+.++||||+++++++...+ .+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--RLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--EEEEEEeCC
Confidence 469999999999999999999999999976532 23445677889999999999999999999886544 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC--CCCcc
Q 006777 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARS 188 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~--~~~~~ 188 (631)
++|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCccccccc
Confidence 99999999998888999999999999999999999999 99999999999998 789999999999865322 22345
Q ss_pred ccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006777 189 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 189 ~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~ 267 (631)
.+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+.......+... ...++...++++++||.+||+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME--DIKFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccC--CccCCCCCCHHHHHHHHHHcC
Confidence 68999999999885 4689999999999999999999999976 4455555555443 223556678999999999998
Q ss_pred -CCCCCC-----CHHHHhcCCCccCCCCCccc
Q 006777 268 -PASLRL-----PALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 268 -~p~~Rp-----ta~elL~hpff~~~~~~~~~ 293 (631)
+|.+|+ ++.++++||||...++..+.
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~ 263 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVY 263 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 899997 89999999999987776543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=375.24 Aligned_cols=255 Identities=21% Similarity=0.389 Sum_probs=217.0
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEecc
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~ 110 (631)
+.||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+++.++||||++++++|.... .+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEEEeCC
Confidence 479999999999999999999999999986532 22345667888999999999999999999886554 799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC--CCCcc
Q 006777 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARS 188 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~--~~~~~ 188 (631)
++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... .....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCcccc
Confidence 99999999998888999999999999999999999999 99999999999998 789999999999864322 22345
Q ss_pred ccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006777 189 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 189 ~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~ 267 (631)
..||+.|+|||++. +.++.++|||||||++|+|++|..||.. .+.......+.... ..++...++++++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 67999999999875 4589999999999999999999999976 44555555554432 23455678999999999998
Q ss_pred -CCCCCC-----CHHHHhcCCCccCCCCCcccc
Q 006777 268 -PASLRL-----PALELLKDPFLVTDNPKDLVC 294 (631)
Q Consensus 268 -~p~~Rp-----ta~elL~hpff~~~~~~~~~~ 294 (631)
+|.+|+ ++.++++||||....+.....
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 264 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 264 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence 899998 899999999999877765443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=372.76 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=216.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|++.+.||+|+||.||+|.+..+|..||+|.+.... .....+++.+|+++|++++||||+++++++.+.. .+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EE
Confidence 468999999999999999999999999999999987542 2445677999999999999999999999887654 78
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++||||+++|+|.+++...+.+++..+..++.|++.||.|||+.+ +|+||||||+|||++ .+|.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEc-CCCcEEEccCcccccccc
Confidence 999999999999999998888999999999999999999999853 399999999999998 789999999999976655
Q ss_pred CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHH---------------------
Q 006777 184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV--------------------- 241 (631)
Q Consensus 184 ~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i--------------------- 241 (631)
.......||+.|+|||++.+ .++.++|||||||++|+|+||+.||... +...+...+
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCccccc
Confidence 55556789999999998764 5899999999999999999999999653 222222111
Q ss_pred -------------------------HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 242 -------------------------TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 242 -------------------------~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.....+.......++++++||.+||+ +|.+|||+.++|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 11111222223467899999999998 999999999999999998644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=380.14 Aligned_cols=247 Identities=33% Similarity=0.517 Sum_probs=208.9
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeE-EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIE-VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~-VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
...+.+.||.|+||+||+|... |.. ||+|.+..... +....+.|.+|+.+|.+|+|||||+|++++..... .+.
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~ 116 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDF--DDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLC 116 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhc--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceE
Confidence 4455677999999999999974 666 99999987654 22337789999999999999999999998765542 588
Q ss_pred EEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC-cEEEccccchhhc
Q 006777 105 MITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVM 181 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-~vKI~DFGlA~~~ 181 (631)
+||||+++|+|.+++.+ .+.++...+..|+.||+.|++|||+++| ||||||||+|||++ .++ ++||+|||+++..
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~-~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVD-LKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEc-CCCCEEEECCCccceee
Confidence 99999999999999988 5789999999999999999999999986 99999999999998 676 9999999999866
Q ss_pred cC--CCCccccCCCCCCCccccccc---cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 182 QQ--PTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~--~~~~~~~GTp~y~APE~l~~~---y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
.. .......||+.|||||++.+. |+.++||||||+++|||+||+.||.+... .+....+..+...+.++...++
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCH
Confidence 54 333447899999999999853 99999999999999999999999998666 4444444433344445555889
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+..+|..|+. +|..||+..+++.
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999998 9999999988765
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=372.13 Aligned_cols=262 Identities=27% Similarity=0.394 Sum_probs=221.0
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc--
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD-- 97 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~-- 97 (631)
.-.+...|...+.||+|+||.|..|.++.+|+.||+|.+. +..++.-..++.++|+++|+.++|+||+.+++.+..
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 3445667888899999999999999999999999999876 223456778899999999999999999999998865
Q ss_pred -CCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 98 -DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 98 -~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
+.-..+|+|+|+|+ .+|.+.++..+.+++..++.+++||+.||.|+|+.+ |+||||||.|+|++ .+..+||+|||
T Consensus 95 ~~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n-~~c~lKI~DFG 170 (359)
T KOG0660|consen 95 RDKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLN-ADCDLKICDFG 170 (359)
T ss_pred ccccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeec-cCCCEEecccc
Confidence 22357999999995 799999999888999999999999999999999999 99999999999998 78899999999
Q ss_pred chhhcc----CCCCccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHH--------
Q 006777 177 LAIVMQ----QPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-------- 242 (631)
Q Consensus 177 lA~~~~----~~~~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~-------- 242 (631)
+|+... ....+.++-|.+|+|||++. .+|+.++||||.|||+.||++|++-|.|.....++...+.
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 998774 33446678899999999764 4699999999999999999999999988655544322211
Q ss_pred ---------------c-CCC-CC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 243 ---------------S-GIK-PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 243 ---------------~-~~~-p~---~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+ ... +. .+.+..++.+.+|+++||+ +|.+|+|++|+|.||||..-
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 0 111 11 1224568999999999999 99999999999999999763
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=379.08 Aligned_cols=260 Identities=19% Similarity=0.312 Sum_probs=218.3
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
....|++.+.||+|+||.||+|.+..+|..||+|++...... .......+.+|+.+++.++||||++++++|.+.. .
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~--~ 117 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK--Y 117 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--E
Confidence 356899999999999999999999999999999999754321 1233455778999999999999999999886544 7
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+++||||++||+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeecc
Confidence 99999999999999998764 5899999999999999999999999 99999999999997 78999999999997554
Q ss_pred CC---CCccccCCCCCCCcccccc-----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--
Q 006777 183 QP---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK-- 252 (631)
Q Consensus 183 ~~---~~~~~~GTp~y~APE~l~~-----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~-- 252 (631)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+....+..+........++.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcC
Confidence 32 2235679999999998753 378899999999999999999999987 455566667765443333333
Q ss_pred CCcHHHHHHHHHhcC-CCCC--CCCHHHHhcCCCccCCCCC
Q 006777 253 VTDPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~--Rpta~elL~hpff~~~~~~ 290 (631)
..+.++++||.+||. +|.+ |+++.++++||||+...|.
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 468999999999998 6766 9999999999999886654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=372.97 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=215.4
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
+.||+|+||+||+|.++.+|+.||+|++....... .....++..|.. +++.++||||++++++|.+. ..+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcC
Confidence 47999999999999999999999999997654322 223344555554 56889999999999988654 378999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccc
Confidence 999999999998889999999999999999999999999 99999999999997 78999999999986432 22234
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+.+..+..+. ..++...++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKP--LRLKPNISVSARHLLEGLL 231 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHh
Confidence 5679999999998764 589999999999999999999999986 55666777666542 2344456899999999999
Q ss_pred C-CCCCCCCH----HHHhcCCCccCCCCCccccCCCC
Q 006777 267 V-PASLRLPA----LELLKDPFLVTDNPKDLVCDPLR 298 (631)
Q Consensus 267 ~-~p~~Rpta----~elL~hpff~~~~~~~~~~~~l~ 298 (631)
+ +|.+||++ .+++.||||....+..+....+.
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~ 268 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKIT 268 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCC
Confidence 8 89999997 69999999998877665544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=379.97 Aligned_cols=262 Identities=21% Similarity=0.371 Sum_probs=219.3
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC----------HHHHHHHHHHHHHHHhCCCCCccee
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS----------PDQLERLYSEVHLLKSLKHENIIKF 91 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~----------~~~~~~~~~Ei~iL~~L~HpnIV~l 91 (631)
..-++|++.+.||+|.||.|-+|++..+|+.||+|++....+... ....+++++||.+|++|+|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 346799999999999999999999999999999999976543211 1124789999999999999999999
Q ss_pred eeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEE
Q 006777 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 92 ~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
+++.-+.....+|||+|||..|.+...-.....+++.+++.|++.++.||+|||.+| ||||||||+|+|++ .+|+||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~-~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLS-SDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEc-CCCcEE
Confidence 998777777899999999999988654333333999999999999999999999999 99999999999998 789999
Q ss_pred EccccchhhccCC-------CCccccCCCCCCCccccccc-----cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006777 172 IGDLGLAIVMQQP-------TARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 239 (631)
Q Consensus 172 I~DFGlA~~~~~~-------~~~~~~GTp~y~APE~l~~~-----y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~ 239 (631)
|+|||.+...... .....+|||.|||||++.++ .+.+.||||+|++||.|+.|+.||.+ .....++.
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~ 329 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFD 329 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHH
Confidence 9999998755222 12246899999999987652 36789999999999999999999987 56677777
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 240 ~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+|..........+...+.+++||.++|. ||..|.+..++..|||....
T Consensus 330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 7776532222222357899999999998 89999999999999999764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=371.82 Aligned_cols=260 Identities=19% Similarity=0.316 Sum_probs=216.8
Q ss_pred cEEEEEEEeecCCeEEEEEEEc---CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 26 FWISWVVVLNCTFMCRYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~---~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
.|++.+.||+|+||+||+|.+. .+|..||+|++............+++.+|+.+++.+ +||||++++++|... .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--A 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--C
Confidence 4899999999999999999874 478999999997654433344556788999999999 599999999987654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+++||||+.+|+|.+++.+++.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCccc
Confidence 78999999999999999998888999999999999999999999999 99999999999997 7899999999999754
Q ss_pred cCC---CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCC---CCHHHHHHHHHcCCCCCCCCCC
Q 006777 182 QQP---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 182 ~~~---~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~---~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
... .....+||+.|+|||++.+ .++.++|||||||++|+|+||..||... .....+...+.... ..++..
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~ 233 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSF 233 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCC
Confidence 322 2235679999999998864 3788999999999999999999999642 23334444444332 234556
Q ss_pred CcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCccCCCCCcc
Q 006777 254 TDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~ 292 (631)
.++.+++||.+||. +|.+|| ++.++++||||+...+...
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 278 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEAL 278 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 78999999999998 899999 7889999999988665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=373.08 Aligned_cols=254 Identities=21% Similarity=0.364 Sum_probs=216.0
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
++||+|+||+||+|.++.+|+.||+|++...... .....+.+..|+.+++.+ +||||++++++|.+. ..+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcC
Confidence 4799999999999999999999999998765321 224456677888888876 699999999988654 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCccc
Confidence 999999999998889999999999999999999999999 99999999999997 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL 266 (631)
...||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+ .+...++..+..+.. .++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence 5679999999998864 589999999999999999999999986 556667777765432 344557899999999999
Q ss_pred C-CCCCCCCH------HHHhcCCCccCCCCCccc
Q 006777 267 V-PASLRLPA------LELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 267 ~-~p~~Rpta------~elL~hpff~~~~~~~~~ 293 (631)
. +|.+||++ .++++||||....+..+.
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~ 265 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLN 265 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 8 99999998 899999999887765543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=372.95 Aligned_cols=261 Identities=18% Similarity=0.273 Sum_probs=220.2
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.+.||+|+||+||+|.++.+|+.||+|+++.... ......+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEE
Confidence 469999999999999999999999999999999986542 2234556788999999999999999999988654 4799
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+++|+|.+++.+. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTA 154 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCC
Confidence 999999999999999886 67999999999999999999999999 99999999999998 789999999999976543
Q ss_pred CC---CccccCCCCCCCccccc-------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Q 006777 184 PT---ARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-- 251 (631)
Q Consensus 184 ~~---~~~~~GTp~y~APE~l~-------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~-- 251 (631)
.. .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+. +....+..+........++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPED 233 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCC
Confidence 22 23457999999999874 34788999999999999999999999874 4455555555443322222
Q ss_pred CCCcHHHHHHHHHhcCCCCCCCCHHHHhcCCCccCCCCCcc
Q 006777 252 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~~p~~Rpta~elL~hpff~~~~~~~~ 292 (631)
...++.+++||.+||.+|.+||++.++++||||...++..+
T Consensus 234 ~~~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~~~ 274 (330)
T cd05601 234 PKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNI 274 (330)
T ss_pred CCCCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHHHH
Confidence 24678999999999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=370.13 Aligned_cols=257 Identities=27% Similarity=0.393 Sum_probs=218.0
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
.....-.|.-.+++|.|+||.||.|...++++.||||.+-.+...+ .+|+++|+.++|||||++..+|....
T Consensus 19 ~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~ 90 (364)
T KOG0658|consen 19 GKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSST 90 (364)
T ss_pred CcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecC
Confidence 3345567999999999999999999999999999999987665322 26999999999999999988887544
Q ss_pred Cc---eEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 100 NR---TINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 100 ~~---~l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
.. ++++||||++ .+|.++++. +..++.-.++-+.+||++||.|||+.| |+||||||.|+|+|.+.|.+||
T Consensus 91 ~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKi 167 (364)
T KOG0658|consen 91 ESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKI 167 (364)
T ss_pred CCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEe
Confidence 43 7789999998 699888874 567999999999999999999999999 9999999999999988899999
Q ss_pred ccccchhhccC-CCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc------
Q 006777 173 GDLGLAIVMQQ-PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------ 243 (631)
Q Consensus 173 ~DFGlA~~~~~-~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~------ 243 (631)
||||.|+.+.. ....+++.|..|+|||++-+ .|+.++||||.||++.||+-|++-|.+....+++...+.-
T Consensus 168 cDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred ccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 99999987654 34567889999999998754 6999999999999999999999999997766666554431
Q ss_pred ----------------CCCCCC----CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 244 ----------------GIKPAS----LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 ----------------~~~p~~----l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
...+.. +.+..++++.+|+.++|+ +|.+|.++.|+|.||||...
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 011111 334568999999999999 99999999999999999764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=377.25 Aligned_cols=260 Identities=19% Similarity=0.321 Sum_probs=216.3
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
...+|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||++++++|.++ ..
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~ 117 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--KY 117 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CE
Confidence 356899999999999999999999999999999998754321 223445678899999999999999999988654 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+|+||||+++|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceecc
Confidence 99999999999999999765 5899999999999999999999999 99999999999998 78999999999997654
Q ss_pred CCC---CccccCCCCCCCcccccc-----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--
Q 006777 183 QPT---ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK-- 252 (631)
Q Consensus 183 ~~~---~~~~~GTp~y~APE~l~~-----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~-- 252 (631)
... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+....+..+........++.
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCcc
Confidence 322 245689999999998753 278899999999999999999999987 455556666655433222332
Q ss_pred CCcHHHHHHHHHhcCC-C--CCCCCHHHHhcCCCccCCCCC
Q 006777 253 VTDPQVKQFIEKCIVP-A--SLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~~-p--~~Rpta~elL~hpff~~~~~~ 290 (631)
..++.++++|.+||.+ + ..|+++.++++||||+...+.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~ 313 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence 3578999999999974 3 348899999999999876543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=372.84 Aligned_cols=253 Identities=22% Similarity=0.387 Sum_probs=215.1
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEecc
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~ 110 (631)
+.||+|+||.||+|.+..+|..||+|++..... .......++.+|+++++.++||||++++++|... ..+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 469999999999999999999999999986543 2334556778899999999999999999988654 4799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 111 ~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
++|+|..++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccc
Confidence 999999999888889999999999999999999997 67 99999999999998 78999999999986432 22234
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|+||..||.+ .+.......+... ...++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME--EIRFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHh
Confidence 5679999999998854 689999999999999999999999986 4455555555443 22345567899999999999
Q ss_pred C-CCCCCC-----CHHHHhcCCCccCCCCCcc
Q 006777 267 V-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 267 ~-~p~~Rp-----ta~elL~hpff~~~~~~~~ 292 (631)
+ +|.+|+ ++.++++||||....+...
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~ 263 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDV 263 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 8 899997 8999999999998766543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=370.07 Aligned_cols=259 Identities=20% Similarity=0.296 Sum_probs=220.2
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC-CcceeeeEEEcCCCceEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-nIV~l~~~f~~~~~~~l~ 104 (631)
.|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+..|+.++..+.|+ +|++++++|.+.+ .+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--RLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC--EEE
Confidence 48999999999999999999999999999999886533 2234556788899999999765 5788888876543 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-- 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~-- 182 (631)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFG 154 (324)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCC
Confidence 99999999999999998888999999999999999999999999 99999999999998 78999999999986432
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
.......+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+ .+....+..+.... ..++...++.+++|
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~l 231 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSI 231 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHH
Confidence 223345679999999998764 589999999999999999999999986 45666667666543 23455678999999
Q ss_pred HHHhcC-CCCCCCCH-----HHHhcCCCccCCCCCccc
Q 006777 262 IEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 262 I~kcL~-~p~~Rpta-----~elL~hpff~~~~~~~~~ 293 (631)
|.+||. +|.+|+++ .+++.||||...++..+.
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~ 269 (324)
T cd05587 232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLE 269 (324)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 999998 89999986 899999999987776543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=370.42 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=216.1
Q ss_pred EEEeecCCeEEEEEEEc---CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEE
Q 006777 31 VVVLNCTFMCRYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~---~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
+.||+|+||.||+|.+. .+|+.||+|+++.............+..|+.+|+.++||||++++++|..+ ..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 68999999999999874 578999999998654433344556778999999999999999999988664 3799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCC
Q 006777 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPT 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~ 185 (631)
||+.+|+|.+++.+.+.+.+..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... ...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCc
Confidence 99999999999999888999999999999999999999999 99999999999997 78999999999986432 222
Q ss_pred CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006777 186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 186 ~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~k 264 (631)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......+..+. ..++...++.+++||.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGK--LNLPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence 345679999999998764 588999999999999999999999987 44555556665543 23455678999999999
Q ss_pred hcC-CCCCCC-----CHHHHhcCCCccCCCCCccc
Q 006777 265 CIV-PASLRL-----PALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 265 cL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~ 293 (631)
||+ +|.+|| ++.+++.||||....+..+.
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~ 268 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLL 268 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 998 899999 89999999999887665543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=370.81 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=227.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
-+.|++++.||+|..|+||+|....++..+|+|++....+. ..+.+.++..|-.||+.++||.++.+|..|..+ .++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~--~~~ 152 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-SRKKLKRAQTEREILSLLDHPFLPTLYASFETD--KYS 152 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-hhhHHHHHHHHHHHHHhcCCCccchhhheeecc--cee
Confidence 34677889999999999999999999999999999987653 356778889999999999999999999998655 489
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++|||||+||+|..+++++ +.|++..++.|+..++.||+|||..| ||+|||||+||||. ++|+|-|.||.|+...
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccC
Confidence 9999999999999999875 57999999999999999999999999 99999999999998 8999999999886311
Q ss_pred c----------------------------------C-C-----------------------CCccccCCCCCCCcccccc
Q 006777 182 Q----------------------------------Q-P-----------------------TARSVIGTPEFMAPELYEE 203 (631)
Q Consensus 182 ~----------------------------------~-~-----------------------~~~~~~GTp~y~APE~l~~ 203 (631)
. . . ...+++||-+|.|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 0 0 0 0124689999999999986
Q ss_pred -ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC----HHH
Q 006777 204 -EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP----ALE 277 (631)
Q Consensus 204 -~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpt----a~e 277 (631)
+.+.++|+|+|||.+|||+.|..||.+..+.+.+...+.+....+..+ ..+..+++||+++|+ ||.+|.. |.|
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHH
Confidence 589999999999999999999999999888888877777654433333 457899999999998 8999998 999
Q ss_pred HhcCCCccCCCCCc
Q 006777 278 LLKDPFLVTDNPKD 291 (631)
Q Consensus 278 lL~hpff~~~~~~~ 291 (631)
|-+||||+..+|.-
T Consensus 389 IK~HpFF~gVnWaL 402 (459)
T KOG0610|consen 389 IKRHPFFEGVNWAL 402 (459)
T ss_pred hhcCccccCCChhh
Confidence 99999999999983
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=366.52 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=208.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|.+.+.||+|+||.||+|.++.+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTKE--TL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecCC--eE
Confidence 4689999999999999999999999999999999875432 122345678999999999999999999886554 78
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++||||+. ++|.+++.++ +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKS 154 (303)
T ss_pred EEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceecc
Confidence 99999996 6787777654 56999999999999999999999999 99999999999997 78999999999986433
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--C-----------
Q 006777 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I----------- 245 (631)
Q Consensus 183 ~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~--~----------- 245 (631)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..+.......+... .
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 22 2344678999999998753 48899999999999999999999998765554443333210 0
Q ss_pred ----CCCCCC-------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 246 ----KPASLS-------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 246 ----~p~~l~-------------~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
.+..+. ...++.+++||.+||+ +|.+|||+.++|+||||+...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 000000 0124678999999998 9999999999999999987543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=361.89 Aligned_cols=253 Identities=18% Similarity=0.284 Sum_probs=207.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.+.||+|+||+||+|.++.++..||+|++..... .....+.+.+|+.+++.++||||++++++|... ..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 76 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLY 76 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecC--CEEE
Confidence 379999999999999999999999999999999876532 233456788999999999999999999988654 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||+++++|..+......+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCccccccc
Confidence 99999998888777666667999999999999999999999999 99999999999997 7899999999999765432
Q ss_pred ---CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHH--cC--------------
Q 006777 185 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SG-------------- 244 (631)
Q Consensus 185 ---~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~--~~-------------- 244 (631)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+............ ..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 2234578999999998754 589999999999999999999999987444333222111 00
Q ss_pred ----CCCC---------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 245 ----IKPA---------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 245 ----~~p~---------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
..+. .+....++.+++||.+||+ +|.+|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 0112357789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=370.33 Aligned_cols=254 Identities=18% Similarity=0.326 Sum_probs=212.6
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.+..+|+.||+|+++.... ........+.+|+.+++.+ +||||++++++|.+.. .+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--RLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--EEEEEEeC
Confidence 479999999999999999999999999986543 2234556788999999998 7999999999886654 79999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCccc
Confidence 999999999988889999999999999999999999999 99999999999997 78999999999986422 22344
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~--------~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .......+.+... +..++...++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCCCCCCHHH
Confidence 5689999999998865 5899999999999999999999999631 1122344444443 223455678899
Q ss_pred HHHHHHhcC-CCCCCCC------HHHHhcCCCccCCCCCcc
Q 006777 259 KQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpt------a~elL~hpff~~~~~~~~ 292 (631)
+++|.+||+ +|.+|++ +.++++||||....+...
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~ 273 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLL 273 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHH
Confidence 999999998 9999987 789999999987665443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=369.43 Aligned_cols=257 Identities=26% Similarity=0.364 Sum_probs=208.3
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC---ce
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RT 102 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~---~~ 102 (631)
+|++.++||+|+||.||+|.+..+|..||+|++.... .......++.+|+.+++.++||||+++++++..... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 5999999999999999999999999999999987432 122344578899999999999999999998865432 35
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+|+||||+. ++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCccccccc
Confidence 899999995 799999998888999999999999999999999999 99999999999998 78999999999997543
Q ss_pred CCC-----CccccCCCCCCCccccc---cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHH--------------HHH
Q 006777 183 QPT-----ARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI--------------YKK 240 (631)
Q Consensus 183 ~~~-----~~~~~GTp~y~APE~l~---~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~--------------~~~ 240 (631)
... ....+||+.|+|||++. ..++.++|||||||++|+|+||+.||.+....... ...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 211 23457999999999875 36899999999999999999999999764322211 011
Q ss_pred HHc-----------CCCCCC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 241 VTS-----------GIKPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 241 i~~-----------~~~p~~---l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+.. ...+.. .....++.+.+||.+||. +|.+||++.++|+||||+...
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 100 001111 112356889999999998 999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=377.44 Aligned_cols=262 Identities=25% Similarity=0.399 Sum_probs=228.3
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEc
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD 97 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~ 97 (631)
........|.+.+.||+|.||.||++.++.+|..+|+|.+....... ....+.+.+|+.+|++|. |||||.++++|.+
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 34567889999999999999999999999999999999998776533 335577899999999998 9999999999976
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC---CCcEEEcc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGD 174 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~---~g~vKI~D 174 (631)
.. .+++|||+|.||.|.+.+.+. .+++..+..+++||+.|+.|||+.| |+||||||+|+|+... ++.+|++|
T Consensus 108 ~~--~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 108 PD--SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred CC--eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEee
Confidence 65 799999999999999999877 5999999999999999999999999 9999999999999743 35899999
Q ss_pred ccchhhccCC-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCC
Q 006777 175 LGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASL 250 (631)
Q Consensus 175 FGlA~~~~~~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l 250 (631)
||+|...... .....+|||.|+|||++. ..|+..+||||+|+++|.|++|..||.+. +.......|..+.. +...
T Consensus 183 FGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~-~~~~~~~~i~~~~~~f~~~~ 261 (382)
T KOG0032|consen 183 FGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE-TEFEIFLAILRGDFDFTSEP 261 (382)
T ss_pred CCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC-ChhHHHHHHHcCCCCCCCCC
Confidence 9999877653 456789999999999988 68999999999999999999999999884 44555556666533 3334
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
...++..+++||.+||. +|.+|+||.++|+|||++..
T Consensus 262 w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 262 WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 45568999999999998 99999999999999999864
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=367.60 Aligned_cols=263 Identities=20% Similarity=0.289 Sum_probs=221.8
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCceEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~l~ 104 (631)
.|.+.+.||+|+||.||+|.+..++..||+|++..... ......+.+..|..++..+ +||+|+++++++.+. ..++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEE
Confidence 48899999999999999999999999999999886532 1233445667788888877 589999999988654 3799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-- 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~-- 182 (631)
+||||+++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWD 154 (323)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCC
Confidence 99999999999999998889999999999999999999999999 99999999999998 78999999999986432
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
.......+||+.|+|||++.+ .++.++|||||||++|+|+||..||.+ .+...++..+.... ..++...+++++++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~l 231 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN--VAYPKSMSKEAVAI 231 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCcCCHHHHHH
Confidence 223345689999999998764 589999999999999999999999987 45666666666543 23455678999999
Q ss_pred HHHhcC-CCCCCCCH-----HHHhcCCCccCCCCCccccCCC
Q 006777 262 IEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPL 297 (631)
Q Consensus 262 I~kcL~-~p~~Rpta-----~elL~hpff~~~~~~~~~~~~l 297 (631)
|.+||+ +|.+|+++ .+++.||||+..+|..+.....
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~ 273 (323)
T cd05616 232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEV 273 (323)
T ss_pred HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCC
Confidence 999998 89999984 8999999999888776554443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=368.19 Aligned_cols=257 Identities=24% Similarity=0.390 Sum_probs=214.3
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHH---HhCCCCCcceeeeEEEcCCCceE
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL---KSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL---~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
|.+.+.||+|+||.||+|.+..+|+.||+|+++..... .....+.+.+|++++ +.++||||++++++|.+. ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEE
Confidence 78899999999999999999999999999999865421 233456677776665 566899999999988654 379
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc-
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ- 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~- 182 (631)
|+||||+++|+|..++.. +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++....
T Consensus 78 ~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCC
Confidence 999999999999988865 56999999999999999999999999 99999999999998 78999999999986432
Q ss_pred -CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 183 -QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 183 -~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......+..+.. .++...++.+.+
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 230 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAIS 230 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHH
Confidence 222345789999999998764 588999999999999999999999986 455556666655422 244557889999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHhcCCCccCCCCCccc
Q 006777 261 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 261 lI~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~ 293 (631)
||.+||. +|.+|| ++.++++||||....+....
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~ 269 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLL 269 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHH
Confidence 9999998 999999 69999999999887665543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=368.24 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=216.0
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.+..+|+.||+|++..... ......+.+..|..+++.+ +||||++++++|.+.. .+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--RLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--eEEEEEeC
Confidence 469999999999999999999999999986532 2234556677899998866 8999999999987654 79999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCcccc
Confidence 999999999998889999999999999999999999999 99999999999997 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+..+.. .++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 5679999999998764 589999999999999999999999987 456666666665432 234456889999999999
Q ss_pred C-CCCCCC-------CHHHHhcCCCccCCCCCccc
Q 006777 267 V-PASLRL-------PALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 267 ~-~p~~Rp-------ta~elL~hpff~~~~~~~~~ 293 (631)
. +|.+|+ ++.++++||||....|..+.
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~ 266 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLE 266 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 8 899999 89999999999887776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=387.27 Aligned_cols=258 Identities=29% Similarity=0.497 Sum_probs=226.4
Q ss_pred CCCcEEEE-----EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 23 VSYFWISW-----VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 i~~~Y~i~-----e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
+...|..- -+||+|+||+||.|+|..+...+|||.|..++ ....+-+..||.+.++|+|.|||++.+++
T Consensus 568 iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~-- 641 (1226)
T KOG4279|consen 568 IEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKNIVRYLGSV-- 641 (1226)
T ss_pred eEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHhhHhHHHHhhcc--
Confidence 44455543 38999999999999999999999999997543 45667789999999999999999999986
Q ss_pred CCCceEEEEEeccCCCCHHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKK-HKNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l--~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
..++++-+.||-++||+|..+++. .+++ +|.++..+.+||+.||.|||.+. |+|||||-+|||++.-.|.+||.|
T Consensus 642 senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISD 719 (1226)
T KOG4279|consen 642 SENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISD 719 (1226)
T ss_pred CCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecc
Confidence 344588899999999999999875 5777 89999999999999999999999 999999999999998899999999
Q ss_pred ccchhhcc--CCCCccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006777 175 LGLAIVMQ--QPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249 (631)
Q Consensus 175 FGlA~~~~--~~~~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~ 249 (631)
||.++.+. ++...++.||..|||||++.. +|+.++|||||||++.||+||++||.+..++...+-++.--...+.
T Consensus 720 FGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~ 799 (1226)
T KOG4279|consen 720 FGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPP 799 (1226)
T ss_pred cccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCC
Confidence 99997664 345678999999999999963 5999999999999999999999999998888777666655555566
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 250 l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
++...+.+++.||.+|+. +|..||+|.+||.+||++..+
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 777788999999999998 899999999999999998763
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=362.19 Aligned_cols=258 Identities=23% Similarity=0.288 Sum_probs=219.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
.-+.|+.+..|++|+||.||+|+|+.+++.||+|+++.+.-. .-.--...+||.+|.+++|||||.+..+.+..+-+.
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek--~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK--EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc--CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 356799999999999999999999999999999999876411 112234678999999999999999999988877788
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+|+|||||+ -+|+.++..-+ +|...+++.++.|++.||+|||.+. |+||||||+|+|++ +.|.+||+|||+|+.+
T Consensus 152 iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 152 IYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREY 227 (419)
T ss_pred eeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhh
Confidence 999999998 49999998765 8999999999999999999999998 99999999999998 8999999999999988
Q ss_pred cCC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC----------
Q 006777 182 QQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---------- 247 (631)
Q Consensus 182 ~~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p---------- 247 (631)
..+ .....+-|.+|+|||++-+ .|+.++|+||+|||+.||+++++.|.+....+|+.+.+..--.|
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 765 2445677999999997754 59999999999999999999999999977777776554320000
Q ss_pred ----------C----C----CCCC-CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 248 ----------A----S----LSKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 248 ----------~----~----l~~~-~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
. . +... .+....+|+..+|. +|.+|.||.+.|+|+||..
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 0 0 0111 34778999999998 9999999999999999986
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=361.88 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=204.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.++||.|+||+||+|.+..++..||+|+++.... ......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEE
Confidence 569999999999999999999999999999999875432 12234577899999999999999999988654 4799
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+. |+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 80 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSV 155 (288)
T ss_pred EEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeeccC
Confidence 9999997 59999887654 5799999999999999999999999 99999999999997 789999999999865432
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--C-----------
Q 006777 184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--K----------- 246 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~--~----------- 246 (631)
. ......|++.|+|||++.+ .++.++|||||||++|+|+||+.||.+.. ..+....+.... .
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST-VKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChHHhhccccc
Confidence 2 2334578999999998753 58999999999999999999999998743 333322221100 0
Q ss_pred --------CC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 247 --------PA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 --------p~-------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
|. ......++++++||.+||+ +|.+|||+.|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 0012357889999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=371.75 Aligned_cols=258 Identities=19% Similarity=0.314 Sum_probs=216.9
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
..+|++.+.||+|+||.||+|.++.+++.||+|++...... .......+.+|+.+++.++||||+++++.|.+. ..+
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~ 118 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYL 118 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEE
Confidence 47999999999999999999999999999999998754321 223445678899999999999999999988654 479
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++||||++||+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCc
Confidence 9999999999999998764 5899999999999999999999999 99999999999998 789999999999976543
Q ss_pred C---CCccccCCCCCCCcccccc-----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CC
Q 006777 184 P---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KV 253 (631)
Q Consensus 184 ~---~~~~~~GTp~y~APE~l~~-----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~--~~ 253 (631)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+........++ ..
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDND 273 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCC
Confidence 2 2235689999999998753 278899999999999999999999986 56666677776543322222 34
Q ss_pred CcHHHHHHHHHhcCCCC---CCCCHHHHhcCCCccCCCC
Q 006777 254 TDPQVKQFIEKCIVPAS---LRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 254 ~~~~lk~lI~kcL~~p~---~Rpta~elL~hpff~~~~~ 289 (631)
.++.+++||.+||.+|. .|+++.++++||||+...+
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 68899999999998543 3789999999999987554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=369.20 Aligned_cols=253 Identities=21% Similarity=0.414 Sum_probs=227.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
.+.+|++.+.||+|+||.|-+|++...|++||||.|+.+.+ .+.+.+-++.+||+||..|+||||+.+|.+|.. ...
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-kdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdK 127 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDK 127 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc-ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--Cce
Confidence 57899999999999999999999999999999999998775 567888899999999999999999999998854 457
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+.+||||..+|.|.+|+...+.+++.+.+.+++||++|+.|||.++ ++|||||.+|||++ .++++||+|||++..+.
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD-~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLD-QNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeec-CCCCeeeeccchhhhhc
Confidence 9999999999999999999999999999999999999999999999 99999999999998 89999999999998876
Q ss_pred CC-CCccccCCCCCCCccccccc-c-CccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 183 QP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 ~~-~~~~~~GTp~y~APE~l~~~-y-~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
.. ...++||+|-|.+||++++. | ++.+|.||||+++|-|+.|..||.+ .+-..++++|..|..... ..+..+.
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP---~~PSdA~ 280 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREP---ETPSDAS 280 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCC---CCCchHH
Confidence 55 46789999999999998874 5 6889999999999999999999988 566777888888754322 2245788
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
-||+.||. +|.+|.|+.++-.|=|+.
T Consensus 281 gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 281 GLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHHhcCcccchhHHHHhhhheee
Confidence 99999996 999999999999998874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=351.42 Aligned_cols=254 Identities=22% Similarity=0.385 Sum_probs=228.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
-+.|.+++.||+|-||.||+|+.+.++..||+|++.++.+.+ .....++.+|+.+-..|+||||+++|++|.+.. ++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~--ri 97 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK--RI 97 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheeccc--ee
Confidence 467899999999999999999999999999999998777543 233466889999999999999999999998765 79
Q ss_pred EEEEeccCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRK--KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~--~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
|+++||...|+|...+. +.+++++...+.+++|++.||.|+|.++ ||||||||+|+|+. ..|.+||+|||-+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCceeec
Confidence 99999999999999999 6678999999999999999999999999 99999999999996 8899999999999877
Q ss_pred cCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 182 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
......+.|||..|.|||+.++ .++..+|+|++|++.||++.|.+||.. .+..+.|++|..- ...++..++..+++
T Consensus 175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes-~~~~etYkrI~k~--~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES-QSHSETYKRIRKV--DLKFPSTISGGAAD 251 (281)
T ss_pred CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh-hhhHHHHHHHHHc--cccCCcccChhHHH
Confidence 7667788999999999999876 599999999999999999999999987 4478888888764 22344677899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
+|.+||. +|.+|++..|++.|||+..
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHHh
Confidence 9999998 8999999999999999864
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.98 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=212.4
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHH-HHHHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV-HLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei-~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
+.||+|+||+||+|.+..++..||+|++........ .....+..|. .+++.++||||++++++|.+.+ .+|+||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--KLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--eEEEEEeC
Confidence 479999999999999999999999999986543222 2233444444 4578899999999999886554 78999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcc
Confidence 999999999998888999999999999999999999999 99999999999997 78999999999986432 22344
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+....+..+... +..+....++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK--PLQLKPNITNSARHLLEGLL 231 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHc
Confidence 5689999999998765 589999999999999999999999986 4556666666543 23344567889999999999
Q ss_pred C-CCCCCCCHH----HHhcCCCccCCCCCcccc
Q 006777 267 V-PASLRLPAL----ELLKDPFLVTDNPKDLVC 294 (631)
Q Consensus 267 ~-~p~~Rpta~----elL~hpff~~~~~~~~~~ 294 (631)
+ +|.+|+++. ++++|+||...+|..+..
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~ 264 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPINWDDLIN 264 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHh
Confidence 8 899999876 899999999887766543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.33 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=212.6
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHH-HHHHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV-HLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei-~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.+..+|..||+|++....... .....++..|+ .+++.++||||++++++|.+.. .+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEEEEcC
Confidence 47999999999999999999999999987654322 23334455555 4678999999999999886543 79999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC--CCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~--~~~~ 187 (631)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccc
Confidence 999999999988888999999999999999999999999 99999999999998 789999999999865322 2234
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+.+..+... +..++...+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHc
Confidence 5679999999998764 589999999999999999999999987 4566666666654 33455567889999999999
Q ss_pred C-CCCCCCCH----HHHhcCCCccCCCCCccc
Q 006777 267 V-PASLRLPA----LELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 267 ~-~p~~Rpta----~elL~hpff~~~~~~~~~ 293 (631)
+ +|.+|+++ .++++||||...++..+.
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSPINWDDLY 263 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHh
Confidence 8 89999876 499999999987766544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=364.58 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=212.0
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh-CCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.+..+++.||+|+++..... .....+.+..|..++.. ++||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence 4799999999999999999999999999865321 22344556667777765 4899999999988654 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
++||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccc
Confidence 999999999998889999999999999999999999999 99999999999997 78999999999996532 22334
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+++..+.... ..++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDR--PHFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHc
Confidence 5689999999998764 589999999999999999999999987 45566666665542 2345567889999999999
Q ss_pred C-CCCCCCCH-HHHhcCCCccCCCCCcc
Q 006777 267 V-PASLRLPA-LELLKDPFLVTDNPKDL 292 (631)
Q Consensus 267 ~-~p~~Rpta-~elL~hpff~~~~~~~~ 292 (631)
. +|.+||++ .+++.||||....+..+
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~~ 259 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGIDWERL 259 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCCHHHH
Confidence 8 89999986 58999999998776544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=365.71 Aligned_cols=253 Identities=18% Similarity=0.326 Sum_probs=211.4
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
+.||+|+||.||+|.+..+++.||+|+++.... ........+.+|+.++.++ +||||++++++|.+.. .+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--RLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--EEEEEEeC
Confidence 479999999999999999999999999986543 2334556788899988877 8999999999887654 79999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCccc
Confidence 999999999988889999999999999999999999999 99999999999997 78999999999986432 22234
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCC--------CCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~--------~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+.+.+... ...++...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHH
Confidence 5689999999998764 5899999999999999999999999521 1122334444433 223555678999
Q ss_pred HHHHHHhcC-CCCCCCC------HHHHhcCCCccCCCCCc
Q 006777 259 KQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpt------a~elL~hpff~~~~~~~ 291 (631)
++||.+||+ +|.+||+ ..++++||||...+|..
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~ 272 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDL 272 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHH
Confidence 999999998 8999998 47999999998876644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=364.65 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=212.8
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.++.+|..||+|.++..... .......+..|..++..+ +||||++++++|.+. ..+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECC
Confidence 4799999999999999999999999999865321 123445567788888754 899999999988664 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
+.+|+|..++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCcee
Confidence 999999999998888999999999999999999999999 99999999999998 78999999999986432 22344
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...+.+.+.... ..++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHc
Confidence 5789999999998864 589999999999999999999999986 45666666665542 2344567899999999999
Q ss_pred C-CCCCCCCH-HHHhcCCCccCCCCCcc
Q 006777 267 V-PASLRLPA-LELLKDPFLVTDNPKDL 292 (631)
Q Consensus 267 ~-~p~~Rpta-~elL~hpff~~~~~~~~ 292 (631)
. +|.+|+++ .++++||||....+..+
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~~~~ 259 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINWTAL 259 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCHHHH
Confidence 8 89999998 58999999988766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=364.39 Aligned_cols=253 Identities=21% Similarity=0.341 Sum_probs=215.2
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
+.||+|+||+||+|.+..++..||+|+++.... ........+.+|+.+++.+ +||||++++++|.+.. .+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcC
Confidence 479999999999999999999999999986532 2234456678899999888 7999999999886544 79999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCccc
Confidence 999999999998888999999999999999999999999 99999999999997 78999999999986432 22234
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......+..... .++...++.+++||.+||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHc
Confidence 5679999999998764 689999999999999999999999976 455666666655422 344567899999999999
Q ss_pred C-CCCCCCCH-----HHHhcCCCccCCCCCcc
Q 006777 267 V-PASLRLPA-----LELLKDPFLVTDNPKDL 292 (631)
Q Consensus 267 ~-~p~~Rpta-----~elL~hpff~~~~~~~~ 292 (631)
. +|.+||++ .+++.||||....+...
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~ 263 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDWDKL 263 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 8 99999999 99999999998776543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=357.95 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=209.1
Q ss_pred EeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCC
Q 006777 33 VLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~g 112 (631)
||+|+||+||+|.++.+|+.||+|.+..... ......+.+..|+.+++.++||||++++++|... ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence 6999999999999999999999999876543 2223446778899999999999999999987654 478999999999
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC--CC
Q 006777 113 GSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 186 (631)
Q Consensus 113 GsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~--~~ 186 (631)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++...... ..
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccc
Confidence 999988743 356999999999999999999999999 99999999999997 7899999999998655432 23
Q ss_pred ccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006777 187 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 187 ~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~---~~~~~~i~~~~~p~~l~~~~~~~lk~lI 262 (631)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ......+... +..++...++.+++|+
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHH
Confidence 34679999999998764 5889999999999999999999999763322 2222222222 3344556789999999
Q ss_pred HHhcC-CCCCCC-----CHHHHhcCCCccCCCCCcccc
Q 006777 263 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVC 294 (631)
Q Consensus 263 ~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~ 294 (631)
.+||+ +|.+|| +++++++||||+...+..+..
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 270 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEA 270 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhh
Confidence 99998 899999 889999999999877765433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=356.22 Aligned_cols=261 Identities=23% Similarity=0.343 Sum_probs=215.8
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|++.++||+|+||.||+|.+..+|+.||+|++...... .......+.+|+.+++.++||||+++++.+.+.+ .+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--ALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--eEEE
Confidence 589999999999999999999999999999998765431 2233455778999999999999999999886543 7999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
||||+.+|+|..++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ +++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPE 154 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCC
Confidence 99999999999887653 46999999999999999999999999 99999999999997 789999999999875432
Q ss_pred C-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHH---HHHHHHHcCCCCCCCCCCCcHHH
Q 006777 184 P-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~---~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
. .....+|++.|+|||++. ..++.++|||||||++|+|++|+.||.+..... .+...+... +..++...++.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 232 (285)
T cd05605 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAA 232 (285)
T ss_pred CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHH
Confidence 2 223457899999999875 458899999999999999999999998643322 122222221 233445578899
Q ss_pred HHHHHHhcC-CCCCCC-----CHHHHhcCCCccCCCCCcccc
Q 006777 259 KQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVC 294 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~ 294 (631)
++||.+||. +|.+|| ++.++++||||...+++.+..
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~ 274 (285)
T cd05605 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA 274 (285)
T ss_pred HHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence 999999998 999999 899999999999887776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=365.42 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=214.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|++.+.||.|+||.||+|.+..+|..||+|.+.... .....+.+.+|++++++++||||++++++|.+.. .+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--EE
Confidence 478999999999999999999999999999999987642 2345567899999999999999999999987654 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+. + |+||||||+|||++ .+|.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhhh
Confidence 99999999999999999888899999999999999999999975 6 99999999999998 78999999999997655
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHH-----------------------
Q 006777 183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY----------------------- 238 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~----------------------- 238 (631)
........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred hhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCCc
Confidence 444456689999999998865 58899999999999999999999997532 21111
Q ss_pred ---------------------HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 239 ---------------------KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 239 ---------------------~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
..+.....+.......++++++||.+||+ +|.+|||+.|++.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 11111111222222357889999999998 99999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=365.82 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=211.3
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
+.||+|+||.||+|.+..+|+.||+|++...... ......++..|.. +++.++||||++++++|...+ .+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~--~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--KLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC--EEEEEEcC
Confidence 4699999999999999999999999998765332 2233445555654 577899999999999886544 78999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcc
Confidence 999999999998889999999999999999999999999 99999999999997 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL 266 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+.... ..+....+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKP--LVLRPGASLTAWSILEELL 231 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHh
Confidence 5679999999998764 589999999999999999999999986 45566666665542 2333456789999999999
Q ss_pred C-CCCCCCCH----HHHhcCCCccCCCCCccc
Q 006777 267 V-PASLRLPA----LELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 267 ~-~p~~Rpta----~elL~hpff~~~~~~~~~ 293 (631)
. +|.+||++ .++++||||....+..+.
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~ 263 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESLSWTDLE 263 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 8 89999876 589999999987765543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=364.45 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=213.7
Q ss_pred EEEeecCCeEEEEEEE---cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEE
Q 006777 31 VVVLNCTFMCRYKGFD---EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d---~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
+.||+|+||.||++.+ ..+|..||+|++..... ......++.+|+.+|++++||||++++++|.+. ..+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEE
Confidence 6799999999999987 35789999999986542 123345677899999999999999999988654 4799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC--C
Q 006777 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~--~ 185 (631)
||+++|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...... .
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCc
Confidence 99999999999988888999999999999999999999999 99999999999998 7899999999998754332 2
Q ss_pred CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006777 186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 186 ~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~k 264 (631)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+.......+.... ..++...++.+++||.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAK--LGMPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence 345689999999998764 588999999999999999999999986 45555555555442 23445678999999999
Q ss_pred hcC-CCCCCCC-----HHHHhcCCCccCCCCCccc
Q 006777 265 CIV-PASLRLP-----ALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 265 cL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~ 293 (631)
||+ +|.+||+ +.+++.||||....+..+.
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLY 266 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHH
Confidence 998 9999999 6789999999987665543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=362.14 Aligned_cols=261 Identities=17% Similarity=0.299 Sum_probs=214.5
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+.|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+.+|+.+++.++||||++++++|.+. ..+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEE
Confidence 4799999999999999999999999999999999754321 233456688899999999999999999988654 4799
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||++||+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCC
Confidence 99999999999999987 457999999999999999999999999 99999999999997 789999999999865433
Q ss_pred CC---CccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Q 006777 184 PT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLS 251 (631)
Q Consensus 184 ~~---~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~---~l~ 251 (631)
.. ....+||+.|+|||++. +.++.++|||||||++|+|++|+.||.. .+..+.+..+....... ...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 21 12356999999999875 3478899999999999999999999986 44555555554432211 112
Q ss_pred CCCcHHHHHHHHHhcCC---CCCCCCHHHHhcCCCccCCCCCcc
Q 006777 252 KVTDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~~---p~~Rpta~elL~hpff~~~~~~~~ 292 (631)
...++.+++||.+||.. +..|+++.++++||||....+...
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~ 277 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNI 277 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHH
Confidence 23678999999999963 345889999999999988766543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=380.44 Aligned_cols=254 Identities=25% Similarity=0.332 Sum_probs=205.7
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC----
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD---- 98 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~---- 98 (631)
....|.+.++||+|+||.||+|.+..+|+.||+|++.... ....+|+.+|+.++|||||+++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 4568999999999999999999999999999999885432 1234699999999999999999887542
Q ss_pred --CCceEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 99 --TNRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 99 --~~~~l~lV~Ey~~gGsL~~~l~----~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
...++++||||++ ++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||
T Consensus 136 ~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 136 NEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceee
Confidence 2236789999997 57776654 3467999999999999999999999999 9999999999999855567999
Q ss_pred ccccchhhccCC-CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---
Q 006777 173 GDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--- 246 (631)
Q Consensus 173 ~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--- 246 (631)
+|||+|+..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|.+||.+......+.+.+.....
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999999765432 3345688999999998754 5899999999999999999999999886555544443321100
Q ss_pred ---------------CC--------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 247 ---------------PA--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 ---------------p~--------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
|. .++...++++++||.+||+ +|.+|||+.|+|+||||...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 00 1223356899999999998 99999999999999999764
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=361.90 Aligned_cols=261 Identities=20% Similarity=0.294 Sum_probs=219.5
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCceEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~~l~ 104 (631)
.|.+.++||+|+||.||+|.++.+|+.||+|++...... .....+.+..|+.+++.+. ||+|++++++|.+.+ .+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD--RLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC--EEE
Confidence 478899999999999999999999999999998865321 2334566778999998885 577888988876544 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC-
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~- 183 (631)
+||||+++|+|.+++.+.+.+++.+++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCC
Confidence 99999999999999998889999999999999999999999999 99999999999998 789999999999875322
Q ss_pred -CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 184 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 184 -~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.....+.+.... ..++...++.++++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~l 231 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSI 231 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHH
Confidence 22345679999999998764 589999999999999999999999987 45666666666542 23455678899999
Q ss_pred HHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCccccC
Q 006777 262 IEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCD 295 (631)
Q Consensus 262 I~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~~ 295 (631)
|.+||. +|.+|++ ..++++||||...++..+...
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~ 271 (323)
T cd05615 232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENR 271 (323)
T ss_pred HHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcC
Confidence 999998 8999997 579999999998877665443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=381.51 Aligned_cols=259 Identities=28% Similarity=0.464 Sum_probs=226.1
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
..|.-++.||.|+||.||.|+|..+.+.||||.+..... ++....+.+.+||+.|++|+|||+|.|.++|..+. ..|
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--TaW 102 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--TAW 102 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--hHH
Confidence 356667899999999999999999999999999998764 55667788999999999999999999999997655 689
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+|||||- |+-.+++.-+ +++.+.+|..++.+.+.||.|||+++ .||||||..|||++ +.|.|||+|||.|....
T Consensus 103 LVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~~- 177 (948)
T KOG0577|consen 103 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLADFGSASIMA- 177 (948)
T ss_pred HHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeeccccchhhcC-
Confidence 9999996 6888888765 57999999999999999999999999 99999999999998 89999999999997654
Q ss_pred CCCccccCCCCCCCcccc----ccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 184 PTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 184 ~~~~~~~GTp~y~APE~l----~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
.+++++|||+|||||++ +|.|+.++||||||++..||+-.++|+.. -|.-.....|..+-.|.-....++..++
T Consensus 178 -PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn-MNAMSALYHIAQNesPtLqs~eWS~~F~ 255 (948)
T KOG0577|consen 178 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPTLQSNEWSDYFR 255 (948)
T ss_pred -chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC-chHHHHHHHHHhcCCCCCCCchhHHHHH
Confidence 36789999999999976 47899999999999999999999999887 4444444556666556555667899999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCccc
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~~~ 293 (631)
+||..||+ .|..|||+.++|+|+|.....+..++
T Consensus 256 ~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi 290 (948)
T KOG0577|consen 256 NFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVI 290 (948)
T ss_pred HHHHHHHhhCcccCCcHHHHhhcchhccCCCchHH
Confidence 99999998 68999999999999999887665543
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=362.51 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=212.8
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh-CCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
+.||+|+||.||+|.+..++..||+|+++..... ..........|..+++. ++||||++++++|.+.. .+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--NLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--EEEEEEeC
Confidence 4799999999999999999999999999865321 12334556677888875 49999999999887654 79999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
+++|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCcee
Confidence 999999999998888999999999999999999999999 99999999999998 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL 266 (631)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+..+.+.... ..++...+..+++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDN--PCYPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHh
Confidence 5679999999998764 589999999999999999999999987 45566666665442 2244557889999999999
Q ss_pred C-CCCCCCCHH-HHhcCCCccCCCCCcc
Q 006777 267 V-PASLRLPAL-ELLKDPFLVTDNPKDL 292 (631)
Q Consensus 267 ~-~p~~Rpta~-elL~hpff~~~~~~~~ 292 (631)
. +|.+||++. +++.||||....+..+
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~~ 259 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREIDWSAL 259 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCCHHHH
Confidence 8 899999996 8999999998776544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=362.15 Aligned_cols=254 Identities=19% Similarity=0.327 Sum_probs=213.6
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
++||+|+||.||+|.+..+++.||+|++..... ......+.+.+|+.++.++ +||||++++++|.+.. .+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--RLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--EEEEEEeC
Confidence 479999999999999999999999999986533 2234566788999999888 6999999999886554 79999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCcee
Confidence 999999999988889999999999999999999999999 99999999999998 78999999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCC------CCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 188 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC------KNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~------~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .......+.+... +..++...++.+++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence 5789999999998754 6899999999999999999999999532 2223344444433 33456667899999
Q ss_pred HHHHhcC-CCCCCCC------HHHHhcCCCccCCCCCcc
Q 006777 261 FIEKCIV-PASLRLP------ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 261 lI~kcL~-~p~~Rpt------a~elL~hpff~~~~~~~~ 292 (631)
+|.+||. +|.+|++ ..+++.||||...+|..+
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~ 271 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHH
Confidence 9999998 8999998 469999999998776554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=367.56 Aligned_cols=256 Identities=26% Similarity=0.478 Sum_probs=220.7
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
.-|-++++||+|+||.||+|.++++|..||||+|..+ ..++++.+|+.+|++|+.|+||++|++|+... .+|
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DLW 104 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DLW 104 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ceE
Confidence 3466789999999999999999999999999998854 45678999999999999999999999887654 699
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+|||||..|+..++++. ++++++.++..+++..+.||+|||... -||||||..|||++ .+|..||+|||.|..+..
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADFGVAGQLTD 181 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhccccchhhh
Confidence 99999999999998764 578999999999999999999999988 89999999999998 789999999999987765
Q ss_pred C--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCcHHH
Q 006777 184 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQV 258 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~--~~~~~~l 258 (631)
. ..++++|||.|||||+++. +|+.++||||||++..||+.|++||.+.. +-...-.|.. .+|+.+. ..++.++
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH-PMRAIFMIPT-~PPPTF~KPE~WS~~F 259 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH-PMRAIFMIPT-KPPPTFKKPEEWSSEF 259 (502)
T ss_pred hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc-ccceeEeccC-CCCCCCCChHhhhhHH
Confidence 4 3568999999999999975 79999999999999999999999998743 3222222222 2344433 3478899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCccc
Q 006777 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~~~ 293 (631)
.+||++||. +|.+|.||.+|++|||++......++
T Consensus 260 ~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~ 295 (502)
T KOG0574|consen 260 NDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIM 295 (502)
T ss_pred HHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHH
Confidence 999999998 89999999999999999987776654
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=358.96 Aligned_cols=261 Identities=18% Similarity=0.300 Sum_probs=215.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.+.||+|+||.||+|.++.+++.||+|++..... ........+.+|+.+++.++||||++++++|.+. ..+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEE
Confidence 479999999999999999999999999999999875432 1233455678899999999999999999988654 4799
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+.||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccC
Confidence 99999999999999987 467999999999999999999999999 99999999999997 789999999999875543
Q ss_pred CC---CccccCCCCCCCcccccc------ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC---
Q 006777 184 PT---ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--- 251 (631)
Q Consensus 184 ~~---~~~~~GTp~y~APE~l~~------~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~--- 251 (631)
.. ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+........++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 22 223579999999998753 478899999999999999999999986 44555566665432212222
Q ss_pred CCCcHHHHHHHHHhcCCCCC---CCCHHHHhcCCCccCCCCCcc
Q 006777 252 KVTDPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~~p~~---Rpta~elL~hpff~~~~~~~~ 292 (631)
...++++++||.+||..+.+ |+++.++++||||...+|..+
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~ 277 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI 277 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence 23578999999999974333 568999999999998777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=384.26 Aligned_cols=258 Identities=27% Similarity=0.461 Sum_probs=223.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.|.|+..||.|+||.||+|..+.++...|-|+|... +..+++.+.-||.||..|+||+||++++.|+.++ .+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~en--kL 104 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN--KL 104 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--ce
Confidence 56788999999999999999999999999999998754 5688899999999999999999999999887665 58
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
|++.|||.||-...++-. ..++.+.+|..+++|++.||.|||+++ |||||||..|||++ -+|.|+|+|||.+....
T Consensus 105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADFGVSAKNK 181 (1187)
T ss_pred EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeecccccccch
Confidence 999999999999988665 457999999999999999999999999 99999999999998 89999999999986443
Q ss_pred C--CCCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCC
Q 006777 183 Q--PTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKV 253 (631)
Q Consensus 183 ~--~~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p-~~l~~~ 253 (631)
. ....+++|||+|||||+.. .+|+.++||||||+++.||+.+++|-++. ++....-+|....+| ..-+..
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-npMRVllKiaKSePPTLlqPS~ 260 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLLQPSH 260 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-chHHHHHHHhhcCCCcccCcch
Confidence 2 2356899999999999752 46999999999999999999999999884 555555555544333 344667
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCc
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~ 291 (631)
++..+++|+.+||+ +|..||++.+||+||||+....+.
T Consensus 261 Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 261 WSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred hhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcch
Confidence 89999999999998 899999999999999998665543
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=363.97 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=210.1
Q ss_pred EeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCcceeeeEEEcCCCceEEEEEec
Q 006777 33 VLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 33 LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
||+|+||+||+|.+..+|..||+|++....... .........|..++..+ +||||++++++|.+.. .+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--DLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--eEEEEEcC
Confidence 699999999999999999999999987654322 23344556677777665 7999999999886654 79999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc--CCCCc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTAR 187 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~--~~~~~ 187 (631)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCcc
Confidence 999999999998889999999999999999999999999 99999999999997 78999999999986432 22344
Q ss_pred cccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 006777 188 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kc 265 (631)
..+||+.|+|||++.+ .++.++|||||||++|+|+||..||.+ .+..+.++.+..+.... .....++.+++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHH
Confidence 6789999999998754 478999999999999999999999986 55666777776553321 1234678999999999
Q ss_pred cC-CCCCCC----CHHHHhcCCCccCCCCCcc
Q 006777 266 IV-PASLRL----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 266 L~-~p~~Rp----ta~elL~hpff~~~~~~~~ 292 (631)
|. +|.+|| ++.+++.||||....+..+
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~ 264 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADIDWDLL 264 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCCHHHH
Confidence 98 899998 6899999999987665443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.50 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=201.4
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcC-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCcceeeeEEEc---
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVD--- 97 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~-~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~f~~--- 97 (631)
.+|++.+.||+|+||.||+|.+.. .|..||+|.++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 379999999999999999999854 57899999987653221 2223455677766655 79999999998753
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
.....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Df 154 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADF 154 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccc
Confidence 23356899999996 6999998764 45899999999999999999999999 99999999999997 7899999999
Q ss_pred cchhhccCC-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC---CCCC-
Q 006777 176 GLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPAS- 249 (631)
Q Consensus 176 GlA~~~~~~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~---~p~~- 249 (631)
|++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+ ..+.... .+..
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-~~i~~~~~~~~~~~~ 233 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDW 233 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHHhCCCChhhc
Confidence 999765433 234567899999999875 46899999999999999999999999875444333 3332210 0000
Q ss_pred ---------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 250 ---------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 250 ---------------------l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+....++.+++||.+||+ +|.+|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 112357788999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=358.93 Aligned_cols=261 Identities=17% Similarity=0.299 Sum_probs=215.3
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.++||+|+||.||+|.++.+++.||+|++...... .......+.+|+.++..++||||+++++.+.+. ..++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEE
Confidence 3699999999999999999999999999999998754321 123345578899999999999999999988655 4799
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+.+|+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLME 154 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheeccc
Confidence 99999999999999987 467999999999999999999999999 99999999999997 789999999999865432
Q ss_pred C---CCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC---C
Q 006777 184 P---TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL---S 251 (631)
Q Consensus 184 ~---~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l---~ 251 (631)
. .....+||+.|+|||++. +.++.++|||||||++|||++|+.||.. .+..+.+..+........+ .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 233 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQV 233 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCcc
Confidence 2 122357999999999874 3478999999999999999999999987 4555666666554322222 2
Q ss_pred CCCcHHHHHHHHHhcC-C--CCCCCCHHHHhcCCCccCCCCCcc
Q 006777 252 KVTDPQVKQFIEKCIV-P--ASLRLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~--p~~Rpta~elL~hpff~~~~~~~~ 292 (631)
...++++++||.+||. + +..|+++.++++||||...++..+
T Consensus 234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~ 277 (332)
T cd05623 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI 277 (332)
T ss_pred ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHH
Confidence 3468899999999996 3 344789999999999998776554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=349.98 Aligned_cols=266 Identities=25% Similarity=0.406 Sum_probs=226.0
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|++++++++||||+++++++.+.. .++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS--NLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--eEE
Confidence 479999999999999999999999999999999876543 22345677899999999999999999999886554 789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||+++++|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .+|.+||+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC
Confidence 99999999999999998889999999999999999999999999 99999999999997 7899999999998765443
Q ss_pred CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006777 185 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~ 263 (631)
.....|++.|+|||.+. ..++.++||||||+++|+|++|..||... +.....+.+..+. ..++...++.++++|.
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~--~~~~~~~~~~l~~li~ 230 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGK--VRFPSFFSPDAKDLIR 230 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCC--ccCCccCCHHHHHHHH
Confidence 34567899999999775 45788999999999999999999999764 4555555555443 2344556899999999
Q ss_pred HhcC-CCCCCC-----CHHHHhcCCCccCCCCCccccCCCCCC
Q 006777 264 KCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 264 kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~~~l~~p 300 (631)
+||. +|.+|+ ++.++++||||....|..+....+..|
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 273 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAP 273 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCC
Confidence 9998 899999 899999999999887766554444333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=342.23 Aligned_cols=254 Identities=31% Similarity=0.526 Sum_probs=215.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+|.+.+.||+|++|.||+|.+..+|..||+|++....... .......+.+|+.++++++||||+++++++.+.. .+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE--TL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC--eE
Confidence 46899999999999999999999999999999987653221 2234567889999999999999999999887654 89
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++|+||+++++|.+++...+.+++..++.++.|++.||.|||+.+ ++||||+|+||+++ .++.++|+|||++.....
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceeccc
Confidence 999999999999999998888999999999999999999999999 99999999999997 789999999999865432
Q ss_pred CC-----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 184 PT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 184 ~~-----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
.. .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.......... .+........++...+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPD 235 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHhccCCCCCCCccCCHH
Confidence 21 134568899999998765 48899999999999999999999998754443333 333333344566678899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+++||.+||. +|.+||++.++|+||||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999998 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=362.45 Aligned_cols=257 Identities=28% Similarity=0.378 Sum_probs=207.1
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC-
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~- 100 (631)
.+..+|++.+.||+|+||.||+|.+..+|..||+|++.... .......++.+|+.+++.++||||++++++|.....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 45689999999999999999999999999999999987542 233455678899999999999999999998865432
Q ss_pred ---ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 101 ---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 101 ---~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
..+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCC
Confidence 358999999975 6666654 35899999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc------------
Q 006777 178 AIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------ 243 (631)
Q Consensus 178 A~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~------------ 243 (631)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..........+..
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 9754332 2345678999999998764 5899999999999999999999999875433222111100
Q ss_pred ---------CC-C-C----------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 244 ---------GI-K-P----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 244 ---------~~-~-p----------------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.. . + .......++.+++||.+||+ +|.+|||+.|+|.||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00 0 0 00112346789999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=378.38 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=223.6
Q ss_pred CccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006777 17 EPISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~ 96 (631)
.+.......+|.+.+.||+|+||+||+|.+..+|+.||+|++..... ......++.+|+.++..++|+||++++..|.
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence 34455567899999999999999999999999999999999987643 3456677889999999999999999988775
Q ss_pred cCCC------ceEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC
Q 006777 97 DDTN------RTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 97 ~~~~------~~l~lV~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 166 (631)
.... ..+++||||+++|+|.+++..+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~ 178 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-S 178 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-C
Confidence 4322 2478999999999999998653 46899999999999999999999998 99999999999998 7
Q ss_pred CCcEEEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006777 167 NGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 167 ~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i 241 (631)
++.+||+|||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+ .+...++..+
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~ 257 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKT 257 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHH
Confidence 899999999998754322 2345689999999998865 589999999999999999999999986 5566666666
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
..+..+ .++...+++++++|.+||. +|.+||++.++|.|||++.
T Consensus 258 ~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 258 LAGRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred hcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 655433 3455678999999999998 8999999999999999865
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=344.93 Aligned_cols=251 Identities=30% Similarity=0.542 Sum_probs=208.6
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEE
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV 106 (631)
|++.+.||+|+||+||+|.+..++..||+|++..... .........+|+.++++++||||+++++++.+. ..+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQDD--NYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES--SEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhcccccccccccccccccccc--cccccc
Confidence 8999999999999999999999999999999987643 122333445699999999999999999988774 478899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc--cCC
Q 006777 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~--~~~ 184 (631)
|||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++... ...
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccccccccc
Confidence 999999999999998888999999999999999999999999 99999999999998 8999999999998743 233
Q ss_pred CCccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCC--CHHHHHHHHHcCCCCCCCC--CCCcHHH
Q 006777 185 TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLS--KVTDPQV 258 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~--~~~~~~~~i~~~~~p~~l~--~~~~~~l 258 (631)
......+++.|+|||++. ..++.++||||||+++|+|++|..||.... +.............+.... ....+.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 345677899999999986 468999999999999999999999998741 2222222222211111111 1124899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 259 KQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+++|.+||. +|.+||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999998 89999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=359.07 Aligned_cols=256 Identities=27% Similarity=0.362 Sum_probs=207.7
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC--
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-- 99 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~-- 99 (631)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++.... .......++.+|+.+++.++||||++++++|....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 45789999999999999999999999999999999987542 23345567889999999999999999999876432
Q ss_pred --CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 100 --NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 100 --~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
...+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~ 172 (364)
T cd07875 99 EEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGL 172 (364)
T ss_pred cccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCC
Confidence 246899999997 577777753 4889999999999999999999999 99999999999997 789999999999
Q ss_pred hhhccCCC-CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---------
Q 006777 178 AIVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--------- 246 (631)
Q Consensus 178 A~~~~~~~-~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--------- 246 (631)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..... .+..+.....
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHh
Confidence 97654332 345678999999998764 58999999999999999999999998744333 2222221100
Q ss_pred ------------C-------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 247 ------------P-------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 247 ------------p-------------------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
| .......+..+++||.+||+ +|.+|||+.++|+||||..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 00111235678999999998 9999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.21 Aligned_cols=257 Identities=32% Similarity=0.516 Sum_probs=216.5
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
..|.+.+.||+|+||.||+|.+..+|..||+|++...... ......+.+.+|+++++.++||||++++++|.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4789999999999999999999999999999998754321 223456788999999999999999999998877655688
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCcccccccc
Confidence 999999999999999998888999999999999999999999999 99999999999997 789999999999875432
Q ss_pred C-----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 184 P-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 184 ~-----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
. ......|+..|+|||++.+ .++.++|||||||++|+|++|+.||.......... .+.........+...+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPVLPPHVSDH 237 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-HHhcCCCCCCCchhhCHH
Confidence 1 2234568999999998754 58899999999999999999999998754444433 333332233344556788
Q ss_pred HHHHHHHhcCCCCCCCCHHHHhcCCCcc
Q 006777 258 VKQFIEKCIVPASLRLPALELLKDPFLV 285 (631)
Q Consensus 258 lk~lI~kcL~~p~~Rpta~elL~hpff~ 285 (631)
+.++|.+|+.+|.+||++.++++|||+.
T Consensus 238 ~~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 238 CRDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 9999999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=347.62 Aligned_cols=257 Identities=23% Similarity=0.391 Sum_probs=220.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~ 98 (631)
...|...+.||+|..++|.++.++.+|.++|+|++.......+ ....+.-.+|+.+|+++ -||||+++.++|..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 4567778999999999999999999999999999876432222 23345667899999999 699999999988544
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+++|+|+|+.|.|.+|+...-.++++..+++++|++.|++|||.++ |+||||||+|||++ ++.++||.|||+|
T Consensus 96 --sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILld-dn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 --AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLD-DNMNIKISDFGFA 170 (411)
T ss_pred --chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeec-cccceEEecccee
Confidence 489999999999999999999888999999999999999999999999 99999999999998 7889999999999
Q ss_pred hhccCC-CCccccCCCCCCCccccc-------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--
Q 006777 179 IVMQQP-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-- 248 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~y~APE~l~-------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~-- 248 (631)
+.+... ..+..||||.|+|||.++ .+|+..+|+|++|+|+|.|+.|.+||.- .......+.|.+|...-
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCC
Confidence 887654 467889999999999774 2589999999999999999999999986 33444566777775422
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 249 ~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.-+...+..+++||.+||+ ||.+|.|++|.|.||||..
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 2234467899999999998 9999999999999999965
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=345.87 Aligned_cols=253 Identities=27% Similarity=0.369 Sum_probs=200.7
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCcceeeeEEEcC---C
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDD---T 99 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~f~~~---~ 99 (631)
+|++.+.||+|+||+||+|.++.+|+.||+|.++...... .....+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 5899999999999999999999999999999987643211 1112344566666555 799999999987643 2
Q ss_pred CceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 100 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
...+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||+
T Consensus 79 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg~ 154 (288)
T cd07863 79 ETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGL 154 (288)
T ss_pred CceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccCc
Confidence 346899999997 5899988764 34899999999999999999999999 99999999999997 789999999999
Q ss_pred hhhccCC-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCC------
Q 006777 178 AIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP------ 247 (631)
Q Consensus 178 A~~~~~~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~--~~p------ 247 (631)
+...... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+........+.+... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 155 ARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 9765433 234467899999999875 468999999999999999999999997754433332222110 000
Q ss_pred ----------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 248 ----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 248 ----------------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
.......+..+++||.+||+ +|.+|||+.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00112356788999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=366.93 Aligned_cols=248 Identities=26% Similarity=0.336 Sum_probs=201.6
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
...+|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|++|+|||||+++++|.... .
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~ 157 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYNK--F 157 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEECC--e
Confidence 34689999999999999999999999999999996431 24678999999999999999999886643 6
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
.++|+|++. ++|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|....
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPV 233 (391)
T ss_pred eEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCcccccc
Confidence 889999995 799999988888999999999999999999999999 99999999999998 78999999999996432
Q ss_pred C---CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCC-------HHHHHHHHHc-CCC----
Q 006777 183 Q---PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-------PAQIYKKVTS-GIK---- 246 (631)
Q Consensus 183 ~---~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~-------~~~~~~~i~~-~~~---- 246 (631)
. ......+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+... ..++...+.. +..
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 2 22335689999999998754 589999999999999999999988754221 1111111100 000
Q ss_pred ----------------------CCCCC-----CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 247 ----------------------PASLS-----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 247 ----------------------p~~l~-----~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
+...+ ...+.++++||.+||. +|.+||||.|+|+||||+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 00000 0135678999999998 9999999999999999976
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=390.72 Aligned_cols=265 Identities=24% Similarity=0.396 Sum_probs=223.9
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
+......|.+.+.||+|+||+||+|.+..++..||+|++..... .......+..|+.+|++|+|||||+++++|.+..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 55566799999999999999999999999999999999986643 3445677899999999999999999999998777
Q ss_pred CceEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeEecCCCCCceEEeC-----
Q 006777 100 NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHN-----PPIIHRDLKCDNIFVNG----- 165 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~-----~~IiHrDLKp~NILl~~----- 165 (631)
...+||||||+.+|+|.+++.. .+.+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 7789999999999999999875 357999999999999999999999854 34999999999999952
Q ss_pred -----------CCCcEEEccccchhhccCC-CCccccCCCCCCCccccc---cccCccceEeehhhHHHHHhhcCCCCCC
Q 006777 166 -----------NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNE 230 (631)
Q Consensus 166 -----------~~g~vKI~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~---~~y~~~sDIwSLG~il~emltG~~Pf~~ 230 (631)
..+.+||+|||++...... .....+||+.|+|||++. ..++.++||||||||+|+|+||..||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 1345899999999765433 234568999999999874 2488999999999999999999999987
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 231 ~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
..+..++...+..+... .....++++.+||..||. +|.+||++.++|.|||+....
T Consensus 246 ~~~~~qli~~lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 246 ANNFSQLISELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCcHHHHHHHHhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 77777776666654321 223457899999999998 899999999999999997543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.45 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=213.5
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-cceeeeEEEcCC----
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDT---- 99 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~f~~~~---- 99 (631)
..|...++||+|+||+||+|.++.+|+.||+|.++.+.-. .-.-....+|+.+|+.|+|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 3466678899999999999999999999999999876421 112234678999999999999 999999887655
Q ss_pred CceEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 100 NRTINMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~----~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
...+++|+||+. -+|.+|+.... .++...++.+++||+.||+|||+++ |+||||||+||+++ ..|.+||+||
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDF 164 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADF 164 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeecc
Confidence 247999999997 79999998865 5888999999999999999999999 99999999999998 7999999999
Q ss_pred cchhhccCC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CC
Q 006777 176 GLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--AS 249 (631)
Q Consensus 176 GlA~~~~~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p--~~ 249 (631)
|+|+...-+ .....++|.+|+|||++-+ .|+..+||||+|||++||++++..|.+..+.+++......--.| ..
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 999866533 2455688999999997754 59999999999999999999999999877766665544321000 11
Q ss_pred CC-------------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 250 LS-------------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 250 l~-------------------------~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
|+ +..++...+++.+||+ +|.+|.||..+|.||||....
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 11 1123588999999999 999999999999999998753
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=359.32 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=207.0
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|.+.++||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 147 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEI 147 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC--CeE
Confidence 457888999999999999999999999999999986432 234557789999999999999999999988554 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++||||+.+|+|... ...++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceeccc
Confidence 999999999998653 34678889999999999999999999 99999999999998 789999999999976543
Q ss_pred C--CCccccCCCCCCCcccccc-----c-cCccceEeehhhHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCC
Q 006777 184 P--TARSVIGTPEFMAPELYEE-----E-YNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~-----~-y~~~sDIwSLG~il~emltG~~Pf~~~~~--~~~~~~~i~~~~~p~~l~~~ 253 (631)
. ......||+.|+|||++.. . ++.++|||||||++|+|++|+.||..... .......+.... +...+..
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~ 299 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPAT 299 (353)
T ss_pred ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCc
Confidence 2 2345689999999998743 2 35689999999999999999999974322 222222332222 2334456
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.++++++||.+||. +|.+||++.|+|+||||....
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 78899999999998 999999999999999998754
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=346.91 Aligned_cols=259 Identities=20% Similarity=0.317 Sum_probs=212.5
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|++.++||+|+||.||+|.+..+++.||+|.+...... .......+.+|+.++++++|+||+++++.+.+.+ .+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETKD--ALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--EEEE
Confidence 478899999999999999999999999999998765432 2333456778999999999999999999886543 7999
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
||||+.+|+|.+++...+ .+++.+++.++.|++.||.|||+++ |+||||||+||+++ .++.++|+|||++.....
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCC
Confidence 999999999999986543 5899999999999999999999998 99999999999998 788999999999865432
Q ss_pred C-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 184 P-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA--QIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 184 ~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~--~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
. ......|++.|+|||++. ..++.++||||||+++|+|++|..||....... .....+... .+..++...++.++
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (285)
T cd05630 155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDAR 233 (285)
T ss_pred CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHH
Confidence 2 223457999999999875 458999999999999999999999998643221 111222111 12234456788999
Q ss_pred HHHHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCc
Q 006777 260 QFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~ 291 (631)
+||.+||+ +|.+||| +.|+++||||+...+..
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKR 271 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHH
Confidence 99999998 8999999 99999999998766554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=358.39 Aligned_cols=257 Identities=27% Similarity=0.353 Sum_probs=207.5
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC--
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-- 99 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~-- 99 (631)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.... .......++.+|+.+++.++||||++++++|....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 35679999999999999999999999999999999987543 23445677889999999999999999999886533
Q ss_pred --CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 100 --NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 100 --~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
...+++||||+.+ +|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCcc
Confidence 2368999999974 67776653 5899999999999999999999999 99999999999997 789999999999
Q ss_pred hhhccCCC-CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc------------
Q 006777 178 AIVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------ 243 (631)
Q Consensus 178 A~~~~~~~-~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~------------ 243 (631)
++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+..
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 97654332 345679999999998764 5899999999999999999999999874332222111110
Q ss_pred ---------C-CC------C-----------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 244 ---------G-IK------P-----------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 244 ---------~-~~------p-----------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
. .. + .......+..+++||.+||. +|.+|||+.|+|+||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 0 00 0 00112235678999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.97 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=212.1
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.+.||+|+||.||+|.+..+|..||+|.+.... ......++.+|++++++++||||++++++|.++. .++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG--EIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--EEE
Confidence 36999999999999999999999999999999987542 2445567889999999999999999999987654 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+++++|.+++.+.+.+++..+..++.||+.||.|||+ ++ ++||||||+|||++ .+|.+||+|||++.....
T Consensus 76 lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLID 152 (308)
T ss_pred EEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCcccccc
Confidence 999999999999999988889999999999999999999997 56 99999999999998 789999999999876554
Q ss_pred CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHH--------------------
Q 006777 184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-------------------- 242 (631)
Q Consensus 184 ~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~-------------------- 242 (631)
.......|++.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+.
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCC
Confidence 44556789999999998764 48889999999999999999999996532 222222111
Q ss_pred ----------------cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 243 ----------------SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 243 ----------------~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
....|.......++++++||.+||. +|.+||++.++++||||..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 1111111122357789999999998 9999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=338.81 Aligned_cols=256 Identities=31% Similarity=0.515 Sum_probs=214.2
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
.|.+.++||+|+||.||+|.+..+|..||+|.+...... ........+.+|+.++++++||||+++++++.+.....++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 688999999999999999999999999999998765321 1234556788999999999999999999988766556889
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+++||+++++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCccccccc
Confidence 99999999999999988888999999999999999999999998 99999999999997 7889999999998654321
Q ss_pred -----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 185 -----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 185 -----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
......++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+.... .......++...++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA-TQPTNPQLPSHISEHA 238 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh-cCCCCCCCchhcCHHH
Confidence 1223568899999998764 47889999999999999999999998754444444333 3323344556678899
Q ss_pred HHHHHHhcCCCCCCCCHHHHhcCCCcc
Q 006777 259 KQFIEKCIVPASLRLPALELLKDPFLV 285 (631)
Q Consensus 259 k~lI~kcL~~p~~Rpta~elL~hpff~ 285 (631)
++||..|+.+|.+||++.|++.||||+
T Consensus 239 ~~li~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 239 RDFLGCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHhcCChhhCcCHHHHhcCcccc
Confidence 999954445999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=370.75 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=214.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCC-CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~-g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++|||||+++++|.... .
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDD--K 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC--E
Confidence 45599999999999999999999887 788999977543 2344566788999999999999999999987654 7
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 103 INMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
+|+||||+++|+|.+++.. ..++++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DFgla 216 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeCcCc
Confidence 9999999999999988754 356899999999999999999999998 99999999999998 7899999999999
Q ss_pred hhccCC----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 179 IVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 179 ~~~~~~----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...+...+..+..+ .++..
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~ 294 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-PFPCP 294 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-CCCcc
Confidence 765432 2345679999999998764 589999999999999999999999976 4555666666554332 23445
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.++.+++||.+||. +|.+||++.++|.|||++.
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 67899999999998 8999999999999999964
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=354.91 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=204.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEE-----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d-----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
.++|++.++||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 46899999999999999999975 2456789999987432 234556789999999999 89999999998765
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC-------------------------------------------------------
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH------------------------------------------------------- 122 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~------------------------------------------------------- 122 (631)
.. ..+++||||+++|+|.+++...
T Consensus 83 ~~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 PN-GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CC-CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 43 4689999999999999998753
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC----CccccC
Q 006777 123 -------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIG 191 (631)
Q Consensus 123 -------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~G 191 (631)
..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++...... .....+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCCCC
Confidence 23778889999999999999999998 99999999999998 78999999999997543221 123456
Q ss_pred CCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-C
Q 006777 192 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 268 (631)
Q Consensus 192 Tp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~ 268 (631)
++.|+|||++. ..++.++|||||||++|||++ |..||.+..........+..+..+ ..+...++.++++|.+||. +
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQGD 317 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCC
Confidence 78899999775 458999999999999999997 999998755445555555554333 3345678899999999998 8
Q ss_pred CCCCCCHHHHhc
Q 006777 269 ASLRLPALELLK 280 (631)
Q Consensus 269 p~~Rpta~elL~ 280 (631)
|.+|||+.++++
T Consensus 318 p~~RPs~~el~~ 329 (338)
T cd05102 318 PKERPTFSALVE 329 (338)
T ss_pred hhhCcCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=333.12 Aligned_cols=251 Identities=27% Similarity=0.501 Sum_probs=212.6
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|++.+.||.|++|.||+|.++.+++.||+|.+..... .....+.+.+|+.++++++||||+++++.|... ...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEE
Confidence 58999999999999999999999999999999876543 234556788999999999999999999977543 347899
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
||||+++++|.+++... ..+++.+++.++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++.....
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLEN 154 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEecc
Confidence 99999999999998763 45899999999999999999999999 99999999999998 789999999999875533
Q ss_pred C--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 184 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
. ......|++.|+|||++.+ .++.++||||||+++++|++|+.||... +.......+..+..+ ..+...++.+.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (257)
T cd08223 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKLP-PMPKDYSPELGE 232 (257)
T ss_pred cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCC-CCccccCHHHHH
Confidence 2 2334578999999998754 5888999999999999999999999763 444444455554333 244567899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
||.+|++ +|.+||++.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.05 Aligned_cols=253 Identities=21% Similarity=0.306 Sum_probs=204.6
Q ss_pred EeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCC
Q 006777 33 VLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~g 112 (631)
||+|+||.||+|.++.+|+.||+|.+....... ......+..|+.++++++||||+++++++.+. ..+++||||++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecCCC
Confidence 699999999999999999999999987544321 22234456799999999999999999988654 479999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC-Cccc
Q 006777 113 GSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSV 189 (631)
Q Consensus 113 GsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~-~~~~ 189 (631)
|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++....... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeecc
Confidence 99998886543 5899999999999999999999999 99999999999997 78999999999986554322 2345
Q ss_pred cCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 006777 190 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265 (631)
Q Consensus 190 ~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~---~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kc 265 (631)
.|++.|+|||++.+ .++.++|||||||++|+|++|..||..... ..+..........+. .....++++++||.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHH
Confidence 78999999998754 589999999999999999999999975432 223333333222221 2235688999999999
Q ss_pred cC-CCCCCCCH----HHHhcCCCccCCCCCcc
Q 006777 266 IV-PASLRLPA----LELLKDPFLVTDNPKDL 292 (631)
Q Consensus 266 L~-~p~~Rpta----~elL~hpff~~~~~~~~ 292 (631)
|+ +|.+||++ .++++||||+..++..+
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~ 265 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINFPRL 265 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCHHHH
Confidence 98 89999999 67889999988666543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=333.74 Aligned_cols=252 Identities=29% Similarity=0.490 Sum_probs=218.8
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|.+.+.||.|+||.||+|.+..+|..||+|++..... .....+++..|+.+++.++||||+++++++.......+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 48899999999999999999999999999999876543 3455678899999999999999999999888766678999
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 106 ITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLH-----SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLH-----s~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
+|||+++++|.+++.. ...+++..++.++.||+.||.||| +.+ ++||||+|+||+++ .++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEeccc
Confidence 9999999999999876 357899999999999999999999 777 99999999999998 78999999999
Q ss_pred chhhccCCC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 177 LAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 177 lA~~~~~~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
++....... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||... +.....+.+..+..+ .++..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~ 233 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPYR 233 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCccc
Confidence 997665433 345678999999998754 5788999999999999999999999874 466666666665433 35556
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
.+..+.+++.+||. +|.+||++.++|+|||+
T Consensus 234 ~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 234 YSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 78899999999998 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=359.69 Aligned_cols=255 Identities=27% Similarity=0.359 Sum_probs=209.2
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC---ce
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RT 102 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~---~~ 102 (631)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......++.+|+.+|+.++||||+++++++..... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 3678999999999999999999999999999886431 233455678899999999999999999998865431 26
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeecc
Confidence 899999996 689998888888999999999999999999999999 99999999999998 78999999999997543
Q ss_pred CC---CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--------------
Q 006777 183 QP---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------- 243 (631)
Q Consensus 183 ~~---~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-------------- 243 (631)
.. ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. +......+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS-PIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHcCCCCHHHHHHhh
Confidence 22 2234568999999998764 47899999999999999999999998643 3332222211
Q ss_pred ----------CCCCC------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 244 ----------GIKPA------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 ----------~~~p~------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
...+. .+....++++++||.+||. +|.+|||+.++|.||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 11111 1223357899999999998 99999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.23 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=226.0
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...+..-|-+.+.||+|-|++|-+|++..+|..||||+|...++ +......+++|++.|+.++|||||++|++. +.
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DT 88 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DT 88 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehh--cc
Confidence 44567789999999999999999999999999999999998765 234456799999999999999999999954 45
Q ss_pred CceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
...+|+|+|+-.+|+|.+|+-+| ..+.|...+.|+.||+.|+.|||+.. ++||||||+||.+-.+-|.|||.|||++
T Consensus 89 QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFS 166 (864)
T KOG4717|consen 89 QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFS 166 (864)
T ss_pred cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeecccc
Confidence 56899999999999999999887 46999999999999999999999999 9999999999987668999999999999
Q ss_pred hhccCC-CCccccCCCCCCCcccccc-ccC-ccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 179 IVMQQP-TARSVIGTPEFMAPELYEE-EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~y~APE~l~~-~y~-~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
..+... ...+.||+..|.|||++-+ .|+ +++||||||+|+|-|++|+.||.+.++.+. ..+|..... ..+...+
T Consensus 167 Nkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-LTmImDCKY--tvPshvS 243 (864)
T KOG4717|consen 167 NKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-LTMIMDCKY--TVPSHVS 243 (864)
T ss_pred ccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-hhhhhcccc--cCchhhh
Confidence 766544 5678999999999997755 475 789999999999999999999998655444 444544322 3456778
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
.+.++||..||+ +|.+|.+.+||..|+|++....
T Consensus 244 ~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 244 KECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 999999999998 9999999999999999987543
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.79 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=205.4
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
.+|.+.+.||+|+||.||+|.++.++..||+|+++.... ......+.+|+.+++.++||||+++++++..+. .++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK--SLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC--eEE
Confidence 579999999999999999999999999999999876532 122345678999999999999999999886554 789
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 81 LVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSV 156 (309)
T ss_pred EEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecCC
Confidence 9999997 5888887665 45899999999999999999999999 99999999999998 789999999999865432
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC---C-----------
Q 006777 184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---I----------- 245 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~---~----------- 245 (631)
. ......+|+.|+|||++.+ .++.++|||||||++|+|+||..||.+..... ....+... .
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcch
Confidence 2 2234568999999998753 57899999999999999999999998643322 22222110 0
Q ss_pred -------CCC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 246 -------KPA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 246 -------~p~-------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.+. ......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 000 0112357889999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=354.55 Aligned_cols=257 Identities=27% Similarity=0.387 Sum_probs=208.1
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC-
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~- 100 (631)
.+.++|.+.+.||+|+||+||+|.+..++..||+|.+.... .......++.+|+.+|++++||||++++++|.....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 45678999999999999999999999999999999987542 122345667899999999999999999998764321
Q ss_pred ---ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 101 ---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 101 ---~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
..+|++++++ +++|.++++. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~ 164 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGL 164 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCcc
Confidence 3578999998 7899888764 56999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CC-------
Q 006777 178 AIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IK------- 246 (631)
Q Consensus 178 A~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~--~~------- 246 (631)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... .....+... ..
T Consensus 165 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 165 ARQADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ceecCCC-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 9765432 345678999999998754 5889999999999999999999999764322 222222110 00
Q ss_pred -----------------CC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 247 -----------------PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 -----------------p~---~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.. ......++.+.+||.+||. +|.+|||+.++|.||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00 0012346778999999998 99999999999999999763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.22 Aligned_cols=251 Identities=25% Similarity=0.438 Sum_probs=210.8
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|++.++||+|+||.||+|.+..++..||+|.+.... ......++.+|+.++++++||||+++++++.... ..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--RISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--EEEE
Confidence 5788999999999999999999999999999987542 2445567889999999999999999999987654 6889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~ 185 (631)
||||+++|+|..+ ..+++..+..++.||+.||.|||+++ |+|+||||+||+++ .+|.+||+|||++.......
T Consensus 77 v~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 77 CTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred EEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceeccccc
Confidence 9999999999765 35789999999999999999999999 99999999999997 78999999999997665555
Q ss_pred CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCC------HHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 186 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN------PAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 186 ~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~------~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
....+||+.|+|||++.+ .++.++|+||||+++|+|++|..||..... +......+.....+.......++++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 556789999999998754 588999999999999999999999964221 1233333333333333334467899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
++||.+||. +|.+||++.+++.||||+..+
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 999999998 899999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.48 Aligned_cols=254 Identities=18% Similarity=0.275 Sum_probs=200.3
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC------CCcceeeeEEEc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH------ENIIKFYNSWVD 97 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H------pnIV~l~~~f~~ 97 (631)
.++|++.++||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.++| ++|++++++|..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 478999999999999999999999999999999986421 223345567777776654 458889988865
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCC--------
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNG-------- 168 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g-------- 168 (631)
.. ..+++|||++ |++|.+++.+++.+++..++.++.||+.||.|||+ .| ||||||||+|||++ .++
T Consensus 203 ~~-~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~-~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ET-GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILME-TSDTVVDPVTN 277 (467)
T ss_pred CC-ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEe-cCCcccccccc
Confidence 43 4789999998 68999999888899999999999999999999998 48 99999999999997 343
Q ss_pred --------cEEEccccchhhccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006777 169 --------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 239 (631)
Q Consensus 169 --------~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~ 239 (631)
.+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+..+...+ .
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-~ 355 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL-H 355 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-H
Confidence 499999998854322 2345789999999998764 6999999999999999999999999875443322 1
Q ss_pred HHHc--CCCCCC-------------------------------------C-CCCCcHHHHHHHHHhcC-CCCCCCCHHHH
Q 006777 240 KVTS--GIKPAS-------------------------------------L-SKVTDPQVKQFIEKCIV-PASLRLPALEL 278 (631)
Q Consensus 240 ~i~~--~~~p~~-------------------------------------l-~~~~~~~lk~lI~kcL~-~p~~Rpta~el 278 (631)
.+.. +..|.. + ....++.+.+||.+||+ ||.+|||+.|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 1111 000000 0 01124678899999998 99999999999
Q ss_pred hcCCCccCCCC
Q 006777 279 LKDPFLVTDNP 289 (631)
Q Consensus 279 L~hpff~~~~~ 289 (631)
|+||||....+
T Consensus 436 L~Hp~~~~~~~ 446 (467)
T PTZ00284 436 TTHPYVLKYYP 446 (467)
T ss_pred hcCccccccCC
Confidence 99999987443
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=332.12 Aligned_cols=250 Identities=29% Similarity=0.524 Sum_probs=214.9
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|.+.+.||+|+||.||+|.+..+|..|++|.+..... .....+.+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEE
Confidence 48899999999999999999999999999999886543 245567789999999999999999999988755 47899
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
||||+++++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccC
Confidence 99999999999999774 56899999999999999999999998 99999999999998 789999999999875543
Q ss_pred CC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 184 PT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.. .....|++.|+|||++.+ .++.++|+|||||++++|++|..||... +.......+..+..+. ++...++.+++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd08529 154 NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFPP-VSQMYSQQLAQ 231 (256)
T ss_pred ccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC-CccccCHHHHH
Confidence 22 234578999999998754 5789999999999999999999999764 4555556665554333 33467889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+|.+||+ +|.+||++.+++.|||+
T Consensus 232 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 232 LIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHccCCcccCcCHHHHhhCCCC
Confidence 9999998 89999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=349.13 Aligned_cols=271 Identities=21% Similarity=0.341 Sum_probs=236.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
-..|.++++||+|.||+|.+++.+.+|+.+|+|+++.+-+ -..++...-..|-++|+.++||.+..+..+|... .++
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi-iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~--drl 243 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI-IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ--DRL 243 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhe-eehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC--ceE
Confidence 4568889999999999999999999999999999886644 3467777888899999999999999998888654 489
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc--
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-- 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~-- 181 (631)
++||||..||.|.-++.+.+.+++...+.+...|+.||.|||+++ |++||||.+|+|++ .+|++||.|||+++.-
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhccc
Confidence 999999999999999999999999999999999999999999999 99999999999998 8999999999999643
Q ss_pred cCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 182 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
......++||||+|+|||+++. .|+.++|+|.+|+++|||++|+.||... +-..++..|..+ ...++...+++++.
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~-dh~kLFeLIl~e--d~kFPr~ls~eAkt 397 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK-DHEKLFELILME--DLKFPRTLSPEAKT 397 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc-chhHHHHHHHhh--hccCCccCCHHHHH
Confidence 3445788999999999999975 6999999999999999999999999874 444455555433 33456677899999
Q ss_pred HHHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCccccCCCCCCCCc
Q 006777 261 FIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPNLV 303 (631)
Q Consensus 261 lI~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~~~l~~p~~~ 303 (631)
|+..+|. +|.+|.. |.|+..|+||...+|..++.+.+..|..+
T Consensus 398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKP 446 (516)
T KOG0690|consen 398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKP 446 (516)
T ss_pred HHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCC
Confidence 9999998 8999985 88999999999999999887777666543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=342.48 Aligned_cols=242 Identities=23% Similarity=0.307 Sum_probs=206.6
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc--CCCceEEEEEe
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD--DTNRTINMITE 108 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~--~~~~~l~lV~E 108 (631)
..||+|+++.||+|.. +|+.||+|.++.... ......+.+.+|+.+|++++||||+++++++.+ +....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5799999999999986 699999999876532 233445778899999999999999999999877 44457899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCCc
Q 006777 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~ 187 (631)
|+++|+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+||+++ .+|.+||+|||++...... ..
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~-~~ 178 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSP-PF 178 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhccc-cc
Confidence 999999999999888899999999999999999999985 6 88999999999998 7899999999999765433 23
Q ss_pred cccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006777 188 SVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~k 264 (631)
...|++.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+..+++..+........++...++.+++||.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4578999999998864 689999999999999999999999987 455666666654434444555678999999999
Q ss_pred hcC-CCCCCCCHHHHhc
Q 006777 265 CIV-PASLRLPALELLK 280 (631)
Q Consensus 265 cL~-~p~~Rpta~elL~ 280 (631)
||+ +|.+|||+.+++.
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 998 9999999999985
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=342.75 Aligned_cols=255 Identities=22% Similarity=0.328 Sum_probs=204.5
Q ss_pred EEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHH---HHHhCCCCCcceeeeEEEcCCCceEEEEEe
Q 006777 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH---LLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~---iL~~L~HpnIV~l~~~f~~~~~~~l~lV~E 108 (631)
+||+|+||.||+|.+..+|..||+|.+........ .......+|.. ++...+||||+.+++++...+ .+++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEEEEEe
Confidence 48999999999999999999999999876543221 22222334443 344458999999999886544 7899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCCcc
Q 006777 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~~ 188 (631)
|+++|+|.+++..++.+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..........
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccC
Confidence 9999999999998889999999999999999999999999 99999999999997 78999999999987554444445
Q ss_pred ccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 006777 189 VIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQFIEKC 265 (631)
Q Consensus 189 ~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~-~~~~i~~~~~p~~l~~~~~~~lk~lI~kc 265 (631)
..||+.|+|||.+. ..++.++|||||||++|+|++|..||........ ....... ..+..++...++.+++||.+|
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-cCCcCCccccCHHHHHHHHHH
Confidence 67999999999875 3478999999999999999999999975332211 1111111 123345556789999999999
Q ss_pred cC-CCCCCC-----CHHHHhcCCCccCCCCCccc
Q 006777 266 IV-PASLRL-----PALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 266 L~-~p~~Rp-----ta~elL~hpff~~~~~~~~~ 293 (631)
|. +|.+|+ ++.++++||||+..++....
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~ 267 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHh
Confidence 98 899999 69999999999987766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=336.01 Aligned_cols=253 Identities=30% Similarity=0.476 Sum_probs=211.1
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc--CCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
+|++.+.||+|+||.||+|.+ .+|..||+|.+...... ........+.+|+.++++++|+||+++++++.+. ..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeE
Confidence 488899999999999999987 57899999998765321 1233456788999999999999999999988665 479
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++|+||+++++|.+++.+.+.+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ .++.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhh
Confidence 999999999999999998888999999999999999999999999 99999999999997 789999999999865421
Q ss_pred --------CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006777 184 --------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 184 --------~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~ 254 (631)
.......|++.|+|||++.+ .++.++|+|||||++|+|++|..||.....................++...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF 234 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCC
Confidence 11234568999999998764 578999999999999999999999986544443333222212223355567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+.++.+||.+||. +|.+||++.++|+||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999998 89999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=341.26 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=213.3
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|+..+.||+|+||+||+|.+..+|+.||+|.+...... .......+.+|+.+|+.++|+||+++++.+...+ .+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETKD--ALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--EEEE
Confidence 478889999999999999999999999999998765432 2233455778999999999999999999886544 7999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
||||+.+|+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPE 154 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCC
Confidence 99999999999888653 36999999999999999999999999 99999999999997 678999999999865432
Q ss_pred C-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHH---HHHHHHcCCCCCCCCCCCcHHH
Q 006777 184 P-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~---~~~~i~~~~~p~~l~~~~~~~l 258 (631)
. ......|++.|+|||++. ..++.++|+|||||++|+|++|..||........ +...+... ...++...++.+
T Consensus 155 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 232 (285)
T cd05632 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEA 232 (285)
T ss_pred CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHH
Confidence 2 234567899999999875 4589999999999999999999999986433222 22222222 223445567899
Q ss_pred HHHHHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCcc
Q 006777 259 KQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~ 292 (631)
.+||.+||+ +|.+||+ +.+++.||||....++.+
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 272 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL 272 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHH
Confidence 999999998 8999999 889999999998766554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.90 Aligned_cols=251 Identities=26% Similarity=0.430 Sum_probs=209.9
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
..+|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~--~~ 81 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD--KL 81 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--EE
Confidence 357889999999999999999999999999999987553 233456788999999999999999999887654 78
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++||||+++++|.+++...+.+++.+++.++.||+.||.|||++| ++||||||+||+++ .++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSAQITA 158 (267)
T ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeeeEccC
Confidence 999999999999999998889999999999999999999999999 99999999999997 788999999999865432
Q ss_pred C--CCccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCCc
Q 006777 184 P--TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTD 255 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~--~~~~ 255 (631)
. ......|++.|+|||++. +.++.++|+|||||++|+|++|..||..................+..+. ..++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS 238 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCC
Confidence 2 223457899999999863 3488899999999999999999999976443333333322332232222 1356
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpf 283 (631)
..+++||.+||. +|.+||++.+++.|||
T Consensus 239 ~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 789999999998 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=335.76 Aligned_cols=256 Identities=29% Similarity=0.486 Sum_probs=212.2
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccC--CHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQ--SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
+|+..+.||+|+||.||+|.+..+|..||+|++....... .....+.+.+|+++++.++||||+++++++.+. ..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--SHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--CeE
Confidence 4888999999999999999999999999999987543211 123457889999999999999999999988654 378
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++|+||+.+++|.+++.+.+.+++..++.|+.||+.||.|||++| ++||||+|+||+++..+..+||+|||++.....
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999999998888999999999999999999999999 999999999999974444699999999865543
Q ss_pred CC------CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCC
Q 006777 184 PT------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 184 ~~------~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~--~~~~~~~i~~~~~p~~l~~~~ 254 (631)
.. .....|+..|+|||++. ..++.++|+||||+++|+|++|+.||..... .......+.........+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence 21 22356889999999875 4588999999999999999999999965332 222222333333344555567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
++.++++|.+||. +|..||++.++++||||+
T Consensus 237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 237 SPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 8999999999998 899999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=333.32 Aligned_cols=256 Identities=29% Similarity=0.500 Sum_probs=217.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccc-cCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDV-MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
..|.+.+.||+|+||.||+|.+..+|..||+|.+..... .........+.+|+.++++++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999865421 1234556788899999999999999999999877666688
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++|+||+++++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcccccccccc
Confidence 999999999999999988888999999999999999999999999 99999999999997 788999999999975432
Q ss_pred C-----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 184 P-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 184 ~-----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
. ......|++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+......+. .+.....+..++...++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF-KIATQPTKPMLPDGVSDA 237 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH-HHHcCCCCCCCCcccCHH
Confidence 1 1234568999999998764 47889999999999999999999998754444443 333333344566677899
Q ss_pred HHHHHHHhcCCCCCCCCHHHHhcCCCc
Q 006777 258 VKQFIEKCIVPASLRLPALELLKDPFL 284 (631)
Q Consensus 258 lk~lI~kcL~~p~~Rpta~elL~hpff 284 (631)
++++|.+||++|..||++.++|.|||.
T Consensus 238 ~~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhcCcccCccHHHHhcCCCC
Confidence 999999999988999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.87 Aligned_cols=251 Identities=25% Similarity=0.425 Sum_probs=204.9
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|.+.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.++++++||||+++++++.+.. .+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSDK--KLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--ceEE
Confidence 58999999999999999999999999999999976532 1223345778999999999999999999886554 7899
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 106 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
|+||+. ++|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 77 VFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIP 152 (284)
T ss_pred EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCCC
Confidence 999997 588887765 567999999999999999999999999 99999999999998 7899999999999755432
Q ss_pred C--CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--------------
Q 006777 185 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-------------- 246 (631)
Q Consensus 185 ~--~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-------------- 246 (631)
. .....+++.|+|||++.+ .++.++|||||||++|+|+||..||....+....++.+.....
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 1 234567899999998754 3789999999999999999999997655555444443321100
Q ss_pred -----C--------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 247 -----P--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 -----p--------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+ .......++++++||.+||. +|.+|||+.++|.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 00112357889999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=345.97 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=193.6
Q ss_pred EEEEeecCCeEEEEEEEc--CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEE
Q 006777 30 WVVVLNCTFMCRYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~--~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
..+||+|+||+||+|.++ .+++.||+|.+..... ...+.+|+.+|++++||||++++++|.......+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 468999999999999975 4678999999865432 13467899999999999999999999877667899999
Q ss_pred eccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe---CCCCcEEEccc
Q 006777 108 ELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDL 175 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~---------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~---~~~g~vKI~DF 175 (631)
||+. ++|.+++... ..+++..++.+++||+.||.|||+++ |+||||||+|||+. ..++.+||+||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9996 6888887532 24899999999999999999999999 99999999999994 24578999999
Q ss_pred cchhhccCC-----CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCH---------HHHHH
Q 006777 176 GLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIYK 239 (631)
Q Consensus 176 GlA~~~~~~-----~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~---------~~~~~ 239 (631)
|++...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...... .++..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 999765432 1235678999999998754 4899999999999999999999999643221 11111
Q ss_pred HHHc-CCC-----------C-----------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 006777 240 KVTS-GIK-----------P-----------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 240 ~i~~-~~~-----------p-----------------------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpf 283 (631)
.+.. +.+ + .......+..+.+||.+||+ +|.+|||+.|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 1000 000 0 00001235678999999998 9999999999999999
Q ss_pred c
Q 006777 284 L 284 (631)
Q Consensus 284 f 284 (631)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.11 Aligned_cols=254 Identities=25% Similarity=0.428 Sum_probs=216.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||.|+||.||+|.++.+++.||+|++.... ......++.+|+++++.++||||+++++.+... ..++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEE
Confidence 36788899999999999999999999999999987653 235567788999999999999999999988765 4799
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+|+||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+ ++||||||+||+++ .+|.++|+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhH
Confidence 999999999999999876 789999999999999999999999 88 99999999999998 68999999999987654
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCC----CCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~----~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
........+++.|+|||.+.+ .++.++||||||+++|+|++|..||... .......+.+..+..+.......+++
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd06605 153 NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232 (265)
T ss_pred HHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 433334778999999998754 5889999999999999999999999764 23344455555554444333337889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
+++||.+||. +|.+||++.+++.||||+.
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999999998 8999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=337.44 Aligned_cols=253 Identities=29% Similarity=0.487 Sum_probs=210.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCC--
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT-- 99 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~-- 99 (631)
....|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||++++++|....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 4567899999999999999999999999999999987542 2235678899999998 7999999999987543
Q ss_pred --CceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 100 --NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 100 --~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
...+++||||+.+|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+||+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l~Df 155 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDF 155 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEEccC
Confidence 24689999999999999998864 35899999999999999999999998 99999999999998 7899999999
Q ss_pred cchhhccCC--CCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006777 176 GLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 176 GlA~~~~~~--~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p 247 (631)
|++...... ......|++.|+|||++. ..|+.++|||||||++|+|++|..||.... .......+.....+
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~ 234 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAP 234 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhcCCCC
Confidence 998754322 234567899999999874 247889999999999999999999997643 33333333333233
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
.......+..+++||.+||. +|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 33344567899999999998 89999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=363.52 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=213.4
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CC-----Ccceeee
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HE-----NIIKFYN 93 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----nIV~l~~ 93 (631)
.+.+..+|.+.++||+|+||.|-+|.|..+++.||||+|+.. +....+...|+++|..|+ |. |||++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 344567999999999999999999999999999999999743 456677788999999997 43 8999999
Q ss_pred EEEcCCCceEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC-CCCcE
Q 006777 94 SWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEV 170 (631)
Q Consensus 94 ~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~v 170 (631)
+|...+ +++||+|++. .+|.++++.++ +|+...++.+++||+.||.+||+.+ |||+||||+||||.. ....|
T Consensus 256 ~F~fr~--HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 256 YFYFRN--HLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred cccccc--ceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCce
Confidence 997654 7999999995 89999999864 6999999999999999999999999 999999999999962 23379
Q ss_pred EEccccchhhccCCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CC---
Q 006777 171 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI--- 245 (631)
Q Consensus 171 KI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-~~--- 245 (631)
||+|||.|+....... +++-+..|+|||++- .+|+.+.||||||||++||++|.+.|.+.+..+++...+.- |.
T Consensus 331 KVIDFGSSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 331 KVIDFGSSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred eEEecccccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 9999999987666544 788899999999765 57999999999999999999998888886555555433310 00
Q ss_pred -------------------------------------------------CCCC-------CCCCCcHHHHHHHHHhcC-C
Q 006777 246 -------------------------------------------------KPAS-------LSKVTDPQVKQFIEKCIV-P 268 (631)
Q Consensus 246 -------------------------------------------------~p~~-------l~~~~~~~lk~lI~kcL~-~ 268 (631)
.|.. +....+..+.+||.+||. +
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 0000 011234678999999999 9
Q ss_pred CCCCCCHHHHhcCCCccCC
Q 006777 269 ASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 269 p~~Rpta~elL~hpff~~~ 287 (631)
|..|+|+.++|+||||...
T Consensus 490 P~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 490 PAERITPAQALNHPFLTGT 508 (586)
T ss_pred chhcCCHHHHhcCcccccc
Confidence 9999999999999999853
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=339.63 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=216.6
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..+.|++.+.||+|+||.||+|.+..+|..||+|.+... .....+.+.+|+.+++.++||||+++++.+..+. .
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 83 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--K 83 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--e
Confidence 357899999999999999999999999999999998743 3456778889999999999999999999886554 7
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+++||||+++++|..++.+ ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKN 160 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccceec
Confidence 8999999999999988765 456899999999999999999999998 99999999999997 7899999999998643
Q ss_pred cCC--CCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCC
Q 006777 182 QQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSK 252 (631)
Q Consensus 182 ~~~--~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p-~~l~~ 252 (631)
... ......+++.|+|||++. ..++.++|||||||++|+|++|..||... +.......+.....+ ...+.
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQPS 239 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcCCCccCCCCc
Confidence 222 223457899999999873 23678999999999999999999999764 344444444443332 23344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~ 291 (631)
..+..+.+||.+||. +|.+||++.++++||||....+..
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 567899999999998 899999999999999998765543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=333.88 Aligned_cols=252 Identities=33% Similarity=0.560 Sum_probs=211.7
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC-----HHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS-----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~-----~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
+|.+...||+|+||.||+|.+..++..||+|.+........ ....+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 47889999999999999999998999999999876543221 123467889999999999999999999886654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+++||||+++++|.+++...+.+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++..
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~~ 155 (267)
T cd06628 80 -HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKK 155 (267)
T ss_pred -ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCcc
Confidence 78899999999999999999888999999999999999999999999 99999999999997 789999999999875
Q ss_pred ccCC--------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006777 181 MQQP--------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 181 ~~~~--------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~ 251 (631)
.... ......|++.|+|||.+.+ .++.++|+|||||++|+|++|+.||.+......+ ..+..... ..++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~~ 233 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENAS-PEIP 233 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccCC-CcCC
Confidence 5421 1123468899999998754 5888999999999999999999999875444333 33333322 2344
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
...+..++++|.+||+ +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 5578899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=340.98 Aligned_cols=257 Identities=27% Similarity=0.456 Sum_probs=215.7
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
....+|.+.+.||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.+.||||+++++.|....
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-- 90 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD-- 90 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC--
Confidence 345699999999999999999999999999999999876542 23466889999999999999999999887643
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+++||||+++++|.+++.. ..+++.++..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++...
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQI 166 (296)
T ss_pred EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccccchhc
Confidence 78999999999999999865 45899999999999999999999999 99999999999997 7899999999998754
Q ss_pred cCCC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 182 QQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~~~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.... .....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.........+.....+..+...+...++.+
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (296)
T cd06654 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (296)
T ss_pred cccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence 3322 234578999999998764 4789999999999999999999999875443444433333333333445567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
++||.+||. +|..||++.+++.||||....
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 999999998 899999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=336.98 Aligned_cols=254 Identities=27% Similarity=0.491 Sum_probs=212.1
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|++.+.||+|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.++||||++++++|.... ..++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~~~~ 79 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWI 79 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC--EEEE
Confidence 478889999999999999999999999999998643 3455677889999999999999999999887654 7899
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 106 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
|+||+.+|+|..++.+ ...+++..+..++.||+.||.|||+.+ ++||||||+||+++ .++.+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEcccccccccccc
Confidence 9999999999998765 457999999999999999999999999 99999999999997 7899999999998654322
Q ss_pred --CCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCCc
Q 006777 185 --TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTD 255 (631)
Q Consensus 185 --~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-p~~l~~~~~ 255 (631)
......|++.|+|||++. ..++.++|||||||++|+|++|..||.... .......+..... ....+..++
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWS 235 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccC
Confidence 223457899999999873 237789999999999999999999998744 3334334433322 223345577
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
..+++||.+||. +|.+||++.++++||||.....
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 899999999998 8999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=333.06 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=214.9
Q ss_pred EeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCC
Q 006777 33 VLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~g 112 (631)
||.|+||.||+|.+..++..||+|++..... ......+.+.+|+.+++.++||||+++++.+.+.. .+++|+||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK--YIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc-hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--ccEEEEecCCC
Confidence 6999999999999999999999999986543 22345577999999999999999999999876554 68999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC-CCccccC
Q 006777 113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIG 191 (631)
Q Consensus 113 GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~-~~~~~~G 191 (631)
++|.+++.+.+.+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...... ......|
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccC
Confidence 999999998888999999999999999999999998 99999999999998 7899999999999765443 2334578
Q ss_pred CCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-C
Q 006777 192 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 268 (631)
Q Consensus 192 Tp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~-~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~ 268 (631)
++.|+|||.+. ..++.++|+||||+++|+|++|..||.... ++...+..+..+......+...++.+++||.+||. +
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 99999999875 458899999999999999999999997644 25555666664444444555558899999999998 8
Q ss_pred CCCCCC-----HHHHhcCCCccCCCCC
Q 006777 269 ASLRLP-----ALELLKDPFLVTDNPK 290 (631)
Q Consensus 269 p~~Rpt-----a~elL~hpff~~~~~~ 290 (631)
|.+||+ +.|+++||||...+|.
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 999999 9999999999876553
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.28 Aligned_cols=261 Identities=20% Similarity=0.331 Sum_probs=215.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
.+|.+.+.||+|+||+||+|.+..+|+.||+|.+...... .......+..|+.+++.++||||+++++.+.+. ..++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CEEE
Confidence 3699999999999999999999999999999999876432 224567789999999999999999999987654 4789
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 105 MITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+.+ ++||||||+||+++ .+|.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhccc
Confidence 999999999999998764 56999999999999999999999999 99999999999997 78999999999986432
Q ss_pred CC-------------------------------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCC
Q 006777 183 QP-------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNE 230 (631)
Q Consensus 183 ~~-------------------------------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~ 230 (631)
.. ......||..|+|||++.+ .++.++||||||+++|+|++|..||.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 11 1123478999999998754 588899999999999999999999987
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC----HHHHhcCCCccCCCCCcc
Q 006777 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP----ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 231 ~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpt----a~elL~hpff~~~~~~~~ 292 (631)
...... +..+.............++.+++||.+||. +|.+||+ +.++|.||||+...+..+
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~ 300 (316)
T cd05574 235 SNRDET-FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI 300 (316)
T ss_pred CchHHH-HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhc
Confidence 544433 333333222221222268899999999998 8999999 999999999998765543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=337.48 Aligned_cols=253 Identities=21% Similarity=0.349 Sum_probs=206.0
Q ss_pred EEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHH---HHHHHhCCCCCcceeeeEEEcCCCceEEEEEe
Q 006777 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSE---VHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~E---i~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~E 108 (631)
+||+|+||.||+|.+..+|+.||+|.+......... ....+..| +.+++...||||++++++|.+.. .+++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--KLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch-hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--EEEEEEe
Confidence 489999999999999999999999998865432221 11222333 34555668999999999886544 7899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCCcc
Q 006777 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~~ 188 (631)
|+.||+|.+++.+.+.+++..++.|+.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..........
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCccCCcC
Confidence 9999999999988888999999999999999999999998 99999999999997 78999999999987655444455
Q ss_pred ccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006777 189 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 189 ~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~--~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~k 264 (631)
..|++.|+|||++.+ .++.++||||||+++|+|++|..||.+... .......+.. .+..++...++.++++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHH
Confidence 689999999998853 488999999999999999999999976422 2222222222 2334555568999999999
Q ss_pred hcC-CCCCCC-----CHHHHhcCCCccCCCCCcc
Q 006777 265 CIV-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 265 cL~-~p~~Rp-----ta~elL~hpff~~~~~~~~ 292 (631)
||. +|.+|| ++.++++||||....+...
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 998 899999 9999999999998776654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=333.11 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=214.6
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|++.++||.|+||.||+|.+..+|..||+|++..... ......+++.+|++++++++||||+++++.|.+. ..+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE--ENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC--CeEEE
Confidence 58999999999999999999999999999999986543 2334567899999999999999999999987544 47999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC-
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~- 184 (631)
|+||+.|++|.+++.....+++..+..|+.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCc
Confidence 9999999999999988878999999999999999999999999 99999999999998 7899999999998755433
Q ss_pred CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~--~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
......|+..|+|||.+.. .++.++|+||||+++|+|++|..||..... .......... .....+...++.+.++
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDA 232 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHH
Confidence 2344568899999998754 478999999999999999999999987543 3444433332 2333445567899999
Q ss_pred HHHhcC-CCCCCCCH--HHHhcCCCc
Q 006777 262 IEKCIV-PASLRLPA--LELLKDPFL 284 (631)
Q Consensus 262 I~kcL~-~p~~Rpta--~elL~hpff 284 (631)
|.+||. +|.+||++ .|+++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999998 99999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=347.82 Aligned_cols=251 Identities=21% Similarity=0.400 Sum_probs=202.5
Q ss_pred EEEEEeec--CCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEE
Q 006777 29 SWVVVLNC--TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 29 i~e~LG~G--~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV 106 (631)
++++||+| +|++||+|.++.+|+.||+|+++.... .....+.+.+|+.+++.++||||++++++|..++ .+++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--EEEEE
Confidence 46789999 688999999999999999999876532 2344566788999999999999999999987664 78999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 107 TELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
|||+++|+|.+++..+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+++.||+.+......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccc
Confidence 9999999999999764 45899999999999999999999999 99999999999998 7889999999865432111
Q ss_pred ---------CCccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC----
Q 006777 185 ---------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---- 248 (631)
Q Consensus 185 ---------~~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~---- 248 (631)
......++..|+|||++.+ .|+.++|||||||++|+|++|..||............+... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT-VPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCC-ccccccc
Confidence 1122356788999998853 48899999999999999999999997644333322222111 100
Q ss_pred ----------------------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 249 ----------------------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 ----------------------------------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
......++.+++||.+||+ +|.+|||+.++|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0112346789999999998 99999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=336.40 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=204.5
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|++.+.||.|+||.||+|.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++.++. .+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQES--RLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--eEEE
Confidence 48899999999999999999999999999999876532 1223356778999999999999999999987643 7899
Q ss_pred EEeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 106 ITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~---~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFG 152 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecC
Confidence 999997 6898888653 46899999999999999999999999 99999999999997 78999999999986543
Q ss_pred CCC--CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC------------
Q 006777 183 QPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------------ 246 (631)
Q Consensus 183 ~~~--~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~------------ 246 (631)
... .....+++.|+|||++.+ .++.++|||||||++|+|+||..||.+................
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 221 233467899999998754 4788999999999999999999999875444433322211000
Q ss_pred --------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 247 --------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 --------------p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
........++++++||.+||. +|.+|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 001122357899999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=340.79 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=207.0
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|.+.+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeE
Confidence 4679999999999999999999999999999999876532 12234567899999999999999999998654 478
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKS 155 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccC
Confidence 99999997 6899888764 56899999999999999999999999 99999999999998 78999999999986543
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC---C---------
Q 006777 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---K--------- 246 (631)
Q Consensus 183 ~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~---~--------- 246 (631)
.. ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||.... .......+.... .
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST-VEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCChhhchhhhc
Confidence 22 2234567999999998754 47889999999999999999999998743 333222221100 0
Q ss_pred ---------CC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 247 ---------PA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 247 ---------p~-------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+. ......++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 0112357789999999998 899999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=329.64 Aligned_cols=251 Identities=28% Similarity=0.460 Sum_probs=209.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||.|+||+||+|.+..+|..||+|++..... ....+.+.+|+.+++.++||||+++++.+.... .++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD--ELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC--EEE
Confidence 479999999999999999999988999999999875432 235677899999999999999999999886644 789
Q ss_pred EEEeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 105 MITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~---~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++...
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLG-EDGSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccchHHHh
Confidence 999999999999999764 45899999999999999999999999 99999999999998 6889999999998755
Q ss_pred cCCC------CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC-C--
Q 006777 182 QQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-L-- 250 (631)
Q Consensus 182 ~~~~------~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~-l-- 250 (631)
.... .....|++.|+|||.+.. .++.++|+||||+++|+|++|+.||....... .+..+.....+.. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 231 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPPSLETGA 231 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCCCcCCcc
Confidence 4322 234578999999998754 48899999999999999999999998754433 3333333322111 1
Q ss_pred -CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 251 -SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 251 -~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
....++.+++||.+||. +|.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 12457889999999998 89999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=329.11 Aligned_cols=251 Identities=27% Similarity=0.458 Sum_probs=211.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|++.+.||.|+||.||+|.+..++..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~ 75 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG----DDFEIIQQEISMLKECRHPNIVAYFGSYLRRD--KL 75 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch----hhHHHHHHHHHHHHhCCCCChhceEEEEEeCC--EE
Confidence 4689999999999999999999999999999999986532 35577889999999999999999999886644 79
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+++|||+.+++|.+++... ..+++..++.++.|++.||.|||+++ ++||||+|+||+++ .+|.+||+|||++....
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchhhh
Confidence 9999999999999998876 78999999999999999999999999 99999999999998 78999999999987554
Q ss_pred CC--CCccccCCCCCCCcccccc----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCC
Q 006777 183 QP--TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVT 254 (631)
Q Consensus 183 ~~--~~~~~~GTp~y~APE~l~~----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~--l~~~~ 254 (631)
.. ......+++.|+|||.+.+ .++.++|||||||++|+|+||..||.+................+.. .....
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (262)
T cd06613 153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW 232 (262)
T ss_pred hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhh
Confidence 32 2344578999999998753 5788999999999999999999999875544443333333222222 12235
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpf 283 (631)
+.++++||.+||. +|..||++.+++.|||
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 233 SPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 6789999999998 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=334.80 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=208.5
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
...+.|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-- 79 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-- 79 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--
Confidence 34568999999999999999999999999999999987542 223456788999999999999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+++||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++...
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFGVAAKI 156 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCccceee
Confidence 78999999999999999988888999999999999999999999998 99999999999997 7889999999999755
Q ss_pred cCC--CCccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCC
Q 006777 182 QQP--TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKV 253 (631)
Q Consensus 182 ~~~--~~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l--~~~ 253 (631)
... ......|++.|+|||.+. ..++.++|||||||++|+|++|+.||..................+..+ ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06646 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236 (267)
T ss_pred cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccc
Confidence 332 223457899999999773 347889999999999999999999997543222222111222222222 123
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpf 283 (631)
++..+++||.+||. +|.+||++.++|+|+|
T Consensus 237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 237 WSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 57899999999998 8999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.31 Aligned_cols=261 Identities=21% Similarity=0.357 Sum_probs=217.7
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+.|.+.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 77 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RHLC 77 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CEEE
Confidence 368999999999999999999999999999999876532 2234556788999999999999999999988654 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||++||+|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||+++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcC
Confidence 99999999999999998888999999999999999999999998 99999999999997 7899999999988631110
Q ss_pred -----------------CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006777 185 -----------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246 (631)
Q Consensus 185 -----------------~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~ 246 (631)
......|++.|+|||.+. ..++.++|||||||++|+|++|..||.+ ....+....+..+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~ 233 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDI 233 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccc
Confidence 111246788999999764 4689999999999999999999999986 455566666554432
Q ss_pred -CCCCCCCCcHHHHHHHHHhcC-CCCCCCC---HHHHhcCCCccCCCCCcc
Q 006777 247 -PASLSKVTDPQVKQFIEKCIV-PASLRLP---ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 247 -p~~l~~~~~~~lk~lI~kcL~-~p~~Rpt---a~elL~hpff~~~~~~~~ 292 (631)
........++.+++||.+||+ +|.+||+ +.++|.||||....+...
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~ 284 (305)
T cd05609 234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL 284 (305)
T ss_pred CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence 222223567899999999998 8999998 799999999988666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=327.41 Aligned_cols=250 Identities=27% Similarity=0.471 Sum_probs=215.4
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|++.++||.|+||.||.+.+..+|..|++|.+..... ......++.+|+.++++++||||++++++|.+. ..+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEE
Confidence 58999999999999999999999999999999876543 345566788999999999999999999998764 47999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+|||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++ .++.+||+|||++.....
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGS 153 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEccc
Confidence 99999999999999875 46899999999999999999999999 99999999999998 788999999999875543
Q ss_pred CC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 184 PT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.. .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+..+....+..+..+. .....+..+++
T Consensus 154 ~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd08221 154 EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELIS 231 (256)
T ss_pred ccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHH
Confidence 32 345678999999998754 478899999999999999999999976 45566666665554332 33556889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+|.+||. +|.+||++.++|+|||+
T Consensus 232 ~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 232 LVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHcccCcccCCCHHHHhhCcCC
Confidence 9999998 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=335.63 Aligned_cols=256 Identities=27% Similarity=0.466 Sum_probs=217.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.+.||.|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEE
Confidence 46889999999999999999999999999999987653 234456788999999999999999999988765 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+|+||+++++|.+++... ++++..++.++.||+.||.|||+++ ++||||+|+||+++ .+|.++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeeccc
Confidence 999999999999998875 7999999999999999999999999 99999999999998 7899999999999766543
Q ss_pred --CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 185 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 --~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
......|++.|+|||.+.+ .++.++||||||+++|+|+||..||... ++......+.....+.......++.+.++
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence 2345678999999998754 5899999999999999999999999763 44455555555444333222278899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCccCCCCC
Q 006777 262 IEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~elL~hpff~~~~~~ 290 (631)
|.+||. +|.+||++.++++||||+.....
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 999997 89999999999999999875443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.33 Aligned_cols=253 Identities=33% Similarity=0.529 Sum_probs=214.0
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc-CCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM-QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+|+..+.||+|+||.||+|.+..++..|++|.+...... ...+..+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEE
Confidence 478889999999999999999889999999998765422 2344567889999999999999999999987654 4789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+|+||+++++|.+++.+.+.+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceecccc
Confidence 99999999999999998888999999999999999999999999 99999999999998 7899999999998755433
Q ss_pred C-CccccCCCCCCCcccccc-c-cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 185 T-ARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 ~-~~~~~GTp~y~APE~l~~-~-y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
. .....|++.|+|||.+.. . ++.++|+||||+++|+|++|+.||......... ..+........++...++.+++|
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-FKIGRSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-HHHHhcccCCCcCCCcCHHHHHH
Confidence 2 345678999999997653 3 789999999999999999999999875533333 33333223334555678999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 262 IEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~elL~hpff 284 (631)
|.+||. +|.+||++.++|.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999998 89999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.82 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=206.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCcceeeeEEEcCCCceE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
+.|.+.+.||+|+||.||+|.+..+|+.||+|+++.... .....++..|+.+ ++.++||||+++++++.... .+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~--~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG--DV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC--cE
Confidence 468999999999999999999999999999999875432 1223345556654 67789999999999886544 68
Q ss_pred EEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 104 NMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
++||||++ |+|.+++.. ...+++..++.++.||+.||.|||++ + ++||||||+||+++ .++.+||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecccc
Confidence 99999997 788887754 24689999999999999999999997 7 99999999999998 7899999999998
Q ss_pred hhccCCCC-ccccCCCCCCCcccccc-----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 179 IVMQQPTA-RSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 179 ~~~~~~~~-~~~~GTp~y~APE~l~~-----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
........ ....|++.|+|||.+.+ .++.++|+|||||++|+|++|..||.......+....+..+..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAE 231 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcc
Confidence 76543322 33568999999998753 4688999999999999999999999764444344444444433333334
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.++.++++||.+||. +|.+||++.+++.||||....
T Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 467899999999998 899999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=338.23 Aligned_cols=257 Identities=28% Similarity=0.494 Sum_probs=215.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
...+|++.+.||.|+||+||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~ 90 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELIINEILVMKELKNPNIVNFLDSFLVGD--E 90 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHHHHHHHHHHHhcCCCceeeeeeeEecCc--e
Confidence 34679999999999999999999999999999999875432 23466889999999999999999999886543 7
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+++|+||+.+++|..++... .+++.++..++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccchhcc
Confidence 89999999999999998754 5899999999999999999999999 99999999999997 78999999999987543
Q ss_pred CCC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 183 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 ~~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
... .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||..................+...+...++.++
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246 (296)
T ss_pred cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 322 234578999999998764 58899999999999999999999998754433333332233333334455788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
+||.+||. +|.+||++.++++||||+...+
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 99999998 8999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.81 Aligned_cols=253 Identities=28% Similarity=0.459 Sum_probs=209.7
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCC--
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT-- 99 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~-- 99 (631)
..++|++.+.||+|+||.||+|.++.+++.|++|++.... ...+.+.+|+.+++++ +||||++++++|.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 4579999999999999999999999899999999987543 2346788999999999 7999999999987644
Q ss_pred --CceEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEc
Q 006777 100 --NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 100 --~~~l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~ 173 (631)
...+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~-~~~~~~l~ 155 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLV 155 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEc-cCCeEEEC
Confidence 3568999999999999998865 357999999999999999999999999 99999999999998 68999999
Q ss_pred cccchhhccCC--CCccccCCCCCCCcccccc------ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006777 174 DLGLAIVMQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 174 DFGlA~~~~~~--~~~~~~GTp~y~APE~l~~------~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~ 245 (631)
|||++...... ......|++.|+|||++.. .++.++|||||||++|+|++|..||......... ..+..+.
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~ 234 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-FKIPRNP 234 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-HHhhccC
Confidence 99998654322 2234568999999998742 3678999999999999999999999764333333 3343332
Q ss_pred CCCC-CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 246 KPAS-LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 246 ~p~~-l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
.+.. .+..++..+++||.+||. +|.+|||+.++++|||+
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2221 222356799999999998 99999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=324.72 Aligned_cols=254 Identities=36% Similarity=0.577 Sum_probs=220.9
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|.+.+.||+|++|.||+|.+..+|..|++|++..... .....+.+.+|+.++++++||||+++++.+.+.....+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 48889999999999999999999999999999876643 2456788999999999999999999999887653358999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~ 185 (631)
|+||+.+++|.+++.+...+++..++.++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEcccccEEeccccc
Confidence 9999999999999998889999999999999999999999998 99999999999998 68999999999987655443
Q ss_pred ----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 186 ----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 186 ----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.....++..|+|||.+.. .++.++||||||+++|+|++|..||....+.......+........++...++.+++
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence 345678999999998765 488999999999999999999999987665555555555433444556667899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
||.+||. +|.+||++.++++||||
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=337.30 Aligned_cols=253 Identities=26% Similarity=0.470 Sum_probs=212.7
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.++++++||||+++++++... ..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEE
Confidence 36889999999999999999999999999999987532 334557788999999999999999999988664 4799
Q ss_pred EEEeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 105 MITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~---~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+||||+++++|..++... ..+++..+..++.||+.||.|||. ++ ++||||||+||+++ .++.+||+|||++..
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~ 152 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVN-GNGQVKLCDFGVSGN 152 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEEC-CCCCEEEeecCCccc
Confidence 999999999999998763 379999999999999999999996 47 99999999999998 689999999999976
Q ss_pred ccCCCCccccCCCCCCCcccccc-------ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHH---HHHcCCCCCCC
Q 006777 181 MQQPTARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK---KVTSGIKPASL 250 (631)
Q Consensus 181 ~~~~~~~~~~GTp~y~APE~l~~-------~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~---~i~~~~~p~~l 250 (631)
..........+++.|+|||.+.+ .++.++|||||||++|+|++|..||.... ...... .+..+. +..+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~-~~~~ 230 (286)
T cd06622 153 LVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGD-PPTL 230 (286)
T ss_pred ccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcC-CCCC
Confidence 65544556678999999998743 25789999999999999999999997532 222222 233332 3344
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+...++++++||.+||. +|.+||++.+++.||||...
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 55578999999999998 89999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=334.02 Aligned_cols=258 Identities=25% Similarity=0.432 Sum_probs=214.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.+.||.|++|.||+|.+..++..||+|.+.... ......++.+|++++++++||||++++++|.+.....++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 47899999999999999999999999999999987542 234567789999999999999999999998877767899
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 105 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeecccccc
Confidence 99999999999988654 345899999999999999999999999 99999999999998 788999999999875
Q ss_pred ccCCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCC----CCHHHHHHHHHcCCCCC---CCC-
Q 006777 181 MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPA---SLS- 251 (631)
Q Consensus 181 ~~~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~----~~~~~~~~~i~~~~~p~---~l~- 251 (631)
..........++..|+|||.+. ..++.++|||||||++|+|++|..||... ....+....+.....+. ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 155 LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 5444444566889999999775 46899999999999999999999999764 23334444444322211 111
Q ss_pred -CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 252 -KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 252 -~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
...++.+++||.+||. +|.+|||+.|++.||||+...
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 2346789999999998 899999999999999996643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=340.78 Aligned_cols=259 Identities=28% Similarity=0.473 Sum_probs=215.5
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
.....+|.+.+.||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||++++++|....
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 89 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD- 89 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 3455799999999999999999999999999999999875432 33466889999999999999999999886544
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++ .+|.+||+|||++..
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 90 -ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQ 164 (297)
T ss_pred -EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCccceE
Confidence 78999999999999999865 45899999999999999999999998 99999999999997 789999999999865
Q ss_pred ccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 181 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
.... ......+++.|+|||.+.+ .++.++|+|||||++|+|++|..||...............+..+...+...++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244 (297)
T ss_pred ccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHH
Confidence 4332 2234578999999998754 588999999999999999999999976443333332222233333344556788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
+++||.+||. +|.+||++.++++||||+...+
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 9999999998 8999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.56 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=208.1
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.++++++||||++++++|.... .++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR--KLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC--EEE
Confidence 479999999999999999999999999999999875432 1223345778999999999999999999887654 789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||+++++|..++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++......
T Consensus 77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGP 153 (286)
T ss_pred EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCC
Confidence 99999999999988877778999999999999999999999998 99999999999997 7899999999999765433
Q ss_pred C--CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CC-------------
Q 006777 185 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GI------------- 245 (631)
Q Consensus 185 ~--~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--~~------------- 245 (631)
. .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||.+..+.......... ..
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 2 234567899999998754 4789999999999999999999999875554443322110 00
Q ss_pred -----CCC--C------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 246 -----KPA--S------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 246 -----~p~--~------l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
.+. . .....+..+.+||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0 012346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.21 Aligned_cols=253 Identities=29% Similarity=0.474 Sum_probs=210.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcC---
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD--- 98 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~--- 98 (631)
..+.|++.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ +||||++++++|...
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 457899999999999999999999999999999998653 23445678899999998 799999999988643
Q ss_pred -CCceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 99 -TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 99 -~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
....++++|||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+||
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l~df 165 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLVDF 165 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeC
Confidence 235789999999999999998764 35889999999999999999999999 99999999999997 7899999999
Q ss_pred cchhhccCC--CCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006777 176 GLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 176 GlA~~~~~~--~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p 247 (631)
|++...... ......|++.|+|||.+. ..++.++|||||||++|+|++|..||.......... .+.....+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~ 244 (282)
T cd06636 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPPP 244 (282)
T ss_pred cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hHhhCCCC
Confidence 998754322 234567899999999864 347889999999999999999999997754333332 33333333
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
......+++.+.+||.+||. +|.+||++.+||+||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 33344578899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=355.21 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=205.5
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEc--CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~--~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
......+|.+.+.||+|+||.||+|... .++..||+|.+.... ...+|+.+|++|+|||||+++++|..
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeEee
Confidence 3445678999999999999999999754 456889999876331 24579999999999999999998865
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
. ..+++|||++. ++|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 158 ~--~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~ 231 (392)
T PHA03207 158 K--STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGA 231 (392)
T ss_pred C--CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCcc
Confidence 4 37899999996 789999987888999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCC----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH---HHHHHHHH-------
Q 006777 178 AIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVT------- 242 (631)
Q Consensus 178 A~~~~~~~----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~---~~~~~~i~------- 242 (631)
+....... .....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.... ..+...+.
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~ 311 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL 311 (392)
T ss_pred ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence 96544321 234679999999998864 5899999999999999999999999764321 11111111
Q ss_pred ------------------cCCCC-CCCC-----CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCc
Q 006777 243 ------------------SGIKP-ASLS-----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 243 ------------------~~~~p-~~l~-----~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~ 291 (631)
....+ ..++ ...+.++++||.+||. +|.+||++.|+|.||||....+..
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~ 385 (392)
T PHA03207 312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL 385 (392)
T ss_pred ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence 00000 0011 1246688999999998 999999999999999998755543
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=336.95 Aligned_cols=254 Identities=30% Similarity=0.518 Sum_probs=214.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.+.||.|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE--NKLW 78 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--CeEE
Confidence 5799999999999999999999889999999998754 345667788999999999999999999988754 4789
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+++++|..++.+. +.+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKS 155 (280)
T ss_pred EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccchhhcc
Confidence 999999999999998774 56999999999999999999999999 99999999999997 789999999999865432
Q ss_pred C--CCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCC
Q 006777 184 P--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVT 254 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p-~~l~~~~ 254 (631)
. ......|++.|+|||++. ..++.++||||||+++|+|++|..||... +.......+..+..+ ...+..+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKW 234 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccC
Confidence 2 223457899999999864 23677999999999999999999999864 444445555544332 2234456
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+..+.+||.+||. +|.+||++.++|+||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 7899999999998 899999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.82 Aligned_cols=256 Identities=24% Similarity=0.419 Sum_probs=209.0
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~ 98 (631)
.....++|++.+.||+|+||.||+|.+..+|..||+|++.... .....+..|+.+++.+ +||||+++++++...
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3446779999999999999999999999999999999875321 2234577899999999 799999999987532
Q ss_pred ---CCceEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEE
Q 006777 99 ---TNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 99 ---~~~~l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
....+++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCEE
Confidence 33578999999999999998753 346899999999999999999999998 99999999999997 788999
Q ss_pred EccccchhhccCC--CCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006777 172 IGDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243 (631)
Q Consensus 172 I~DFGlA~~~~~~--~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~ 243 (631)
|+|||++...... ......|++.|+|||++. ..++.++|||||||++|+|++|+.||.......... .+..
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~ 243 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIPR 243 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-hccc
Confidence 9999998654332 223457899999999874 347889999999999999999999998754433332 2222
Q ss_pred CCC-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 244 GIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 244 ~~~-p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
... ....+...+..+++||.+||. +|.+||++.|+|.|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 222 222344567889999999998 99999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=325.30 Aligned_cols=251 Identities=28% Similarity=0.463 Sum_probs=212.4
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|++.+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+.+|+.++||||+++++.+... ..+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEEE
Confidence 58999999999999999999999999999999986543 334567889999999999999999999988654 47899
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
||||+++++|.+++.+. ..+++..++.++.|++.||.|||+++ ++||||+|+||+++..++.+||+|||++.....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999999999764 35899999999999999999999999 999999999999985566789999999976543
Q ss_pred CC-CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 184 PT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 184 ~~-~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
.. .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||... +.......+..+..+ .++...++.++++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 232 (256)
T cd08220 155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-NLPALVLKIMSGTFA-PISDRYSPDLRQL 232 (256)
T ss_pred CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-chHHHHHHHHhcCCC-CCCCCcCHHHHHH
Confidence 32 234578999999998864 4788999999999999999999999874 444444444443322 3344568899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 262 IEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~elL~hpff 284 (631)
|.+||. +|.+|||+.++++||||
T Consensus 233 i~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 233 ILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHccCChhhCCCHHHHhhCCCC
Confidence 999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=327.42 Aligned_cols=254 Identities=28% Similarity=0.480 Sum_probs=219.3
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
.+|.+.+.||.|++|.||+|.+..+|..||+|++..... ......+.+|+..++.++||||+++++++... ..++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEE
Confidence 368999999999999999999999999999999876532 25567789999999999999999999988765 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+++++|.+++.....+++..++.++.||+.||.|||+ ++ ++||||+|+||+++ .++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLEN 152 (264)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceeccc
Confidence 999999999999999988889999999999999999999999 98 99999999999998 789999999999876544
Q ss_pred CCC--ccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCC--CHHHHHHHHHcCCCCCCCCCC-CcHH
Q 006777 184 PTA--RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKV-TDPQ 257 (631)
Q Consensus 184 ~~~--~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~--~~~~~~~~i~~~~~p~~l~~~-~~~~ 257 (631)
... ....++..|+|||.+.. .++.++|+||||+++|+|+||..||.... ...+..+.+.....+. ++.. .+..
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS-LPAEEFSPE 231 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC-CCcccCCHH
Confidence 332 24578999999998754 57889999999999999999999998764 5556666666544433 3333 7889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+.++|.+||. +|.+||++.+++.||||+..
T Consensus 232 l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 232 FRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999999998 89999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=381.77 Aligned_cols=263 Identities=20% Similarity=0.323 Sum_probs=230.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..+.|.|+++||+|+||.|.+++++.+++.||.|+++.-...+ ......|..|-.+|..-+.+-|+.++.+|.|+. +
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~--~ 149 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQDER--Y 149 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc--c
Confidence 4678999999999999999999999999999999988654332 233456888999999999999999999997765 8
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+|+||||++||+|-.++.++.+++++-++.|+..|+.||.-||+.| +|||||||+|||++ ..|+|||+|||.+..+.
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMD 226 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcC
Confidence 9999999999999999999999999999999999999999999999 99999999999998 89999999999987665
Q ss_pred CC-C--CccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Q 006777 183 QP-T--ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-- 251 (631)
Q Consensus 183 ~~-~--~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~-- 251 (631)
.. . ....+|||.|.+||++. +.|+..+|+||+|||+|||+.|..||+. ......|.+|..-.....+|
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~ 305 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDE 305 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcc
Confidence 33 2 34568999999999884 4599999999999999999999999987 56677788887653333333
Q ss_pred CCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCccCCCCCcc
Q 006777 252 KVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~~p~~Rpt---a~elL~hpff~~~~~~~~ 292 (631)
..+++++++||.+.+.+|..|.. +.++-.||||....|..+
T Consensus 306 ~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~i 349 (1317)
T KOG0612|consen 306 TDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNI 349 (1317)
T ss_pred cccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhh
Confidence 34789999999999999999888 999999999999999654
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=332.55 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=208.3
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCC--
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT-- 99 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~-- 99 (631)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++.+ +||||++++++|...+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 4678999999999999999999999999999999986432 2235577899999999 8999999999987543
Q ss_pred -CceEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 100 -NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 100 -~~~l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
...+++||||+++|+|.++++. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEee
Confidence 2468999999999999998763 356899999999999999999999998 99999999999997 788999999
Q ss_pred ccchhhccCCC--CccccCCCCCCCcccccc------ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006777 175 LGLAIVMQQPT--ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246 (631)
Q Consensus 175 FGlA~~~~~~~--~~~~~GTp~y~APE~l~~------~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~ 246 (631)
||++....... .....|++.|+|||.+.. .++.++|||||||++|+|++|+.||........ ...+..+..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~~~~~~~ 250 (291)
T cd06639 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFKIPRNPP 250 (291)
T ss_pred cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHHHhcCCC
Confidence 99987543322 234568999999998743 267899999999999999999999987433333 333433322
Q ss_pred C-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 247 P-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 247 p-~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
+ ...+......+++||.+||. +|.+||++.+++.||||+
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2 11223356789999999998 899999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=331.87 Aligned_cols=252 Identities=21% Similarity=0.362 Sum_probs=206.9
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|++.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.++++++||||+++++++.+. ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeEE
Confidence 58999999999999999999999999999999886543 223456788999999999999999999988764 47899
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 106 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
|+||+ +++|.+++.. ...+++.+++.++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++......
T Consensus 77 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLIS-ADGVLKIADFGLARLFSEE 152 (286)
T ss_pred Eeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEc-CCCcEEEeeeeecccccCC
Confidence 99999 9999999865 356999999999999999999999999 99999999999998 6899999999999765443
Q ss_pred C---CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC------------
Q 006777 185 T---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------ 247 (631)
Q Consensus 185 ~---~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p------------ 247 (631)
. .....|++.|+|||.+.+ .++.++||||||+++|+|+||.+||.+..+.......+.....+
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 2 234578999999998753 46899999999999999999988887644333322222110000
Q ss_pred --------C-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 248 --------A-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 248 --------~-------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
. ......+..+.+||.+||. +|.+||++.++|.||||.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0112346889999999998 899999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.44 Aligned_cols=256 Identities=22% Similarity=0.381 Sum_probs=214.0
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.|++.+.||+|+||+||+|.+..+|..||+|++.... .......+.+|+++++.++||||+++++++... ..+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEE
Confidence 357889999999999999999999999999999887542 234457789999999999999999999998765 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++||||+++|+|.+++.+.+.+++..++.++.|++.||.|||+ ++ ++||||||+||+++ .++.++|+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchh
Confidence 9999999999999999988889999999999999999999997 56 99999999999997 78999999999986554
Q ss_pred CCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCH----------HHHHHHHHcCCCCCCCC
Q 006777 183 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP----------AQIYKKVTSGIKPASLS 251 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~----------~~~~~~i~~~~~p~~l~ 251 (631)
........|+..|+|||++. +.++.++|||||||++|+|+||..||...... ......+.....+....
T Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 156 NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 44445568999999999764 56889999999999999999999999753321 12223333332222222
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
...+..+.+||.+||+ +|.+||++.|+++||||...
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 2367889999999998 89999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=324.63 Aligned_cols=251 Identities=33% Similarity=0.576 Sum_probs=212.9
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|.+.+.||+|+||.||+|.+..++..||+|.+..... .......+..|+.+++.++||||+++++.+... ..+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEEE
Confidence 58999999999999999999998999999999986643 245678899999999999999999999976544 47899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~ 185 (631)
|+||+++++|.+++...+.+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 77 FMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred EEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCCC
Confidence 9999999999999998878999999999999999999999999 99999999999998 68999999999987554321
Q ss_pred ------CccccCCCCCCCcccccc-c---cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC--
Q 006777 186 ------ARSVIGTPEFMAPELYEE-E---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV-- 253 (631)
Q Consensus 186 ------~~~~~GTp~y~APE~l~~-~---y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~-- 253 (631)
.....+++.|+|||++.+ . ++.++||||||+++|+|++|..||....+.......+..+. +..++..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQ 232 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC-CCCCCcccc
Confidence 113567899999998753 2 78899999999999999999999987555544444444432 2223333
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
.++.+++||.+||+ +|.+||++.+++.|||+
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 48899999999998 89999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=339.21 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=192.7
Q ss_pred EEEEEeecCCeEEEEEEEcC--CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEE
Q 006777 29 SWVVVLNCTFMCRYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~--~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV 106 (631)
...+||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+|+.++||||++++++|.......+++|
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 35789999999999999654 668999998864432 2346789999999999999999999887766789999
Q ss_pred EeccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe---CCCCcEEEcc
Q 006777 107 TELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGD 174 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~---------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~---~~~g~vKI~D 174 (631)
|||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ..+|.+||+|
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 99987 5888776532 24889999999999999999999999 99999999999994 2567999999
Q ss_pred ccchhhccCC-----CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCH---------HHHH
Q 006777 175 LGLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIY 238 (631)
Q Consensus 175 FGlA~~~~~~-----~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~---------~~~~ 238 (631)
||+++..... ......||+.|+|||++.+ .++.++|||||||++|+|+||..||...... .+..
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 9999765432 1234578999999998754 4789999999999999999999999643211 1111
Q ss_pred HHHHc-CC---------------------------CC-------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006777 239 KKVTS-GI---------------------------KP-------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 239 ~~i~~-~~---------------------------~p-------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hp 282 (631)
..+.. +. .. .......+..+++||.+||+ +|.+|||+.|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 10000 00 00 00011235678899999998 999999999999999
Q ss_pred Cc
Q 006777 283 FL 284 (631)
Q Consensus 283 ff 284 (631)
||
T Consensus 316 ~f 317 (317)
T cd07867 316 YF 317 (317)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=327.10 Aligned_cols=247 Identities=31% Similarity=0.481 Sum_probs=204.9
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
...||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..+++|+||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 86 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFMEQ 86 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEec
Confidence 468999999999999999999999999887542 34566789999999999999999999987654 478999999
Q ss_pred cCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC--
Q 006777 110 FTSGSLRQYRKKH-KNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 110 ~~gGsL~~~l~~~-~~l--~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~-- 184 (631)
+++++|.+++... ..+ ++..+..++.||+.||.|||+++ |+||||||+||+++..++.+||+|||++......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999998764 455 88999999999999999999998 9999999999999755789999999998654321
Q ss_pred CCccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 185 TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.....................++...++++++|
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 2234568999999998743 3788999999999999999999999865443333222222122334556678899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 262 IEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~elL~hpff 284 (631)
|.+||. +|.+||++.+++.||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999998 89999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=323.72 Aligned_cols=250 Identities=26% Similarity=0.463 Sum_probs=212.3
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|++.+.||+|+||.||++.+..+|+.||+|++..... .......+.+|+.++++++||||+++++++... ...++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEEE
Confidence 58999999999999999999999999999999886543 234556788999999999999999999987554 47899
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|+||+.+++|.+++.... .+++.++..|+.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNS 153 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecCc
Confidence 999999999999987643 5899999999999999999999998 99999999999997 788999999999865533
Q ss_pred CC--CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 184 PT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~~--~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.. .....|++.|+|||++. +.++.++|+|||||++++|++|..||... +.......+..+..+. .+...+..+++
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd08218 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIRGSYPP-VSSHYSYDLRN 231 (256)
T ss_pred chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHhcCCCCC-CcccCCHHHHH
Confidence 21 23456899999999875 45788999999999999999999999864 4555555555554433 34456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+|.+||. +|.+||++.++|.||||
T Consensus 232 li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 232 LVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHhhCChhhCcCHHHHhhCcCC
Confidence 9999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=328.03 Aligned_cols=250 Identities=21% Similarity=0.384 Sum_probs=205.0
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
+.||.|+||.||+|.+..+|+.||+|++....... ......+..|..+ ...++||||++++++|... ..+|+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEec
Confidence 57899999999999999999999999987543211 2223334455444 4566999999999988654 479999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCCccc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~~~ 189 (631)
+.+++|.++++..+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++..... ....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~--~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKKF 153 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccc--cccC
Confidence 999999999998888999999999999999999999999 99999999999997 789999999999865433 3345
Q ss_pred cCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCCcHHHHHHHHHhc
Q 006777 190 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCI 266 (631)
Q Consensus 190 ~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~--~p~~l~~~~~~~lk~lI~kcL 266 (631)
.|++.|+|||.+.+ .++.++||||||+++|+|++|..||.. .+....+..+..+. .+.......++.+.++|.+||
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 68999999998764 478999999999999999999999976 44555555554432 233334456899999999999
Q ss_pred C-CCCCCCCH---HHHhcCCCccCCCC
Q 006777 267 V-PASLRLPA---LELLKDPFLVTDNP 289 (631)
Q Consensus 267 ~-~p~~Rpta---~elL~hpff~~~~~ 289 (631)
. +|.+||++ .|+|.||||...+|
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 8 89999955 79999999988765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=326.96 Aligned_cols=248 Identities=29% Similarity=0.510 Sum_probs=208.2
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+.|.+.+.||.|+||.||+|.+..++..||+|.+.... ..+.+.+|+++++.++||||+++++++.+. ..+|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEE
Confidence 57999999999999999999999889999999986432 256788999999999999999999988765 4789
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+++||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++ .++.+||+|||++.....
T Consensus 75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchhccc
Confidence 99999999999999876 456899999999999999999999999 99999999999998 788999999999976544
Q ss_pred CC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCcHHHH
Q 006777 184 PT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKPASLSKVTDPQVK 259 (631)
Q Consensus 184 ~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~-~~p~~l~~~~~~~lk 259 (631)
.. .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||...... .....+... ......+...+..+.
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-RAIFMIPNKPPPTLSDPEKWSPEFN 230 (256)
T ss_pred CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-hhhhhhccCCCCCCCchhhcCHHHH
Confidence 32 234568999999998754 5889999999999999999999999764332 222222221 111222334678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+||.+||+ +|.+||++.++|.||||
T Consensus 231 ~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 231 DFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99999998 89999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.09 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=196.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
..+|.+.+.||+|+||.||+|.+..++..||+|..... ....|+.++++++||||++++++|.... ..
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~ 132 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGA--IT 132 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCC--ee
Confidence 45799999999999999999999999999999974322 1346899999999999999999887654 68
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++|+||+. |+|.+++.. .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 133 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCccccccc
Confidence 89999996 688888765 467999999999999999999999999 99999999999997 78899999999996433
Q ss_pred C-CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH----------HHHHHHHHc-CCCCCC
Q 006777 183 Q-PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP----------AQIYKKVTS-GIKPAS 249 (631)
Q Consensus 183 ~-~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~----------~~~~~~i~~-~~~p~~ 249 (631)
. .......||+.|+|||++.+ .|+.++|||||||++|||+++..|+...... ..+...+.. +..|..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 2 22345679999999998754 6899999999999999999976555332111 111111111 111111
Q ss_pred CC------------------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 250 LS------------------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 250 l~------------------------------~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
++ ...+..+.+||.+||+ +|.+||||.|+|+||||+.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 11 1235567889999998 9999999999999999975
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=331.32 Aligned_cols=252 Identities=22% Similarity=0.345 Sum_probs=208.5
Q ss_pred EeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCC
Q 006777 33 VLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~g 112 (631)
||+|+||+||+|.+..+|+.||+|.+...... .......+..|+.+|++++||||++++++|... ..+|+||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCC
Confidence 68999999999999999999999998754322 223445667899999999999999999988654 478999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC-CCccc
Q 006777 113 GSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSV 189 (631)
Q Consensus 113 GsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~-~~~~~ 189 (631)
++|.+++.+.+ .+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.+||+|||++...... .....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccc
Confidence 99999998765 7999999999999999999999999 99999999999997 7899999999998755432 22345
Q ss_pred cCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHh
Q 006777 190 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265 (631)
Q Consensus 190 ~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~---~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kc 265 (631)
.++..|+|||.+.+ .++.++||||||+++|+|++|+.||..... ...+...+.. .+...+...++.++++|.+|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 67889999998754 588899999999999999999999976432 1222222221 23345556789999999999
Q ss_pred cC-CCCCCC-----CHHHHhcCCCccCCCCCcc
Q 006777 266 IV-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 266 L~-~p~~Rp-----ta~elL~hpff~~~~~~~~ 292 (631)
|+ +|.+|| ++.+++.||||...++...
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~ 265 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL 265 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence 98 899999 8999999999998777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=336.00 Aligned_cols=257 Identities=22% Similarity=0.285 Sum_probs=208.6
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|.+.+.||.|+||.||+|.+..+|..||+|++....... .....+.+|+.++++++||||+++++++.+.....
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD--GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC--CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 3468999999999999999999999999999999987654211 12234567999999999999999999988766567
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+++||||+. ++|.+++... ..+++.+++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++...
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLARTY 158 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceeeec
Confidence 899999997 5888888763 67999999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--C--------
Q 006777 182 QQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P-------- 247 (631)
Q Consensus 182 ~~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p-------- 247 (631)
... ......+++.|+|||++.+ .++.++|||||||++|+|++|..||... +..+.+..+..... +
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK-SEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChhhchhhh
Confidence 432 2223356888999998753 4789999999999999999999999864 44444333322100 0
Q ss_pred ------------CCC------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 248 ------------ASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 248 ------------~~l------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
..+ ....++.+++||.+||. +|.+|||+.++|.||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000 01247889999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=331.01 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=204.8
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|++.+.||.|+||.||+|.++.+|..||+|.+..... .......+.+|++++++++||||+++++++.+. ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEEE
Confidence 48899999999999999999999999999999875532 223345688899999999999999999987654 47899
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
||||+. ++|..++... ..+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++.....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGV 152 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhccc
Confidence 999996 6899988653 46899999999999999999999998 99999999999998 789999999999875533
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-----------
Q 006777 184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA----------- 248 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~----------- 248 (631)
. ......+++.|+|||++.+ .++.++||||||+++|+|+||..||.+........+.+.....+.
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 153 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 2 2233457889999998754 368899999999999999999999987554444433332111100
Q ss_pred ---------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 249 ---------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 249 ---------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
......++.++++|.+||. +|.+|||+.++|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112357889999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=325.03 Aligned_cols=250 Identities=24% Similarity=0.426 Sum_probs=210.0
Q ss_pred EeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCC
Q 006777 33 VLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~g 112 (631)
||.|+||.||+|.+..+|+.||+|++..... ......+.+.+|+.+++.++||||+++++.+... ..+++|+||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC--cEEEEEEecCCC
Confidence 6899999999999998999999999876543 2245567889999999999999999999987544 478999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC--------
Q 006777 113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------- 184 (631)
Q Consensus 113 GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~-------- 184 (631)
++|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccc
Confidence 999999998888999999999999999999999999 99999999999998 7899999999998654322
Q ss_pred --CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 185 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 --~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
......+++.|+|||.+. ..++.++|+||||+++|+|++|..||.. .........+..+..+.......++.+.+|
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 223456888999999765 4578899999999999999999999976 445566666655433222111247899999
Q ss_pred HHHhcC-CCCCCCCH---HHHhcCCCccCCCC
Q 006777 262 IEKCIV-PASLRLPA---LELLKDPFLVTDNP 289 (631)
Q Consensus 262 I~kcL~-~p~~Rpta---~elL~hpff~~~~~ 289 (631)
|.+||+ +|.+|||+ .++|+||||...+|
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 999998 89999999 99999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.95 Aligned_cols=268 Identities=26% Similarity=0.497 Sum_probs=220.0
Q ss_pred hhcccccCccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcc
Q 006777 10 SRLCMSLEPISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89 (631)
Q Consensus 10 ~~~~~s~~~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV 89 (631)
.+.+..+........+.|.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+
T Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii 82 (292)
T cd06658 7 FRAALQLVVSPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVV 82 (292)
T ss_pred hccceeEEeccCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHH
Confidence 33444455556666778888899999999999999999999999999986432 34556788999999999999999
Q ss_pred eeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc
Q 006777 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 90 ~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
++++.+...+ ..++||||+++++|.+++.. +.+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.
T Consensus 83 ~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~ 156 (292)
T cd06658 83 DMYNSYLVGD--ELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGR 156 (292)
T ss_pred HHHHheecCC--eEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCC
Confidence 9999886654 78999999999999998864 46899999999999999999999999 99999999999997 7899
Q ss_pred EEEccccchhhccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006777 170 VKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246 (631)
Q Consensus 170 vKI~DFGlA~~~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~ 246 (631)
+||+|||++...... ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||... +.......+.....
T Consensus 157 ~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~ 235 (292)
T cd06658 157 IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLP 235 (292)
T ss_pred EEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCC
Confidence 999999998654322 2234578999999998754 5889999999999999999999999863 44444444444322
Q ss_pred CC-CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 247 PA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 247 p~-~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+. ......+..+++||.+||. +|.+|||+.+++.||||....
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 236 PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 22 1223457889999999998 899999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=355.67 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=200.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
.+.+|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|++|+|||||++++++.... .
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~--~ 234 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGG--L 234 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECC--E
Confidence 46689999999999999999999999999999996432 12457999999999999999999876543 6
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.++|||++. ++|..++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++..
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceec
Confidence 889999995 7888888764 46999999999999999999999999 99999999999997 7889999999999755
Q ss_pred cCCC----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCC-------CHHHHHHHHHcCCC---
Q 006777 182 QQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-------NPAQIYKKVTSGIK--- 246 (631)
Q Consensus 182 ~~~~----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~-------~~~~~~~~i~~~~~--- 246 (631)
.... .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ...++.+.+.....
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 3321 224579999999998764 58999999999999999999887654321 12334444332111
Q ss_pred --CC-------------------------CCC--CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 247 --PA-------------------------SLS--KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 247 --p~-------------------------~l~--~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
+. .+. ...++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 011 1235689999999998 9999999999999999974
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.85 Aligned_cols=254 Identities=28% Similarity=0.480 Sum_probs=209.2
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccC------CHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
+|.+.+.||.|+||.||+|.+..+|+.||+|+++...... .....+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 5899999999999999999999999999999987532111 112345688899999999999999999987654
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++.
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 -EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISK 156 (272)
T ss_pred -CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeeccccc
Confidence 478999999999999999998888999999999999999999999998 99999999999997 78999999999986
Q ss_pred hccCC----CCccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC---CCCC
Q 006777 180 VMQQP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPAS 249 (631)
Q Consensus 180 ~~~~~----~~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~---~p~~ 249 (631)
..... ......|+..|+|||.+.. .++.++|+||||+++|+|++|..||..........+...... .+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence 54322 1233568899999998753 378899999999999999999999976444433333222221 1222
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 250 l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
.....+..+++||.+||. +|..||++.++|+||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 334467899999999998 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.05 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=210.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.++||+|+||.||+|.++.+|..||+|.+..... ........+.+|+.+++.++||||+++++++.+.. .++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN--ELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC--eEE
Confidence 579999999999999999999999999999998876443 23455677889999999999999999999887654 789
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 105 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+|+||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~~ 155 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECcccccee
Confidence 99999999999988753 345899999999999999999999999 99999999999997 789999999999875
Q ss_pred ccCCC--CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 181 MQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 181 ~~~~~--~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~-~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
..... .....|++.|+|||.+. ..++.++|+||||+++|+|++|+.||.... +.......+.....+.......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08228 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235 (267)
T ss_pred ccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 54322 23457899999999775 458889999999999999999999996533 334555666555444444445678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.++++|.+||. +|.+||++.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 89999999998 89999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=331.30 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=207.8
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC-HHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+|.+.+.||+|+||.||+|.+..+|+.||+|++........ ......+..|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK--SNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--CEEE
Confidence 48899999999999999999999999999999986643211 22345577899999999999999999998763 4799
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+ +|+|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.....
T Consensus 79 lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeeccC
Confidence 999999 899999998776 7999999999999999999999999 99999999999998 789999999999976543
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-C-----------
Q 006777 184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P----------- 247 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-p----------- 247 (631)
. ......+++.|+|||.+.+ .++.++|||||||++|+|++|..||.+...... ..++..... +
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCCCchhhhhhcccc
Confidence 3 2233456889999998743 478999999999999999999877776443332 223221100 0
Q ss_pred --------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 248 --------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 --------------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.......+..+++||.+||. +|.+|||+.++|.||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 00112346789999999998 89999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=328.43 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=209.2
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... .....+.+.+|+++++.++||||+++++.+.+. ..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 76 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRLY 76 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEEE
Confidence 379999999999999999999999999999999875432 234457788999999999999999999998764 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||+.++.|..+..+...+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++......
T Consensus 77 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRAR 153 (288)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCCC
Confidence 99999998888777776677999999999999999999999999 99999999999998 7899999999998765433
Q ss_pred ---CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCC-----------
Q 006777 185 ---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIK----------- 246 (631)
Q Consensus 185 ---~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--~~~----------- 246 (631)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+......+...... ...
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2334678899999998753 5789999999999999999999999875544433321110 000
Q ss_pred --------C--------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 247 --------P--------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 --------p--------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+ ..++...++++++||.+||. +|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01223347889999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.42 Aligned_cols=252 Identities=24% Similarity=0.397 Sum_probs=202.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|++.+.||+|+||.||+|.+..+|..||+|++..... ......+.+|+.+++.++|+||+++++++.+. ...
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTK--ETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--CeE
Confidence 3689999999999999999999999999999999875532 12223467899999999999999999988654 478
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++....
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKS 154 (291)
T ss_pred EEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEeccccccccC
Confidence 99999996 677776654 356889999999999999999999999 99999999999997 78999999999986543
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--C----------
Q 006777 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--K---------- 246 (631)
Q Consensus 183 ~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~--~---------- 246 (631)
.. ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.......+....+.... +
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 22 2234567999999998754 478899999999999999999999987555433333321100 0
Q ss_pred -------------CCCC----C-CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 247 -------------PASL----S-KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 -------------p~~l----~-~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+..+ . -..++.+.++|.+||+ +|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 0 0125689999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.42 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=204.2
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCC---
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN--- 100 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~--- 100 (631)
++|.+.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 479999999999999999999999999999999876432 1223356788999999995 6999999998865432
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 101 RTINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
..+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++..++.+||+||
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeec
Confidence 247999999985 898887642 35899999999999999999999999 9999999999999843889999999
Q ss_pred cchhhccCCC--CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC---
Q 006777 176 GLAIVMQQPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--- 248 (631)
Q Consensus 176 GlA~~~~~~~--~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~--- 248 (631)
|++....... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.....+.......-..+.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 9987543321 223457889999997753 478999999999999999999999987555544433222100000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 249 ----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 249 ----------------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
......++.+++||.+||. +|.+||++.++|.||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0112357889999999998 899999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=317.40 Aligned_cols=250 Identities=29% Similarity=0.505 Sum_probs=215.6
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|.+.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+++++.++|||++++++.+... ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEE
Confidence 58999999999999999999999999999999876543 245567788999999999999999999988765 47999
Q ss_pred EEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 106 ITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
|+||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVL 153 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceeec
Confidence 99999999999998874 67999999999999999999999998 99999999999998 7899999999999755
Q ss_pred cCC--CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 182 QQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~~~--~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
... ......|++.|+|||.+. ..++.++|+||||+++++|++|..||... +...+...+.... ...++...+..+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQ-YPPIPSQYSSEL 231 (258)
T ss_pred ccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCC-CCCCCCCCCHHH
Confidence 443 234457899999999765 45889999999999999999999999764 4555555555443 334455678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 259 KQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+++|.+||. +|.+||++.++|.||||
T Consensus 232 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 232 RNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.23 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=202.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.|++.+.||.|+||.||+|.++.+|+.||+|++...... .....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTK--KTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecC--CeE
Confidence 36899999999999999999999999999999998764321 1223466899999999999999999988654 479
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++....
T Consensus 79 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKS 154 (291)
T ss_pred EEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccC
Confidence 99999998 5999988765 46899999999999999999999999 99999999999998 78999999999986433
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC---C---------
Q 006777 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---K--------- 246 (631)
Q Consensus 183 ~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~---~--------- 246 (631)
.. ......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+..........+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 21 1223457889999998753 478999999999999999999999976543333332221100 0
Q ss_pred -------------CCC---CCCCCc--HHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 247 -------------PAS---LSKVTD--PQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 -------------p~~---l~~~~~--~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+.. .....+ +.+.++|.+||. +|.+|||+.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 001123 788999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=331.77 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=207.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+.|++.+.||.|+||.||+|.+..+|+.||+|.++..... ......+.+|+.++++++||||+++++++.......++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 4799999999999999999999999999999999865432 22334567899999999999999999998877556899
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.....
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccC
Confidence 9999997 59999887654 5899999999999999999999999 99999999999998 789999999999876544
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-------------
Q 006777 184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------------- 246 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~------------- 246 (631)
. ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||........ ..++.....
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhcc
Confidence 3 2234567899999998754 368899999999999999999999987443332 222211000
Q ss_pred ----------------CCCCCCC-CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 247 ----------------PASLSKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 ----------------p~~l~~~-~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
...++.. .++.+++||.+||+ +|.+|||+.|+|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0112222 47889999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=324.67 Aligned_cols=247 Identities=18% Similarity=0.264 Sum_probs=204.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEc---CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~---~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
...|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-- 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--
Confidence 357999999999999999999875 456799999987542 234456788999999999999999999988654
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+++||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ ++||||||+|||++ .++.+|++|||.+.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~ 155 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQ 155 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCcccc
Confidence 4689999999999999999875 57899999999999999999999999 99999999999997 78999999999875
Q ss_pred hccCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006777 180 VMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~ 254 (631)
...... .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ .+.....+.+..+..+. .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~ 233 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD-MSGQDVIKAVEDGFRLP-APRNC 233 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHCCCCCC-CCCCC
Confidence 432221 11234567899999875 568999999999999999775 9999986 44555666666654433 35567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+..+.+++.+||. +|.+||++.+|++
T Consensus 234 ~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 234 PNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 8899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=331.08 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=212.4
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.....|.+.+.||+|+||+||+|.+..+|..||+|++..... ......+.+.+|+.+++.++||||+++++++.+..
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-- 88 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-- 88 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC--
Confidence 344679999999999999999999999999999999875432 23445567889999999999999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 102 TINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
..++|+||+. |+|.+++.. .+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .+|.+||+|||++..
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~ 164 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASL 164 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEeecCccee
Confidence 6889999997 677777654 456999999999999999999999999 99999999999997 789999999999865
Q ss_pred ccCCCCccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 181 MQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 181 ~~~~~~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
... .....+++.|+|||++. +.++.++||||||+++|+|+||..||.... .......+.....+......++.
T Consensus 165 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 241 (307)
T cd06607 165 VSP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNDSPTLSSNDWSD 241 (307)
T ss_pred cCC--CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcCCCCCCCchhhCH
Confidence 432 23467899999999763 458889999999999999999999997643 33333334433333333344678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.++++|.+||. +|.+||++.+++.||||....
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 99999999998 899999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.07 Aligned_cols=260 Identities=22% Similarity=0.335 Sum_probs=214.5
Q ss_pred cEEEEEEEeecCCeEEEEEEEc---CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 26 FWISWVVVLNCTFMCRYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~---~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
.|++.+.||.|+||.||+|.+. .+|..||+|++............+++.+|+++++++ +||||+++++.|... .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--T 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--C
Confidence 4889999999999999999874 478999999987654333334557788999999999 599999999987654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+++||||+++++|.+++...+.+++..+..++.||+.||.|||+++ ++||||+|+|||++ .++.+||+|||++...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEF 155 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceec
Confidence 78999999999999999998888999999999999999999999999 99999999999997 7899999999998754
Q ss_pred cCC---CCccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCC
Q 006777 182 QQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 182 ~~~---~~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~~~---~~~~~~~i~~~~~p~~l~~ 252 (631)
... ......|++.|+|||.+.. .++.++||||||+++|+|++|..||..... ...+...+.... ..++.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 233 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQ 233 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--CCCCc
Confidence 332 2234578999999998753 467899999999999999999999964222 223333333322 22345
Q ss_pred CCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCccCCCCCcc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~ 292 (631)
..++.+.+||.+||. +|.+|| ++.+++.||||+..+|..+
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence 578999999999998 899997 8899999999999887554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=344.98 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=204.6
Q ss_pred CCcEEEEEEEeecCCeEEEEEEE-----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d-----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
.++|++.++||+|+||+||+|.+ ..++..||+|+++... .....+.+.+|+++|+.+ +||||++++++|.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 45799999999999999999964 4567799999987443 234456788999999999 89999999998865
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCC------------------------------------------------------
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHK------------------------------------------------------ 123 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~------------------------------------------------------ 123 (631)
.. ..++||||+++|+|.+++....
T Consensus 111 ~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 GG--PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred CC--cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 54 6899999999999999986532
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 124 ---------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 124 ---------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEE-CCCcEEEecCccceecc
Confidence 4678889999999999999999999 99999999999998 78899999999997553
Q ss_pred CCCC----ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 183 QPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 183 ~~~~----~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
.... ....+++.|+|||++. ..++.++|||||||++|+|++ |..||..........+.+..+..+. .+...+.
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 344 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-SPECAPS 344 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-CCCCCCH
Confidence 3221 1233456799999875 468999999999999999998 8999987655566666666654332 3345678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
++++||.+||. +|.+||++.+++..
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=387.16 Aligned_cols=264 Identities=29% Similarity=0.489 Sum_probs=231.9
Q ss_pred cCccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEE
Q 006777 16 LEPISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 16 ~~~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f 95 (631)
++.-...+.-+|.-...||.|.||.||.|.+..+|+..|+|.+++.... ......+.+|..+|..|+|||+|++|++=
T Consensus 1226 la~~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVE 1303 (1509)
T KOG4645|consen 1226 LASSLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVE 1303 (1509)
T ss_pred HHHHhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCcee
Confidence 3344445666888899999999999999999999999999999887543 34456688999999999999999999954
Q ss_pred EcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
++ +..+++.||||.+|+|.+.+...+..+|...+.+..|++.||.|||++| |+||||||.|||++ .+|.+|++||
T Consensus 1304 vH--Rekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1304 VH--REKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDF 1378 (1509)
T ss_pred ec--HHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecc
Confidence 44 4468899999999999999998888899999999999999999999999 99999999999998 8899999999
Q ss_pred cchhhccCC------CCccccCCCCCCCcccccc----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006777 176 GLAIVMQQP------TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 176 GlA~~~~~~------~~~~~~GTp~y~APE~l~~----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~ 245 (631)
|.|....+. ..+..+|||-|||||++.+ +...+.|||||||++.||+||+.||....+..+++-++..|.
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH 1458 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC
Confidence 999755433 2346789999999999854 467899999999999999999999999999999999999998
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 246 ~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+|..... .+++.++||+.||. ||.+|.++.|||.|.|-+..
T Consensus 1459 ~Pq~P~~-ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1459 KPQIPER-LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred CCCCchh-hhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 8876555 88999999999997 99999999999999987654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=320.40 Aligned_cols=251 Identities=26% Similarity=0.441 Sum_probs=209.4
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|.+.+.||+|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+... ..+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEEE
Confidence 58999999999999999999999999999999876543 223456788999999999999999999987554 47999
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|+||+++++|.+++.+.. .+++..+..|+.|++.||.|||+++ ++|+||||+||+++..+..+||+|||.+.....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999999999987654 4799999999999999999999999 999999999999984434679999999876543
Q ss_pred CC--CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 184 PT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~~--~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.. .....|++.|+|||.+. ..++.++|+||||+++++|++|..||... +.......+..+..+ ......+..+++
T Consensus 155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (257)
T cd08225 155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFA-PISPNFSRDLRS 232 (257)
T ss_pred CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCC-CCCCCCCHHHHH
Confidence 32 23356899999999875 45889999999999999999999999764 444444444444322 223456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+|.+||. +|.+|||+.++++||||
T Consensus 233 ~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 233 LISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHhccChhhCcCHHHHhhCCCC
Confidence 9999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.38 Aligned_cols=259 Identities=26% Similarity=0.442 Sum_probs=225.8
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.....|.+...||+|.|++|.+|.+..+|..||+|.+..... +...++.+.+|+++|+.|+|||||++|.+.... .
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~--~ 128 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE--A 128 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec--c
Confidence 346789999999999999999999999999999999987754 455667799999999999999999999976544 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+|+||||+.+|.+++|+.++++..+..++.++.|+++|++|||+++ |+|||||++|||++ .+..+||+|||++..+
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~-~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLD-ENMNIKIADFGFSTFF 205 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccc-cccceeeeccccceee
Confidence 79999999999999999999999999999999999999999999999 99999999999998 6778999999999877
Q ss_pred cCC-CCccccCCCCCCCccccccc-c-CccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 182 QQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~~~-~~~~~~GTp~y~APE~l~~~-y-~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
... ...++||+|.|.|||++.+. | ++.+|+||+|+++|-|+.|..||.+ .+...+..++..+... ++...+-+.
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~r--Ip~~ms~dc 282 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYR--IPFYMSCDC 282 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeec--ccceeechh
Confidence 643 46789999999999999764 4 6899999999999999999999987 4555555555554333 233456789
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCC
Q 006777 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~ 290 (631)
+++|.++|. +|.+|++.+++.+|+|.......
T Consensus 283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 999999998 99999999999999999765443
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.62 Aligned_cols=255 Identities=27% Similarity=0.380 Sum_probs=206.6
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC--
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~-- 100 (631)
+..+|.+.+.||+|+||.||+|.+..+|..||+|.+.... .......++.+|+.+++.++||||++++++|.....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 5678999999999999999999999999999999886432 233445678889999999999999999998864432
Q ss_pred --ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 101 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+|+||||+. ++|.+++... +++..++.++.||+.||+|||++| ++||||||+||+++ .+|.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~ 165 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 165 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccc
Confidence 35799999996 6888887654 899999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCCC-CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-C--------
Q 006777 179 IVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P-------- 247 (631)
Q Consensus 179 ~~~~~~~-~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-p-------- 247 (631)
....... .....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||........ +..+..... |
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHh
Confidence 7654332 234568999999998754 589999999999999999999999976433222 222211000 0
Q ss_pred ----------------CC---------C-------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 248 ----------------AS---------L-------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 248 ----------------~~---------l-------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.. + ....++.+++||.+||. +|.+|||+.|+|.||||..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 00 0 12345678999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=318.60 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=210.0
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|.+.+.||.|+||.||+|.+..++..||+|.++... .....+.+.+|+.+++.++||||++++++|.+. ..+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEE
Confidence 4889999999999999999999999999999987543 234567788999999999999999999988655 47999
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
||||+++|+|.+++... ..+++..++.|+.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++.....
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTS 152 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeecc
Confidence 99999999999988653 45899999999999999999999999 99999999999997 789999999999875543
Q ss_pred C--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 184 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
. ......|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..+ .++...+..+++
T Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (255)
T cd08219 153 PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYK-PLPSHYSYELRS 230 (255)
T ss_pred cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCC-CCCcccCHHHHH
Confidence 2 2334678999999998864 588999999999999999999999986 4555555566555333 234456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCC
Q 006777 261 FIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hp 282 (631)
||.+||. +|.+||++.+++.--
T Consensus 231 li~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 231 LIKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHHHhCCcccCCCHHHHhhcc
Confidence 9999998 999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=362.86 Aligned_cols=250 Identities=21% Similarity=0.339 Sum_probs=206.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEE-cC---
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWV-DD--- 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~-~~--- 98 (631)
+.+++|.++|.+|||+.||+|.+...|..||+|++-.. +...+..+.+||.+|+.|+ |||||.|+++.. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 67899999999999999999999888899999987643 5678889999999999997 999999999432 21
Q ss_pred C-CceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 99 T-NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 99 ~-~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
. .-.++|.||||.||.|-+++.++ .+|++.+|.+|+.|++.|+.+||.+.|||||||||-+||||+ .+|+.|||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDF 190 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDF 190 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCcc
Confidence 1 23678999999999999999854 469999999999999999999999999999999999999998 7899999999
Q ss_pred cchhhccCCC--Cc---------cccCCCCCCCccccc---c-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006777 176 GLAIVMQQPT--AR---------SVIGTPEFMAPELYE---E-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240 (631)
Q Consensus 176 GlA~~~~~~~--~~---------~~~GTp~y~APE~l~---~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~ 240 (631)
|.|+...... .. ...-||.|+|||++. + ..++|+|||+|||+||-|+....||.+.... .
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----a 265 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----A 265 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----e
Confidence 9986332211 11 123599999999764 3 5899999999999999999999999874221 2
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 006777 241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 241 i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpf 283 (631)
|..+.........++..+++||..||+ +|.+||++-+++.+-+
T Consensus 266 Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 266 ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 334433222234567899999999998 9999999998886644
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=329.86 Aligned_cols=248 Identities=22% Similarity=0.272 Sum_probs=197.3
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcC----------------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEV----------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~----------------~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 87 (631)
.++|++.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|++++|||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCC
Confidence 4689999999999999999997532 44579999887542 3445677899999999999999
Q ss_pred cceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 006777 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------------------NVDMKAIKNWARQILRGLHYLHSHN 148 (631)
Q Consensus 88 IV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~-------------------~l~e~~i~~i~~QIl~gL~yLHs~~ 148 (631)
|+++++++.+.+ .+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++
T Consensus 81 iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 81 IIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred eeEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999987654 6899999999999999986532 3677889999999999999999999
Q ss_pred CCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh
Q 006777 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 223 (631)
Q Consensus 149 ~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt 223 (631)
|+||||||+|||++ .++.+||+|||++....... .....+++.|+|||++. +.++.++|||||||++|+|++
T Consensus 159 --ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 159 --FVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred --ccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 99999999999998 78999999999997543322 12334578999999764 568999999999999999987
Q ss_pred --cCCCCCCCCCHHHHHHHHHc----CC--CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 224 --CEYPYNECKNPAQIYKKVTS----GI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 224 --G~~Pf~~~~~~~~~~~~i~~----~~--~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+..||.+.. ..+....+.. .. .....+...++.+++||.+||. +|.+|||+.++..
T Consensus 236 ~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 236 LCKEQPYGELT-DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred ccCCCCCCcCC-HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 567887643 3333332221 11 1111233457899999999998 8999999999843
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=326.25 Aligned_cols=251 Identities=31% Similarity=0.525 Sum_probs=209.3
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCcceeeeEEEcCCCce
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~f~~~~~~~ 102 (631)
.|.+.+.||+|+||.||+|.+..+|..||+|.+.... .....+++.+|+.+++.++ ||||+++++++.+. ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CE
Confidence 5788999999999999999999999999999987542 2345567889999999996 99999999988654 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+++||||+.+++|.+++... .+++..+..++.||+.||.|||+.+ ++||||+|+||+++ .++.++|+|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecC
Confidence 89999999999999998764 7999999999999999999999999 99999999999998 68999999999987554
Q ss_pred CCC--CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC-CCcHH
Q 006777 183 QPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK-VTDPQ 257 (631)
Q Consensus 183 ~~~--~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~-~~~~~ 257 (631)
... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.. .......+... .+..+.. ..+++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~ 230 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKS-KPPRLEDNGYSKL 230 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhccccC-CCCCCCcccCCHH
Confidence 332 234578999999998754 36889999999999999999999997643 33333333222 2233332 36789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+.+||.+||. +|.+||++.+++.||||+..
T Consensus 231 ~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 231 LREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 9999999998 89999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.84 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=207.2
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g-----~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
..|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-
Confidence 36889999999999999999876555 789999886432 345567789999999999999999999987654
Q ss_pred CceEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEE
Q 006777 100 NRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 163 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 163 (631)
...+++|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||++
T Consensus 81 -~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~ 157 (283)
T cd05048 81 -QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV 157 (283)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEE
Confidence 3688999999999999999765 45788999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHH
Q 006777 164 NGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237 (631)
Q Consensus 164 ~~~~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~ 237 (631)
+ .++.+||+|||++...... ......+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ .+...+
T Consensus 158 ~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~ 235 (283)
T cd05048 158 G-EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEV 235 (283)
T ss_pred c-CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 7 7889999999998654322 123345688999999765 568999999999999999998 9999987 455667
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 238 ~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
...+..+..+. .+...++++.+|+.+||. +|.+||++.+++++
T Consensus 236 ~~~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77776654433 345678999999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=325.08 Aligned_cols=250 Identities=26% Similarity=0.447 Sum_probs=203.9
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|++.+.||.|++|.||+|.+..+|..||+|+++.... ....+.+.+|+.++++++||||+++++++.+.. .+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTEN--KLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEEE
Confidence 58999999999999999999999999999999986532 223355778999999999999999999987654 6899
Q ss_pred EEeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 106 ITELFTSGSLRQYRKKH---KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~---~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
||||++ |+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 76 VFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFG 151 (284)
T ss_pred EEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhc
Confidence 999998 5898888764 35899999999999999999999999 99999999999997 78999999999997543
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Q 006777 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------- 247 (631)
Q Consensus 183 ~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p----------- 247 (631)
.. ......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+........+.+.....|
T Consensus 152 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 152 IPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred CCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence 32 1234567899999998754 47889999999999999999999998755443332222110000
Q ss_pred --------C-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 248 --------A-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 248 --------~-------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
. .+....++.++++|.+||+ +|.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 0112346789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.70 Aligned_cols=256 Identities=29% Similarity=0.490 Sum_probs=211.9
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLVGD--EL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC--cE
Confidence 578999999999999999999998899999999986442 234567889999999999999999999887654 68
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|+|+||+++++|.+++.+. .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCcceecccc
Confidence 9999999999999998764 5889999999999999999999999 99999999999997 788999999998864432
Q ss_pred C--CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 184 P--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
. ......|++.|+|||.+. +.++.++|+||||+++|+|++|..||...............+......+...+..+++
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247 (293)
T ss_pred cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHH
Confidence 2 223456899999999775 4588999999999999999999999976443333222222222222233345788999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
||.+||. +|.+||++.+++.||||+..++
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 9999998 8999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.74 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=200.0
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCceEEE
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~~l~l 105 (631)
|++.+.||+|+||.||+|.+..++..||+|+++.... .... ....+|+.+++++. ||||+++++++.+.....+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 6789999999999999999999999999998865421 1222 23457889999885 999999999988765568999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 106 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ . |.+||+|||++......
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~-~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIK-D-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEc-C-CCeEEEecccccccccC
Confidence 999997 577777765 457899999999999999999999999 99999999999998 4 99999999999765433
Q ss_pred C-CccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC----------------
Q 006777 185 T-ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---------------- 245 (631)
Q Consensus 185 ~-~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~---------------- 245 (631)
. .....+++.|+|||.+. +.++.++|||||||++|+|++|..||.+. +.......+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT-NELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC-CHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2 23456899999999763 34788999999999999999999999764 3333222222100
Q ss_pred CCCCC-----------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 246 KPASL-----------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 246 ~p~~l-----------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
....+ ....+..+++||.+||. +|.+||++.++|.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00001 12356899999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.23 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=206.2
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.++||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|.+. ..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK--KRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcccC--CeEE
Confidence 379999999999999999999998999999998765432 223445678899999999999999999988644 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+|+||+.+++|..+......+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCC
Confidence 99999999999988877777999999999999999999999998 99999999999997 7899999999998754332
Q ss_pred --CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-----------------
Q 006777 185 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------------- 243 (631)
Q Consensus 185 --~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~----------------- 243 (631)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||...............
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 2234568899999998753 4788999999999999999999999764433322221110
Q ss_pred --CCC-CC--------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 244 --GIK-PA--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 244 --~~~-p~--------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+.. +. ......+..+++||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 00 0112356789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=312.63 Aligned_cols=249 Identities=31% Similarity=0.546 Sum_probs=209.0
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|.+.+.||+|++|.||+|.+..+|..|++|++..... .....+.+|+.+++.++||||+++++.+... ...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEE
Confidence 38889999999999999999998999999999875432 4567788999999999999999999988765 47899
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 106 ITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
++||+++++|.+++... +.+++..+..++.|++.||.|||.++ ++||||+|+||+++ .++.++|+|||.+......
T Consensus 75 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeecccccccccc
Confidence 99999999999999876 67999999999999999999999998 99999999999998 6899999999998765543
Q ss_pred C-CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006777 185 T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 185 ~-~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI 262 (631)
. .....++..|+|||.+.+ .++.++|+||||+++|+|++|..||.........................++..+.++|
T Consensus 152 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 231 (253)
T cd05122 152 KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFL 231 (253)
T ss_pred ccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHH
Confidence 3 345678999999998754 47889999999999999999999998753333333322222111112222378999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCC
Q 006777 263 EKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 263 ~kcL~-~p~~Rpta~elL~hpf 283 (631)
.+||. +|.+|||+.++|+|||
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHccCChhhCCCHHHHhcCCC
Confidence 99998 8999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=324.26 Aligned_cols=256 Identities=27% Similarity=0.529 Sum_probs=214.5
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.....|...++||.|++|.||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-- 89 (285)
T cd06648 16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-- 89 (285)
T ss_pred cchHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--
Confidence 34456777889999999999999999999999999886432 234566889999999999999999999887644
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
..++|+||+++++|.+++.. +++++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++...
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQV 165 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccchhh
Confidence 68999999999999999887 67999999999999999999999999 99999999999998 7899999999988644
Q ss_pred cCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCCcHH
Q 006777 182 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTDPQ 257 (631)
Q Consensus 182 ~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~-l~~~~~~~ 257 (631)
... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.. .++......+.....+.. .....+..
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (285)
T cd06648 166 SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPR 244 (285)
T ss_pred ccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHH
Confidence 322 2234578999999998754 588999999999999999999999976 455555666665532221 12236789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+.+||.+||. +|.+||++.+++.||||....
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 9999999998 899999999999999998744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.92 Aligned_cols=248 Identities=22% Similarity=0.316 Sum_probs=202.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~-----g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
.++|.+.+.||+|+||.||+|.+... +..||+|.++... .....+.+.+|+.+++.+ +|||||+++++|..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 55799999999999999999986443 3579999987543 234567788999999999 89999999998865
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC-------------------------------------------------------
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH------------------------------------------------------- 122 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~------------------------------------------------------- 122 (631)
.. .+++||||+.+|+|.+++...
T Consensus 114 ~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 114 GG--PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred CC--CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 54 689999999999999998642
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCCc
Q 006777 123 ---------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187 (631)
Q Consensus 123 ---------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~ 187 (631)
.++++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCcce
Confidence 24788899999999999999999998 99999999999998 7889999999999755432221
Q ss_pred ----cccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 188 ----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 188 ----~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
...+++.|||||++. ..++.++|||||||++|+|++ |..||............+..+..+ ..+...+++++++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 347 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPDFAPPEIYSI 347 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-cCCCCCCHHHHHH
Confidence 223456899999775 568999999999999999997 999998754444444555444322 3344567999999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006777 262 IEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~elL~ 280 (631)
|.+||+ +|.+||++.++++
T Consensus 348 i~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=324.98 Aligned_cols=258 Identities=33% Similarity=0.559 Sum_probs=217.1
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.....|.+.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 88 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVG--D 88 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--C
Confidence 466789999999999999999999998999999999875432 456688999999999999999999998776 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+++|+||+++++|.+++..++ .++...+..++.||+.||.|||++| ++|+||+|+||+++ .+|.++|+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~ 165 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQ 165 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccchhhh
Confidence 7999999999999999999877 8999999999999999999999998 99999999999998 789999999999865
Q ss_pred ccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCcH
Q 006777 181 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPASLSKVTDP 256 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-~~~p~~l~~~~~~ 256 (631)
.... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||... ++......+.. ...+......++.
T Consensus 166 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (286)
T cd06614 166 LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKWSP 244 (286)
T ss_pred hccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhhCCH
Confidence 4332 2234568899999998754 5889999999999999999999999864 34333333333 2222222333678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~ 290 (631)
.+++||.+||. +|..||++.++|.||||....++
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 279 (286)
T cd06614 245 EFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279 (286)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhChHhhccCch
Confidence 99999999998 89999999999999999885543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=314.49 Aligned_cols=250 Identities=32% Similarity=0.545 Sum_probs=214.2
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|.+.+.||+|++|.||+|.+..++..|++|.+..... .....+.+.+|++++++++||||+++++++.+. ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEE
Confidence 58899999999999999999999999999999986643 235667899999999999999999999987654 47899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~ 185 (631)
||||+++++|.+++.+...+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 77 ILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTT-KDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred EEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEC-CCCCEEEeccccceecCCCc
Confidence 9999999999999998888999999999999999999999999 99999999999998 68999999999997654433
Q ss_pred C--ccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006777 186 A--RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 186 ~--~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI 262 (631)
. ....+++.|+|||...+ .++.++||||||+++|+|++|..||........... +.... ...++...++.++++|
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~i 231 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQDD-HPPLPEGISPELKDFL 231 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HhccC-CCCCCCCCCHHHHHHH
Confidence 2 34578999999998754 478899999999999999999999987543333333 33222 2335556788999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCc
Q 006777 263 EKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 263 ~kcL~-~p~~Rpta~elL~hpff 284 (631)
.+||. +|.+||++.+++.||||
T Consensus 232 ~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 232 MQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHhCChhhCcCHHHHhcCCCC
Confidence 99998 89999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.92 Aligned_cols=254 Identities=28% Similarity=0.517 Sum_probs=214.0
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|...+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++++.||||+++++++.+.. .+
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 77 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT--KL 77 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--EE
Confidence 346888999999999999999999999999999987543 2455678899999999999999999999887654 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++||||+++|+|.+++.. +++++..+..++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEcccccceeccC
Confidence 999999999999999875 46899999999999999999999998 99999999999998 788999999999965433
Q ss_pred CC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 184 PT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.. .....++..|+|||++.+ .++.++|+|||||++|+|+||..||.+. ++......+..+. +..+....+..+.+
T Consensus 154 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (277)
T cd06640 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPKNN-PPTLTGEFSKPFKE 231 (277)
T ss_pred CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc-ChHhHhhhhhcCC-CCCCchhhhHHHHH
Confidence 22 234568889999998754 5789999999999999999999999864 3444444443332 33444556788999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+|.+||. +|.+||++.++++||||....
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 232 FIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 9999998 899999999999999997644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=329.70 Aligned_cols=254 Identities=28% Similarity=0.414 Sum_probs=201.9
Q ss_pred cEEEEEEEeecCCeEEEEEEEcC--CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~--~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
+|.+.+.||+|+||.||+|.+.. +|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 48899999999999999999988 899999999886431 122334567889999999999999999999987755689
Q ss_pred EEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC----CCcEEEcc
Q 006777 104 NMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----NGEVKIGD 174 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~----~g~vKI~D 174 (631)
++||||+. ++|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+||+++ . +|.+||+|
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~-~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVM-GEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEc-CCCCccceEEECC
Confidence 99999997 4777766532 26899999999999999999999999 99999999999997 6 78999999
Q ss_pred ccchhhccCC-----CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHH--------HHHH
Q 006777 175 LGLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------QIYK 239 (631)
Q Consensus 175 FGlA~~~~~~-----~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~--------~~~~ 239 (631)
||++...... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+..... ....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 9998754322 1234578999999997754 47899999999999999999999997533211 0000
Q ss_pred HHHc------------------------CCCCCCCC-----------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 006777 240 KVTS------------------------GIKPASLS-----------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPF 283 (631)
Q Consensus 240 ~i~~------------------------~~~p~~l~-----------~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpf 283 (631)
.+.. .......+ ...++.+.++|.+||. +|.+|||+.|++.|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 0000 00000011 1456789999999998 8999999999999999
Q ss_pred c
Q 006777 284 L 284 (631)
Q Consensus 284 f 284 (631)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.74 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=205.0
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC---
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~--- 99 (631)
++++|.+.+.||+|+||.||+|.+..+|..||+|++.... ......++.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 4678999999999999999999999999999999986432 2234566788999999999999999998775443
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
...+++|+||+. ++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECccccee
Confidence 236899999997 588888754 56999999999999999999999999 99999999999997 78999999999986
Q ss_pred hccCC-----CCccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc---------
Q 006777 180 VMQQP-----TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------- 243 (631)
Q Consensus 180 ~~~~~-----~~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--------- 243 (631)
..... ......||+.|+|||.+. ..++.++|||||||++|+|++|+.||.+...... ...+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~~~~~~~~ 233 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVLGTPSQED 233 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCHHH
Confidence 54322 123357899999999764 3588999999999999999999999976432221 111100
Q ss_pred ---------------CCC--CCC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 244 ---------------GIK--PAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 ---------------~~~--p~~---l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
... ... .....++++.+||.+||. +|.+|||+.+++.||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000 000 112346789999999998 89999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=327.02 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=202.3
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC--
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-- 99 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~-- 99 (631)
..-++|.+.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 344579999999999999999999999999999999875432 1122334668999999999999999999876543
Q ss_pred ----CceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 100 ----NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 100 ----~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
....++||||+. ++|.+++... ..+++.+++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~d 162 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLAD 162 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCcEEECc
Confidence 236799999996 5888877654 36899999999999999999999999 99999999999997 789999999
Q ss_pred ccchhhccCCC------CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc---
Q 006777 175 LGLAIVMQQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--- 243 (631)
Q Consensus 175 FGlA~~~~~~~------~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--- 243 (631)
||++....... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.. .......+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~-~~~~~~~~~~~~~ 241 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT-EQHQLTLISQLCG 241 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhC
Confidence 99996543221 123467889999997754 37889999999999999999999997643 3222221111
Q ss_pred CCCCCC---------------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 244 GIKPAS---------------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 244 ~~~p~~---------------------------l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
...+.. .....++.+++||.+||. +|.+|||+.++|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 111000 011235778899999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=325.79 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=205.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|++|+||+|.++.+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+.. .++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK--RLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecCC--eEE
Confidence 479999999999999999999999999999999875432 1233456788999999999999999999987543 799
Q ss_pred EEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 105 MITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+||||+. ++|.+++..... +++..++.++.||+.||+|||+++ ++||||+|+||+++..++.+||+|||++....
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 9999996 688888765443 588999999999999999999998 99999999999998556689999999996543
Q ss_pred CC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Q 006777 183 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------- 247 (631)
Q Consensus 183 ~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p----------- 247 (631)
.. ......+++.|+|||.+.+ .++.++|||||||++|+|+||..||........+.+.+.....|
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 22 2234467899999998754 47889999999999999999999997644444433322110000
Q ss_pred ------------C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 248 ------------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 ------------~---~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
. ......++.++++|.+||. +|.+||++.++|.||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0112357889999999998 89999999999999999764
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=316.14 Aligned_cols=250 Identities=29% Similarity=0.454 Sum_probs=214.6
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
+|++.+.||.|+||.||+|.+..+|..||+|.+..... ......++.+|+.+++.++||||+++++++.+. ...++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEE
Confidence 58999999999999999999999999999999876543 234556788999999999999999999988765 47899
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 106 ITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
|+||+++++|.+++.+ ...+++..++.++.|++.||.|||++| ++||||+|+||+++ .++.+||+|||++...
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGISKVL 153 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEe-cCCcEEEeeccchhhh
Confidence 9999999999999876 356899999999999999999999999 99999999999998 6889999999999776
Q ss_pred cCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 182 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.........+++.|+|||.+.+ .++.++|+||||+++|+|++|..||... +...+...+..+..+. .+...+.++++
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd08530 154 KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYPP-IPPIYSQDLQN 231 (256)
T ss_pred ccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCC-CchhhCHHHHH
Confidence 5554455678999999998754 5788999999999999999999999874 4555555555544333 33467789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+|.+||. +|.+||++.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999998 89999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=317.17 Aligned_cols=250 Identities=28% Similarity=0.449 Sum_probs=209.9
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.+.||+|+||.||+|.+..+|..||+|.++.... ......+++.+|+.++++++|+||++++++|.+.. ..+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~--~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN--ELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--eEE
Confidence 579999999999999999999999999999999876443 23345678899999999999999999999987653 789
Q ss_pred EEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 105 MITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+||||+++|+|..++... ..+++.+++.|+.||+.||.|||+++ ++||||+|+||+++ .+|.++|+|||++..
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~~ 155 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceeee
Confidence 999999999999998642 45899999999999999999999999 99999999999998 789999999999865
Q ss_pred ccCC--CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 181 MQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~-~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
.... ......+++.|+|||.+. ..++.++||||||+++|+|++|..||.... +.......+..+..+.......+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08224 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235 (267)
T ss_pred ccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCH
Confidence 4332 223457899999999775 458899999999999999999999996532 334455555555444443435678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.++++|.+||. +|.+||++.+++.
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999998 8999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=322.63 Aligned_cols=251 Identities=28% Similarity=0.422 Sum_probs=212.2
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCceE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~~l 103 (631)
++|.+.+.||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+++++. ||||+++++++.+. ..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceE
Confidence 479999999999999999999999999999999876543 22344567889999999998 99999999987554 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++||||+.+++|.+++.+.+.+++..++.++.|++.||.|||+++ ++|+||+|+||+++ .+|.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCC
Confidence 999999999999999999888999999999999999999999999 99999999999997 789999999999865433
Q ss_pred CC----------------------CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006777 184 PT----------------------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240 (631)
Q Consensus 184 ~~----------------------~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~ 240 (631)
.. .....|++.|+|||.+. ..++.++||||||+++++|++|..||.... ....++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~ 233 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQK 233 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHH
Confidence 21 12346789999999765 457889999999999999999999998743 3344444
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH----HHHhcCCCc
Q 006777 241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELLKDPFL 284 (631)
Q Consensus 241 i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta----~elL~hpff 284 (631)
+... ...++...++.+.+||.+||. +|.+||++ .++|+||||
T Consensus 234 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhc--CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 4432 223344568899999999998 89999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=326.85 Aligned_cols=254 Identities=23% Similarity=0.367 Sum_probs=204.6
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCceEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~~l~ 104 (631)
.|...+.||+|+||.||++.+..+|..||+|.+..... ......+.+|+.++.++. ||||+++++++..+. ..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~--~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG--DCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC--cEE
Confidence 56667899999999999999999999999999875532 245567889999999996 999999999887644 578
Q ss_pred EEEeccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 105 MITELFTSGSLRQYRK-----KHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~-----~~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
++|||+. ++|.++.. ..+.+++..+..++.|++.||+|||+. + ++||||||+||+++ .++.+||+|||++
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~ 155 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGIS 155 (288)
T ss_pred EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchh
Confidence 8999986 46555432 246799999999999999999999974 7 99999999999997 7889999999999
Q ss_pred hhccCCC-CccccCCCCCCCcccccc----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC---C
Q 006777 179 IVMQQPT-ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---L 250 (631)
Q Consensus 179 ~~~~~~~-~~~~~GTp~y~APE~l~~----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~---l 250 (631)
....... .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.......+....+..+..+.. .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd06616 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235 (288)
T ss_pred HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence 7554332 234568999999998754 4889999999999999999999999875433333333333322221 1
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
....++++.+||.+||. +|.+|||+.+++.||||+...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 22367899999999998 899999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=335.40 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=206.0
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC--
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~-- 100 (631)
.+.+|.+.+.||.|+||.||+|.++.+|..||+|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 46799999999999999999999999999999999876542 345668889999999999999999987654322
Q ss_pred ----------ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcE
Q 006777 101 ----------RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 101 ----------~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 170 (631)
..+++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++| ++||||||+||+++..++.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceE
Confidence 35789999997 699988864 46999999999999999999999999 99999999999997566789
Q ss_pred EEccccchhhccCCC-----CccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006777 171 KIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243 (631)
Q Consensus 171 KI~DFGlA~~~~~~~-----~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~ 243 (631)
||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++|+.||............+..
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999987543221 12346788999999764 34788999999999999999999999764433322221111
Q ss_pred C-----------------------CCC----CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 244 G-----------------------IKP----ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 244 ~-----------------------~~p----~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
. ..+ ..+....+.++++||.+||+ +|.+|||+.++|.||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 0 000 00112356889999999998 8999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=335.47 Aligned_cols=258 Identities=25% Similarity=0.348 Sum_probs=209.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC--
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~-- 100 (631)
+..+|.+.+.||+|+||+||+|.+..+|..||+|.+..... ......++.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 35689999999999999999999999999999999875421 22334567789999999999999999998765432
Q ss_pred -ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+++|+||+. ++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCcccc
Confidence 35899999996 799999988888999999999999999999999999 99999999999997 78999999999997
Q ss_pred hccCC--CCccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc---C--------
Q 006777 180 VMQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---G-------- 244 (631)
Q Consensus 180 ~~~~~--~~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~---~-------- 244 (631)
..... ......++..|+|||.+. ..++.++|||||||++|+|++|..||.+.. .......+.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD-YVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCChHHhhh
Confidence 55432 233457899999999775 358899999999999999999999997632 2211111110 0
Q ss_pred ----------------CCC--CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 245 ----------------IKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ----------------~~p--~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
..+ .......++.+++||.+||+ +|.+|||+.++|+||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 01123467889999999998 89999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=335.29 Aligned_cols=260 Identities=24% Similarity=0.389 Sum_probs=210.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC--CC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TN 100 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~--~~ 100 (631)
+.++|.+.+.||.|+||.||+|.++.+|..||+|++..... .......+.+|+.+|++++||||++++++|... ..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 45789999999999999999999999999999999875432 223456678899999999999999999987543 23
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
..+++||||+. |+|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~ 156 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARG 156 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEeccccccee
Confidence 47899999996 699999988888999999999999999999999999 99999999999998 789999999999865
Q ss_pred ccCCC------CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CC------
Q 006777 181 MQQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI------ 245 (631)
Q Consensus 181 ~~~~~------~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-~~------ 245 (631)
..... .....|+..|+|||.+.+ .++.++|||||||++|+|++|..||.+.....++...... +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 43221 124578999999998743 4889999999999999999999999764332221111100 00
Q ss_pred ------------------CCCC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 246 ------------------KPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 246 ------------------~p~~---l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.+.. +....++.+++||.+||+ +|.+||++.+++.||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0000 113357889999999998 899999999999999998643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=329.57 Aligned_cols=253 Identities=28% Similarity=0.504 Sum_probs=211.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|.+.+.||+|+||.||+|.+..+|..||+|.+.... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 77 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT--KL 77 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccCC--ce
Confidence 345777788999999999999999999999999987543 2345677899999999999999999999886544 78
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++||||+++++|.+++.. ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEccccccccccC
Confidence 999999999999999865 46899999999999999999999998 99999999999997 789999999999865443
Q ss_pred CC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 184 PT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.. .....|+..|+|||.+.+ .++.++|+|||||++|+|++|..||... .+......+..+. +..+....+..+.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (277)
T cd06642 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQYSKPFKE 231 (277)
T ss_pred cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCC-CCCCCcccCHHHHH
Confidence 22 233568899999998764 5788999999999999999999999763 3333333333332 33344456788999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+|.+||. +|.+||++.++++||||...
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 232 FVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 9999998 89999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=347.24 Aligned_cols=233 Identities=28% Similarity=0.408 Sum_probs=198.6
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
++.||.|+.|.||+|+. .++.||||.|+.- -..+|+-|++|+||||+.|.+++. ..-+++|||||
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVCt--qsPcyCIiMEf 193 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVCT--QSPCYCIIMEF 193 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeeec--CCceeEEeeec
Confidence 78999999999999985 5899999987521 124889999999999999999774 34589999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC-CCcc
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS 188 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~-~~~~ 188 (631)
|..|-|...++....+....+..|..+|+.|+.|||.+. |||||||.-||||. .+..|||+|||.++..... +.-+
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~STkMS 270 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILIS-YDDVVKISDFGTSKELSDKSTKMS 270 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEee-ccceEEeccccchHhhhhhhhhhh
Confidence 999999999999999999999999999999999999999 99999999999998 7789999999999866544 3457
Q ss_pred ccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006777 189 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 189 ~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~ 267 (631)
++||..|||||++++ ..++++|||||||+|||||||+.||.+... ..++--+-.+..-...+..++.-++-||+.||.
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-heeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 899999999999975 589999999999999999999999976322 222222333333334556678899999999998
Q ss_pred -CCCCCCCHHHHhcC
Q 006777 268 -PASLRLPALELLKD 281 (631)
Q Consensus 268 -~p~~Rpta~elL~h 281 (631)
+|..||+..++|.|
T Consensus 350 sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLH 364 (904)
T ss_pred cCCCCCccHHHHHHH
Confidence 99999999999998
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=330.03 Aligned_cols=255 Identities=27% Similarity=0.511 Sum_probs=212.0
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
..+..|.....||+|+||.||+|.+..+|..||+|++..... ...+.+.+|+.+++.++||||++++++|....
T Consensus 18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-- 91 (297)
T cd06659 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE-- 91 (297)
T ss_pred cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeCC--
Confidence 445566667789999999999999999999999999875432 23456889999999999999999999887644
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+++|+||+++++|..++.. ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++...
T Consensus 92 ~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 92 ELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQI 167 (297)
T ss_pred eEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhc
Confidence 78999999999999998765 56899999999999999999999999 99999999999997 7899999999998654
Q ss_pred cCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHH
Q 006777 182 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p-~~l~~~~~~~ 257 (631)
... ......|++.|+|||++.+ .++.++|||||||++|+|++|+.||... ........+.....+ .......++.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T cd06659 168 SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPV 246 (297)
T ss_pred ccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHH
Confidence 332 2344678999999998754 5889999999999999999999999763 444444455443221 1223346788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+.+||.+||+ +|.+||++.++++||||...
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 9999999998 89999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=349.44 Aligned_cols=272 Identities=21% Similarity=0.333 Sum_probs=243.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
-....+...||.|+||.|-++........+|+|.++...+. ..++.+.++.|-++|..++.|.||++|..|.+. .++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV-dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~--kyv 495 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV-DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS--KYV 495 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc-chhHHHHHHhHHHHHHhcCchHHHHHHHHhccc--hhh
Confidence 34566788999999999999987766667999998877654 356778999999999999999999999988654 589
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
||.||-|-||.|+..++.++.|++.+.+.++.-++.|++|||++| ||+|||||+|.+++ .+|.+||.|||+|+....
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhcc
Confidence 999999999999999999999999999999999999999999999 99999999999997 899999999999987754
Q ss_pred -CCCccccCCCCCCCccc-cccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 184 -PTARSVIGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 184 -~~~~~~~GTp~y~APE~-l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
....++||||+|.|||+ +..+.+.++|.||||+++|||+||.+||++ .++...|..|.+|+.-..+|+.+...+.+|
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 45678999999999996 467799999999999999999999999998 789999999999999999999999999999
Q ss_pred HHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCccccCCCCCCCC
Q 006777 262 IEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPNL 302 (631)
Q Consensus 262 I~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~~~l~~p~~ 302 (631)
|+++.. .|.+|.. +.+|-+|.||..-+|..+....++.|..
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~ 698 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPII 698 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCcc
Confidence 999886 7999886 7899999999999998876655555443
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=326.42 Aligned_cols=257 Identities=24% Similarity=0.328 Sum_probs=202.8
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
....++|.+.++||.|+||.||+|.+..+|..||+|++....... .....+.+|+++++.++||||+++++.+.+...
T Consensus 4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 344689999999999999999999999999999999987653211 122346789999999999999999998765432
Q ss_pred ------ceEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEc
Q 006777 101 ------RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 101 ------~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~ 173 (631)
..+++|+||+.+ +|..++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~ 157 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIA 157 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEC
Confidence 368999999974 67766654 457999999999999999999999999 99999999999998 78999999
Q ss_pred cccchhhccCCC-------------CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHH
Q 006777 174 DLGLAIVMQQPT-------------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238 (631)
Q Consensus 174 DFGlA~~~~~~~-------------~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~ 238 (631)
|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++|..||.+..... ..
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~ 236 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QL 236 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 999996543221 123467889999998753 47899999999999999999999997644332 22
Q ss_pred HHHHcC---CCCCC------------------C-------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 239 KKVTSG---IKPAS------------------L-------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 239 ~~i~~~---~~p~~------------------l-------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
..+... ..+.. . .....+.+.+||.+||. +|.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 222210 00000 0 01234678999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=323.92 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=203.8
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEE
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV 106 (631)
|++.+.||.|++|.||+|.++.+|..||+|++..... .......+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEE
Confidence 6788999999999999999999999999999876532 122335677899999999999999999988655 478999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 107 TELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
|||+. ++|.+++.... .+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVP 152 (283)
T ss_pred EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCcEEEeecccccccCCC
Confidence 99995 79999998766 7999999999999999999999998 99999999999998 6899999999998654322
Q ss_pred --CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--------------
Q 006777 185 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-------------- 246 (631)
Q Consensus 185 --~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-------------- 246 (631)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||.......+..+.......
T Consensus 153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1223456889999997754 4688999999999999999999999865443333332211000
Q ss_pred ------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 247 ------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 ------------p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
........++.+.++|.+||+ +|.+|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 001123456889999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=340.45 Aligned_cols=275 Identities=23% Similarity=0.347 Sum_probs=230.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..+.|..-++||+|+||.||-+..+.+|+-+|.|.+..+.+.. .........|-++|..++.|.||.+-.+|...+ .
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd--~ 259 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAFETKD--A 259 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC--c
Confidence 3567888999999999999999999999999999887765532 233445678999999999999999987775554 7
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+++|+..|.||+|+-+|-+.+ .|++..+..++.+|+.||++||..+ |++|||||+|||++ ++|+|+|+|+|+|..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEe
Confidence 999999999999999998876 7999999999999999999999999 99999999999998 899999999999987
Q ss_pred ccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCc
Q 006777 181 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~---~~~~~~i~~~~~p~~l~~~~~ 255 (631)
+... .....+||.+|||||++.+ .|+..+|+|||||++|||+.|+.||...... .++-+++.. .+..++...+
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS 414 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFS 414 (591)
T ss_pred cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccC
Confidence 6544 3445599999999998864 5999999999999999999999999764322 122333332 3566777789
Q ss_pred HHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCccccCCCCCCCCchh
Q 006777 256 PQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPNLVPE 305 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~~~l~~p~~~~~ 305 (631)
++++++.+.+|. +|.+|.. +.++-.||||+..+|+.+....+..|..++.
T Consensus 415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp 470 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDP 470 (591)
T ss_pred HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCc
Confidence 999999999998 8988875 6799999999999999876666666655443
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=319.42 Aligned_cols=250 Identities=30% Similarity=0.456 Sum_probs=209.0
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.+.||+|+||.||+|.+..+|..||+|.+..... ......+++.+|+.+++.++||||++++++|.+.. .++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC--eEE
Confidence 478899999999999999999999999999998876442 23345577889999999999999999999887654 789
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 105 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
++|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~ 155 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhc
Confidence 99999999999998864 346899999999999999999999999 99999999999998 788999999999875
Q ss_pred ccCCC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCcH
Q 006777 181 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-PAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 181 ~~~~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~-~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
..... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+... .....+.+.....+.......++
T Consensus 156 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred cccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence 54322 234578999999998754 588899999999999999999999975332 23444555554444444455788
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.++++|.+||. +|.+|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999998 9999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=327.98 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=203.6
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeE----EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIE----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~----VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...|++.+.||+|+||.||+|.+..+|.. ||+|.++.. ......+++.+|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 35799999999999999999998666654 899988643 2345567788999999999999999999988654
Q ss_pred CceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..++|+||+.+|+|.+++..+. .+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 82 --~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a 156 (316)
T cd05108 82 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLA 156 (316)
T ss_pred --CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEcccccc
Confidence 3678999999999999998754 6899999999999999999999999 99999999999997 7889999999999
Q ss_pred hhccCCCC----ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 179 IVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 179 ~~~~~~~~----~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
........ ....+++.|+|||++. ..++.++|||||||++|||++ |..||.+ ....++...+..+..+. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 234 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPP 234 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCCC-CCC
Confidence 76543221 1223467899999775 468999999999999999998 9999976 34555555555443332 234
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..+..+.++|.+||. +|..||++.+++.+
T Consensus 235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 567899999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=321.69 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=205.3
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
...|.+.+.||+|+||.||+|.+. .++..||+|.++... .....+.+.+|+++|+.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 456889999999999999999874 346889999886432 233557889999999999999999999988765
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHK--------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~--------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 164 (631)
..+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~ 156 (280)
T cd05049 81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG 156 (280)
T ss_pred --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc
Confidence 47899999999999999997643 3788999999999999999999999 99999999999998
Q ss_pred CCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHH
Q 006777 165 GNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 238 (631)
Q Consensus 165 ~~~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~ 238 (631)
.++.+||+|||++...... ......+++.|+|||++. +.++.++|||||||++|+|++ |..||.+. +.....
T Consensus 157 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~ 234 (280)
T cd05049 157 -YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVI 234 (280)
T ss_pred -CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHH
Confidence 7899999999998644221 122345678999999875 458999999999999999998 99999874 455566
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+..+..+. .+...+..++++|.+||+ +|.+||++.|++.
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6666554433 334578899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=342.64 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=212.4
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEc
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD 97 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~ 97 (631)
+....+..|++++.||+||.+.||++... +...||+|.+.... .+...++-+..|+.+|.+|+ |.+||++|+|=+.
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 34445889999999999999999999974 44556777666543 35677888999999999995 9999999997655
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCCCCH-HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKNVDM-KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e-~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
.+++||||||-+ .+|..++++.+...+ -.++.+..|+|.|+.++|++| |||.||||.|+|+- .|.+||+|||
T Consensus 432 --d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFG 504 (677)
T KOG0596|consen 432 --DGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFG 504 (677)
T ss_pred --CceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeec
Confidence 458999999976 799999998765433 589999999999999999999 99999999999985 6999999999
Q ss_pred chhhccCCCC----ccccCCCCCCCcccccc------------ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006777 177 LAIVMQQPTA----RSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240 (631)
Q Consensus 177 lA~~~~~~~~----~~~~GTp~y~APE~l~~------------~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~ 240 (631)
+|......+. .+.+||+.||+||.+.. ..+.++||||||||+|+|+.|+.||....+....+..
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~a 584 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHA 584 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHh
Confidence 9987766543 46689999999997631 1567999999999999999999999876655555555
Q ss_pred HHcCCCCCCCCCCCcHH-HHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 241 VTSGIKPASLSKVTDPQ-VKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 241 i~~~~~p~~l~~~~~~~-lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
|........++...... +.++++.||+ ||.+||++.+||+|||++.
T Consensus 585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 55543333455444443 9999999998 9999999999999999976
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.58 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=206.8
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcC-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~-----~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
.++|.+.++||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4689999999999999999997652 35689999876432 234455688899999999999999999987654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHK----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~----------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
. ..++||||+++|+|.+++.+.+ .++...+..++.||+.||.|||+++ |+||||||+||+++ .++
T Consensus 82 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~-~~~ 156 (288)
T cd05061 82 Q--PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA-HDF 156 (288)
T ss_pred C--CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc-CCC
Confidence 3 6899999999999999997532 3466788999999999999999999 99999999999998 789
Q ss_pred cEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006777 169 EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 169 ~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~ 242 (631)
.+||+|||+++...... .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+ .......+.+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~ 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVM 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 99999999987443221 12234567899999875 468999999999999999998 7889976 45555656555
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc------CCCccCCCC
Q 006777 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK------DPFLVTDNP 289 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~------hpff~~~~~ 289 (631)
.+..+. .+...++.++++|.+||+ +|.+||++.++++ ||||....|
T Consensus 236 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 236 DGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred cCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 543322 234457899999999998 8999999999886 899987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=330.75 Aligned_cols=260 Identities=25% Similarity=0.334 Sum_probs=207.2
Q ss_pred ccCCCcEEE-EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHH----------HHHHHHHHHHHHHhCCCCCcc
Q 006777 21 SSVSYFWIS-WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPD----------QLERLYSEVHLLKSLKHENII 89 (631)
Q Consensus 21 ~~i~~~Y~i-~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~----------~~~~~~~Ei~iL~~L~HpnIV 89 (631)
..+..+|.. .+.||.|+||+||+|.+..+|+.||+|.+.......... ....+.+|+.++++++||||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 345667764 578999999999999999999999999987653321110 012477899999999999999
Q ss_pred eeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc
Q 006777 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 90 ~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
+++++|.... .+++||||+. |+|.+++.....+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.
T Consensus 84 ~~~~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~ 157 (335)
T PTZ00024 84 GLVDVYVEGD--FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGI 157 (335)
T ss_pred eeeEEEecCC--cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCC
Confidence 9999887554 7899999997 699999988888999999999999999999999999 99999999999997 7899
Q ss_pred EEEccccchhhccC----------------CCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCC
Q 006777 170 VKIGDLGLAIVMQQ----------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC 231 (631)
Q Consensus 170 vKI~DFGlA~~~~~----------------~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~ 231 (631)
+||+|||++..... .......+++.|+|||.+.+ .++.++|||||||++|+|++|..||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999865441 11123356889999998754 3788999999999999999999999875
Q ss_pred CCHHHHHHHHHcC---CCCC-----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 232 KNPAQIYKKVTSG---IKPA-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 232 ~~~~~~~~~i~~~---~~p~-----------------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
..... ...+... ..+. ......+..+.+||.+||. +|.+||++.++|.||||
T Consensus 238 ~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 238 NEIDQ-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CHHHH-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 44333 2222210 0000 0012346789999999998 89999999999999999
Q ss_pred cCC
Q 006777 285 VTD 287 (631)
Q Consensus 285 ~~~ 287 (631)
+..
T Consensus 317 ~~~ 319 (335)
T PTZ00024 317 KSD 319 (335)
T ss_pred CCC
Confidence 864
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=321.27 Aligned_cols=252 Identities=30% Similarity=0.525 Sum_probs=212.9
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
..|.+.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||++++++|.+.. .++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 78 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--KLW 78 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--eEE
Confidence 46888999999999999999999999999999886543 2345567889999999999999999999987654 789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++ .+|.++|+|||++......
T Consensus 79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccc
Confidence 99999999999999875 46899999999999999999999998 99999999999997 7899999999998654332
Q ss_pred --CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 185 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 --~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
......++..|+|||.+.. .++.++|+|||||++|+|++|..||.. .+.......+..+. +..+....+..+.++
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKNN-PPTLEGNYSKPLKEF 232 (277)
T ss_pred hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcCC-CCCCCcccCHHHHHH
Confidence 1234568899999998754 578899999999999999999999976 34444444454432 334455678899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 262 IEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
|.+||. +|.+||++.++++||||...
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 233 VEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 999998 89999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=320.54 Aligned_cols=245 Identities=21% Similarity=0.301 Sum_probs=196.4
Q ss_pred CcEEEEEEE--eecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh-CCCCCcceeeeEEEcCCCc
Q 006777 25 YFWISWVVV--LNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 25 ~~Y~i~e~L--G~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~f~~~~~~ 101 (631)
+.|.+.+.+ |+|+||.||++.++.+|..+|+|.+....... . |+..... .+||||++++++|...+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~-----e~~~~~~~~~h~~iv~~~~~~~~~~-- 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I-----EPMVHQLMKDNPNFIKLYYSVTTLK-- 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h-----hHHHHHHhhcCCCEEEEEEEEecCC--
Confidence 355666665 99999999999999999999999987543211 1 2222221 27999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC-cEEEccccchhh
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-~vKI~DFGlA~~ 180 (631)
.+++||||+++|+|.+++...+.+++.+++.++.||+.||.|||+.+ ++||||||+||+++ .++ .++|+|||++..
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYD-RAKDRIYLCDYGLCKI 159 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEe-CCCCeEEEecCcccee
Confidence 79999999999999999998888999999999999999999999999 99999999999998 555 999999999865
Q ss_pred ccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCcHHH
Q 006777 181 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-TSGIKPASLSKVTDPQV 258 (631)
Q Consensus 181 ~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i-~~~~~p~~l~~~~~~~l 258 (631)
.... ....|++.|+|||++.+ .++.++||||||+++|+|++|..||............+ .....+....+..++.+
T Consensus 160 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 160 IGTP--SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred cCCC--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 5432 33568999999998864 58899999999999999999999997533221111111 11122334445688999
Q ss_pred HHHHHHhcC-CCCCCCC-HHHHhcCCCcc
Q 006777 259 KQFIEKCIV-PASLRLP-ALELLKDPFLV 285 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpt-a~elL~hpff~ 285 (631)
++||.+||+ +|.+||+ .+++|+||||.
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999998 8999997 59999999996
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=334.60 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=203.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
.++|++.++||+|+||.||+|.+. .+++.||+|+++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 468999999999999999999753 345789999887432 234556788999999999 89999999998765
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC-------------------------------------------------------
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH------------------------------------------------------- 122 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~------------------------------------------------------- 122 (631)
.. ..+++++||+++|+|.+++...
T Consensus 83 ~~-~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 PG-GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred CC-CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 43 4788999999999999998642
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC----CccccCC
Q 006777 123 ------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGT 192 (631)
Q Consensus 123 ------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GT 192 (631)
..+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++....... .....++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 25789999999999999999999998 99999999999998 68899999999997653221 2234557
Q ss_pred CCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CC
Q 006777 193 PEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PA 269 (631)
Q Consensus 193 p~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p 269 (631)
+.|+|||++. ..++.++|||||||++|+|++ |..||.+..........+..+..+ ..+...++.+.+++.+||+ +|
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCCh
Confidence 7899999764 568999999999999999998 999998644334444455444333 2344567899999999998 89
Q ss_pred CCCCCHHHHhcC
Q 006777 270 SLRLPALELLKD 281 (631)
Q Consensus 270 ~~Rpta~elL~h 281 (631)
.+||++.++++|
T Consensus 318 ~~RPs~~ell~~ 329 (337)
T cd05054 318 EDRPTFSELVEI 329 (337)
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.59 Aligned_cols=248 Identities=19% Similarity=0.298 Sum_probs=203.2
Q ss_pred EEEEEEEeecCCeEEEEEEEcCC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC---
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 100 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~---g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~--- 100 (631)
|.+++.||+|+||.||+|.+..+ +..||+|.++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 56789999999999999987654 47899999876532 34556789999999999999999999997765432
Q ss_pred -ceEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEc
Q 006777 101 -RTINMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~l~~~------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~ 173 (631)
...++|+||+++|+|..++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEEC
Confidence 3478999999999999998542 35899999999999999999999998 99999999999997 78899999
Q ss_pred cccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 006777 174 DLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 174 DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p 247 (631)
|||+++...... .....++..|+|||.+. ..++.++|||||||++|||++ |..||.+ ....+..+.+..+..+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRL 234 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC
Confidence 999997543321 11223467899999875 458899999999999999999 8899976 4455566666655433
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..+...++.+.++|.+||+ +|.+||++.+++++
T Consensus 235 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 -KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3445678899999999998 89999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=325.25 Aligned_cols=253 Identities=24% Similarity=0.396 Sum_probs=215.2
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCceEEEEEe
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~l~lV~E 108 (631)
.+.||+|+|+.|..+....+|.+||||+|.+. ......++++|++++.++ .|+||+.++++|.++. .+|+|||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLVfE 156 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLVFE 156 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEEEe
Confidence 46899999999999999999999999998754 245678899999999999 5999999999887665 7999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC--cEEEccccchhhcc--C-
Q 006777 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQ--Q- 183 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g--~vKI~DFGlA~~~~--~- 183 (631)
-+.||.|...+.+++.|+|.++.++.+.|+.||.|||.+| |.||||||+|||....+. -||||||.++.... .
T Consensus 157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 9999999999999999999999999999999999999999 999999999999963222 48999999874321 1
Q ss_pred ------CCCccccCCCCCCCccccc---c---ccCccceEeehhhHHHHHhhcCCCCCCCC--------------CHHHH
Q 006777 184 ------PTARSVIGTPEFMAPELYE---E---EYNELVDIYSFGMCILEMVTCEYPYNECK--------------NPAQI 237 (631)
Q Consensus 184 ------~~~~~~~GTp~y~APE~l~---~---~y~~~sDIwSLG~il~emltG~~Pf~~~~--------------~~~~~ 237 (631)
+...+.+|+.+|||||+.. + .|+.+.|.||||||+|-||.|.+||.+.= -...+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 1233568889999999753 2 48999999999999999999999996521 13567
Q ss_pred HHHHHcCCC--CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCC
Q 006777 238 YKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 238 ~~~i~~~~~--p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~ 290 (631)
+..|.+|.. |..-+..++.+++++|+.+|. ++..|.+|.++|+|||++...+.
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 788888854 444455678999999999998 99999999999999999876554
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=332.54 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=212.0
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 99 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~ 99 (631)
..+.++|++.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++++ +||||++++++|...+
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 456788999999999999999999999899999999885432 2234456678899999999 9999999999987666
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
...+++||||+. ++|..++... .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~ 155 (337)
T cd07852 81 DKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLAR 155 (337)
T ss_pred CceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchh
Confidence 667899999997 6999998776 7899999999999999999999998 99999999999998 78999999999996
Q ss_pred hccCC-------CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC------
Q 006777 180 VMQQP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG------ 244 (631)
Q Consensus 180 ~~~~~-------~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~------ 244 (631)
..... ......||+.|+|||.+.+ .++.++||||||+++|+|+||+.||.+........+.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 54322 2234578999999997643 47889999999999999999999997654443322211110
Q ss_pred ----------------------CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 245 ----------------------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ----------------------~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
..+....+..+.++.+||.+||+ +|.+|||+.+++.||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00111222357899999999998 89999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.88 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=205.5
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEE
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV 106 (631)
|.+.+.||.|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.+.....+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 678999999999999999999999999999998653 122344567889999999999999999999876634589999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC
Q 006777 107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~ 185 (631)
+||++ ++|..++... ..+++..++.++.||+.||+|||+++ ++|+||+|+||+++ .+|.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCC
Confidence 99997 5899888765 57999999999999999999999998 99999999999998 78999999999997654432
Q ss_pred ---CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC---CCC---------
Q 006777 186 ---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPA--------- 248 (631)
Q Consensus 186 ---~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~---~p~--------- 248 (631)
.....+++.|+|||.+.+ .++.++||||||+++|+|+||+.||...... .....+.... .+.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccch
Confidence 233467889999997653 4789999999999999999999999875433 3333222110 000
Q ss_pred -----------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 249 -----------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 249 -----------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
.+....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0111237889999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=312.65 Aligned_cols=241 Identities=22% Similarity=0.370 Sum_probs=205.9
Q ss_pred EEEeecCCeEEEEEEEcCC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEE
Q 006777 31 VVVLNCTFMCRYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~---g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
++||+|+||.||+|.+... +..||+|.+..... ....+.+.+|+.+++.++||||+++++++.+ ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence 4689999999999999866 89999999876532 2256788999999999999999999998866 45799999
Q ss_pred eccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 108 ELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~---------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~-~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVG-EDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEEC-CCCcEEEcccccc
Confidence 999999999999885 67999999999999999999999998 99999999999998 7899999999999
Q ss_pred hhccCC----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 179 IVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 179 ~~~~~~----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
...... ......+++.|+|||.+.. .++.++||||||+++|+|++ |..||... ...++...+..+... ..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 230 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PKPE 230 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCc
Confidence 765442 2344567899999998764 68999999999999999999 59999874 566677777665433 3344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..++++.++|.+||. +|.+||++.+++++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 568999999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=314.75 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=206.3
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|.+.+.||+|+||.||+|.+..++..||+|.+... ......+.+|+.+++.++||||+++++++.... .+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 77 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PF 77 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCC--Cc
Confidence 34689999999999999999999999999999987643 233566889999999999999999999876543 68
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~ 154 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLM 154 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCcccccc
Confidence 9999999999999998764 35899999999999999999999998 99999999999997 7899999999999765
Q ss_pred cCCCCc---cccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 182 QQPTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~~~~---~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
...... ...+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+ .+.......+..+..+ ..+...++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (263)
T cd05052 155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPP 232 (263)
T ss_pred ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCH
Confidence 433211 223456899999875 458899999999999999998 8999976 5666666777665443 34556789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
++.++|.+||. +|.+||++.++++
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.39 Aligned_cols=262 Identities=21% Similarity=0.323 Sum_probs=212.9
Q ss_pred cEEEEEEEeecCCeEEEEEEEc---CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 26 FWISWVVVLNCTFMCRYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~---~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
.|.+.+.||+|+||.||+|.+. .++..||+|.++...........+++.+|+.++.++ +||||+++++.|... .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--T 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--C
Confidence 4889999999999999999864 467899999987654333334456788999999999 699999999987554 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+++||||+.+|+|.+++.+...+++..++.++.|++.||.|||+.+ ++||||+|+||+++ .++.++|+|||++...
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLD-SEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEEECcccccc
Confidence 78999999999999999988788999999999999999999999998 99999999999997 6889999999998654
Q ss_pred cCCC---CccccCCCCCCCccccccc---cCccceEeehhhHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCC
Q 006777 182 QQPT---ARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 182 ~~~~---~~~~~GTp~y~APE~l~~~---y~~~sDIwSLG~il~emltG~~Pf~~~~~---~~~~~~~i~~~~~p~~l~~ 252 (631)
.... .....|++.|+|||.+.+. ++.++||||||+++|+|++|..||..... ...+.+.+..... ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 233 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPK 233 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCc
Confidence 3321 2235689999999987542 67899999999999999999999964221 2233333333322 2344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCC---HHHHhcCCCccCCCCCcccc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLP---ALELLKDPFLVTDNPKDLVC 294 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpt---a~elL~hpff~~~~~~~~~~ 294 (631)
..++.++++|.+||+ +|.+||| +.++|+||||+...|..+..
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~ 279 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAA 279 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhh
Confidence 567899999999998 8999998 56889999999887765543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=323.86 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=212.3
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
....|...+.||+|+||+||+|.+..+|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 95 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--T 95 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--E
Confidence 34557888999999999999999999999999999876543 23345567889999999999999999999987654 7
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.|+||||+. |+|.+++.. ...+++.++..++.||+.||.|||++| ++||||+|+||+++ .++.+||+|||++...
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKS 171 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEeecCCCccc
Confidence 899999996 577777655 456899999999999999999999999 99999999999997 7899999999998543
Q ss_pred cCCCCccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 182 QQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
. ......|++.|+|||++. +.++.++|||||||++|+|++|..||.......... .+.....+......++..
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 248 (313)
T cd06633 172 S--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQSNEWTDS 248 (313)
T ss_pred C--CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCccccCHH
Confidence 2 234567899999999873 457889999999999999999999998754434443 333333344344456778
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
+++||.+||+ +|.+||++.+++.||||.....
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 9999999998 8999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=328.96 Aligned_cols=261 Identities=28% Similarity=0.365 Sum_probs=211.6
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
.-.+.++|.+.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+|+.++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 3346789999999999999999999999999999999986432 23344567889999999999999999999886543
Q ss_pred C----ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 100 N----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 100 ~----~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
. ..+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~df 162 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDF 162 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeec
Confidence 2 2568999999 7899988864 56999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-------
Q 006777 176 GLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------- 246 (631)
Q Consensus 176 GlA~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~------- 246 (631)
|++...... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+..........+.....
T Consensus 163 g~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 163 GLARQTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccccccccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 998755432 234567999999998754 4788999999999999999999999875443332221111000
Q ss_pred ------------------C---CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 247 ------------------P---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 247 ------------------p---~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+ ..+....++.+.++|.+||. +|.+|||+.+++.||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 01123457789999999998 999999999999999998643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=320.04 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=204.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEE-----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d-----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
.++.|.+.+.||+|+||.||++.+ ..++..||+|.+... .......+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 356899999999999999999986 345677999987643 23456678999999999999999999998865
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHK-------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~-------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 164 (631)
. ..+++||||+++++|.+++..++ .+++..++.++.||+.||+|||+++ ++||||||+||+++
T Consensus 79 ~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~ 154 (288)
T cd05093 79 G--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG 154 (288)
T ss_pred C--CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence 4 47899999999999999997654 4899999999999999999999999 99999999999997
Q ss_pred CCCCcEEEccccchhhccCCC----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHH
Q 006777 165 GNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 238 (631)
Q Consensus 165 ~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~ 238 (631)
.++.+||+|||++....... .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||... +.....
T Consensus 155 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~ 232 (288)
T cd05093 155 -ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVI 232 (288)
T ss_pred -cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHH
Confidence 78999999999987543221 223345778999998764 58899999999999999998 89999764 455566
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+..+..+ ..+...++.+++||.+||+ +|.+|||+.+++.
T Consensus 233 ~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 233 ECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 666665433 2344567899999999998 8999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.73 Aligned_cols=240 Identities=21% Similarity=0.354 Sum_probs=197.0
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEecc
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~ 110 (631)
+.||+|+||.||+|.+..+|..||+|.+... ........+.+|+.+++.++||||+++++++... ..+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeec
Confidence 4689999999999999999999999987633 2345567789999999999999999999988654 3689999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCCc--
Q 006777 111 TSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-- 187 (631)
Q Consensus 111 ~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~-- 187 (631)
.+++|.+++.+. ..+++..++.++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||++.........
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCccccccccccc
Confidence 999999998764 46899999999999999999999999 99999999999997 7889999999998654322111
Q ss_pred --cccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006777 188 --SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 188 --~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~ 263 (631)
...++..|+|||.+. +.++.++||||||+++|+|++ |..||... ........+..... ...+...+..+.+||.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 230 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVR-LPCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCC-CCCcccCCHHHHHHHH
Confidence 112245799999875 458899999999999999998 88888753 44444444544333 2345566889999999
Q ss_pred HhcC-CCCCCCCHHHHhc
Q 006777 264 KCIV-PASLRLPALELLK 280 (631)
Q Consensus 264 kcL~-~p~~Rpta~elL~ 280 (631)
+||+ +|.+||++.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.09 Aligned_cols=248 Identities=20% Similarity=0.295 Sum_probs=202.2
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCe--EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC----C
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT----N 100 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~--~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~----~ 100 (631)
|.+.++||+|+||.||+|.+..++. .||+|.++... ......+.+.+|+.+++.++||||+++++++.... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 3567899999999999999877765 69999887543 23456778899999999999999999998765322 2
Q ss_pred ceEEEEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 101 RTINMITELFTSGSLRQYRKK------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~------~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
...++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECC
Confidence 357899999999999998742 234899999999999999999999998 99999999999997 789999999
Q ss_pred ccchhhccCCC----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 006777 175 LGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 175 FGlA~~~~~~~----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~ 248 (631)
||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++ |+.||.+ .....+...+..+..+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK 234 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC
Confidence 99997654321 123346778999998754 58999999999999999999 8899976 45566677776654432
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 249 ~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+...+..++++|.+||+ +|.+|||+.+++++
T Consensus 235 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 -QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 233567889999999998 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.87 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=201.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
..++|++.+.||+|+||.||+|.+. ..+..||+|.+.... ......++.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4568999999999999999999864 345789999875432 23455678899999999999999999998754
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCC
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHK----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~----------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
. ..+++||||+++|+|.+++.+.+ .++...+..++.|++.||.|||+++ ++||||||+||+++ .+
T Consensus 81 ~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~-~~ 155 (277)
T cd05062 81 G--QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-ED 155 (277)
T ss_pred C--CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc-CC
Confidence 4 46899999999999999987532 2577889999999999999999998 99999999999998 78
Q ss_pred CcEEEccccchhhccCCC----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006777 168 GEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 168 g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i 241 (631)
+.+||+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+ .+.....+.+
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~ 234 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFV 234 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 999999999986443221 112345778999998764 58999999999999999999 7889876 4455555555
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..+.. ...+...++.++++|.+||+ +|.+||++.|++++
T Consensus 235 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54432 23345567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.45 Aligned_cols=243 Identities=27% Similarity=0.463 Sum_probs=199.3
Q ss_pred EEEEEEeecCCeEEEEEEEc----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 28 ISWVVVLNCTFMCRYKGFDE----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 ~i~e~LG~G~fg~VY~A~d~----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.+.||.|+||.||+|... ..+..|+||.++.. ......+.+.+|++.+++++||||+++++++.... .+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeecccccccccccccccccccccccc--cc
Confidence 46899999999999999987 45789999998542 24556788999999999999999999999988433 58
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++|+||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ ++||+|+|+|||++ .++.+||+|||++...
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLD-SNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEE-TTTEEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-cccccccccccccccc
Confidence 9999999999999999987 67999999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCCC----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 182 QQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 182 ~~~~----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
.... .....+...|+|||.+.. .++.++||||||+++|||++ |+.||.+. +...+...+..+..+. .+...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 231 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCP 231 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccchh
Confidence 2211 223456778999998864 58999999999999999999 78999875 6777777776664433 445578
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+.++|..||. +|.+||++.++++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 899999999998 8999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=315.26 Aligned_cols=247 Identities=22% Similarity=0.354 Sum_probs=204.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~-----g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
.++|.+.+.||+|+||.||+|.++.. +..||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 46899999999999999999988643 4889999976432 234456788999999999999999999988655
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHK----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~----------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
..+++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+|||++ .+|
T Consensus 82 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~-~~~ 156 (277)
T cd05032 82 --QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA-EDL 156 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc-CCC
Confidence 46899999999999999987532 3678899999999999999999998 99999999999998 789
Q ss_pred cEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006777 169 EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 169 ~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~ 242 (631)
.+||+|||+++...... .....++..|+|||.+. +.++.++|||||||++|+|+| |..||.+ .+.....+.+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~ 235 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVI 235 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHh
Confidence 99999999987543321 22345678999999775 468899999999999999998 9999976 45666666666
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+..+ ..+...+..+.++|.+||+ +|.+|||+.+++.
T Consensus 236 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 DGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 54332 3344568899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=317.92 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=204.1
Q ss_pred CcEEEEEEEeecCCeEEEEEEE----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 25 YFWISWVVVLNCTFMCRYKGFD----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
+.|++.+.||+|+||+||+|.+ ..++..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ- 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-
Confidence 5689999999999999999985 3456789999987432 3445577889999999999999999999876554
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEE
Q 006777 101 RTINMITELFTSGSLRQYRKKH-----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 163 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 163 (631)
..++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||++
T Consensus 81 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili 157 (283)
T cd05090 81 -PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI 157 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE
Confidence 689999999999999998532 23788899999999999999999999 9999999999999
Q ss_pred eCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHH
Q 006777 164 NGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237 (631)
Q Consensus 164 ~~~~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~ 237 (631)
+ .++.+||+|||++...... ......++..|+|||.+. +.++.++|||||||++|+|++ |..||.+ .....+
T Consensus 158 ~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~ 235 (283)
T cd05090 158 G-EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEV 235 (283)
T ss_pred c-CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 8 7889999999999754322 123345677899999875 458999999999999999998 9999976 345566
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 238 ~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
...+.....+ ..+...++.++++|.+||+ +|.+||++.+++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6666655433 3455678999999999998 89999999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=314.09 Aligned_cols=258 Identities=20% Similarity=0.231 Sum_probs=208.6
Q ss_pred CccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006777 17 EPISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~ 96 (631)
.........+|+|.+.||.|||+.||++....++..+|+|.|.+.. .+..+...+|+++.++++||||++++++.+
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 4455566889999999999999999999999999999999998764 467788999999999999999999988765
Q ss_pred cC---CCceEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc
Q 006777 97 DD---TNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 97 ~~---~~~~l~lV~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
.+ .....|+++.|...|+|.+.+... ..++|.++..|+.+|+.||++||...||++||||||.||++. ..+.
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-~~~~ 167 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-DSGL 167 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec-CCCc
Confidence 43 234799999999999999998753 259999999999999999999999999999999999999997 6899
Q ss_pred EEEccccchhhccCC-----C------CccccCCCCCCCcccccc----ccCccceEeehhhHHHHHhhcCCCCCCCCCH
Q 006777 170 VKIGDLGLAIVMQQP-----T------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNP 234 (631)
Q Consensus 170 vKI~DFGlA~~~~~~-----~------~~~~~GTp~y~APE~l~~----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~ 234 (631)
++|.|||.++...-. . .....+|..|+|||++.- ..++++|||||||++|.|+.|..||......
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 999999998644211 0 012346999999999863 3689999999999999999999999641000
Q ss_pred -HHHHHHHHcC--CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 235 -AQIYKKVTSG--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 235 -~~~~~~i~~~--~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..+.-.+..+ ..|.. ..++..+.+||+.||+ +|.+||++.+|+.+
T Consensus 248 GgSlaLAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLALAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEEEeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0000001111 11222 2378899999999998 99999999999874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.99 Aligned_cols=261 Identities=29% Similarity=0.419 Sum_probs=212.0
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
....+.++|.+.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 34456789999999999999999999999999999999886532 2234456788899999999999999999877544
Q ss_pred CC----ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 99 TN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 99 ~~----~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
.. ..+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+||+++ .+|.+||+|
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~d 161 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILD 161 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEcc
Confidence 32 3589999999 6799999876 56999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CC---
Q 006777 175 LGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA--- 248 (631)
Q Consensus 175 FGlA~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-p~--- 248 (631)
||++...... .....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+... ...+..+..... +.
T Consensus 162 fg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 162 FGLARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHH
Confidence 9999765433 345578999999998754 578899999999999999999999986443 333333322110 00
Q ss_pred -------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 249 -------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 249 -------------------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
......++.+.+||.+||. +|.+|||+.++|.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0112347889999999998 899999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=339.20 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=213.2
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
.++||.|-||+||-|+++.+|+.||||+|.+..+. .++...+..|+.||+.++||.||.+.-.|... .++++|||-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp--~kqesqlR~EVaILq~l~HPGiV~le~M~ET~--ervFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP--TKQESQLRNEVAILQNLHHPGIVNLECMFETP--ERVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCC--CchHHHHHHHHHHHHhcCCCCeeEEEEeecCC--ceEEEEehh
Confidence 47999999999999999999999999999877653 34447788999999999999999999877554 479999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCC--CcEEEccccchhhccCC-C
Q 006777 110 FTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQP-T 185 (631)
Q Consensus 110 ~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~--g~vKI~DFGlA~~~~~~-~ 185 (631)
+.|.-|.-++.. .+++++...+.++.||+.||.|||-+| |+|+||||+|||+.... -++||||||+|+..... .
T Consensus 645 l~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 645 LHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 975445555543 578999999999999999999999999 99999999999997433 37999999999987655 4
Q ss_pred CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006777 186 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 186 ~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~k 264 (631)
.++++|||.|+|||++. .+|+..-|+||.|+|+|.-+.|..||.+..+....++... -..|...++.+++++.+||..
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-FMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-FMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-cccCCCchhhcCHHHHHHHHH
Confidence 67899999999999886 5699999999999999999999999987655444333222 234666667788999999999
Q ss_pred hcC-CCCCCCCHHHHhcCCCccCC
Q 006777 265 CIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 265 cL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+|+ +-.+|.+.+..|.|||++..
T Consensus 802 LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHhcchHhhccchhhhcc
Confidence 998 89999999999999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=312.61 Aligned_cols=244 Identities=23% Similarity=0.362 Sum_probs=202.0
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.|++.++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 76 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPI 76 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCc
Confidence 468999999999999999999974 56789999876432 2356788999999999999999999987554 368
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVI 153 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCccceec
Confidence 9999999999999998763 56899999999999999999999998 99999999999998 7899999999999765
Q ss_pred cCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 182 QQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
.... .....++..|+|||.+. +.++.++|||||||++|+|+| |..||.. .........+..+...+ .....+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRMP-RMENCPD 231 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCH
Confidence 4322 12234567899999875 458889999999999999998 9999976 44555555665554333 2335678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
++.++|.+||. +|.+||+++++++
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999998 8999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.52 Aligned_cols=249 Identities=20% Similarity=0.316 Sum_probs=203.3
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcC-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~-----~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4679999999999999999999987 78899999876432 234456688999999999999999999987655
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC--CCc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGE 169 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~-------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~g~ 169 (631)
. ..++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++.. ...
T Consensus 82 ~--~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 82 L--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred C--CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcc
Confidence 4 5789999999999999997653 4899999999999999999999999 9999999999999732 236
Q ss_pred EEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHc
Q 006777 170 VKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 243 (631)
Q Consensus 170 vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~ 243 (631)
+||+|||++....... ......++.|+|||++. ..++.++|||||||++|+|++ |..||.+. +.......+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~~~~ 236 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFVTG 236 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHc
Confidence 9999999997553221 11223356899999875 468999999999999999997 99999864 44455555554
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 244 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 244 ~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
...+ ..+...++.+.+||.+||+ +|.+||++.++|+|
T Consensus 237 ~~~~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 GGRL-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4332 3345567899999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=314.02 Aligned_cols=253 Identities=21% Similarity=0.385 Sum_probs=214.0
Q ss_pred EEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCceEEEE
Q 006777 28 ISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 ~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~~l~lV 106 (631)
+++..||.|+.|.|+++..+.+|...|||++.... +..+..++++.+.++...+ .|+||+.|++|+.+. .+++.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV~Ic 169 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DVFIC 169 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hHHHH
Confidence 34678999999999999999999999999998653 5678899999998877664 999999999998776 47778
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC
Q 006777 107 TELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~ 185 (631)
||.|. .-+..++++ .++++|..+-.+..-++.||.||-.+. +|||||+||+|||++ ..|.|||||||++..+-...
T Consensus 170 MelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-cCCCEEeecccccceeeccc
Confidence 89984 445555554 467999999999999999999997764 499999999999998 89999999999997665554
Q ss_pred Cc-cccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCcHHHH
Q 006777 186 AR-SVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-KVTDPQVK 259 (631)
Q Consensus 186 ~~-~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~-~~~~~~lk 259 (631)
+. .-.|.+.|||||.+. ..|+.++||||||++++||+||++||.+++...+...+|....+|.-.. ...++.++
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence 43 457999999999875 3599999999999999999999999999988888888887754433222 23799999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+|+..||. |+.+||...+||+|||+....
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 99999998 899999999999999997643
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=332.22 Aligned_cols=271 Identities=20% Similarity=0.321 Sum_probs=233.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCce
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~ 102 (631)
...|.++.+||+|+||.|.+|..+.+.+.+|||+++.+-+.++ +..+--..|-++|... +-|.++.++..|...+ +
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTmD--R 424 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD--R 424 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhhh--h
Confidence 4568889999999999999999999999999999887655443 3334444566677665 5778999999887655 7
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh--
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV-- 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~-- 180 (631)
+|+||||+.||+|-..+++.+++.|..+..++..|+-||-|||++| ||+||||.+|||++ ..|+|||+|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEec-cCCceEeeecccccccc
Confidence 9999999999999999999999999999999999999999999999 99999999999998 789999999999963
Q ss_pred ccCCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 181 MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 181 ~~~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
....+.+++||||.|+|||++. .+|+.++|+||+|+++|||+.|++||.+ .+..++++.|... ...+++..+.++.
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~eh--nvsyPKslSkEAv 578 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEH--NVSYPKSLSKEAV 578 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHc--cCcCcccccHHHH
Confidence 4455678999999999999775 6799999999999999999999999987 6788888888764 4457778889999
Q ss_pred HHHHHhcC-CCCCCCCH-----HHHhcCCCccCCCCCccccCCCCCCCCc
Q 006777 260 QFIEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLRLPNLV 303 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta-----~elL~hpff~~~~~~~~~~~~l~~p~~~ 303 (631)
.++...|. .|.+|..+ .++-.||||+...|..+...+++.|..+
T Consensus 579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkP 628 (683)
T KOG0696|consen 579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKP 628 (683)
T ss_pred HHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCC
Confidence 99999997 79999864 5899999999999988766666665543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.33 Aligned_cols=244 Identities=31% Similarity=0.463 Sum_probs=211.2
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
....+.+.||+|.||+||+|++-. .||||+++.+.. .++.++.|++|+.++++-+|.||+-|.+++..+. +.
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~A 463 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LA 463 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---ee
Confidence 456678999999999999998743 399999998764 5678999999999999999999999999886543 58
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc-
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ- 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~- 182 (631)
+|+-+|+|.+|..++... ..|+..+.+.|++||+.|+.|||.++ |||||||..|||+. +++.|||+|||++..-.
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEecccceeeeee
Confidence 999999999999998754 46999999999999999999999999 99999999999997 67999999999996432
Q ss_pred ---CCCCccccCCCCCCCcccccc----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCC
Q 006777 183 ---QPTARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSK 252 (631)
Q Consensus 183 ---~~~~~~~~GTp~y~APE~l~~----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~---~~p~~l~~ 252 (631)
........|...|||||++.. +|++.+|||||||++|||+||..||. ..+.++++-.+..| ..+.....
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhc
Confidence 223345568889999998853 59999999999999999999999999 68899998888888 34444555
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+.++++|+..|+. ++.+||...+||.
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 677899999999998 8999999999886
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=312.74 Aligned_cols=239 Identities=21% Similarity=0.330 Sum_probs=199.8
Q ss_pred EEeecCCeEEEEEEE--cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 32 VVLNCTFMCRYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d--~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
.||+|+||.||+|.+ +.++..||+|+++... ......+.+.+|+.+++.++||||+++++++.. ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEec
Confidence 589999999999964 5678999999887543 234556788999999999999999999997643 257899999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCC---
Q 006777 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 186 (631)
Q Consensus 110 ~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~--- 186 (631)
+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCCeee
Confidence 999999999988888999999999999999999999999 99999999999998 788999999999975543221
Q ss_pred --ccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006777 187 --RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 187 --~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI 262 (631)
....+++.|+|||.+.. .++.++|||||||++|||++ |..||.. .+...+...+..+..+ ..+...+++++++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 12234578999998754 58889999999999999998 9999976 4556667777766443 34556789999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006777 263 EKCIV-PASLRLPALELLK 280 (631)
Q Consensus 263 ~kcL~-~p~~Rpta~elL~ 280 (631)
.+|++ +|.+||++.++..
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99998 8999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=310.87 Aligned_cols=243 Identities=21% Similarity=0.368 Sum_probs=200.9
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+.|.+.+.||+|+||.||+|..+ .+..||+|.+..... ....+.+|+.+|+.++||||+++++++... ..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLY 75 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEE
Confidence 46889999999999999999875 466899998764332 234678899999999999999999987554 4689
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+++|+|.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCC
Confidence 999999999999998754 46899999999999999999999999 99999999999998 788999999999875432
Q ss_pred CCC---ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 184 PTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~~~---~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
... ....++..|+|||.+. ..++.++||||||+++|+|++ |+.||.. .+..+....+..+..+ ..+...+..+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~ 230 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRL-YRPKLASMTV 230 (256)
T ss_pred CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHH
Confidence 221 1223456899999876 458899999999999999999 8999976 4555666666665433 2344567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 006777 259 KQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.++|.+||. +|.+||++.++++
T Consensus 231 ~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 231 YEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 999999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.03 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=199.5
Q ss_pred EEEeec--CCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEe
Q 006777 31 VVVLNC--TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 31 e~LG~G--~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~E 108 (631)
..||+| +|++||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|.... .+++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEEEEe
Confidence 456666 999999999999999999999876532 3355678899999999999999999999987654 6899999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC--
Q 006777 109 LFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 109 y~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~-- 184 (631)
|+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++ ++||||||+||+++ .++.+|++||+.+......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCc
Confidence 99999999998875 35899999999999999999999998 99999999999998 7889999999865332111
Q ss_pred CC-------ccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-C------
Q 006777 185 TA-------RSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P------ 247 (631)
Q Consensus 185 ~~-------~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-p------ 247 (631)
.. ....++..|+|||++.+ .++.++|||||||++|+|++|..||............+..... |
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence 00 11234667999998864 3789999999999999999999999875544443333221100 0
Q ss_pred -------------------------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 248 -------------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 -------------------------------------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.......++.+++||.+||. +|.+|||+.++|+||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00112245789999999998 99999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=315.96 Aligned_cols=246 Identities=23% Similarity=0.367 Sum_probs=203.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~----~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...|++.++||+|+||+||+|.+..+|. .||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 4689999999999999999999877776 48999886542 345567788999999999999999999988643
Q ss_pred CceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..++++||+++|+|.+++..+ +.+++..+..++.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++
T Consensus 82 --~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~ 156 (279)
T cd05109 82 --TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGLA 156 (279)
T ss_pred --CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCce
Confidence 467899999999999999774 56999999999999999999999999 99999999999997 7889999999999
Q ss_pred hhccCCCC----ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 179 IVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 179 ~~~~~~~~----~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
........ ....+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .....+...+..+..+. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 234 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QPP 234 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCc
Confidence 76543221 1223467899999775 468999999999999999998 8999975 34555555555554332 344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..++.+.++|.+||. +|..||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 235 ICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 567899999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=322.66 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=214.7
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
.......|...+.||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+++.++||||+++++++.+..
T Consensus 20 ~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (317)
T cd06635 20 KEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH 98 (317)
T ss_pred CCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 34455668999999999999999999999999999999876533 23455567889999999999999999999887654
Q ss_pred CceEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..++||||+. |+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.+||+|||++
T Consensus 99 --~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~dfg~~ 172 (317)
T cd06635 99 --TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSA 172 (317)
T ss_pred --eEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecCCCc
Confidence 6889999997 577777654 456899999999999999999999999 99999999999997 7899999999998
Q ss_pred hhccCCCCccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006777 179 IVMQQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 179 ~~~~~~~~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~ 254 (631)
..... .....|++.|+|||.+. +.++.++|||||||++|+|++|..||........ ...+..+..+.......
T Consensus 173 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 249 (317)
T cd06635 173 SIASP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPTLQSNEW 249 (317)
T ss_pred cccCC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhccCCCCCCccc
Confidence 64432 23457899999999863 4588899999999999999999999987443333 33444433333334456
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~ 290 (631)
++.+++||.+||+ +|.+||++.+++.|||+....+.
T Consensus 250 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred cHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 7899999999998 89999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.18 Aligned_cols=255 Identities=28% Similarity=0.387 Sum_probs=210.9
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC---Cce
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---NRT 102 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~---~~~ 102 (631)
+|.+.+.||.|+||.||+|.+..+|..||+|.+.... ......+.+.+|+.+++.++||||+++++++.+.. ...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 5899999999999999999999899999999987542 12345577899999999999999999999886653 236
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+|+||||+. ++|.+++.+...+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~-~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVN-SNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccCceEeec
Confidence 899999997 589999988888999999999999999999999999 99999999999998 67999999999997654
Q ss_pred CCC-----CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CC------
Q 006777 183 QPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA------ 248 (631)
Q Consensus 183 ~~~-----~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-p~------ 248 (631)
... .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||.+.. ....+..+..... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhhh
Confidence 432 334578999999998754 57899999999999999999999998743 3333333332110 00
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 249 ----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 ----------------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
......++.+.+||.+||. +|.+||++.++|.||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0112246789999999998 89999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.68 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=205.7
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC-
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT- 99 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~- 99 (631)
....+.|.+.+.||+|+||.||+|.++.+|+.||+|+++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 34567899999999999999999999999999999998765321 222345678999999999999999999886543
Q ss_pred -------CceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEE
Q 006777 100 -------NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 100 -------~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
...+++|+||+++ +|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~k 156 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIK 156 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEE
Confidence 3478999999985 777776654 46999999999999999999999999 99999999999997 789999
Q ss_pred EccccchhhccCCC---CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc---
Q 006777 172 IGDLGLAIVMQQPT---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--- 243 (631)
Q Consensus 172 I~DFGlA~~~~~~~---~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--- 243 (631)
|+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++|..||...... .....+..
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhC
Confidence 99999997554322 122356888999998753 4788999999999999999999999764333 22222222
Q ss_pred CCCCCC-------------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 244 GIKPAS-------------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 244 ~~~p~~-------------------------l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
...+.. .....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 111110 112357899999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.30 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=200.0
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeE--EEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~--VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
+.|.+.+.||+|+||.||+|.+..+|.. +|+|.++.. ........+.+|+.++.++ +||||+++++++.+. .
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--C
Confidence 4789999999999999999999877765 466665422 2345567788999999999 899999999987654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC
Q 006777 102 TINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
.+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||+++ ++||||||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~- 158 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG- 158 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-
Confidence 6899999999999999997543 4789999999999999999999999 99999999999997
Q ss_pred CCCcEEEccccchhhccCCC-CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006777 166 NNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 166 ~~g~vKI~DFGlA~~~~~~~-~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~ 242 (631)
.++.+||+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|+| |..||.. .+..+..+.+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~ 237 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLP 237 (303)
T ss_pred CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHh
Confidence 78899999999985332111 111234667999998754 47899999999999999998 9999976 44555666665
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+..+. .+...++.+.+||.+||+ +|..||++.++|.+
T Consensus 238 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 543222 233467899999999998 89999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=315.96 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=207.2
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceee
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 92 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~-----g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~ 92 (631)
......++|.+.+.||+|+||.||+|.+... ...||+|.+.... ......++.+|+.+++.+ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 3344567899999999999999999988643 3789999887532 234556788999999999 899999999
Q ss_pred eEEEcCCCceEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC
Q 006777 93 NSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156 (631)
Q Consensus 93 ~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 156 (631)
+++... ..+++||||+++|+|..++... +.+++..+..++.||+.||.|||+++ |+||||
T Consensus 83 ~~~~~~--~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dl 158 (293)
T cd05053 83 GVCTQE--GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDL 158 (293)
T ss_pred EEEcCC--CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--cccccc
Confidence 987654 4689999999999999998642 45889999999999999999999998 999999
Q ss_pred CCCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCC
Q 006777 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNE 230 (631)
Q Consensus 157 Kp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~ 230 (631)
||+|||++ .++.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||..
T Consensus 159 kp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 159 AARNVLVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred ceeeEEEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 99999997 78999999999997654321 11223456899999765 458999999999999999997 9999976
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 231 ~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+..+..+.+..+..+. .+...+..+.+||.+||. +|.+|||+.+++.+
T Consensus 238 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 238 -IPVEELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred -CCHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 45556666666654433 334567899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=328.05 Aligned_cols=258 Identities=28% Similarity=0.380 Sum_probs=207.1
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC-
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT- 99 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~- 99 (631)
....++|.+.+.||+|+||.||+|.+..+|..||+|++.... ......+.+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 345689999999999999999999999999999999887532 22334567889999999999999999999876432
Q ss_pred ---CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 100 ---NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 100 ---~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
...++++++++ +++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg 165 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFG 165 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEeccc
Confidence 23578888887 7899888765 46999999999999999999999999 99999999999997 78999999999
Q ss_pred chhhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC----------
Q 006777 177 LAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---------- 244 (631)
Q Consensus 177 lA~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~---------- 244 (631)
++..... ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||....... ....+...
T Consensus 166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 166 LARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLK 243 (345)
T ss_pred ccccccc-cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHh
Confidence 9875433 2334578999999998754 47889999999999999999999997633322 22221110
Q ss_pred ----------------CCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 245 ----------------IKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ----------------~~p~---~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.... ......++.+++||.+||. +|.+||++.++|.||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 0000 0111357889999999998 89999999999999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=322.17 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=210.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
....|...+.||+|+||.||+|.++.++..||+|.+..... .......++.+|+.+++.++||||+++++++.... .
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~ 89 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--T 89 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--e
Confidence 34568888999999999999999999999999999875432 22345567889999999999999999999887653 6
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.++||||+. |+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||+|+||+++ .+|.+||+|||++...
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIM 165 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECCcccceee
Confidence 889999997 688777654 456899999999999999999999998 99999999999997 6899999999998654
Q ss_pred cCCCCccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 182 QQPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
.. .....|++.|+|||.+. +.++.++|||||||++|+|++|..||......... ..+..+..+.......+..
T Consensus 166 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 242 (308)
T cd06634 166 AP--ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESPALQSGHWSEY 242 (308)
T ss_pred cC--cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-HHHhhcCCCCcCcccccHH
Confidence 33 23457899999999863 35788999999999999999999999764333333 3344444444444567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+++||.+||. +|.+||++.+++.|||+...
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999998 89999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=319.47 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=206.9
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEE-----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeee
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 93 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d-----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~ 93 (631)
.....++|.+.+.||+|+||.||+|.+ ..++..||+|.++... .....+.+.+|+.+++++ +||||+++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 344567899999999999999999975 3456689999876542 234557789999999999 7999999999
Q ss_pred EEEcCCCceEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEE
Q 006777 94 SWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 94 ~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
++.... .+++||||+.+|+|.+++.... .+++.++..++.||+.||.|||+++ ++||||||+||+++ .++.+|
T Consensus 107 ~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~ 181 (302)
T cd05055 107 ACTIGG--PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVK 181 (302)
T ss_pred EEecCC--ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEE
Confidence 886544 6899999999999999997643 3899999999999999999999999 99999999999997 788999
Q ss_pred EccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC
Q 006777 172 IGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 172 I~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~ 245 (631)
|+|||++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||..........+.+..+.
T Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~ 261 (302)
T cd05055 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY 261 (302)
T ss_pred ECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC
Confidence 99999997543321 12234578899999765 458999999999999999998 9999987555555555555553
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 246 ~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+ ..+...++.+++||.+||. +|.+||++.++++
T Consensus 262 ~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 262 RM-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred cC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 33 2344567899999999998 8999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=311.33 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=203.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~---g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.+|++.+.||+|+||+||+|.++.. ...||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--R 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--C
Confidence 5799999999999999999998654 4589999876432 344556788999999999999999999987654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+++||||+++|+|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++..
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~ 155 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRR 155 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhc
Confidence 689999999999999998764 46899999999999999999999998 99999999999998 788999999999976
Q ss_pred ccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006777 181 MQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 181 ~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~ 254 (631)
..... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ........+..+..+. .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~ 233 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKAVEDGYRLP-PPMDC 233 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCC
Confidence 64211 11223467899999876 458899999999999999998 99999764 4445556665543322 23456
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
++.+.+|+.+||. +|.+||++.+++++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=315.69 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=197.5
Q ss_pred cEEEEEEEeecCCeEEEEEE----EcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 26 FWISWVVVLNCTFMCRYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~----d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.|.+.+.||+|+||+||++. ...++..||+|.+.... .......+.+|+++|+.++||||+++++++......
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 34999999999999998764 34578899999987542 233456788999999999999999999988766666
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+++||||+.+|+|.+++... .+++..++.++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAV 157 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeeccccccc
Confidence 799999999999999999765 4999999999999999999999999 99999999999997 7889999999999755
Q ss_pred cCCC-----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHH--------------HHHHHH
Q 006777 182 QQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------------QIYKKV 241 (631)
Q Consensus 182 ~~~~-----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~--------------~~~~~i 241 (631)
.... .....++..|+|||.+. ..++.++||||||+++|+|+||..||....... .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 4321 12234566799999875 458999999999999999999999986432111 011111
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+.. ...+...+.++++++.+||. +|+.|||+.+++.
T Consensus 238 ~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111 11234567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=319.24 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=201.4
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCe--EEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~--~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
++|++.++||+|+||.||+|.++.+|. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--G 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--C
Confidence 579999999999999999999887775 4688876632 1234456788999999999 799999999987654 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC
Q 006777 102 TINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
.+++|+||+++|+|.+++.+.+ .+++..++.++.||+.||+|||+++ ++||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~- 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG- 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-
Confidence 6899999999999999997643 4888999999999999999999998 99999999999997
Q ss_pred CCCcEEEccccchhhccCCCCcc-ccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006777 166 NNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 166 ~~g~vKI~DFGlA~~~~~~~~~~-~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~ 242 (631)
.++.+||+|||++.......... ...+..|+|||.+.. .++.++|||||||++|+|++ |..||.. .........+.
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~ 232 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLP 232 (297)
T ss_pred CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHh
Confidence 68899999999986432221111 223457999998754 58999999999999999997 9999976 45566666666
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+..+ ..+...++.+++||.+||. +|.+||++.++++.
T Consensus 233 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 233 QGYRM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55332 2345578899999999998 89999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=309.37 Aligned_cols=243 Identities=25% Similarity=0.432 Sum_probs=208.5
Q ss_pred EeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCC
Q 006777 33 VLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~g 112 (631)
||.|+||.||+|.+..+|+.||+|++..... ......+.+..|+.+++.++||||+++++.+... ..+++||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE--EKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC--CeeEEEEecCCC
Confidence 6999999999999998999999999886643 2334567889999999999999999999987544 479999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC--CCcccc
Q 006777 113 GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI 190 (631)
Q Consensus 113 GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~--~~~~~~ 190 (631)
++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...... ......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCc
Confidence 999999998888999999999999999999999998 99999999999998 7899999999998765432 234567
Q ss_pred CCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-C
Q 006777 191 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 268 (631)
Q Consensus 191 GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~ 268 (631)
++..|+|||...+ ..+.++|+||||+++|+|++|..||.. .+.......+... ...++...+..+++||.+||. +
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKD--PLRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcCC
Confidence 8999999998754 478899999999999999999999976 3445555555553 233455568899999999998 8
Q ss_pred CCCCCCH---HHHhcCCCc
Q 006777 269 ASLRLPA---LELLKDPFL 284 (631)
Q Consensus 269 p~~Rpta---~elL~hpff 284 (631)
|.+||++ .++++||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.15 Aligned_cols=244 Identities=23% Similarity=0.354 Sum_probs=201.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
+..|++.+.||+|+||.||+|.+. .+..||+|.++.... ..+.+.+|+.++++++||||+++++++.... .+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 76 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE--PI 76 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecCC--Ce
Confidence 467999999999999999999975 567899999875432 2345788999999999999999999876543 68
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLARVI 153 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcceEEEc
Confidence 99999999999999997654 6899999999999999999999998 99999999999998 7899999999999765
Q ss_pred cCCCCccccC---CCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 182 QQPTARSVIG---TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~~~~~~~G---Tp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
.........| +..|+|||.+.+ .++.++||||||+++|+|+| |+.||.+ .+.......+.....+ ..+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGYRM-PCPPGCPK 231 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCH
Confidence 4332222222 457999998754 58899999999999999999 9999976 4455555666554332 23445678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.++++|.+||. +|.+||++.++++
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=336.27 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=203.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcC-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEE
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWV 96 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~-----~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~ 96 (631)
..++|+++++||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+++|+++. |||||+++++|.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 36788999999999999999998643 34579999986542 2344577899999999996 999999999986
Q ss_pred cCCCceEEEEEeccCCCCHHHHHHhC------------------------------------------------------
Q 006777 97 DDTNRTINMITELFTSGSLRQYRKKH------------------------------------------------------ 122 (631)
Q Consensus 97 ~~~~~~l~lV~Ey~~gGsL~~~l~~~------------------------------------------------------ 122 (631)
+. ..+|+|||||++|+|.+++.+.
T Consensus 112 ~~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 112 KS--GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred cC--CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 54 4789999999999999988642
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCc
Q 006777 123 ------------------------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160 (631)
Q Consensus 123 ------------------------------------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~N 160 (631)
+.+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~N 267 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHh
Confidence 23778888999999999999999999 9999999999
Q ss_pred eEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCH
Q 006777 161 IFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNP 234 (631)
Q Consensus 161 ILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~ 234 (631)
||++ .++.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||......
T Consensus 268 ill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 268 VLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EEEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9998 68899999999997543221 22345678899999775 458999999999999999997 99999875545
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 235 ~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
...+..+..+..+. .+...++.++++|.+||. +|.+||++.++.+
T Consensus 347 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 STFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 55566666654332 344567899999999998 8999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=310.09 Aligned_cols=241 Identities=21% Similarity=0.350 Sum_probs=201.9
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
..|.+.+.||+|+||.||+|.. .|..||+|.++.. ...+.+.+|+.++++++||||+++++++.... ..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~ 76 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLY 76 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-CceE
Confidence 4789999999999999999976 4888999987532 22456889999999999999999999765543 4689
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 105 MITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS 153 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceecc
Confidence 9999999999999998654 4889999999999999999999999 99999999999997 78999999999986543
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
... ....++..|+|||++.+ .++.++|||||||++|+|++ |+.||.. .+.......+..+..+ ..+...++.+++
T Consensus 154 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (256)
T cd05082 154 STQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYD 230 (256)
T ss_pred ccC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHH
Confidence 322 23345678999998764 58899999999999999998 9999975 4566666666665433 344567899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 006777 261 FIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~ 280 (631)
+|.+||. +|.+|||+.++++
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=316.64 Aligned_cols=248 Identities=22% Similarity=0.244 Sum_probs=202.3
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCC----------------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDG----------------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g----------------~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 87 (631)
...|++.+.||+|+||.||+|.+...+ ..||+|.+.... .....+.+.+|++++++++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCC
Confidence 457999999999999999999876544 568999887543 2355678899999999999999
Q ss_pred cceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC
Q 006777 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156 (631)
Q Consensus 88 IV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~-----------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 156 (631)
|++++++|..+ ..+++||||+.+++|.+++.+.. .+++..++.++.|++.||.|||+++ ++||||
T Consensus 81 i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dl 156 (296)
T cd05051 81 IARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDL 156 (296)
T ss_pred EeEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccc
Confidence 99999988765 47899999999999999998766 6899999999999999999999999 999999
Q ss_pred CCCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh--cCCCCC
Q 006777 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT--CEYPYN 229 (631)
Q Consensus 157 Kp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt--G~~Pf~ 229 (631)
||+||+++ .++.++|+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|+|++ +..||.
T Consensus 157 kp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 157 ATRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred chhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999998 67999999999987543221 223456789999998754 68999999999999999998 778887
Q ss_pred CCCCHHHHHHHHHcC------CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 230 ECKNPAQIYKKVTSG------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 230 ~~~~~~~~~~~i~~~------~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
... ..+....+... ......+...+.++.++|.+||+ +|.+||++.++++
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLT-DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcC-hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 643 34444443322 11112233456899999999998 8999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.97 Aligned_cols=239 Identities=24% Similarity=0.373 Sum_probs=200.6
Q ss_pred EEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEE
Q 006777 28 ISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 ~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
.+.+.||+|-||.||+|... ....||+|.++.... ..+.|.+|+++|++|+|+|||++|+++..+. .+||||
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVt 280 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVT 280 (468)
T ss_pred HHHHHhcCCccceEEEEEEc-CCCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEE
Confidence 34578999999999999975 344799999886532 2245779999999999999999999875543 799999
Q ss_pred eccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC
Q 006777 108 ELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~ 185 (631)
||++.|+|.+|++. ++.+...+...++.||++|++||++++ +|||||...||||+ +++.+||+|||+|+......
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcccccccccCCCc
Confidence 99999999999997 467999999999999999999999999 99999999999997 88899999999999543332
Q ss_pred Cccc---cCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 186 ARSV---IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 186 ~~~~---~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.... .-..-|.|||.+. +.++.++||||||++|+||+| |+.||.+ ....+..+.+..|...+.. ..+++++.+
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyRlp~P-~~CP~~vY~ 435 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYRLPRP-EGCPDEVYE 435 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCcCCCC-CCCCHHHHH
Confidence 1111 1234699999875 679999999999999999999 8888877 5677788899998765543 357899999
Q ss_pred HHHHhcC-CCCCCCCHHHHh
Q 006777 261 FIEKCIV-PASLRLPALELL 279 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL 279 (631)
++..|+. +|.+|||...+.
T Consensus 436 lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 436 LMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHhhCCcccCCCHHHHH
Confidence 9999998 999999998654
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=357.02 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=200.4
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.++||+|+||.||+|.+..+|+.||+|++.... .......+++.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEEE
Confidence 57999999999999999999999999999999987542 23345567899999999999999999999987654 4789
Q ss_pred EEEeccCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEc
Q 006777 105 MITELFTSGSLRQYRKKH-----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-----------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~ 173 (631)
+||||++||+|.+++... ..++...+..++.||+.||+|||+++ |+||||||+||+++ .+|.+||+
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKLi 155 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVIL 155 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEEE
Confidence 999999999999998642 23566788999999999999999999 99999999999997 78999999
Q ss_pred cccchhhccCC--------------------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCC
Q 006777 174 DLGLAIVMQQP--------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK 232 (631)
Q Consensus 174 DFGlA~~~~~~--------------------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~ 232 (631)
|||++...... .....+||+.|+|||++.+ .++.++|||||||++|||+||..||....
T Consensus 156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred ecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 99999754110 1123579999999998754 58999999999999999999999997633
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 233 ~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
......................++.+.+++.+||. +|.+|+++.+.|.+
T Consensus 236 ~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 236 GRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32222221111111111123467889999999998 89999887665543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=326.37 Aligned_cols=258 Identities=27% Similarity=0.363 Sum_probs=206.1
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC-
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~- 100 (631)
.+..+|.+.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 345789999999999999999999999999999999875421 22334567889999999999999999998865432
Q ss_pred ---ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 101 ---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 101 ---~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
..+++|+||+. ++|..++. ..+++..++.++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||+
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~ 163 (342)
T cd07879 90 DEFQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGL 163 (342)
T ss_pred CCCceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCCC
Confidence 35789999996 58877653 46899999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC----------
Q 006777 178 AIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---------- 245 (631)
Q Consensus 178 A~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~---------- 245 (631)
+..... ......+++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+...... +..+....
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 164 ARHADA-EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CcCCCC-CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHH
Confidence 875432 2234577899999998754 488999999999999999999999987432222 22221100
Q ss_pred ------------CC----CC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 246 ------------KP----AS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 246 ------------~p----~~---l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
.+ .. .....++.+++||.+||+ +|.+||++.++|.||||....+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 00 012356789999999998 8999999999999999987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.86 Aligned_cols=257 Identities=23% Similarity=0.398 Sum_probs=207.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
..+.|.+.+.||+|+||.||+|.+..+|..||+|.++.... .....++.+|+.++..+ .||||+++++++.+..
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-- 87 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-- 87 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC--
Confidence 45779999999999999999999998899999999875432 23445566777766666 4999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 102 TINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+++||||+. ++|..++.. ...+++..+..++.||+.||.|||+ ++ |+||||+|+||+++ .++.+||+|||++.
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~ 163 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISG 163 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccch
Confidence 6899999985 578877765 4578999999999999999999997 47 99999999999997 78999999999987
Q ss_pred hccCCC-CccccCCCCCCCcccccc-----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCC
Q 006777 180 VMQQPT-ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSK 252 (631)
Q Consensus 180 ~~~~~~-~~~~~GTp~y~APE~l~~-----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~-~l~~ 252 (631)
...... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......+....+.....+. ....
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06618 164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE 243 (296)
T ss_pred hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCC
Confidence 554322 223457889999998753 378899999999999999999999976444444444444433222 2222
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
..+.++++||.+||. +|.+||++.+++.||||....
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 467899999999998 899999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=309.56 Aligned_cols=239 Identities=22% Similarity=0.361 Sum_probs=198.1
Q ss_pred EEEeecCCeEEEEEEEcCCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEE
Q 006777 31 VVVLNCTFMCRYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g---~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
++||+|+||.||+|.....+ ..||+|.+..... ....+.+.+|+.+++.+.||||+++++++.. ..+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEE
Confidence 46999999999999876554 7999999876543 2455678899999999999999999997643 2578999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCC-
Q 006777 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA- 186 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~- 186 (631)
||+.+|+|.+++.+.+.+++..+..++.|++.||.|||.++ ++||||||+|||++ .++.+||+|||++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCCcc
Confidence 99999999999998888999999999999999999999999 99999999999998 789999999999975533221
Q ss_pred ----ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 187 ----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 187 ----~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
....++..|+|||.+. ..++.++|||||||++|+|++ |..||... +..+....+..+.. ...+...++.+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGER-LPRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCc-CCCCCCCCHHHHH
Confidence 1112345799999875 458899999999999999998 99999774 45566666665543 2344556789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 006777 261 FIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~ 280 (631)
+|.+||. +|.+||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.79 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=202.8
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
...|.+.+.||+|+||.||+|.+. .++..|++|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT----LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc----HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 356999999999999999999853 356679999876432 34456788999999999999999999987654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceE
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 162 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NIL 162 (631)
..+++||||+++++|.+++..++ .+++..++.++.||+.||.|||+++ ++||||||+||+
T Consensus 80 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil 155 (291)
T cd05094 80 --DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCL 155 (291)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEE
Confidence 46899999999999999997643 3789999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHH
Q 006777 163 VNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 236 (631)
Q Consensus 163 l~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~ 236 (631)
++ .++.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|+| |..||.. .+...
T Consensus 156 ~~-~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~ 233 (291)
T cd05094 156 VG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTE 233 (291)
T ss_pred Ec-cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHH
Confidence 98 78999999999996543221 22345688999999775 458899999999999999999 9999976 34555
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 237 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 237 ~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
....+..+..+. .+...+..++++|.+||. +|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 234 VIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 555565554332 344567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=327.59 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=203.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEE-----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d-----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
.++|++.+.||+|+||.||+|.+ ..+++.||+|.++... .......+.+|+.+|.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 45899999999999999999984 3567899999987542 234456788999999999 78999999998765
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC-------------------------------------------------------
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH------------------------------------------------------- 122 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~------------------------------------------------------- 122 (631)
.. ..+++||||+++|+|.+++...
T Consensus 83 ~~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 PG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred CC-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 44 4788999999999999998642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC----C
Q 006777 123 ------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----A 186 (631)
Q Consensus 123 ------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~----~ 186 (631)
..++...+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++....... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcchhhc
Confidence 23677888999999999999999999 99999999999997 78999999999987543221 1
Q ss_pred ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006777 187 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 187 ~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~k 264 (631)
....+++.|+|||.+. ..++.++||||||+++|+|++ |..||............+..+..+ ..+...++.+.+++.+
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 317 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLD 317 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHHHH
Confidence 1234567899999764 458999999999999999997 999998755445555555554332 2334567899999999
Q ss_pred hcC-CCCCCCCHHHHhcC
Q 006777 265 CIV-PASLRLPALELLKD 281 (631)
Q Consensus 265 cL~-~p~~Rpta~elL~h 281 (631)
||. +|.+||++.++++|
T Consensus 318 cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 318 CWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=352.45 Aligned_cols=150 Identities=23% Similarity=0.344 Sum_probs=136.0
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|.+.++||+|+||+||+|.+..+|+.||+|+++.... ........+..|+.+++.++||||+++++++.... .+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN--NV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC--EE
Confidence 3689999999999999999999999999999999986543 23455677889999999999999999998876543 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
|+||||+.|++|.+++...+.+++..++.|+.||+.||.|||.++ |+||||||+|||++ .+|.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 999999999999999998888999999999999999999999998 99999999999997 78999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=314.97 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=201.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEE----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 25 YFWISWVVVLNCTFMCRYKGFD----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..|++.+.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 4689999999999999999974 4578899999986442 24455678999999999999999999998877655
Q ss_pred ceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+++||||++|++|.+++.+.. .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCcccc
Confidence 67899999999999999997653 5899999999999999999999999 99999999999997 78999999999997
Q ss_pred hccCCC-----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCC--------------CCHHHHHH
Q 006777 180 VMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC--------------KNPAQIYK 239 (631)
Q Consensus 180 ~~~~~~-----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~--------------~~~~~~~~ 239 (631)
...... .....++..|+|||.+. ..++.++|||||||++|+|+|+..|+... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 554321 12345677899999765 45889999999999999999987665321 11122222
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 240 ~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+..+... ..+...+..+.+||.+||+ +|.+||++.+++++
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 33333222 2234567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.77 Aligned_cols=244 Identities=22% Similarity=0.368 Sum_probs=201.0
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
..|.+.+.||+|+||+||+|.+. .+..||+|.+..... ..+.+.+|+.++++++||||+++++++... ..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIY 75 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcE
Confidence 46899999999999999999875 355699998874432 235688999999999999999999987544 3689
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCC
Confidence 999999999999999764 46899999999999999999999999 99999999999997 788999999999865433
Q ss_pred CCCc---cccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 184 PTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~~~~---~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.... ...++..|+|||.+. ..++.++|||||||++|+|++ |..||... +.......+..+..+ ..+...++.+
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLRL-YRPHLASEKV 230 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHhcCCCC-CCCCCCCHHH
Confidence 2211 123456799999886 468999999999999999999 99999764 344555566555333 2344567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 259 KQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+++|.+||. +|.+||++.+++.+
T Consensus 231 ~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 231 YAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHh
Confidence 999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=319.26 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=204.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcC-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeE
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~-------~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~ 94 (631)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ......++.+|+.+++.+ +||||++++++
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 35789999999999999999998643 33579999887542 234556788999999999 79999999998
Q ss_pred EEcCCCceEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006777 95 WVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158 (631)
Q Consensus 95 f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp 158 (631)
+.... .+|+||||+.+|+|.+++..++ .++..++..++.||+.||+|||+++ ++||||||
T Consensus 93 ~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 93 CTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 86554 6899999999999999997642 3788999999999999999999998 99999999
Q ss_pred CceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCC
Q 006777 159 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECK 232 (631)
Q Consensus 159 ~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~ 232 (631)
+||+++ .++.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+ .
T Consensus 169 ~Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~ 246 (307)
T cd05098 169 RNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-V 246 (307)
T ss_pred HheEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-C
Confidence 999998 78999999999986543211 11123456899999775 458999999999999999998 8888865 5
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 233 ~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+...+...+..+..+ ..+...+.++++||.+||. +|.+||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 247 PVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 666677766665433 3445567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.79 Aligned_cols=245 Identities=22% Similarity=0.356 Sum_probs=200.3
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeE----EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIE----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~----VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..|++.+.||+|+||+||+|.+..+|.. |++|.+... .......++..|+.+++++.||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---
Confidence 5788999999999999999999777764 666665422 223445678889999999999999999997643
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+++++||+++|+|.+++... +.+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||+++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~ 157 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVAD 157 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccce
Confidence 2478899999999999999764 56899999999999999999999998 99999999999998 78999999999997
Q ss_pred hccCC----CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 180 VMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 180 ~~~~~----~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
..... ......++..|+|||.+. +.++.++|||||||++|||++ |..||.+ ..+......+..+..+ ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~ 235 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG-MRPHEVPDLLEKGERL-AQPQI 235 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcC-CCCCC
Confidence 54322 122345677899999875 568999999999999999998 9999976 3455555555555433 23445
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+..+.+++.+|+. +|.+||++.|+++
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 67889999999998 9999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=315.17 Aligned_cols=250 Identities=27% Similarity=0.415 Sum_probs=204.7
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEE
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV 106 (631)
|.+.+.||.|++|.||+|.+..+|+.+|+|++..... .......+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEE
Confidence 6678999999999999999999999999999876543 223456788899999999999999999987655 478999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC
Q 006777 107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~ 185 (631)
+||+.+ +|.+++... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++ .++.+||+|||.+.......
T Consensus 77 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred EeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCc
Confidence 999974 888887664 57999999999999999999999999 99999999999998 78999999999987554432
Q ss_pred --CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--C-----------
Q 006777 186 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--A----------- 248 (631)
Q Consensus 186 --~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p--~----------- 248 (631)
.....++..|+|||.+.+ .++.++|+||||+++|+|+||+.||.......++.........+ .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 223467889999997753 57899999999999999999999998755444433322211110 0
Q ss_pred --------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 249 --------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 249 --------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
......+..+++||.+||. +|.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112356889999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.99 Aligned_cols=242 Identities=21% Similarity=0.336 Sum_probs=204.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|++.+.||.|+||.||+|... |..||+|.+.... ...+++.+|+.+++.++||||+++++++.+. ...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 75 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQG--NPL 75 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCC--CCe
Confidence 457899999999999999999864 8899999987542 2567789999999999999999999987653 468
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEA 152 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEccccccccc
Confidence 99999999999999998765 6999999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 182 QQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
..... ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.+.
T Consensus 153 ~~~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (256)
T cd05039 153 SQGQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVY 229 (256)
T ss_pred ccccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHH
Confidence 33222 334466799999775 468889999999999999997 9999976 4556666666555433 33455689999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhc
Q 006777 260 QFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~ 280 (631)
++|.+||. +|.+||++.++++
T Consensus 230 ~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 230 KVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHhccChhhCcCHHHHHH
Confidence 99999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.17 Aligned_cols=255 Identities=29% Similarity=0.443 Sum_probs=206.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
+.++|.+.+.||.|+||.||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||++++++|.... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 84 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-ED 84 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-Cc
Confidence 57789999999999999999999999999999998865422 2234566889999999999999999999886543 36
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+++|+||+ +++|..+++. ..+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCccccccccC
Confidence 88999998 5799988865 45889999999999999999999999 99999999999997 78999999999987543
Q ss_pred CCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-----------------
Q 006777 183 QPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------------- 243 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~----------------- 243 (631)
.. .....+++.|+|||.+.+ .++.++|||||||++|+|+||..||.... .......+..
T Consensus 160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 160 PQ-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-HVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred CC-cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 32 234567899999998754 58999999999999999999999997633 2111111100
Q ss_pred -------CC--CC---CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 244 -------GI--KP---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 -------~~--~p---~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.. .+ .......++.++++|.+||+ +|.+||++.+++.||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00 00 01112356899999999998 89999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=320.44 Aligned_cols=244 Identities=24% Similarity=0.437 Sum_probs=196.2
Q ss_pred CCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCCCCHH
Q 006777 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR 116 (631)
Q Consensus 37 ~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~ 116 (631)
+++.||.+.+..+|+.||+|++..... .....+++.+|+.+++.++||||++++++|.+.. ..+++|||+++|+|.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--~~~~~~e~~~~~~l~ 87 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--ELYVVSPLMAYGSCE 87 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--eEEEEEeccCCCCHH
Confidence 445566666667999999999986532 3456678999999999999999999999987654 689999999999999
Q ss_pred HHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC---------C
Q 006777 117 QYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------T 185 (631)
Q Consensus 117 ~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~---------~ 185 (631)
+++.+. ..+++..++.+++||+.||.|||+++ |+||||||+||+++ .+|.+||+|||.+...... .
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeeccccccccccccc
Confidence 999864 45899999999999999999999999 99999999999998 7899999999988543211 1
Q ss_pred CccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC----------------
Q 006777 186 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---------------- 246 (631)
Q Consensus 186 ~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~---------------- 246 (631)
.....++..|+|||++.. .|+.++|||||||++|+|++|..||............+.....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 223457889999998754 4889999999999999999999999875555444444332110
Q ss_pred ---------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 247 ---------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 ---------------p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+.......+.++++||.+||. +|.+|||+.++|.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000111234678999999998 99999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.77 Aligned_cols=249 Identities=26% Similarity=0.357 Sum_probs=202.2
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCceEEE
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~~l~l 105 (631)
|.+.+.||.|+||+||+|.+..+++.||+|++..... . .......+|+..++.++ ||||+++++++.+. ...++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNEHPNIVKLKEVFREN--DELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--CcEEE
Confidence 6789999999999999999998999999998865421 1 22234567999999999 99999999988663 47899
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
||||+ +|+|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceeccC
Confidence 99999 789999888764 7899999999999999999999999 99999999999998 789999999999975543
Q ss_pred C-CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 006777 184 P-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------- 247 (631)
Q Consensus 184 ~-~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p------------- 247 (631)
. ......++..|+|||++.. .++.++|+||||+++++|++|+.||..........+.......+
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 3 2234568999999998743 47899999999999999999999997755444433322110000
Q ss_pred -----------C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 248 -----------A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 248 -----------~---~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
. .+....++.+++||.+||+ +|.+||++.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 0111225789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=311.01 Aligned_cols=244 Identities=21% Similarity=0.350 Sum_probs=201.1
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
..|++.+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++... ..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIF 75 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceE
Confidence 35889999999999999999885 567899998764322 224577899999999999999999987544 4789
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+++++|.+++..+ +.+++..+..++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLD 152 (256)
T ss_pred EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceeccc
Confidence 999999999999998764 46899999999999999999999999 99999999999997 789999999999875543
Q ss_pred CCCcccc---CCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 184 PTARSVI---GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~~~~~~~---GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
....... ++..|+|||.+. ..++.++||||||+++|+|++ |..||.. .........+..+..+ ..+...++++
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSEVVESVSAGYRL-YRPKLAPTEV 230 (256)
T ss_pred ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHcCCcC-CCCCCCCHHH
Confidence 3222222 345799999875 468999999999999999999 8999976 3455666666655332 3345678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 259 KQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+++.+||. +|.+||++.++++.
T Consensus 231 ~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 231 YTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.24 Aligned_cols=240 Identities=26% Similarity=0.403 Sum_probs=198.8
Q ss_pred EEEeecCCeEEEEEEEcC-CC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEE
Q 006777 31 VVVLNCTFMCRYKGFDEV-DG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~-~g--~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
++||+|++|.||+|.+.. .+ ..||+|.+...... ...+++.+|+.++++++||||+++++.+.+ ..+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 468999999999998865 33 36999998765431 566789999999999999999999998876 4789999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC
Q 006777 108 ELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~ 185 (631)
||+++|+|.+++.+.. .+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEe-cCCEEEeccccccccccccc
Confidence 9999999999998764 6899999999999999999999999 99999999999998 67999999999997654321
Q ss_pred -----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 186 -----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 186 -----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.....++..|+|||.+.. .++.++|||||||++|+|++ |..||... +..+..+.+.........+...+..+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHH
Confidence 123456788999998764 68999999999999999998 99999764 45555555553322223344567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 006777 259 KQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.++|.+||. +|.+||++.+++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.04 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=204.0
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEc-------CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceee
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 92 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~-------~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~ 92 (631)
....++|.+.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++++ +||||++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 334578999999999999999999863 235679999876432 245567788999999999 699999999
Q ss_pred eEEEcCCCceEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC
Q 006777 93 NSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156 (631)
Q Consensus 93 ~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 156 (631)
+++.+. ..+++||||+.+|+|.+++... ..++..++..++.||+.||.|||++| ++||||
T Consensus 85 ~~~~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dl 160 (314)
T cd05099 85 GVCTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDL 160 (314)
T ss_pred EEEccC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccc
Confidence 987654 4689999999999999999763 24788999999999999999999998 999999
Q ss_pred CCCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCC
Q 006777 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNE 230 (631)
Q Consensus 157 Kp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~ 230 (631)
||+|||++ .++.+||+|||+++...... .....+++.|+|||++. +.++.++||||||+++|+|++ |..||..
T Consensus 161 kp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 161 AARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred cceeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 99999997 78999999999997553221 11223456899999875 458999999999999999999 8899976
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 231 ~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+.......+..+..+ ..+...+..++++|.+||. +|.+||++.+++.
T Consensus 240 -~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 240 -IPVEELFKLLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred -CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5566667766665433 2344567899999999998 8999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=316.98 Aligned_cols=255 Identities=20% Similarity=0.297 Sum_probs=212.2
Q ss_pred CCCcEEE-EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc--C
Q 006777 23 VSYFWIS-WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD--D 98 (631)
Q Consensus 23 i~~~Y~i-~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~--~ 98 (631)
+.+.|.+ .++||-|-.|.|-.++++.+|+.+|+|++.-. ++..+|+++.-.. .|||||.++++|.. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS---------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC---------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 4555655 36999999999999999999999999986522 3356788876655 69999999998753 3
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEEcc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGD 174 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI~D 174 (631)
...++.+|||.++||.|...++.++. ++|+++..+++||..|+.|||+.+ |.||||||+|+|+.+ .+..+||+|
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecc
Confidence 34689999999999999999988764 999999999999999999999999 999999999999973 345799999
Q ss_pred ccchhhccC-CCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCC--C
Q 006777 175 LGLAIVMQQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIK--P 247 (631)
Q Consensus 175 FGlA~~~~~-~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~---~~~~~~~i~~~~~--p 247 (631)
||+|+.... ....+.|.||+|.|||++. ..|+...|+||+|+++|-|+.|.+||..... ......+|..|.. |
T Consensus 208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred cccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 999987653 3456788999999999986 4699999999999999999999999975322 2234556666643 4
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
..-+..++..++++|+++|. +|.+|.|+.+++.|||+....
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 44445678999999999997 999999999999999997643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=360.88 Aligned_cols=255 Identities=29% Similarity=0.483 Sum_probs=212.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC----
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD---- 98 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~---- 98 (631)
-...|+.+++||+||||.||+++++-+|+.||||+|.... +.....++.+|+..|.+|+|||||+||.+|++.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 4456788899999999999999999999999999998764 345667899999999999999999999888530
Q ss_pred --------------------------------------------------C-----------------------------
Q 006777 99 --------------------------------------------------T----------------------------- 99 (631)
Q Consensus 99 --------------------------------------------------~----------------------------- 99 (631)
.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred --------------------------C--------ceEEEEEeccCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHH
Q 006777 100 --------------------------N--------RTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWARQILRGLHYL 144 (631)
Q Consensus 100 --------------------------~--------~~l~lV~Ey~~gGsL~~~l~~~~~l-~e~~i~~i~~QIl~gL~yL 144 (631)
+ ..+|+-||||+..+|++++.++... .....+++++||+.||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 2578899999988888888876654 5788999999999999999
Q ss_pred HhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc----------C----------CCCccccCCCCCCCcccccc-
Q 006777 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----------Q----------PTARSVIGTPEFMAPELYEE- 203 (631)
Q Consensus 145 Hs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~----------~----------~~~~~~~GTp~y~APE~l~~- 203 (631)
|++| ||||||||.|||++ .++.|||+|||+|+... . ....+.+||--|+|||++.+
T Consensus 714 H~~g--iIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG--IIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc--eeeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 99999999999998 78899999999997511 0 01235689999999999853
Q ss_pred ---ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHH
Q 006777 204 ---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALE 277 (631)
Q Consensus 204 ---~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~--l~~~~~~~lk~lI~kcL~-~p~~Rpta~e 277 (631)
.|+.|+|+|||||+++||+. ||........+...+..+..|.. +....-+.-+.+|..+|+ +|++||||.|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 59999999999999999985 78776666777777777766655 222223567889999998 9999999999
Q ss_pred HhcCCCccC
Q 006777 278 LLKDPFLVT 286 (631)
Q Consensus 278 lL~hpff~~ 286 (631)
||++.||..
T Consensus 868 LL~s~llpp 876 (1351)
T KOG1035|consen 868 LLNSELLPP 876 (1351)
T ss_pred HhhccCCCc
Confidence 999999974
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.79 Aligned_cols=249 Identities=22% Similarity=0.283 Sum_probs=207.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcC----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~----~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
.+++|.+.++||+|+||.||+|.+.. ++..|++|.+... ......+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 46789999999999999999999875 3688999987632 2345667789999999999999999999987654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcE
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH--------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~--------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 170 (631)
....++++||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+
T Consensus 81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~ 156 (280)
T cd05043 81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQV 156 (280)
T ss_pred -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCCcE
Confidence 34678999999999999998764 35889999999999999999999998 99999999999997 78999
Q ss_pred EEccccchhhccCCC----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006777 171 KIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 171 KI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~ 244 (631)
||+|||+++.+.... .....++..|+|||++.+ .++.++|||||||++|+|++ |+.||.. .++..+...+..+
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~ 235 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDG 235 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcC
Confidence 999999997553321 122345678999998754 58999999999999999999 9999986 4666677666665
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 245 ~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+. .....++.+++++.+|+. +|++|||+.+++.
T Consensus 236 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 YRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4433 233467899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.34 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=206.8
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEc-------CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCccee
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKF 91 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~-------~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l 91 (631)
-....++|.+.+.||+|+||.||+|.+. .++..||+|.+.... ......++.+|+.+++.+ +||||+++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchhe
Confidence 3455789999999999999999999752 245689999876431 234567789999999999 89999999
Q ss_pred eeEEEcCCCceEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecC
Q 006777 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155 (631)
Q Consensus 92 ~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrD 155 (631)
++++... ..+++||||+.+|+|.+++.+. ..++...+..++.||+.||.|||++| ++|||
T Consensus 87 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~d 162 (304)
T cd05101 87 LGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRD 162 (304)
T ss_pred eEEEecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecc
Confidence 9988654 3789999999999999999764 24778889999999999999999999 99999
Q ss_pred CCCCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCC
Q 006777 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYN 229 (631)
Q Consensus 156 LKp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~ 229 (631)
|||+||+++ .++.+||+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.
T Consensus 163 lkp~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 163 LAARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred cccceEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999999997 78999999999997553321 12234567899999775 458999999999999999998 788887
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 230 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 230 ~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+ .+...+.+.+..+..+ ..+...+..+++||.+||. +|.+||++.++++.
T Consensus 242 ~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 242 G-IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred c-CCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 6 4566777777665433 2344567899999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=310.83 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=204.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|++.++||.|+||.||+|.+.. +..||+|.+.... ......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~ 77 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE--PV 77 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCC--Ce
Confidence 3568999999999999999999977 8999999987543 234566889999999999999999999876544 68
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLARLI 154 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchhhc
Confidence 9999999999999999763 46899999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCCC--CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 182 QQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~~--~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
.... .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.. .+..+....+..+..+ ..+...++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQE 232 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCHH
Confidence 4332 12334567899999875 458899999999999999998 8999976 4455566666655333 234466789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 258 VKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+.++|.+||. +|.+|||+.+|++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 233 IYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.23 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=197.9
Q ss_pred CcEEEEEEEeecCCeEEEEEE----EcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 25 YFWISWVVVLNCTFMCRYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~----d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..|++.+.||+|+||.||+|. +..+|..||+|.+... .....+.+.+|+++++.++||||+++++++.....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 478999999999999999997 4567899999998643 24556778899999999999999999998766555
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++| ++||||||+||+++ .++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCcccc
Confidence 6789999999999999999764 46899999999999999999999999 99999999999997 78899999999997
Q ss_pred hccCCCC-----ccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH---------------HHHH
Q 006777 180 VMQQPTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP---------------AQIY 238 (631)
Q Consensus 180 ~~~~~~~-----~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~---------------~~~~ 238 (631)
....... ....++..|+|||++.+ .++.++||||||+++|||++|..|+...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 6543221 11223456999998754 5889999999999999999987776432110 0111
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+..+.. ...+...+..+.+||.+||. +|.+|||+.++++
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11222211 12234467899999999998 8999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.77 Aligned_cols=246 Identities=23% Similarity=0.353 Sum_probs=202.3
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g---~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.+|.+.+.||+|+||.||+|.+..++ ..||+|.++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--K 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 57899999999999999999986444 479999886432 234566789999999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+++||||+++|+|.+++.+. +.+++.++..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~~ 155 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRV 155 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCcccc
Confidence 789999999999999999775 46899999999999999999999999 99999999999997 788999999999875
Q ss_pred ccCCCC-----ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 181 MQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 181 ~~~~~~-----~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
...... ....+++.|+|||.+. +.++.++|+||||+++|+|++ |..||.+. ........+..+..+. .+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~ 233 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRLP-APMD 233 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcCC-CCCC
Confidence 533211 1122356899999886 468999999999999999886 99999764 4455566666553332 2344
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.++.+++++.+|++ +|.+||++.+++.
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 234 CPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 67899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.72 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=202.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEE-----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d-----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
..+|.+.++||+|+||.||+|.. ..++..||+|.+... .....+.+.+|+++++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 45788999999999999999974 335778999987633 345567899999999999999999999988665
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEE
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHK---------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 163 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~---------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 163 (631)
. .+++||||+++|+|.+++..++ .+++..+..++.||+.||.|||+++ ++||||||+|||+
T Consensus 80 ~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~ 155 (280)
T cd05092 80 R--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV 155 (280)
T ss_pred C--ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEE
Confidence 4 6899999999999999997653 4789999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHH
Q 006777 164 NGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237 (631)
Q Consensus 164 ~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~ 237 (631)
+ .++.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||... .....
T Consensus 156 ~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~ 233 (280)
T cd05092 156 G-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEA 233 (280)
T ss_pred c-CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHHH
Confidence 7 78999999999986543221 12234578899999775 458999999999999999998 89999764 34445
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 238 ~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
...+..+..+ ..+...++.+.+||.+||+ +|.+||++.+++.
T Consensus 234 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 234 IECITQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHcCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5555554333 2344567899999999998 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=309.99 Aligned_cols=251 Identities=28% Similarity=0.463 Sum_probs=205.1
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+|.+.+.||+|+||.||+|.+...+..+++|.++...... ......++..|+.+++.++||||+++++++.+.. ..+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD--AFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ceE
Confidence 5899999999999999999998877777777665432211 1233455778999999999999999999886544 688
Q ss_pred EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 105 MITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+|+||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++ ++.+||+|||++..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~--~~~~~l~d~g~~~~ 154 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLK--NNLLKIGDFGVSRL 154 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEee--cCCEeecccCceee
Confidence 99999999999988764 356899999999999999999999998 99999999999996 46799999999865
Q ss_pred ccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 181 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
.... ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.. .........+..+..+ .++...+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (260)
T cd08222 155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTP-SLPETYSRQ 232 (260)
T ss_pred cCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCC-CCcchhcHH
Confidence 5332 2334568999999997754 578899999999999999999999976 3444444555444333 345567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+.++|.+||. +|.+||++.+++.||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.42 Aligned_cols=242 Identities=21% Similarity=0.293 Sum_probs=190.9
Q ss_pred EEEeecCCeEEEEEEEc--CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEe
Q 006777 31 VVVLNCTFMCRYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~--~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~E 108 (631)
+.||+|+||.||+|.+. .++..+|+|.++... .......+.+|+.++++++||||+++++++.+.. .+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--CcEEEEE
Confidence 36899999999999864 355789999876543 2334456888999999999999999999886543 6889999
Q ss_pred ccCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 109 LFTSGSLRQYRKKHK-----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 109 y~~gGsL~~~l~~~~-----~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|+++|+|.+++...+ ..++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEECCccccccccC
Confidence 999999999987532 4567788899999999999999999 99999999999998 688999999999864332
Q ss_pred CC----CccccCCCCCCCcccccc--------ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC---C
Q 006777 184 PT----ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---P 247 (631)
Q Consensus 184 ~~----~~~~~GTp~y~APE~l~~--------~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~---p 247 (631)
.. .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||............+..... .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence 21 123457889999998753 25789999999999999996 99999775444433333332211 1
Q ss_pred CCCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhc
Q 006777 248 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 280 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~~p~~Rpta~elL~ 280 (631)
..+....++.+++++.+|+.+|.+|||+.+|+.
T Consensus 233 ~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred CccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 223334578899999999989999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.47 Aligned_cols=252 Identities=28% Similarity=0.520 Sum_probs=208.2
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|....+||+|+||.||+|.+..+|..||+|++... .......+.+|+.+++.++||||+++++.|...+ ..++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 94 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWV 94 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--EEEE
Confidence 344456899999999999999999999999987643 2344567889999999999999999999887654 7899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC-
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~- 184 (631)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 95 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceeccccc
Confidence 9999999999998754 46899999999999999999999998 99999999999998 7899999999988644322
Q ss_pred -CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHHH
Q 006777 185 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQF 261 (631)
Q Consensus 185 -~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~-~l~~~~~~~lk~l 261 (631)
......|++.|+|||.+. ..++.++|+||||+++|+|++|..||.. .........+.....+. ......++.+.++
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGF 249 (292)
T ss_pred ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCcccCCcccCCHHHHHH
Confidence 223457899999999875 4578899999999999999999999976 34444444444433221 1223467899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 262 IEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
|.+||. +|.+||++.++|.||||....
T Consensus 250 i~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 250 LDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 999998 899999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=307.36 Aligned_cols=244 Identities=22% Similarity=0.342 Sum_probs=201.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..+.|++.++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 74 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EP 74 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CC
Confidence 3568999999999999999999974 678899998875432 23568889999999999999999997632 35
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
++++|||+.+|+|.+++... ..+++.++..++.|++.||+|||+++ ++||||||+||+++ .++.++|+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~ 151 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARL 151 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceee
Confidence 89999999999999998764 36899999999999999999999999 99999999999998 789999999999865
Q ss_pred ccCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 181 MQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
..... .....++..|+|||.+. ..++.++||||||+++|+|++ |+.||.+. +.......+..+..+ ..+...+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 229 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCP 229 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCC
Confidence 54221 12234567899999875 458899999999999999999 99999874 445555566555433 2344567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+++++|.+||. +|.+||++++++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.14 Aligned_cols=241 Identities=22% Similarity=0.329 Sum_probs=190.6
Q ss_pred EEeecCCeEEEEEEEc--CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 32 VVLNCTFMCRYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d~--~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
.||+|+||.||+|... .....||+|.+.... .......+.+|+.+++.++||||+++++++... ..+++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEe
Confidence 5899999999999653 244578888765432 334456788999999999999999999988654 368999999
Q ss_pred cCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 110 FTSGSLRQYRKKHK-----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 110 ~~gGsL~~~l~~~~-----~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+++|+|.+++...+ ..++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEec-CCCcEEEeccccccccccc
Confidence 99999999997653 2467888999999999999999999 99999999999998 7899999999998643221
Q ss_pred ----CCccccCCCCCCCccccc--------cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC---CC
Q 006777 185 ----TARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PA 248 (631)
Q Consensus 185 ----~~~~~~GTp~y~APE~l~--------~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~---p~ 248 (631)
......+++.|+|||++. ..++.++|||||||++|+|++ |..||....+...+...+..+.. ..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 112334577899999864 246789999999999999999 78888775544444444444322 22
Q ss_pred CCCCCCcHHHHHHHHHhcCCCCCCCCHHHHhc
Q 006777 249 SLSKVTDPQVKQFIEKCIVPASLRLPALELLK 280 (631)
Q Consensus 249 ~l~~~~~~~lk~lI~kcL~~p~~Rpta~elL~ 280 (631)
.+....++.+++++..|+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 34456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=309.25 Aligned_cols=251 Identities=28% Similarity=0.402 Sum_probs=199.7
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCcceeeeEEEcCCC---
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDDTN--- 100 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~f~~~~~--- 100 (631)
|.+.+.||+|+||.||+|.++.+|..||+|.++.... .......+.+|+.+++++ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 6789999999999999999988899999999976532 112234456777777666 69999999999876542
Q ss_pred ceEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 101 RTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..++++|||+. ++|.+++...+ .+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++
T Consensus 79 ~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~-~~~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEc-cCCCEEEeccCcc
Confidence 24899999997 58999887643 4899999999999999999999999 99999999999998 6799999999998
Q ss_pred hhccCC-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC----------
Q 006777 179 IVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---------- 246 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~---------- 246 (631)
...... ......+++.|+|||.+. ..++.++|||||||++|+|++|..||.+... .+...++.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCC
Confidence 765433 223446788999999875 4588899999999999999999999987443 333333322100
Q ss_pred ------------CC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 247 ------------PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 247 ------------p~---~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
+. ......++.+.+||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 0011235778999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.69 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=203.2
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCC--CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcC--CC
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVD--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD--TN 100 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~--g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~--~~ 100 (631)
+|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 589999999999999999999888 9999999986432 1223456678899999999 599999999875432 22
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
..+++++||+. ++|.+++.....+++..++.++.||+.||.|||++| ++||||||+|||++ .++.+||+|||++..
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARG 154 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCcee
Confidence 46788999986 799999988888999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCC------CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc---------
Q 006777 181 MQQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------- 243 (631)
Q Consensus 181 ~~~~------~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--------- 243 (631)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ....+..
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence 4321 1234578999999997653 58899999999999999999999997643221 1111110
Q ss_pred -----------------CCCCC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 244 -----------------GIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 244 -----------------~~~p~---~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
..... ......+..+++||.+||+ +|.+|||+.+++.||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 00001 1122347889999999998 8999999999999999965
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.21 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=200.9
Q ss_pred cEEEEEEEeecCCeEEEEEEEcC-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~-----~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
.|++.+.||+|+||.||+|.+.. ....|++|.+.... .....+++.+|+.+++.++||||+++++.+....
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG- 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence 47889999999999999998753 23578888876432 2345677899999999999999999999876543
Q ss_pred ceEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC
Q 006777 101 RTINMITELFTSGSLRQYRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~------------------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 156 (631)
..++|+||+.+|+|.+++... ..+++.++..++.|++.||.|||+++ ++||||
T Consensus 77 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~di 153 (290)
T cd05045 77 -PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDL 153 (290)
T ss_pred -CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhh
Confidence 688999999999999998642 24788999999999999999999998 999999
Q ss_pred CCCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCC
Q 006777 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNE 230 (631)
Q Consensus 157 Kp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~ 230 (631)
||+|||++ .++.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|+|+| |..||.+
T Consensus 154 kp~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 154 AARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhheEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999997 78899999999987543221 12234567899999764 458999999999999999998 9999976
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 231 ~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+..+...+..+..+. .+...+..+++||.+||+ +|.+||++.++++
T Consensus 233 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 -IAPERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred -CCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 56667777666654333 344567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=316.06 Aligned_cols=259 Identities=29% Similarity=0.430 Sum_probs=204.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~----~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
....|++...||+|+||.||+|..+.++- ++|+|.++.++... .......+|+.+++.|+||||+.+..+|...
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t--GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT--GISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC--CcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 35689999999999999999997765543 78999988663211 1124467899999999999999999988765
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC---CCcE
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEV 170 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~-----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~---~g~v 170 (631)
...+++++||.+. +|.++++-+ +.++...++.++.||+.|+.|||++. |+||||||.|||+.++ .|.|
T Consensus 100 -d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 -DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred -CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCee
Confidence 4689999999985 898888644 35899999999999999999999998 9999999999999842 4899
Q ss_pred EEccccchhhccCCC-----CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCC------CHHH-
Q 006777 171 KIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECK------NPAQ- 236 (631)
Q Consensus 171 KI~DFGlA~~~~~~~-----~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~------~~~~- 236 (631)
||+|||+|+.++.+. ...++-|.+|+|||++-+ .|+.++|||+.|||+.||+|.++-|.+.. ++.+
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 999999999887652 345778999999997754 69999999999999999999998886521 1111
Q ss_pred -HHHHHHc--CCC-----------CC-----------C-----C------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 006777 237 -IYKKVTS--GIK-----------PA-----------S-----L------SKVTDPQVKQFIEKCIV-PASLRLPALELL 279 (631)
Q Consensus 237 -~~~~i~~--~~~-----------p~-----------~-----l------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL 279 (631)
...+|.. |.+ |. . + .+.-++...+|+.++|. ||-+|.|+++.|
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 1112211 000 00 0 0 12246678999999998 999999999999
Q ss_pred cCCCccCC
Q 006777 280 KDPFLVTD 287 (631)
Q Consensus 280 ~hpff~~~ 287 (631)
.|+||...
T Consensus 336 eh~yF~~d 343 (438)
T KOG0666|consen 336 EHPYFTED 343 (438)
T ss_pred cccccccC
Confidence 99999875
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.15 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=198.9
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
..+|++.++||+|+||.||+|.+..+ ..||+|.+..... ..+++.+|+.+++.++||||+++++.+.. ...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~ 75 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI 75 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC---CCc
Confidence 46799999999999999999998655 4599999875332 22468889999999999999999987632 357
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++ .++.+||+|||++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLI 152 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCceeec
Confidence 8999999999999999764 35899999999999999999999998 99999999999997 7899999999999755
Q ss_pred cCCCC---ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 182 QQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~~~---~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
..... ....++..|+|||+.. ..++.++|||||||++|+|+| |..||.+. ........+..+..+ ......++
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 230 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPECPE 230 (262)
T ss_pred cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCC-CCccccCH
Confidence 43221 2234567899999765 568999999999999999999 88888763 445555555554332 22345678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+.++|.+|++ +|.+||++.+++.
T Consensus 231 ~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 231 SLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999998 8999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.24 Aligned_cols=248 Identities=19% Similarity=0.294 Sum_probs=203.7
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcC-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~-----~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
..|.+.+.||+|+||.||+|..+. ....|++|.+.... .....+.+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA- 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-
Confidence 578999999999999999999754 34678888775432 233567799999999999999999999987554
Q ss_pred CceEEEEEeccCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcE
Q 006777 100 NRTINMITELFTSGSLRQYRKKHK---------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~---------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 170 (631)
...++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~ 156 (275)
T cd05046 81 -EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQREV 156 (275)
T ss_pred -CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCcE
Confidence 46899999999999999998765 6899999999999999999999999 99999999999998 78999
Q ss_pred EEccccchhhccCC---CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC
Q 006777 171 KIGDLGLAIVMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 171 KI~DFGlA~~~~~~---~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~ 245 (631)
+|+|||++...... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ........+..+.
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~~ 235 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAGK 235 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcCC
Confidence 99999998643221 123345678899999765 457889999999999999999 88899764 3445555555444
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 246 ~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+...+...+..+.++|.+||. +|.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 3333444567899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=306.32 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=201.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~---g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
.++|.+.+.||+|+||.||+|.+... ...||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-- 79 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-- 79 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC--
Confidence 45799999999999999999987544 3578999876442 245567889999999999999999999987543
Q ss_pred ceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..++||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~ 155 (270)
T cd05056 80 -PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGLSR 155 (270)
T ss_pred -CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCceee
Confidence 4689999999999999998754 5899999999999999999999999 99999999999998 68899999999986
Q ss_pred hccCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006777 180 VMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~ 254 (631)
...... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+... ......+..+..+ ..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~ 233 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERL-PMPPNC 233 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcC-CCCCCC
Confidence 543321 11223456899999775 458899999999999999996 9999987544 3444555554333 234556
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
++.++++|.+|+. +|.+|||+.+++..
T Consensus 234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 234 PPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7899999999998 89999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=302.88 Aligned_cols=243 Identities=26% Similarity=0.415 Sum_probs=204.3
Q ss_pred EEEEEEeecCCeEEEEEEEcCCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 28 ISWVVVLNCTFMCRYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 ~i~e~LG~G~fg~VY~A~d~~~g----~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
++.+.||.|+||.||+|.+...+ ..||+|.+.... .....+.+..|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--Cee
Confidence 56789999999999999998766 899999986542 223567889999999999999999999988665 478
Q ss_pred EEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+++|||+++++|.+++..... +++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceec
Confidence 999999999999999987554 999999999999999999999999 99999999999998 7889999999999655
Q ss_pred cCCCC-c--cccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 182 QQPTA-R--SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~~~-~--~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
..... . ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+.......+..+..+. .+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPP 231 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCH
Confidence 43211 1 123678999999875 458999999999999999998 7888876 56666666776654443 3344788
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
++.++|.+||. +|.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999998 8999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=344.45 Aligned_cols=261 Identities=24% Similarity=0.319 Sum_probs=192.6
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCC-eEEEEEEee-------------cccccCCHHHHHHHHHHHHHHHhCCCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDG-IEVAWNQVN-------------IEDVMQSPDQLERLYSEVHLLKSLKHENI 88 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g-~~VAvK~v~-------------~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 88 (631)
....|++.+.||+|+||+||+|..+... ..++.|.+. .............+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999998764332 222222111 01111223345668899999999999999
Q ss_pred ceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEE
Q 006777 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 163 (631)
Q Consensus 89 V~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~-----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 163 (631)
|++++++.+.+ ..|+|++++. ++|..++... .......++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 226 v~l~~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl 300 (501)
T PHA03210 226 LKIEEILRSEA--NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFL 300 (501)
T ss_pred CcEeEEEEECC--eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 99999887654 6889999995 6777776542 23456778899999999999999999 9999999999999
Q ss_pred eCCCCcEEEccccchhhccCC---CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCC--CH-HH
Q 006777 164 NGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NP-AQ 236 (631)
Q Consensus 164 ~~~~g~vKI~DFGlA~~~~~~---~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~--~~-~~ 236 (631)
+ .+|.+||+|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|||++|..|+.... ++ .+
T Consensus 301 ~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 N-CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred C-CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 8 7899999999999765432 2234689999999998764 58999999999999999999886543211 22 22
Q ss_pred HHHHHHcCC-C----C-------------------CCC-----CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 237 IYKKVTSGI-K----P-------------------ASL-----SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 237 ~~~~i~~~~-~----p-------------------~~l-----~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
+.+.+.... . | ..+ ....+..+.++|.+||. +|.+|||+.|+|.||||..
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 222222100 0 0 000 01235677888999998 9999999999999999987
Q ss_pred CCC
Q 006777 287 DNP 289 (631)
Q Consensus 287 ~~~ 289 (631)
...
T Consensus 460 ~~~ 462 (501)
T PHA03210 460 EEE 462 (501)
T ss_pred CCc
Confidence 543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.50 Aligned_cols=242 Identities=21% Similarity=0.350 Sum_probs=194.4
Q ss_pred EEEeecCCeEEEEEEEcC---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEE
Q 006777 31 VVVLNCTFMCRYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~---~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
+.||+|+||.||+|.+.. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++...+ ...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEE
Confidence 468999999999998753 3468999987532 23455678889999999999999999999765443 3578999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC-
Q 006777 108 ELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~- 185 (631)
||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccCCcc
Confidence 999999999999764 45678888999999999999999998 99999999999998 78899999999986543211
Q ss_pred -----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 186 -----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE-YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 186 -----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~-~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.....+++.|+|||.+. ..++.++|||||||++|||++|. +||.. .+...+...+..+..+. .+...++.+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCPDPL 231 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHH
Confidence 12334677899999775 56889999999999999999964 55554 55666666666554333 334567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 259 KQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+++.+||. +|.+||++.++++.
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=305.62 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=202.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~---~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
.+.|...+.||+|+||.||+|.++.++. .||+|.+.... .....+.+..|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK- 79 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC-
Confidence 3578899999999999999999876654 78999876432 2345677889999999999999999999886544
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+++||||+++++|.+++..+ +.+++.++..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.
T Consensus 80 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~ 155 (268)
T cd05063 80 -PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSR 155 (268)
T ss_pred -CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccce
Confidence 689999999999999999764 57899999999999999999999999 99999999999998 78899999999986
Q ss_pred hccCCCCc-----cccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 180 VMQQPTAR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 180 ~~~~~~~~-----~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
........ ....++.|+|||++. ..++.++|||||||++|+|++ |..||... +.......+..+...+ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~~-~~~ 233 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRLP-APM 233 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCCC-CCC
Confidence 54332111 112345799999875 458899999999999999998 99999764 4455666666543322 233
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+..+.++|.+|+. +|..||++.++++
T Consensus 234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 234 DCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 457899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.09 Aligned_cols=247 Identities=19% Similarity=0.246 Sum_probs=202.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
.++|.+.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 467999999999999999999874 367899999886432 244556788999999999999999999987654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHK----------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~----------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 156 (631)
. .+++|+||+++|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||
T Consensus 81 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl 156 (288)
T cd05050 81 K--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDL 156 (288)
T ss_pred C--ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccc
Confidence 3 6899999999999999997532 3678889999999999999999998 999999
Q ss_pred CCCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCC
Q 006777 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNE 230 (631)
Q Consensus 157 Kp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~ 230 (631)
||+|||++ .++.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+
T Consensus 157 ~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 157 ATRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred cHhheEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999997 78999999999986443221 12234467899999765 468999999999999999998 8889876
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 231 ~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+..+....+..+..+. .+...+.++.+||.+||+ +|.+||++.|+++
T Consensus 236 -~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 -MAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred -CCHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 45566666666554332 234567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.96 Aligned_cols=247 Identities=19% Similarity=0.227 Sum_probs=202.7
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcC-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~-----~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
..|.+.+.||+|+||.||+|.+.. .+..||+|+++... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 357788999999999999998754 36789999987442 2344567889999999999999999999876554
Q ss_pred CceEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEE
Q 006777 100 NRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 163 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 163 (631)
.+++++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||++
T Consensus 82 --~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~ 157 (283)
T cd05091 82 --PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLV 157 (283)
T ss_pred --ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEe
Confidence 688999999999999998532 34788899999999999999999999 9999999999999
Q ss_pred eCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHH
Q 006777 164 NGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 237 (631)
Q Consensus 164 ~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~ 237 (631)
+ .++.+||+|||+++...... .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ .....+
T Consensus 158 ~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~ 235 (283)
T cd05091 158 F-DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDV 235 (283)
T ss_pred c-CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 7 78899999999987543221 12334678999999764 568999999999999999998 8888876 455666
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 238 ~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
...+..+..+ ..+...+..+.+||.+||+ +|.+||++.+++..
T Consensus 236 ~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 236 IEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 6766665432 2345577899999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.23 Aligned_cols=248 Identities=23% Similarity=0.275 Sum_probs=197.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCC--------------CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVD--------------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~--------------g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV 89 (631)
..+|++.+.||+|+||.||+|.+..+ ...||+|.+.... .....+.+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 45899999999999999999987543 2358999887432 345567799999999999999999
Q ss_pred eeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCC
Q 006777 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157 (631)
Q Consensus 90 ~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLK 157 (631)
++++++... ..+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++|||||
T Consensus 81 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlk 156 (295)
T cd05097 81 RLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLA 156 (295)
T ss_pred eEEEEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccC
Confidence 999988654 36899999999999999986532 3688899999999999999999999 9999999
Q ss_pred CCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh--cCCCCCC
Q 006777 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--CEYPYNE 230 (631)
Q Consensus 158 p~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt--G~~Pf~~ 230 (631)
|+||+++ .++.+||+|||++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ +..||..
T Consensus 157 p~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 157 TRNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999998 78899999999986543221 12234567899999764 568999999999999999988 6788876
Q ss_pred CCCHHHHHHHHHc------CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 231 CKNPAQIYKKVTS------GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 231 ~~~~~~~~~~i~~------~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
. +..+....+.. .......+...++.+++||.+|+. +|.+||++.++++
T Consensus 236 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 L-SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred c-ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4 33333333221 111122334567899999999998 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=304.48 Aligned_cols=245 Identities=23% Similarity=0.337 Sum_probs=202.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|++.++||.|+||+||+|.+. .+..||+|.+..... ..+.+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 75 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EP 75 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecC--Cc
Confidence 4678999999999999999999975 567899999875432 235688999999999999999999987543 46
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~ 152 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGLARL 152 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECcccccee
Confidence 899999999999999997653 6899999999999999999999999 99999999999997 789999999999865
Q ss_pred ccCCC---CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 181 MQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~~---~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
..... .....++..|+|||.+.+ .++.++||||||+++|+|++ |+.||.+ .+.......+..+..+. .+...+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~ 230 (261)
T cd05034 153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG-MTNREVLEQVERGYRMP-RPPNCP 230 (261)
T ss_pred ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCC
Confidence 54221 112234678999998764 58899999999999999999 9999976 44555556665543322 233447
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+++++.+||. +|.+||++.+++.
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 231 EELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHH
Confidence 899999999998 8999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=332.78 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=205.8
Q ss_pred EEEEEEeecCCeEEEEEEEcCCCe---E-EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 28 ISWVVVLNCTFMCRYKGFDEVDGI---E-VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 ~i~e~LG~G~fg~VY~A~d~~~g~---~-VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.++||+|+||.||+|..+..+. . ||+|..+.+.. .......++.+|.++|++++|||||+||++.+++. .+
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--Pl 236 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--PL 236 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--cc
Confidence 345899999999999998765432 3 89999886332 34678889999999999999999999999876654 79
Q ss_pred EEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~-l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++|||+|.||+|.+|+++.+. ++..+...++.+.+.||+|||+++ +|||||-..|+|+. .++.+||+|||+++...
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeEEeCccccccCCc
Confidence 999999999999999999874 999999999999999999999999 99999999999997 67788999999986543
Q ss_pred CCCC-c-cccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 183 QPTA-R-SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 183 ~~~~-~-~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.... . ...-...|+|||.+.. -|+.++|||||||++||+++ |..||.+ ....++..+|.....+...+...+.++
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKEL 392 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence 2111 1 1123568999998864 59999999999999999998 8889988 566677777755445555566778899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 006777 259 KQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..++.+|+. +|..||++.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 999999998 9999999988765
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=304.53 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=201.2
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~---~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
..|.+.+.||+|+||.||+|.++.+|. .||+|.+... .......++..|+.++++++||||+++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--R 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--C
Confidence 468999999999999999999887665 6999988643 2345667899999999999999999999987544 3
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+++||||+++|+|.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~ 155 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRF 155 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCccccc
Confidence 689999999999999998764 56899999999999999999999998 99999999999998 688999999999865
Q ss_pred ccCCCC-----cccc--CCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006777 181 MQQPTA-----RSVI--GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 181 ~~~~~~-----~~~~--GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~ 251 (631)
...... .... .+..|+|||.+. ..++.++|||||||++|||++ |..||.. .+.......+...... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~ 233 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQDYRL-PPP 233 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCCcC-CCc
Confidence 432211 1111 135799999875 468999999999999999886 9999976 3445555566544322 223
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
...+..+.+++.+||. +|.+||++.+++.
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 234 MDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3457889999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=304.91 Aligned_cols=238 Identities=18% Similarity=0.360 Sum_probs=195.2
Q ss_pred EEeecCCeEEEEEEEc--CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 32 VVLNCTFMCRYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d~--~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.++++++||||+++++++.. ..+++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEe
Confidence 3899999999999765 456689999886542 24455778999999999999999999997632 368899999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCC--
Q 006777 110 FTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-- 186 (631)
Q Consensus 110 ~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~-- 186 (631)
+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCccce
Confidence 999999999875 457999999999999999999999999 99999999999997 788999999999875432211
Q ss_pred ---ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 187 ---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 187 ---~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
....+++.|+|||.+. ..++.++|||||||++|+|++ |..||... ........+..+..+ ..+...+++++++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 230 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYAL 230 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 1112357899999875 458899999999999999996 99999874 445556666665443 3455678999999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006777 262 IEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~elL~ 280 (631)
|.+||. +|.+||++.++.+
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999998 8999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=304.97 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=199.3
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|++.+.||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|+.+++.++||||+++++++.. ..+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~ 75 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVSE---EPI 75 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEECC---CCc
Confidence 357999999999999999999875 667799999875432 12458899999999999999999997632 347
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+++|||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGLARLI 152 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCceeeeec
Confidence 8999999999999998764 35899999999999999999999999 99999999999998 7889999999999754
Q ss_pred cCCCC---ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 182 QQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~~~---~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
..... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+. +.......+..+..+ ..+...+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 230 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRM-PCPQDCPI 230 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCH
Confidence 33221 1233556899999765 458899999999999999999 88999764 444555555554333 33455678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+++||.+||. +|.+|||+.+++.
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999999998 8999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.34 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=204.6
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD 97 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~ 97 (631)
.++|.+.+.||+|+||.||+|.+. ..+..||+|+++... .....+.+.+|+.+|.++. |||||+++++|..
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 467889999999999999999853 456789999987542 2334557889999999997 9999999998866
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCC------------------------------------------------------
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHK------------------------------------------------------ 123 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~------------------------------------------------------ 123 (631)
.. .+++||||+.+|+|.+++.+.+
T Consensus 113 ~~--~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 113 GG--PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred CC--CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 53 6899999999999999986532
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006777 124 --------------------------------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159 (631)
Q Consensus 124 --------------------------------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~ 159 (631)
.+++..+..++.||+.||.|||+++ ++||||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~ 268 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAAR 268 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcc
Confidence 2566778899999999999999998 999999999
Q ss_pred ceEEeCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCC
Q 006777 160 NIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKN 233 (631)
Q Consensus 160 NILl~~~~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~ 233 (631)
|||++ .++.+||+|||++...... ......+++.|+|||.+. ..++.++||||||+++|||++ |..||.....
T Consensus 269 NiLl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 269 NVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eEEEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99998 6889999999999754321 122345788999999875 458899999999999999998 8999987665
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 234 ~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.......+..+..+. .+...+.++.+||.+|+. +|..||++.+|+..
T Consensus 348 ~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 566666666654332 344568899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=303.72 Aligned_cols=243 Identities=23% Similarity=0.334 Sum_probs=198.6
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|.+.+.||.|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 75 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPI 75 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCc
Confidence 35799999999999999999998654 4699998764432 23567889999999999999999987632 357
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+||+++ .++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLARLI 152 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccceEc
Confidence 89999999999999997643 4789999999999999999999998 99999999999997 7899999999999755
Q ss_pred cCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 182 QQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
.... .....++..|+|||... +.++.++||||||+++|+|+| |..||.+. ........+..+..+ ..+...+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 230 (260)
T cd05069 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRM-PCPQGCPE 230 (260)
T ss_pred cCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCcccCH
Confidence 3322 12234567899999775 458899999999999999999 89999874 444555555554333 23445678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.++++|.+||. +|.+||++.+++.
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 231 SLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999998 8999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.12 Aligned_cols=265 Identities=25% Similarity=0.398 Sum_probs=216.8
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC---HHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS---PDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
.++.++|-++..||+|+|+.||+|+|....+.||+|+-...+--.. ........+|.+|.+.|+||-||++|++|.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 3467899999999999999999999999999999997654421011 1123556789999999999999999999865
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEEccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDL 175 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI~DF 175 (631)
+. ..++-|+|||+|.+|.-|+++++-+++++++.|+.||+.||.||....|||||-||||.|||+-. ..|.+||.||
T Consensus 539 Dt-dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DT-DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cc-ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 54 47889999999999999999999999999999999999999999999999999999999999841 3468999999
Q ss_pred cchhhccCCCC---------ccccCCCCCCCccccc-c----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006777 176 GLAIVMQQPTA---------RSVIGTPEFMAPELYE-E----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 176 GlA~~~~~~~~---------~~~~GTp~y~APE~l~-~----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i 241 (631)
|+++++..... ....||-+|++||.|- + ..+.++||||.|+|+|..+.|+.||........+.+..
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 99998765432 3467999999999763 2 37889999999999999999999997654444443322
Q ss_pred H--cC-CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 242 T--SG-IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 242 ~--~~-~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
+ .. .......+++++++++||++||+ .-.+|....+|-+||||.+
T Consensus 698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 1 11 11111234678999999999999 6789999999999999976
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=310.30 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=196.0
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcC----------------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEV----------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~----------------~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 87 (631)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|+.+|+.++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCC
Confidence 4579999999999999999986432 35579999886442 2445677899999999999999
Q ss_pred cceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC
Q 006777 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-----------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156 (631)
Q Consensus 88 IV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~-----------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 156 (631)
|+++++++.... .+++||||+.+|+|.+++.... .+++.++..++.||+.||+|||+++ ++||||
T Consensus 81 i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl 156 (296)
T cd05095 81 IIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDL 156 (296)
T ss_pred cceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccC
Confidence 999999886654 6899999999999999987643 3667899999999999999999999 999999
Q ss_pred CCCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCcccc-ccccCccceEeehhhHHHHHhh--cCCCCC
Q 006777 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT--CEYPYN 229 (631)
Q Consensus 157 Kp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l-~~~y~~~sDIwSLG~il~emlt--G~~Pf~ 229 (631)
||+||+++ .++.+||+|||++....... .....+++.|+|||.. .+.++.++|||||||++|||++ |..||.
T Consensus 157 kp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 157 ATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred ChheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999997 78999999999987543322 1223446789999965 4568999999999999999998 778997
Q ss_pred CCCCHHHHHHHHHc----C--CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 230 ECKNPAQIYKKVTS----G--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 230 ~~~~~~~~~~~i~~----~--~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.. +..+....... . ......+...++.+++||.+||. +|.+||++.++++
T Consensus 236 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 236 QL-SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cc-ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 63 33333322211 1 01111233456899999999998 8999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.18 Aligned_cols=246 Identities=25% Similarity=0.399 Sum_probs=204.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~----~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...|.+.+.||+|+||.||+|.++.+|. .||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 4679999999999999999999877665 58888776442 24556778999999999999999999998875
Q ss_pred CceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
...++||||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~~ 156 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGLA 156 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCccc
Confidence 3688999999999999998874 46999999999999999999999998 99999999999997 7889999999999
Q ss_pred hhccCCCC----ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 179 IVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 179 ~~~~~~~~----~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
........ ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+. ....+...+..+... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 234 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERL-PQPP 234 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCCCC-CCCC
Confidence 76543211 1122356899999775 568899999999999999998 99999874 556666666655332 3344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+..+.+++.+||. +|..||++.++++
T Consensus 235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 567899999999997 9999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=301.75 Aligned_cols=239 Identities=24% Similarity=0.375 Sum_probs=197.1
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEecc
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~ 110 (631)
++||+|+||.||+|.+.. |+.||+|.+..... ......+.+|++++++++||||+++++++.+.. ..++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--PIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--CeEEEEEcC
Confidence 468999999999999977 99999998875532 245677899999999999999999999876554 689999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCC---
Q 006777 111 TSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 186 (631)
Q Consensus 111 ~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~--- 186 (631)
.+++|.+++.+. ..+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceec
Confidence 999999998663 56899999999999999999999999 99999999999997 789999999999875432111
Q ss_pred -ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006777 187 -RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 187 -~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~ 263 (631)
....++..|+|||.+. +.++.++||||||+++|+|+| |..||... ........+..+.. ...+...+.++.++|.
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 229 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGYR-MPAPQLCPEEIYRLML 229 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCCC-CCCCccCCHHHHHHHH
Confidence 1223356799999775 458899999999999999999 88888763 44445555554422 2234556789999999
Q ss_pred HhcC-CCCCCCCHHHHhc
Q 006777 264 KCIV-PASLRLPALELLK 280 (631)
Q Consensus 264 kcL~-~p~~Rpta~elL~ 280 (631)
+||. +|.+||++.|+|+
T Consensus 230 ~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 230 QCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=316.16 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=203.0
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcC-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeE
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~-------~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~ 94 (631)
...+|.+.+.||+|+||.||+|.+.. .+..||+|.++.. ......+.+.+|+.+++++ +||||++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 34589999999999999999998643 2347899987643 2234567889999999999 89999999998
Q ss_pred EEcCCCceEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006777 95 WVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158 (631)
Q Consensus 95 f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp 158 (631)
+... ..+++|+||+++|+|.+++.+.. .++..++..++.||+.||.|||+++ ++||||||
T Consensus 87 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 162 (334)
T cd05100 87 CTQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAA 162 (334)
T ss_pred EccC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eecccccc
Confidence 8654 36899999999999999987632 3778889999999999999999999 99999999
Q ss_pred CceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCC
Q 006777 159 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECK 232 (631)
Q Consensus 159 ~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~ 232 (631)
+||+++ .++.+||+|||+++...... .....++..|+|||++. ..++.++||||||+++|+|++ |..||.+ .
T Consensus 163 ~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~ 240 (334)
T cd05100 163 RNVLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-I 240 (334)
T ss_pred ceEEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-C
Confidence 999997 78899999999987543321 11223456799999875 458899999999999999998 8889976 4
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 233 ~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+.......+..+..+. .+...+.++.+||.+||. +|.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 241 PVEELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5666666666654332 334567899999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=303.49 Aligned_cols=233 Identities=22% Similarity=0.362 Sum_probs=188.6
Q ss_pred EEEeecCCeEEEEEEEcCCC----------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 31 VVVLNCTFMCRYKGFDEVDG----------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g----------~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence 46899999999999998776 457777765432 115678899999999999999999998876
Q ss_pred ceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC-------cEEE
Q 006777 101 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-------EVKI 172 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-------~vKI 172 (631)
...++||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++ .+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~-~~~~~~~~~~~~kl 149 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVA-RYGLNEGYVPFIKL 149 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEe-cCccccCCceeEEe
Confidence 34689999999999999998766 7999999999999999999999998 99999999999998 555 7999
Q ss_pred ccccchhhccCCCCccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 006777 173 GDLGLAIVMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~ 248 (631)
+|||++..... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.... ........... .
T Consensus 150 ~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~---~ 223 (259)
T cd05037 150 SDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQ---H 223 (259)
T ss_pred CCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcC---C
Confidence 99999975443 234457788999998764 48899999999999999999 578887643 33322222221 1
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 249 ~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+......+.++|.+||. +|.+||++.++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1122223789999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=306.22 Aligned_cols=241 Identities=20% Similarity=0.293 Sum_probs=188.0
Q ss_pred EEeecCCeEEEEEEEcCC--CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 32 VVLNCTFMCRYKGFDEVD--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d~~~--g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
.||+|+||.||+|..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+.. .+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--PYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCCC--ccEEEEec
Confidence 589999999999975433 2356666655432 3445678999999999999999999999887543 68999999
Q ss_pred cCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC--
Q 006777 110 FTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-- 183 (631)
Q Consensus 110 ~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~-- 183 (631)
+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccccCcch
Confidence 9999999999764 34677888999999999999999998 99999999999997 789999999999853211
Q ss_pred --CCCccccCCCCCCCcccccc--------ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCC---CCCC
Q 006777 184 --PTARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI---KPAS 249 (631)
Q Consensus 184 --~~~~~~~GTp~y~APE~l~~--------~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~---~p~~ 249 (631)
.......+++.|+|||++.. .++.++||||||+++|||++ |..||............+.... ..+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 11234568899999998742 35778999999999999997 5678876444333333333221 1223
Q ss_pred CCCCCcHHHHHHHHHhcCCCCCCCCHHHHhc
Q 006777 250 LSKVTDPQVKQFIEKCIVPASLRLPALELLK 280 (631)
Q Consensus 250 l~~~~~~~lk~lI~kcL~~p~~Rpta~elL~ 280 (631)
+....++.++++|..|+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 234 LELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred cCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 3445678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=290.41 Aligned_cols=254 Identities=23% Similarity=0.379 Sum_probs=204.6
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|.-.++||+|.||+||+|++..+++.||+|.++.++- +...-....+|+-+|+.|+|.|||++++....+. .+-+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhsdk--kltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc--eeEE
Confidence 45567899999999999999999999999999998753 2222345789999999999999999999765544 6889
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 106 ITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
|+|||. .+|..|... ++.++.+.++.++.|++.||.|+|+++ +.||||||+|.+++ .+|++|++|||+|+.+.-+
T Consensus 79 vfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgip 154 (292)
T KOG0662|consen 79 VFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIP 154 (292)
T ss_pred eHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCCc
Confidence 999996 689988875 578999999999999999999999999 99999999999998 8999999999999877655
Q ss_pred C--CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--C-CCCCCC------
Q 006777 185 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I-KPASLS------ 251 (631)
Q Consensus 185 ~--~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~--~-~p~~l~------ 251 (631)
. ....+-|.+|++|.++-+ -|+...|+||.|||+.|+.....|...+.+.....++|... . ....|+
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 3 123456999999998754 49999999999999999998554543445555555554321 0 001111
Q ss_pred ------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 252 ------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 252 ------------------~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
...+..-++++.++|. +|..|.+|++.|+||||...
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 1113456899999997 99999999999999999764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.97 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=195.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|.....||+|+||.||+|... +|..||||++...... . ..+|.+|+.+|.+++|||+|++++|+.+... ..
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~ 147 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HR 147 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eE
Confidence 467777899999999999999974 5699999977654321 1 3449999999999999999999999987653 58
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 104 NMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+||+||++.|+|.+++.... .+++.....|+.+++.||+|||.. .|||||||||+.|||+| .+...||+|||+|+.
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCccc
Confidence 89999999999999998765 899999999999999999999995 45899999999999998 899999999999965
Q ss_pred ccC-CCC-ccc-cCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCC-----CHHHH-HHHHHcCC----C
Q 006777 181 MQQ-PTA-RSV-IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-----NPAQI-YKKVTSGI----K 246 (631)
Q Consensus 181 ~~~-~~~-~~~-~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~-----~~~~~-~~~i~~~~----~ 246 (631)
... ... .+. .||..|+|||.+. +..+.++||||||++++||+||+.|..... +.... ...+..+. .
T Consensus 227 ~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 227 GPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred CCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 543 222 222 8999999999886 578999999999999999999998876422 11121 22222221 1
Q ss_pred CCCCC-CCCc--HH---HHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 247 PASLS-KVTD--PQ---VKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 247 p~~l~-~~~~--~~---lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+.+. ...+ .. +..+..+|+. +|..||+..++++
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11221 2222 23 4456668998 7899999998643
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.44 Aligned_cols=250 Identities=30% Similarity=0.428 Sum_probs=202.7
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEE
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV 106 (631)
|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+..|+.+++.++||||+++++++.+. ..+++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc--cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEE
Confidence 6778999999999999999999999999999886531 223345677899999999999999999987655 478999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC
Q 006777 107 TELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~ 185 (631)
+||+. ++|.+++.+. ..+++..++.++.|++.||.|||+++ |+||||+|+||+++ .++.+||+|||++.......
T Consensus 77 ~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 77 FEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred ecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCCCc
Confidence 99998 6999999886 57999999999999999999999999 99999999999997 68999999999987554322
Q ss_pred --CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC-----------------
Q 006777 186 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG----------------- 244 (631)
Q Consensus 186 --~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~----------------- 244 (631)
.....+++.|+|||.+.+ .++.++|||||||++|+|++|..||..........+.....
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 223456788999997743 57889999999999999999999997644333222111100
Q ss_pred --CCCC-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 245 --IKPA-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 245 --~~p~-------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
..+. ......+..++++|.+||. +|.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000 0011236789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=305.88 Aligned_cols=240 Identities=24% Similarity=0.350 Sum_probs=194.0
Q ss_pred EEEeecCCeEEEEEEEcCCCe--EEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCceEEEEE
Q 006777 31 VVVLNCTFMCRYKGFDEVDGI--EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~--~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
++||+|+||.||+|.+..+|. .+|+|.++.. ......+.+.+|+.+++.+ +||||+++++++.... .+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--YLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--CceEEE
Confidence 368999999999999988775 4688877632 2344556788999999999 8999999999886543 689999
Q ss_pred eccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEE
Q 006777 108 ELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
||+++|+|.+++...+ .+++.+++.++.|++.||+|||+++ ++||||||+||+++ .++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCeEE
Confidence 9999999999987643 4789999999999999999999998 99999999999997 789999
Q ss_pred EccccchhhccCCC-CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCC
Q 006777 172 IGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 172 I~DFGlA~~~~~~~-~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~ 248 (631)
|+|||++....... ......++.|+|||++. ..++.++|||||||++|+|++ |..||.+ .+.......+..+..+
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~- 230 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL- 230 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-
Confidence 99999985322111 11123356799999875 458899999999999999997 9999976 4455556666554332
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 249 ~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+...+.++.++|.+|+. +|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2334567899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.96 Aligned_cols=240 Identities=24% Similarity=0.353 Sum_probs=196.6
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEecc
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~ 110 (631)
++||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++.... ..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--PIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--ccEEEEECC
Confidence 47899999999999864 68899999876432 2344557889999999999999999999876544 689999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCC---
Q 006777 111 TSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 186 (631)
Q Consensus 111 ~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~--- 186 (631)
++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++........
T Consensus 75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccccC
Confidence 999999998764 45899999999999999999999999 99999999999997 789999999999865432211
Q ss_pred ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006777 187 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 187 ~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~k 264 (631)
....+++.|+|||++. +.++.++||||||+++|+|++ |..||.+. +.......+..+... ..+...+..+.+||.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 229 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 1223466799999876 458889999999999999998 99999874 455555556554333 3344567899999999
Q ss_pred hcC-CCCCCCCHHHHhcC
Q 006777 265 CIV-PASLRLPALELLKD 281 (631)
Q Consensus 265 cL~-~p~~Rpta~elL~h 281 (631)
|+. +|.+||++.++++.
T Consensus 230 ~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 230 CWDYKPENRPKFSELQKE 247 (250)
T ss_pred HcccCcccCCCHHHHHHH
Confidence 998 89999999998763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.46 Aligned_cols=227 Identities=16% Similarity=0.229 Sum_probs=187.8
Q ss_pred cCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCCCCH
Q 006777 36 CTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL 115 (631)
Q Consensus 36 G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL 115 (631)
|.|+.||+|.++.+|+.||+|++..... ..+|...+....||||+++++++.+. ..+++||||+++|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---------~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---------YSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---------hhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCH
Confidence 8999999999999999999999875421 22345555666899999999988654 478999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCCccccCCCCC
Q 006777 116 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 195 (631)
Q Consensus 116 ~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~~~~GTp~y 195 (631)
.+++.+...+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||.+...... .....+++.|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~-~~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDS-CDGEAVENMY 148 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhccccc-cccCCcCccc
Confidence 999988888999999999999999999999999 99999999999998 7889999999987655433 2334567889
Q ss_pred CCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCC
Q 006777 196 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL 273 (631)
Q Consensus 196 ~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rp 273 (631)
+|||.+. +.++.++|+||+|+++|+|++|..||..... . + .......++...++.+++||.+||+ +|.+|+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~--~----~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS--G----I-NTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch--h----c-ccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 9999875 4588999999999999999999988864211 1 1 1111223445578899999999998 899999
Q ss_pred CH-----HHHhcCCCc
Q 006777 274 PA-----LELLKDPFL 284 (631)
Q Consensus 274 ta-----~elL~hpff 284 (631)
++ .++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 96 899999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.84 Aligned_cols=244 Identities=19% Similarity=0.370 Sum_probs=201.5
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
..|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|++++++++||||+++++++.... .++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 75 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS--PIC 75 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC--ceE
Confidence 47899999999999999999885 477899998864432 1245788999999999999999999876543 689
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+|+||+.+++|.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeeccc
Confidence 999999999999998764 46899999999999999999999999 99999999999997 788999999999865433
Q ss_pred CCCc---cccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 184 PTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~~~~---~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.... ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .........+..+..+. .+...+..+
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 230 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRLY-KPRLASQSV 230 (256)
T ss_pred CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCCC-CCCCCCHHH
Confidence 2211 223456899999876 468889999999999999998 9999976 44556666666553332 234567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 259 KQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+|+.+||+ +|.+||++.+++++
T Consensus 231 ~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 231 YELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHcccChhhCCCHHHHHHh
Confidence 999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=307.71 Aligned_cols=236 Identities=19% Similarity=0.333 Sum_probs=188.6
Q ss_pred EEEeecCCeEEEEEEEcCCCe-------EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 31 VVVLNCTFMCRYKGFDEVDGI-------EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~-------~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
+.||+|+||.||+|.+...+. .||+|.+... .....+.+..|+.+++.++||||+++++++.... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--Cc
Confidence 468999999999999865544 4888876533 2344567889999999999999999999987654 57
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc--------EEEcc
Q 006777 104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--------VKIGD 174 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~--------vKI~D 174 (631)
++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++. ++++|
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLI-REEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEe-cccccccCCCceEEecc
Confidence 89999999999999998754 5899999999999999999999999 99999999999997 3433 79999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcC-CCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006777 175 LGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCE-YPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 175 FGlA~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~-~Pf~~~~~~~~~~~~i~~~~~p~~l~ 251 (631)
||++..... .....+++.|+|||++.+ .++.++||||||+++|+|++|. .||.. ............ ...++
T Consensus 152 ~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~~---~~~~~ 225 (258)
T cd05078 152 PGISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYED---RHQLP 225 (258)
T ss_pred cccccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHHc---cccCC
Confidence 999865432 234568899999998864 4789999999999999999985 66654 333332222222 12233
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.....++.+||.+||+ +|.+|||+.++++.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 3455789999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=336.65 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=218.6
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~ 98 (631)
..+-.+.|+|.++||+|.+|.||++..+.+|+.+|+|+..... +..+++..|.++|+.+ +|||++.+|++|.-.
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 4445678999999999999999999999999999999876543 2334566788888877 799999999998743
Q ss_pred C---CceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEc
Q 006777 99 T---NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 99 ~---~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~ 173 (631)
+ .+.+|||||||.|||.-+++++. .++.|..|..+++.++.||.+||.+. +||||||-.|||++ .+|.|||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT-~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT-ENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe-ccCcEEEe
Confidence 2 35899999999999999998864 46899999999999999999999998 99999999999998 79999999
Q ss_pred cccchhhccCC--CCccccCCCCCCCcccccc------ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006777 174 DLGLAIVMQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 174 DFGlA~~~~~~--~~~~~~GTp~y~APE~l~~------~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~ 245 (631)
|||++..+... ...+.+|||+|||||++.. .|+..+|+||||++..||.-|.+|+.+ ..+....-.|..+.
T Consensus 166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D-mHPmraLF~IpRNP 244 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNP 244 (953)
T ss_pred eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC-cchhhhhccCCCCC
Confidence 99999877554 4567899999999998842 378899999999999999999999987 34444444444443
Q ss_pred CCCCC-CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 246 KPASL-SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 246 ~p~~l-~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+|... ++.++.++.+||..||. +-.+||+..++|+|||+...
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 43333 56688999999999998 88999999999999999843
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=299.23 Aligned_cols=244 Identities=21% Similarity=0.319 Sum_probs=200.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
....|.+.+.||+|+||.||+|.+. .+..||+|.+... ....+.+.+|+.+++.++|+||+++++.+.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~ 74 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EP 74 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CC
Confidence 3568999999999999999999864 5667999987643 2345678899999999999999999998765 36
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+++|||+++|+|.+++.+. ..++...+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~ 151 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARV 151 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCcceee
Confidence 88999999999999999764 35788999999999999999999998 99999999999997 789999999999865
Q ss_pred ccCCC---CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 181 MQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~~---~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
..... .....++..|+|||++.. .++.++|+||||+++|+|+| |..||.+. +.......+..+.... .....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 229 (260)
T cd05073 152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMP-RPENCP 229 (260)
T ss_pred ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCCC-CcccCC
Confidence 43321 112235667999998764 57889999999999999999 89999864 4445555555553332 334567
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.++.+++.+|+. +|.+||++.+++.
T Consensus 230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 230 EELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 899999999998 8999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.10 Aligned_cols=239 Identities=20% Similarity=0.354 Sum_probs=199.3
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
..|++.+.||+|+||.||++. .++..||+|.+.... ..+.+.+|+.+++.++||||+++++++..+ ..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~ 74 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLY 74 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcE
Confidence 569999999999999999997 478899999886432 235688999999999999999999987543 368
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 105 MITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+||||+.+|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGS 151 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCccceecc
Confidence 9999999999999997653 4899999999999999999999998 99999999999997 78999999999986543
Q ss_pred CCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 183 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.. ......+..|+|||.+. +.++.++|+|||||++|+|++ |..||.. .+.......+..+..+. .+...++.+++
T Consensus 152 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (254)
T cd05083 152 MG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK-MSLKEVKECVEKGYRME-PPEGCPADVYV 228 (254)
T ss_pred cc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhCCCCCC-CCCcCCHHHHH
Confidence 32 22234467899999775 468899999999999999998 9999976 44555666666654433 34456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 006777 261 FIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~ 280 (631)
+|.+||. +|..||++.+++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 9999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.43 Aligned_cols=263 Identities=21% Similarity=0.327 Sum_probs=221.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
+.-|..++.||-|+||.|-++....+...||.|.+.+.++.. ..+...++.|-.||..-+.+-||++|.+|.|.+ .+
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--nL 704 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NL 704 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--ce
Confidence 456889999999999999999998999999999998887643 456678889999999999999999999998766 69
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc--
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-- 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~-- 181 (631)
||||+|++||++-.+|-+-+.|+|..++.++..+.+|+++.|..| +|||||||+||||+ .+|+|||.||||++-+
T Consensus 705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeecccccccee
Confidence 999999999999999999999999999999999999999999999 99999999999998 8999999999998521
Q ss_pred -------cCC-----------------------------------CCccccCCCCCCCccccc-cccCccceEeehhhHH
Q 006777 182 -------QQP-----------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 218 (631)
Q Consensus 182 -------~~~-----------------------------------~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il 218 (631)
... .+...+||+.|+|||++. .+|+...|+||.|+||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 100 011457999999999875 5799999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCcHHHHHHHHHhcCCCCCCCC---HHHHhcCCCccCCCCCcc
Q 006777 219 LEMVTCEYPYNECKNPAQIYKKVTSG-IKPASLSKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 219 ~emltG~~Pf~~~~~~~~~~~~i~~~-~~p~~l~~~~~~~lk~lI~kcL~~p~~Rpt---a~elL~hpff~~~~~~~~ 292 (631)
|||+.|+.||.........++.+.-. ..........++++.++|.++...++.|.. ++++-.||||+..++..+
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfssl 939 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSL 939 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhh
Confidence 99999999998754444333333211 112233445789999999999988888775 778999999999877664
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.17 Aligned_cols=250 Identities=24% Similarity=0.418 Sum_probs=204.3
Q ss_pred cEEEEEEEeecCCeEEEEEEEcC-CCeEEEEEEeeccccc------CCHHHHHHHHHHHHHHHh-CCCCCcceeeeEEEc
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEV-DGIEVAWNQVNIEDVM------QSPDQLERLYSEVHLLKS-LKHENIIKFYNSWVD 97 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~-~g~~VAvK~v~~~~~~------~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~f~~ 97 (631)
.|++.+.||+|+||.||+|.+.. .+..||+|++...... .......++.+|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 6889999998754321 223455677889988875 799999999998865
Q ss_pred CCCceEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 98 DTNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
. ..+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++||||+|+||+++ .++.+||
T Consensus 81 ~--~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l 155 (269)
T cd08528 81 N--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTI 155 (269)
T ss_pred C--CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEE
Confidence 4 479999999999999998743 3468999999999999999999996 56 99999999999997 7899999
Q ss_pred ccccchhhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006777 173 GDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 173 ~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l 250 (631)
+|||++...... ......|+..|+|||.+.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..++..
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLP 234 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCC
Confidence 999999765443 2345678999999998754 588999999999999999999999976 3444455555554433333
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
....++.+.+||.+||. +|.+||++.|+..+
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 34567899999999998 89999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.74 Aligned_cols=257 Identities=20% Similarity=0.212 Sum_probs=194.7
Q ss_pred CccCccCCCcEEEEEEEeecCCeEEEEEEEcCC---CeEEEEEEeecccccCCHHH-------HHHHHHHHHHHHhCCCC
Q 006777 17 EPISSSVSYFWISWVVVLNCTFMCRYKGFDEVD---GIEVAWNQVNIEDVMQSPDQ-------LERLYSEVHLLKSLKHE 86 (631)
Q Consensus 17 ~~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~---g~~VAvK~v~~~~~~~~~~~-------~~~~~~Ei~iL~~L~Hp 86 (631)
.++......+|.+.++||+|+||+||+|.+..+ +..+|+|...........+. ......+...+..+.|+
T Consensus 4 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~ 83 (294)
T PHA02882 4 IPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL 83 (294)
T ss_pred eeeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence 455667788999999999999999999998877 67788876544321100000 01122344556678999
Q ss_pred CcceeeeEEEcCCC--ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe
Q 006777 87 NIIKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164 (631)
Q Consensus 87 nIV~l~~~f~~~~~--~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 164 (631)
||+++++.+..... ...+++++++. .++.+++......++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~ 160 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD 160 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc
Confidence 99999987654432 24567888875 578888877666889999999999999999999998 99999999999997
Q ss_pred CCCCcEEEccccchhhccCC---------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH
Q 006777 165 GNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP 234 (631)
Q Consensus 165 ~~~g~vKI~DFGlA~~~~~~---------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~ 234 (631)
.++.+||+|||+|+..... ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+....
T Consensus 161 -~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 161 -GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred -CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 6889999999999754211 1223579999999998764 5899999999999999999999999875333
Q ss_pred HHH--------HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 235 AQI--------YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 235 ~~~--------~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
... ...+..+.. .....++++.+++..|+. +|.+||+..+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 240 GNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222 222322211 123346889999999998 9999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.91 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=201.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEc----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDE----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...|.+.+.||+|+||.||+|... .++..||+|.+..... ....+.+.+|+.+++.+.||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 346788899999999999999864 3488999999875532 145677999999999999999999999887766
Q ss_pred CceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
...+++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~ 156 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLA 156 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccccc
Confidence 668999999999999999998765 6999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCCCC-----ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHH--------------HHH
Q 006777 179 IVMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------------QIY 238 (631)
Q Consensus 179 ~~~~~~~~-----~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~--------------~~~ 238 (631)
........ ....++..|+|||.+. ..++.++||||||+++|+|+||..||....... .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 76542211 1223456799999765 468889999999999999999999986532211 112
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+..+... ..+...+.++.+|+.+||. +|..||++.+++.
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222222221 2233456889999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.43 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=200.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~----~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 4578889999999999999999887776 46888775432 234445688999999999999999999987643
Q ss_pred CceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..++++||+++|+|.+++..++ .+++..+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~ 156 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLA 156 (303)
T ss_pred --CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEcccccc
Confidence 3578999999999999988754 5899999999999999999999998 99999999999997 7889999999999
Q ss_pred hhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 179 IVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 179 ~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
....... .....+++.|+|||.+. ..++.++|||||||++|||++ |..||.+. ........+..+..+. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~ 234 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLP-QPP 234 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCCC-CCC
Confidence 7554321 12234577899999876 458899999999999999997 89999763 3444444554443332 334
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..+..++++|.+|+. +|.+||++.++++.
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 567899999999998 89999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.45 Aligned_cols=248 Identities=20% Similarity=0.280 Sum_probs=199.8
Q ss_pred EEEEEEEeecCCeEEEEEEEcC---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC---
Q 006777 27 WISWVVVLNCTFMCRYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 100 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~---~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~--- 100 (631)
|.+.++||+|+||.||+|.++. +|..||+|++..+. ......+++.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 6778999999999999998653 57899999987543 234556778999999999999999999998865432
Q ss_pred -ceEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEc
Q 006777 101 -RTINMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~l~~~------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~ 173 (631)
...+++++|+.+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++ .++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEEC
Confidence 1347889999999999887532 24789999999999999999999998 99999999999997 78899999
Q ss_pred cccchhhccCCC----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 006777 174 DLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 174 DFGlA~~~~~~~----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p 247 (631)
|||++....... .....+++.|++||.+.. .++.++|||||||++|+|++ |..||.+ .+.......+..+..+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL 234 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC
Confidence 999987543221 223345678999998754 57889999999999999999 8899876 4455555555554332
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
. .+...++.+.+++.+||. +|..||++.+++.+
T Consensus 235 ~-~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 K-QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred C-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 233456899999999998 89999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.70 Aligned_cols=236 Identities=19% Similarity=0.288 Sum_probs=185.5
Q ss_pred EEeecCCeEEEEEEEcCC------------------------CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC
Q 006777 32 VVLNCTFMCRYKGFDEVD------------------------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN 87 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d~~~------------------------g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 87 (631)
.||+|+||.||+|....+ ...||+|.+.... ......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 589999999999975322 2468888876432 234567888999999999999
Q ss_pred cceeeeEEEcCCCceEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC
Q 006777 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 88 IV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 166 (631)
|+++++++.+.. ..++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+||+++..
T Consensus 78 iv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 999999887654 68899999999999999876 467899999999999999999999998 9999999999999721
Q ss_pred ------CCcEEEccccchhhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHh-hcCCCCCCCCCHHHH
Q 006777 167 ------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQI 237 (631)
Q Consensus 167 ------~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~eml-tG~~Pf~~~~~~~~~ 237 (631)
.+.+||+|||++..... .....+++.|+|||.+.+ .++.++|||||||++|||+ +|..||... .+.+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~--~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALS--REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER-TPSEK 230 (274)
T ss_pred CcccCccceeeecCCcccccccc--ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc-ChHHH
Confidence 22489999998754322 123457889999998754 4889999999999999985 699999764 33333
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 238 ~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
...+.... .++....+.+.++|.+||. +|.+||++.++|++
T Consensus 231 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222211 1222345789999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=300.92 Aligned_cols=236 Identities=19% Similarity=0.317 Sum_probs=186.1
Q ss_pred EEEeecCCeEEEEEEEcC------------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 31 VVVLNCTFMCRYKGFDEV------------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~------------~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
+.||+|+||.||+|.... ....||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 468999999999998532 23468888765432 34456788899999999999999999988755
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc-------E
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-------V 170 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~-------v 170 (631)
. ..++||||+++|+|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +
T Consensus 77 ~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~~~~~~~~ 151 (262)
T cd05077 77 V--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLA-REGIDGECGPFI 151 (262)
T ss_pred C--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEe-cCCccCCCCcee
Confidence 4 578999999999999998764 56999999999999999999999999 99999999999997 4443 8
Q ss_pred EEccccchhhccCCCCccccCCCCCCCccccc--cccCccceEeehhhHHHHHh-hcCCCCCCCCCHHHHHHHHHcCCCC
Q 006777 171 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 171 KI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~eml-tG~~Pf~~~~~~~~~~~~i~~~~~p 247 (631)
|++|||++..... .....+++.|+|||.+. ..++.++|||||||++|+|+ +|..||... ...+.. ....+..+
T Consensus 152 ~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~-~~~~~~~~ 227 (262)
T cd05077 152 KLSDPGIPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-RFYEGQCM 227 (262)
T ss_pred EeCCCCCCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHH-HHHhcCcc
Confidence 9999999864432 23456788999999875 45889999999999999998 588888753 332222 22222111
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.....++++++||.+||. +|.+||+..+|+.+
T Consensus 228 --~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 --LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 122235789999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.74 Aligned_cols=210 Identities=30% Similarity=0.488 Sum_probs=181.0
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...-.+.|.-.+.||+||||.||+++++++|+.||||.++... +....++.-+|+++|++|+|||||+++++=.+..
T Consensus 8 ~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 8 TSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKF 84 (732)
T ss_pred ccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence 3444578888999999999999999999999999999998654 4556778899999999999999999998543333
Q ss_pred ----CceEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe-CCCCc--
Q 006777 100 ----NRTINMITELFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGE-- 169 (631)
Q Consensus 100 ----~~~l~lV~Ey~~gGsL~~~l~~---~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~-~~~g~-- 169 (631)
.....+|||||.||||+.++.+ +..+++.++..++..+..||.|||.+| |+||||||+||++. |.+|+
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceE
Confidence 3356799999999999999975 356999999999999999999999999 99999999999985 34453
Q ss_pred EEEccccchhhccCC-CCccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCH
Q 006777 170 VKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNP 234 (631)
Q Consensus 170 vKI~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~ 234 (631)
-||+|||.|+.+... ...+++||+.|.+||+++ +.|+..+|.|||||++|+.+||..||.....+
T Consensus 163 yKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred EeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 599999999877544 567899999999999998 46899999999999999999999999765444
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=299.50 Aligned_cols=239 Identities=25% Similarity=0.384 Sum_probs=193.3
Q ss_pred EEeecCCeEEEEEEEcCCC------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 32 VVLNCTFMCRYKGFDEVDG------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d~~~g------~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.||+|+||.||+|.++..+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+.. ..++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE--PQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--CeEE
Confidence 6899999999999986544 789999876432 1234567889999999999999999999886544 6899
Q ss_pred EEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC-----cEEEc
Q 006777 106 ITELFTSGSLRQYRKKH-------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-----EVKIG 173 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~-------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-----~vKI~ 173 (631)
||||+++|+|.+++.+. ..+++.++..++.||+.||.|||+.+ ++|+||||+||+++ .++ .+||+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVS-EKGYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEe-cCCCCCCcceEEC
Confidence 99999999999998753 34788999999999999999999998 99999999999998 555 89999
Q ss_pred cccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 006777 174 DLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 174 DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p 247 (631)
|||++....... .....++..|+|||.+. +.++.++|||||||++|+|+| |..||... +.......+..+..+
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~ 232 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGRL 232 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcCCcc
Confidence 999986543221 12234578899999775 458999999999999999998 99999764 444555555544322
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+...+..+.+||.+||. +|.+||++.+++.
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 -QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2334567899999999998 8999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=326.54 Aligned_cols=244 Identities=21% Similarity=0.342 Sum_probs=207.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
....|.+...+|.|+|+.|-.+.+..+++..++|++...... ..+|+.++... +||||+++++.+.+ ..
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~--------~~~e~~~~~~~~~h~niv~~~~v~~~--~~ 389 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD--------NQDEIPISLLVRDHPNIVKSHDVYED--GK 389 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc--------cccccchhhhhcCCCcceeecceecC--Cc
Confidence 467889999999999999999999999999999999865221 23466555444 89999999997754 45
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+|+|||++.||-|.+-+...+.+. ..+..|+.||+.|+.|||.+| |+||||||+|||+.+..|+++|+|||.++..
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 7999999999999988877766555 788899999999999999999 9999999999999547899999999999876
Q ss_pred cCCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 182 QQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
+.. ..+.+-|..|.|||++. .+|++++||||||+++|+||+|..||....+..+++.++..+ .+...++..+|+
T Consensus 467 ~~~-~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~----~~s~~vS~~AKd 541 (612)
T KOG0603|consen 467 ERS-CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP----KFSECVSDEAKD 541 (612)
T ss_pred chh-hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC----ccccccCHHHHH
Confidence 655 33445688999999886 469999999999999999999999998766666777777654 333678899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
||.+||+ +|.+|+++.+++.||||
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHhccCChhhCcChhhhccCcch
Confidence 9999998 99999999999999999
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=329.67 Aligned_cols=256 Identities=20% Similarity=0.236 Sum_probs=181.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCC----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc-
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVD----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD- 97 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~----g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~- 97 (631)
..++|.+.++||+|+||.||+|.+..+ +..||+|++.... ..+....+ .++...+.+++.+...|..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 457899999999999999999999988 9999999875321 11111111 1223334444443332221
Q ss_pred ---CCCceEEEEEeccCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 006777 98 ---DTNRTINMITELFTSGSLRQYRKKHKN--------------------VDMKAIKNWARQILRGLHYLHSHNPPIIHR 154 (631)
Q Consensus 98 ---~~~~~l~lV~Ey~~gGsL~~~l~~~~~--------------------l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 154 (631)
.....+++|+||+.+++|.+++..... .....++.++.||+.||.|||+++ |+||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 334578999999999999999875421 123457789999999999999998 9999
Q ss_pred CCCCCceEEeCCCCcEEEccccchhhccCC---CCccccCCCCCCCcccccc-----------------------ccCcc
Q 006777 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-----------------------EYNEL 208 (631)
Q Consensus 155 DLKp~NILl~~~~g~vKI~DFGlA~~~~~~---~~~~~~GTp~y~APE~l~~-----------------------~y~~~ 208 (631)
||||+|||++..++.+||+|||+|+..... ....+++|+.|+|||.+.. .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999999855689999999999755332 2346789999999996521 23456
Q ss_pred ceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC----------CCC---C------CCCCCcHHHHHHHHHhcC-C
Q 006777 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------KPA---S------LSKVTDPQVKQFIEKCIV-P 268 (631)
Q Consensus 209 sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~----------~p~---~------l~~~~~~~lk~lI~kcL~-~ 268 (631)
+|||||||++|||+++..|+.. +..+....+.... .+. . .....+....+||.+||+ +
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 7999999999999998766542 2223322222110 000 0 011123445699999998 9
Q ss_pred CCCCCCHHHHhcCCCccCCCCC
Q 006777 269 ASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 269 p~~Rpta~elL~hpff~~~~~~ 290 (631)
|.+|||+.++|+||||+...+.
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCcc
Confidence 9999999999999999886554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.88 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=211.4
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHH-HhCCCCCcceeeeEEEcCCCceEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
..+-+..||.|+||+|++..++.+|+..|||+|+.... ..+..++..|.... +.-+.||||+||+..+.+. ..|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--dcW 139 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--DCW 139 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--cee
Confidence 33446789999999999999999999999999987643 56677888888764 5558999999999877654 578
Q ss_pred EEEeccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 105 MITELFTSGSLRQYRK-----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~-----~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
+.||+|. .||..+-+ +..+++|..+-.+..-.+.||.||-..- .|||||+||+|||++ ..|.|||||||++.
T Consensus 140 iCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILld-r~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 140 ICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLD-RHGDVKLCDFGICG 216 (361)
T ss_pred eeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEe-cCCCEeeecccchH
Confidence 9999996 67766533 3467999999999999999999996642 399999999999998 78999999999998
Q ss_pred hccCCCCccc-cCCCCCCCccccc---cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC---
Q 006777 180 VMQQPTARSV-IGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--- 252 (631)
Q Consensus 180 ~~~~~~~~~~-~GTp~y~APE~l~---~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~--- 252 (631)
.+....+.+. .|...|||||.+. .+|+.++|+||||+++||++||.+||.+..+..+....+..|-+|.-...
T Consensus 217 qLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~ 296 (361)
T KOG1006|consen 217 QLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKEC 296 (361)
T ss_pred hHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccc
Confidence 7776655543 7889999999885 35999999999999999999999999988777776777777766554332
Q ss_pred -CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 253 -VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 253 -~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
..+..++.||.-||. +.+.||...+|+++||++.
T Consensus 297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 257899999999997 8899999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=330.81 Aligned_cols=246 Identities=21% Similarity=0.302 Sum_probs=205.9
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
+.+-+..+.||+|+||.||+|... .....||||.++... +.+..+.|.+|+.+|..|+|||||+|++++...
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 456677899999999999999763 345689999887542 355778899999999999999999999988655
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHK--------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~--------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 164 (631)
+ .++||+|||..|+|.+||..+. +++..+...++.||+.|++||-++. ++||||-..|+||.
T Consensus 562 ~--P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 562 D--PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG 637 (774)
T ss_pred C--eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec
Confidence 4 7999999999999999997542 2788899999999999999999999 99999999999996
Q ss_pred CCCCcEEEccccchhhcc-CCCCc---cccCCCCCCCcc-ccccccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHH
Q 006777 165 GNNGEVKIGDLGLAIVMQ-QPTAR---SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 238 (631)
Q Consensus 165 ~~~g~vKI~DFGlA~~~~-~~~~~---~~~GTp~y~APE-~l~~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~ 238 (631)
++..|||+|||+++..- ....+ ...-..+||||| ++.++|+.++|||||||++||+++ |..||.+.. .++.+
T Consensus 638 -e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-n~EVI 715 (774)
T KOG1026|consen 638 -ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-NQEVI 715 (774)
T ss_pred -cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-hHHHH
Confidence 88899999999997432 22111 112356899999 457889999999999999999998 899999854 45667
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 006777 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL 279 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL 279 (631)
+.|..+.. ..-+...+.++..|+..|++ .|.+||+..||-
T Consensus 716 e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 716 ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 78888866 44556788999999999998 899999999863
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.59 Aligned_cols=269 Identities=22% Similarity=0.303 Sum_probs=211.3
Q ss_pred ccccCccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceee
Q 006777 13 CMSLEPISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92 (631)
Q Consensus 13 ~~s~~~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~ 92 (631)
..+...+.......|.-..++|+|.||.||+|..+.+|+.||+|.+-.+.-. ...-....+|+++|..|+|+|++.+.
T Consensus 5 ~~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK--eGfpitalreikiL~~lkHenv~nli 82 (376)
T KOG0669|consen 5 KDSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 82 (376)
T ss_pred hhcccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc--cCCcHHHHHHHHHHHHhcchhHHHHH
Confidence 3344455666777888899999999999999999999999999877653211 11224467899999999999999887
Q ss_pred eEEEc------CCCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC
Q 006777 93 NSWVD------DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 93 ~~f~~------~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
+.+-. ..+..+|+|+++|+ -+|..++... .+++..+|+.++.+++.||.|+|... |+|||+|+.|+||+
T Consensus 83 Eic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt- 158 (376)
T KOG0669|consen 83 EICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLIT- 158 (376)
T ss_pred HHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEc-
Confidence 64422 22346999999998 4898888776 57999999999999999999999999 99999999999998
Q ss_pred CCCcEEEccccchhhccCCC------CccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHH
Q 006777 166 NNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237 (631)
Q Consensus 166 ~~g~vKI~DFGlA~~~~~~~------~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~ 237 (631)
.+|.+||+|||+|+.+.... ....+-|.+|++||.+- .+|+++.|||..||++.||.|+.+-+.+..+..++
T Consensus 159 ~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql 238 (376)
T KOG0669|consen 159 KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL 238 (376)
T ss_pred CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH
Confidence 78999999999997654322 12235599999999764 46999999999999999999999999875544433
Q ss_pred H--HHHHcCCCCCCCC------------------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 238 Y--KKVTSGIKPASLS------------------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 238 ~--~~i~~~~~p~~l~------------------------------~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
. ..+...+.+..|+ -+.++++.+|++++|. ||.+|+.+.++|+|.||
T Consensus 239 ~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 239 HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 1 1111111111111 1236789999999999 99999999999999999
Q ss_pred cCC
Q 006777 285 VTD 287 (631)
Q Consensus 285 ~~~ 287 (631)
.++
T Consensus 319 ~kd 321 (376)
T KOG0669|consen 319 WKD 321 (376)
T ss_pred hcC
Confidence 764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=333.06 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=204.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcC-CCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEV-DGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~-~g~----~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
-...-+..+.||+|+||.||.|.-.. .|. .||+|.++.. .+..+...|.+|..+|+.++|||||++.+...+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 35678889999999999999997643 232 4888876643 356778889999999999999999999998877
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcE
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH-------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~-------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 170 (631)
....++++|||+||+|+.|+++. ..++...+..++.||+.|.+||++++ +|||||.+.|+|++ ....|
T Consensus 767 --~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~-~~r~V 841 (1025)
T KOG1095|consen 767 --SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLD-ERRVV 841 (1025)
T ss_pred --CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeec-ccCcE
Confidence 34688999999999999999875 24899999999999999999999999 99999999999998 67899
Q ss_pred EEccccchhhccCCCCccc----cCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006777 171 KIGDLGLAIVMQQPTARSV----IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 171 KI~DFGlA~~~~~~~~~~~----~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~ 244 (631)
||+|||+|+..-....... .-...|||||.+. +.++.++|||||||++||++| |..||.+..+.+.+......+
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 9999999984322211111 2245899999876 679999999999999999999 889998865555544455555
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 245 ~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
....+..++..+.+++..|+. +|.+||+...|++
T Consensus 922 --RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 --RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 334556778888999999998 9999999999988
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=281.32 Aligned_cols=240 Identities=34% Similarity=0.577 Sum_probs=205.2
Q ss_pred CCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCCCCHH
Q 006777 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLR 116 (631)
Q Consensus 37 ~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~ 116 (631)
+||.||+|.+..+|..||+|++...... ...+.+.+|++.+++++|+||+++++.+... ...++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHH
Confidence 5899999999988999999998765421 1157789999999999999999999988654 4789999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC-CCccccCCCCC
Q 006777 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEF 195 (631)
Q Consensus 117 ~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~-~~~~~~GTp~y 195 (631)
.++.....++...+..++.|++.+|.|||+.+ ++|+||+|+||+++ .++.++|+|||.+...... ......+++.|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCCcCC
Confidence 99988777999999999999999999999998 99999999999998 6799999999999765543 34456789999
Q ss_pred CCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC-CcHHHHHHHHHhcC-CCCCC
Q 006777 196 MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV-TDPQVKQFIEKCIV-PASLR 272 (631)
Q Consensus 196 ~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~-~~~~lk~lI~kcL~-~p~~R 272 (631)
+|||.+. ..++.++||||||+++++|++|..||....+...+...+..+..+...... .+..+.+++.+||. +|.+|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999875 568889999999999999999999998756667777766665443322222 67899999999998 99999
Q ss_pred CCHHHHhcCCCc
Q 006777 273 LPALELLKDPFL 284 (631)
Q Consensus 273 pta~elL~hpff 284 (631)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=296.53 Aligned_cols=269 Identities=17% Similarity=0.284 Sum_probs=223.0
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCce
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~ 102 (631)
...|.++++||+|+|++|-++..+.+.+.+|+|+++.+-+ +..+..+=+..|-++..+- +||.+|.++..|..+. +
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~-nddedidwvqtek~vfe~asn~pflvglhscfqtes--r 325 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES--R 325 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc-CCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc--e
Confidence 4678999999999999999999999999999999987654 3344556667777777766 7999999999887655 7
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc-
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM- 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~- 181 (631)
+++|.||++||+|--++++...++++.++.+...|..||.|||++| ||+||||.+|||++ ..|++||.|+|.++.-
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlld-aeghikltdygmcke~l 402 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEc-cCCceeecccchhhcCC
Confidence 9999999999999999999999999999999999999999999999 99999999999998 7899999999998643
Q ss_pred -cCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCC--C-----CCHHHHHHHHHcCCCCCCCCC
Q 006777 182 -QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNE--C-----KNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 182 -~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~--~-----~~~~~~~~~i~~~~~p~~l~~ 252 (631)
......++||||.|.|||++++ .|+..+|+|+||++++||+.|+.||.- . +..+-+++.|.+. ...++.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--qiripr 480 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--QIRIPR 480 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--cccccc
Confidence 2345678999999999999986 599999999999999999999999952 1 2233345555443 223444
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCC------HHHHhcCCCccCCCCCccccCCCCCC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLP------ALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpt------a~elL~hpff~~~~~~~~~~~~l~~p 300 (631)
..+-.+..+++..|. +|.+|.. ..++-.||||+...|..+.++....|
T Consensus 481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~pp 535 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPP 535 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCC
Confidence 455667788888887 8888775 56899999999999887665544333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.31 Aligned_cols=259 Identities=27% Similarity=0.435 Sum_probs=226.3
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.-.+.|...+.+|.|+||.||+|+|+.+|+..|+|+|+.+.- +...-+.+|+-+++.++|||||.+++.+...+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~----dd~~~iqqei~~~~dc~h~nivay~gsylr~d-- 85 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG----DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-- 85 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC----ccccccccceeeeecCCCcChHHHHhhhhhhc--
Confidence 446789999999999999999999999999999999998753 33445678999999999999999999987655
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+|+.||||.||+|.+.-.-.+++++.++...++..+.||+|||+.+ -+|||||-.||+++ +.|.||++|||.+..+
T Consensus 86 klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLADFGVSAQI 162 (829)
T ss_pred CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecccCchhhh
Confidence 68999999999999998888899999999999999999999999999 89999999999998 8999999999999766
Q ss_pred cCC--CCccccCCCCCCCcccc----ccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC--C
Q 006777 182 QQP--TARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--V 253 (631)
Q Consensus 182 ~~~--~~~~~~GTp~y~APE~l----~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~--~ 253 (631)
... ..++++|||+|||||+- .+.|+..+|||++|+...|+.-.+.|.........++-.-+++..|+.+.. .
T Consensus 163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~k 242 (829)
T KOG0576|consen 163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTK 242 (829)
T ss_pred hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCcc
Confidence 543 45689999999999975 367999999999999999999999998775444555556667777776653 4
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
+++.+.+|++.+|. +|.+||+++.+|.|||......
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~ 279 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLS 279 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccchh
Confidence 78999999999997 8999999999999999976543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=282.18 Aligned_cols=253 Identities=20% Similarity=0.323 Sum_probs=212.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~ 101 (631)
..+.|++.+++|+|.|+.||.|.+..+++.++||.++. -...++.+|+.+|+.|. ||||+++++...+....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 45789999999999999999999999999999999873 34567899999999997 99999999998888888
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
...+|+||+...+.+++- ..++...|+.++.|++.||.|||+.| |+|||+||.|++++.....++|+|+|+|..+
T Consensus 109 tpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred CchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhc
Confidence 889999999998887665 45888999999999999999999999 9999999999999977778999999999887
Q ss_pred cCCCC-ccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCC-CCCCCHHHHHHHHHc--------------
Q 006777 182 QQPTA-RSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTS-------------- 243 (631)
Q Consensus 182 ~~~~~-~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf-~~~~~~~~~~~~i~~-------------- 243 (631)
..... +-.+.+..|--||++. ..|+..-|+|||||++..|+..+-|| .+..|.+|+.+...-
T Consensus 184 Hp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 184 HPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred CCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 76543 3345678899999875 45899999999999999999988886 455677776543210
Q ss_pred -CCC-------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 244 -GIK-------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 -~~~-------------------p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
... +..-....++++.+||.++|. |..+|+||.|.+.||||.+.
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 000 011112357999999999999 99999999999999999763
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.53 Aligned_cols=257 Identities=21% Similarity=0.332 Sum_probs=210.2
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC------CCCcceeee
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK------HENIIKFYN 93 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~------HpnIV~l~~ 93 (631)
+..+..+|.+....|+|-|++|-.|.|...|.+||||+|...+++ ...=++|+++|+.|+ --|+++|+-
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-----HKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-----hhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 445678999999999999999999999999999999999866543 234567999999994 348999998
Q ss_pred EEEcCCCceEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcE
Q 006777 94 SWVDDTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 94 ~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~---~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 170 (631)
.|... .+++||+|.+. .+|++.+++.+ .|...+++.|+.|++.||..|-.+| |+|.||||+|||++.....+
T Consensus 502 ~F~hk--nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 502 HFKHK--NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred Hhhhc--ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCccee
Confidence 88654 47999999994 89999999876 4899999999999999999999999 99999999999999777789
Q ss_pred EEccccchhhccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHH-cCCCCC
Q 006777 171 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-SGIKPA 248 (631)
Q Consensus 171 KI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~-~~~~p~ 248 (631)
||||||.|..........+..+..|.|||++-+ .|+...|+||.||+||||.||+..|.+..|...+...+. .|..|.
T Consensus 577 KLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 577 KLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred eeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 999999997766555555666778999997755 799999999999999999999999999776654422111 111110
Q ss_pred C-----------------------------------------------------CCCC---CcHHHHHHHHHhcC-CCCC
Q 006777 249 S-----------------------------------------------------LSKV---TDPQVKQFIEKCIV-PASL 271 (631)
Q Consensus 249 ~-----------------------------------------------------l~~~---~~~~lk~lI~kcL~-~p~~ 271 (631)
. ++.. .-.++++|+.+||. +|.+
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 0 0000 01368999999998 9999
Q ss_pred CCCHHHHhcCCCccC
Q 006777 272 RLPALELLKDPFLVT 286 (631)
Q Consensus 272 Rpta~elL~hpff~~ 286 (631)
|.|..++|+||||+.
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999974
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=296.41 Aligned_cols=257 Identities=18% Similarity=0.280 Sum_probs=203.2
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--C----Ccceeee
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--E----NIIKFYN 93 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H--p----nIV~l~~ 93 (631)
++.+..+|.+...||+|+||.|-.+.|..++..||+|+++-- .+..+...-|+++|+++.+ | -+|.+.+
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 344588999999999999999999999999999999998732 2344556779999999932 2 2677777
Q ss_pred EEEcCCCceEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC------
Q 006777 94 SWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------ 165 (631)
Q Consensus 94 ~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~------ 165 (631)
+| + -++.+++|+|.+ |-|+.++++.+. +++...++.+++||+.+++|||+.+ ++|-||||+|||+..
T Consensus 159 wF-d-yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 159 WF-D-YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hh-h-ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEE
Confidence 55 2 235799999999 569999998864 6899999999999999999999999 999999999999841
Q ss_pred -------------CCCcEEEccccchhhccCCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCC
Q 006777 166 -------------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC 231 (631)
Q Consensus 166 -------------~~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~ 231 (631)
++-.|+|+|||.|+...... .+.+.|..|+|||++- -+++.+.||||+||||+|+.||...|...
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 12358999999997654433 6678899999999765 48999999999999999999999999876
Q ss_pred CCHHH--HHHHHHcCCCCC----------------CCC----------------------CC---CcHHHHHHHHHhcC-
Q 006777 232 KNPAQ--IYKKVTSGIKPA----------------SLS----------------------KV---TDPQVKQFIEKCIV- 267 (631)
Q Consensus 232 ~~~~~--~~~~i~~~~~p~----------------~l~----------------------~~---~~~~lk~lI~kcL~- 267 (631)
.+.+. ++++|....+.. .|+ .. ...++.+||++||.
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 65543 333333211100 000 00 12367899999999
Q ss_pred CCCCCCCHHHHhcCCCccCC
Q 006777 268 PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 268 ~p~~Rpta~elL~hpff~~~ 287 (631)
||.+|+|+.|+|.||||...
T Consensus 393 DP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFARL 412 (415)
T ss_pred CccccccHHHHhcCHHhhcC
Confidence 99999999999999999753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=305.87 Aligned_cols=261 Identities=22% Similarity=0.262 Sum_probs=186.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEc----------------CCCeEEEEEEeecccccCCHH----------HHHHHHHH
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDE----------------VDGIEVAWNQVNIEDVMQSPD----------QLERLYSE 76 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~----------------~~g~~VAvK~v~~~~~~~~~~----------~~~~~~~E 76 (631)
..++|.+.++||+|+||+||+|.+. ..++.||||++.........+ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 345689999987542110000 11223347
Q ss_pred HHHHHhCCCCCc-----ceeeeEEEcC------CCceEEEEEeccCCCCHHHHHHhCC----------------------
Q 006777 77 VHLLKSLKHENI-----IKFYNSWVDD------TNRTINMITELFTSGSLRQYRKKHK---------------------- 123 (631)
Q Consensus 77 i~iL~~L~HpnI-----V~l~~~f~~~------~~~~l~lV~Ey~~gGsL~~~l~~~~---------------------- 123 (631)
+.++.+++|.++ ++++++|... .....++|+||+.+|+|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777876654 6677766432 1246899999999999999886421
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC-Cc--cccCCCCCCCc
Q 006777 124 --NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-AR--SVIGTPEFMAP 198 (631)
Q Consensus 124 --~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~-~~--~~~GTp~y~AP 198 (631)
.+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++....... .. ...+||.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 2356778999999999999999998 99999999999998 67899999999996543321 11 23458999999
Q ss_pred cccccc---------------------cC--ccceEeehhhHHHHHhhcCC-CCCCCCCHH----------HHHHHHHcC
Q 006777 199 ELYEEE---------------------YN--ELVDIYSFGMCILEMVTCEY-PYNECKNPA----------QIYKKVTSG 244 (631)
Q Consensus 199 E~l~~~---------------------y~--~~sDIwSLG~il~emltG~~-Pf~~~~~~~----------~~~~~i~~~ 244 (631)
|.+... |+ .++||||+||++|+|++|.. ||....... ..++.+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 976421 22 24799999999999999985 775421111 111122222
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CC---CCCCCHHHHhcCCCccC
Q 006777 245 IKPASLSKVTDPQVKQFIEKCIV-PA---SLRLPALELLKDPFLVT 286 (631)
Q Consensus 245 ~~p~~l~~~~~~~lk~lI~kcL~-~p---~~Rpta~elL~hpff~~ 286 (631)
..........++..++||.+||. +| .+|+|+.|+|+||||..
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 22222334467899999999997 44 68999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=288.22 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=212.9
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
.-+.-.+|.-+..+|.|+- .|-.|+|..+++.||+|.+... . .+.....+.++|..++..++|+||++++.+|.-..
T Consensus 12 ~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 12 TFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-F-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred ceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-c-ccCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 4456678999999999999 8999999999999999998766 2 23455678899999999999999999999886432
Q ss_pred C----ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 100 N----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 100 ~----~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
. ..+|+||||+. ++|.+.+. -.++-+.++.++.|++.|+.|||+.+ |+||||||+||+++ .++.+||.||
T Consensus 89 ~l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~df 162 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDF 162 (369)
T ss_pred cHHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccc
Confidence 2 36899999996 79998887 45888999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCC-CCccccCCCCCCCcccc-ccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC---------
Q 006777 176 GLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--------- 244 (631)
Q Consensus 176 GlA~~~~~~-~~~~~~GTp~y~APE~l-~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~--------- 244 (631)
|+|+..... ....++.|..|.|||++ ...|.+.+||||+||++.||++|...|.+....++..+.+..-
T Consensus 163 g~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 163 GLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred hhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 999866555 44567889999999976 4469999999999999999999999998866555554433210
Q ss_pred ------------------------CCCCCC------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 245 ------------------------IKPASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 245 ------------------------~~p~~l------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
.+...+ ++.....+++++.+||. +|.+|.+++++|.|||++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 000011 12234578999999998 999999999999999998
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.29 Aligned_cols=245 Identities=25% Similarity=0.363 Sum_probs=193.2
Q ss_pred CcEEEEEEEeecCCeE-EEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCce
Q 006777 25 YFWISWVVVLNCTFMC-RYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~-VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~ 102 (631)
-.|.-.+++|.|+-|+ ||+|. ..|++||||++-.+ .-+...+||++|+.- +|||||++|+ .+.+...
T Consensus 509 ~~~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF 577 (903)
T KOG1027|consen 509 LFFSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQF 577 (903)
T ss_pred eeeccHHHcccCCCCcEEEEEe--eCCceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEe--eccCCce
Confidence 3455567899999996 89998 57999999987532 334577899999988 6999999998 5667779
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CC---CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC--C--CcEEEcc
Q 006777 103 INMITELFTSGSLRQYRKKHK-NV---DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--N--GEVKIGD 174 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~-~l---~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~--g~vKI~D 174 (631)
+|+..|+|. .+|.+++.... .+ .....+..+.|++.||++||+.+ |+||||||+||||... + ..++|+|
T Consensus 578 ~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSD 654 (903)
T KOG1027|consen 578 LYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISD 654 (903)
T ss_pred EEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecc
Confidence 999999997 69999998851 11 11345788999999999999999 9999999999999842 2 4689999
Q ss_pred ccchhhccCCC-----CccccCCCCCCCccccccc-cCccceEeehhhHHHHHhhc-CCCCCCCCCHHHHHHHHHcCCCC
Q 006777 175 LGLAIVMQQPT-----ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 175 FGlA~~~~~~~-----~~~~~GTp~y~APE~l~~~-y~~~sDIwSLG~il~emltG-~~Pf~~~~~~~~~~~~i~~~~~p 247 (631)
||+++.+.... .....||-+|+|||++... -+.++||+||||++|+.++| ..||.. +.......+......
T Consensus 655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~NIl~~~~~L 732 (903)
T KOG1027|consen 655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQANILTGNYTL 732 (903)
T ss_pred cccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--hHHhhhhhhcCccce
Confidence 99998765432 3356799999999988754 56799999999999999986 899975 233323333333333
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
..+....+.++++||.+||. +|..||+|.++|.||||=
T Consensus 733 ~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 733 VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 33444444499999999998 899999999999999994
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=295.91 Aligned_cols=240 Identities=25% Similarity=0.441 Sum_probs=198.7
Q ss_pred EEEEEeecCCeEEEEEEEcC----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 29 SWVVVLNCTFMCRYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~----~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+.++||.|-||.||.|.-.. ....||||..+.+. .++..+.|..|..+|+.++|||||++++.+.+. ..|
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e~---P~W 466 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ---PMW 466 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc---cee
Confidence 34689999999999996532 23478999877543 456688999999999999999999999988654 589
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+|||+++-|.|+.|++.++ .++...+..++.||+.||.|||+.. ++||||...|||+. ...-|||+|||+++.+..
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVs-Sp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVS-SPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeec-Ccceeeecccchhhhccc
Confidence 9999999999999999876 5999999999999999999999999 99999999999997 677899999999987765
Q ss_pred CC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 184 PT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.. +....-..-|||||-++ ..++.++|||.||+|+||++. |..||.+-.|.+.+ ..+..|..++ .+..++|.+
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeRlP-~P~nCPp~L 621 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGERLP-CPPNCPPAL 621 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCCCC-CCCCCChHH
Confidence 42 12222345799999775 679999999999999999876 88999986665443 3445554433 456788999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHh
Q 006777 259 KQFIEKCIV-PASLRLPALELL 279 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL 279 (631)
..+..+|++ +|.+||...+|.
T Consensus 622 YslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHH
Confidence 999999999 999999987653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=263.23 Aligned_cols=213 Identities=24% Similarity=0.400 Sum_probs=183.0
Q ss_pred EEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCceEEEE
Q 006777 28 ISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 ~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~l~lV 106 (631)
..+..||+|+||.|-+.++..+|...|+|.+...- +.+...++.+|+.+..+. ..|.+|.||+.+..+. .+|+.
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg--dvwIc 123 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG--DVWIC 123 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc--cEEEe
Confidence 34678999999999999999999999999998552 346667888899876555 7999999999876654 68999
Q ss_pred EeccCCCCHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 107 TELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 107 ~Ey~~gGsL~~~----l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
||.|. .||..+ +++.+.++|..+-+++..++.||.|||++= .+||||+||+|||++ .+|+|||||||++..+.
T Consensus 124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc-cCCcEEEcccccceeeh
Confidence 99996 688665 455678999999999999999999999983 499999999999998 89999999999998887
Q ss_pred CCCCcc-ccCCCCCCCcccccc-----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 006777 183 QPTARS-VIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 183 ~~~~~~-~~GTp~y~APE~l~~-----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~ 248 (631)
...+.+ -.|...|||||.+.. .|+-++||||||++++||+++++||.....+.+..+.+.+...|.
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 776666 578899999998753 588999999999999999999999999899998888888765543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=291.00 Aligned_cols=249 Identities=21% Similarity=0.269 Sum_probs=201.3
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.-++...+.++||+|-||.|.++.- ..+..||+|.++... .......|.+|+++|.+|+|||||+++++++.++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-- 608 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-- 608 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--
Confidence 3466788999999999999999985 346999999988654 2445678999999999999999999999987665
Q ss_pred eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 102 TINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+++||||++.|+|.+|+.++. ...-....+++.||++|++||.+.+ ++||||.+.|+|++ .++++||+|||.++
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~-~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVD-GEFTIKIADFGMSR 685 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeec-CcccEEecCccccc
Confidence 6999999999999999999984 3345566789999999999999999 99999999999998 68999999999997
Q ss_pred hccCCCC----ccccCCCCCCCcc-ccccccCccceEeehhhHHHHHhh--cCCCCCCCCCHHHHHHHHHcC---CCC--
Q 006777 180 VMQQPTA----RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTSG---IKP-- 247 (631)
Q Consensus 180 ~~~~~~~----~~~~GTp~y~APE-~l~~~y~~~sDIwSLG~il~emlt--G~~Pf~~~~~~~~~~~~i~~~---~~p-- 247 (631)
-+-.... ...+-...||||| ++.++++.++|+|+||+++||+++ .+.||....+ ++..+....- ..+
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGRQV 764 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCcce
Confidence 4433221 2234567999999 557899999999999999999766 7899987443 3333333221 111
Q ss_pred -CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 248 -ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 248 -~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
...+..++..+.+++.+|+. +..+||+.+++..
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 12345677889999999998 8899999999754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=293.83 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=208.0
Q ss_pred cEEEEEEEeecCCeEEEEEEEcC-CC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEV-DG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~-~g--~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
...+.+.||+|.||+|++|.++. .| ..||||.++..... ..+..|.+|+.+|..|+|||+|++|+...+. .
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~q---p 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLDQ---P 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeeccc---h
Confidence 34456899999999999998754 33 47899998866542 3678899999999999999999999987663 5
Q ss_pred EEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+.||||++++|+|.+.+.+ ...|....+-.|+.||+.|+.||.+++ +|||||...|+++- ....|||+||||.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNllla-sprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLA-SPRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheec-ccceeeeecccceec
Confidence 8899999999999999887 245888999999999999999999999 99999999999997 577999999999987
Q ss_pred ccCCCCcccc-----CCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 181 MQQPTARSVI-----GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 181 ~~~~~~~~~~-----GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
+.......+. -...|+|||.++ ..++.++|+|+||+++|||+| |+-||.++ ...++.+.|..+... .-++.
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~erL-pRPk~ 339 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGERL-PRPKY 339 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhccccccC-CCCCC
Confidence 7654333222 244799999876 579999999999999999999 88999984 678888888855332 23556
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
++..+.+++..||. +|.+|||...|...-++..
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 78999999999999 8999999998875555443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-33 Score=276.51 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=202.8
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC---ceEEEE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMI 106 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~---~~l~lV 106 (631)
.+.||.|+||.||.+.|..+|+.||+|.+. .+.++-..-.++++|+++|...+|.|++...+...-..- ..+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 578999999999999999999999999765 233445566889999999999999999998876543322 257889
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC-
Q 006777 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 185 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~- 185 (631)
+|++. .+|..++-.-..++...++-+++||+.||.|||+.+ |.||||||.|.|++ .|-.+||||||+|+.-....
T Consensus 136 TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEec-cCceEEecccccccccchhhh
Confidence 99996 599999888888999999999999999999999999 99999999999998 78899999999998665432
Q ss_pred --CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc------------------
Q 006777 186 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------------ 243 (631)
Q Consensus 186 --~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~------------------ 243 (631)
....+-|.+|+|||++.+ .|+.++||||.|||+.||+..+..|.. .++.+..+.|+.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA-q~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA-AGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc-cChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 234466899999998754 699999999999999999999999976 445444444331
Q ss_pred ------CCCCCCCCCC--------CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 244 ------GIKPASLSKV--------TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 ------~~~p~~l~~~--------~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+.+++.++.. ..-+..+++.++|. +|.+|.+..+.+.|+++...
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 2233332211 23456777788888 89999999999999998653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=286.59 Aligned_cols=242 Identities=24% Similarity=0.367 Sum_probs=208.8
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
..+...+||.|-||.||.|.++.....||||.++-+ .-..++|++|..+|+.++|||+|++.+++..+ ..+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E--pPFYI 340 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--PPFYI 340 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCccHHHHhhhhccC--CCeEE
Confidence 445678999999999999999999999999988743 34678899999999999999999999987654 47999
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 106 ITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|+|||..|+|.+|++... .++.-.+..++.||.+|++||..++ +|||||...|+|+. ++..|||+|||+++.+..
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVg-EnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccc-ccceEEeeccchhhhhcC
Confidence 999999999999998754 3677778899999999999999999 99999999999996 888999999999999887
Q ss_pred CCCccccC---CCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 184 PTARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~~~~~~~G---Tp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.+.....| ..-|.|||-+. +.++.++|||+||++|||++| |-.||.+ .+..+.|..+..+..-.. +..+++.+
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~~-PeGCPpkV 495 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMDG-PEGCPPKV 495 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhccccccC-CCCCCHHH
Confidence 65444444 44799999664 668999999999999999998 7789987 678899988888865433 44578999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHh
Q 006777 259 KQFIEKCIV-PASLRLPALELL 279 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL 279 (631)
..|+..||+ .|++||+..|+-
T Consensus 496 YeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHHH
Confidence 999999999 999999988764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=319.74 Aligned_cols=239 Identities=21% Similarity=0.304 Sum_probs=181.6
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
.|...++||+|+||.||+|.+..+|..||+|.+..... ....|++.+++++|||||++++++.+.. ..++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~l 760 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYL 760 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEE
Confidence 45667899999999999999999999999998864321 1124688999999999999999987654 6889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
||||+++|+|.++++ .+++..+..++.||+.||+|||.. .++|+||||||+||+++ .++..++. ||.+.....
T Consensus 761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCT- 834 (968)
T ss_pred EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC-CCCceEEE-ecccccccc-
Confidence 999999999999996 388999999999999999999954 33499999999999998 56677765 665533222
Q ss_pred CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCC----CHHHHHHHHHcC------CCCCC----
Q 006777 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK----NPAQIYKKVTSG------IKPAS---- 249 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~----~~~~~~~~i~~~------~~p~~---- 249 (631)
.....||+.|+|||++.+ .|+.++|||||||++|||+||+.||.... ......+..... ..|..
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 223468999999998764 59999999999999999999999985321 111111111110 01110
Q ss_pred -CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 250 -LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 250 -l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.......++.+++.+|+. +|.+||++.|+++.
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000112356789999998 89999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=277.69 Aligned_cols=138 Identities=22% Similarity=0.343 Sum_probs=118.4
Q ss_pred cCccCC-CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----C---CCcc
Q 006777 19 ISSSVS-YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----H---ENII 89 (631)
Q Consensus 19 ~~~~i~-~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-----H---pnIV 89 (631)
++.... .+|.+.++||.|-|+|||+|+|....+.||+|+++-. ....+....||++|++++ | ..||
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 455555 8999999999999999999999999999999998743 344566788999999983 3 3699
Q ss_pred eeeeEEEc--CCCceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEE
Q 006777 90 KFYNSWVD--DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV 163 (631)
Q Consensus 90 ~l~~~f~~--~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl 163 (631)
++++.|.. .+..+++||+|++ |.+|..+|+.. +.++...++.|++|||.||.|||..- +|||-||||+|||+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 99999864 3456899999999 57888888764 67999999999999999999999873 59999999999998
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=293.03 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=207.7
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g---~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
..-.|.++||.|.||.|++|..+.-| ..||||.++.. ...++...|+.|..||-++.||||+++.++.. ..+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G---ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT--ks~ 703 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG---YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT--KSK 703 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC---ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe--cCc
Confidence 34578899999999999999987766 48999998854 34667788999999999999999999999653 345
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+.+|+|||+.|+|+.||+++ +.|+.-++..+++.|+.|+.||-+.+ ++||||...|||+| .+-..|++|||+++.
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVN-snLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRV 780 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeec-cceEEEeccccceee
Confidence 899999999999999999876 57999999999999999999999999 99999999999998 788899999999997
Q ss_pred ccCCC--Ccccc-C--CCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 181 MQQPT--ARSVI-G--TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 181 ~~~~~--~~~~~-G--Tp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
+.... ..+.. | ...|.|||.+. ++++.++||||+|++|||.++ |+.||.+-.| ...++.|.++...+. +-.
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~gyRLPp-PmD 858 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQGYRLPP-PMD 858 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhccCCCC-CCC
Confidence 75443 22222 2 35899999775 679999999999999999554 9999998554 555677877765433 334
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
++..+.+|+..|++ +-.+||...+|+.+
T Consensus 859 CP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 67899999999998 78999999998874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=292.60 Aligned_cols=246 Identities=23% Similarity=0.332 Sum_probs=204.2
Q ss_pred cEEEEEEEeecCCeEEEEEEEc----C---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 26 FWISWVVVLNCTFMCRYKGFDE----V---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~----~---~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
+..+.+.||.|+||.|++|.-. . ....||||..+... ...+.+.+..|+.+|+.+ +||||+.+.+++..
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3456779999999999999643 1 25689999877543 236678899999999999 69999999998766
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCce
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NI 161 (631)
.+.+++|+||+..|+|..|++..+ .++...+..++.||+.|++||++.. ++||||-+.||
T Consensus 374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNV 449 (609)
T KOG0200|consen 374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNV 449 (609)
T ss_pred --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhE
Confidence 558999999999999999998766 3889999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEccccchhhccCCCCcc---ccC--CCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCH
Q 006777 162 FVNGNNGEVKIGDLGLAIVMQQPTARS---VIG--TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNP 234 (631)
Q Consensus 162 Ll~~~~g~vKI~DFGlA~~~~~~~~~~---~~G--Tp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~ 234 (631)
|+. .+..+||+|||+|+......... -.| ...|||||.+.. .|+.++||||||+++||++| |..||.+....
T Consensus 450 Li~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 450 LIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred Eec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 997 67899999999998544332222 122 235999997764 69999999999999999999 88999886556
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 235 ~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+++.+..|..... +...++++.+++..|+. +|.+||+..++..
T Consensus 529 ~~l~~~l~~G~r~~~-P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQ-PEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHhcCCCCCC-CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 677888988877554 44568999999999998 9999999988765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=283.21 Aligned_cols=201 Identities=26% Similarity=0.389 Sum_probs=179.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHH----HHHHHHHHHHHHHhCC---CCCcceeeeEEEc
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPD----QLERLYSEVHLLKSLK---HENIIKFYNSWVD 97 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~----~~~~~~~Ei~iL~~L~---HpnIV~l~~~f~~ 97 (631)
..|...+.||.|+||.|++|.++++..+|++|.|.++++..+.- .+-.+-.||+||..|+ |+||+++.++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45999999999999999999999999999999998776543221 1233567999999997 9999999999865
Q ss_pred CCCceEEEEEecc-CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 98 DTNRTINMITELF-TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 98 ~~~~~l~lV~Ey~-~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
+ +++|++||-. +|.+|.+|+..++.++|.+.+-+++|++.|+++||++| |||||||-+||.++ .+|.+||+|||
T Consensus 641 d--d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd-~~g~~klidfg 715 (772)
T KOG1152|consen 641 D--DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVD-SNGFVKLIDFG 715 (772)
T ss_pred C--CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEe-cCCeEEEeecc
Confidence 5 4899999976 46799999999999999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCCCCccccCCCCCCCccccccc-c-CccceEeehhhHHHHHhhcCCCCCC
Q 006777 177 LAIVMQQPTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNE 230 (631)
Q Consensus 177 lA~~~~~~~~~~~~GTp~y~APE~l~~~-y-~~~sDIwSLG~il~emltG~~Pf~~ 230 (631)
.|..........++||..|.|||++.+. | +..-|||+||+++|.++..+.||..
T Consensus 716 saa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9988888888999999999999999874 4 6788999999999999999999963
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=287.91 Aligned_cols=243 Identities=28% Similarity=0.415 Sum_probs=202.7
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~----~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
.+..++||+|+||+||+|.+-..|+ +||+|++... ...+..+.+..|+-+|.+|+|||++++.++.....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---
Confidence 3446799999999999998876665 7888877643 34556678999999999999999999999776543
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+.||++|+++|+|.+|++.++ .+..+....|+.||++|+.|||.+. ++||||-..|||+. .-.+|||.|||+|+.+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVk-sP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVK-SPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeec-CCCeEEEEecchhhcc
Confidence 889999999999999998764 6999999999999999999999998 99999999999997 6779999999999877
Q ss_pred cCCCCc----cccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 182 QQPTAR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 182 ~~~~~~----~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
...... ...-.+-|||-|.+. ..|+.++||||||+++||++| |..||.+ ....++-..+..+.. ..-+...+
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCt 926 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICT 926 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCcc
Confidence 544321 122355688888665 569999999999999999998 8899987 567777777777766 44456778
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+..++.+||. |+..||+++++-.
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHH
Confidence 899999999997 9999999988654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=269.82 Aligned_cols=249 Identities=28% Similarity=0.459 Sum_probs=189.0
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCcceeeeEEEcC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDD 98 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~~~f~~~ 98 (631)
.++..+-++.+.||+|.||.||+|.+. |+.||||++.-.+ ...+++|.++.+. |+|+||+.|+.+=..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd-------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD-------ERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc-------hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 457888999999999999999999974 9999999986432 2446777777765 4999999998742222
Q ss_pred C--CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCeEecCCCCCceEEeCCCCcE
Q 006777 99 T--NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 99 ~--~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs------~~~~IiHrDLKp~NILl~~~~g~v 170 (631)
+ ...+|||++|.+.|||.||+.+ ..++.+...+++.-+++||++||. ..|.|.|||||..|||+. .+|..
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C 355 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTC 355 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcE
Confidence 1 2479999999999999999998 569999999999999999999995 235699999999999997 89999
Q ss_pred EEccccchhhccCC------CCccccCCCCCCCccccccccC-------ccceEeehhhHHHHHhh----------cCCC
Q 006777 171 KIGDLGLAIVMQQP------TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVT----------CEYP 227 (631)
Q Consensus 171 KI~DFGlA~~~~~~------~~~~~~GTp~y~APE~l~~~y~-------~~sDIwSLG~il~emlt----------G~~P 227 (631)
-|+|+|||...... ..+..+||..|||||++....+ ..+||||||.++||++. -+.|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 99999999655433 2456789999999999975432 36899999999999985 2478
Q ss_pred CCCCCC----HHHHHHHHHcCCCCCCCCCC--CcHH---HHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 228 YNECKN----PAQIYKKVTSGIKPASLSKV--TDPQ---VKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 228 f~~~~~----~~~~~~~i~~~~~p~~l~~~--~~~~---lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
|.+-.. .+++.+.+--....+.++.. .++. +-.+++.|+. +|..|.||--+-+
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 865332 23333322222111112211 2343 4567889997 8999999876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-29 Score=239.62 Aligned_cols=209 Identities=35% Similarity=0.594 Sum_probs=183.7
Q ss_pred EeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCC
Q 006777 33 VLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS 112 (631)
Q Consensus 33 LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~g 112 (631)
||.|++|.||++.+..+|..+++|.+...... ...+.+.+|++.++.+.|++|+++++++... ...++++||+.|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCC
Confidence 68999999999999888999999998865421 1456788999999999999999999988654 478999999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC--Cccc
Q 006777 113 GSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSV 189 (631)
Q Consensus 113 GsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~--~~~~ 189 (631)
++|.+++... ..++...++.++.+++.+|.|||+++ ++|+||+|.||+++..++.++|+|||.+....... ....
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 9999999876 57999999999999999999999998 99999999999998327899999999997665543 4446
Q ss_pred cCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006777 190 IGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 190 ~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~ 267 (631)
.+...|++||.+.. .++.++|+|+||+++++| ..+.++|.+|+.
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhh
Confidence 67889999998865 678899999999999999 678999999998
Q ss_pred -CCCCCCCHHHHhcCC
Q 006777 268 -PASLRLPALELLKDP 282 (631)
Q Consensus 268 -~p~~Rpta~elL~hp 282 (631)
+|.+||++.++++|+
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 899999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=272.29 Aligned_cols=242 Identities=26% Similarity=0.394 Sum_probs=183.8
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHH--hCCCCCcceeeeEEEcC--C
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK--SLKHENIIKFYNSWVDD--T 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~--~L~HpnIV~l~~~f~~~--~ 99 (631)
.....+.+++|+|.||.||+|.. +++.||||++... +.+.+..|-.|.+ .++|+||++|+++=... .
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~-------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ-------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH-------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 34556789999999999999985 5799999998744 3455666666655 45899999998742111 1
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCeEecCCCCCceEEeCCCCcEEE
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-------NPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~-------~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
...++||++|.+.|+|.+|++.+- ++.....+++.-++.||+|||.- .|+|+|||||..||||. ++++.-|
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccI 357 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCI 357 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEe
Confidence 337899999999999999999864 89999999999999999999973 36799999999999997 8999999
Q ss_pred ccccchhhccCCC----CccccCCCCCCCccccccccC-------ccceEeehhhHHHHHhhcC------------CCCC
Q 006777 173 GDLGLAIVMQQPT----ARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTCE------------YPYN 229 (631)
Q Consensus 173 ~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~~~y~-------~~sDIwSLG~il~emltG~------------~Pf~ 229 (631)
+|||+|..+.... ....+||.+|||||++++..+ .+.||||+|.+++||++.- .||.
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 9999997665332 234689999999999987533 2589999999999999843 2232
Q ss_pred C----CCCHHHHHHHHHcCCCC----CCCCCCC-cHHHHHHHHHhcC-CCCCCCCHH
Q 006777 230 E----CKNPAQIYKKVTSGIKP----ASLSKVT-DPQVKQFIEKCIV-PASLRLPAL 276 (631)
Q Consensus 230 ~----~~~~~~~~~~i~~~~~p----~~l~~~~-~~~lk~lI~kcL~-~p~~Rpta~ 276 (631)
. ....+++...+...... ..|.+.. -..+++.|+.|+. ||..|.||.
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 0 11223333333333222 2333332 3467999999998 999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=270.10 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=202.5
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcC---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEE
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~---~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f 95 (631)
...+...|.+.++||.|.|++||+|.+.. ..+.||+|.+.... ...++..|+++|..+ -+.||+++.+.+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhh
Confidence 44567789999999999999999999987 78899999987653 235688999999999 589999999977
Q ss_pred EcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
-. ++.+.+|+||+++...+++... ++...++.+++.++.||.++|.+| ||||||||.|++.+...+.-.|+||
T Consensus 105 rn--nd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 105 RN--NDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred cc--CCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEec
Confidence 44 4578899999999999998764 779999999999999999999999 9999999999999988888999999
Q ss_pred cchhhcc---------C------CC----------------C---------------ccccCCCCCCCccccc--cccCc
Q 006777 176 GLAIVMQ---------Q------PT----------------A---------------RSVIGTPEFMAPELYE--EEYNE 207 (631)
Q Consensus 176 GlA~~~~---------~------~~----------------~---------------~~~~GTp~y~APE~l~--~~y~~ 207 (631)
|+|.... . .. . -...|||+|+|||++- ..-++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9996110 0 00 0 0234999999999874 35788
Q ss_pred cceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHH--------------cCC----------------------------
Q 006777 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--------------SGI---------------------------- 245 (631)
Q Consensus 208 ~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~--------------~~~---------------------------- 245 (631)
++||||.|+|++-++++.+||....+.......+. .|.
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 99999999999999999999975433211110000 000
Q ss_pred -------CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 246 -------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 246 -------~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.+..+....+..+.+|+.+||. +|.+|.||+++|+||||...
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0111223345688999999998 99999999999999999853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=241.87 Aligned_cols=212 Identities=31% Similarity=0.484 Sum_probs=182.8
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEE
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV 106 (631)
|.+.+.||.|+++.||+|.+..++..+|+|.+...... ...+.+.+|+..++.++|+||+++++++... ...+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEE
Confidence 56789999999999999999888999999998865421 3567888999999999999999999987654 368899
Q ss_pred EeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC-
Q 006777 107 TELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP- 184 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~-l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~- 184 (631)
+||+.+++|.+++..... +++..+..++.|++.+|.|||+++ ++|+||+|.||+++ .++.++|+|||++......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLG-MDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeCceeeEecCcc
Confidence 999999999999988776 899999999999999999999998 99999999999998 6799999999998766543
Q ss_pred --CCccccCCCCCCCcccc-c-cccCccceEeehhhHHHHHhhcCCCCCC-CCCHHHHHHHHHcCCC
Q 006777 185 --TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTCEYPYNE-CKNPAQIYKKVTSGIK 246 (631)
Q Consensus 185 --~~~~~~GTp~y~APE~l-~-~~y~~~sDIwSLG~il~emltG~~Pf~~-~~~~~~~~~~i~~~~~ 246 (631)
......++..|++||.+ . ..++.++|+|+||+++++|++|+.||.. ..+...+.+.+..+..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 23456788899999987 3 3477799999999999999999999977 5666677777777653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-28 Score=285.06 Aligned_cols=199 Identities=19% Similarity=0.226 Sum_probs=148.5
Q ss_pred HhCCC-CCcceeeeEEEcC-----CCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEe
Q 006777 81 KSLKH-ENIIKFYNSWVDD-----TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153 (631)
Q Consensus 81 ~~L~H-pnIV~l~~~f~~~-----~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiH 153 (631)
+.++| +||++++++|... ....+++++||+ +++|.+++... ..+++..++.+++||+.||.|||++| |+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 45566 6888888877211 123678889987 57999999753 56999999999999999999999999 999
Q ss_pred cCCCCCceEEeC------------------CCCcEEEccccchhhccCC------------------CCccccCCCCCCC
Q 006777 154 RDLKCDNIFVNG------------------NNGEVKIGDLGLAIVMQQP------------------TARSVIGTPEFMA 197 (631)
Q Consensus 154 rDLKp~NILl~~------------------~~g~vKI~DFGlA~~~~~~------------------~~~~~~GTp~y~A 197 (631)
|||||+||||+. .++.+||+|||+++..... .....+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999951 3456777778877532110 0012468999999
Q ss_pred ccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCH
Q 006777 198 PELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA 275 (631)
Q Consensus 198 PE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta 275 (631)
||++. ..|+.++|||||||++|||++|..|+... ......+.....|..... ..+...+++.+||. +|.+||++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQILL-NWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhhhh-cCHHHHHHHHHhCCCChhhCcCh
Confidence 99865 46999999999999999999998887542 222222322222222211 24567899999998 89999999
Q ss_pred HHHhcCCCccC
Q 006777 276 LELLKDPFLVT 286 (631)
Q Consensus 276 ~elL~hpff~~ 286 (631)
.|+|+||||..
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 99999999975
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=237.21 Aligned_cols=254 Identities=19% Similarity=0.257 Sum_probs=192.2
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 99 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~ 99 (631)
-++.+.|.|.+.||.|.||.+-+|.++.++..+|+|.+... ......|.+|.+---.| .|.||+.-|+.-+. .
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq-t 93 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ-T 93 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHHHHHhccceeeccchhhhHHHHHHhh-c
Confidence 34578999999999999999999999999999999998754 34556799999877677 69999998875433 2
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe-CCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~-~~~g~vKI~DFGlA 178 (631)
.+.+++++||++-|+|..-+... .+.|...+.++.|+++|+.|+|+++ ++|||||.+||||- .+.-.|||||||+.
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred CceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccc
Confidence 34788999999999999877664 4889999999999999999999999 99999999999984 33447999999998
Q ss_pred hhccCCCCccccCCCCCCCccccc----cc--cCccceEeehhhHHHHHhhcCCCCCCCCCHH---HHHHHHHcCCCC--
Q 006777 179 IVMQQPTARSVIGTPEFMAPELYE----EE--YNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIKP-- 247 (631)
Q Consensus 179 ~~~~~~~~~~~~GTp~y~APE~l~----~~--y~~~sDIwSLG~il~emltG~~Pf~~~~~~~---~~~~~i~~~~~p-- 247 (631)
+..... ....-.+..|.|||+.. +. .++.+|||.||+++|.++||..||....... .-+.....+..+
T Consensus 171 ~k~g~t-V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 171 RKVGTT-VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred cccCce-ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 643322 22233466799999763 22 5788999999999999999999996422111 122223333222
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCC---CCHHHHhcCCCc
Q 006777 248 ASLSKVTDPQVKQFIEKCIV-PASLR---LPALELLKDPFL 284 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~-~p~~R---pta~elL~hpff 284 (631)
+...+..++.+..+.++-|. .+.+| .++....+..|.
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 11223356777778888887 67777 456666666554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=224.28 Aligned_cols=160 Identities=26% Similarity=0.351 Sum_probs=128.8
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCCccccC
Q 006777 113 GSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 191 (631)
Q Consensus 113 GsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~~~~G 191 (631)
|+|.+++..+ +.+++.+++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~---~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPE---QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeeccc---cCCC
Confidence 7999999874 46999999999999999999999987 99999997 7899999 9998765432 2368
Q ss_pred CCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC-----CCCCCcH--HHHHHHH
Q 006777 192 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-----LSKVTDP--QVKQFIE 263 (631)
Q Consensus 192 Tp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~-----l~~~~~~--~lk~lI~ 263 (631)
|+.|||||++.+ .|+.++|||||||++|||+||+.||............+.....+.. .....+. .+++||.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999998754 5899999999999999999999999765444444444443322221 1111222 6999999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCccC
Q 006777 264 KCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 264 kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
+||. +|.+||++.+++.|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 9998 8999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=218.73 Aligned_cols=252 Identities=28% Similarity=0.407 Sum_probs=206.2
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC-CcceeeeEEEcCCCceEEE
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-nIV~l~~~f~~~~~~~l~l 105 (631)
|.+.+.||.|+|+.||++.+. ..+++|.+....... ......+.+|+.+++.+.|+ +|+++++.+... ...++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEE
Confidence 788999999999999999987 789999987664322 23567789999999999988 799999988443 35899
Q ss_pred EEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC-cEEEccccchhhc
Q 006777 106 ITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVM 181 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~---~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-~vKI~DFGlA~~~ 181 (631)
+++|+.+++|.+++.... .+.+..+..++.|++.+|.|+|+.+ ++|||+||+||+++ ..+ .++++|||++...
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~-~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLD-RDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-CCCCeEEEeccCcceec
Confidence 999999999998887765 7999999999999999999999999 99999999999998 555 7999999999754
Q ss_pred cCC--------CCccccCCCCCCCcccccc----ccCccceEeehhhHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCC
Q 006777 182 QQP--------TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIK 246 (631)
Q Consensus 182 ~~~--------~~~~~~GTp~y~APE~l~~----~y~~~sDIwSLG~il~emltG~~Pf~~~~~---~~~~~~~i~~~~~ 246 (631)
... ......||+.|+|||.+.+ .+....|+||+|++++++++|..||..... .......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 432 2356789999999998764 678899999999999999999999877554 4566666655543
Q ss_pred C-CCCCCCC------cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 247 P-ASLSKVT------DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 p-~~l~~~~------~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+ ....... ...+.+++.+|+. +|..|.+..+...++|....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 3 2111111 2578999999998 89999999999888666543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=226.38 Aligned_cols=248 Identities=21% Similarity=0.270 Sum_probs=203.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCe-----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGI-----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~-----~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
+.+++...++-+|.||.||.|.+.+... .|-+|.++.. .++-+...+..|--++..+.|||+..+.++...+
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 4567778889999999999997765433 4556655532 2456678899999999999999999999987765
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcE
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH--------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~--------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 170 (631)
. ...++++.+..-|+|+.++... ..++..++..++.|+..|++|||+++ |||.||...|++|+ +.-+|
T Consensus 360 ~-~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqV 435 (563)
T KOG1024|consen 360 Y-ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQV 435 (563)
T ss_pred c-CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeE
Confidence 4 4677889999999999999832 23677788899999999999999999 99999999999998 67899
Q ss_pred EEccccchhhccCCCC----ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006777 171 KIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 171 KI~DFGlA~~~~~~~~----~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~ 244 (631)
||+|-.+++.+..... ...-....||+||.+. ..|+.++|+||||+++|||+| |+.||.+ .+|.+....+..|
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdG 514 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDG 514 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhcc
Confidence 9999999986544321 1122355799999775 569999999999999999998 8899987 7899999999998
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 245 ~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..... +..+++++..++..|++ .|.+||+..++..
T Consensus 515 yRlaQ-P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 YRLAQ-PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ceecC-CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 66443 45678899999999998 9999999998753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=227.41 Aligned_cols=177 Identities=19% Similarity=0.219 Sum_probs=136.7
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcC-CCeEEEEEEeecccc-cCCHHHHHHHHHHHHHHHhCCCCCcce-eeeEEE
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEV-DGIEVAWNQVNIEDV-MQSPDQLERLYSEVHLLKSLKHENIIK-FYNSWV 96 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~-~g~~VAvK~v~~~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIV~-l~~~f~ 96 (631)
...+.+.|.+.++||+|+||+||+|.+.. +|..||+|++..... .......+.+.+|+++|++|+|+||++ +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 44567889999999999999999999876 688889998652210 012334567899999999999999995 5431
Q ss_pred cCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC-CCCceEEeCCCCcEEEccc
Q 006777 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL-KCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 97 ~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL-Kp~NILl~~~~g~vKI~DF 175 (631)
...|+||||++|++|... .. .. ...|+.|++.||.|||++| |+|||| ||+|||++ .++.+||+||
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDF 156 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDF 156 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEEC
Confidence 247899999999999732 11 11 1578999999999999999 999999 99999997 6789999999
Q ss_pred cchhhccCCC----------CccccCCCCCCCccccccc-------cCccceEe
Q 006777 176 GLAIVMQQPT----------ARSVIGTPEFMAPELYEEE-------YNELVDIY 212 (631)
Q Consensus 176 GlA~~~~~~~----------~~~~~GTp~y~APE~l~~~-------y~~~sDIw 212 (631)
|+|+...... .....+++.|+|||.+... .+...|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9997554322 1356789999999988532 33456766
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-25 Score=248.75 Aligned_cols=257 Identities=23% Similarity=0.307 Sum_probs=198.9
Q ss_pred EEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecc--cccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 28 ISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 28 ~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~--~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
....++|.|++|.|+.+........+++|.+... ...........+..|+-+-..|+||||+.....+.+.. ..+-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cchh
Confidence 4578999999999999998877777887766532 11111222233667888888999999988766554433 2334
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~ 185 (631)
+||||++ +|..++...+.+....+-.+++||+.||.|+|+.| |.||||||+|++++ .+|.+||+|||.+.....+.
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCcceeeccCc
Confidence 4999998 99999998888999999999999999999999999 99999999999998 78999999999997665432
Q ss_pred ------CccccCCCCCCCcccccc-ccC-ccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHH-c-----CCCCCCCC
Q 006777 186 ------ARSVIGTPEFMAPELYEE-EYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-S-----GIKPASLS 251 (631)
Q Consensus 186 ------~~~~~GTp~y~APE~l~~-~y~-~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~-~-----~~~p~~l~ 251 (631)
...++|+..|+|||++.+ .|+ ..+||||.|++++.|++|+.||.-....++.+.... . ...+..+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 345789999999998865 576 469999999999999999999975433333211111 0 01122333
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~ 290 (631)
...+.+.+.+|.++|+ +|.+|.|+.+|++.+||+.....
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 4456788999999998 99999999999999999876543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-25 Score=223.08 Aligned_cols=245 Identities=33% Similarity=0.535 Sum_probs=188.7
Q ss_pred CeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC---ceEEEEEeccCCCC
Q 006777 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN---RTINMITELFTSGS 114 (631)
Q Consensus 38 fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~---~~l~lV~Ey~~gGs 114 (631)
.-.||+|.+++.|.+|+|+.|+.....+...+.+....-++.|.++.|.|||+++.||.+... .++.|++||+..|+
T Consensus 79 id~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs 158 (458)
T KOG1266|consen 79 IDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGS 158 (458)
T ss_pred hHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchh
Confidence 346899999999999999999887665545555566667888999999999999999976543 47889999999999
Q ss_pred HHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc------CC
Q 006777 115 LRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ------QP 184 (631)
Q Consensus 115 L~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~------~~ 184 (631)
|.+++++. +.+....+++|+.||++||.|||+..|||+|+++.|+.||+. ++|.|||+--....... ..
T Consensus 159 ~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq-~ngLIkig~~ap~s~h~s~~~~~~~ 237 (458)
T KOG1266|consen 159 LKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ-HNGLIKIGSVAPDSTHPSVNSTREA 237 (458)
T ss_pred HHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec-CCceEEecccCccccchhhhhhhHh
Confidence 99999863 568999999999999999999999999999999999999998 89999997644332110 00
Q ss_pred CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006777 185 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~ 263 (631)
......+-++|.|||.-. ...+.++|||+||+|.++|..|+..-.........-..+.. ......++.-+++|.
T Consensus 238 Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~-----~i~~len~lqr~~i~ 312 (458)
T KOG1266|consen 238 EKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN-----VIIGLENGLQRGSIT 312 (458)
T ss_pred hhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh-----heeeccCccccCcCc
Confidence 111234678999999754 34677999999999999999998764432221111111111 111223455688999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 264 KCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 264 kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+||. .|..||++.++|.||.+....
T Consensus 313 kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 313 KCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred ccccCCCCCCcchhhhhcCceeeecc
Confidence 9999 899999999999999887644
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=236.55 Aligned_cols=251 Identities=18% Similarity=0.233 Sum_probs=205.1
Q ss_pred EEeecCCeEEEEE---EEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCceEEEEE
Q 006777 32 VVLNCTFMCRYKG---FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 32 ~LG~G~fg~VY~A---~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
++|+|+||.|+++ .....|..+|.|+.+.......... +-..|.+++..++ ||.+|+++..|..+. .+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~--kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDG--KLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeecccc--chhHhh
Confidence 4799999999865 3345678899998776554332222 5566888899887 999999999887655 588899
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCCc
Q 006777 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~ 187 (631)
++..||.|...+.+...+.+...+.+...++.+++++|+.+ ++|||+|++||+++ .+|++|+.|||+++..-.....
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeec-ccCccccCCchhhhHhHhhhhc
Confidence 99999999999998889999999999999999999999999 99999999999998 7999999999999765433322
Q ss_pred cccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006777 188 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 188 ~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~ 267 (631)
|||..|||||+++ .+..++|.||||++++||+||..||.+ +....|... ....+...+..+++++..++.
T Consensus 154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~--~~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKA--ELEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhh--ccCCchhhhHHHHHHHHHHHh
Confidence 9999999999988 678899999999999999999999986 444444442 122344567889999999987
Q ss_pred -CCCCCCC-----HHHHhcCCCccCCCCCccccCCCCC
Q 006777 268 -PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRL 299 (631)
Q Consensus 268 -~p~~Rpt-----a~elL~hpff~~~~~~~~~~~~l~~ 299 (631)
+|..|.- +.|+++|+||+..+|..+.....+.
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~ 261 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPP 261 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCC
Confidence 8888876 4799999999999998765444433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-21 Score=208.18 Aligned_cols=252 Identities=19% Similarity=0.163 Sum_probs=185.8
Q ss_pred ccCCC-cEEEEEEEeecCCeEEEEEEEcCCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC----CCcceeeeE
Q 006777 21 SSVSY-FWISWVVVLNCTFMCRYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH----ENIIKFYNS 94 (631)
Q Consensus 21 ~~i~~-~Y~i~e~LG~G~fg~VY~A~d~~~g-~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H----pnIV~l~~~ 94 (631)
..... +|.+.+.||+|+||.||+|.+..++ ..+|+|.......... ..+..|+.++..+.. +++..+++.
T Consensus 13 ~~~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~ 88 (322)
T KOG1164|consen 13 NDKVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDH 88 (322)
T ss_pred hcccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEe
Confidence 33344 8999999999999999999998775 6899998775432111 146778888888863 688999887
Q ss_pred EEcCCCceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCC----C
Q 006777 95 WVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN----G 168 (631)
Q Consensus 95 f~~~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~----g 168 (631)
+. ....+-|+||+++ |.+|.+++... +.++..++..++.|++.+|++||+.| ++||||||+|+.+.... .
T Consensus 89 G~-~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~ 164 (322)
T KOG1164|consen 89 GR-STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVR 164 (322)
T ss_pred cc-CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccc
Confidence 64 3345788999998 68999998765 47999999999999999999999999 99999999999996332 4
Q ss_pred cEEEccccchh--hccCC---------C-CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHH
Q 006777 169 EVKIGDLGLAI--VMQQP---------T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA 235 (631)
Q Consensus 169 ~vKI~DFGlA~--~~~~~---------~-~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~ 235 (631)
.+.|.|||+|+ .+... . ...+.||..|+++....+ +.+.+.|+||++.++.+|+.|..||.......
T Consensus 165 ~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~ 244 (322)
T KOG1164|consen 165 TLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD 244 (322)
T ss_pred eEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence 69999999998 32111 1 123569999999997754 58899999999999999999999997654332
Q ss_pred HH--HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 236 QI--YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 236 ~~--~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.. +................+.++..+...+-. +...+|....+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 245 LKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 22 222222111111223344566666655554 6677887766544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=196.05 Aligned_cols=179 Identities=17% Similarity=0.125 Sum_probs=138.5
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHH------HHHHHHHHHhCCCCCcceeee
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLER------LYSEVHLLKSLKHENIIKFYN 93 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~------~~~Ei~iL~~L~HpnIV~l~~ 93 (631)
...+.++|++.++||.|+||.||++.+ ++..+|+|++..... ..+...++ +.+|++.+.+|.||+|..+.+
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~-~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d 102 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVK-RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLND 102 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcC-chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceE
Confidence 345688999999999999999999755 467899999875532 33444444 578999999999999999999
Q ss_pred EEEcCCC------ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCC
Q 006777 94 SWVDDTN------RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 94 ~f~~~~~------~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~ 167 (631)
++.+... ...++||||++|.+|.++.. +++ ....+++.+|..+|.+| ++|||+||+||+++ .+
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~-~~ 171 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVS-KN 171 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEe-CC
Confidence 8775432 35789999999999988732 333 34669999999999999 99999999999998 67
Q ss_pred CcEEEccccchhhccCCCCccccCCCCCCCccccccccCccceEeehhhHHHHHh
Q 006777 168 GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 222 (631)
Q Consensus 168 g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~eml 222 (631)
| ++|+|||.........+... =+++..|+.++|||+||+++....
T Consensus 172 g-i~liDfg~~~~~~e~~a~d~---------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAKDR---------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhHHH---------HHHHhHhcccccccceeEeehHHH
Confidence 7 99999998764432221110 023456788999999999877653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.4e-22 Score=225.33 Aligned_cols=225 Identities=24% Similarity=0.406 Sum_probs=172.1
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
...-..|..++.+..|+||.||+..|+.+.+.+|.| ++...+ +.+. ++.....|.+|
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l---------ilRn--ilt~a~npfvv----------- 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL---------ILRN--ILTFAGNPFVV----------- 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch---------hhhc--cccccCCccee-----------
Confidence 344567888999999999999999999999999984 443221 1111 22222222222
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
|+-...++.-+.++... +.+++|||+.+ |+|||+||+|.+|+ .-|++|+.|||+++.
T Consensus 136 ------------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKK 192 (1205)
T ss_pred ------------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhhh
Confidence 77777777767666544 78999999998 99999999999998 789999999999853
Q ss_pred cc--C---------------CCCccccCCCCCCCcccc-ccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006777 181 MQ--Q---------------PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 181 ~~--~---------------~~~~~~~GTp~y~APE~l-~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~ 242 (631)
.- . -..+.++|||.|.|||++ ..+|+..+|+|++|+|+||.+.|..||.+ ..+++++..+.
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~vi 271 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVI 271 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhh
Confidence 11 0 013467999999999976 56799999999999999999999999998 66777776665
Q ss_pred cC-CC-CCCCCCCCcHHHHHHHHHhcC-CCCCCC---CHHHHhcCCCccCCCCCccc
Q 006777 243 SG-IK-PASLSKVTDPQVKQFIEKCIV-PASLRL---PALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 243 ~~-~~-p~~l~~~~~~~lk~lI~kcL~-~p~~Rp---ta~elL~hpff~~~~~~~~~ 293 (631)
.. +. |+. ..-..++++++|.++|+ .|..|. .+-++.+|+||+..+|+.++
T Consensus 272 sd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~ll 327 (1205)
T KOG0606|consen 272 SDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLL 327 (1205)
T ss_pred hhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhh
Confidence 43 22 333 34457899999999997 787775 46799999999999888544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=189.05 Aligned_cols=146 Identities=15% Similarity=0.127 Sum_probs=113.8
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCH--------------------H--HHHHHHHHHHHHHhCCCCC
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSP--------------------D--QLERLYSEVHLLKSLKHEN 87 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~--------------------~--~~~~~~~Ei~iL~~L~Hpn 87 (631)
...||+|+||.||+|.+. +|+.||+|+++........ . ......+|+++|..|.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999996 8999999999765321000 0 0123345999999998888
Q ss_pred cceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEecCCCCCceEEeCC
Q 006777 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 88 IV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp~NILl~~~ 166 (631)
|...+.... .. .++||||++|++|...+.+.+.+++..+..++.|++.+|.|+ |+.| |+||||||+|||++
T Consensus 81 v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-- 152 (190)
T cd05147 81 IPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-- 152 (190)
T ss_pred CCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE--
Confidence 754433221 11 279999999988876655567899999999999999999999 7988 99999999999997
Q ss_pred CCcEEEccccchhhccCC
Q 006777 167 NGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 167 ~g~vKI~DFGlA~~~~~~ 184 (631)
++.++|+|||+|.....+
T Consensus 153 ~~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 153 DGKLYIIDVSQSVEHDHP 170 (190)
T ss_pred CCcEEEEEccccccCCCc
Confidence 478999999999754443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-21 Score=188.20 Aligned_cols=235 Identities=21% Similarity=0.249 Sum_probs=182.8
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCcceeeeEEEcCCC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~f~~~~~ 100 (631)
.....|.++++||.|+||.+|.|....+|.+||||+-...- .-..+..|.++.+.|+| ..|..++.++.+.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a------~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~-- 83 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA------KHPQLLYESKVYRILQGGVGIPHIRHYGTEK-- 83 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC------CCcchhHHHHHHHHhccCCCCchhhhhcccc--
Confidence 45678999999999999999999999999999999755331 22346778899998864 5676666655433
Q ss_pred ceEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe--CCCCcEEEccccc
Q 006777 101 RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGL 177 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKI~DFGl 177 (631)
.+-.+||++. |.+|.++..- .+.++.+++.-++-|++.-++|+|.++ +|||||||+|.|+. .+...+.++|||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccc
Confidence 3667899999 6899998764 357999999999999999999999999 99999999999984 2345789999999
Q ss_pred hhhccCC---------CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCC--CHHHHHHHHHcCC
Q 006777 178 AIVMQQP---------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGI 245 (631)
Q Consensus 178 A~~~~~~---------~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~--~~~~~~~~i~~~~ 245 (631)
|+.+... ..+...||..|.+--..- -+-+.+-|+-|+|.++..+..|..||.+.. +..+.+++|.+..
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 9765432 233467999998766433 345778899999999999999999998853 3456677776543
Q ss_pred ---CCCCCCCCCcHHHHHHHHHhcC
Q 006777 246 ---KPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 246 ---~p~~l~~~~~~~lk~lI~kcL~ 267 (631)
.+..+-+..+.++.-.+.-|-.
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~ 265 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRG 265 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhh
Confidence 2334556677888888887743
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-22 Score=226.56 Aligned_cols=250 Identities=19% Similarity=0.228 Sum_probs=188.2
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
..+.+...|...+.||.+.|-+|.+|++. .|. |+||++-..+-.-+-....+...|++ .+.++|||+++|-.+- .
T Consensus 17 yfsd~~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~ 91 (1431)
T KOG1240|consen 17 YFSDLSVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--V 91 (1431)
T ss_pred HhhcCccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--H
Confidence 34445558899999999999999999984 566 88999866543333344445555666 6777999999997743 3
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+..|||-+|.. -+|.|.+.-++-+..-+.+.++.||+.||.-+|..| |+|||||++||||+ .-+.+.|.||..-
T Consensus 92 t~kAAylvRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiT-SWNW~~LtDFAsF 167 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILIT-SWNWLYLTDFASF 167 (1431)
T ss_pred hhHHHHHHHHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEe-eechhhhhccccc
Confidence 3346788999997 599999988888999999999999999999999999 99999999999998 6778999999865
Q ss_pred hhc----cCCCC-c----cccCCCCCCCcccccc-----------c-cCccceEeehhhHHHHHhh-cCCCCCCCCCHHH
Q 006777 179 IVM----QQPTA-R----SVIGTPEFMAPELYEE-----------E-YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 236 (631)
Q Consensus 179 ~~~----~~~~~-~----~~~GTp~y~APE~l~~-----------~-y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~ 236 (631)
+.. .++.. . +-..-.||.|||.+.. . .+++-||||+||+++||++ |.+||. ..+
T Consensus 168 KPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQ 243 (1431)
T KOG1240|consen 168 KPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQ 243 (1431)
T ss_pred CCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHH
Confidence 421 11111 1 1123448999997632 1 4568899999999999988 677773 344
Q ss_pred HHHHHHcCCC-C-CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 237 IYKKVTSGIK-P-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 237 ~~~~i~~~~~-p-~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+...-..+.. + ..+.+..+..++++|..|++ +|++|.+|++.|+-
T Consensus 244 L~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 244 LLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 4443333211 1 12344556789999999998 99999999999976
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=183.90 Aligned_cols=145 Identities=17% Similarity=0.165 Sum_probs=114.7
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc--------------------CCHHH--HHHHHHHHHHHHhCCCCC
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM--------------------QSPDQ--LERLYSEVHLLKSLKHEN 87 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~--------------------~~~~~--~~~~~~Ei~iL~~L~Hpn 87 (631)
...||+|+||.||+|.+. +|+.||+|+++..... ..... ...+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 8999999998865210 00111 233467999999999999
Q ss_pred cceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCC
Q 006777 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 88 IV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~ 166 (631)
|.....++... .++||||++|+++.........++...+..++.|++.+|.++|+ +| |+||||||+||+++
T Consensus 81 i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-- 152 (190)
T cd05145 81 VPVPEPILLKK----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-- 152 (190)
T ss_pred CCCceEEEecC----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--
Confidence 86555443322 37999999988665443344568899999999999999999999 88 99999999999997
Q ss_pred CCcEEEccccchhhccC
Q 006777 167 NGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 167 ~g~vKI~DFGlA~~~~~ 183 (631)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 68999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=190.22 Aligned_cols=213 Identities=20% Similarity=0.281 Sum_probs=173.0
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~ 100 (631)
..+-.|.++++||+|+||.++.|.+..++++||||.-... .+..++..|.+..+.|. .++|..+|.+. ...
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG 96 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEG 96 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeeec--ccc
Confidence 4588999999999999999999999999999999975432 22345677888888884 68999888643 334
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC----CCCcEEEccc
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDL 175 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~----~~g~vKI~DF 175 (631)
.+-.||+|++ |-+|.++..-. .+|+.+++.-++.|++.-++|+|+++ +|+|||||+|+||.. ....|.|+||
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEec
Confidence 4567899999 68999988754 46999999999999999999999999 999999999999951 2235899999
Q ss_pred cchhhccCCC---------CccccCCCCCCCcccc-ccccCccceEeehhhHHHHHhhcCCCCCCCC--CHHHHHHHHHc
Q 006777 176 GLAIVMQQPT---------ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTS 243 (631)
Q Consensus 176 GlA~~~~~~~---------~~~~~GTp~y~APE~l-~~~y~~~sDIwSLG~il~emltG~~Pf~~~~--~~~~~~~~i~~ 243 (631)
|+|+.+..+. .++..||..||+--.. ..+-+.+-|+=|||-++++.|-|..||.+.. +..+.|++|-.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 9998776543 2356799999997743 4457889999999999999999999998853 44567777765
Q ss_pred CC
Q 006777 244 GI 245 (631)
Q Consensus 244 ~~ 245 (631)
..
T Consensus 254 ~K 255 (449)
T KOG1165|consen 254 TK 255 (449)
T ss_pred cc
Confidence 43
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-20 Score=193.67 Aligned_cols=199 Identities=21% Similarity=0.359 Sum_probs=148.1
Q ss_pred CCCCcceeeeEEEcC-------------------------CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 006777 84 KHENIIKFYNSWVDD-------------------------TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138 (631)
Q Consensus 84 ~HpnIV~l~~~f~~~-------------------------~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl 138 (631)
+|||||+++++|.+. ....+|+||.... .+|++|+-.+ ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 799999999988652 2357899999987 6999998754 467788889999999
Q ss_pred HHHHHHHhCCCCeEecCCCCCceEEeC-CCC--cEEEccccchhhccC-----CC---CccccCCCCCCCcccccc---c
Q 006777 139 RGLHYLHSHNPPIIHRDLKCDNIFVNG-NNG--EVKIGDLGLAIVMQQ-----PT---ARSVIGTPEFMAPELYEE---E 204 (631)
Q Consensus 139 ~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g--~vKI~DFGlA~~~~~-----~~---~~~~~GTp~y~APE~l~~---~ 204 (631)
+|+.|||++| |.|||||.+|||+.- +++ .+.|+|||.+-.-.. +. .-..-|.-.-||||+... +
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 999999999999852 233 578999998732221 11 113357889999998753 2
Q ss_pred ----cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH---
Q 006777 205 ----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL--- 276 (631)
Q Consensus 205 ----y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~--- 276 (631)
.-.++|.|+.|.+.||+++...||.+.. ...+-...-+....+.++..+++.+++++..+|+ +|++|+++.
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 1248999999999999999999998622 1111111122223455677788999999999998 999999954
Q ss_pred HHhcCCCccCC
Q 006777 277 ELLKDPFLVTD 287 (631)
Q Consensus 277 elL~hpff~~~ 287 (631)
.+|+-..+...
T Consensus 509 Nvl~LsLw~~~ 519 (598)
T KOG4158|consen 509 NVLNLSLWRMG 519 (598)
T ss_pred hHHHHHHhcCc
Confidence 56655444443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=179.77 Aligned_cols=184 Identities=15% Similarity=0.061 Sum_probs=139.7
Q ss_pred EEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCceEEEEE
Q 006777 29 SWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
+...|++|+||+||.+.. .+..++.+.+.....-...-....+.+|+++|++|. |++|++++++ ...+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 478999999999998875 677888776665432111122336789999999995 5889999884 1368999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC-CCCceEEeCCCCcEEEccccchhhccCCCC
Q 006777 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL-KCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 186 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL-Kp~NILl~~~~g~vKI~DFGlA~~~~~~~~ 186 (631)
||+.|.+|.+.+.. . ...++.|++.+|.++|++| |+|||| ||+|||++ .+|.++|+|||+|........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcch
Confidence 99999999754321 1 1357899999999999999 999999 79999997 788999999999974433221
Q ss_pred ------c---------cccCCCCCCCccccc--cccC-ccceEeehhhHHHHHhhcCCCCCC
Q 006777 187 ------R---------SVIGTPEFMAPELYE--EEYN-ELVDIYSFGMCILEMVTCEYPYNE 230 (631)
Q Consensus 187 ------~---------~~~GTp~y~APE~l~--~~y~-~~sDIwSLG~il~emltG~~Pf~~ 230 (631)
. -..+++.|+.|+... ...+ ...++++.|+-+|.++|+..|+.+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 113688889988432 2333 567899999999999999999865
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=179.07 Aligned_cols=137 Identities=17% Similarity=0.163 Sum_probs=109.5
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-----CCCCcceeeeEEEcCCC-ceE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-----KHENIIKFYNSWVDDTN-RTI 103 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIV~l~~~f~~~~~-~~l 103 (631)
.+.||+|+|+.||. ++.++.. +||++..... ...+.+.+|+.++++| .||||+++|+++.++.. +.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 58999999999995 7777766 6998876432 2345689999999999 67999999999877542 344
Q ss_pred E-EEEec--cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeEecCCCCCceEEeC---CCCcEEEcccc
Q 006777 104 N-MITEL--FTSGSLRQYRKKHKNVDMKAIKNWARQILRGL-HYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLG 176 (631)
Q Consensus 104 ~-lV~Ey--~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL-~yLHs~~~~IiHrDLKp~NILl~~---~~g~vKI~DFG 176 (631)
+ +|+|| +.+|+|.+++++. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. .++.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 4 78999 5589999999764 46666 46788999888 9999999 999999999999973 23479999955
Q ss_pred ch
Q 006777 177 LA 178 (631)
Q Consensus 177 lA 178 (631)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=187.16 Aligned_cols=235 Identities=16% Similarity=0.154 Sum_probs=150.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC----------CCcceeeeE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH----------ENIIKFYNS 94 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H----------pnIV~l~~~ 94 (631)
..+...+.||.|+++.||.+.|..+|+++|+|++.... .......+.+.+|......+.+ -.++.-++.
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 36778899999999999999999999999999988766 3344567777777755555433 112222221
Q ss_pred EEc---------C-CCc-----eEEEEEeccCCCCHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006777 95 WVD---------D-TNR-----TINMITELFTSGSLRQYRKK---HKN----VDMKAIKNWARQILRGLHYLHSHNPPII 152 (631)
Q Consensus 95 f~~---------~-~~~-----~l~lV~Ey~~gGsL~~~l~~---~~~----l~e~~i~~i~~QIl~gL~yLHs~~~~Ii 152 (631)
... . +.. ..+++|+-+. ++|.+++.- ... +.......+..|++..+++||.+| ++
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lV 167 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LV 167 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eE
Confidence 111 1 111 1356777774 799887542 222 233344566699999999999999 99
Q ss_pred ecCCCCCceEEeCCCCcEEEccccchhhccCCCCccccCCCCCCCcccccc---------ccCccceEeehhhHHHHHhh
Q 006777 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE---------EYNELVDIYSFGMCILEMVT 223 (631)
Q Consensus 153 HrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~---------~y~~~sDIwSLG~il~emlt 223 (631)
|+||+|+|+|++ .+|.++|+||+.....+..... ...+..|.|||+... .++.+.|.|+||+++|.|.+
T Consensus 168 Hgdi~~~nfll~-~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 168 HGDIKPENFLLD-QDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp EST-SGGGEEE--TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEc-CCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999998 7899999999877544332221 344678999997632 37889999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCC
Q 006777 224 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLR 272 (631)
Q Consensus 224 G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~R 272 (631)
|..||..... ...... . -..-...+..++.||..+|+ +|.+|
T Consensus 246 ~~lPf~~~~~-~~~~~~-----~-f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSP-EADPEW-----D-FSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGG-GSTSGG-----G-GTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCc-cccccc-----c-chhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999975211 100000 0 01112467889999999998 77776
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=174.77 Aligned_cols=152 Identities=17% Similarity=0.114 Sum_probs=118.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEE-EcCCCeEEEEEEeecccccC------------------CHH--HHHHHHHHHHHHH
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGF-DEVDGIEVAWNQVNIEDVMQ------------------SPD--QLERLYSEVHLLK 81 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~-d~~~g~~VAvK~v~~~~~~~------------------~~~--~~~~~~~Ei~iL~ 81 (631)
.+..|.+.+.||+|+||.||+|. +..+|+.||+|+++...... ... ....+.+|+++++
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 35578999999999999999999 77899999999988643110 011 1134568999999
Q ss_pred hCCCC--CcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006777 82 SLKHE--NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159 (631)
Q Consensus 82 ~L~Hp--nIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~ 159 (631)
++.+. .++++++. . ..++||||+.|++|..+......+...++..++.||+.+|.+||++| +++||||||+
T Consensus 106 ~L~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~ 178 (237)
T smart00090 106 RLYEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEY 178 (237)
T ss_pred HHHhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChh
Confidence 99763 33444431 1 24799999999888776544556777788899999999999999986 5999999999
Q ss_pred ceEEeCCCCcEEEccccchhhccC
Q 006777 160 NIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 160 NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
||+++ ++.++|+|||.+.....
T Consensus 179 NIli~--~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH--DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE--CCCEEEEEChhhhccCC
Confidence 99997 67999999999875443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4e-19 Score=192.15 Aligned_cols=248 Identities=19% Similarity=0.296 Sum_probs=169.0
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceee-----
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY----- 92 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~---g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~----- 92 (631)
.....+.+.+..+..+++.+....-... .+.++-+......+ .......+++-.+... .|+..+..-
T Consensus 241 ~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~----~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~ 316 (516)
T KOG1033|consen 241 EESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL----CACKYTFRQLGVLVDSSHSNRSILEDLRPSL 316 (516)
T ss_pred cccccccccccccccccCCchhhhhcccchhhhhccchhhhccch----hhhhhhhhhhhheeccccCCcccccCCCCch
Confidence 3344555566677777777766554333 23333333332221 1222233444444444 455444332
Q ss_pred -eEEEcCC---CceEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC
Q 006777 93 -NSWVDDT---NRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 93 -~~f~~~~---~~~l~lV~Ey~~gGsL~~~l~~~~---~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
..+.... ..++|+.|++|.-.+|.+++.+.. ..+....+.|+.|+..|++| ++ .+|||+||.||++.
T Consensus 317 ~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~- 390 (516)
T KOG1033|consen 317 FESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS- 390 (516)
T ss_pred hhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-
Confidence 1221111 236899999999999999998654 35677889999999999999 66 99999999999997
Q ss_pred CCCcEEEccccchhhccCCC--------CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHH
Q 006777 166 NNGEVKIGDLGLAIVMQQPT--------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPA 235 (631)
Q Consensus 166 ~~g~vKI~DFGlA~~~~~~~--------~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~ 235 (631)
.+..+||+|||+........ ....+||+.||+||.+.+ .|+.++||||||++++|+++ -..+|.. .
T Consensus 391 ~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~ 466 (516)
T KOG1033|consen 391 DDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----I 466 (516)
T ss_pred cchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----H
Confidence 77899999999986543322 234589999999998874 69999999999999999998 4444432 2
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 236 ~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
.....+..+..|+.+... .|+-..|+..+|. .|.+||++.+.--|+|.
T Consensus 467 ~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 467 ATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 233445666666443332 4677899999997 89999988887777765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.5e-19 Score=201.93 Aligned_cols=256 Identities=22% Similarity=0.292 Sum_probs=204.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcC-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR 101 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~-~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~ 101 (631)
...|.+.+.||+|+|+.|-.+.... ....+|.|.+.... .......+...|..+-+.+. |+|++.+++.+... .
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--~ 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP--R 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCC--c
Confidence 5689999999999999999987743 34456666665443 34556667778888888887 99999999976444 4
Q ss_pred eEEEEEeccCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCceEEeCCCC-cEEEccccc
Q 006777 102 TINMITELFTSGSLRQYR-KKHK-NVDMKAIKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGL 177 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l-~~~~-~l~e~~i~~i~~QIl~gL~yLH-s~~~~IiHrDLKp~NILl~~~~g-~vKI~DFGl 177 (631)
..+++++|..||++...+ .... ..+......++.|+..+|.|+| ..+ +.||||||+|.+++ ..+ .+|+.|||+
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~-~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLD-ESGSALKIADFGL 171 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhc-cCCCcccCCCchh
Confidence 678899999999999988 5554 6788889999999999999999 888 99999999999998 677 999999999
Q ss_pred hhhccC-CC----CccccC-CCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--C
Q 006777 178 AIVMQQ-PT----ARSVIG-TPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 247 (631)
Q Consensus 178 A~~~~~-~~----~~~~~G-Tp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p 247 (631)
|..+.. .. ....+| ++.|+|||.+.+ ...+..|+||.|+++.-|++|..|+.........+........ .
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT 251 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc
Confidence 986655 22 234578 999999998766 3578999999999999999999999764433333322222211 2
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.......+....+++.++|. +|..|.+.+++-.+||+..
T Consensus 252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 33445567889999999996 8999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.3e-17 Score=160.75 Aligned_cols=138 Identities=20% Similarity=0.202 Sum_probs=112.7
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEE
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV 106 (631)
+.||+|++|.||+|.+ .|..|++|+......... .....++.+|+.++..+.|++|+....++.+.. ..++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEE
Confidence 5799999999999986 678899997654322111 112356788999999999999877666655544 46789
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
|||++|++|.+++..... ....++.+++.+|.++|+++ ++|||++|.|||++ ++.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 999999999999876432 78899999999999999999 99999999999997 68899999998864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-17 Score=194.76 Aligned_cols=191 Identities=20% Similarity=0.239 Sum_probs=153.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCcceeeeEEEcCCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~f~~~~~ 100 (631)
+..|.|.+.||+|+||+||+|.+.. |+.||+|+-+.... -+|+-=.+++.+|+ -+.|+.++..++-.+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~-------WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~- 767 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP-------WEFYICLQVMERLKPQMLPSIMHISSAHVFQN- 767 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc-------eeeeehHHHHHhhchhhhcchHHHHHHHccCC-
Confidence 6789999999999999999999865 99999998654421 11222334444554 245566655554444
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC------CCCcEEEcc
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------NNGEVKIGD 174 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~------~~g~vKI~D 174 (631)
.-++|+||.+.|+|.+++...+.+++..+..+..|++..++.||.++ |||+||||+|.||.. ..--++|+|
T Consensus 768 -~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 768 -ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred -cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEe
Confidence 35689999999999999998899999999999999999999999999 999999999999951 123589999
Q ss_pred ccchhhcc----CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCC
Q 006777 175 LGLAIVMQ----QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEY 226 (631)
Q Consensus 175 FGlA~~~~----~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~ 226 (631)
||.+..+. ......+++|-.|-.+|+..+ .+++.+|.|.|+.+++-||.|++
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99996543 223456788999999999876 58999999999999999999964
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-17 Score=167.49 Aligned_cols=238 Identities=18% Similarity=0.276 Sum_probs=181.7
Q ss_pred EEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEE
Q 006777 28 ISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 28 ~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
.+.-+|.....|..|+|++. |..++.|+++..++ ...-...|..|.-.|+-+.||||+++.+.+... ..+.+|.
T Consensus 193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~is 266 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVIIS 266 (448)
T ss_pred hhhhhhccCCCccccccccc--Ccchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceEee
Confidence 34567788889999999975 55677788776654 223345688899999999999999999987554 3688999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEE--ccccchhhccC
Q 006777 108 ELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI--GDLGLAIVMQQ 183 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI--~DFGlA~~~~~ 183 (631)
.||+-|+|...+.... .++..++.+++..|+.|++|||+..|-|.--.|....++++ ++-+.+| +|--++- +
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfsf---q 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFSF---Q 342 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceeee---e
Confidence 9999999999998754 36888999999999999999999985444556888899997 5665554 4433331 1
Q ss_pred CCCccccCCCCCCCccccccc----cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 184 PTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 184 ~~~~~~~GTp~y~APE~l~~~----y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
. ......|.||+||.+... .-.++|+|||+++++||.|.+.||.+..+.+--.+...+|..+ .+++..++.+.
T Consensus 343 e--~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv-~ippgis~hm~ 419 (448)
T KOG0195|consen 343 E--VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV-HIPPGISRHMN 419 (448)
T ss_pred c--cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc-cCCCCccHHHH
Confidence 1 122348999999988643 2357999999999999999999999865555445555555444 45556788999
Q ss_pred HHHHHhcC-CCCCCCCHHHH
Q 006777 260 QFIEKCIV-PASLRLPALEL 278 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~el 278 (631)
.|+.-|+. ||.+||....+
T Consensus 420 klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 420 KLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred HHHHHHhcCCCCcCCCccee
Confidence 99999998 99999987654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-16 Score=154.92 Aligned_cols=134 Identities=20% Similarity=0.231 Sum_probs=106.1
Q ss_pred EEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEE
Q 006777 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
.||+|+||.||+|. .+|..|++|+......... .....++.+|+++++.+.|+++....-++.+.. ..++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEE
Confidence 37999999999998 4678899998654322111 123467889999999999887655444444443 457899
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
||++|++|.+++..... .++.|++.+|.+||+.+ ++|||++|.||+++ ++.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999999998765332 88999999999999999 99999999999997 68999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=157.35 Aligned_cols=143 Identities=20% Similarity=0.099 Sum_probs=110.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc-----CC-------------HHHHHHHHHHHHHHHhCCCC
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM-----QS-------------PDQLERLYSEVHLLKSLKHE 86 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~-----~~-------------~~~~~~~~~Ei~iL~~L~Hp 86 (631)
..|.+.+.||+|+||.||+|.+. +|+.||+|++...... .. .........|+.++..+.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred chhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 35888999999999999999874 7999999997754210 00 00112366799999999887
Q ss_pred C--cceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe
Q 006777 87 N--IIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164 (631)
Q Consensus 87 n--IV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 164 (631)
+ ++..++ . ...++||||++|++|..+... .....++.+|+.++.++|+++ ++||||||+||+++
T Consensus 94 ~i~v~~~~~----~--~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~ 159 (198)
T cd05144 94 GFPVPKPID----W--NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVD 159 (198)
T ss_pred CCCCCceee----c--CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEc
Confidence 4 444443 1 245899999999999765431 345788999999999999998 99999999999998
Q ss_pred CCCCcEEEccccchhhccC
Q 006777 165 GNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 165 ~~~g~vKI~DFGlA~~~~~ 183 (631)
.++.++|+|||++.....
T Consensus 160 -~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 -DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred -CCCcEEEEECCccccCCC
Confidence 689999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=175.07 Aligned_cols=195 Identities=27% Similarity=0.426 Sum_probs=153.0
Q ss_pred HHhCCCCCcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCe-EecCCC
Q 006777 80 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPI-IHRDLK 157 (631)
Q Consensus 80 L~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~I-iHrDLK 157 (631)
|+.+.|.|+.+|++..++. ...+.|.+||..|+|.+.+... -.++......+++.|+.||.|||... | .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999998877 4688999999999999999874 46888888999999999999999875 5 999999
Q ss_pred CCceEEeCCCCcEEEccccchhhccC----CCCccccCCCCCCCccccccc--------cCccceEeehhhHHHHHhhcC
Q 006777 158 CDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYEEE--------YNELVDIYSFGMCILEMVTCE 225 (631)
Q Consensus 158 p~NILl~~~~g~vKI~DFGlA~~~~~----~~~~~~~GTp~y~APE~l~~~--------y~~~sDIwSLG~il~emltG~ 225 (631)
..|++++ ....+||.|||+...... .......-...|.|||++... .+.+.||||||++++|+++..
T Consensus 77 s~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 77 SSNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred cccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999998 788999999999865532 111111234469999988653 466799999999999999999
Q ss_pred CCCCCC---CCHHHHHHHHHc-CCC---CCCCCC-CCcHHHHHHHHHhcC-CCCCCCCHHHHh
Q 006777 226 YPYNEC---KNPAQIYKKVTS-GIK---PASLSK-VTDPQVKQFIEKCIV-PASLRLPALELL 279 (631)
Q Consensus 226 ~Pf~~~---~~~~~~~~~i~~-~~~---p~~l~~-~~~~~lk~lI~kcL~-~p~~Rpta~elL 279 (631)
-||... ..+.++..++.. +.. |..... ...+++..++..|+. +|..||++..+-
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 999763 223456666666 322 221111 344578999999998 899999988754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.5e-16 Score=176.39 Aligned_cols=141 Identities=18% Similarity=0.124 Sum_probs=110.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc----CCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...|...+.||+|+||+||+|... +..+++|+....... ......+++.+|+++++.++|++|+..+.++.+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344566899999999999999864 334555543222111 11123467889999999999999988776665543
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..++||||++|++|.+++. ....++.|++.+|.|||+++ ++||||||+||+++ ++.++|+|||+++
T Consensus 410 --~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~ 475 (535)
T PRK09605 410 --EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGK 475 (535)
T ss_pred --CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCcccc
Confidence 4679999999999999886 35689999999999999999 99999999999994 6789999999986
Q ss_pred h
Q 006777 180 V 180 (631)
Q Consensus 180 ~ 180 (631)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=148.10 Aligned_cols=140 Identities=20% Similarity=0.142 Sum_probs=100.0
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHH---------------------HHHHHHHHHHhCCCCC-
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE---------------------RLYSEVHLLKSLKHEN- 87 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~---------------------~~~~Ei~iL~~L~Hpn- 87 (631)
.+.||+|+||+||+|.+. +|+.||+|++....... ..... ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSF-KKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccch-hhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 468999999999999986 89999999987543211 11111 1135666677665443
Q ss_pred -cceeeeEEEcCCCceEEEEEeccCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEe
Q 006777 88 -IIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVN 164 (631)
Q Consensus 88 -IV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~-l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~ 164 (631)
+.+.+... ..++||||++++.+... +.... .. ..++.++.|++.++.++|. ++ |+||||||+||+++
T Consensus 80 ~~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~ 149 (187)
T cd05119 80 PVPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD 149 (187)
T ss_pred CCCceEecC------CCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE
Confidence 44454421 35899999998543221 11111 11 6788999999999999999 88 99999999999997
Q ss_pred CCCCcEEEccccchhhccC
Q 006777 165 GNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 165 ~~~g~vKI~DFGlA~~~~~ 183 (631)
++.++|+|||.+.....
T Consensus 150 --~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 --DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred --CCcEEEEECcccccccC
Confidence 78999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2e-14 Score=146.57 Aligned_cols=141 Identities=14% Similarity=0.133 Sum_probs=106.9
Q ss_pred EEEEe-ecCCeEEEEEEEcCCCeEEEEEEeecccc----cC-----CHHHHHHHHHHHHHHHhCCCCCc--ceeeeEEEc
Q 006777 30 WVVVL-NCTFMCRYKGFDEVDGIEVAWNQVNIEDV----MQ-----SPDQLERLYSEVHLLKSLKHENI--IKFYNSWVD 97 (631)
Q Consensus 30 ~e~LG-~G~fg~VY~A~d~~~g~~VAvK~v~~~~~----~~-----~~~~~~~~~~Ei~iL~~L~HpnI--V~l~~~f~~ 97 (631)
..+|| .|+.|+||.+... |..+|+|.+....+ .. ......++.+|+.++..|.|++| ++.+.+...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35677 7888888888753 78899998864321 00 12334678899999999998885 666665433
Q ss_pred CCCc--eEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 98 DTNR--TINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 98 ~~~~--~l~lV~Ey~~g-GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
.... ..++||||++| .+|.+++.. ..+++.. +.||+.+|.+||++| |+||||||.|||++ .++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~-~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLD-PDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEc-CCCCEEEEE
Confidence 3221 23599999997 699998865 3466543 578999999999999 99999999999997 578999999
Q ss_pred ccchhh
Q 006777 175 LGLAIV 180 (631)
Q Consensus 175 FGlA~~ 180 (631)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=4e-14 Score=129.94 Aligned_cols=134 Identities=19% Similarity=0.073 Sum_probs=109.5
Q ss_pred EEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCcceeeeEEEcCCCceEEEE
Q 006777 29 SWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~~f~~~~~~~l~lV 106 (631)
+.+.||+|.++.||++.+. +..+++|.+..... ...+.+|+.+++.+.| +++++++.++... ...+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v 71 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLL 71 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEE
Confidence 4678999999999999974 37799998764421 4567889999999976 5888988765433 468999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~-~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+||+.|+.+..+ +......++.+++.+|.++|... ++++|+||+|+||+++ ..+.+++.|||.+..
T Consensus 72 ~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~~ 138 (155)
T cd05120 72 MEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGY 138 (155)
T ss_pred EEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-CCcEEEEEecccccC
Confidence 999998888654 56677888999999999999852 2499999999999998 578999999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-14 Score=158.07 Aligned_cols=255 Identities=22% Similarity=0.224 Sum_probs=197.7
Q ss_pred CCCcEEEEEEEee--cCCeEEEEEEE--cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 23 VSYFWISWVVVLN--CTFMCRYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 23 i~~~Y~i~e~LG~--G~fg~VY~A~d--~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
....+.+.+.+|. |.+|.||.+.. ..++..+|+|.=++.. ..+....+=++|+...+.+ .|+|.++.+..|..
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC--CCccccccccchhhcccccCccccccccCccccc
Confidence 4567778889999 99999999999 8999999998733221 1122223334677666767 49999999998855
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILR----GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~-l~e~~i~~i~~QIl~----gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
. +.+++-+|+|. .+|..|...... ++...++..+.+... ||..+|+.+ ++|-|+||+||++..+....++
T Consensus 190 ~--~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 190 S--GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred C--Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeec
Confidence 4 47888899985 899998876554 899999999999999 999999999 9999999999999743378999
Q ss_pred ccccchhhccCCCC-------ccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006777 173 GDLGLAIVMQQPTA-------RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 173 ~DFGlA~~~~~~~~-------~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~ 245 (631)
+|||+......... ....|...|++||+.++-++...|||+||.++.+-.++..++..+.+.. +..+..+.
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~~r~~~ 342 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQLRQGY 342 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC--cccccccc
Confidence 99999876554321 1225677899999999999999999999999999999887776542221 12233333
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 246 ~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.|..+-...+..+...+..++. +|..|+++..+++|+++..
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 4555554556677778888887 8999999999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.4e-14 Score=166.65 Aligned_cols=264 Identities=17% Similarity=0.276 Sum_probs=204.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
--+.+.+.+.+-+|+++.++.+.-..+|...+.++......... ...+....+-.++-..+||-++..+..|.. ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP 878 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSFPC--RSP 878 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCCCC--CCC
Confidence 34567777799999999999998777776666665544332111 122334445555555677888877765433 346
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++++++|..+++|...+...+..+++..+.++..+..+++|||+.. +.|||++|+|++.. .+|+.++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccccccc
Confidence 8999999999999999998888999999999999999999999987 99999999999997 89999999998432100
Q ss_pred -------C---------------------C-----CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCC
Q 006777 183 -------Q---------------------P-----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPY 228 (631)
Q Consensus 183 -------~---------------------~-----~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf 228 (631)
. . ......||+.|.|||... ......+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 012356899999999764 46788999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCC-CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH---HHhcCCCccCCCCCccc
Q 006777 229 NECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPAL---ELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 229 ~~~~~~~~~~~~i~~~~~-p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~---elL~hpff~~~~~~~~~ 293 (631)
.. ..+.++++.+..+.. ...-+...++++++++.+.|. .|.+|.++. ++-.||||+...|..+.
T Consensus 1036 na-~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1036 NA-ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred CC-cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccc
Confidence 87 567777776665533 333444568899999999998 899999987 99999999999887653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-11 Score=137.90 Aligned_cols=167 Identities=26% Similarity=0.335 Sum_probs=128.3
Q ss_pred EEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhC
Q 006777 43 KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH 122 (631)
Q Consensus 43 ~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~ 122 (631)
.|..+.+|.+|.+...+... ....+...+-++.|+.|+||||++|++.+..+. ++|+|||.+. -|..++++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV~--Pl~~~lk~l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERVR--PLETVLKEL 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeeccc--cHHHHHHHh
Confidence 57778899999998877553 244556778899999999999999999886554 8999999995 788888764
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC--CccccCCCCCCCcc
Q 006777 123 KNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE 199 (631)
Q Consensus 123 ~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~--~~~~~GTp~y~APE 199 (631)
+ ...+..-++||+.||.|||. ++ ++|++|.-+.||++ ..|..||++|-++....... .+...---.|..|+
T Consensus 102 ~---~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 G---KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred H---HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 4 66777788999999999984 55 99999999999998 89999999999885443322 12222222355555
Q ss_pred ccccccCccceEeehhhHHHHHhhc
Q 006777 200 LYEEEYNELVDIYSFGMCILEMVTC 224 (631)
Q Consensus 200 ~l~~~y~~~sDIwSLG~il~emltG 224 (631)
.+... .-..|.|-|||++++++.|
T Consensus 176 ~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCcc-ccchhhhhHHHHHHHHhCc
Confidence 43211 1457999999999999998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.2e-12 Score=143.73 Aligned_cols=146 Identities=12% Similarity=0.099 Sum_probs=98.3
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc--------------------------CCH----HHHHH--
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM--------------------------QSP----DQLER-- 72 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~--------------------------~~~----~~~~~-- 72 (631)
..|.. +.||.|++|.||+|..+.+|+.||||+.+..-.. ... +..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34555 7999999999999999878999999998743100 000 11122
Q ss_pred ----HHHHHHHHHhC----CCCCcceeeeEEEcCCCceEEEEEeccCCCCHHHH--HHhCC----CCCHHHHHHHHHHHH
Q 006777 73 ----LYSEVHLLKSL----KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHK----NVDMKAIKNWARQIL 138 (631)
Q Consensus 73 ----~~~Ei~iL~~L----~HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~--l~~~~----~l~e~~i~~i~~QIl 138 (631)
+.+|...+.++ .+.+.+.+-..+.+-. ..-++||||+.|+.+.++ +.+.+ .+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 33444444444 2344444433333322 245799999999999875 33333 355666777777775
Q ss_pred HHHHHHHhCCCCeEecCCCCCceEEeCCCC----cEEEccccchhhcc
Q 006777 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQ 182 (631)
Q Consensus 139 ~gL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKI~DFGlA~~~~ 182 (631)
..| ++|+|+||.||+++ .+| .++++|||++..+.
T Consensus 278 -------~~G--ffHaDpHPGNIlv~-~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDG--FFHADMHPGNIFVS-YDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCC--eeeCCCChHHeEEe-cCCCCCCeEEEEecceEEECC
Confidence 367 99999999999998 566 99999999986543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.9e-11 Score=135.24 Aligned_cols=145 Identities=21% Similarity=0.166 Sum_probs=97.0
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccC-------------------------CH-HH----------HHHH
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQ-------------------------SP-DQ----------LERL 73 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~-------------------------~~-~~----------~~~~ 73 (631)
.+.||.|++|.||+|.. .+|+.||||+.+..-... .. .- .-.+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 46899999999999987 479999999976431000 00 00 0124
Q ss_pred HHHHHHHHhC----CCCCcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 006777 74 YSEVHLLKSL----KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILR-GLHYLHSH 147 (631)
Q Consensus 74 ~~Ei~iL~~L----~HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~-gL~yLHs~ 147 (631)
.+|.+.+.++ +|.+-+.+-..+.+.. ..-++||||++|++|.++.... ...+ ...++.+++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4566666655 2333333333332222 2357999999999998876532 1222 2345555555 46788999
Q ss_pred CCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 148 ~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
| ++|+|++|.||+++ .+|.++|+|||++..+.
T Consensus 277 g--~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G--FFHADLHPGNIFVL-KDGKIIALDFGIVGRLS 308 (437)
T ss_pred C--ceeCCCCcccEEEC-CCCcEEEEeCCCeeECC
Confidence 8 99999999999997 78999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.2e-11 Score=118.35 Aligned_cols=145 Identities=14% Similarity=0.110 Sum_probs=104.1
Q ss_pred EEEEeecCCeEEEEEEEcC------CCeEEEEEEeecccc--c-------CC---------HHHHHHHH----HHHHHHH
Q 006777 30 WVVVLNCTFMCRYKGFDEV------DGIEVAWNQVNIEDV--M-------QS---------PDQLERLY----SEVHLLK 81 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~------~g~~VAvK~v~~~~~--~-------~~---------~~~~~~~~----~Ei~iL~ 81 (631)
..+||.|-=+.||.|.... .+..+|+|+.+.... . +. ......+. +|+++|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 358999998764210 0 00 01122233 7999999
Q ss_pred hCCC--CCcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEecCCCC
Q 006777 82 SLKH--ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKC 158 (631)
Q Consensus 82 ~L~H--pnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp 158 (631)
+|.. -++.+.+++ . .-++||||+.++.+....-+...+++..+..+..|++.+|..| |..| ++|+||++
T Consensus 82 rl~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence 9953 567777763 1 2468999998654433222233466677888899999999999 8998 99999999
Q ss_pred CceEEeCCCCcEEEccccchhhccCC
Q 006777 159 DNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 159 ~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
.||++. +|.+.|+|||.+.....+
T Consensus 154 ~NIL~~--~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 154 YNMLWH--DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred HHEEEE--CCcEEEEECCCceeCCCC
Confidence 999996 478999999988655443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.9e-11 Score=114.25 Aligned_cols=129 Identities=19% Similarity=0.044 Sum_probs=95.3
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcc-eeeeEEEcCCCceEEEEEe
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII-KFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV-~l~~~f~~~~~~~l~lV~E 108 (631)
.+.|+.|.++.||++... |..|++|+...... ....+.+|+.+++.+.+.+++ +++.. +.. .-++|||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~--~~~lv~e 71 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYF--DPE--TGVLITE 71 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEE--eCC--CCeEEEE
Confidence 478899999999999864 88899998654321 112356799999988665554 44443 222 2368999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP---PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~---~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
|++|.++... ......++.+++.+|..||+.+. .++|+|++|.||+++ ++.++++|||.+.
T Consensus 72 ~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~ 135 (170)
T cd05151 72 FIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG 135 (170)
T ss_pred ecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence 9999888643 11123567899999999999872 259999999999997 5689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-11 Score=136.13 Aligned_cols=253 Identities=19% Similarity=0.124 Sum_probs=179.6
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEc-CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~-~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
......+|..+..||.|.|+.|+...-. .++..|++|.+...-. + ......-..|+.+...| -|.+++.++..|..
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~-~-~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA-T-FASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc-c-hHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 3344667889999999999999987544 6788899998764322 2 22223344577777766 59999999999976
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
..+ .|+=-|||.++++...+.-...+++...++...|++.++.++|+.. ++|+|+||+||++....+.-+++|||.
T Consensus 338 ~r~--~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 338 LRQ--GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccc--ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccc
Confidence 654 4577899999999877755556899999999999999999999998 999999999999972237889999999
Q ss_pred hhhccCCCCccccCCCCCC-Ccccc-cc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006777 178 AIVMQQPTARSVIGTPEFM-APELY-EE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 178 A~~~~~~~~~~~~GTp~y~-APE~l-~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~ 254 (631)
+..+.-.. ....+.-.++ .+|++ +. .+..++|++|||..+.+.+++..--.... ....+..+..|.. +..
T Consensus 414 ~t~~~~~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~-~~~- 486 (524)
T KOG0601|consen 414 WTRLAFSS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNL-PGL- 486 (524)
T ss_pred ccccceec-ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCC-Cch-
Confidence 86422211 1122333444 25544 33 47889999999999999999874332211 1223444433322 222
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
..++..+.+.++. ++..||.+.++..|.=|.
T Consensus 487 ~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 487 KLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred HHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 2566777777776 788899999988886553
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2e-09 Score=117.19 Aligned_cols=214 Identities=18% Similarity=0.254 Sum_probs=152.5
Q ss_pred CCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC--CceEEEEEeccCC-C
Q 006777 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--NRTINMITELFTS-G 113 (631)
Q Consensus 37 ~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~--~~~l~lV~Ey~~g-G 113 (631)
--.+.|+|+...+|..|++|++...+..... ..-.-+++++++.|+|||+|.++|.... ...++||++|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n----k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN----KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc----cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 3457899999999999999999554432211 1234678999999999999999887432 2378999999985 6
Q ss_pred CHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 114 SLRQYRKK---------------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 114 sL~~~l~~---------------~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
+|.++--. ....+|..+|.++.||..||.++|+.| +..+-|.|.+|+++| +-.++|...|+.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G-~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTG-KMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeC-cceEEEecccce
Confidence 78775421 234788999999999999999999999 888999999999985 337888877776
Q ss_pred hhccCCCCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCcHH
Q 006777 179 IVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 179 ~~~~~~~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~-~~~i~~~~~p~~l~~~~~~~ 257 (631)
.+...... +.+++ -.+-|.=.||.+++.|.||..--......... .+.|.. .++.+
T Consensus 441 Dvl~~d~~------------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~---------~yS~D 497 (655)
T KOG3741|consen 441 DVLQEDPT------------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITT---------TYSTD 497 (655)
T ss_pred eeecCCCC------------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhh---------hhhHH
Confidence 55444321 11211 13457778999999999995432222222222 333332 35678
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
++++|.-+.. .+.. .++.+++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 9999988876 4544 788888765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.4e-09 Score=100.91 Aligned_cols=146 Identities=18% Similarity=0.224 Sum_probs=108.6
Q ss_pred EEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCH-----HHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 29 SWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSP-----DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~-----~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
....|-||+-+.|+++.. .|+.+.||.=..+. -..+ -...+..+|+++|.++.--.|.--.-+|.|...+.
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~-YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~- 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKR-YRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ- 86 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeeccccc-ccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe-
Confidence 578999999999999985 58888888532221 1222 23567888999999997655544444456666555
Q ss_pred EEEEeccCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcE--EEccccch
Q 006777 104 NMITELFTS-GSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV--KIGDLGLA 178 (631)
Q Consensus 104 ~lV~Ey~~g-GsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v--KI~DFGlA 178 (631)
++|||++| -++++++.... .........++++|-..+.-||..+ |||+||..+||++..+++.+ .++|||++
T Consensus 87 -i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 87 -IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred -EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecch
Confidence 46799986 48899987653 2333344789999999999999999 99999999999998555544 89999998
Q ss_pred hhc
Q 006777 179 IVM 181 (631)
Q Consensus 179 ~~~ 181 (631)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 644
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.3e-09 Score=106.00 Aligned_cols=145 Identities=17% Similarity=0.154 Sum_probs=106.2
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCcceeeeEEEcCC-CceEEEE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDT-NRTINMI 106 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~~f~~~~-~~~l~lV 106 (631)
.+.|+.|.++.||++... +|..+++|........ .....+.+|+.+++.+.+ .++.+++.+..... .+..++|
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 367899999999999864 3688999987644321 123457889999999976 34566666433221 1256899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 006777 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-------------------------------------- 148 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~-------------------------------------- 148 (631)
|||++|++|...+.. ..+++.....++.+++.+|.+||+..
T Consensus 79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999999988765432 45777788888888888888888531
Q ss_pred ----------------CCeEecCCCCCceEEeCC-CCcEEEccccchh
Q 006777 149 ----------------PPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAI 179 (631)
Q Consensus 149 ----------------~~IiHrDLKp~NILl~~~-~g~vKI~DFGlA~ 179 (631)
..++|+|+.|+||+++.. ++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 237999999999999832 5678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.8e-08 Score=97.66 Aligned_cols=134 Identities=20% Similarity=0.222 Sum_probs=97.0
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHH-----HHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEE
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPD-----QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~-----~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~l 105 (631)
..+++|+-+.+|.+.. -|.++++|. .+.+.-..+. ...+-.+|++++..++--.|..-+=++++.++ -.+
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~--~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN--GLI 76 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CEE
Confidence 4578999999999964 465677774 3322222222 24566789999998865544333333366654 357
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+|||++|-.|++++... . ..+++.+-.-+.-||..| |+|+||.++||++. ++.+.++|||++..
T Consensus 77 ~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~--~~~i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILS--GGRIYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcC--eecCCCccceEEEe--CCcEEEEECCcccc
Confidence 89999999999998875 2 456666667777899999 99999999999997 35599999999964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.8e-08 Score=96.17 Aligned_cols=131 Identities=26% Similarity=0.274 Sum_probs=85.0
Q ss_pred EEEEEEEcCCCeEEEEEEeeccccc---------------------CC-HHHHHHHHHHHHHHHhCCCC--CcceeeeEE
Q 006777 40 CRYKGFDEVDGIEVAWNQVNIEDVM---------------------QS-PDQLERLYSEVHLLKSLKHE--NIIKFYNSW 95 (631)
Q Consensus 40 ~VY~A~d~~~g~~VAvK~v~~~~~~---------------------~~-~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~f 95 (631)
.||.|.. .+|..||+|..+..... .. ........+|.++|..+..- ++.+.+++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899997 57889999987652100 00 11235677899999999766 56677753
Q ss_pred EcCCCceEEEEEeccC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 96 VDDTNRTINMITELFT--SGSLRQYRKKHKNVDMKAIKNWARQILRGLHY-LHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~--gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~y-LHs~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
..+ ++||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.||+++ ++.+.|
T Consensus 79 -~~~----~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~--~~~~~i 147 (188)
T PF01163_consen 79 -NRN----VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVD--DGKVYI 147 (188)
T ss_dssp -ETT----EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEE--TTCEEE
T ss_pred -eCC----EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEee--cceEEE
Confidence 222 58999998 65665443321 2245567788888885555 57888 99999999999997 348999
Q ss_pred ccccchhhccC
Q 006777 173 GDLGLAIVMQQ 183 (631)
Q Consensus 173 ~DFGlA~~~~~ 183 (631)
+|||.+.....
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99998865443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.8e-07 Score=95.67 Aligned_cols=145 Identities=14% Similarity=0.039 Sum_probs=98.3
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc---CC----HHHHHHHHHHHHHHHhCCCCCc--ceeeeEEEcCC--
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM---QS----PDQLERLYSEVHLLKSLKHENI--IKFYNSWVDDT-- 99 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~---~~----~~~~~~~~~Ei~iL~~L~HpnI--V~l~~~f~~~~-- 99 (631)
+++-......|++.. ..|+.|.+|+....... +. ..-...+.+|...+..|..-+| ++...++....
T Consensus 28 e~v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 444444444566654 46788999976433210 00 0001136788888887743333 23333332211
Q ss_pred -CceEEEEEeccCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC------CCCc
Q 006777 100 -NRTINMITELFTSG-SLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------NNGE 169 (631)
Q Consensus 100 -~~~l~lV~Ey~~gG-sL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~------~~g~ 169 (631)
...-++|||++++. +|.+++.. ....+......++.+++..+.-||..| |+|+||++.|||++. .++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCce
Confidence 23567999999875 89999864 245667788899999999999999999 999999999999973 2468
Q ss_pred EEEccccchh
Q 006777 170 VKIGDLGLAI 179 (631)
Q Consensus 170 vKI~DFGlA~ 179 (631)
+.|+||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.6e-09 Score=120.25 Aligned_cols=248 Identities=18% Similarity=0.219 Sum_probs=171.7
Q ss_pred CccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-cceeeeEE
Q 006777 17 EPISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSW 95 (631)
Q Consensus 17 ~~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~f 95 (631)
.|.+.+...-|....-+++|+++++|+++...+...+ .+.|... ....-++++|.+++||| .+..++.+
T Consensus 234 pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~ 303 (829)
T KOG0576|consen 234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY 303 (829)
T ss_pred CCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC
Confidence 3455555666777788899999999999987766655 6666533 22445889999999999 55555543
Q ss_pred EcCCCceEEEEEeccCCC-CHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEc
Q 006777 96 VDDTNRTINMITELFTSG-SLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~gG-sL~~~l~-~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~ 173 (631)
+.+.+.+++++++.+| +...... .--.+.+-+....++.=+.+|+|+|+.. -+||| ||+.. ++.+|.+
T Consensus 304 --~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~ 373 (829)
T KOG0576|consen 304 --DGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLL 373 (829)
T ss_pred --CcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccc--ccccccc
Confidence 3345889999999887 2221111 1112445556677788889999999875 58998 77774 5899999
Q ss_pred cccchhhccCC-CCccccCCCCCCCcccc-ccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC-CCCCC
Q 006777 174 DLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-KPASL 250 (631)
Q Consensus 174 DFGlA~~~~~~-~~~~~~GTp~y~APE~l-~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~-~p~~l 250 (631)
||+....+... ..++..+|+.++|||+. ++.+....|.|++|.-..+|.-|..|-.. +......+..+. .+...
T Consensus 374 ~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~~g~~p~s~~L~ 450 (829)
T KOG0576|consen 374 DFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPMIGNGPNSPMLT 450 (829)
T ss_pred cccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC---CccccCCCCCCCCccccc
Confidence 99998766544 45678899999999965 45689999999999988899988888754 111111111111 00000
Q ss_pred C-CCCcHHH-HHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 251 S-KVTDPQV-KQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 251 ~-~~~~~~l-k~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
. ..+++.. +++...|+. .|..|+..-..+.|.+|...
T Consensus 451 ~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 451 DKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred hhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 0 1111222 357788998 79999999999999999653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.1e-08 Score=111.49 Aligned_cols=148 Identities=20% Similarity=0.303 Sum_probs=106.8
Q ss_pred HHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCCc-----------cccCCCCCCCcccccc-ccC
Q 006777 139 RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----------SVIGTPEFMAPELYEE-EYN 206 (631)
Q Consensus 139 ~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~-----------~~~GTp~y~APE~l~~-~y~ 206 (631)
.||.|+|.+- .++|++|.|++|.++ .+|..||+.|+++.....+... .......|.|||++.. ..+
T Consensus 110 dgl~flh~sA-k~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~ 187 (700)
T KOG2137|consen 110 DGLAFLHRSA-KVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNT 187 (700)
T ss_pred chhhhhccCc-ceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccc
Confidence 9999999874 699999999999998 7899999999988544332111 1123557999997755 467
Q ss_pred ccceEeehhhHHHHHhhcCCC-CCCCCCHHHHHHHH--HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006777 207 ELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKV--TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 207 ~~sDIwSLG~il~emltG~~P-f~~~~~~~~~~~~i--~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hp 282 (631)
.++|+||||+++|.+..|..+ +.. .+....+... ..+..........++++++-+.++|. ++.-||++.+++..|
T Consensus 188 ~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 188 PASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred ccccceeeeeEEEEEecCCcchhhc-cCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence 899999999999999844444 433 2222221111 11112223345678899999999997 899999999999999
Q ss_pred CccCCCC
Q 006777 283 FLVTDNP 289 (631)
Q Consensus 283 ff~~~~~ 289 (631)
||....-
T Consensus 267 ff~D~~~ 273 (700)
T KOG2137|consen 267 FFSDPGL 273 (700)
T ss_pred ccCCchh
Confidence 9976543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.7e-06 Score=86.36 Aligned_cols=108 Identities=21% Similarity=0.210 Sum_probs=84.0
Q ss_pred HHHHHHHHHHHHhCCCCC--cceeeeEEEcCC--CceEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 006777 70 LERLYSEVHLLKSLKHEN--IIKFYNSWVDDT--NRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYL 144 (631)
Q Consensus 70 ~~~~~~Ei~iL~~L~Hpn--IV~l~~~f~~~~--~~~l~lV~Ey~~g-GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yL 144 (631)
..+..+|...+..|..-. +++.+.+..... ....++|||++++ .+|.+++......+......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 456788888888885333 334444333222 1356899999987 48999998866688888899999999999999
Q ss_pred HhCCCCeEecCCCCCceEEeCCCC---cEEEccccchhh
Q 006777 145 HSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDLGLAIV 180 (631)
Q Consensus 145 Hs~~~~IiHrDLKp~NILl~~~~g---~vKI~DFGlA~~ 180 (631)
|..| |+|+|+++.|||++ .++ .+.++||+-+..
T Consensus 135 H~~g--i~H~Dl~~~NILv~-~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVD-PDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEe-CCCCceeEEEEcchhcee
Confidence 9999 99999999999998 444 789999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.8e-07 Score=64.23 Aligned_cols=32 Identities=38% Similarity=0.523 Sum_probs=27.4
Q ss_pred eEEEEEecCCCC------CceeeeeeeecCCCCHHHHH
Q 006777 366 VSLTLRIGDKSG------HVSNIHFVFYLNADTAISIA 397 (631)
Q Consensus 366 i~L~Lri~d~~~------~~~~i~f~f~~~~Dta~~va 397 (631)
|.|+||++|+.+ +.++|+|+|++++|+|++||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 679999999998 89999999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.7e-06 Score=88.59 Aligned_cols=140 Identities=20% Similarity=0.134 Sum_probs=99.8
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecc-----ccc-----------CC--HHHHHHHHHHHHHHHhCCCC-
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIE-----DVM-----------QS--PDQLERLYSEVHLLKSLKHE- 86 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~-----~~~-----------~~--~~~~~~~~~Ei~iL~~L~Hp- 86 (631)
-+.++..||-|--+.||.|.+. .|.++|+|.=+.. .+. .+ .-......+|..+|..|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 4567889999999999999985 7999999963321 110 01 01234466899999999655
Q ss_pred -CcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC
Q 006777 87 -NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 87 -nIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
.|.+.+++ .+-.+||||++|-.|.... ++.+....++..|+.-+.-+-..| ++|+|+.+-||+++
T Consensus 171 ~~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~- 236 (304)
T COG0478 171 VKVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVT- 236 (304)
T ss_pred CCCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEe-
Confidence 77777762 2456899999987775443 233444455555555555555677 99999999999998
Q ss_pred CCCcEEEccccchhh
Q 006777 166 NNGEVKIGDLGLAIV 180 (631)
Q Consensus 166 ~~g~vKI~DFGlA~~ 180 (631)
.+|.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 789999999987643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.4e-06 Score=87.51 Aligned_cols=233 Identities=15% Similarity=0.184 Sum_probs=148.6
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHH-hCCCCCcceeeeEEE------cCCCce
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWV------DDTNRT 102 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~-~L~HpnIV~l~~~f~------~~~~~~ 102 (631)
.+.||+|+-+.+|..-.. +. .+-|++..... ....+ -+..|. .-.||-+-. .-.|. .+....
T Consensus 16 gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Ppp----a~~aq---k~a~la~~p~~p~~~~-rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPP----AAQAQ---KVAELAATPDAPLLNY-RVAWPQATLHGGRRGKV 84 (637)
T ss_pred CccccCCccceeeecchh--hc-hhheeecCCCc----hHHHH---HHHHhccCCCCcchhh-hhcccHHHhhCCCccce
Confidence 578999999999976422 22 33466554321 11111 122233 335664332 11221 122234
Q ss_pred EEEEEeccCCCC-HHHHH------HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 103 INMITELFTSGS-LRQYR------KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 103 l~lV~Ey~~gGs-L~~~l------~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
+-|+|..+.|.. ...+. +.........+.+.++.|+.+..-||.+| ..-+|+.++|+|+. +++.|.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-DDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-cCceEEEEcc
Confidence 788999887642 22221 22345778889999999999999999999 99999999999997 7899999885
Q ss_pred cchhhc-cCCCCccccCCCCCCCccccc-c-----ccCccceEeehhhHHHHHhhc-CCCCCCCCC----HHHHHHHHHc
Q 006777 176 GLAIVM-QQPTARSVIGTPEFMAPELYE-E-----EYNELVDIYSFGMCILEMVTC-EYPYNECKN----PAQIYKKVTS 243 (631)
Q Consensus 176 GlA~~~-~~~~~~~~~GTp~y~APE~l~-~-----~y~~~sDIwSLG~il~emltG-~~Pf~~~~~----~~~~~~~i~~ 243 (631)
..-... +.......+|.++|.+||+-. + +.+...|.|-||+++++++.| +.||.+..- +.-.-..|..
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 533222 222233457899999999654 1 356789999999999999987 899986311 1111112222
Q ss_pred -----------CCC--CCCCC-CCCcHHHHHHHHHhcCC---CCCCCCHH
Q 006777 244 -----------GIK--PASLS-KVTDPQVKQFIEKCIVP---ASLRLPAL 276 (631)
Q Consensus 244 -----------~~~--p~~l~-~~~~~~lk~lI~kcL~~---p~~Rpta~ 276 (631)
+.+ |..++ ...++.+..+..+|+.+ +.-||+++
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 222 22222 33578999999999973 56899975
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.7e-06 Score=102.31 Aligned_cols=206 Identities=22% Similarity=0.348 Sum_probs=146.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc--eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 006777 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR--TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH 145 (631)
Q Consensus 68 ~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~--~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLH 145 (631)
........|+..+....|+|++.++.+-...... .+.+..++|..-++...+..-+.++...++.|..+++.||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 4445555677788888999999999876654322 23456789999999999998899999999999999999999999
Q ss_pred hCCCCeEecCCCCC---ceEEeCCCCcEEEc--cccchhhccCC-CCccccCCCCCCCccccccc-c--CccceEeehhh
Q 006777 146 SHNPPIIHRDLKCD---NIFVNGNNGEVKIG--DLGLAIVMQQP-TARSVIGTPEFMAPELYEEE-Y--NELVDIYSFGM 216 (631)
Q Consensus 146 s~~~~IiHrDLKp~---NILl~~~~g~vKI~--DFGlA~~~~~~-~~~~~~GTp~y~APE~l~~~-y--~~~sDIwSLG~ 216 (631)
+.. ..|.-|..+ +--.+ ..+.+.++ ||+.+..+... .......+..+.|||..... + ....|+|.+|.
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred Hhc--cceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 986 666655555 33333 34566766 88877654433 22334456678888877543 2 34579999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 217 il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
....+..|..+-.....+. ..++........+++.+|+. ++.+|+.+.+++.|||.+...
T Consensus 381 l~~~~~~~~~i~~~~~~~~------------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAVPV------------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred HHhhhhhcCcccccccchh------------hhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 9999998865543211110 11111122267889999997 899999999999999997644
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.7e-05 Score=79.34 Aligned_cols=141 Identities=14% Similarity=0.112 Sum_probs=100.0
Q ss_pred eecCCeEEEEEEEcCCCeEEEEEEeec--ccccCCHHHHHHHHHHHHHHHhCCCCC--cceee--eEEEcCCCceEEEEE
Q 006777 34 LNCTFMCRYKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFY--NSWVDDTNRTINMIT 107 (631)
Q Consensus 34 G~G~fg~VY~A~d~~~g~~VAvK~v~~--~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~--~~f~~~~~~~l~lV~ 107 (631)
|+||-+.|+.... .|..+-+|+-.- ......+-....|.+|+..|.+|..-+ +.+.. +.--....-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688889998763 455688887531 111111334567999999999985433 33332 211122223577999
Q ss_pred eccCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc--EEEccccchh
Q 006777 108 ELFTS-GSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAI 179 (631)
Q Consensus 108 Ey~~g-GsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~--vKI~DFGlA~ 179 (631)
|-+.| -+|.+++... .+.++.....++.+|...+.-||..| +.|+|+-+.|||++ .+|. |+++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~-~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVK-TEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeec-CCCCeeEEEEEhhccc
Confidence 97754 6899988764 34678888899999999999999999 99999999999997 3456 9999997654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1e-05 Score=91.07 Aligned_cols=144 Identities=14% Similarity=0.136 Sum_probs=88.9
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccc--------------------------cCCHHH----HHH------HH
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDV--------------------------MQSPDQ----LER------LY 74 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~--------------------------~~~~~~----~~~------~~ 74 (631)
+.|+.++-|.||+|... +|+.||||+....-. ..-... .+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 78999999999999985 599999998654200 000000 111 33
Q ss_pred HHHHHHHhC-----CCCCcceeeeEEEcCCCceEEEEEeccCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 006777 75 SEVHLLKSL-----KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSH 147 (631)
Q Consensus 75 ~Ei~iL~~L-----~HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~--l~~~~~l~e~~i~~i~~QIl~gL~yLHs~ 147 (631)
+|...+.++ +.|+| .+=..+.+-.. .-.++|||+.|..+.++ ++. ..++.+.+...+.++.-- -+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~-~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~--q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTT-RRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLR--QLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccC-CcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHH--HHHhc
Confidence 455555544 22332 22222222222 34689999999888887 444 345544444333332211 11124
Q ss_pred CCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 148 ~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
| +.|.|..|.||+++ .+|.+.+.|||+......
T Consensus 285 g--ffHaDpHpGNi~v~-~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 G--FFHADPHPGNILVR-SDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred C--ccccCCCccceEEe-cCCcEEEEcCcceecCCH
Confidence 6 99999999999998 689999999999865443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.08 E-value=0.00012 Score=72.42 Aligned_cols=142 Identities=18% Similarity=0.155 Sum_probs=82.6
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CcceeeeEEEc-CCCceEEEE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNSWVD-DTNRTINMI 106 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~f~~-~~~~~l~lV 106 (631)
++.|+.|..+.||+..... ..+++|..... .....+.+|..+++.|... .+.+++..... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 5789999999999999754 48889985422 3456677888888888533 35566653322 223457899
Q ss_pred EeccCCCCHHH----------------HHH---hC----CCCCHH------H---HHHH------------HHHHHH-HH
Q 006777 107 TELFTSGSLRQ----------------YRK---KH----KNVDMK------A---IKNW------------ARQILR-GL 141 (631)
Q Consensus 107 ~Ey~~gGsL~~----------------~l~---~~----~~l~e~------~---i~~i------------~~QIl~-gL 141 (631)
|++++|..+.. .+. +. ..+... . ...+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999988877 111 11 011100 0 0000 111222 23
Q ss_pred HHHHh-----CCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 142 HYLHS-----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 142 ~yLHs-----~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..++. ....++|+|+.|.||+++..++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33332 223499999999999998456777899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.3e-05 Score=77.10 Aligned_cols=142 Identities=18% Similarity=0.163 Sum_probs=94.4
Q ss_pred EEeecCCeEEEEEEEcCCCeEEEEEEeecccc------------------cCCHHHHHH--HHHHHHHHHhCC--CCCcc
Q 006777 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDV------------------MQSPDQLER--LYSEVHLLKSLK--HENII 89 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~------------------~~~~~~~~~--~~~Ei~iL~~L~--HpnIV 89 (631)
.|..|.-+.||+|.. .++..||+|+++.... ..+...+.. ..+|+..|+++. +=.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 555666778999986 5789999999875321 011111111 236888888884 44555
Q ss_pred eeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCC
Q 006777 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 90 ~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g 168 (631)
+-+.++ .-.+||||+...-+..-.-+.-.+...+...+..+++..+.-|-. .+ ++|+||+.-|||+. +|
T Consensus 134 ~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~--~~ 203 (268)
T COG1718 134 EPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH--DG 203 (268)
T ss_pred Cceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE--CC
Confidence 556533 135899999643111000011123444678888889998888876 66 99999999999996 68
Q ss_pred cEEEccccchhhccCC
Q 006777 169 EVKIGDLGLAIVMQQP 184 (631)
Q Consensus 169 ~vKI~DFGlA~~~~~~ 184 (631)
.+.|+|||-|.....+
T Consensus 204 ~p~iID~~QaV~~~hp 219 (268)
T COG1718 204 EPYIIDVSQAVTIDHP 219 (268)
T ss_pred eEEEEECccccccCCC
Confidence 9999999998655544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.4e-05 Score=77.48 Aligned_cols=143 Identities=15% Similarity=0.138 Sum_probs=91.4
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHH------HHHHHHHHHHhCCC---CCcceee
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLE------RLYSEVHLLKSLKH---ENIIKFY 92 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~------~~~~Ei~iL~~L~H---pnIV~l~ 92 (631)
.+...|.+.+++-......|.+-. .+|..+++|..+..... ...... ...+.+..+..+.. -.+..+|
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 456789999999887766665554 67889999987654321 111111 12234444444432 2233333
Q ss_pred eEEEcCC---CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc
Q 006777 93 NSWVDDT---NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 93 ~~f~~~~---~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
-+..-.. ....+++|||++|..|.++.. +++ .+...|..++.-||+.| +.|+|..|.|++++ ++.
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~--~~~ 172 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS--NNG 172 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE--CCc
Confidence 2211111 124568999999988876642 333 24456777889999999 99999999999997 456
Q ss_pred EEEccccchh
Q 006777 170 VKIGDLGLAI 179 (631)
Q Consensus 170 vKI~DFGlA~ 179 (631)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.3e-05 Score=76.22 Aligned_cols=135 Identities=13% Similarity=0.089 Sum_probs=79.2
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc--ceeeeEEEcCCCceEEEEEe
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI--IKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI--V~l~~~f~~~~~~~l~lV~E 108 (631)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-.+ .+.+.+..+ .....+|||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeee
Confidence 67899999999984 25567888865321 12346789999998864433 555654322 335778999
Q ss_pred ccCCCC-HHH-----------H---HHh-----CC----CCCHHH-HHHHHHHH----------HHH-HHHH--HhCCCC
Q 006777 109 LFTSGS-LRQ-----------Y---RKK-----HK----NVDMKA-IKNWARQI----------LRG-LHYL--HSHNPP 150 (631)
Q Consensus 109 y~~gGs-L~~-----------~---l~~-----~~----~l~e~~-i~~i~~QI----------l~g-L~yL--Hs~~~~ 150 (631)
+++|.+ +.. + +.+ |. ...... ...+..++ ... ..+| +...+.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 999863 111 1 100 11 111111 11111111 111 1122 222335
Q ss_pred eEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 151 IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
++|+|+.|.||+++ .+| +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~-~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITS-GKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEc-CCC-cEEEechhcC
Confidence 78999999999997 566 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00016 Score=73.48 Aligned_cols=75 Identities=12% Similarity=-0.029 Sum_probs=49.0
Q ss_pred EEeecCC-eEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCceEEEEEec
Q 006777 32 VVLNCTF-MCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 32 ~LG~G~f-g~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
.|-.|.. ..||+.... +..+++|...... ...+.+|+++++.+. +--+.+++.+.... +..++|||+
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~ 73 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSA 73 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEe
Confidence 4445555 789999753 4678888754321 234567888888873 34466677655433 357789999
Q ss_pred cCCCCHHH
Q 006777 110 FTSGSLRQ 117 (631)
Q Consensus 110 ~~gGsL~~ 117 (631)
++|.+|..
T Consensus 74 i~G~~l~~ 81 (244)
T cd05150 74 VPGVPAAA 81 (244)
T ss_pred eCCccHhH
Confidence 99877764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.78 E-value=9.5e-05 Score=83.29 Aligned_cols=143 Identities=15% Similarity=0.105 Sum_probs=89.2
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC----------------------------HHHHHH------HHH
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS----------------------------PDQLER------LYS 75 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~----------------------------~~~~~~------~~~ 75 (631)
.+.||.-+.|.||+|..+. |+.||||+=+.. +... .+-.+. |.+
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence 3689999999999999864 999999974321 1000 000111 233
Q ss_pred HHHHHHh----CCCCC------cceeeeEEEcCCCceEEEEEeccCCCCHHH--HHHhCCCCCHHHHHHHHHHHHHHHHH
Q 006777 76 EVHLLKS----LKHEN------IIKFYNSWVDDTNRTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWARQILRGLHY 143 (631)
Q Consensus 76 Ei~iL~~----L~Hpn------IV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~--~l~~~~~l~e~~i~~i~~QIl~gL~y 143 (631)
|.++..+ +.|-+ |.++|-.+ . ..-.|+||||+|..+.+ ++.+++ ++...+..-+.+...-.-+
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---s-t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVYWDL---S-TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLEQIF 318 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeehhhc---C-cceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHHHHH
Confidence 4443333 24555 55555332 2 23569999999976654 455544 5555554444443332222
Q ss_pred HHhCCCCeEecCCCCCceEEeC---CCCcEEEccccchhhccC
Q 006777 144 LHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 144 LHs~~~~IiHrDLKp~NILl~~---~~g~vKI~DFGlA~~~~~ 183 (631)
..| ++|+|=.|.||+++. .++.+.+.|||+......
T Consensus 319 --~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 --KTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --hcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 246 999999999999983 367899999999865443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00037 Score=83.57 Aligned_cols=148 Identities=18% Similarity=0.227 Sum_probs=91.6
Q ss_pred EEEEeecCCeEEEEEEEcCCC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCc--ceeeeEEEcCC-CceE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENI--IKFYNSWVDDT-NRTI 103 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g--~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI--V~l~~~f~~~~-~~~l 103 (631)
.+.|+.|.+..+|+......+ ..+++|+........ ....+.+|+++|+.|. |++| .+++.++.+.. .+..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~---~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ---SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc---cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 678899999999998764332 467788755433211 1235778999999995 6665 66666544321 1357
Q ss_pred EEEEeccCCCCHHH--------------------HHHh-CC------------C---CCHHHHHHHHHHH----------
Q 006777 104 NMITELFTSGSLRQ--------------------YRKK-HK------------N---VDMKAIKNWARQI---------- 137 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~--------------------~l~~-~~------------~---l~e~~i~~i~~QI---------- 137 (631)
|+||||++|..+.+ .+.+ |. . .-..++..|..|.
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999999764321 1110 10 0 1123454444332
Q ss_pred -----HHHHHHHHhCCC---------CeEecCCCCCceEEeCCCCc-EEEccccchhh
Q 006777 138 -----LRGLHYLHSHNP---------PIIHRDLKCDNIFVNGNNGE-VKIGDLGLAIV 180 (631)
Q Consensus 138 -----l~gL~yLHs~~~---------~IiHrDLKp~NILl~~~~g~-vKI~DFGlA~~ 180 (631)
...+.+|..+-| .++|+|++++||+++..++. +-|.||.++..
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 223566754333 29999999999999743444 47999998753
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=2.9e-06 Score=102.13 Aligned_cols=214 Identities=14% Similarity=0.030 Sum_probs=148.9
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH
Q 006777 70 LERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLH 145 (631)
Q Consensus 70 ~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLH 145 (631)
.+-+..|..-++...|+++...+.-.........|..++|+.+|.+...+-++ ..++..-+.....+.+.+..-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 34456677777888999999988765555556778899999999999988654 34555556666666677777777
Q ss_pred hCC---CCeEecCCCCCceEEeCCCCcEEEccccchhhccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHH
Q 006777 146 SHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCIL 219 (631)
Q Consensus 146 s~~---~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~ 219 (631)
+.. --.+|++||+-|.+|. .+-.||++++|+.+..+.. ......++|.|++|++... .++.++|+|..|+-+|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIV-tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIV-TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred hcccCCccchhhhhhhhcccee-cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 653 2368999999999998 4668999999999844332 3456778999999998765 6888899999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhc-CCCCCCCCHHHHhcCCCccC
Q 006777 220 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVT 286 (631)
Q Consensus 220 emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL-~~p~~Rpta~elL~hpff~~ 286 (631)
+..-|..||... .....+.+..+.....++...+.+.-.....+| -+-..||.-...+.-+.|..
T Consensus 1432 ~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 999998887431 111222233333333444443333333333333 35667888888887776643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00039 Score=70.46 Aligned_cols=75 Identities=7% Similarity=-0.100 Sum_probs=44.7
Q ss_pred EEEEeecCCeE-EEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC---CcceeeeEEEcCC-CceEE
Q 006777 30 WVVVLNCTFMC-RYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---NIIKFYNSWVDDT-NRTIN 104 (631)
Q Consensus 30 ~e~LG~G~fg~-VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIV~l~~~f~~~~-~~~l~ 104 (631)
.+.|+.|+... ||+. +..+++|..... .....+.+|.++|+.|... .+.+++....... ....+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~ 70 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPW 70 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcce
Confidence 35677777774 8876 234777764321 1234688899999888532 3444444222111 12457
Q ss_pred EEEeccCCCCH
Q 006777 105 MITELFTSGSL 115 (631)
Q Consensus 105 lV~Ey~~gGsL 115 (631)
++|++++|.++
T Consensus 71 ~l~~~i~G~~l 81 (235)
T cd05155 71 SVYRWLEGETA 81 (235)
T ss_pred EEEEeecCCCC
Confidence 89999998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00074 Score=65.60 Aligned_cols=130 Identities=22% Similarity=0.146 Sum_probs=89.5
Q ss_pred EEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcce-eeeEEEcCCCceEEEE
Q 006777 28 ISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK-FYNSWVDDTNRTINMI 106 (631)
Q Consensus 28 ~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~-l~~~f~~~~~~~l~lV 106 (631)
...+.||+|.++.||++.. .|.++|+|+=..+ .....+..|.++|..+.--++.+ +|.+ +. .++.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d------s~r~~l~kEakiLeil~g~~~~p~vy~y--g~----~~i~ 90 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD------SPRRNLEKEAKILEILAGEGVTPEVYFY--GE----DFIR 90 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCC------cchhhHHHHHHHHHHhhhcCCCceEEEe--ch----hhhh
Confidence 4567899999999999986 4778999964432 23455888999999998777754 5543 22 3456
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC-C-ceEEeCCCCcEEEccccchhhcc
Q 006777 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC-D-NIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp-~-NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
|||+.|-.|...-... +. .-+..++..---|-..| |-|..|.- . ||+++ ++.+.|+||.-|+...
T Consensus 91 me~i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~--~~~~~iIDFd~At~k~ 157 (201)
T COG2112 91 MEYIDGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVN--DRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhcCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhc--cchhhhcCCceeEEec--CCcEEEEEccchhhcc
Confidence 9999988887664421 22 22334444444455567 88988864 3 66664 5699999999987443
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0021 Score=64.73 Aligned_cols=75 Identities=13% Similarity=0.071 Sum_probs=47.5
Q ss_pred EEEEeecCCeEEEEEEEcC-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-cceeeeEEEcCCCceEEEEE
Q 006777 30 WVVVLNCTFMCRYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~-~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~f~~~~~~~l~lV~ 107 (631)
.+.|..|-...+|+..... .+..|++|....... ......+|+.+++.+...+ +++++..+ .. .+||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-----~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~ 71 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-----LIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIY 71 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-----ceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEE
Confidence 5678888888999997543 356788997653211 1112346888888885333 44555432 22 3699
Q ss_pred eccCCCCH
Q 006777 108 ELFTSGSL 115 (631)
Q Consensus 108 Ey~~gGsL 115 (631)
||++|.++
T Consensus 72 e~i~G~~l 79 (235)
T cd05157 72 EFIPGRTL 79 (235)
T ss_pred EeeCCCcC
Confidence 99998665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0034 Score=66.32 Aligned_cols=78 Identities=10% Similarity=0.042 Sum_probs=53.4
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC---CCcceeeeEEEcC-CCceEEE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDD-TNRTINM 105 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIV~l~~~f~~~-~~~~l~l 105 (631)
.+.||.|..+.||..... +| .+++|..+.. .....+..|...|+.|.- -.+.++++.+.+. ..+..++
T Consensus 19 ~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDS-QG-NPMPLMARSF------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcC-CC-CEEEEEeccc------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 678999999999999643 34 4667764321 011357789999988843 3577788755432 2245789
Q ss_pred EEeccCCCCH
Q 006777 106 ITELFTSGSL 115 (631)
Q Consensus 106 V~Ey~~gGsL 115 (631)
|||+++|+++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.00093 Score=65.87 Aligned_cols=98 Identities=26% Similarity=0.199 Sum_probs=77.3
Q ss_pred HHHHHHHhCCC-CCcceeeeEEEcCCCceEEEEEeccCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-
Q 006777 75 SEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHSHNP- 149 (631)
Q Consensus 75 ~Ei~iL~~L~H-pnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~---l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~- 149 (631)
.|.-+|+.+.+ ++++++++++ . -++|+||...+++... +.+.-..++.....++.+++..+.+++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C--G----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC--G----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC--C----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 48888999976 6999999977 1 2468999987766421 2222346889999999999999999987321
Q ss_pred CeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
++.-.|++++|+-++ ++|.+|++|...+.
T Consensus 82 ~~~lcDv~~~nfgv~-~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVN-DDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEe-CCCcEEEEechhcc
Confidence 388899999999998 78999999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0066 Score=66.68 Aligned_cols=81 Identities=17% Similarity=0.089 Sum_probs=55.5
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc--C-CHHHHHHHHHHHHHHHhCC---CCCcceeeeEEEcCCCceE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM--Q-SPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~--~-~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~f~~~~~~~l 103 (631)
.+.||.|.+..||++.+...++.|+||+-...-.. . .+-..++...|...|+.+. -.+++++|.+ +.. .-
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~--~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE--LA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC--CC
Confidence 47899999999999998644468999985422110 1 1234567778888888762 3467778764 333 35
Q ss_pred EEEEeccCCCC
Q 006777 104 NMITELFTSGS 114 (631)
Q Consensus 104 ~lV~Ey~~gGs 114 (631)
++||||+++..
T Consensus 107 ~lVME~L~~~~ 117 (401)
T PRK09550 107 VTVMEDLSDHK 117 (401)
T ss_pred EEEEecCCCcc
Confidence 78999998643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0056 Score=60.92 Aligned_cols=133 Identities=19% Similarity=0.261 Sum_probs=86.5
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc------------CCHHHHHHHHHHHHHHHhCC------CCCccee
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM------------QSPDQLERLYSEVHLLKSLK------HENIIKF 91 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~------------~~~~~~~~~~~Ei~iL~~L~------HpnIV~l 91 (631)
...||+|+.=.||.=-+ .....||++...... ..........+|+.-..++. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 46799999999997632 334668887765400 00112344556666666655 8899999
Q ss_pred eeEEEcCCCceEEEEEeccCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC
Q 006777 92 YNSWVDDTNRTINMITELFTS------GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 92 ~~~f~~~~~~~l~lV~Ey~~g------GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
|+...++ ..+.+|+|.+.. -+|.++++.. .+++ .++..+.++ ..||-.++ |+.+||+|.||++..
T Consensus 83 ~G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~~f---~~~l~~~~--Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 83 YGFVETN--LGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALDEF---KRYLLDHH--IVIRDLNPHNIVVQR 153 (199)
T ss_pred eEEEecC--CceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHHHH---HHHHHHcC--CeecCCCcccEEEEe
Confidence 9965443 357788888642 4789998554 4666 444444444 44666777 999999999999962
Q ss_pred C-CC--cEEEcc
Q 006777 166 N-NG--EVKIGD 174 (631)
Q Consensus 166 ~-~g--~vKI~D 174 (631)
. +| .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 2 22 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.007 Score=60.32 Aligned_cols=133 Identities=16% Similarity=0.132 Sum_probs=92.0
Q ss_pred CCCcEEEEEEEeecCC-eEEEEEEEcCCCeEEEEEEeec---ccc-------cCC-------HHHHHHHHHHHHHHHhC-
Q 006777 23 VSYFWISWVVVLNCTF-MCRYKGFDEVDGIEVAWNQVNI---EDV-------MQS-------PDQLERLYSEVHLLKSL- 83 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~f-g~VY~A~d~~~g~~VAvK~v~~---~~~-------~~~-------~~~~~~~~~Ei~iL~~L- 83 (631)
....++.++.||.|.- |.||++. ..|..+|+|.+.. ... ... ....+-|..|.+...+|
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk 112 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK 112 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence 3578999999999999 9999998 4688999999432 110 000 02234577888776665
Q ss_pred --CCCCc--ceeeeEEEcCC-C---------------ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 006777 84 --KHENI--IKFYNSWVDDT-N---------------RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHY 143 (631)
Q Consensus 84 --~HpnI--V~l~~~f~~~~-~---------------~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~y 143 (631)
.+.++ |+.|++..-.. . ....||-||.+... .+.. .=+.+|++-+..
T Consensus 113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHH
Confidence 45566 89999874321 0 12357788776544 2233 334677778888
Q ss_pred HHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 144 LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 144 LHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
+|..| |+-+|+++.|.. + =||+|||.+
T Consensus 180 ~~k~g--I~~~Dv~~~ny~-~-----G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG--IVPRDVKPRNYR-G-----GKLVDFSSS 206 (207)
T ss_pred HHHCC--eeeccCcccccc-C-----CEEEecccC
Confidence 99999 999999999964 2 278899864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0081 Score=64.51 Aligned_cols=148 Identities=16% Similarity=0.157 Sum_probs=97.6
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccc--------------------ccCCHHHHHH--HHHHHHHHHhCC
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIED--------------------VMQSPDQLER--LYSEVHLLKSLK 84 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~--------------------~~~~~~~~~~--~~~Ei~iL~~L~ 84 (631)
-.|...|..|--+.||.|.. .+|.++|||+++..- ...++..+-+ ..+|++.|++|+
T Consensus 146 ~~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred eecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 34456777788889999986 689999999876421 1122333333 235888999987
Q ss_pred CCCcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEecCCCCCceEE
Q 006777 85 HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFV 163 (631)
Q Consensus 85 HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp~NILl 163 (631)
.-.|.----..+- .-.|||+++....-..-.-+.-.++...+..+-.|++.-+.-| |.++ ++|.||.--|+|+
T Consensus 225 ~aGIP~PePIlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 225 NAGIPCPEPILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLY 298 (520)
T ss_pred hcCCCCCCceeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheE
Confidence 6654332221121 2358999996322211122233577777888878887777766 4455 9999999999999
Q ss_pred eCCCCcEEEccccchhhccC
Q 006777 164 NGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 164 ~~~~g~vKI~DFGlA~~~~~ 183 (631)
. +|.+.|+|.+-+.....
T Consensus 299 h--dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 299 H--DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred E--CCEEEEEEccccccCCC
Confidence 4 79999999998754443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.0052 Score=63.02 Aligned_cols=134 Identities=17% Similarity=0.154 Sum_probs=75.1
Q ss_pred EEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEEEcCCCceEEEEEecc
Q 006777 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMITELF 110 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~f~~~~~~~l~lV~Ey~ 110 (631)
.+..|-...+|+.. ..|..+++|....... ...-...+|..+++.+..-.+ .+++.. +. -++|+||+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~----~~~v~e~i 70 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILV--NE----HWLLVEWL 70 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEE--eC----CEEEEEec
Confidence 34567778899886 4577888886543211 100123568888888864434 334432 22 25799999
Q ss_pred CCCCHHH-----------H---HHh-C------CCCCH-HHHHHHHHHH---------HHHHHHHHhC------CCCeEe
Q 006777 111 TSGSLRQ-----------Y---RKK-H------KNVDM-KAIKNWARQI---------LRGLHYLHSH------NPPIIH 153 (631)
Q Consensus 111 ~gGsL~~-----------~---l~~-~------~~l~e-~~i~~i~~QI---------l~gL~yLHs~------~~~IiH 153 (631)
+|..+.. . +.+ | .+++. ..+..+..++ ...+..+-.. .+-++|
T Consensus 71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 9866531 1 111 1 11221 2222332222 1112222221 123899
Q ss_pred cCCCCCceEEeCCCCcEEEccccchh
Q 006777 154 RDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 154 rDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
+|+.|.||+++ .++ +.|+||..|.
T Consensus 151 ~Dl~~~Nil~~-~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 151 MDVHAYNLVVT-PQG-LKLIDWEYAS 174 (256)
T ss_pred CCCCcCcEEEe-CCC-CEEEeccccC
Confidence 99999999998 455 7899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0063 Score=67.70 Aligned_cols=162 Identities=20% Similarity=0.284 Sum_probs=101.3
Q ss_pred HHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 006777 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151 (631)
Q Consensus 72 ~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~I 151 (631)
++.-..++++.+.|+|...+.+.- .....+..+|+|++. .+|.+++..+. +-..... .++ +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~-r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~--------------~~~--~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFS-RGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL--------------AHG--V 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeee-cCccceEEEEehhhc-cchHHHHHhcc-cchhhhc--------------ccc--c
Confidence 456678899999999999998743 333456889999995 79999988765 2111111 122 2
Q ss_pred EecCCCCCceEEeCCCCcEEEccccchhhccCCCCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCC
Q 006777 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNEC 231 (631)
Q Consensus 152 iHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~ 231 (631)
.|- +.++++| .++... .+..| +++||||+|.++.++..|...+...
T Consensus 89 ~~~-------------~~~~~td-~~~t~~-----~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 89 LHL-------------NIIYITD-HFLTKY-----PSPIG---------------PKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred cee-------------hhhhccc-cccccC-----CCCCC---------------cchhhhhHHHHHHHHHHhhHHHHHH
Confidence 222 2233334 111100 11111 3999999999999999998777653
Q ss_pred CCHHHHHHHHHcCCCCCCC---------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 232 KNPAQIYKKVTSGIKPASL---------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 232 ~~~~~~~~~i~~~~~p~~l---------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.+.........-...+... ....+..+.++..+|+- .|..||...++.+++-|..
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 3322222111111112111 12246677888999997 8999999999999998864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.034 Score=58.33 Aligned_cols=76 Identities=17% Similarity=0.101 Sum_probs=47.1
Q ss_pred EEEEeecCCeEEEEEEEcC------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEEEcCCCce
Q 006777 30 WVVVLNCTFMCRYKGFDEV------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRT 102 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~------~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~f~~~~~~~ 102 (631)
.+.|..|-.-.+|+..... .+..|++|+..... .......+|+.+++.+....+ .+++.++ ..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~--- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--PN--- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--CC---
Confidence 4567777777899887533 25789999865321 112235678888888853333 4455543 22
Q ss_pred EEEEEeccCCCCHH
Q 006777 103 INMITELFTSGSLR 116 (631)
Q Consensus 103 l~lV~Ey~~gGsL~ 116 (631)
.+|+||++|..+.
T Consensus 73 -~~v~e~i~G~~l~ 85 (302)
T cd05156 73 -GRIEEFIPSRTLT 85 (302)
T ss_pred -CchhheeCCCcCC
Confidence 2478999886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.082 Score=55.86 Aligned_cols=29 Identities=28% Similarity=0.322 Sum_probs=24.0
Q ss_pred CeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
++||+|+.|+||+++ .+...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~-~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFE-GDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEE-CCceEEEEeccccc
Confidence 499999999999997 44445799999874
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.045 Score=57.12 Aligned_cols=140 Identities=15% Similarity=0.097 Sum_probs=79.1
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CcceeeeE----EEcCCCceE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNS----WVDDTNRTI 103 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~----f~~~~~~~l 103 (631)
.+.|..|....+|+... .+..+++|+.... . .+.+..|+.++..|.+- .+++++.. +.....+..
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~----~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV----S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC----C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 56788888889998863 3446888876531 1 23466688888777433 24444331 111112356
Q ss_pred EEEEeccCCCCHHH-----H------HHh-C---CCCCH--------HHH------------HHHHHHHHHHHHHHHh--
Q 006777 104 NMITELFTSGSLRQ-----Y------RKK-H---KNVDM--------KAI------------KNWARQILRGLHYLHS-- 146 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~-----~------l~~-~---~~l~e--------~~i------------~~i~~QIl~gL~yLHs-- 146 (631)
++|++|++|..+.. + +.+ | ..+.. .-. ......+..++.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999866421 1 000 0 00000 000 0011112334444443
Q ss_pred ---CCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 147 ---HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 147 ---~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
....++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~-~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFD-GDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEe-CCceEEEeehhhhc
Confidence 112499999999999998 55566899999774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.04 Score=59.68 Aligned_cols=85 Identities=13% Similarity=0.006 Sum_probs=54.9
Q ss_pred EEeecCCeEEEEEEEcCCCeEEEEEEeecccc---cCCHHHHHHHHHHHHHHHhCC--CC-CcceeeeEEEcCCCceEEE
Q 006777 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDV---MQSPDQLERLYSEVHLLKSLK--HE-NIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~---~~~~~~~~~~~~Ei~iL~~L~--Hp-nIV~l~~~f~~~~~~~l~l 105 (631)
.||.|....||++.+...++.|+||+-...-. ...+-..+|..-|...|+... -| .++++|. .++. ...+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e--~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE--MAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc--ccee
Confidence 46899999999999864447899998542211 122444567778888887763 24 4666765 3433 3558
Q ss_pred EEeccCC-CCHHHHHH
Q 006777 106 ITELFTS-GSLRQYRK 120 (631)
Q Consensus 106 V~Ey~~g-GsL~~~l~ 120 (631)
|||+++. ..|++.+-
T Consensus 78 vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 78 VMEDLSHHKIARKGLI 93 (370)
T ss_pred hHhhCccchHHHHHHH
Confidence 9999954 34555553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.027 Score=61.75 Aligned_cols=87 Identities=16% Similarity=0.100 Sum_probs=58.1
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeeccc-c-cCCHHHHHHHHHHHHHHHhCC--CC-CcceeeeEEEcCCCceEE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIED-V-MQSPDQLERLYSEVHLLKSLK--HE-NIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~-~-~~~~~~~~~~~~Ei~iL~~L~--Hp-nIV~l~~~f~~~~~~~l~ 104 (631)
.+.||.|.-..||++.+...+..|+||+-...- + ...+-..+|..-|...|+.+. -| .++++|. .++. ...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e--~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV--MNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH--Hhh
Confidence 678899999999999985446789999843211 1 122445677888888888763 34 4666775 3333 356
Q ss_pred EEEeccCC-CCHHHHHH
Q 006777 105 MITELFTS-GSLRQYRK 120 (631)
Q Consensus 105 lV~Ey~~g-GsL~~~l~ 120 (631)
+|||+++. ..|++.+-
T Consensus 110 ~vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 110 CVMEDLSDHTILRTALI 126 (409)
T ss_pred HHHHhCcccHHHHHHHH
Confidence 89999954 34555553
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.045 Score=57.75 Aligned_cols=142 Identities=18% Similarity=0.125 Sum_probs=78.6
Q ss_pred EEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CcceeeeE----EEcCCCce
Q 006777 29 SWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNS----WVDDTNRT 102 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~----f~~~~~~~ 102 (631)
..+.++.|....+|+... .+| .+++|+..... .. +.+..|+.++..|... .+++++.. +.....+.
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~---~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV---KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCCC---CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 367778888889998864 344 57788765321 12 2344566777776322 23444331 11112346
Q ss_pred EEEEEeccCCCCH-----HHHH------Hh-C---CCC--------CHHHHH---------------HHHHHHHHHHHHH
Q 006777 103 INMITELFTSGSL-----RQYR------KK-H---KNV--------DMKAIK---------------NWARQILRGLHYL 144 (631)
Q Consensus 103 l~lV~Ey~~gGsL-----~~~l------~~-~---~~l--------~e~~i~---------------~i~~QIl~gL~yL 144 (631)
.+++++|++|..+ .++. .+ | ..+ ...... .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 7899999998543 1111 00 0 001 001000 0011233345555
Q ss_pred Hh-----CCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 145 HS-----HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 145 Hs-----~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.. ..+.++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~-~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFD-GDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEE-CCceEEEeeccccc
Confidence 32 223599999999999998 56667899999773
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.0041 Score=70.08 Aligned_cols=70 Identities=30% Similarity=0.446 Sum_probs=58.8
Q ss_pred CCCceEEEEEecCCCC----CceeeeeeeecCCCCHHHHHHHHHHccCCCcccHHHHHHHHHHHHHHhCCCCCC
Q 006777 362 DDDTVSLTLRIGDKSG----HVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNP 431 (631)
Q Consensus 362 ~~~~i~L~Lri~d~~~----~~~~i~f~f~~~~Dta~~va~EmV~~~~i~~~d~~~ia~~i~~~i~~~~~~~~~ 431 (631)
.+..++|.+|..|.++ ..|.|+|.|++..|+++.||+|||+++++++.|...+|..|...+.++--....
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~ 388 (632)
T KOG0584|consen 315 SDPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRND 388 (632)
T ss_pred ccccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhc
Confidence 3455667788888763 356899999999999999999999999999999999999999988877655543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.0068 Score=64.12 Aligned_cols=139 Identities=18% Similarity=0.119 Sum_probs=95.3
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecc-----cccCCH-----------HHHH--HHHHHHHHHHhCCC-
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIE-----DVMQSP-----------DQLE--RLYSEVHLLKSLKH- 85 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~-----~~~~~~-----------~~~~--~~~~Ei~iL~~L~H- 85 (631)
.-|.++..||-|.-+.||.+-+ ..|.+.++|.=++. .+.... -.+. ...+|+..|+.|..
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 3577889999999999999998 47899998853321 111110 1122 24578888988843
Q ss_pred -CCcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe
Q 006777 86 -ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164 (631)
Q Consensus 86 -pnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 164 (631)
--|.+.++. .+-++|||++.|..|.+..+ ..+.. .+...+..-+--|..+| +||+|..-=||++.
T Consensus 171 gfpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~---v~d~~---~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 171 GFPVPKPIDH------NRHCVVMELVDGYPLRQVRH---VEDPP---TLYDDLMGLIVRLANHG--LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCCcccc------cceeeHHHhhcccceeeeee---cCChH---HHHHHHHHHHHHHHHcC--ceecccchheeEEe
Confidence 345555542 24678999999988876542 22333 33444444455567788 99999999999998
Q ss_pred CCCCcEEEccccchh
Q 006777 165 GNNGEVKIGDLGLAI 179 (631)
Q Consensus 165 ~~~g~vKI~DFGlA~ 179 (631)
+++.++++||--..
T Consensus 237 -dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 -DDDKIVVIDFPQMV 250 (465)
T ss_pred -cCCCEEEeechHhh
Confidence 78899999997654
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.3 Score=52.36 Aligned_cols=141 Identities=16% Similarity=0.168 Sum_probs=79.3
Q ss_pred EEEEEEeecCCeEEEEEEEcCC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEEEcCCCceE
Q 006777 28 ISWVVVLNCTFMCRYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 ~i~e~LG~G~fg~VY~A~d~~~---g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~f~~~~~~~l 103 (631)
.-.+.|..|=.-.+|+...... +..|++|+..... ...-.-.+|..+++.+..-++ ++++.++ .+ +
T Consensus 17 i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-----~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~-G-- 86 (330)
T PLN02421 17 FSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-----DYVIDRERELQAIKYLSAAGFGAKLLGVF--GN-G-- 86 (330)
T ss_pred eEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-----CeEechHHHHHHHHHHHhcCCCCceeEEe--CC-c--
Confidence 3356666677788998864332 3478888765321 111112468888888865555 3455543 22 2
Q ss_pred EEEEeccCCCCHHH-------H-------HHh-CC-C------C-CHHHHHHHHHHH-----------------------
Q 006777 104 NMITELFTSGSLRQ-------Y-------RKK-HK-N------V-DMKAIKNWARQI----------------------- 137 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~-------~-------l~~-~~-~------l-~e~~i~~i~~QI----------------------- 137 (631)
+|.+|++|-+|.. . +++ |. . . -...+..|..++
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 4889998765421 1 111 11 0 1 122333333332
Q ss_pred --HHHHHHHH-hCCC--CeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 138 --LRGLHYLH-SHNP--PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 138 --l~gL~yLH-s~~~--~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
+..+..+. ..+. -++|.||.+.||+++..++.++++||..|.
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11122121 1121 269999999999997456789999999884
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.088 Score=56.79 Aligned_cols=143 Identities=13% Similarity=0.145 Sum_probs=82.5
Q ss_pred cEEEEEEEeecCCeEEEEEEEcC----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEEEcCCC
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEV----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTN 100 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~----~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~f~~~~~ 100 (631)
...-.+.|-.|-.-.+|++.... .++.|++|...... ....++ .+|+.+++.+..-++ .++++.+ .+
T Consensus 37 ~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~idR-~~E~~~~~~l~~~gl~P~~~~~~--~~- 108 (344)
T PLN02236 37 EALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFDR-DDEIRTFECMSRHGQGPRLLGRF--PN- 108 (344)
T ss_pred CcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeech-HHHHHHHHHHHHcCCCCceEEEE--CC-
Confidence 34445667668888999986432 34688898765321 111222 568888888854444 3455544 22
Q ss_pred ceEEEEEeccCCCCHHHH--------------HHh-C--C------CCCHHHHHHHHHHHH-------------------
Q 006777 101 RTINMITELFTSGSLRQY--------------RKK-H--K------NVDMKAIKNWARQIL------------------- 138 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~--------------l~~-~--~------~l~e~~i~~i~~QIl------------------- 138 (631)
+ .|++|++|.+|..- +.+ | . ....+.+..|+.++.
T Consensus 109 g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~ 185 (344)
T PLN02236 109 G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDE 185 (344)
T ss_pred c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHH
Confidence 1 47899987665311 111 1 0 111234445543332
Q ss_pred -HHHHH-HHh--CCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 139 -RGLHY-LHS--HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 139 -~gL~y-LHs--~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..|.- +.. ....++|+|+++.||+++..++.+.|+||..|.
T Consensus 186 ~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 186 INLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11111 111 112389999999999998445789999999874
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.15 Score=56.13 Aligned_cols=84 Identities=15% Similarity=-0.005 Sum_probs=54.9
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC---HHHHHHHHHHHHHHHhCC---CCCcceeeeEEEcCCCceE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS---PDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~---~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~f~~~~~~~l 103 (631)
.+.||.|..-.||+..+. +..|+||+-...-.... +-...+...|...|+.+. ..+++++|.+. ++ .-
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--ed--~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--RT--MA 110 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--CC--CC
Confidence 678899999999998863 45689998552221111 124556667777777663 24788888743 33 34
Q ss_pred EEEEeccCC--CCHHHHH
Q 006777 104 NMITELFTS--GSLRQYR 119 (631)
Q Consensus 104 ~lV~Ey~~g--GsL~~~l 119 (631)
+++|||+++ ..+++.+
T Consensus 111 vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 111 LIGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEEeecCCcceehhhhh
Confidence 678999976 3455544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.12 Score=54.02 Aligned_cols=30 Identities=23% Similarity=0.367 Sum_probs=24.3
Q ss_pred CeEecCCCCCceEEeCCCCc-EEEccccchhh
Q 006777 150 PIIHRDLKCDNIFVNGNNGE-VKIGDLGLAIV 180 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~g~-vKI~DFGlA~~ 180 (631)
-++|+|+.|.||+++ .++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~-~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILID-EDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEe-CCCCEEEEECcHhccc
Confidence 389999999999998 4354 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.18 Score=53.75 Aligned_cols=145 Identities=12% Similarity=0.138 Sum_probs=80.8
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CcceeeeEEEcCCCceEEEEE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~f~~~~~~~l~lV~ 107 (631)
.+.+-.|.--.+|...+. ++.++++ ... ............+|..+++.+.-- -+...+..+.++.-+..|.||
T Consensus 30 v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT--GQKYVLR-KPP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeccCCcccceEEEecC--CceEEEe-cCC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 344433333345555543 7888887 221 111233445567788888877432 233334443333324678999
Q ss_pred eccCCCCH---------H-HHHH--------h-C-------------CCCCHHHHHHHHHHH--------------HHHH
Q 006777 108 ELFTSGSL---------R-QYRK--------K-H-------------KNVDMKAIKNWARQI--------------LRGL 141 (631)
Q Consensus 108 Ey~~gGsL---------~-~~l~--------~-~-------------~~l~e~~i~~i~~QI--------------l~gL 141 (631)
+|++|..+ . ++.. . | ......++..|..+. ..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 99997322 2 2211 0 0 011223344444443 1224
Q ss_pred HHHHhCCC------CeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 142 HYLHSHNP------PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 142 ~yLHs~~~------~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+|+.+-| .++|+|+.+.||+++ ..+.+=+.||+++..
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~-~~~~~gVlDwe~~~l 228 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIID-PGRPTGVLDWELATL 228 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEe-CCCeeEEEecccccc
Confidence 45555543 489999999999998 455688999998854
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.097 Score=56.43 Aligned_cols=73 Identities=19% Similarity=0.236 Sum_probs=57.3
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+.|++|++- |+.|.- .+.-..+++..++++.+..|.-+..+- +.-||||..+||+|+ .|+|-|+||-+++
T Consensus 298 ~~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lekkf-~fehrnlt~~niLId--~GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEKKF-PFEHRNLTLDNILID--EGNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhhcC-Ccccccccccceeee--cCceEEEEeeeee
Confidence 35788888886 455532 233456788888998888887777664 799999999999997 7999999999997
Q ss_pred h
Q 006777 180 V 180 (631)
Q Consensus 180 ~ 180 (631)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 3
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.32 Score=51.38 Aligned_cols=29 Identities=10% Similarity=0.124 Sum_probs=25.5
Q ss_pred CeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.++|+|+.++||+++ .++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD-ETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEc-CCCCEEEEEhhhcc
Confidence 499999999999997 56789999998774
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.45 Score=48.54 Aligned_cols=75 Identities=16% Similarity=0.097 Sum_probs=45.1
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC---CCcceeeeEEEcCCCceEEEEE
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIV~l~~~f~~~~~~~l~lV~ 107 (631)
+.+..|..-..|...+ ...++.+|+=. ......+..|+.-|..|.- -++.+++. ....+.+.|+|+
T Consensus 22 ~~v~gG~inea~~v~d--g~~~~FvK~n~-------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~--~G~~~~~sylVl 90 (286)
T COG3001 22 EEVSGGDINEAWRLRD--GTDPFFVKCNQ-------REQLSMFTAEADGLELLARSNTITVPKVIA--VGASRDHSYLVL 90 (286)
T ss_pred cccCCccccceeEeec--CCcceEEEecc-------hhhHHHHHHHHHHHHHHHhcCCccccceEE--ecCCCCeeEEEE
Confidence 3444444444444432 23467777522 3444567778877777743 44566665 445566899999
Q ss_pred eccCCCCHH
Q 006777 108 ELFTSGSLR 116 (631)
Q Consensus 108 Ey~~gGsL~ 116 (631)
||++-|.+.
T Consensus 91 e~L~~~~~d 99 (286)
T COG3001 91 EYLPTGPLD 99 (286)
T ss_pred eeccCCCCC
Confidence 999876553
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.85 E-value=0.72 Score=50.62 Aligned_cols=80 Identities=13% Similarity=-0.020 Sum_probs=46.5
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCC-CeE-----EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEEEc
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVD-GIE-----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVD 97 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~-g~~-----VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~f~~ 97 (631)
......+.|..|-...+|++..... +.. |.++.... .....-.-.+|+++++.|...++ .++++.|
T Consensus 50 ~~~i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f-- 122 (383)
T PTZ00384 50 PEFIEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF-- 122 (383)
T ss_pred cccEEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-----CCceEeccHHHHHHHHHHHhCCCCCeEEEec--
Confidence 3444566776788889999965332 122 44333211 11111122468999999965555 4566654
Q ss_pred CCCceEEEEEeccCCCCH
Q 006777 98 DTNRTINMITELFTSGSL 115 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL 115 (631)
. -++|.||++|-+|
T Consensus 123 ~----~g~l~efIeGr~l 136 (383)
T PTZ00384 123 G----DFTIQEWVEGNTM 136 (383)
T ss_pred C----CEEEEEEeccccC
Confidence 2 1478999998665
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.83 E-value=1 Score=47.46 Aligned_cols=74 Identities=18% Similarity=0.020 Sum_probs=43.8
Q ss_pred EEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCcceeeeEEEcCCCceEEE
Q 006777 29 SWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINM 105 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~f~~~~~~~l~l 105 (631)
-.+.++.|....+|+.. .++..+.+|.-... ....+..|..-|+.|. --.+++++.+....+ .-+|
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~--~~fL 89 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD--DAFL 89 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS--CCEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChh-------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC--CceE
Confidence 36789999999999987 67888999976522 1234667777777773 345667777655443 3489
Q ss_pred EEeccCCC
Q 006777 106 ITELFTSG 113 (631)
Q Consensus 106 V~Ey~~gG 113 (631)
||||++.+
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=92.46 E-value=0.027 Score=62.60 Aligned_cols=75 Identities=15% Similarity=0.276 Sum_probs=63.2
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
..-...+..+.++|.|+||+|+.|..+.++..+|||+|...+. .....+..+|+.-+..+.|++|++++..|...
T Consensus 45 sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~---e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 45 SREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNR---EESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hhhhccccccccccccCccccCCccccccchhhHHHHhcccch---hhhhhhhhccccchhhhcccchhhheeceecC
Confidence 3345677889999999999999999988888999999987643 45567788999999999999999999988654
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.84 E-value=0.5 Score=51.85 Aligned_cols=64 Identities=17% Similarity=0.193 Sum_probs=45.4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCceEEeCCCC
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLH-s~~~~IiHrDLKp~NILl~~~~g 168 (631)
...++-+|..|-++..+++.. ..+++..+.++.--+.||--+- -.+ ++|.|+.|.||++...++
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNKT 383 (565)
T ss_pred cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecCC
Confidence 356788899999999888753 3566666666666666654332 234 999999999999974433
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=89.69 E-value=5.8 Score=49.10 Aligned_cols=30 Identities=30% Similarity=0.531 Sum_probs=23.9
Q ss_pred CeEecCCCCCceEEeCCC-CcEE-Eccccchh
Q 006777 150 PIIHRDLKCDNIFVNGNN-GEVK-IGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~-g~vK-I~DFGlA~ 179 (631)
.+||.|+.++||++++.. +.+. |+|||-+.
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 499999999999998432 2565 99999874
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.62 E-value=5.4 Score=42.61 Aligned_cols=27 Identities=26% Similarity=0.176 Sum_probs=22.6
Q ss_pred CeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+||+|+.++||+++ + .+.|+||+-+.
T Consensus 197 ~liHgD~h~~NvL~~-d--~~~iIDFDd~~ 223 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D--GPHFVDLDDAR 223 (325)
T ss_pred cceecCCCchhcccc-C--CcEEEeCCCCC
Confidence 489999999999995 3 47799999763
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=87.54 E-value=0.51 Score=47.91 Aligned_cols=87 Identities=22% Similarity=0.282 Sum_probs=59.9
Q ss_pred HHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 006777 72 RLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPI 151 (631)
Q Consensus 72 ~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~I 151 (631)
-++.+.+++.+++ .|+++.. ++.-.+-+|.|+|.-... .. ..++.-=+.+|.-.|+.++..
T Consensus 104 ~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i---------~~----~N~i~agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKI---------NF----SNFITAGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCccc---------ch----hHHHHHhHHHHHHhhccCCCe
Confidence 3566788888764 5777763 233456688999863211 00 112222256778889776789
Q ss_pred EecCCCCCceEEeCCCCcEEEccccch
Q 006777 152 IHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 152 iHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
+|+|-.|+||+.+ ..|.+||.|-+..
T Consensus 165 lHGD~np~NiM~D-~~G~lKlVDP~~L 190 (308)
T PF07387_consen 165 LHGDCNPDNIMCD-KFGYLKLVDPVCL 190 (308)
T ss_pred ecCCCChhheeec-CCCCEEecChhhh
Confidence 9999999999998 7999999997743
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 631 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-71 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-27 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-26 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-24 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-23 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-23 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-23 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-20 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-20 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-20 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-20 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-04 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 5e-04 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 6e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-04 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 8e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 406 bits (1046), Expect = e-139
Identities = 126/249 (50%), Positives = 171/249 (68%), Gaps = 5/249 (2%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD--DT 99
YKG D +EVAW ++ + + +R E +LK L+H NI++FY+SW
Sbjct: 43 YKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ I ++TEL TSG+L+ Y K+ K + +K +++W RQIL+GL +LH+ PPIIHRDLKCD
Sbjct: 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 160
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL 219
NIF+ G G VKIGDLGLA + + A++VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+L
Sbjct: 161 NIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCML 220
Query: 220 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALEL 278
EM T EYPY+EC+N AQIY++VTSG+KPAS KV P+VK+ IE CI R +L
Sbjct: 221 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280
Query: 279 LKDPFLVTD 287
L F +
Sbjct: 281 LNHAFFQEE 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 4e-61
Identities = 67/282 (23%), Positives = 126/282 (44%), Gaps = 16/282 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
DG + ++NI S + E EV +L ++KH NI+++ S+ ++ +
Sbjct: 41 ILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQYRESFEENGS- 97
Query: 102 TINMITELFTSGSLRQYRKKHKNVDM--KAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ ++ + G L + K V I +W QI L ++H I+HRD+K
Sbjct: 98 -LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQ 154
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGM 216
NIF+ +G V++GD G+A V+ AR+ IGTP +++PE+ E + YN DI++ G
Sbjct: 155 NIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGC 213
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 275
+ E+ T ++ + E + + K+ SG +S ++ + + R
Sbjct: 214 VLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSV 271
Query: 276 LELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPM 317
+L+ F + + + L + + S+P P
Sbjct: 272 NSILEKGF-IAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPA 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-61
Identities = 70/256 (27%), Positives = 128/256 (50%), Gaps = 18/256 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
K + DG + W +++ + + + L SEV+LL+ LKH NI+++Y+ +D TN
Sbjct: 23 QKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80
Query: 102 TINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPP---IIHR 154
T+ ++ E G L + K+ + +D + + Q+ L H + ++HR
Sbjct: 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 140
Query: 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDI 211
DLK N+F++G VK+GD GLA ++ T A++ +GTP +M+PE YNE DI
Sbjct: 141 DLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDI 199
Query: 212 YSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-A 269
+S G C+L E+ P+ + ++ K+ G K + ++ + I + +
Sbjct: 200 WSLG-CLLYELCALMPPFTA-FSQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKD 256
Query: 270 SLRLPALELLKDPFLV 285
R E+L++P ++
Sbjct: 257 YHRPSVEEILENPLIL 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-59
Identities = 60/247 (24%), Positives = 104/247 (42%), Gaps = 16/247 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100
+K + DG A + + P R +EV + + +H ++ +W +
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131
Query: 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ + TE SL+Q+ + ++ + + R L L +LHS ++H D+K
Sbjct: 132 --LYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPA 186
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCI 218
NIF+ G G K+GD GL + + G P +MAPEL + Y D++S G+ I
Sbjct: 187 NIFL-GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTI 245
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALE 277
LE+ + + Q+ + A LS +++ + + P LR A
Sbjct: 246 LEVACNMELPHGGEGWQQLRQGYLPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEA 301
Query: 278 LLKDPFL 284
LL P L
Sbjct: 302 LLALPVL 308
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-59
Identities = 74/253 (29%), Positives = 124/253 (49%), Gaps = 15/253 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+ +DG+ VA +V I D+M E+ LLK L H N+IK+Y S+++D
Sbjct: 49 YRAACLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-- 105
Query: 102 TINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+N++ EL +G L + ++K+ + + + + + Q+ L ++HS ++HRD+K
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIK 163
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSF 214
N+F+ G VK+GDLGL T A S++GTP +M+PE E YN DI+S
Sbjct: 164 PANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 222
Query: 215 GMCILEMVTCEYPYN-ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLR 272
G + EM + P+ + N + KK+ P S +++Q + CI P R
Sbjct: 223 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282
Query: 273 LPALELLKDPFLV 285
+ +
Sbjct: 283 PDVTYVYDVAKRM 295
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-58
Identities = 82/263 (31%), Positives = 122/263 (46%), Gaps = 25/263 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y G D + + +A ++ D + L+ E+ L K LKH+NI+++ S+ ++
Sbjct: 39 YAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-- 92
Query: 102 TINMITELFTSGSLRQ-YRKKHKNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
I + E GSL R K + I + +QIL GL YLH + I+HRD+K
Sbjct: 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKG 150
Query: 159 DNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE---LYEEEYNELVDIYS 213
DN+ +N +G +KI D G + + P + GT ++MAPE Y + DI+S
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWS 210
Query: 214 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----PASLSKVTDPQVKQFIEKCIVP- 268
G I+EM T + P+ E P KV P S+S + K FI KC P
Sbjct: 211 LGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS----AEAKAFILKCFEPD 266
Query: 269 ASLRLPALELLKDPFLVTDNPKD 291
R A +LL D FL + K
Sbjct: 267 PDKRACANDLLVDEFLKVSSKKK 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 6e-57
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 19/237 (8%)
Query: 42 YKGFDEVDGIEVA---WNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98
+KG D VA + E + ++ + EV ++ +L H NI+K Y
Sbjct: 36 HKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL---- 91
Query: 99 TNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+ M+ E G L K + I G+ Y+ + NPPI+HRDL+
Sbjct: 92 MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLR 151
Query: 158 CDNIFVNGNNGE----VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE---YNELVD 210
NIF+ + K+ D GL+ + ++G ++MAPE E Y E D
Sbjct: 152 SPNIFLQSLDENAPVCAKVADFGLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKAD 210
Query: 211 IYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
YSF M + ++T E P++E I G++P ++ + P+++ IE C
Sbjct: 211 TYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP-TIPEDCPPRLRNVIELC 266
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 7e-57
Identities = 60/268 (22%), Positives = 106/268 (39%), Gaps = 37/268 (13%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--- 98
+K +DG +V + E+ EV L L H NI+ + W
Sbjct: 28 FKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79
Query: 99 -----------TNRTINMITELFTSGSLRQYRKKHKNVDM--KAIKNWARQILRGLHYLH 145
+ + + E G+L Q+ +K + + QI +G+ Y+H
Sbjct: 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH 139
Query: 146 SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPELYEEE 204
S +I+RDLK NIF+ + +VKIGD GL ++ R GT +M+PE +
Sbjct: 140 SKK--LINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ 196
Query: 205 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
Y + VD+Y+ G+ + E++ E + + GI + K ++
Sbjct: 197 DYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIISDIFD----KKEKTLLQ 249
Query: 264 KCIVP-ASLRLPALELLKDPFLVTDNPK 290
K + R E+L+ + +P+
Sbjct: 250 KLLSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-56
Identities = 66/222 (29%), Positives = 113/222 (50%), Gaps = 12/222 (5%)
Query: 50 GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109
G +VA + +D +++ EV ++K L+H NI+ F + N +I +TE
Sbjct: 60 GSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI--VTEY 115
Query: 110 FTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166
+ GSL + + +D + + A + +G++YLH+ NPPI+HR+LK N+ V+
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-K 174
Query: 167 NGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT 223
VK+ D GL+ + +++S GTPE+MAPE+ E NE D+YSFG+ + E+ T
Sbjct: 175 KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
Query: 224 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
+ P+ + + + + +PQV IE C
Sbjct: 235 LQQPWGNLNPAQVVAAVGFKCKRL-EIPRNLNPQVAAIIEGC 275
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-55
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 63 VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY---R 119
++S + + E+ L + H NI+K Y + + ++ E GSL
Sbjct: 38 QIESESERKAFIVELRQLSRVNHPNIVKLYGA----CLNPVCLVMEYAEGGSLYNVLHGA 93
Query: 120 KKHKNVDMKAIKNWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
+ +W Q +G+ YLHS P +IHRDLK N+ + +KI D G A
Sbjct: 94 EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
Query: 179 IVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ- 236
+Q + G+ +MAPE++E Y+E D++S+G+ + E++T P++E PA
Sbjct: 154 CDIQT-HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR 212
Query: 237 IYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
I V +G +P L K ++ + +C
Sbjct: 213 IMWAVHNGTRP-PLIKNLPKPIESLMTRC 240
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-55
Identities = 57/272 (20%), Positives = 111/272 (40%), Gaps = 39/272 (14%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100
++ ++VD A ++ + + E++ EV L L+H I++++N+W++
Sbjct: 22 FEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 101 ---------RTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHSHN 148
+ + +L +L+ + R + + + QI + +LHS
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG 138
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--------------SVIGTPE 194
++HRDLK NIF + VK+GD GL M Q +GT
Sbjct: 139 --LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL 195
Query: 195 FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253
+M+PE Y+ VDI+S G+ + E++ YP++ + V + K L
Sbjct: 196 YMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNL-KFPPLFTQ 251
Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
P ++ + P R A+ ++++
Sbjct: 252 KYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 3e-53
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 13/225 (5%)
Query: 50 GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109
G EVA + +E + E L LKH NII + + N + + E
Sbjct: 30 GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL--VMEF 87
Query: 110 FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVN---- 164
G L + + + + NWA QI RG++YLH PIIHRDLK NI +
Sbjct: 88 ARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146
Query: 165 ---GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 220
+N +KI D GLA + T S G +MAPE+ +++ D++S+G+ + E
Sbjct: 147 NGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWE 206
Query: 221 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
++T E P+ A Y + + + + +E C
Sbjct: 207 LLTGEVPFRGIDGLAVAYGVAMNKLAL-PIPSTCPEPFAKLMEDC 250
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-53
Identities = 65/307 (21%), Positives = 115/307 (37%), Gaps = 35/307 (11%)
Query: 3 KSWEKEHSRLCMSLEPISSSVSYFWISWVVVLNC----TFMCRYKGFDEVDGIEVAWNQV 58
++ + E L L+P+ + W+ +F ++ D+ G + A +V
Sbjct: 33 ETEDNEGVLLTEKLKPVDYEYREE-VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV 91
Query: 59 NIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY 118
+E E+ L I+ Y + + +N+ EL GSL Q
Sbjct: 92 RLEVFRVE---------ELVACAGLSSPRIVPLYGAVREGP--WVNIFMELLEGGSLGQL 140
Query: 119 RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
K+ + + Q L GL YLH+ I+H D+K DN+ ++ + + D G A
Sbjct: 141 IKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 179 IVMQQ-------PTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNE 230
+ +Q T + GT MAPE+ + + VDI+S +L M+ +P+ +
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258
Query: 231 CKNPAQIYKKVTSGI----KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 285
K + P S + P Q I++ + R A+EL +
Sbjct: 259 YFRGPLCLKIASEPPPIREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
Query: 286 TDNPKDL 292
L
Sbjct: 315 LQEVGGL 321
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-53
Identities = 76/276 (27%), Positives = 118/276 (42%), Gaps = 44/276 (15%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
K + +D A ++ + ++L + SEV LL SL H+ ++++Y +W++ N
Sbjct: 23 VKARNALDSRYYAIKKIR-----HTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF 77
Query: 102 -----------TINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNP 149
T+ + E +G+L ++ N RQIL L Y+HS
Sbjct: 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG- 136
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR----------------SVIGTP 193
IIHRDLK NIF++ + VKIGD GLA + + S IGT
Sbjct: 137 -IIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 194 EFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PAS 249
++A E+ + YNE +D+YS G+ EM+ YP++ I KK+ S P
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKLRSVSIEFPPD 251
Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
K+ I I + R A LL +L
Sbjct: 252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-53
Identities = 44/222 (19%), Positives = 87/222 (39%), Gaps = 13/222 (5%)
Query: 50 GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109
G ++ + + D S + E L+ H N++ + +IT
Sbjct: 33 GNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90
Query: 110 FTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN 167
GSL + VD +A + RG+ +LH+ P I L ++ ++ +
Sbjct: 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-ED 149
Query: 168 GEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVT 223
+I + Q P + P ++APE +++ D++SF + + E+VT
Sbjct: 150 MTARISMADVKFSFQSPG---RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206
Query: 224 CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
E P+ + N K G++P ++ P V + ++ C
Sbjct: 207 REVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVSKLMKIC 247
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-52
Identities = 53/270 (19%), Positives = 108/270 (40%), Gaps = 39/270 (14%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100
+K +DG A + + EV+ L +H ++++++++W +D +
Sbjct: 28 FKCVKRLDGCIYAIKRSKKPL--AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGLHYLHSHNPPIIHRDL 156
+ + E GSL ++ + +K+ Q+ RGL Y+HS + ++H D+
Sbjct: 86 --MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDI 141
Query: 157 KCDNIFVNGNN------------------GEVKIGDLGLAIVMQQPTARSVIGTPEFMAP 198
K NIF++ + KIGDLG + P + G F+A
Sbjct: 142 KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLAN 199
Query: 199 ELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256
E+ +E + DI++ + ++ E + ++ G P + +V
Sbjct: 200 EVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGRLP-RIPQVLSQ 254
Query: 257 QVKQFIEKCIVP-ASLRLPALELLKDPFLV 285
+ + ++ I P R A+ L+K L+
Sbjct: 255 EFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-52
Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 27/232 (11%)
Query: 52 EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFT 111
EVA ++IE + DQL+ EV + +HEN++ F + + + I IT L
Sbjct: 57 EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI--ITSLCK 112
Query: 112 SGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170
+L R +D+ + A++I++G+ YLH+ I+H+DLK N+F + NG+V
Sbjct: 113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKV 168
Query: 171 KIGDLGLAIVM-------QQPTARSVIGTPEFMAPEL----------YEEEYNELVDIYS 213
I D GL + ++ R G +APE+ + +++ D+++
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 214 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
G E+ E+P+ + I ++ +G+KP ++ + C
Sbjct: 229 LGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFC 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-52
Identities = 71/241 (29%), Positives = 119/241 (49%), Gaps = 27/241 (11%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ ++ G +VA +N+ +P QL+ +EV +L+ +H NI+ F +
Sbjct: 41 YKGKWHG-------DVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFM-GYST 90
Query: 98 DTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
I +T+ SL + +MK + + ARQ RG+ YLH+ + IIHRDL
Sbjct: 91 APQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDL 146
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYEEE----YNEL 208
K +NIF+ + VKIGD GLA + + G+ +MAPE+ + Y+
Sbjct: 147 KSNNIFL-HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKC 265
D+Y+FG+ + E++T + PY+ N QI + V G LSKV ++K+ + +C
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
Query: 266 I 266
+
Sbjct: 266 L 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-50
Identities = 58/268 (21%), Positives = 110/268 (41%), Gaps = 29/268 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDT 99
++ +E A VN+E+ L+ +E+ L L+ + II+ Y+ + D
Sbjct: 26 FQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
I M+ E + L + KK K++D K++ + +L +H +H H I+H DLK
Sbjct: 83 Y--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPA 137
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPEL------------YEE 203
N + +G +K+ D G+A MQ T S +GT +M PE +
Sbjct: 138 NFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 195
Query: 204 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263
+ + D++S G + M + P+ + N + + + ++ ++
Sbjct: 196 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK 255
Query: 264 KCIVP-ASLRLPALELLKDPFLVTDNPK 290
C+ R+ ELL P++
Sbjct: 256 CCLKRDPKQRISIPELLAHPYVQIQTHP 283
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 61/263 (23%), Positives = 112/263 (42%), Gaps = 31/263 (11%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDT 99
++ +E A VN+E+ L+ +E+ L L+ + II+ Y+ + D
Sbjct: 45 FQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
I M+ E + L + KK K++D K++ + +L +H +H H I+H DLK
Sbjct: 102 Y--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPA 156
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEEE----------- 204
N + +G +K+ D G+A MQ T S +GT +M PE ++
Sbjct: 157 NFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 214
Query: 205 -YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
+ D++S G CIL M + P+ + N + + + ++ +
Sbjct: 215 KISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVL 273
Query: 263 EKCIVP-ASLRLPALELLKDPFL 284
+ C+ R+ ELL P++
Sbjct: 274 KCCLKRDPKQRISIPELLAHPYV 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 9e-49
Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 31/269 (11%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDT 99
++ +E A VN+E+ L+ +E+ L L+ + II+ Y+ + D
Sbjct: 73 FQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
I M+ E + L + KK K++D K++ + +L +H +H H I+H DLK
Sbjct: 130 Y--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPA 184
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEEE----------- 204
N + +G +K+ D G+A MQ T S +G +M PE ++
Sbjct: 185 NFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 205 -YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
+ D++S G CIL M + P+ + N + + + ++ +
Sbjct: 243 KISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVL 301
Query: 263 EKCIVP-ASLRLPALELLKDPFLVTDNPK 290
+ C+ R+ ELL P++
Sbjct: 302 KCCLKRDPKQRISIPELLAHPYVQIQTHP 330
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 43/246 (17%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNW 133
E++ ++HENI+ F + + T + IT+ +GSL Y K +D K++
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKL 139
Query: 134 ARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
A + GL +LH+ P I HRDLK NI V NG I DLGLA+ T
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTNE 198
Query: 188 ------SVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTC---------- 224
+ +GT +M PE+ +E + + D+YSFG+ + E+
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 225 EYPYNECKNPAQIYKKVTSG---------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+ PY++ Y+ + S Q+ + + +C + RL
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 275 ALELLK 280
AL + K
Sbjct: 319 ALRVKK 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 52/273 (19%), Positives = 106/273 (38%), Gaps = 28/273 (10%)
Query: 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK 90
+V ++ + + E+ + + + SP ++ ++ + +N +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 91 FYNSWVDDTNRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHSH 147
I M +L +L+ + R ++ + + QI + +LHS
Sbjct: 126 QLQPSSPKVYLYIQM--QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--------------SVIGTP 193
++HRDLK NIF + VK+GD GL M Q +GT
Sbjct: 184 G--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 194 EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
+M+PE Y+ VDI+S G+ + E++ Y ++ +I V + P ++
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKFPLLFTQ 297
Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
PQ ++ + P + R A +++++
Sbjct: 298 -KYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 61/246 (24%), Positives = 96/246 (39%), Gaps = 43/246 (17%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNW 133
E++ L+HENI+ F + D + +++ GSL Y ++ V ++ +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKL 144
Query: 134 ARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 185
A GL +LH P I HRDLK NI V NG I DLGLA+ T
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDT 203
Query: 186 ----ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTC---------- 224
+GT +MAPE+ ++ E + DIY+ G+ E+
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263
Query: 225 EYPYNECKNP----AQIYKKVTSG-----IKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+ PY + ++ K V I S + + + +C + RL
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 275 ALELLK 280
AL + K
Sbjct: 324 ALRIKK 329
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 75/270 (27%), Positives = 128/270 (47%), Gaps = 23/270 (8%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F ++ D A V + ++ P Q E++ E+ + +SL H++++ F+ +
Sbjct: 27 GFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
D+ + ++ EL SL + K+ K + + + RQI+ G YLH + +IHRDL
Sbjct: 86 DNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDL 141
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYS 213
K N+F+N + EVKIGD GLA ++ R + GTP ++APE L ++ ++ VD++S
Sbjct: 142 KLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWS 200
Query: 214 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIVP-AS 270
G CI+ + P E + Y ++ P ++ P I+K + +
Sbjct: 201 IG-CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPT 255
Query: 271 LRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
R ELL D F + P RLP
Sbjct: 256 ARPTINELLNDEFFTSG------YIPARLP 279
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 64/246 (26%), Positives = 100/246 (40%), Gaps = 43/246 (17%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNW 133
E++ L+HENI+ F S + + + + IT GSL Y + +D +
Sbjct: 52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRI 110
Query: 134 ARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
I GL +LH P I HRDLK NI V NG+ I DLGLA++ Q T +
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQ 169
Query: 188 ------SVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNP 234
+GT +MAPE+ +E + + VDI++FG+ + E+ ++
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 235 AQIYKKVTSG-------------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+ V I S T + + +++C S RL
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 275 ALELLK 280
AL + K
Sbjct: 290 ALRIKK 295
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 79/264 (29%), Positives = 128/264 (48%), Gaps = 23/264 (8%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+KG D VA +++E ++ D++E + E+ +L + K+Y S++ DT
Sbjct: 39 FKGIDNRTQKVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
I M E GS + +D I R+IL+GL YLHS IHRD+K N+
Sbjct: 96 WIIM--EYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANV 150
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEE-EYNELVDIYSFGMCI 218
++ +GEVK+ D G+A + + + +GTP +MAPE+ ++ Y+ DI+S G+
Sbjct: 151 LLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 209
Query: 219 LEMVTCEYPYNECKNPA----QIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRL 273
+E+ E P++E +P I K P +L +K+F+E C S R
Sbjct: 210 IELARGEPPHSE-LHPMKVLFLIPKN-----NPPTLEGNYSKPLKEFVEACLNKEPSFRP 263
Query: 274 PALELLKDPFLVTDNPKDLVCDPL 297
A ELLK F++ + K L
Sbjct: 264 TAKELLKHKFILRNAKKTSYLTEL 287
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 25/287 (8%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y D + VA +++ QS ++ + + EV L+ L+H N I++ ++ +
Sbjct: 71 YFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 129
Query: 102 TINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ M E + GS K + I L+GL YLHSHN +IHRD+K N
Sbjct: 130 WLVM--E-YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGN 184
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE----LYEEEYNELVDIYSFGM 216
I ++ G VK+GD G A +M A S +GTP +MAPE + E +Y+ VD++S G+
Sbjct: 185 ILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241
Query: 217 CILEMVTCEYPYNECKNPAQ----IYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASL 271
+E+ + P N I + + ++ S + F++ C
Sbjct: 242 TCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWS----EYFRNFVDSCLQKIPQD 296
Query: 272 RLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLAHSEPHPM 317
R + LLK F++ + P ++ D + R + V E+ NL + + +
Sbjct: 297 RPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 343
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 50/265 (18%), Positives = 85/265 (32%), Gaps = 33/265 (12%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
DG A ++ E E + + H NI++ + +
Sbjct: 46 DLVEGLHDGHFYALKRILC----HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101
Query: 102 T--INMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
++ F G+L + K + I I RGL +H+ HRD
Sbjct: 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRD 159
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----------VIGTPEFMAPELYEEE 204
LK NI + + G+ + DLG S T + APEL+ +
Sbjct: 160 LKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ 218
Query: 205 ----YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYK-KVTSGIKPASLSKVTDPQV 258
+E D++S G C+L M+ E PY+ V + + + + +
Sbjct: 219 SHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHS-SAL 276
Query: 259 KQFIEKCIVP-ASLRLPALELLKDP 282
Q + + R LL
Sbjct: 277 WQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 75/271 (27%), Positives = 128/271 (47%), Gaps = 23/271 (8%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
+ P Q E++ E+ + +SL H++++ F+ + D+ + ++ EL SL + K+ K
Sbjct: 79 LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRK 136
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+ + + RQI+ G YLH + +IHRDLK N+F+N + EVKIGD GLA ++
Sbjct: 137 ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEY 193
Query: 184 PTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
R + GTP ++APE L ++ ++ VD++S G CI+ + P E + Y +
Sbjct: 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLR 252
Query: 241 VTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL 297
+ P ++ P I+K + + R ELL D F + P
Sbjct: 253 IKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSG------YIPA 302
Query: 298 RLPNLVPEVMNLAHSEPHPMDIDLNHKKVSA 328
RLP + P +D N K ++
Sbjct: 303 RLPITCLTIPPRFSIAPSSLDPS-NRKPLTV 332
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-41
Identities = 55/262 (20%), Positives = 103/262 (39%), Gaps = 28/262 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
++G + G A + + + + ++ E +LK L H+NI+K + + T R
Sbjct: 26 FRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 102 TINMITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
+I E GSL ++ N R ++ G+++L + I+HR++K
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKP 140
Query: 159 DNIFVNGN---NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE---------EEY 205
NI K+ D G A ++ S+ GT E++ P++YE ++Y
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 206 NELVDIYSFGMCIL-EMVTCE---YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ--VK 259
VD++S G T P+ + ++ K+ +G ++S V +
Sbjct: 201 GATVDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259
Query: 260 QFIEKCIVPASLRLPALELLKD 281
+ V SL LL
Sbjct: 260 DWSGDMPVSCSLSRGLQVLLTP 281
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-41
Identities = 56/219 (25%), Positives = 86/219 (39%), Gaps = 23/219 (10%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 123
+ EV +++ L+H N++KF D +N ITE G+LR +
Sbjct: 46 FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDS 103
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
++A+ I G+ YLHS N IIHRDL N V N V + D GLA +M
Sbjct: 104 QYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENK-NVVVADFGLARLMVD 160
Query: 184 ----------------PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY 226
+V+G P +MAPE + Y+E VD++SFG+ + E++
Sbjct: 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
Query: 227 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 265
+ + G P +C
Sbjct: 221 ADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRC 259
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 67/272 (24%), Positives = 115/272 (42%), Gaps = 41/272 (15%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ +VA ++N+E + ++ L E+ + H NI+ +Y S+V
Sbjct: 32 QAAYCAPKKEKVAIKRINLE---KCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 102 TINMITELFTSGSLR--------QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
+ M +L + GS+ + K +D I R++L GL YLH + IH
Sbjct: 89 WLVM--KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIH 144
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTARSVIGTPEFMAPELYEE--E 204
RD+K NI + +G V+I D G++ + + ++ +GTP +MAPE+ E+
Sbjct: 145 RDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG 203
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNEC-----------KNPAQIYKKVTSGIKPASLSKV 253
Y+ DI+SFG+ +E+ T PY++ +P + V K
Sbjct: 204 YDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS 263
Query: 254 TDPQVKQFIEKC-IVPASLRLPALELLKDPFL 284
++ I C R A ELL+ F
Sbjct: 264 ----FRKMISLCLQKDPEKRPTAAELLRHKFF 291
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 77/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y D G EVA Q+N++ + E + +E+ +++ K+ NI+ + +S++
Sbjct: 37 YTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ M E GSL +D I R+ L+ L +LHS+ +IHRD+K DNI
Sbjct: 93 WVVM--EYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 147
Query: 162 FVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPEL-YEEEYNELVDIYSFGMCI 218
+ +G VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+
Sbjct: 148 LLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 219 LEMVTCEYPYNECKNPAQ-IYKKVTSGI----KPASLSKVTDPQVKQFIEKC-IVPASLR 272
+EM+ E PY +NP + +Y T+G P LS + F+ +C + R
Sbjct: 207 IEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLS----AIFRDFLNRCLEMDVEKR 261
Query: 273 LPALELLKDPFL 284
A ELL+ FL
Sbjct: 262 GSAKELLQHQFL 273
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 67/267 (25%), Positives = 122/267 (45%), Gaps = 25/267 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK ++ G A + + S ++LE E+ +L + H I+K ++ D
Sbjct: 36 YKAKNKETGALAAAKVIETK----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91
Query: 102 TINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
I + E G++ + + + I+ RQ+L L++LHS IIHRDLK N
Sbjct: 92 WIMI--EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGN 147
Query: 161 IFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE------LYEEEYNELVDIY 212
+ + G++++ D G++ + S IGTP +MAPE + + Y+ DI+
Sbjct: 148 VLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 206
Query: 213 SFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVTD--PQVKQFIEKC-IVP 268
S G+ ++EM E P++E NP + + K S P +L + + + F++
Sbjct: 207 SLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSD--PPTLLTPSKWSVEFRDFLKIALDKN 263
Query: 269 ASLRLPALELLKDPFLVTDNPKDLVCD 295
R A +LL+ PF+ + + +
Sbjct: 264 PETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 70/252 (27%), Positives = 120/252 (47%), Gaps = 24/252 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
++ G +VA +++ + E L++EV +++ +H N+++ Y S++
Sbjct: 62 CLAREKHSGRQVAVKMMDLR----KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ M E G+L ++ + I +L+ L YLH+ +IHRD+K D+I
Sbjct: 118 WVLM--EFLQGGALTDIV-SQVRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSI 172
Query: 162 FVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPEL-YEEEYNELVDIYSFGMCI 218
+ +G VK+ D G I P +S++GTP +MAPE+ Y VDI+S G+ +
Sbjct: 173 LLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231
Query: 219 LEMVTCEYPYNECKNPAQ-IYKKVTSGI----KPASLSKVTDPQVKQFIEKC-IVPASLR 272
+EMV E PY +P Q + + S +S P ++ F+E+ + R
Sbjct: 232 IEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVS----PVLRDFLERMLVRDPQER 286
Query: 273 LPALELLKDPFL 284
A ELL PFL
Sbjct: 287 ATAQELLDHPFL 298
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 74/264 (28%), Positives = 123/264 (46%), Gaps = 26/264 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK + G VA QV +E L+ + E+ +++ +++K+Y S+ +T+
Sbjct: 46 YKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99
Query: 102 TINMITELFTSGSLRQ-YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
I M E +GS+ R ++K + I + L+GL YLH IHRD+K N
Sbjct: 100 WIVM--EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGN 155
Query: 161 IFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 217
I +N G K+ D G+A + +VIGTP +MAPE + E YN + DI+S G+
Sbjct: 156 ILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGIT 214
Query: 218 ILEMVTCEYPYNECKNPAQ----IYKKVTSGIK-PASLSKVTDPQVKQFIEKC-IVPASL 271
+EM + PY + +P + I + P S F+++C +
Sbjct: 215 AIEMAEGKPPYAD-IHPMRAIFMIPTNPPPTFRKPELWS----DNFTDFVKQCLVKSPEQ 269
Query: 272 RLPALELLKDPFLVTDNPKDLVCD 295
R A +LL+ PF+ + ++ D
Sbjct: 270 RATATQLLQHPFVRSAKGVSILRD 293
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-40
Identities = 59/278 (21%), Positives = 110/278 (39%), Gaps = 31/278 (11%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
++G + G A + + + + ++ E +LK L H+NI+K + + T R
Sbjct: 26 FRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 102 TINMITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
+I E GSL ++ N R ++ G+++L + I+HR++K
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKP 140
Query: 159 DNIFVNGN---NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE---------EEY 205
NI K+ D G A ++ S+ GT E++ P++YE ++Y
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 206 NELVDIYSFGMCIL-EMVTCE---YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261
VD++S G T P+ + ++ K+ +G ++S V +
Sbjct: 201 GATVDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259
Query: 262 IEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDPLR 298
+P S L L++L P L L D +
Sbjct: 260 DWSGDMPVSCSLSRGLQVLLTPVLA----NILEADQEK 293
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-40
Identities = 56/242 (23%), Positives = 110/242 (45%), Gaps = 14/242 (5%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
++ +L EV + L+H NI++ Y + D T + +I E G++ + +K
Sbjct: 47 LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLS 104
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
D + + ++ L Y HS +IHRD+K +N+ + G+ GE+KI D G ++
Sbjct: 105 KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPS 161
Query: 184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
+ GT +++ PE+ E ++E VD++S G+ E + P E + YK+++
Sbjct: 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRIS 220
Query: 243 SG-IK-PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRL 299
P ++ + I + + S R E+L+ P++ ++ K C
Sbjct: 221 RVEFTFPDFVT----EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKES 276
Query: 300 PN 301
+
Sbjct: 277 AS 278
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 75/277 (27%), Positives = 125/277 (45%), Gaps = 33/277 (11%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100
YKG G A +++ D+ E + E+++LK H NI +Y +++
Sbjct: 41 YKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95
Query: 101 RTIN----MITELFTSGSLRQYRKKHKNVDMK--AIKNWARQILRGLHYLHSHNPPIIHR 154
++ ++ E +GS+ K K +K I R+ILRGL +LH H +IHR
Sbjct: 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHR 153
Query: 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE------LYEEEYN 206
D+K N+ + N EVK+ D G++ + + R + IGTP +MAPE + Y+
Sbjct: 154 DIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 212
Query: 207 ELVDIYSFGMCILEMVTCEYPYNECKNPA----QIYKKVTSGIKPASLSKVTDPQVKQFI 262
D++S G+ +EM P + +P I + +K SK + + FI
Sbjct: 213 FKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWSK----KFQSFI 267
Query: 263 EKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPLR 298
E C + S R +L+K PF+ + V L+
Sbjct: 268 ESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLK 304
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 53/261 (20%), Positives = 120/261 (45%), Gaps = 19/261 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTN 100
+K G +A Q+ + ++ +R+ ++ +LKS I++ + +++ +T+
Sbjct: 42 WKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ + EL + + + ++ + + + I++ L+YL + +IHRD+K N
Sbjct: 99 --VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSN 155
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE------LYEEEYNELVDIYS 213
I ++ G++K+ D G++ + A+ G +MAPE + +Y+ D++S
Sbjct: 156 ILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214
Query: 214 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD--PQVKQFIEKCIV-PAS 270
G+ ++E+ T ++PY CK ++ KV +P L + F++ C+
Sbjct: 215 LGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHR 273
Query: 271 LRLPALELLKDPFLVTDNPKD 291
R +LL+ F+ +
Sbjct: 274 KRPKYNKLLEHSFIKRYETLE 294
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-38
Identities = 62/356 (17%), Positives = 116/356 (32%), Gaps = 70/356 (19%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ G V ++N+E S + + L E+H+ K H NI+ + +++ D
Sbjct: 44 NLARYKPTGEYVTVRRINLEA--CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE- 100
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMK--AIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ ++T GS + H M AI + +L+ L Y+H +HR +K
Sbjct: 101 -LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKAS 157
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPTAR---------SVIGTPEFMAPELYEE---EYNE 207
+I ++ +G+V + L + M R + +++PE+ ++ Y+
Sbjct: 158 HILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 216
Query: 208 LVDIYSFGMCILEMVTCEYPY---------------------------NECKNPAQIYKK 240
DIYS G+ E+ P+ E +
Sbjct: 217 KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSV 276
Query: 241 VTSGIKPASLSKVTDPQV----------------KQFIEKC-IVPASLRLPALELLKDPF 283
SG+ + + P F+E+C R A LL F
Sbjct: 277 ANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336
Query: 284 LVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTW 339
+ LP L+ V + + E D + + + W
Sbjct: 337 FKQIKRRASEA----LPELLRPVTPITNFEGSQSQ-DHSGIFGLVTNLEELEVDDW 387
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-37
Identities = 85/378 (22%), Positives = 132/378 (34%), Gaps = 38/378 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ + G +VA + SP ER E+ ++K L H N++ V D +
Sbjct: 31 LRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE--VPDGLQ 85
Query: 102 TIN------MITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGLHYLHSHNPPII 152
+ + E G LR+Y + +N I+ I L YLH + II
Sbjct: 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--II 143
Query: 153 HRDLKCDNI--FVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEYNEL 208
HRDLK +NI KI DLG A + Q +GT +++APEL E ++Y
Sbjct: 144 HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT 203
Query: 209 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268
VD +SFG E +T P+ P Q + KV + +F P
Sbjct: 204 VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTP 263
Query: 269 ASL---------RLPALELLKDP-----FLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEP 314
L R L+ N L + VMN+
Sbjct: 264 NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRV 323
Query: 315 HPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGD 374
H + N + S + +TG + E Q L + + L + V + + D
Sbjct: 324 HTYPVTENENLQNLKSWLQQDTG---IPEEEQELLQASGLALNSAQPLTQYV-IDCTVID 379
Query: 375 KSGHVSNIHFVFYLNADT 392
++ F+F
Sbjct: 380 GRQGEGDLIFLFDNRKTV 397
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (354), Expect = 1e-37
Identities = 59/235 (25%), Positives = 111/235 (47%), Gaps = 19/235 (8%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKH 122
M ++R+ +EV + LKH +I++ YN + D + ++ E+ +G + +Y + +
Sbjct: 49 MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRV 106
Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
K +++ QI+ G+ YLHSH I+HRDL N+ + N +KI D GLA ++
Sbjct: 107 KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLL-TRNMNIKIADFGLATQLK 163
Query: 183 QPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIY 238
P + ++ GTP +++PE + D++S G C+ ++ P+ +
Sbjct: 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPF-DTDTVKNTL 221
Query: 239 KKVTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
KV P+ LS + K I + + + RL +L PF+ ++
Sbjct: 222 NKVVLADYEMPSFLS----IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 56/231 (24%), Positives = 113/231 (48%), Gaps = 14/231 (6%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
++ +L E+ + L+H NI++ YN + D I ++ E G L + +KH
Sbjct: 52 LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR--IYLMLEFAPRGELYKELQKHG 109
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
D + + ++ LHY H +IHRD+K +N+ + G GE+KI D G ++
Sbjct: 110 RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLM-GYKGELKIADFGWSVHAPS 166
Query: 184 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
R++ GT +++ PE+ E + ++E VD++ G+ E + P+ + + + ++++
Sbjct: 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIV 225
Query: 243 SG-IK-PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
+ +K P LS K I K + RLP +++ P++ ++ +
Sbjct: 226 NVDLKFPPFLS----DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 62/300 (20%), Positives = 130/300 (43%), Gaps = 32/300 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTN 100
K + G +A ++ + ++L ++ +++S I++FY + + +
Sbjct: 39 NKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDM----KAIKNWARQILRGLHYLHS-HNPPIIHRD 155
+ EL ++ + Y+ + +D + + ++ L++L IIHRD
Sbjct: 96 --CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRD 151
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPE-----LYEEEYNELV 209
+K NI ++ +G +K+ D G++ + A++ G +MAPE + Y+
Sbjct: 152 IKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRS 210
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD----PQVKQFIEKC 265
D++S G+ + E+ T +PY + + +V G P LS + P F+ C
Sbjct: 211 DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREFSPSFINFVNLC 269
Query: 266 IV-PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEP-HPMDIDLNH 323
+ S R ELLK PF++ + + + V ++++ + P PM +D +H
Sbjct: 270 LTKDESKRPKYKELLKHPFILMYEERA-----VEVACYVCKILDQMPATPSSPMYVDHHH 324
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 43/246 (17%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINM--ITELFTSGSLRQYRKKHKNVDMKAIKNW 133
EV+ L +KHENI++F + T+ +++ IT GSL + K + V + +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHI 126
Query: 134 ARQILRGLHYLHS--------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---- 181
A + RGL YLH H P I HRD+K N+ + NN I D GLA+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGK 185
Query: 182 QQPTARSVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 235
+GT +MAPE+ ++ + +D+Y+ G+ + E+ + + +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 236 QI--------------------YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+ +KK ++ + + IE+C A RL
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 275 ALELLK 280
A + +
Sbjct: 306 AGCVGE 311
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 59/304 (19%), Positives = 107/304 (35%), Gaps = 42/304 (13%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD--- 97
Y+ D G E A ++ ++ + EV +K L H NI++F ++
Sbjct: 45 YEAQDVGSGREYALKRLLS----NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100
Query: 98 --DTNRTINMITELFTSGSLRQYRKKHKNVDM---KAIKNWARQILRGLHYLHSHNPPII 152
DT + ++ G L ++ KK ++ + Q R + ++H PPII
Sbjct: 101 ESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPII 160
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV--------------IGTPEFMAP 198
HRDLK +N+ + N G +K+ D G A + S TP + P
Sbjct: 161 HRDLKVENLLL-SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219
Query: 199 ELYE----EEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253
E+ + E DI++ G CIL + ++P+ + +I S +
Sbjct: 220 EIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED-GAKLRIVNGKYSIPPHDTQY-- 275
Query: 254 TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHS 312
I + RL E++ + P + L+ + +
Sbjct: 276 --TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP--ITELLEQNGGYGSA 331
Query: 313 EPHP 316
Sbjct: 332 TLSR 335
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 58/263 (22%), Positives = 113/263 (42%), Gaps = 22/263 (8%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDTN 100
K G +A ++ + + +RL ++ ++++ + FY + + +
Sbjct: 24 EKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80
Query: 101 RTINMITELFTSGSL----RQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRD 155
+ + E SL +Q K + + + A I++ L +LHS + +IHRD
Sbjct: 81 --VWICME-LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRD 135
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPEFMAPE-----LYEEEYNELV 209
+K N+ +N G+VK+ D G++ + A+ G +MAPE L ++ Y+
Sbjct: 136 VKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKS 194
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P 268
DI+S G+ ++E+ +PY+ P Q K+V P + + F +C+
Sbjct: 195 DIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKN 254
Query: 269 ASLRLPALELLKDPFLVTDNPKD 291
+ R EL++ PF K
Sbjct: 255 SKERPTYPELMQHPFFTLHESKG 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 62/294 (21%), Positives = 115/294 (39%), Gaps = 52/294 (17%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+K + G+ +A +++E P ++ E+ +L I+ FY ++ D
Sbjct: 50 FKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 104
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDN 160
I++ E GSL Q KK + + + + +++GL YL H I+HRD+K N
Sbjct: 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSN 162
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 219
I VN + GE+K+ D G++ + A S +GT +M+PE L Y+ DI+S G+ ++
Sbjct: 163 ILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221
Query: 220 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD------------------------ 255
EM YP A+ +
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281
Query: 256 -----------------PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291
+ + F+ KC++ + R +L+ F+ + ++
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 52/261 (19%), Positives = 103/261 (39%), Gaps = 33/261 (12%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
D + + + +E+ ++ +K+E + + + +I E + S+ ++ +
Sbjct: 78 NDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDE 135
Query: 121 KHKNVDMKA--------IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172
+D IK + +L Y+H+ I HRD+K NI + NG VK+
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILM-DKNGRVKL 193
Query: 173 GDLGLAIVMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYN 229
D G + M + GT EFM PE + E VDI+S G+C+ M P++
Sbjct: 194 SDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
Query: 230 ECKNPAQIYKKVTSG-----------------IKPASLSKVTDPQVKQFIEKCIVP-ASL 271
+ +++ + + K + + F++ + +
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
Query: 272 RLPALELLKDPFLVTDNPKDL 292
R+ + + LK +L N +DL
Sbjct: 314 RITSEDALKHEWLADTNIEDL 334
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-36
Identities = 73/269 (27%), Positives = 119/269 (44%), Gaps = 14/269 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
D++ G E A ++ ++ E L EV LLK L H NI+K Y + D
Sbjct: 43 ILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY- 100
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
++ E++T G L K RQ+L G+ Y+H + I+HRDLK +N+
Sbjct: 101 -FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENL 157
Query: 162 -FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCI 218
+ + ++I D GL+ + + IGT ++APE+ Y+E D++S G I
Sbjct: 158 LLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTG-VI 216
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
L ++ P N I KKV G + KV++ K I K + S+R+
Sbjct: 217 LYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE-SAKDLIRKMLTYVPSMRIS 275
Query: 275 ALELLKDPFLVTDNPKDLVCDPLRLPNLV 303
A + L ++ T + + D L N +
Sbjct: 276 ARDALDHEWIQTYTKEQISVDVPSLDNAI 304
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 59/242 (24%), Positives = 95/242 (39%), Gaps = 22/242 (9%)
Query: 66 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 123
P+ EV LL+ +H N+I+++ + D + EL + +L++Y +K
Sbjct: 57 LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQF--QYIAIEL-CAATLQEYVEQKDF 113
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAI 179
+Q GL +LHS N I+HRDLK NI ++ N I D GL
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 180 VMQQP-----TARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEY-PYN 229
+ V GT ++APE+ E+ VDI+S G +++ P+
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 230 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 288
+ + K D ++ IEK I R A +LK PF +
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291
Query: 289 PK 290
+
Sbjct: 292 KQ 293
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 54/232 (23%), Positives = 104/232 (44%), Gaps = 17/232 (7%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
+ ++R E+ ++KSL H NII+ Y ++ D+T+ I ++ EL T G L + +
Sbjct: 48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD--IYLVMELCTGGELFERVVHKRVFRE 105
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPT 185
+ +L + Y H N + HRDLK +N + + +K+ D GLA +
Sbjct: 106 SDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163
Query: 186 A-RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVT 242
R+ +GTP +++P++ E Y D +S G ++ ++ C YP +++ K+
Sbjct: 164 MMRTKVGTPYYVSPQVLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIR 220
Query: 243 SGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
G V+ Q + I + + R+ +L+ L+ +
Sbjct: 221 EGTFTFPEKDWLNVSP-QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 68/266 (25%), Positives = 120/266 (45%), Gaps = 23/266 (8%)
Query: 42 YKGFDEVDGIEVAWNQVN----IEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
F+ +VA ++ + D + +E+ +LK L H IIK N D
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FD 210
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+ ++ EL G L +K + K + Q+L + YLH + IIHRDLK
Sbjct: 211 AED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLK 266
Query: 158 CDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE----LYEEEYNELVD 210
+N+ + + +KI D G + ++ + + R++ GTP ++APE + YN VD
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD 326
Query: 211 IYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCI 266
+S G IL + Y P++E + + ++TSG P ++V++ ++K +
Sbjct: 327 CWSLG-VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK-ALDLVKKLL 384
Query: 267 VP-ASLRLPALELLKDPFLVTDNPKD 291
V R E L+ P+L ++ K
Sbjct: 385 VVDPKARFTTEEALRHPWLQDEDMKR 410
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 70/235 (29%), Positives = 112/235 (47%), Gaps = 17/235 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
+ EV LLK L H NI+K + D ++ ++ EL+T G L K K
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRF 118
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 183
+Q+ G+ Y+H HN I+HRDLK +NI + + ++KI D GL+ QQ
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 184 PTA-RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKK 240
T + IGT ++APE+ Y+E D++S G IL ++ P Y + N I K+
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGK--NEYDILKR 233
Query: 241 VTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
V +G ++D K I K + SLR+ A + L+ P++ + ++
Sbjct: 234 VETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 75/269 (27%), Positives = 117/269 (43%), Gaps = 15/269 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
K D + E A +N + EV LLK L H NI+K + D ++
Sbjct: 39 LKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS- 95
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
++ EL+T G L K K +Q+ G+ Y+H HN I+HRDLK +NI
Sbjct: 96 -FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENI 152
Query: 162 -FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCI 218
+ + ++KI D GL+ QQ + IGT ++APE+ Y+E D++S G I
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG-VI 211
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
L ++ P KN I K+V +G ++D K I K + SLR+
Sbjct: 212 LYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLRIT 270
Query: 275 ALELLKDPFLVTDNPKDLVCDPLRLPNLV 303
A + L+ P++ + + L
Sbjct: 271 ATQCLEHPWIQKYSSETPTISDLPSLESA 299
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 54/233 (23%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQYRK 120
+S +E++ +E+ +LKSL H NIIK + + D N + ++ E G L +
Sbjct: 59 RSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN--MYIVMETCEGGELLERIVSAQA 116
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLA 178
+ K + + +Q++ L Y HS + ++H+DLK +NI F + + +KI D GLA
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 179 IVMQQPTA-RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237
+ + + GT +MAPE+++ + DI+S G ++ + + ++
Sbjct: 175 ELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGTSLEEV 233
Query: 238 YKKVTSGI-----KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+K T + L+ PQ +++ + R A ++L +
Sbjct: 234 QQKATYKEPNYAVECRPLT----PQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 25/286 (8%)
Query: 42 YKGFDEVDGIEVAWNQVN----IEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
F+ +VA ++ + D + +E+ +LK L H IIK N + D
Sbjct: 27 KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN-FFD 85
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+ ++ EL G L +K + K + Q+L + YLH + IIHRDLK
Sbjct: 86 AED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLK 141
Query: 158 CDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE----LYEEEYNELVD 210
+N+ + + +KI D G + ++ + + R++ GTP ++APE + YN VD
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD 201
Query: 211 IYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKC 265
+S G IL + YP + + ++TSG P ++V++ ++K
Sbjct: 202 CWSLG-VILFICLSGYPPFSEH-RTQVSLKDQITSGKYNFIPEVWAEVSEK-ALDLVKKL 258
Query: 266 IVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA 310
+V R E L+ P+L ++ K D L N + +
Sbjct: 259 LVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVL 304
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-34
Identities = 75/283 (26%), Positives = 121/283 (42%), Gaps = 22/283 (7%)
Query: 42 YKGFDEVDGIEVA---------WNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY 92
++ E A +D E +Y+E+ LLKSL H NIIK +
Sbjct: 53 LLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
+ + D ++TE + G L + D N +QIL G+ YLH HN I+
Sbjct: 113 DVFEDKKY--FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IV 168
Query: 153 HRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNELV 209
HRD+K +NI N + +KI D GL+ + R +GT ++APE+ +++YNE
Sbjct: 169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKC 228
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCI 266
D++S G I+ ++ C YP +N I KKV G ++ + K+ I+ +
Sbjct: 229 DVWSCG-VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNIS-DEAKELIKLML 286
Query: 267 VP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
+ R A E L ++ D L + +
Sbjct: 287 TYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRK 329
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-34
Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 15/269 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
D+V +E A + V S +L EV +LK L H NI+K Y+ + D N
Sbjct: 54 LLCRDKVTHVERAIKIIRKTSV--STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN- 110
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
++ E + G L + +Q+L G+ YLH HN I+HRDLK +N+
Sbjct: 111 -YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENL 167
Query: 162 -FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCI 218
+ + +KI D GL+ V + + +GT ++APE+ ++Y+E D++S G I
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIG-VI 226
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
L ++ YP + +I +KV G V++ K I++ + + R+
Sbjct: 227 LFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE-GAKDLIKQMLQFDSQRRIS 285
Query: 275 ALELLKDPFLVTDNPKDLVCDPLRLPNLV 303
A + L+ P++ K L
Sbjct: 286 AQQALEHPWIKEMCSKKESGIELPSLANA 314
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 7e-34
Identities = 35/235 (14%), Positives = 71/235 (30%), Gaps = 31/235 (13%)
Query: 69 QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS------GSLRQYRKKH 122
R L+K + + +I+ D + + S L + H
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
K++ A Q++R L LH + ++H L+ +I ++ G V + +
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRDG 257
Query: 183 QPTARSVIGTPEFMAPELYEEE------------YNELVDIYSFGMCILEMVTCEYPYNE 230
+ F PEL D ++ G+ I + + P +
Sbjct: 258 ARV--VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
Query: 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+ + K V+ +E + RL L+ ++ P
Sbjct: 316 -DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 58/236 (24%), Positives = 112/236 (47%), Gaps = 18/236 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
S ++L E + + L+H NI++ ++S +++ ++ +L T G L + +
Sbjct: 45 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFY 102
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ- 182
+ +QIL + Y HS+ I+HR+LK +N+ + VK+ D GLAI +
Sbjct: 103 SEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
Query: 183 QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYK 239
GTP +++PE L ++ Y++ VDI++ G IL ++ YP ++E + ++Y
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYA 217
Query: 240 KVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
++ +G VT + K I+ + R+ A + LK P++
Sbjct: 218 QIKAGAYDYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 30/176 (17%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLRQYRKKHKNVDMKAIKN 132
++ + ++H+NI +F T ++ E + +GSL +Y H D +
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCR 115
Query: 133 WARQILRGLHYLHS-------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---- 181
A + RGL YLH+ + P I HRDL N+ V N+G I D GL++ +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNR 174
Query: 182 ------QQPTARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT 223
+ A S +GT +MAPE+ E E + VD+Y+ G+ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 20/231 (8%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMK 128
+ +E+ ++ L H +I ++++ D + +I E + G L R + +K + +
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAE 150
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA- 186
I N+ RQ GL ++H H+ I+H D+K +NI VKI D GLA +
Sbjct: 151 VI-NYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTS 243
+ T EF APE + E D+++ G + ++ E + + + V
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQNVKR 264
Query: 244 GI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
+ S V+ + K FI+ + RL + L+ P+L D+
Sbjct: 265 CDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 6e-32
Identities = 60/243 (24%), Positives = 111/243 (45%), Gaps = 21/243 (8%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKHKNVDMK 128
L +E+ +LK +KHENI+ + + T+ ++ +L + G L R + K
Sbjct: 51 SSLENEIAVLKKIKHENIVTLEDIYESTTH--YYLVMQLVSGGELFDRILERGVYT--EK 106
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA 186
+Q+L + YLH + I+HRDLK +N+ N ++ I D GL+ + Q
Sbjct: 107 DASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTS 243
+ GTP ++APE L ++ Y++ VD +S G I ++ C YP Y E +++++K+
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKE 221
Query: 244 GI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRL 299
G + +++ K FI + + R + L P++ + P
Sbjct: 222 GYYEFESPFWDDISE-SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVS 280
Query: 300 PNL 302
+
Sbjct: 281 LQI 283
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 65/278 (23%), Positives = 116/278 (41%), Gaps = 26/278 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQ-LERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
+ + G + A V++ SP E L E + LKH +I++ ++ D
Sbjct: 41 RRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100
Query: 101 RTINMITELFTSGSL--RQYRKKHKNVDM--KAIKNWARQILRGLHYLHSHNPPIIHRDL 156
+ M+ E L ++ ++ RQIL L Y H +N IIHRD+
Sbjct: 101 --LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDV 156
Query: 157 KCDNI-FVN-GNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDI 211
K + + N+ VK+G G+AI + + A +GTP FMAPE + E Y + VD+
Sbjct: 157 KPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDV 216
Query: 212 YSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCI 266
+ G IL ++ Y ++++ + G P S +++ K + + +
Sbjct: 217 WGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQWSHISE-SAKDLVRRML 271
Query: 267 VP-ASLRLPALELLKDPFLVTDNPK-DLVCDPLRLPNL 302
+ + R+ E L P+L + + P + L
Sbjct: 272 MLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQL 309
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 8e-32
Identities = 37/274 (13%), Positives = 80/274 (29%), Gaps = 31/274 (11%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTS---------GS 114
+++ Q + + +K K +D+ + + L+
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197
Query: 115 LRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174
L + HK++ A Q++R L LH + ++H L+ +I + G V +
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVL-DQRGGVFLTG 254
Query: 175 LGLAIVMQQPT---ARSVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTCE 225
+ PE A + D ++ G+ I + +
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 226 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
P + + + K V+ +E + RL L+ ++ P
Sbjct: 315 LPNTD-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY 367
Query: 285 VTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMD 318
+ + + L L E + P
Sbjct: 368 --EQLRTELSAALPLYQTDGEPTREGGAPPSGTS 399
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 43/240 (17%), Positives = 88/240 (36%), Gaps = 32/240 (13%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
+P + + LK +KFY++ + ++ EL++ G+L +KN
Sbjct: 106 ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKN 163
Query: 125 VDMKAIKN-----WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----------NNGE 169
K + +A ++L + +H IIH D+K DN + +
Sbjct: 164 TPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 170 VKIGDLGLAIVMQQP----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC 224
+ + DLG +I M+ + T F E L + +N +D + + M+
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 225 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPF 283
Y + + + + + + +F + +P LP+L+LL+
Sbjct: 282 TYMKVKNEGGECKPEGLFRRLPHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 31/239 (12%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDV----MQSPDQLERLYSEVHLLKSLKHENIIKFYN 93
+CRY + G VA V PDQ E+ +LK+L + I+K+
Sbjct: 40 ELCRYDPLGDNTGALVA--------VKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRG 91
Query: 94 SWVDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPII 152
+++ ++ E SG LR + ++H+ +D + ++ QI +G+ YL S +
Sbjct: 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CV 149
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MAPE-LYEEEYN 206
HRDL NI V + VKI D GLA ++ R +P F APE L + ++
Sbjct: 150 HRDLAARNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 208
Query: 207 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
D++SFG+ + E+ T C+ + ++ ++ + +E+
Sbjct: 209 RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP--------ALSRLLELLEE 259
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 61/249 (24%), Positives = 115/249 (46%), Gaps = 19/249 (7%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
+ E + EV +L+ + H N+I ++ + + T+ + +I EL + G L + + ++
Sbjct: 54 RRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFLAQKES 111
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVM 181
+ + ++ +QIL G++YLH+ I H DLK +NI + N +K+ D GLA +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 182 QQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQI 237
+ +++ GTPEF+APE + E D++S G I ++ + +
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQET 226
Query: 238 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 293
+TS S ++ K FI K +V RL E L+ P++ + + +
Sbjct: 227 LANITSVSYDFDEEFFSHTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAM 285
Query: 294 CDPLRLPNL 302
+ NL
Sbjct: 286 VRRESVVNL 294
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 59/245 (24%), Positives = 113/245 (46%), Gaps = 20/245 (8%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKH 122
+ E + +E+ ++ L H N+I+ Y+++ + I ++ E G L R + +
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELFDRIIDESY 182
Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVM 181
++ I + +QI G+ ++H I+H DLK +NI VN + ++KI D GLA
Sbjct: 183 NLTELDTI-LFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 182 QQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQI 237
+ + GTPEF+APE + + + D++S G+ I M+ + N A+
Sbjct: 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAET 296
Query: 238 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 293
+ + + +++ + K+FI K ++ S R+ A E LK P+L +
Sbjct: 297 LNNILACRWDLEDEEFQDISE-EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRL 355
Query: 294 CDPLR 298
+
Sbjct: 356 SAQKK 360
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 62/245 (25%), Positives = 122/245 (49%), Gaps = 17/245 (6%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
+P L++L+ EV ++K L H NI+K + V +T +T+ +I E + G + Y H +
Sbjct: 54 NPTSLQKLFREVRIMKILNHPNIVKLFE--VIETEKTLYLIMEYASGGEVFDYLVAHGRM 111
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 185
K ++ RQI+ + Y H I+HRDLK +N+ + + +KI D G +
Sbjct: 112 KEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLL-DADMNIKIADFGFSNEFTVGG 168
Query: 186 A-RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
+ G P + APEL++ ++Y+ VD++S G+ + +V+ P++ +N ++ ++V
Sbjct: 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVL 227
Query: 243 SGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRL 299
G P +S + +++ +V R +++KD ++ + +D + P
Sbjct: 228 RGKYRIPFYMS----TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL-KPFVE 282
Query: 300 PNLVP 304
P L
Sbjct: 283 PELDI 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 21/233 (9%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
+ + +E+ +L L H NIIK + T I+++ EL T G L + +
Sbjct: 93 KIVRTEIGVLLRLSHPNIIKLKEIFETPTE--ISLVLELVTGGELFDRIVEKGYYSERDA 150
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-R 187
+ +QIL + YLH + I+HRDLK +N+ + + +KI D GL+ +++ +
Sbjct: 151 ADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 188 SVIGTPEFMAPE-LYEEEYNELVDIYSFG--MCILEMVTCEYP--YNECKNPAQIYKKVT 242
+V GTP + APE L Y VD++S G IL C + Y+E + +++++
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL---LCGFEPFYDE-RGDQFMFRRIL 264
Query: 243 SGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
+ +V+ K + K IV RL + L+ P++
Sbjct: 265 NCEYYFISPWWDEVSL-NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 20/234 (8%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
MCRY + G VA ++ + + L E+ +LKSL+H+NI+K+
Sbjct: 27 EMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82
Query: 98 DTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
R + +I E GSLR Y +KHK +D + + QI +G+ YL + IHRDL
Sbjct: 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDL 140
Query: 157 KCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT--PEF-MAPE-LYEEEYNELVD 210
NI V N VKIGD GL + + + P F APE L E +++ D
Sbjct: 141 ATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASD 199
Query: 211 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
++SFG+ + E+ T Y E G ++ + + ++
Sbjct: 200 VWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDK--QGQMIVFHLIELLKN 247
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-31
Identities = 59/234 (25%), Positives = 113/234 (48%), Gaps = 18/234 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
S ++L E + + L+H NI++ ++S +++ ++ +L T G L + +
Sbjct: 68 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFY 125
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 183
+ +QIL + Y HS+ I+HR+LK +N+ + VK+ D GLAI +
Sbjct: 126 SEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 184 PTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYK 239
A GTP +++PE L ++ Y++ VDI++ G IL ++ YP ++E + ++Y
Sbjct: 184 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYA 240
Query: 240 KVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 289
++ +G VT + K I+ + R+ A + LK P++
Sbjct: 241 QIKAGAYDYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 68/234 (29%), Positives = 105/234 (44%), Gaps = 20/234 (8%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
MCRY + G VA ++ + + L E+ +LKSL+H+NI+K+
Sbjct: 58 EMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113
Query: 98 DTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
R + +I E GSLR Y +KHK +D + + QI +G+ YL + IHRDL
Sbjct: 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDL 171
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVD 210
NI V N VKIGD GL V+ Q + +P F APE L E +++ D
Sbjct: 172 ATRNILV-ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASD 230
Query: 211 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
++SFG+ + E+ T Y E G ++ + + ++
Sbjct: 231 VWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDK--QGQMIVFHLIELLKN 278
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 62/304 (20%), Positives = 106/304 (34%), Gaps = 61/304 (20%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
+ A +N + Q +P +ER+ +EV L+K L H NI + Y + D+
Sbjct: 43 RVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWA-------------------------- 134
I ++ EL G L +
Sbjct: 103 --ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRES 160
Query: 135 --------------RQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAI 179
RQI LHYLH+ I HRD+K +N F + E+K+ D GL+
Sbjct: 161 LDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSK 218
Query: 180 VMQQPTA------RSVIGTPEFMAPEL---YEEEYNELVDIYSFGMCILEMVTCEYPYNE 230
+ + GTP F+APE+ E Y D +S G +L ++
Sbjct: 219 EFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLHLLLMGAVPFP 277
Query: 231 CKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVT 286
N A +V + + + + ++ + + + R A+ L+ P++
Sbjct: 278 GVNDADTISQVLNKKLCFENPNYNVLSP-LARDLLSNLLNRNVDERFDAMRALQHPWISQ 336
Query: 287 DNPK 290
+ K
Sbjct: 337 FSDK 340
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 61/249 (24%), Positives = 116/249 (46%), Gaps = 19/249 (7%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
+ E + EV +L+ + H NII ++ + + T+ + +I EL + G L + + ++
Sbjct: 54 RRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD--VVLILELVSGGELFDFLAQKES 111
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVM 181
+ + ++ +QIL G++YLH+ I H DLK +NI + N +K+ D GLA +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 182 QQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQI 237
+ +++ GTPEF+APE + E D++S G I ++ + +
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQET 226
Query: 238 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 293
+T+ S+ ++ K FI K +V RL E L+ P++ + + +
Sbjct: 227 LANITAVSYDFDEEFFSQTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAM 285
Query: 294 CDPLRLPNL 302
+ NL
Sbjct: 286 VRRESVVNL 294
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 47/231 (20%), Positives = 100/231 (43%), Gaps = 20/231 (8%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM--K 128
+ E+ +L +H NI+ + S+ + MI E + + + R ++ +
Sbjct: 46 VLVKKEISILNIARHRNILHLHESFESMEE--LVMIFEFISGLDIFE-RINTSAFELNER 102
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA- 186
I ++ Q+ L +LHSHN I H D++ +NI + + +KI + G A ++
Sbjct: 103 EIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTS 243
R + PE+ APE + + D++S G ++ ++ E QI + + +
Sbjct: 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIMN 217
Query: 244 GI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 290
+ +++ + F+++ +V R+ A E L+ P+L +
Sbjct: 218 AEYTFDEEAFKEISI-EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 32/204 (15%)
Query: 42 YKG--FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99
YK D D + A Q+ + S E+ LL+ LKH N+I ++
Sbjct: 38 YKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRELKHPNVISLQKVFLSHA 91
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKA---------IKNWARQILRGLHYLHSHNPP 150
+R + ++ + + L K H+ +K+ QIL G+HYLH++
Sbjct: 92 DRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-- 148
Query: 151 IIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-----APELY- 201
++HRDLK NI V G G VKI D+G A + P P + APEL
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 208
Query: 202 -EEEYNELVDIYSFGMCIL-EMVT 223
Y + +DI++ G CI E++T
Sbjct: 209 GARHYTKAIDIWAIG-CIFAELLT 231
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 57/239 (23%), Positives = 112/239 (46%), Gaps = 19/239 (7%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
+ E + EV++L+ ++H NII ++ + + T+ + +I EL + G L + + ++
Sbjct: 47 RRGVSREEIEREVNILREIRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLAEKES 104
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVM 181
+ + +QIL G+HYLHS I H DLK +NI + N N +K+ D G+A +
Sbjct: 105 LTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162
Query: 182 QQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQI 237
+ +++ GTPEF+APE + E D++S G I ++ E +
Sbjct: 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGE--TKQET 219
Query: 238 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
+++ S ++ K FI + +V R+ + L+ ++ +++
Sbjct: 220 LTNISAVNYDFDEEYFSNTSE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 49/195 (25%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 56 NQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL 115
+ +Q +E++Y E+ +LK L H N++K D + M+ EL G +
Sbjct: 66 TRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV 125
Query: 116 RQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175
+ + +A + + +++G+ YLH IIHRD+K N+ V G +G +KI D
Sbjct: 126 MEVPTLKPLSEDQARF-YFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHIKIADF 181
Query: 176 GLAIVMQQPTA--RSVIGTPEFMAPEL---YEEEYN-ELVDIYSFGMCILEMVTCEYPYN 229
G++ + A + +GTP FMAPE + ++ + +D+++ G+ + V + P+
Sbjct: 182 GVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
Query: 230 ECKNPAQIYKKVTSG 244
+ + ++ K+ S
Sbjct: 242 D-ERIMCLHSKIKSQ 255
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 58/232 (25%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
E + EV +LK ++H N+I + + + T+ + +I EL G L + + +++ +
Sbjct: 59 EDIEREVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEA 116
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA- 186
+ +QIL G++YLHS I H DLK +NI + N +KI D GLA +
Sbjct: 117 TEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTS 243
+++ GTPEF+APE + E D++S G I ++ + + V++
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANVSA 231
Query: 244 GI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
+ S + K FI + +V R+ + L+ P++ + +
Sbjct: 232 VNYEFEDEYFSNTSA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 55/291 (18%), Positives = 118/291 (40%), Gaps = 21/291 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ D A + + + + P+ + E+ LL+ L+H+N+I+ + ++ +
Sbjct: 22 KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81
Query: 102 TINMITELFTSGS--LRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ M+ E G + + + +A + Q++ GL YLHS I+H+D+K
Sbjct: 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG-YFCQLIDGLEYLHSQG--IVHKDIKPG 138
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELY--EEEYN-ELVDIY 212
N+ + G +KI LG+A + A G+P F PE+ + ++ VDI+
Sbjct: 139 NLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIW 197
Query: 213 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIVP-A 269
S G+ + + T YP+ N ++++ + G P P + ++ +
Sbjct: 198 SAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSYAIPGDCG----PPLSDLLKGMLEYEP 252
Query: 270 SLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDID 320
+ R ++ + + +P P+ + P+ D+
Sbjct: 253 AKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDLH 303
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 13/192 (6%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ Y ++ G VA V P E+ +L++L HE+IIK+ D
Sbjct: 48 SLYCYDPTNDGTGEMVA---VKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
++ ++ E GSLR Y +H + + + +A+QI G+ YLH+ + IHRDL
Sbjct: 105 AGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLA 161
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDI 211
N+ + N+ VKIGD GLA + + R +P F APE L E ++ D+
Sbjct: 162 ARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDV 220
Query: 212 YSFGMCILEMVT 223
+SFG+ + E++T
Sbjct: 221 WSFGVTLYELLT 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 61/193 (31%), Positives = 100/193 (51%), Gaps = 13/193 (6%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+CRY + G +VA V + + L E+ +L++L HENI+K+ +
Sbjct: 38 ELCRYDPEGDNTGEQVA---VKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94
Query: 98 DTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
D I +I E SGSL++Y K+K +++K +A QI +G+ YL S +HRDL
Sbjct: 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDL 152
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVD 210
N+ V + +VKIGD GL ++ T + +P F APE L + ++ D
Sbjct: 153 AARNVLV-ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASD 211
Query: 211 IYSFGMCILEMVT 223
++SFG+ + E++T
Sbjct: 212 VWSFGVTLHELLT 224
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 60/249 (24%), Positives = 116/249 (46%), Gaps = 20/249 (8%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
S ++L E + + LKH NI++ ++S ++ + +I +L T G L + +
Sbjct: 50 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGH--HYLIFDLVTGGELFEDIVAREYY 107
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 183
+ +QIL + + H ++HR+LK +N+ + VK+ D GLAI ++
Sbjct: 108 SEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 184 PTA--RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIY 238
GTP +++PE L ++ Y + VD+++ G IL ++ YP ++E + ++Y
Sbjct: 166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG-VILYILLVGYPPFWDE--DQHRLY 222
Query: 239 KKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP-KDLV 293
+++ +G VT + K I K + S R+ A E LK P++ + +
Sbjct: 223 QQIKAGAYDFPSPEWDTVTP-EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCM 281
Query: 294 CDPLRLPNL 302
+ L
Sbjct: 282 HRQETVDCL 290
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 56/250 (22%), Positives = 107/250 (42%), Gaps = 20/250 (8%)
Query: 65 QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RQYRKKHK 123
E + E+ + L+H ++ ++++ DD + MI E + G L + +H
Sbjct: 193 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHN 250
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQ 182
+ + RQ+ +GL ++H +N +H DLK +NI F + E+K+ D GL +
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 183 QPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIY 238
+ + GT EF APE + D++S G + ++ E N +
Sbjct: 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETL 365
Query: 239 KKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN--PKDL 292
+ V S ++ S +++ K FI K ++ + R+ + L+ P+L N +D
Sbjct: 366 RNVKSCDWNMDDSAFSGISE-DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 424
Query: 293 VCDPLRLPNL 302
R +
Sbjct: 425 QIPSSRYTKI 434
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 40/284 (14%), Positives = 81/284 (28%), Gaps = 47/284 (16%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-------------- 87
+ D + A +V S +LERL+ L E+
Sbjct: 79 FLVRDVERLEDFAL-KVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137
Query: 88 ----------IIKFYNSWVDDTNRTINMITELFTS------GSLRQYRKKHKNVDMKAIK 131
+ D ++ + +L + + A+
Sbjct: 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALH 197
Query: 132 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 191
Q++R L S ++H DN+F+ +G + +GD+ + T
Sbjct: 198 ILTAQLIRLAANLQSKG--LVHGHFTPDNLFI-MPDGRLMLGDVSAL--WKVGTRGPASS 252
Query: 192 TPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNEC-KNPAQIYKKVTSGIK 246
P AP + + ++ + G+ I + P+ +K+ + +
Sbjct: 253 VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVP 312
Query: 247 -----PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
VK I + + RL LE ++ P
Sbjct: 313 GTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 57/263 (21%), Positives = 97/263 (36%), Gaps = 43/263 (16%)
Query: 66 SPDQLERLYSEVHLL-KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-------RQ 117
D + E+ LL +S H N+I++Y S D + + EL + +L
Sbjct: 48 LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRF--LYIALEL-CNLNLQDLVESKNV 104
Query: 118 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------G 165
+ K + RQI G+ +LHS IIHRDLK NI V+
Sbjct: 105 SDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGA 162
Query: 166 NNGEVKIGDLGLAIVMQ------QPTARSVIGTPEFMAPEL--------YEEEYNELVDI 211
N + I D GL + + + GT + APEL + +DI
Sbjct: 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222
Query: 212 YSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCIVP 268
+S G +++ ++ + I + + S + L + + I + I
Sbjct: 223 FSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH 282
Query: 269 -ASLRLPALELLKDPFLVTDNPK 290
R A+++L+ P + K
Sbjct: 283 DPLKRPTAMKVLRHPLFWPKSKK 305
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 49/162 (30%), Positives = 87/162 (53%), Gaps = 19/162 (11%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 134
E+ LLK LKH+NI++ ++ V +++ + ++ E F L++Y D + +K++
Sbjct: 51 EICLLKELKHKNIVRLHD--VLHSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 194
Q+L+GL + HS N ++HRDLK N+ +N NGE+K+ + GLA P R + E
Sbjct: 108 FQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPV-RCY--SAE 161
Query: 195 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVTCEYPY 228
+ P++ + Y+ +D++S G CI E+ P
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPL 202
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 77/314 (24%), Positives = 128/314 (40%), Gaps = 63/314 (20%)
Query: 56 NQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVDDTNRTINMITELFT 111
++V I+ V+Q E+ +++ +KH N++ FY++ +N++ E
Sbjct: 65 DEVAIKKVLQDK---RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121
Query: 112 S---GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168
+ R Y K + + M IK + Q+LR L Y+HS I HRD+K N+ ++ +G
Sbjct: 122 ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSG 179
Query: 169 EVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTC 224
+K+ D G A I++ S I + + APEL Y +DI+S G C++ E++
Sbjct: 180 VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQG 238
Query: 225 E--------------------YPYNE---CKNPAQIYKKVTSGIKPASLSKV----TDPQ 257
+ P E NP + K I+P SKV T P
Sbjct: 239 QPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPD 297
Query: 258 VKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPH 315
I + + P S RL A+E L PF D LR + +
Sbjct: 298 AIDLISRLLEYTP-SARLTAIEALCHPFF----------DELRTGE-----ARMPNGREL 341
Query: 316 PMDIDLNHKKVSAD 329
P + +++S
Sbjct: 342 PPLFNWTKEELSVR 355
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 56/263 (21%), Positives = 106/263 (40%), Gaps = 25/263 (9%)
Query: 71 ERLYSEVHLLKSL-KHENIIKFYNSWVDDTN--RTINMITELFTSGSL--RQYRKKHKNV 125
+ EV +I+ + + + + R + +I E G L R + +
Sbjct: 66 PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF 125
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 183
+ R I + +LHSHN I HRD+K +N+ + + + +K+ D G A Q
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 184 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKN--PAQIY 238
++ TP ++APE L E+Y++ D++S G I+ ++ C +P Y+ +
Sbjct: 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAISPGMK 242
Query: 239 KKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL-----VTDNP 289
+++ G S+V++ KQ I + + RL + + P++ V P
Sbjct: 243 RRIRLGQYGFPNPEWSEVSE-DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301
Query: 290 KDLVCDPLRLPNLVPEVMNLAHS 312
+ EV S
Sbjct: 302 LHTARVLQEDKDHWDEVKEEMTS 324
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 60/274 (21%), Positives = 112/274 (40%), Gaps = 35/274 (12%)
Query: 42 YKGFDEVDGIEVA--------WNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFY 92
+ + E A + E+V + + + EV +L+ + H NII+
Sbjct: 34 RRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK---EVDILRKVSGHPNIIQLK 90
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
+++ +T ++ +L G L Y + + K + R +L + LH N I+
Sbjct: 91 DTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IV 146
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-------LYEEE 204
HRDLK +NI ++ ++ +K+ D G + + R V GTP ++APE
Sbjct: 147 HRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPG 205
Query: 205 YNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQVK 259
Y + VD++S G I+ + P ++ + + + SG +D VK
Sbjct: 206 YGKEVDMWSTG-VIMYTLLAGSPPFWHR--KQMLMLRMIMSGNYQFGSPEWDDYSDT-VK 261
Query: 260 QFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
+ + +V R A E L PF +++
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 21/160 (13%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWAR 135
EV LLK L+H NII+ + V N +++I E + L++Y K+ +V M+ IK++
Sbjct: 83 EVSLLKELQHRNIIELKS--VIHHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFLY 139
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQPTARSVIG 191
Q++ G+++ HS +HRDLK N+ ++ +KIGD GLA P +
Sbjct: 140 QLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--- 194
Query: 192 TPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 223
T E + PE+ Y+ VDI+S CI EM+
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLM 233
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 24/253 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99
Y D + I+VA + + + L+R EVH L H+NI+ + +D
Sbjct: 28 YLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ M E +L +Y + H + + N+ QIL G+ + H I+HRD+K
Sbjct: 85 CYYLVM--EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQ 140
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFG 215
NI + +N +KI D G+A + + + V+GT ++ +PE + E +E DIYS G
Sbjct: 141 NILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIG 199
Query: 216 MCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP 274
+ + EM+ E P+N + I K + + P + V + Q + I+ A+ +
Sbjct: 200 IVLYEMLVGEPPFNG-ETAVSIAIKHIQDSV-PNVTTDV-RKDIPQSLSNVILRATEKDK 256
Query: 275 ------ALELLKD 281
E+ D
Sbjct: 257 ANRYKTIQEMKDD 269
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 52/157 (33%), Positives = 82/157 (52%), Gaps = 19/157 (12%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 134
E+ LLK L H NI+ + V + R + ++ E F L++ ++K IK +
Sbjct: 69 EISLLKELHHPNIVSLID--VIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYL 125
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 194
Q+LRG+ + H H I+HRDLK N+ +N ++G +K+ D GLA P T E
Sbjct: 126 YQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSY---THE 179
Query: 195 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 223
+ AP++ ++Y+ VDI+S G CI EM+T
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 59/261 (22%), Positives = 109/261 (41%), Gaps = 25/261 (9%)
Query: 69 QLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
E+ LK + H NI+K + + D + ++ EL G L + KK K+
Sbjct: 48 MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH--TFLVMELLNGGELFERIKKKKHFSE 105
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ--Q 183
R+++ + ++H ++HRDLK +N+ F + +N E+KI D G A +
Sbjct: 106 TEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 184 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP-------YNECKNPA 235
++ T + APE L + Y+E D++S G IL + C +
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAV 222
Query: 236 QIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
+I KK+ G + + V+ + K I+ + + RL L + +L +
Sbjct: 223 EIMKKIKKGDFSFEGEAWKNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
Query: 292 LVCDPLRLPNLVPEVMNLAHS 312
+PL P+++ H+
Sbjct: 282 S--NPLMTPDILGSSGAAVHT 300
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 55/241 (22%), Positives = 102/241 (42%), Gaps = 21/241 (8%)
Query: 66 SPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTNRTINMITELFTSGSL--RQYRKKH 122
D + E+ +L+ K +I + + + + I +I E G + +
Sbjct: 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE--IILILEYAAGGEIFSLCLPELA 125
Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGN-NGEVKIGDLGLAIV 180
+ V + +QIL G++YLH +N I+H DLK NI + G++KI D G++
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183
Query: 181 MQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQ 236
+ R ++GTPE++APE L + D+++ G+ I M+ E + +
Sbjct: 184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQE 240
Query: 237 IYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
Y ++ + S V+ FI+ +V R A L +L + ++L
Sbjct: 241 TYLNISQVNVDYSEETFSSVSQ-LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299
Query: 293 V 293
Sbjct: 300 F 300
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 61/258 (23%), Positives = 112/258 (43%), Gaps = 15/258 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ V VA V+++ + P+ +++ E+ + K L HEN++KFY
Sbjct: 24 QLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYG--HRREGN 78
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ E + G L + + + + Q++ G+ YLH I HRD+K +N+
Sbjct: 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 136
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPE-LYEEEYN-ELVDIYSFG 215
++ +KI D GLA V + ++ GT ++APE L E++ E VD++S G
Sbjct: 137 LLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 195
Query: 216 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+ + M+ E P+++ + Q Y + K D + K +V S R+
Sbjct: 196 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255
Query: 275 ALELLKDPFLVTDNPKDL 292
++ KD + K
Sbjct: 256 IPDIKKDRWYNKPLKKGA 273
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 54/272 (19%), Positives = 103/272 (37%), Gaps = 29/272 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSL----KHENIIKFYNSW 95
+ G D ++VA + V+ EV LL + H +I+ +
Sbjct: 48 FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD-- 105
Query: 96 VDDTNRTINMITELFTSGS-LRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 154
+T ++ E L Y + + + + Q++ + + HS ++HR
Sbjct: 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHR 163
Query: 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN-ELVDIY 212
D+K +NI ++ G K+ D G ++ GT + PE +Y+ ++
Sbjct: 164 DIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVW 223
Query: 213 SFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIVPA 269
S G+ +L +MV + P+ +++ PA +S P I +C+ P
Sbjct: 224 SLGI-LLYDMVCGDIPFER-------DQEILEAELHFPAHVS----PDCCALIRRCLAPK 271
Query: 270 -SLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
S R E+L DP++ T + P
Sbjct: 272 PSSRPSLEEILLDPWMQTPAEDVPLNPSKGGP 303
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 70/301 (23%), Positives = 118/301 (39%), Gaps = 65/301 (21%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVD 97
Y+ G VA I+ V+Q E+ +++ L H NI++ FY+S
Sbjct: 71 YQAKLCDSGELVA-----IKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122
Query: 98 DTNRTINMITELFTS---GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 154
+N++ + R Y + + + + +K + Q+ R L Y+HS I HR
Sbjct: 123 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHR 180
Query: 155 DLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELY--EEEYNELVDI 211
D+K N+ ++ + +K+ D G A +++ S I + + APEL +Y +D+
Sbjct: 181 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 240
Query: 212 YSFGMCIL-EMVTCE--------------------YPYNE---CKNPAQIYKKVT-SGIK 246
+S G C+L E++ + P E NP Y + IK
Sbjct: 241 WSAG-CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIK 297
Query: 247 PASLSKV----TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
+KV T P+ + + P + RL LE F D LR P
Sbjct: 298 AHPWTKVFRPRTPPEAIALCSRLLEYTP-TARLTPLEACAHSFF----------DELRDP 346
Query: 301 N 301
N
Sbjct: 347 N 347
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 19/157 (12%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 134
E+ +LK LKH NI+K Y+ V T + + ++ E L++ + + K++
Sbjct: 50 EISILKELKHSNIVKLYD--VIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFL 106
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 194
Q+L G+ Y H ++HRDLK N+ +N GE+KI D GLA P R T E
Sbjct: 107 LQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV-RKY--THE 160
Query: 195 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 223
+ AP++ ++Y+ +DI+S G CI EMV
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 51/274 (18%), Positives = 105/274 (38%), Gaps = 26/274 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHE--NIIKFYNSWVD 97
Y G D + VA V + + R+ EV LLK + +I+ +
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD--WF 117
Query: 98 DTNRTINMITELFT-SGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
+ + +I E L + + + + +++ Q+L + + H+ ++HRD+
Sbjct: 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDI 175
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN-ELVDIYSF 214
K +NI ++ N GE+K+ D G +++ GT + PE Y+ ++S
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 235
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIVPASLR 272
G+ + +MV + P+ +++ G +S + + I C+
Sbjct: 236 GILLYDMVCGDIPFEH-------DEEIIRGQVFFRQRVS----SECQHLIRWCLALRPSD 284
Query: 273 LPAL-ELLKDPFLVTDNPKDLVCDPLRLPNLVPE 305
P E+ P++ + L +L P
Sbjct: 285 RPTFEEIQNHPWMQDVLLPQETA-EIHLHSLSPG 317
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 62/287 (21%), Positives = 118/287 (41%), Gaps = 17/287 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ V VA V+++ + P+ +++ E+ + K L HEN++KFY
Sbjct: 24 QLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYG--HRREGN 78
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ E + G L + + + + Q++ G+ YLH I HRD+K +N+
Sbjct: 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 136
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVI----GTPEFMAPELYE-EEYN-ELVDIYSFG 215
++ +KI D GLA V + ++ GT ++APEL + E++ E VD++S G
Sbjct: 137 LLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 195
Query: 216 MCILEMVTCEYPYNECKNPAQIY-KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRL 273
+ + M+ E P+++ + Q Y K+ D + K +V S R+
Sbjct: 196 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSAPLALLHKILVENPSARI 254
Query: 274 PALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDID 320
++ KD + K + + + +D
Sbjct: 255 TIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFS 301
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 19/157 (12%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 134
EV LLK LKH NI+ ++ + T +++ ++ E + L+QY N+ +M +K +
Sbjct: 50 EVSLLKDLKHANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFL 106
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 194
Q+LRGL Y H ++HRDLK N+ +N GE+K+ D GLA PT E
Sbjct: 107 FQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY---DNE 160
Query: 195 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 223
+ P++ +Y+ +D++ G CI EM T
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ + E I VA + SP + + E +++ S+ + ++ + +
Sbjct: 32 YKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDNPHVCRLLG--IC 86
Query: 98 DTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
T+ +IT+L G L Y ++HK N+ + + NW QI +G++YL ++HRDL
Sbjct: 87 -LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDL 143
Query: 157 KCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDI 211
N+ V VKI D GLA ++ + G P ++MA E + Y D+
Sbjct: 144 AARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 202
Query: 212 YSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+S+G+ + E++T PY+ ++I + G
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 19/157 (12%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWA 134
E+ +LK LKH N++ V R ++++ E + ++ +++ V +K+
Sbjct: 52 EIRMLKQLKHPNLVNLLE--VFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSIT 108
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 194
Q L+ +++ H HN IHRD+K +NI + + +K+ D G A ++ P+ E
Sbjct: 109 WQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYY---DDE 162
Query: 195 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 223
+PEL + +Y VD+++ G C+ E+++
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIG-CVFAELLS 198
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 60/262 (22%), Positives = 114/262 (43%), Gaps = 28/262 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQL----ERLYSEVHLLKSLK-HENIIKFYNSWV 96
+ G E A + + SP+QL E E H+L+ + H +II +S+
Sbjct: 111 RRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
+ + ++ +L G L Y + + K ++ R +L + +LH++N I+HRDL
Sbjct: 171 SSSF--MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDL 226
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPE-------LYEEEYNEL 208
K +NI ++ +N ++++ D G + ++ R + GTP ++APE Y +
Sbjct: 227 KPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKE 285
Query: 209 VDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIE 263
VD+++ G IL + P ++ + + + G + VK I
Sbjct: 286 VDLWACG-VILFTLLAGSPPFWHR--RQILMLRMIMEGQYQFSSPEWDDRSST-VKDLIS 341
Query: 264 KCIVP-ASLRLPALELLKDPFL 284
+ + RL A + L+ PF
Sbjct: 342 RLLQVDPEARLTAEQALQHPFF 363
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 24/162 (14%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA------ 129
E+ L+K LKHENI++ Y+ V T + ++ E F L++Y +
Sbjct: 53 EISLMKELKHENIVRLYD--VIHTENKLTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNL 109
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
+K + Q+L+GL + H + I+HRDLK N+ +N G++K+GD GLA P
Sbjct: 110 VKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTF- 165
Query: 190 IGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 223
+ E + AP++ Y+ +DI+S G CIL EM+T
Sbjct: 166 --SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 19/223 (8%)
Query: 79 LLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQIL 138
LL+ +H NII + V D + + ++TEL G L + K + I
Sbjct: 69 LLRYGQHPNIITLKD--VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 139 RGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP 193
+ + YLH+ ++HRDLK NI +GN ++I D G A ++ + T
Sbjct: 127 KTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECK-NPAQIYKKVTSG---IK 246
F+APE L + Y+ DI+S G +L + Y N P +I ++ SG +
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS 243
Query: 247 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 288
+ V+D K + K + RL A +L+ P++V +
Sbjct: 244 GGYWNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 66/266 (24%), Positives = 106/266 (39%), Gaps = 52/266 (19%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWA 134
E+ LLK L+HEN++ V + ++ E F ++ + N +D + ++ +
Sbjct: 74 EIKLLKQLRHENLVNLLE--VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYL 130
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 194
QI+ G+ + HSHN IIHRD+K +NI V+ +G VK+ D G A + P E
Sbjct: 131 FQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY---DDE 184
Query: 195 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVTCEYPY------------------ 228
APEL + +Y + VD+++ G C++ EM E P
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSDIDQLYHIMMCLG 242
Query: 229 --NE------CKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIV--PASLRLPA 275
KNP ++ + L + V +KC+ P R
Sbjct: 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK-RPFC 301
Query: 276 LELLKDPFLVTDNPKDLVCDPLRLPN 301
ELL F D + L+L
Sbjct: 302 AELLHHDFFQMDGFAERFSQELQLKV 327
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 19/157 (12%)
Query: 76 EVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV-DMKAIKNWA 134
E+ LL+ L H NII +++ +N I+++ + F L K + V IK +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSN--ISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYM 118
Query: 135 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 194
L+GL YLH H I+HRDLK +N+ ++ NG +K+ D GLA P R+ T +
Sbjct: 119 LMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPN-RAY--THQ 172
Query: 195 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 223
+ APEL Y VD+++ G CIL E++
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVG-CILAELLL 208
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 50/235 (21%), Positives = 101/235 (42%), Gaps = 21/235 (8%)
Query: 71 ERLYSEVHLLKSL-KHENIIKFYNSWVD--DTNRTINMITELFTSGSL--RQYRKKHKNV 125
+ EV L + +I++ + + + + + ++ E G L R + +
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ- 182
+ + I + YLHS N I HRD+K +N+ + + N +K+ D G A
Sbjct: 159 TEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 183 QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQ--I 237
+ + TP ++APE L E+Y++ D++S G I+ ++ C YP Y+ +
Sbjct: 217 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGM 275
Query: 238 YKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 288
++ G S+V++ +VK I + + R+ E + P+++
Sbjct: 276 KTRIRMGQYEFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 58/276 (21%), Positives = 112/276 (40%), Gaps = 28/276 (10%)
Query: 42 YKGFDEVDGIEVAWNQVN----IEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ D+ EV + +ED +L ++ E+ +L ++H NIIK + +
Sbjct: 41 WTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD--IF 98
Query: 98 DTNRTINMITELFTSGS-LRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
+ ++ E SG L + +H +D RQ++ + YL + IIHRD+
Sbjct: 99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDI 156
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYE-EEYN-ELVDIYS 213
K +NI + + +K+ D G A +++ + GT E+ APE+ Y ++++S
Sbjct: 157 KDENIVIAE-DFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWS 215
Query: 214 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIVP-AS 270
G+ L + E NP ++ P +S ++ + + P
Sbjct: 216 LGV-TLYTLVFEE------NPFCELEETVEAAIHPPYLVS----KELMSLVSGLLQPVPE 264
Query: 271 LRLPALELLKDPFLVTD-NPKDLVCDPLRLPNLVPE 305
R +L+ DP++ N D + + N
Sbjct: 265 RRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPES 300
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 18/236 (7%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
++S D + ++ E+ LK +H +IIK Y V T M+ E + G L Y KH
Sbjct: 49 IRSLDVVGKIKREIQNLKLFRHPHIIKLYQ--VISTPTDFFMVMEYVSGGELFDYICKHG 106
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
V+ + +QIL + Y H H ++HRDLK +N+ ++ + KI D GL+ +M
Sbjct: 107 RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSD 163
Query: 184 PTA-RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYK 239
R+ G+P + APE+ Y VDI+S G+ IL + C P+++ ++ ++K
Sbjct: 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGV-ILYALLCGTLPFDD-EHVPTLFK 221
Query: 240 KVTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 292
K+ G+ P L+ V + + R ++ + + D P L
Sbjct: 222 KIRGGVFYIPEYLN----RSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 53/210 (25%), Positives = 80/210 (38%), Gaps = 16/210 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ G D VA E + PD + E +LK H NI++ V +
Sbjct: 131 FSGRLRADNTLVAVKSCR-ETLP--PDLKAKFLQEARILKQYSHPNIVRLIG--VCTQKQ 185
Query: 102 TINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
I ++ EL G + R + + +K + G+ YL S IHRDL N
Sbjct: 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARN 243
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFG 215
V N +KI D G++ + G + APE L Y+ D++SFG
Sbjct: 244 CLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFG 302
Query: 216 MCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ + E + PY N Q + V G
Sbjct: 303 ILLWETFSLGASPYPNLSN-QQTREFVEKG 331
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 62/268 (23%), Positives = 115/268 (42%), Gaps = 31/268 (11%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAI 130
E + E+ +SL+H NI++F V T + +I E + G L +
Sbjct: 61 ENVQREIINHRSLRHPNIVRFKE--VILTPTHLAIIMEYASGGELYERICNAGRFSEDEA 118
Query: 131 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTA-RS 188
+ + +Q+L G+ Y HS I HRDLK +N ++G+ +KI D G + + +S
Sbjct: 119 RFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176
Query: 189 VIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
+GTP ++APE+ +EY+ ++ D++S G+ + M+ YP+ E + Y+K I
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRIL 235
Query: 247 PAS--------LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL 297
+S P+ I + V + R+ E+ + + + P DL+ +
Sbjct: 236 SVKYSIPDDIRIS----PECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESN 291
Query: 298 RLPNL---------VPEVMNLAHSEPHP 316
+ +M + P
Sbjct: 292 TGSQFQEPEQPMQSLDTIMQIISEATIP 319
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 78/298 (26%), Positives = 136/298 (45%), Gaps = 22/298 (7%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
++ D R+ E+ LK L+H +IIK Y+ V T I M+ E + G L Y + K
Sbjct: 47 LKKSDMHMRVEREISYLKLLRHPHIIKLYD--VITTPTDIVMVIE-YAGGELFDYIVEKK 103
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+ + + +QI+ + Y H H I+HRDLK +N+ ++ +N VKI D GL+ +M
Sbjct: 104 RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTD 160
Query: 184 PT-ARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
++ G+P + APE+ + Y VD++S G+ + M+ P+++ + ++KK
Sbjct: 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKK 219
Query: 241 VTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL 297
V S + P LS P + I + IV R+ E+ +DP+ + P L
Sbjct: 220 VNSCVYVMPDFLS----PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEE 275
Query: 298 RLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSN--TGTWFLTLELQRLTENNE 353
+ + E D + + +D ++N + L E Q + E E
Sbjct: 276 VQGSYADSRIVSKLGEAMGFSEDYIVEALRSD---ENNEVKEAYNLLHENQVIQEKLE 330
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 56/266 (21%), Positives = 107/266 (40%), Gaps = 43/266 (16%)
Query: 71 ERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA 129
R++ EV +L + H N+++ + ++ ++ E GS+ + K ++ +
Sbjct: 55 SRVFREVEMLYQCQGHRNVLELIEFFEEEDR--FYLVFEKMRGGSILSHIHKRRHFNELE 112
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ----- 182
+ + L +LH+ I HRDLK +NI + VKI D L ++
Sbjct: 113 ASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 183 ----QPTARSVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNE 230
P + G+ E+MAPE Y++ D++S G IL ++ YP
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYILLSGYPPFVGR 229
Query: 231 CK-------------NPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRL 273
C +++ + G + ++ K I K +V A RL
Sbjct: 230 CGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC-AAKDLISKLLVRDAKQRL 288
Query: 274 PALELLKDPFLVTDNPKDLVCDPLRL 299
A ++L+ P++ P++ + P+ L
Sbjct: 289 SAAQVLQHPWVQGCAPENTLPTPMVL 314
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 43/168 (25%), Positives = 86/168 (51%), Gaps = 15/168 (8%)
Query: 67 PDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV 125
P + +++ E+ +L++L+ NII + D +RT ++ E + +Q + +
Sbjct: 71 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY 130
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQ 182
D I+ + +IL+ L Y HS I+HRD+K N+ ++ + ++++ D GLA Q
Sbjct: 131 D---IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
Query: 183 QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCEYP 227
+ R + + F PE + + Y+ +D++S G C+L M+ + P
Sbjct: 186 EYNVR--VASRYFKGPELLVDYQMYDYSLDMWSLG-CMLASMIFRKEP 230
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 19/194 (9%)
Query: 42 YKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
Y D V+G V + + +E L + H +I++ +N +V+ T+
Sbjct: 97 YLALDRNVNGRPVV---LKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN-FVEHTD 152
Query: 101 RTINMIT----ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
R + + E SL++ + + V +AI + +IL L YLHS +++ DL
Sbjct: 153 RHGDPVGYIVMEYVGGQSLKRSKGQKLPVA-EAI-AYLLEILPALSYLHSIG--LVYNDL 208
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 216
K +NI + ++K+ DLG + + GTP F APE+ DIY+ G
Sbjct: 209 KPENIMLTE--EQLKLIDLGAVSRINSFGY--LYGTPGFQAPEIVRTGPTVATDIYTVG- 263
Query: 217 CIL-EMVTCEYPYN 229
L + N
Sbjct: 264 RTLAALTLDLPTRN 277
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 51/228 (22%), Positives = 116/228 (50%), Gaps = 20/228 (8%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
+++ ++ E+ +++ L+H ++ + S+ D+ + + M+ +L G LR + +++ +
Sbjct: 57 NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED--MFMVVDLLLGGDLRYHLQQNVHFKE 114
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-A 186
+ +K + +++ L YL + IIHRD+K DNI ++ +G V I D +A ++ + T
Sbjct: 115 ETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQI 171
Query: 187 RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKK 240
++ GT +MAPE++ Y+ VD +S G+ E++ PY + +I
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
Query: 241 VTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD-PFL 284
+ + P++ S ++ ++K + P R L +++ P++
Sbjct: 232 FETTVVTYPSAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 24/163 (14%)
Query: 76 EVHLLKSLK---HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DM 127
EV +L+ L+ H N+++ ++ D + ++ E L Y K
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPT 119
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
+ IK+ Q+LRGL +LHSH ++HRDLK NI V ++G++K+ D GLA + A
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL 176
Query: 188 SVIGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 223
T + APE L + Y VD++S G CI EM
Sbjct: 177 ----TSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 15/189 (7%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
DV+ P+ ++ EV+ + SL H N+I+ Y V + M+TEL GSL +
Sbjct: 56 PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG--V-VLTPPMKMVTELAPLGSLLDRLR 112
Query: 121 KHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA- 178
KH+ + + + +A Q+ G+ YL S IHRDL N+ + + VKIGD GL
Sbjct: 113 KHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMR 169
Query: 179 -IVMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECK 232
+ P + APE L ++ D + FG+ + EM T + P+
Sbjct: 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229
Query: 233 NPAQIYKKV 241
+QI K+
Sbjct: 230 G-SQILHKI 237
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 56/163 (34%), Positives = 80/163 (49%), Gaps = 24/163 (14%)
Query: 76 EVHLLKSLK---HENIIKFYN---SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKA 129
EV LL+ L+ H N+++ + + D + ++ E LR Y K + A
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPA 119
Query: 130 --IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
IK+ RQ LRGL +LH++ I+HRDLK +NI V + G VK+ D GLA + A
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL 176
Query: 188 SVIGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 223
TP + APE L + Y VD++S G CI EM
Sbjct: 177 ----TPVVVTLWYRAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 49/186 (26%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 124
SP + + E +++ S+ + ++ + T+ +IT+L G L Y ++HK N
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDN 113
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 182
+ + + NW QI +G++YL ++HRDL N+ V VKI D GLA + +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAE 170
Query: 183 QPTARSVIG-TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 238
+ + G P ++MA E + Y D++S+G+ + E++T PY+ ++I
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEIS 229
Query: 239 KKVTSG 244
+ G
Sbjct: 230 SILEKG 235
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 37/196 (18%), Positives = 77/196 (39%), Gaps = 30/196 (15%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 124
+ E + ++ L H++++ Y V ++ E GSL Y KK+KN
Sbjct: 52 HRNYSESFFEAASMMSKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNC 109
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-------GNNGEVKIGDLGL 177
+++ A+Q+ +H+L + +IH ++ NI + GN +K+ D G+
Sbjct: 110 INILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
Query: 178 AIVMQQPTARSVIGTPEF------MAPE--LYEEEYNELVDIYSFGMCILEMVTC-EYPY 228
+ +V+ + PE + N D +SFG + E+ + + P
Sbjct: 168 --------SITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
Query: 229 NECKNPAQIYKKVTSG 244
+ + + +
Sbjct: 220 SALDS-QRKLQFYEDR 234
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 66/239 (27%), Positives = 115/239 (48%), Gaps = 16/239 (6%)
Query: 64 MQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK 123
++S D + ++ E+ LK +H +IIK Y V T I M+ E + G L Y K+
Sbjct: 54 IRSLDVVGKIRREIQNLKLFRHPHIIKLYQ--VISTPSDIFMVMEYVSGGELFDYICKNG 111
Query: 124 NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183
+D K + +QIL G+ Y H H ++HRDLK +N+ ++ + KI D GL+ +M
Sbjct: 112 RLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSD 168
Query: 184 -PTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
R+ G+P + APE+ Y VDI+S G+ + ++ P+++ + ++KK
Sbjct: 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKK 227
Query: 241 VTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDP 296
+ GI P L+ P V ++ + R ++ + + D PK L +
Sbjct: 228 ICDGIFYTPQYLN----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPED 282
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 76 EVHLLKSLKHENIIKFY------NSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMK 128
E+ +L+ LKHEN++ S + +I ++ + F L +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTLS 124
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
IK + +L GL+Y+H + I+HRD+K N+ + +G +K+ D GLA
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQ 181
Query: 189 VIG-TPE-----FMAPELY--EEEYNELVDIYSFGMCIL-EMVT 223
T + PEL E +Y +D++ G CI+ EM T
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWT 224
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
+++ + E ++ L H +K Y ++ DD + +G L +Y +K + D
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDE 129
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQ 183
+ + +I+ L YLH IIHRDLK +NI +N + ++I D G A +Q
Sbjct: 130 TCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQ 186
Query: 184 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242
A S +GT ++++PE L E+ + D+++ G I ++V P+ N I++K+
Sbjct: 187 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKII 245
Query: 243 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRL 273
+ P+ + +EK +V A+ RL
Sbjct: 246 KL--EYDFPEKFFPKARDLVEKLLVLDATKRL 275
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 40/191 (20%), Positives = 86/191 (45%), Gaps = 15/191 (7%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
+ P + L +E ++++ L + I++ + + ++ E+ G L +Y +
Sbjct: 54 NEAN-DPALKDELLAEANVMQQLDNPYIVRMIG--IC-EAESWMLVMEMAELGPLNKYLQ 109
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-- 178
++++V K I Q+ G+ YL N +HRDL N+ + KI D GL+
Sbjct: 110 QNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL-VTQHYAKISDFGLSKA 166
Query: 179 IVMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKN 233
+ + ++ P ++ APE + +++ D++SFG+ + E + + PY K
Sbjct: 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226
Query: 234 PAQIYKKVTSG 244
++ + G
Sbjct: 227 S-EVTAMLEKG 236
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 44/214 (20%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ E I V + + + + + + + SL H +I++
Sbjct: 30 HKGVWIPEGESIKIPVC---IKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-- 84
Query: 98 DTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
++ ++T+ GSL + ++H+ + + + NW QI +G++YL H ++HR+L
Sbjct: 85 -PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNL 141
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTP-EFMAPE-LYEEEYNELVDI 211
N+ + + +V++ D G+A ++ S TP ++MA E ++ +Y D+
Sbjct: 142 AARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDV 200
Query: 212 YSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+S+G+ + E++T PY + A++ + G
Sbjct: 201 WSYGVTVWELMTFGAEPYAGLRL-AEVPDLLEKG 233
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 59/259 (22%), Positives = 102/259 (39%), Gaps = 31/259 (11%)
Query: 42 YKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99
+ D D +VA V + D+ + P R E +L H I+ Y++ +T
Sbjct: 29 HLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85
Query: 100 NRT----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
I M E +LR + K + L++ H + IIHRD
Sbjct: 86 PAGPLPYIVM--EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRD 141
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----SVIGTPEFMAPELYE-EEYNELV 209
+K NI + VK+ D G+A + +VIGT ++++PE + +
Sbjct: 142 VKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS 200
Query: 210 DIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP 268
D+YS G + E++T E P+ +P + Y+ V P S + ++ ++
Sbjct: 201 DVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPS---ARHEGLSADLDAVVLK 256
Query: 269 ASLRLP------ALELLKD 281
A + P A E+ D
Sbjct: 257 ALAKNPENRYQTAAEMRAD 275
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 53/262 (20%), Positives = 103/262 (39%), Gaps = 49/262 (18%)
Query: 51 IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN---SWVDDTNRTINMIT 107
+ + +++ +R+ E+ LL H NI+ + + + + ++T
Sbjct: 54 VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVT 113
Query: 108 ELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166
EL + L Q + + + I+ + IL GLH LH ++HRDL NI + N
Sbjct: 114 ELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN 170
Query: 167 NGEVKIGDLGLAIVMQQPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSF 214
N ++ I D L AR APE + + + +LVD++S
Sbjct: 171 N-DITICDFNL--------ARE-DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSA 220
Query: 215 GMCIL-EMVTCE--YPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCI-- 266
G C++ EM + + + N Q+ K+ + K + + P + ++ +
Sbjct: 221 G-CVMAEMFNRKALFRGSTFYN--QL-NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSN 276
Query: 267 ---VPASLRLP-----ALELLK 280
+ +P AL+L+
Sbjct: 277 VPARAWTAVVPTADPVALDLIA 298
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 55/204 (26%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
Q+E +E +L+++ ++K S+ D++N + M+ E G + + ++
Sbjct: 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
+ +A QI+ YLHS + +I+RDLK +N+ ++ G +++ D G A ++ T
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-W 196
Query: 188 SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-I 245
++ GTPE +APE + + YN+ VD ++ G+ I EM P+ P QIY+K+ SG +
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKV 255
Query: 246 K-PASLSKVTDPQVKQFIEKCIVP 268
+ P+ S +K + +
Sbjct: 256 RFPSHFS----SDLKDLLRNLLQV 275
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 67/312 (21%), Positives = 108/312 (34%), Gaps = 78/312 (25%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVD 97
G ++ G+ VA I+ V+Q P R + L L H NI++ FY
Sbjct: 40 QLGKEKSTGMSVA-----IKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94
Query: 98 DTNRT-INMITELFTS---GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIH 153
D +N++ E R Y ++ IK + Q++R + LH + + H
Sbjct: 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCH 154
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----------APELY-- 201
RD+K N+ VN +G +K+ D G A+ + + E APEL
Sbjct: 155 RDIKPHNVLVNEADGTLKLCDFGS--------AKKLSPS-EPNVAYICSRYYRAPELIFG 205
Query: 202 EEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKN------------PAQIYKKVTSG-- 244
+ Y VDI+S G CI EM+ E + + ++ +K+
Sbjct: 206 NQHYTTAVDIWSVG-CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHT 264
Query: 245 ------IKPASLSKV-------TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNP 289
K S V + + + P R+ E L P+
Sbjct: 265 DVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP-EERMKPYEALCHPYF----- 318
Query: 290 KDLVCDPLRLPN 301
D L P
Sbjct: 319 -----DELHDPA 325
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-24
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ +K + VA + ED M+ +E E ++K +KH N+++ V
Sbjct: 237 YEGVWKK----YSLTVAV-KTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLG--VC 285
Query: 98 DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
+ITE T G+L Y ++ + V + A QI + YL N IHR+
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRN 343
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP-EFMAPE-LYEEEYNELVDI 211
L N V G N VK+ D GL+ +M TA + P ++ APE L +++ D+
Sbjct: 344 LAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 212 YSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
++FG+ + E+ T PY +Q+Y+ +
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 435
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 42/177 (23%), Positives = 77/177 (43%), Gaps = 14/177 (7%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNW 133
E ++ L H +++ Y V I ++TE G L Y + + + +
Sbjct: 52 EEAEVMMKLSHPKLVQLYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM 109
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
+ G+ YL +IHRDL N V G N +K+ D G+ + S GT
Sbjct: 110 CLDVCEGMAYLEEAC--VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGT- 165
Query: 194 EF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+F +PE Y+ D++SFG+ + E+ + + PY N +++ + +++G
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKA 129
+ + E + L H ++KFY V I ++TE ++G L Y R K ++
Sbjct: 48 DEFFQEAQTMMKLSHPKLVKFYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ 105
Query: 130 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 189
+ + G+ +L SH IHRDL N V+ + VK+ D G+ + S
Sbjct: 106 LLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVSS 162
Query: 190 IGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTS 243
+GT +F APE + +Y+ D+++FG+ + E+ + + PY+ N +++ KV+
Sbjct: 163 VGT-KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQ 220
Query: 244 G 244
G
Sbjct: 221 G 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 62/299 (20%), Positives = 112/299 (37%), Gaps = 75/299 (25%)
Query: 43 KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN--------- 93
D VA ++ + D + E+ +++ L H+NI+K +
Sbjct: 29 SAVDNDCDKRVAIKKIVLTDPQSV----KHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84
Query: 94 ---SWVDDTNRTINMITEL--------FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142
++ ++ E G L ++H + + Q+LRGL
Sbjct: 85 TDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL---EEH-------ARLFMYQLLRGLK 134
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FMA 197
Y+HS N ++HRDLK N+F+N + +KIGD GLA +M + + + +
Sbjct: 135 YIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192
Query: 198 PE--LYEEEYNELVDIYSFGMCIL-EMVT------------------------CEYPYNE 230
P L Y + +D+++ G CI EM+T E E
Sbjct: 193 PRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQE 251
Query: 231 CKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIV--PASLRLPALELLKDPFL 284
+ +Y + L+++ + F+E+ + P RL A E L P++
Sbjct: 252 LLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD-RLTAEEALSHPYM 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 68/369 (18%), Positives = 130/369 (35%), Gaps = 107/369 (28%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVD 97
+ FD G A ++ V+Q P E+ ++K L H NIIK FY + +
Sbjct: 24 CEVFDIESGKRFA-----LKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75
Query: 98 DTNRT--------------------------------INMITELFTS---GSLRQYRKKH 122
+ +N+I E L+ + +
Sbjct: 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSG 135
Query: 123 KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182
+++ M I + Q+ R + ++HS I HRD+K N+ VN + +K+ D G
Sbjct: 136 RSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGS----- 188
Query: 183 QPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL-EMVTCE--YP 227
A+ +I + E APEL EY +D++S G C+ E++ + +
Sbjct: 189 ---AKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVFGELILGKPLFS 243
Query: 228 YNECKN------------PAQIYKKVTSG--------IKPASLSKV----TDPQVKQFIE 263
+ + ++ +K K+ T +E
Sbjct: 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303
Query: 264 KCIV--PASLRLPALELLKDPFLVT-DNPKDL-VCDPLRLPNL----VPEVMNLAHSEPH 315
+ + P LR+ E + PF N + V + P+ +P++ N + E
Sbjct: 304 QILRYEP-DLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELS 362
Query: 316 PMDIDLNHK 324
+ ++ ++
Sbjct: 363 IIPGNVLNR 371
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 51/185 (27%), Positives = 90/185 (48%), Gaps = 13/185 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 124
S E+ E ++ H +I+K V T + +I EL T G LR + + K +
Sbjct: 56 SDSVREKFLQEALTMRQFDHPHIVKLIG--V-ITENPVWIIMELCTLGELRSFLQVRKYS 112
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
+D+ ++ +A Q+ L YL S +HRD+ N+ V+ N+ VK+GD GL+ M+
Sbjct: 113 LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDS 169
Query: 185 TARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 239
T P ++MAPE + + D++ FG+C+ E++ P+ KN +
Sbjct: 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIG 228
Query: 240 KVTSG 244
++ +G
Sbjct: 229 RIENG 233
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 58/199 (29%), Positives = 83/199 (41%), Gaps = 27/199 (13%)
Query: 43 KGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102
+ G VA ++ P R E+ +LK KHENII +N D+
Sbjct: 29 SATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85
Query: 103 IN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
N +I EL + L + D I+ + Q LR + LH N +IHRDLK
Sbjct: 86 FNEVYIIQELMQT-DLHRVISTQMLSDDH-IQYFIYQTLRAVKVLHGSN--VIHRDLKPS 141
Query: 160 NIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFM----------APE--LYEEEY 205
N+ +N N ++K+ D GLA I G M APE L +Y
Sbjct: 142 NLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY 200
Query: 206 NELVDIYSFGMCIL-EMVT 223
+ +D++S G CIL E+
Sbjct: 201 SRAMDVWSCG-CILAELFL 218
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 58/189 (30%), Positives = 90/189 (47%), Gaps = 17/189 (8%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN----SWVD 97
D+ G +VA + + QS +R Y E+ LLK ++HEN+I + +
Sbjct: 41 CSAIDKRSGEKVAIKK--LSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
++ + L++ + I+ Q+L+GL Y+HS ++HRDLK
Sbjct: 99 RNFYDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLK 153
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFG 215
N+ VN + E+KI D GLA V+ T + APE L YN+ VDI+S G
Sbjct: 154 PGNLAVNE-DCELKILDFGLARHADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVG 211
Query: 216 MCIL-EMVT 223
CI+ EM+T
Sbjct: 212 -CIMAEMLT 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 45/185 (24%), Positives = 88/185 (47%), Gaps = 13/185 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 124
+ D E+ SE ++K+L H +I+K + +I EL+ G L Y + +
Sbjct: 53 TLDNKEKFMSEAVIMKNLDHPHIVKLIG--II-EEEPTWIIMELYPYGELGHYLERNKNS 109
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
+ + + ++ QI + + YL S N +HRD+ NI V + VK+GD GL+ ++
Sbjct: 110 LKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDE 166
Query: 185 TARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 239
T P ++M+PE + + D++ F +C+ E+++ + P+ +N +
Sbjct: 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIG 225
Query: 240 KVTSG 244
+ G
Sbjct: 226 VLEKG 230
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 75 SEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNW 133
E ++ +L HE +++ Y V R I +ITE +G L Y R+ + +
Sbjct: 68 EEAKVMMNLSHEKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM 125
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 193
+ + + YL S +HRDL N VN VK+ D GL+ + S +G+
Sbjct: 126 CKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGS- 181
Query: 194 EF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+F PE L +++ DI++FG+ + E+ + + PY N ++ + + G
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQG 237
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMK 128
E E ++K L+HE +++ Y + I ++TE + GSL + K K + +
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP 280
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 186
+ + A QI G+ Y+ N +HRDL+ NI V N K+ D GLA +++ TA
Sbjct: 281 QLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTA 337
Query: 187 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTS 243
R P ++ APE + D++SFG+ + E+ T PY N ++ +V
Sbjct: 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVER 396
Query: 244 G 244
G
Sbjct: 397 G 397
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 20/193 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+D ++ + VA +++ + +R E+ +L +HENII + T
Sbjct: 44 CSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100
Query: 102 TIN---MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
+ ++ +L + L + K + I + QILRGL Y+HS N ++HRDLK
Sbjct: 101 QMKDVYIVQDLMET-DLYKLLKTQHLSNDH-ICYFLYQILRGLKYIHSAN--VLHRDLKP 156
Query: 159 DNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FMAPE--LYEEEYNELVDI 211
N+ +N ++KI D GLA V + T + APE L + Y + +DI
Sbjct: 157 SNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 212 YSFGMCIL-EMVT 223
+S G CIL EM++
Sbjct: 216 WSVG-CILAEMLS 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 3e-23
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMK 128
E E ++K L+HE +++ Y + I ++TE + GSL + K K + +
Sbjct: 307 EAFLQEAQVMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP 363
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 186
+ + A QI G+ Y+ N +HRDL+ NI V N K+ D GLA +++ TA
Sbjct: 364 QLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTA 420
Query: 187 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTS 243
R P ++ APE + D++SFG+ + E+ T PY N ++ +V
Sbjct: 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVER 479
Query: 244 G 244
G
Sbjct: 480 G 480
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 50/221 (22%), Positives = 88/221 (39%), Gaps = 42/221 (19%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN---SWVDD 98
+ +D+++ VA + I V + +R+ E+ +L L H++++K + +
Sbjct: 70 CEAYDKLEKRVVAIKK--ILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127
Query: 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
+ ++ E+ S ++ + + IK +L G+ Y+HS I+HRDLK
Sbjct: 128 KFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKP 184
Query: 159 DNIFVNGNNGEVKIGDLGLA-------------------IVMQQPTARSVIGTPEFM--- 196
N VN + VK+ D GLA M T +
Sbjct: 185 ANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243
Query: 197 -------APE--LYEEEYNELVDIYSFGMCIL-EMVTCEYP 227
APE L +E Y E +D++S G CI E++
Sbjct: 244 VVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKE 283
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-23
Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 13/185 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 124
S E+ E ++ H +I+K T + +I EL T G LR + + K
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFS 487
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
+D+ ++ +A Q+ L YL S +HRD+ N+ V+ N+ VK+GD GL+ M+
Sbjct: 488 LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDS 544
Query: 185 TARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 239
T P ++MAPE + + D++ FG+C+ E++ P+ KN +
Sbjct: 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIG 603
Query: 240 KVTSG 244
++ +G
Sbjct: 604 RIENG 608
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-23
Identities = 66/204 (32%), Positives = 95/204 (46%), Gaps = 36/204 (17%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN--- 93
+ FD G+ VA + QS +R Y E+ LLK +KHEN+I +
Sbjct: 41 AYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98
Query: 94 -SWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
+ + + ++T L + L K + + ++ QILRGL Y+HS + II
Sbjct: 99 PARSLEEFNDVYLVTHLMGA-DLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSAD--II 154
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----------APE--L 200
HRDLK N+ VN + E+KI D GL AR T + M APE L
Sbjct: 155 HRDLKPSNLAVNEDC-ELKILDFGL--------ARH---TADEMTGYVATRWYRAPEIML 202
Query: 201 YEEEYNELVDIYSFGMCIL-EMVT 223
YN+ VDI+S G CI+ E++T
Sbjct: 203 NWMHYNQTVDIWSVG-CIMAELLT 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-23
Identities = 46/194 (23%), Positives = 82/194 (42%), Gaps = 35/194 (18%)
Query: 60 IEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN---MITELFTSGSLR 116
+ + + +R+ E+ +L LK + II+ Y+ + D + ++ E+ S L+
Sbjct: 59 VNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLK 117
Query: 117 QYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176
+ K + + IK +L G +++H IIHRDLK N +N + VK+ D G
Sbjct: 118 KLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVCDFG 174
Query: 177 LA--------------IVMQQPTARSVIGTPEFM----------APE--LYEEEYNELVD 210
LA + + + + APE L +E Y + +D
Sbjct: 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID 234
Query: 211 IYSFGMCIL-EMVT 223
I+S G CI E++
Sbjct: 235 IWSTG-CIFAELLN 247
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 36/187 (19%), Positives = 79/187 (42%), Gaps = 15/187 (8%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 124
E + E ++ L + I++ V + ++ E+ G L ++ K +
Sbjct: 50 EKADTEEMMREAQIMHQLDNPYIVRLIG--VC-QAEALMLVMEMAGGGPLHKFLVGKREE 106
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 182
+ + + Q+ G+ YL N +HRDL N+ + + KI D GL+ +
Sbjct: 107 IPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRH-YAKISDFGLSKALGAD 163
Query: 183 QPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
+ P ++ APE + +++ D++S+G+ + E ++ + PY + K ++
Sbjct: 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEV 222
Query: 238 YKKVTSG 244
+ G
Sbjct: 223 MAFIEQG 229
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 43/188 (22%), Positives = 78/188 (41%), Gaps = 14/188 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 124
++ + +E ++K H N++ + + ++ G LR + R + N
Sbjct: 66 DIGEVSQFLTEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHN 124
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
+K + + Q+ +G+ YL S +HRDL N ++ VK+ D GLA M
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK 181
Query: 185 TARSVIGTPEF------MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 236
SV MA E L +++ D++SFG+ + E++T PY +
Sbjct: 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FD 240
Query: 237 IYKKVTSG 244
I + G
Sbjct: 241 ITVYLLQG 248
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 42/188 (22%), Positives = 77/188 (40%), Gaps = 14/188 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 124
Q+E E L++ L H N++ + +++ G L Q+ R +N
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQRN 120
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 182
+K + ++ Q+ RG+ YL +HRDL N ++ + VK+ D GLA I+ +
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESF-TVKVADFGLARDILDR 177
Query: 183 QPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQ 236
+ + A E L + D++SFG+ + E++T PY
Sbjct: 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FD 236
Query: 237 IYKKVTSG 244
+ + G
Sbjct: 237 LTHFLAQG 244
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+G + + VA + ED M+ E E ++K +KH N+++ V
Sbjct: 30 YEGVWKKYSLTVAVKTLK-EDTMEV----EEFLKEAAVMKEIKHPNLVQLLG--VCTREP 82
Query: 102 TINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ITE T G+L Y ++ + V + A QI + YL N IHRDL
Sbjct: 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAAR 140
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSF 214
N V N+ VK+ D GL+ +M T + G +F APE L +++ D+++F
Sbjct: 141 NCLVGENH-LVKVADFGLSRLMTGDTYTAHAGA-KFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 215 GMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
G+ + E+ T PY +Q+Y+ +
Sbjct: 199 GVLLWEIATYGMSPYPGIDL-SQVYELLEKD 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 61/189 (32%), Positives = 91/189 (48%), Gaps = 16/189 (8%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
D G +VA + + QS +R Y E+ LLK ++HEN+I + + D
Sbjct: 42 CSAVDGRTGAKVAIKK--LYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99
Query: 102 T----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
++ + L + KH+ + I+ Q+L+GL Y+H+ IIHRDLK
Sbjct: 100 DDFTDFYLVMPFMGT-DLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLK 155
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFG 215
N+ VN + E+KI D GLA V+ T + APE L Y + VDI+S G
Sbjct: 156 PGNLAVNE-DCELKILDFGLARQADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVG 213
Query: 216 MCIL-EMVT 223
CI+ EM+T
Sbjct: 214 -CIMAEMIT 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 50/248 (20%), Positives = 87/248 (35%), Gaps = 28/248 (11%)
Query: 42 YKGFDEVDGIEVAWNQVNI--EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99
Y+ D V VA + + E + P R+ E L+ +++ ++ D
Sbjct: 51 YEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
++M L L ++ + RQI L H+ HRD+K +
Sbjct: 108 QLYVDM--RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPE 163
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFG 215
NI V + + D G+A + +GT +MAPE + DIY+
Sbjct: 164 NILV-SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALT 222
Query: 216 MCIL-EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP 274
C+L E +T PY + + + + I S P + + I
Sbjct: 223 -CVLYECLTGSPPY-QGDQLSVMGAHINQAIPRPS---TVRPGIPVAFDAVIARG----- 272
Query: 275 ALELLKDP 282
+ K+P
Sbjct: 273 ---MAKNP 277
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+D + VA + + Q+ +R Y E+ L+K + H+NII N + +
Sbjct: 42 CAAYDAILERNVAIKK--LSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99
Query: 102 T----INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+ ++ EL + +L Q + +D + + Q+L G+ +LHS IIHRDLK
Sbjct: 100 EEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK 154
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDI 211
NI V ++ +KI D GLA + S + TP + APE + Y E VDI
Sbjct: 155 PSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 212 YSFGMCIL-EMVT 223
+S G CI+ EM+
Sbjct: 210 WSVG-CIMGEMIK 221
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 4e-22
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 68 DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDM 127
Q+E E +L + H II+ + ++ D I MI + G L +K +
Sbjct: 48 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPN 105
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 187
K +A ++ L YLHS + II+RDLK +NI ++ NG +KI D G A + T
Sbjct: 106 PVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVT-Y 161
Query: 188 SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246
++ GTP+++APE + + YN+ +D +SFG+ I EM+ P+ N + Y+K+ +
Sbjct: 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNA-- 218
Query: 247 PASLSKVTDPQVKQFIEKCIVP 268
+ VK + + I
Sbjct: 219 ELRFPPFFNEDVKDLLSRLITR 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 41 RYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
K + VA + +++ L E ++ H NII+ V
Sbjct: 64 MLKTSSGKKEVPVAIKTLK-AGYT-EKQRVDFL-GEAGIMGQFSHHNIIRLEG--VISKY 118
Query: 101 RTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ + +ITE +G+L ++ ++ + + R I G+ YL + N +HRDL
Sbjct: 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAAR 176
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYS 213
NI VN N K+ D GL+ V++ + G P + APE + ++ D++S
Sbjct: 177 NILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWS 235
Query: 214 FGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
FG+ + E++T E PY E N ++ K + G
Sbjct: 236 FGIVMWEVMTYGERPYWELSN-HEVMKAINDG 266
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 45/223 (20%), Positives = 93/223 (41%), Gaps = 19/223 (8%)
Query: 62 DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK 121
M + E ++ +++ + ++ DD + M+ E G L
Sbjct: 105 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSN 162
Query: 122 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181
+ V K + + +++ L +HS IHRD+K DN+ ++ +G +K+ D G + M
Sbjct: 163 YD-VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKM 218
Query: 182 QQP---TARSVIGTPEFMAPEL-----YEEEYNELVDIYSFGMCILEMVTCEYP-YNECK 232
+ + +GTP++++PE+ + Y D +S G+ + EM+ + P Y +
Sbjct: 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-- 276
Query: 233 NPAQIYKKVTSGIKPASLSKVTD--PQVKQFIEKCIVPASLRL 273
+ Y K+ + + D + K I + +RL
Sbjct: 277 SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRL 319
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 14/187 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 124
+ Q SE ++ H NII+ V R ++TE +GSL + + H
Sbjct: 90 TERQRRDFLSEASIMGQFDHPNIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQ 147
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 182
+ + R + G+ YL +HRDL N+ V+ N K+ D GL+ +
Sbjct: 148 FTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDD 204
Query: 183 QPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
A + G P + APE + ++ D++SFG+ + E++ E PY N +
Sbjct: 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDV 263
Query: 238 YKKVTSG 244
V G
Sbjct: 264 ISSVEEG 270
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 6e-22
Identities = 41/170 (24%), Positives = 82/170 (48%), Gaps = 9/170 (5%)
Query: 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
T ++ I +L G L + +H ++ +A +I+ GL ++H+ +++RDLK
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKP 320
Query: 159 DNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGM 216
NI ++ +G V+I DLGLA + + +GT +MAPE Y+ D +S G
Sbjct: 321 ANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 217 CILEMVTCEYPY--NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
+ +++ P+ ++ K+ +I + + L P+++ +E
Sbjct: 380 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEG 427
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 7e-22
Identities = 53/181 (29%), Positives = 93/181 (51%), Gaps = 14/181 (7%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMK 128
E +E +++K+L+H+ ++K + T I +ITE GSL + K + +
Sbjct: 228 EAFLAEANVMKTLQHDKLVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP 284
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 186
+ +++ QI G+ ++ N IHRDL+ NI V+ + KI D GLA V++ TA
Sbjct: 285 KLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTA 341
Query: 187 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTS 243
R P ++ APE + + D++SFG+ ++E+VT PY NP ++ + +
Sbjct: 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALER 400
Query: 244 G 244
G
Sbjct: 401 G 401
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-21
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 17/213 (7%)
Query: 62 DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL----RQ 117
++ + E +L + I+ ++ +T + ++ + G +
Sbjct: 221 KRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYN 278
Query: 118 YRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177
+ + + QI+ GL +LH N II+RDLK +N+ ++ ++G V+I DLGL
Sbjct: 279 VDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGL 335
Query: 178 A--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY---NEC 231
A + Q + GTP FMAPE L EEY+ VD ++ G+ + EM+ P+ E
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 395
Query: 232 KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
++ ++V + P K F E
Sbjct: 396 VENKELKQRVLEQ--AVTYPDKFSPASKDFCEA 426
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 45/199 (22%), Positives = 78/199 (39%), Gaps = 49/199 (24%)
Query: 60 IEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITEL--------F 110
I D Q+ +R + E+ +L L HENI+ N D +R + ++ +
Sbjct: 42 IFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI 101
Query: 111 TSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170
+ L H + Q+++ + YLHS ++HRD+K NI +N V
Sbjct: 102 RANIL---EPVH-------KQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNA-ECHV 148
Query: 171 KIGDLGLA-------------IVMQQPTARSVIGTPEFM----------APE--LYEEEY 205
K+ D GL+ + + + APE L +Y
Sbjct: 149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY 208
Query: 206 NELVDIYSFGMCIL-EMVT 223
+ +D++S G CIL E++
Sbjct: 209 TKGIDMWSLG-CILGEILC 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 42/188 (22%), Positives = 79/188 (42%), Gaps = 14/188 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHKN 124
++ + +E ++K H N++ + + ++ G LR + R + N
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHN 188
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184
+K + + Q+ +G+ +L S +HRDL N ++ VK+ D GLA M
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK 245
Query: 185 TARSVIGTPE------FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 236
SV +MA E L +++ D++SFG+ + E++T PY +
Sbjct: 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FD 304
Query: 237 IYKKVTSG 244
I + G
Sbjct: 305 ITVYLLQG 312
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-21
Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 34/200 (17%)
Query: 40 CRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYN----SW 95
+D V VA + + Q+ +R Y E+ L+K + H+NII N
Sbjct: 77 IVCAAYDAVLDRNVAIKK--LSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134
Query: 96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
+ + + ++ EL + +L Q + +D + + Q+L G+ +LHS IIHRD
Sbjct: 135 TLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRD 189
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----------APE-LYEEE 204
LK NI V + +KI D GL AR+ GT M APE +
Sbjct: 190 LKPSNIVVKSDC-TLKILDFGL--------ART-AGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 205 YNELVDIYSFGMCIL-EMVT 223
Y E VDI+S G CI+ EMV
Sbjct: 240 YKENVDIWSVG-CIMGEMVR 258
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN- 124
+ Q E ++ H NII+ V ++ + ++TE +GSL + +KH
Sbjct: 86 TEKQRRDFLGEASIMGQFDHPNIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-- 182
+ + R I G+ YL +HRDL NI +N N K+ D GL V++
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNL-VCKVSDFGLGRVLEDD 200
Query: 183 QPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
A + G P + +PE + ++ D++S+G+ + E+++ E PY E N +
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 238 YKKVTSG 244
K V G
Sbjct: 260 IKAVDEG 266
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 2e-21
Identities = 35/187 (18%), Positives = 78/187 (41%), Gaps = 15/187 (8%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-N 124
E + E ++ L + I++ + ++ E+ G L ++ +
Sbjct: 376 EKADTEEMMREAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREE 432
Query: 125 VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ 182
+ + + Q+ G+ YL N +HR+L N+ + N KI D GL+ +
Sbjct: 433 IPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLL-VNRHYAKISDFGLSKALGAD 489
Query: 183 QPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 237
+ P ++ APE + +++ D++S+G+ + E ++ + PY + K P ++
Sbjct: 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EV 548
Query: 238 YKKVTSG 244
+ G
Sbjct: 549 MAFIEQG 555
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 14/181 (7%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMK 128
+ +E +L+K L+H+ +++ Y T I +ITE +GSL + K + +
Sbjct: 53 DAFLAEANLMKQLQHQRLVRLYAVV---TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TA 186
+ + A QI G+ ++ N IHRDL+ NI V+ KI D GLA +++ TA
Sbjct: 110 KLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTA 166
Query: 187 RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTS 243
R P ++ APE + + D++SFG+ + E+VT PY NP ++ + +
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLER 225
Query: 244 G 244
G
Sbjct: 226 G 226
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 48/231 (20%), Positives = 87/231 (37%), Gaps = 39/231 (16%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFY----N 93
+ K D ++VA + D++ + +E E +K H ++ K
Sbjct: 40 REAQLKQEDG-SFVKVAVKMLK-ADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96
Query: 94 SWVDDTNRTINMITELFTSGSLRQYRKKHK------NVDMKAIKNWARQILRGLHYLHSH 147
S +I G L + + N+ ++ + + I G+ YL S
Sbjct: 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR 156
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF------------ 195
N IHRDL N + + V + D GL+ R + +
Sbjct: 157 N--FIHRDLAARNCMLAEDM-TVCVADFGLS--------RKIYSGDYYRQGCASKLPVKW 205
Query: 196 MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+A E L + Y D+++FG+ + E++T + PY +N A+IY + G
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYNYLIGG 255
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 49/236 (20%), Positives = 97/236 (41%), Gaps = 41/236 (17%)
Query: 62 DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT------ELFTSGSL 115
M + E +L + + I + ++ DD N + ++ +L T L
Sbjct: 110 WEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN--LYLVMDYYVGGDLLTL--L 165
Query: 116 RQYRKKHKNVDMKAIKNWAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171
++ + AR +++ + +H + +HRD+K DNI ++ NG ++
Sbjct: 166 SKFEDRLPE-------EMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIR 215
Query: 172 IGDLGLA---IVMQQPTARSVIGTPEFMAPELYEEE------YNELVDIYSFGMCILEMV 222
+ D G + + +GTP++++PE+ + Y D +S G+C+ EM+
Sbjct: 216 LADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
Query: 223 TCEYP-YNECKNPAQIYKKVTSGIK----PASLSKVTDPQVKQFIEKCIVPASLRL 273
E P Y E + + Y K+ + + P ++ V K I + I RL
Sbjct: 276 YGETPFYAE--SLVETYGKIMNHKERFQFPTQVTDV-SENAKDLIRRLICSREHRL 328
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 46/195 (23%), Positives = 79/195 (40%), Gaps = 22/195 (11%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY------- 118
S + +E ++K ++++ V + +I EL T G L+ Y
Sbjct: 68 SMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPA 125
Query: 119 ---RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175
+ + A +I G+ YL+++ +HRDL N V + VKIGD
Sbjct: 126 MANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDF 182
Query: 176 GLAIVMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYN 229
G+ + + G M+PE L + + D++SFG+ + E+ T E PY
Sbjct: 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 230 ECKNPAQIYKKVTSG 244
N Q+ + V G
Sbjct: 243 GLSN-EQVLRFVMEG 256
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 45/230 (19%), Positives = 91/230 (39%), Gaps = 38/230 (16%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
K D ++VA + +++ S ++E SE +K H N+I+ ++
Sbjct: 51 MEGNLKQEDGTS-LKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107
Query: 98 DTNRTIN---MITELFTSGSLRQYRKKHK------NVDMKAIKNWARQILRGLHYLHSHN 148
+++ I +I G L Y + ++ ++ + + I G+ YL + N
Sbjct: 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN 167
Query: 149 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF------------M 196
+HRDL N + + V + D GL ++ + + +
Sbjct: 168 --FLHRDLAARNCMLRDDM-TVCVADFGL--------SKKIYSGDYYRQGRIAKMPVKWI 216
Query: 197 APE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
A E L + Y D+++FG+ + E+ T PY +N ++Y + G
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDYLLHG 265
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-21
Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 20/194 (10%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--- 122
S E ++ H+NI++ V + ++ EL G L+ + ++
Sbjct: 73 SEQDELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPR 130
Query: 123 ----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLG 176
++ M + + AR I G YL ++ IHRD+ N + G KIGD G
Sbjct: 131 PSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 177 LAIVMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNE 230
+A + + + G M PE E + D +SFG+ + E+ + PY
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 231 CKNPAQIYKKVTSG 244
N ++ + VTSG
Sbjct: 249 KSN-QEVLEFVTSG 261
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 38/124 (30%), Positives = 69/124 (55%), Gaps = 9/124 (7%)
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
A +I L YLHS N I++RDLK +NI ++ + G + + D GL + T + G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCG 201
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PA 248
TPE++APE L+++ Y+ VD + G + EM+ P+ +N A++Y + + ++
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKP 260
Query: 249 SLSK 252
+++
Sbjct: 261 NITN 264
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 44/209 (21%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--- 122
+ + E LL +L+HE+I+KFY V + M+ E G L ++ + H
Sbjct: 57 TLAARKDFQREAELLTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPD 114
Query: 123 -------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
+ + + + A QI G+ YL S + +HRDL N V N
Sbjct: 115 AMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-L 171
Query: 170 VKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGM 216
VKIGD G+ +R V T + M PE + ++ D++SFG+
Sbjct: 172 VKIGDFGM--------SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 223
Query: 217 CILEMVT-CEYPYNECKNPAQIYKKVTSG 244
+ E+ T + P+ + N ++ + +T G
Sbjct: 224 ILWEIFTYGKQPWFQLSN-TEVIECITQG 251
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 39/179 (21%), Positives = 80/179 (44%), Gaps = 12/179 (6%)
Query: 71 ERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMK 128
+ +E ++ L+H N+++ + + + ++TE GSL Y + +
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 188
+ ++ + + YL +N +HRDL N+ V+ +N K+ D GL
Sbjct: 118 CLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTG 174
Query: 189 VIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ P ++ APE L E++++ D++SFG+ + E+ + PY + +V G
Sbjct: 175 KL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 40/195 (20%), Positives = 81/195 (41%), Gaps = 29/195 (14%)
Query: 61 EDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRK 120
D + +E ++ L+H N+++ + + + ++TE GSL Y +
Sbjct: 226 NDATA-----QAFLAEASVMTQLRHSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLR 279
Query: 121 KH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178
+ + ++ + + YL +N +HRDL N+ V+ +N K+ D GL
Sbjct: 280 SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VAKVSDFGL- 335
Query: 179 IVMQQPTARSVIGTPE-------FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYN 229
+ T + + APE L E++++ D++SFG+ + E+ + PY
Sbjct: 336 -------TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388
Query: 230 ECKNPAQIYKKVTSG 244
+ +V G
Sbjct: 389 RIPL-KDVVPRVEKG 402
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 27/200 (13%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--- 122
S + E LL L+H++I++F+ V R + M+ E G L ++ + H
Sbjct: 83 SESARQDFQREAELLTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPD 140
Query: 123 ------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170
+ + + A Q+ G+ YL + +HRDL N V V
Sbjct: 141 AKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VV 197
Query: 171 KIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-C 224
KIGD G++ + V G M PE + ++ D++SFG+ + E+ T
Sbjct: 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 225 EYPYNECKNPAQIYKKVTSG 244
+ P+ + N + +T G
Sbjct: 258 KQPWYQLSN-TEAIDCITQG 276
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 39/122 (31%), Positives = 61/122 (50%), Gaps = 9/122 (7%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
+I L +LH II+RDLK +NI +N + G VK+ D GL + + GT
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASL 250
E+MAPE L +N VD +S G + +M+T P+ +N + K+ + P L
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYL 244
Query: 251 SK 252
++
Sbjct: 245 TQ 246
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 44/233 (18%), Positives = 91/233 (39%), Gaps = 38/233 (16%)
Query: 71 ERLYSEVHLLKSL-KHENIIKFYNSWVD--DTNRTINMITELFTSGSL--RQYRKKHKNV 125
+ EV L + +I++ + + + + + ++ E G L R + +
Sbjct: 55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114
Query: 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ 183
+ + I + YLHS N I HRD+K +N+ + + N +K+ D G
Sbjct: 115 TEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF------ 166
Query: 184 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYP----YNECKNPAQIYK 239
A E E+Y++ D++S G I+ ++ C YP + +
Sbjct: 167 -------------AKETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKT 212
Query: 240 KVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 288
++ G S+V++ +VK I + + R+ E + P+++
Sbjct: 213 RIRMGQYEFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 46/210 (21%), Positives = 86/210 (40%), Gaps = 43/210 (20%)
Query: 66 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-- 122
+ + L SE+ +L + H N++ + + +I E G+L Y +
Sbjct: 70 THSEHRALMSELKILIHIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRN 128
Query: 123 --------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168
+ ++ + ++ Q+ +G+ +L S IHRDL NI ++ N
Sbjct: 129 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN- 185
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFG 215
VKI D GL AR + P++ MAPE +++ Y D++SFG
Sbjct: 186 VVKICDFGL--------ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 216 MCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ + E+ + PY K + +++ G
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 20/194 (10%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-- 123
S E ++ H+NI++ V + ++ EL G L+ + ++ +
Sbjct: 114 SEQDELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPR 171
Query: 124 -----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLG 176
++ M + + AR I G YL ++ IHRD+ N + G KIGD G
Sbjct: 172 PSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 177 LAIVMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNE 230
+A + + G M PE E + D +SFG+ + E+ + PY
Sbjct: 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 231 CKNPAQIYKKVTSG 244
N ++ + VTSG
Sbjct: 290 KSN-QEVLEFVTSG 302
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 43/201 (21%), Positives = 79/201 (39%), Gaps = 28/201 (13%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--- 122
E E L L+H N++ V ++ ++MI + G L ++
Sbjct: 52 EGPLREEFRHEAMLRARLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 109
Query: 123 -------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169
++ + QI G+ YL SH+ ++H+DL N+ V
Sbjct: 110 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-N 166
Query: 170 VKIGDLGLAIVMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT- 223
VKI DLGL + ++G MAPE + +++ DI+S+G+ + E+ +
Sbjct: 167 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 226
Query: 224 CEYPYNECKNPAQIYKKVTSG 244
PY N + + + +
Sbjct: 227 GLQPYCGYSN-QDVVEMIRNR 246
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 38/122 (31%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
++ L +LHS II+RDLK +NI ++ G +K+ D GL+ + + A S GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 250
E+MAPE + + + D +SFG+ + EM+T P+ + K+ + + P L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFL 249
Query: 251 SK 252
S
Sbjct: 250 SP 251
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 40/227 (17%), Positives = 92/227 (40%), Gaps = 21/227 (9%)
Query: 62 DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSL-RQYRK 120
M ++ E +L + I + + ++ D+ + ++ E + G L K
Sbjct: 97 WDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY--LYLVMEYYVGGDLLTLLSK 154
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-- 178
+ + + + + +I+ + +H +HRD+K DNI ++ G +++ D G
Sbjct: 155 FGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLK 211
Query: 179 -IVMQQPTARSVIGTPEFMAPEL--------YEEEYNELVDIYSFGMCILEMVTCEYPYN 229
+ +GTP++++PE+ Y D ++ G+ EM + P+
Sbjct: 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF- 270
Query: 230 ECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVPASLRL 273
+ A+ Y K+ + + + + + FI++ + P RL
Sbjct: 271 YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRL 317
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 14/128 (10%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGT 192
+I+ L +LH II+RD+K +NI ++ +NG V + D GL+ + + A GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 193 PEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSG-I 245
E+MAP++ +++ VD +S G+ + E++T P+ E + A+I +++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
Query: 246 K-PASLSK 252
P +S
Sbjct: 284 PYPQEMSA 291
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 46/210 (21%), Positives = 92/210 (43%), Gaps = 14/210 (6%)
Query: 62 DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQ--YR 119
++ +E +L+ + ++ ++ +T + ++ L G L+ Y
Sbjct: 220 KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY--ETKDALCLVLTLMNGGDLKFHIYH 277
Query: 120 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179
+A +I GL LH I++RDLK +NI ++ ++G ++I DLGLA+
Sbjct: 278 MGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAV 334
Query: 180 VMQQP-TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY---NECKNP 234
+ + T + +GT +MAPE + E Y D ++ G + EM+ + P+ +
Sbjct: 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394
Query: 235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
++ + V P S+ PQ + +
Sbjct: 395 EEVERLVKE--VPEEYSERFSPQARSLCSQ 422
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 36/124 (29%), Positives = 70/124 (56%), Gaps = 9/124 (7%)
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
+I+ L YLHS + +++RD+K +N+ ++ +G +KI D GL + T ++ G
Sbjct: 111 GAEIVSALEYLHSRD--VVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCG 167
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PA 248
TPE++APE L + +Y VD + G+ + EM+ P+ ++ ++++ + I+ P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPR 226
Query: 249 SLSK 252
+LS
Sbjct: 227 TLSP 230
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 48/212 (22%), Positives = 83/212 (39%), Gaps = 46/212 (21%)
Query: 66 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-- 122
+ E L SE+ +L L H NI+ +ITE G L + ++
Sbjct: 66 HLTEREALMSELKVLSYLGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 123 ----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166
+D++ + +++ Q+ +G+ +L S N IHRDL NI + +
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL-TH 180
Query: 167 NGEVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYS 213
KI D GL AR + + MAPE ++ Y D++S
Sbjct: 181 GRITKICDFGL--------ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 232
Query: 214 FGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+G+ + E+ + PY ++ YK + G
Sbjct: 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
+ +I L+YLH II+RDLK DN+ ++ G +K+ D G+ + T + G
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
TP ++APE L E+Y VD ++ G+ + EM+ P++ + +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
+I+ GL +LHS I++RDLK DNI ++ +G +KI D G+ ++ + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 250
+++APE L ++YN VD +SFG+ + EM+ + P+ ++ +++ + P L
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWL 241
Query: 251 SKVTDPQVKQFIEKCIVPASLRLPALELLKD-PF 283
K + + + RL ++ P
Sbjct: 242 EKEAKDLLVKLFVRE---PEKRLGVRGDIRQHPL 272
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 42/208 (20%)
Query: 66 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY-RKKHK 123
D+ E L SE+ ++ L +HENI+ + +ITE G L + R+K +
Sbjct: 89 HADEKEALMSELKIMSHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSR 146
Query: 124 NVDMKAIKN-------------WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170
++ ++ Q+ +G+ +L S N IHRD+ N+ + N
Sbjct: 147 VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVA 203
Query: 171 KIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMC 217
KIGD GL AR ++ + MAPE +++ Y D++S+G+
Sbjct: 204 KIGDFGL--------ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 218 ILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ E+ + PY ++ YK V G
Sbjct: 256 LWEIFSLGLNPYPGILVNSKFYKLVKDG 283
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 36/122 (29%), Positives = 64/122 (52%), Gaps = 9/122 (7%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
+I+ L +LH II+RDLK DN+ ++ G K+ D G+ + T + GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 250
+++APE L E Y VD ++ G+ + EM+ P+ E +N +++ + + + P L
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWL 247
Query: 251 SK 252
+
Sbjct: 248 HE 249
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 38/122 (31%), Positives = 71/122 (58%), Gaps = 9/122 (7%)
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 193
+I GL +L S II+RDLK DN+ ++ + G +KI D G+ + T ++ GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 250
+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P S+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244
Query: 251 SK 252
SK
Sbjct: 245 SK 246
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
+ +I L+YLH II+RDLK DN+ ++ G +K+ D G+ + T + G
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240
TP ++APE L E+Y VD ++ G+ + EM+ P++ + +
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 41/217 (18%), Positives = 72/217 (33%), Gaps = 52/217 (23%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--- 122
S D E L+ + NI+K + + ++ E G L ++ +
Sbjct: 90 SADMQADFQREAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPH 147
Query: 123 ---------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ ARQ+ G+ YL +HRDL N
Sbjct: 148 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNC 205
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNEL 208
V N VKI D GL+ R++ + M PE ++ Y
Sbjct: 206 LVGENM-VVKIADFGLS--------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE 256
Query: 209 VDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244
D++++G+ + E+ + PY + ++ V G
Sbjct: 257 SDVWAYGVVLWEIFSYGLQPYYGMAH-EEVIYYVRDG 292
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 2e-18
Identities = 39/124 (31%), Positives = 71/124 (57%), Gaps = 9/124 (7%)
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 191
A +I GL +L S II+RDLK DN+ ++ G +KI D G+ + T ++ G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFCG 504
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPA 248
TP+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++++ + P
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPK 563
Query: 249 SLSK 252
S+SK
Sbjct: 564 SMSK 567
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 52/217 (23%)
Query: 66 SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH--- 122
SP +L L SE ++LK + H ++IK Y + + +I E GSLR + ++
Sbjct: 66 SPSELRDLLSEFNVLKQVNHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 123 ---------------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ + M + ++A QI +G+ YL ++HRDL NI
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNI 181
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNEL 208
V ++KI D GL +R V + MA E L++ Y
Sbjct: 182 LVAEGR-KMKISDFGL--------SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 209 VDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
D++SFG+ + E+VT PY +++ + +G
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTG 268
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 48/208 (23%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 62 DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK 121
+V+ + D++ +E +L++ +H + S+ T+ + + E G L + +
Sbjct: 184 EVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF--QTHDRLCFVMEYANGGELFFHLSR 241
Query: 122 HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--I 179
+ + + +I+ L YLHS +++RDLK +N+ ++ + G +KI D GL
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKITDFGLCKEG 299
Query: 180 VMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 238
+ T ++ GTPE++APE L + +Y VD + G+ + EM+ P+ ++ +++
Sbjct: 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLF 358
Query: 239 KKVTSG-IK-PASLSKVTDPQVKQFIEK 264
+ + I+ P +L P+ K +
Sbjct: 359 ELILMEEIRFPRTLG----PEAKSLLSG 382
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 45/210 (21%)
Query: 66 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-- 122
+ L L SE+ ++K + KH+NII + + +I E + G+LR+Y +
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 123 --------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168
+ + K + + Q+ RG+ YL S IHRDL N+ V NN
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFG 215
+KI D GL AR + + MAPE L++ Y D++SFG
Sbjct: 195 VMKIADFGL--------ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 216 MCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ + E+ T PY +++K + G
Sbjct: 247 VLMWEIFTLGGSPYPGIPV-EELFKLLKEG 275
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 50/217 (23%), Positives = 81/217 (37%), Gaps = 51/217 (23%)
Query: 66 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
+ E L SE+ ++ L HENI+ + I +I E G L Y + +
Sbjct: 88 DSSEREALMSELKMMTQLGSHENIVNLLGACTLS--GPIYLIFEYCCYGDLLNYLRSKRE 145
Query: 125 VDMKAIKN-----------------------WARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ +A Q+ +G+ +L + +HRDL N+
Sbjct: 146 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNV 203
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNEL 208
V VKI D GL AR ++ + MAPE L+E Y
Sbjct: 204 LVTHGK-VVKICDFGL--------ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254
Query: 209 VDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
D++S+G+ + E+ + PY A YK + +G
Sbjct: 255 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG 291
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 45/210 (21%)
Query: 66 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-- 122
+ L L SE+ ++K + KH+NII + + +I E + G+LR+Y +
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRP 183
Query: 123 --------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168
+ + K + + Q+ RG+ YL S IHRDL N+ V NN
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 240
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFG 215
+KI D GLA R + + MAPE L++ Y D++SFG
Sbjct: 241 VMKIADFGLA--------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 216 MCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ + E+ T PY +++K + G
Sbjct: 293 VLMWEIFTLGGSPYPGIPV-EELFKLLKEG 321
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 45/210 (21%)
Query: 66 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKH-- 122
+ L L SE+ ++K + KH+NII + + +I E + G+LR+Y +
Sbjct: 114 TEKDLSDLISEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRP 171
Query: 123 --------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168
+ + K + + A Q+ RG+ YL S IHRDL N+ V +N
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN- 228
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFG 215
+KI D GLA R + + MAPE L++ Y D++SFG
Sbjct: 229 VMKIADFGLA--------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 216 MCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
+ + E+ T PY +++K + G
Sbjct: 281 VLLWEIFTLGGSPYPGVPV-EELFKLLKEG 309
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YKG DG VA ++ E Q + +EV ++ H N+++ + T R
Sbjct: 47 YKGRLA-DGTLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHRNLLRLRGFCMTPTER 102
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNW-ARQ-----ILRGLHYLHSH-NPPIIHR 154
+ + +GS+ + + + +W RQ RGL YLH H +P IIHR
Sbjct: 103 LL--VYPYMANGSVASCL--RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158
Query: 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPELYEEEY---- 205
D+K NI ++ E +GD GLA +M + V GT +AP EY
Sbjct: 159 DVKAANILLDEEF-EAVVGDFGLAKLM--DYKDTHVTTAVRGTIGHIAP-----EYLSTG 210
Query: 206 --NELVDIYSFGMCILEMVTCEYPYNECKNPAQ 236
+E D++ +G+ +LE++T + ++ +
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHENIIKFYNSWVDDTN 100
YKG+ V+ VA ++ + + +L++ E+ ++ +HEN+++ D +
Sbjct: 48 YKGY--VNNTTVAVKKLAAMVDITTE-ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104
Query: 101 RTINMITELFTSGSLRQY---RKKHKNVD----MKAIKNWARQILRGLHYLHSHNPPIIH 153
++ +GSL + K + A G+++LH IH
Sbjct: 105 LC--LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFLH--ENHHIH 156
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS--VIGTPEFMAPELYEEEYNELV 209
RD+K NI ++ KI D GLA T + ++GT +MAPE E
Sbjct: 157 RDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKS 215
Query: 210 DIYSFGMCILEMVT 223
DIYSFG+ +LE++T
Sbjct: 216 DIYSFGVVLLEIIT 229
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 49/199 (24%), Positives = 79/199 (39%), Gaps = 26/199 (13%)
Query: 66 SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN 124
S D E+ +L L H NII + + + E G+L + +K +
Sbjct: 65 SKDDHRDFAGELEVLCKLGHHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRV 122
Query: 125 VDMKAIKNW----------------ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168
++ A + RG+ YL IHRDL NI V N
Sbjct: 123 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY- 179
Query: 169 EVKIGDLGLAIVMQQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-E 225
KI D GL+ + +++ P +MA E L Y D++S+G+ + E+V+
Sbjct: 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 239
Query: 226 YPYNECKNPAQIYKKVTSG 244
PY A++Y+K+ G
Sbjct: 240 TPYCGMTC-AELYEKLPQG 257
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 33/198 (16%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLER-LYSEVHLLKSLKHENIIKFYNSWVDDTN 100
YKG DG +VA + E Q +E+ L +H +++ +
Sbjct: 56 YKGVLR-DGAKVALKRRTPESS-----QGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109
Query: 101 RTINMITELFTSGSLRQ--YRKKHKNVDMKAIKNWAR--QIL----RGLHYLHSHNPPII 152
+ I + +G+L++ Y + M +W + +I RGLHYLH II
Sbjct: 110 MIL--IYKYMENGNLKRHLYGSDLPTMSM----SWEQRLEICIGAARGLHYLH--TRAII 161
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYEEEY- 205
HRD+K NI ++ N KI D G++ + T V GT ++ PE + +
Sbjct: 162 HRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTV--VKGTLGYIDPEYFIKGRL 218
Query: 206 NELVDIYSFGMCILEMVT 223
E D+YSFG+ + E++
Sbjct: 219 TEKSDVYSFGVVLFEVLC 236
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 24/172 (13%)
Query: 76 EVHLLKSLK-----------HENIIKFYNS--WVDDTNRTINMITELFTSGSLRQYRKKH 122
E+ LL+ + +I+K + + M+ E+ +L KK+
Sbjct: 65 EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV-LGENLLALIKKY 123
Query: 123 KNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-----NGNNGEVKIGDL 175
++ + +K ++Q+L GL Y+H IIH D+K +N+ + N ++KI DL
Sbjct: 124 EHRGIPLIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
Query: 176 GLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY 226
G A + + I T E+ +PE L + DI+S I E++T ++
Sbjct: 183 GNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 26/245 (10%), Positives = 59/245 (24%), Gaps = 48/245 (19%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
++ D +VA V+ + D L+ S L + + + +
Sbjct: 48 WQALDTALDRQVALTFVD-PQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ E GSL++ + + + H + +
Sbjct: 107 LVVA--EWIRGGSLQEVADTSPSPVGAI--RAMQSLAAAADAAHRAG--VALSIDHPSRV 160
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 221
V +G+V + M + DI G + +
Sbjct: 161 RV-SIDGDVVLAYPA---TMPDANPQD---------------------DIRGIGASLYAL 195
Query: 222 VTCEYPYNECKNPAQI---YKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALEL 278
+ +P E + + + + D +P + A
Sbjct: 196 LVNRWPLPEAGVRSGLAPAERDTAGQPIEPA---DIDRD---------IPFQISAVAARS 243
Query: 279 L-KDP 282
+ D
Sbjct: 244 VQGDG 248
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 34/158 (21%), Positives = 67/158 (42%), Gaps = 9/158 (5%)
Query: 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
+S ++ + + + ++ + ++ Q+ +G+ +L S I
Sbjct: 158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CI 215
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTP---EFMAPE-LYEEEYNE 207
HRDL NI + VKI D GLA + + P ++MAPE +++ Y
Sbjct: 216 HRDLAARNILL-SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 208 LVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 244
D++SFG+ + E+ + PY K + +++ G
Sbjct: 275 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 16/159 (10%)
Query: 76 EVHLLKSLKHE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKN--VDM 127
EV LL+ + I+ N ++ E+ S +L + V +
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKR-HFMFRNHLC-LVFEML-SYNLYDLLRNTNFRGVSL 156
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA 186
+ +A+Q+ L +L + IIH DLK +NI N +KI D G + + Q
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 223
I + + +PE L Y+ +D++S G CIL EM T
Sbjct: 217 -QYIQSRFYRSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 76 EVHLLKSLKHE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DM 127
E+ +L+ L+ + N+I N M EL S +L + KK+K +
Sbjct: 143 EIRILEHLRKQDKDNTMNVIHMLE-NFTFRNHIC-MTFELL-SMNLYELIKKNKFQGFSL 199
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA 186
++ +A IL+ L LH + IIH DLK +NI +K+ D G + Q
Sbjct: 200 PLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY 257
Query: 187 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 223
+ I + + APE + Y +D++S G CIL E++T
Sbjct: 258 -TYIQSRFYRAPEVILGARYGMPIDMWSLG-CILAELLT 294
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 2e-11
Identities = 101/672 (15%), Positives = 195/672 (29%), Gaps = 210/672 (31%)
Query: 43 KGFD--EV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99
FD +V D + ++ I+ ++ S D + L S K E +++ + V
Sbjct: 31 DNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS-KQEEMVQKFVEEVLRI 89
Query: 100 N------------RTINMITELFTSGSLRQYR-----KKHKNV----DMKAIKNWARQIL 138
N R +M+T ++ R Y K+ NV ++ + L
Sbjct: 90 NYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY-NVSRLQPYLKLRQALLE-L 147
Query: 139 RGLHYLHSHNPPIIH---------------RDLKCDNIFVNG----NNGEVKIGDLGLAI 179
R + +I K N + L +
Sbjct: 148 RPAKNV------LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEM 201
Query: 180 -------VMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC--ILEMV----TCEY 226
+ T+RS + + + E L+ + C +L V
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA 261
Query: 227 PYNECKNPAQI-----YKKVTSGIKPASLSKVT-DPQVKQFIEKCIVPASLRLPALELLK 280
CK I +K+VT + A+ + ++ D LL
Sbjct: 262 FNLSCK----ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD---------EVKSLLL 308
Query: 281 DPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTW- 339
K L C P LP EV+ +P + + A+S + TW
Sbjct: 309 ---------KYLDCRPQDLP---REVLTT-----NPRRLSI-----IAESI-RDGLATWD 345
Query: 340 -FLTLELQRLTENNEFTLRGEKNDDDT---VSLTLRIGDKSGHVSNIHFVFYLNADTAIS 395
+ + +LT E +L + + L VF +A
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL---------------SVFPPSAH---- 386
Query: 396 IAEEMVEQL--DLSHEDVVSIAELIDNLIMK--LVPSWNPSLGSTASQQNGLLKGSPVSQ 451
I ++ + D+ DV ++ N + K LV ST S + L+
Sbjct: 387 IPTILLSLIWFDVIKSDV----MVVVNKLHKYSLVEKQPKE--STISIPSIYLE------ 434
Query: 452 GNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAH 511
+ +K E + + + Y + D+ +
Sbjct: 435 ---LKVKLENEYALHRSIVD--------------HYNIPKTFDSDDLIPPYL-------- 469
Query: 512 IDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDS---CSGMSK 568
D Y + + H + + ++L + + F++ +
Sbjct: 470 -------DQYFYSHIGH-HLKNIEHPERMTLFRMVFLD-------FRFLEQKIRHDSTAW 514
Query: 569 NLSFSSISSLS--------LADKE-HSDGL---------KLELDAINSKYQQCFQELLRQ 610
N S S +++L + D + + L K+E + I SKY + L
Sbjct: 515 NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMA 574
Query: 611 REDEM--ENARK 620
++ + E ++
Sbjct: 575 EDEAIFEEAHKQ 586
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 34/176 (19%), Positives = 72/176 (40%), Gaps = 35/176 (19%)
Query: 76 EVHLLKSLKHE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DM 127
E+++LK +K + + + W + + + EL + ++ K++ +
Sbjct: 66 EINVLKKIKEKDKENKFLCVLMSD-WFNFHGH-MCIAFELL-GKNTFEFLKENNFQPYPL 122
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NGE 169
+++ A Q+ L +LH + + H DLK +NI + N
Sbjct: 123 PHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 170 VKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 223
+++ D G A + +++ T + PE + E + + D++S G CIL E
Sbjct: 181 IRVADFGSATFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIG-CILFEYYR 234
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 32/184 (17%), Positives = 63/184 (34%), Gaps = 39/184 (21%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y F + A + V +E + L+SE+ + + ++ I W++
Sbjct: 54 YLAFPTNKPEKDARHVVKVE-----YQENGPLFSELKFYQRVAKKDCI---KKWIERKQL 105
Query: 102 TINMITELFTSG-------------------SLRQYRKKHKNVDMKAIKNWARQILRGLH 142
I + SG L++ ++ + ++L L
Sbjct: 106 DYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLE 165
Query: 143 YLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQQPTARSVIGT 192
Y+H + +H D+K N+ + N +V + D GL+ Q+ + GT
Sbjct: 166 YIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT 223
Query: 193 PEFM 196
EF
Sbjct: 224 IEFT 227
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 51/279 (18%), Positives = 101/279 (36%), Gaps = 77/279 (27%)
Query: 76 EVHLLKSLKHE------NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DM 127
E+ +L+ L ++ W + I ++ EL S + K++ + +
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLE-WFEHHGH-ICIVFELL-GLSTYDFIKENGFLPFRL 117
Query: 128 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NGE 169
I+ A QI + +++LHS+ + H DLK +NI + N +
Sbjct: 118 DHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 170 VKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL--------- 219
+K+ D G A + +++ T + APE + +++ D++S G CIL
Sbjct: 176 IKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIG-CILIEYYLGFTV 233
Query: 220 -------EMVTC-------------------------EYPYNECKNPAQIYKKVTSGIKP 247
E + ++E + + + +K
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293
Query: 248 ASLSK-VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
LS+ V ++ I+K + + R+ E LK PF
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 41/181 (22%), Positives = 79/181 (43%), Gaps = 40/181 (22%)
Query: 76 EVHLLKSLKHE-----NIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNV--DMK 128
E +LK ++++ NI+K++ + + +I E SL + ++ ++
Sbjct: 81 EADILKKIQNDDINNNNIVKYHG-KFMYYDH-MCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 129 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------------------ 164
IK + +IL+ L+YL + + H DLK +NI ++
Sbjct: 138 DIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 165 GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMV 222
+ +K+ D G A S+I T ++ APE + ++ D++SFG C+L E+
Sbjct: 196 TKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG-CVLAELY 253
Query: 223 T 223
T
Sbjct: 254 T 254
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 41/168 (24%), Positives = 62/168 (36%), Gaps = 24/168 (14%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTN 100
Y G D G EVA + +E V QL E + K ++ I +
Sbjct: 26 YLGTDIAAGEEVA---IKLECVKTKHPQLHI---ESKIYKMMQGGVGIPTIRWCGAEGDY 79
Query: 101 RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
M+ EL SL + +K + A Q++ + Y+HS N IHRD+K D
Sbjct: 80 NV--MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPD 134
Query: 160 NIFV--NGNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFM 196
N + V I D GLA + +++ GT +
Sbjct: 135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 37/165 (22%), Positives = 58/165 (35%), Gaps = 53/165 (32%)
Query: 114 SLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-------- 163
L ++ K + + +K +Q+L+GL YLH+ IIH D+K +NI +
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIR 188
Query: 164 ----------------------------------------NGNNGEVKIGDLGLAIVMQQ 183
N +VKI DLG A + +
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248
Query: 184 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 227
I T ++ + E L YN DI+S E+ T +Y
Sbjct: 249 HF-TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 22/129 (17%), Positives = 45/129 (34%), Gaps = 16/129 (12%)
Query: 80 LKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQI 137
L S I V ++ SL+ + +++ A ++
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRL 168
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQQPTAR 187
L L +LH + +H ++ +NIFV+ + +V + G A + + +
Sbjct: 169 LDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226
Query: 188 SVIGTPEFM 196
G EF+
Sbjct: 227 PHEGDLEFI 235
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 34/148 (22%), Positives = 54/148 (36%), Gaps = 17/148 (11%)
Query: 37 TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSW 95
F G + VA + +E + QL E K L + I + Y
Sbjct: 21 NFGELRLGKNLYTNEYVA---IKLEPMKSRAPQLHL---EYRFYKQLGSGDGIPQVYYFG 74
Query: 96 VDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 154
M+ EL SL + +K + A Q++ + Y+HS N +I+R
Sbjct: 75 PCGKYNA--MVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYR 129
Query: 155 DLKCDNIFV----NGNNGEVKIGDLGLA 178
D+K +N + N + I D LA
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 33/141 (23%), Positives = 58/141 (41%), Gaps = 15/141 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN 100
Y G + EVA + +E+V QL E + + L+ I V+
Sbjct: 24 YLGTNIQTNEEVA---IKLENVKTKHPQLLY---ESKIYRILQGGTGIPNVRWFGVEGDY 77
Query: 101 RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
++ +L SL + + +K + A Q++ + ++HS + +HRD+K D
Sbjct: 78 NV--LVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPD 132
Query: 160 NIFV--NGNNGEVKIGDLGLA 178
N + +V I D GLA
Sbjct: 133 NFLMGLGRRANQVYIIDFGLA 153
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 27/143 (18%), Positives = 56/143 (39%), Gaps = 17/143 (11%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTN 100
++G + ++ +VA + E QL E K L I Y + +
Sbjct: 27 FEGTNLLNNQQVA---IKFEPRRSDAPQLRD---EYRTYKLLAGCTGIPNVYYFGQEGLH 80
Query: 101 RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
++ +L SL + +K + A+Q+L + +H + +++RD+K D
Sbjct: 81 NV--LVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPD 135
Query: 160 NIFVNGNNGE----VKIGDLGLA 178
N + N + + + D G+
Sbjct: 136 NFLIGRPNSKNANMIYVVDFGMV 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 22/73 (30%), Positives = 31/73 (42%), Gaps = 12/73 (16%)
Query: 134 ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQQ 183
+ +IL L Y+H H +H D+K N+ +N N +V + D GLA
Sbjct: 158 SLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 184 PTARSVIGTPEFM 196
R GT EF
Sbjct: 216 DPKRCHDGTIEFT 228
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 4e-06
Identities = 20/73 (27%), Positives = 33/73 (45%), Gaps = 6/73 (8%)
Query: 359 EKNDDDTVSLTLRIGD----KSGHVSN--IHFVFYLNADTAISIAEEMVEQLDLSHEDVV 412
+ + + L LRI D K + N I F F L D +A+EMVE + D
Sbjct: 19 DDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHK 78
Query: 413 SIAELIDNLIMKL 425
++A+ I + + +
Sbjct: 79 TMAKAIKDRVSLI 91
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 1e-05
Identities = 48/307 (15%), Positives = 82/307 (26%), Gaps = 73/307 (23%)
Query: 42 YKGFDEVDGIEVAWNQVNIED----VMQSPDQLERLYSEVHLLKSL---------KHENI 88
++ D VA + IE E + E+ + K L + E
Sbjct: 37 FQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94
Query: 89 IKFYNSWV----------------DDTNRTINMITELFTSG-------------SLRQYR 119
I + + T + N + F L Q R
Sbjct: 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR 154
Query: 120 KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN----------GNNGE 169
K ++ K+ Q+ L + HRDL N+ + N
Sbjct: 155 TKLSSLAT--AKSILHQLTASLAVAE-ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKS 211
Query: 170 VKIGDLGLAIVMQQPTAR--SVIGTPEFM----APELYEEEYNELVDIYSFGMCILEMVT 223
I GL + + T G F +L+ + + DIY
Sbjct: 212 STIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRW 271
Query: 224 CEY-PYNECK-----NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALE 277
EY PY+ + + K ++++F + +S A +
Sbjct: 272 GEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSS----ATD 327
Query: 278 LLKDPFL 284
LL L
Sbjct: 328 LLCQHSL 334
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 631 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 99.56 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 99.09 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.78 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.71 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.48 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.08 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.93 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.91 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.59 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.53 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.05 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.88 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.27 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.23 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.28 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 90.29 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.44 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-62 Score=508.21 Aligned_cols=266 Identities=48% Similarity=0.875 Sum_probs=240.5
Q ss_pred CccCCCc-EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 20 SSSVSYF-WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~~~i~~~-Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
+.....+ |++.++||+|+||+||+|.++.+|..||+|++..... .....+++.+|+.+|++|+|||||++|++|.+.
T Consensus 20 ~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 97 (290)
T 3fpq_A 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp EECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence 3334444 4888999999999999999999999999999986643 456678899999999999999999999998653
Q ss_pred --CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 99 --TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 99 --~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
....+|||||||+||+|.+++.+.+.+++..++.|++||+.||+|||+++++||||||||+|||+++.+|.+||+|||
T Consensus 98 ~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFG 177 (290)
T 3fpq_A 98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp ETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred cCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCc
Confidence 345799999999999999999999999999999999999999999999998899999999999998568999999999
Q ss_pred chhhccCCCCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 177 LAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 177 lA~~~~~~~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
+|+........+.+|||.|||||++.+.|+.++|||||||++|||+||+.||.+..+..+++..+..+..|..++...++
T Consensus 178 la~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (290)
T 3fpq_A 178 LATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred CCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence 99877666677889999999999999899999999999999999999999999888889999999998888777888899
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
++++||.+||+ +|.+|||+.|+|+||||++.
T Consensus 258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 99999999998 89999999999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-59 Score=491.04 Aligned_cols=262 Identities=24% Similarity=0.372 Sum_probs=232.3
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
-++|+++++||+|+||+||+|.++.+|+.||+|++....... ....+++.+|+++|++|+|||||++|++|.+++ .+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~ 107 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE--KL 107 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC--EE
Confidence 357999999999999999999999999999999998654321 234567899999999999999999999997654 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|||||||+||+|.+++++.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEc-CCCCEEEEEcCCceecCC
Confidence 999999999999999999999999999999999999999999999 99999999999998 789999999999986642
Q ss_pred C----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 184 P----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
. ...+++|||.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..+++..|..+.. .++...++++
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 261 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKA 261 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHH
Confidence 2 3457899999999999865 599999999999999999999999987 677788888877643 3556788999
Q ss_pred HHHHHHhcC-CCCCCCCHHH------HhcCCCccCCCCCcccc
Q 006777 259 KQFIEKCIV-PASLRLPALE------LLKDPFLVTDNPKDLVC 294 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~e------lL~hpff~~~~~~~~~~ 294 (631)
++||.+||+ +|.+|||+.| |++||||+..+|..+..
T Consensus 262 ~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~ 304 (311)
T 4aw0_A 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 304 (311)
T ss_dssp HHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred HHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcC
Confidence 999999998 9999999987 68999999999987643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-58 Score=473.89 Aligned_cols=256 Identities=24% Similarity=0.455 Sum_probs=211.7
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||+||+|.++.+|+.||+|++...... ......++.+|+++|++|+|||||+++++|.++ ..+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--DEII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEE
Confidence 5799999999999999999999999999999999866432 234456799999999999999999999998765 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||| +|+|.+++.+++++++..++.|++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTCCEEECCSSCC------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEEC-CCCCEEEeecCCCeecCCC
Confidence 999999 6899999999999999999999999999999999999 99999999999998 7899999999999765443
Q ss_pred -CCccccCCCCCCCccccccc-c-CccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 185 -TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 -~~~~~~GTp~y~APE~l~~~-y-~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
...+.+|||.|||||++.+. | +.++|||||||++|+|+||+.||.+ .+..++++.+..+.. .++...++++++|
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~l 242 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVY--TLPKFLSPGAAGL 242 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHH
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 34568999999999998754 4 6899999999999999999999987 677788888877643 3556788999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCccCCCCC
Q 006777 262 IEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~elL~hpff~~~~~~ 290 (631)
|.+||+ +|.+|||+.|+|+||||+...+.
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~~~p~ 272 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKVDLPE 272 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHTTCCG
T ss_pred HHHHccCChhHCcCHHHHHcCcccccCCCh
Confidence 999998 99999999999999999865443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-58 Score=486.25 Aligned_cols=255 Identities=28% Similarity=0.521 Sum_probs=224.8
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|.+.+.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|++|+|||||++|++|.+++ .+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~ 146 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--EL 146 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EE
Confidence 4679999999999999999999999999999999986643 22345789999999999999999999998764 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|||||||+||+|.+++.+ +++++..++.|++||+.||+|||++| ||||||||+|||++ .+|.|||+|||+|+....
T Consensus 147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCS
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEC-CCCCEEEecCcCceecCC
Confidence 999999999999999976 56999999999999999999999999 99999999999998 789999999999986644
Q ss_pred C--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHH
Q 006777 184 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVK 259 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~-~l~~~~~~~lk 259 (631)
. ...+.+|||.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+..+.+..+..+..+. .....++++++
T Consensus 223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 301 (346)
T 4fih_A 223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLK 301 (346)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSCHHHH
T ss_pred CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 3 3567899999999998864 699999999999999999999999987 56777777777664432 23345789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
+||.+||+ +|.+|||+.|+|+||||+...+
T Consensus 302 dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 302 GFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 99999998 9999999999999999987543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-58 Score=487.46 Aligned_cols=254 Identities=25% Similarity=0.432 Sum_probs=220.1
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++++.||+|+||+||+|.++.+|+.||||++..... .....+++.+|+++|++|+|||||++|++|.++. .+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~--~~y 99 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEENG--SLY 99 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC--EEE
Confidence 689999999999999999999999999999999987653 4566788999999999999999999999997654 799
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 105 MITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
||||||+||+|.+++...+ .+++..++.|+.||+.||+|||++| ||||||||+|||++ .+|.|||+|||+|+...
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEEC-TTCCEEECSTTEESCCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCCEEEcccccceeec
Confidence 9999999999999997653 5799999999999999999999999 99999999999998 78999999999998665
Q ss_pred CC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 183 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 ~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
.. ...+.+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+..|. ++..++++++
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~-~~~~~s~~~~ 254 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPP-VSLHYSYDLR 254 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCHHHH
T ss_pred CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCC-CCccCCHHHH
Confidence 33 2356789999999999875 599999999999999999999999987 56777777777765543 4456789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+||.+||+ +|.+|||+.|+|+||||+..
T Consensus 255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 99999998 99999999999999999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=483.49 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=224.7
Q ss_pred CcEEEEEEEeecCCeEEEEEEEc---CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~---~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
++|++.+.||+|+||+||+|.+. .+++.||+|+++...... ....++.+|+.+|++|+|||||+++++|.+++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-- 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-- 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEEETT--
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--
Confidence 57999999999999999999984 468899999997654321 12335788999999999999999999997654
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+..
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTSCEEEESSEEEEC-
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEc-CCCCEEecccccceec
Confidence 79999999999999999999999999999999999999999999999 99999999999998 7899999999999754
Q ss_pred cC--CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 182 QQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~~--~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.. ....+.+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+.. .++...++++
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 253 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKL--GMPQFLSPEA 253 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCcCCHHH
Confidence 32 33567899999999998864 599999999999999999999999987 567777777776633 3456789999
Q ss_pred HHHHHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCccccCCCCCC
Q 006777 259 KQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~~~l~~p 300 (631)
++||.+||+ +|.+||| ++|+++||||+..+|..+....+..|
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP 301 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 301 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcC
Confidence 999999998 9999998 47999999999998877655545444
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=488.56 Aligned_cols=254 Identities=28% Similarity=0.512 Sum_probs=224.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|.+.+.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.|+|||||++|++|.+.+ .+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~ 223 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--EL 223 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEECC--EE
Confidence 4679999999999999999999999999999999986543 22356889999999999999999999998764 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|||||||+||+|.++++. +++++..++.|++||+.||+|||++| ||||||||+||||+ .+|.|||+|||+|+....
T Consensus 224 ~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~-~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEEC-TTCCEEECCCTTCEECCS
T ss_pred EEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEecCccceECCC
Confidence 999999999999999876 46999999999999999999999999 99999999999998 789999999999986643
Q ss_pred C--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCcHHHH
Q 006777 184 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVK 259 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p-~~l~~~~~~~lk 259 (631)
. ...+.+|||.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+..+.+..+..+..+ ......++++++
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 378 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLK 378 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCHHHH
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCCHHHH
Confidence 3 3567899999999998864 599999999999999999999999987 5677777777766443 233456789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+||.+||+ +|.+|||+.|+|+||||+...
T Consensus 379 dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 379 GFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 99999998 999999999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-56 Score=471.11 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=213.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.|.+.++||+|+||+||+|.++.+|+.||||+++.+.. ..+|+.+|+.|+|||||++|++|.+.. .+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~--~~ 125 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGP--WV 125 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETT--EE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECC--EE
Confidence 3579999999999999999999999999999999986543 136999999999999999999987654 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC-cEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-~vKI~DFGlA~~~~ 182 (631)
|||||||+||+|.+++++.+.+++..++.|+.||+.||+|||+++ ||||||||+|||++ .+| .+||+|||+|+...
T Consensus 126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLS-SDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEC-TTSCCEEECCCTTCEEC-
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEe-CCCCEEEEeeCCCCeEcc
Confidence 999999999999999999999999999999999999999999999 99999999999998 566 69999999997654
Q ss_pred CC-------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Q 006777 183 QP-------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKV 253 (631)
Q Consensus 183 ~~-------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-p~~l~~~ 253 (631)
.. ....++|||.|||||++.+ .|+.++|||||||++|||+||+.||.+.. ...+...+..+.. ...++..
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 281 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF-RGPLCLKIASEPPPIREIPPS 281 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC-CSCCHHHHHHSCCGGGGSCTT
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHHcCCCCchhcCcc
Confidence 32 1234689999999998865 59999999999999999999999998743 3444455555433 3346677
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHH-------------hcCCCccC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALEL-------------LKDPFLVT 286 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~el-------------L~hpff~~ 286 (631)
+++++++||.+||+ +|.+|||+.|| |+|||+..
T Consensus 282 ~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 89999999999998 99999999998 57888865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=466.09 Aligned_cols=258 Identities=25% Similarity=0.356 Sum_probs=217.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC----
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD---- 98 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~---- 98 (631)
++++|++++.||+|+||+||+|.++.+|+.||||+++... ......+++.+|+++|+.|+|||||+++++|...
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 5678999999999999999999999999999999997543 2455667899999999999999999999987643
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
+...+|||||||. |+|.+++.+.+++++..++.|++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~-~~~~~Ki~DFGla 205 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMA 205 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccC-CCCCEEEeeccee
Confidence 2357999999996 789999999999999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccC------CCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCCC
Q 006777 179 IVMQQ------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPA 248 (631)
Q Consensus 179 ~~~~~------~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~--~~p~ 248 (631)
+.... ....+.+||+.|||||++.+ .|+.++||||+||++|||++|+.||.+. +.......|... .++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-NYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-SHHHHHHHHHHHHCCCCG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhcCCCCh
Confidence 75432 23456799999999998754 4799999999999999999999999874 444444444321 1110
Q ss_pred ------------------------C---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 249 ------------------------S---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 ------------------------~---l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
. +....++++++||.+||+ +|.+||||.|+|+||||+..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0 112357899999999998 99999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=454.70 Aligned_cols=254 Identities=21% Similarity=0.378 Sum_probs=203.5
Q ss_pred cEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC-----
Q 006777 26 FWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN----- 100 (631)
Q Consensus 26 ~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~----- 100 (631)
.|++.+.||+|+||+||+|.++.+|+.||+|+++... .....+++.+|+++|++|+|||||++|++|.+.+.
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 5999999999999999999999999999999997653 34566789999999999999999999999976542
Q ss_pred -----ceEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 101 -----RTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 101 -----~~l~lV~Ey~~gGsL~~~l~~~~~---l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
.++|+|||||+||+|.+++...+. .++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~-~~~~vKl 159 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKV 159 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC-CCCcEEE
Confidence 358999999999999999988765 445678999999999999999999 99999999999998 7899999
Q ss_pred ccccchhhccCCC--------------CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHH
Q 006777 173 GDLGLAIVMQQPT--------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI 237 (631)
Q Consensus 173 ~DFGlA~~~~~~~--------------~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~ 237 (631)
+|||+|+...... ..+.+|||.|||||++.+ .|+.++|||||||++|||++ ||....+....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 9999997654321 234689999999998865 59999999999999999996 88653333344
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 238 ~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
...+.....|..+ ...++.+++||.+||+ +|.+|||+.|+|+||||+..++
T Consensus 237 ~~~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 237 LTDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHHhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 4445544433322 2235678999999998 9999999999999999987543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=484.29 Aligned_cols=273 Identities=20% Similarity=0.302 Sum_probs=234.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc--CCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
-+.|.++++||+|+||+||+|.++.+|+.||+|++....+. ...........++.+++.++|||||+++++|.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~-- 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-- 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC--
Confidence 45799999999999999999999999999999999865432 12222333445577888899999999999997654
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++| ||||||||+|||++ .+|+|||+|||+|+..
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld-~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEe-CCCCEEecccceeeec
Confidence 79999999999999999999999999999999999999999999999 99999999999998 7899999999999887
Q ss_pred cCCCCccccCCCCCCCccccc-c-ccCccceEeehhhHHHHHhhcCCCCCCC--CCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 182 QQPTARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~-~-~y~~~sDIwSLG~il~emltG~~Pf~~~--~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
......+.+|||.|||||++. + .|+.++|||||||++|||++|..||.+. .+..++...+... +..++...+++
T Consensus 343 ~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--~~~~p~~~S~~ 420 (689)
T 3v5w_A 343 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPE 420 (689)
T ss_dssp SSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--CCCCCTTSCHH
T ss_pred CCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--CCCCCccCCHH
Confidence 777778899999999999885 3 5999999999999999999999999753 3445556666554 33455678999
Q ss_pred HHHHHHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCccccCCCCCCCCc
Q 006777 258 VKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPNLV 303 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~~~l~~p~~~ 303 (631)
+++||.+||+ +|.+|++ +.|+++||||+..+|..+....+..|..+
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P 472 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 472 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccC
Confidence 9999999998 9999998 79999999999999988766666555443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=447.47 Aligned_cols=253 Identities=17% Similarity=0.276 Sum_probs=207.9
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEc---CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~---~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
.+.+.|++.+.||+|+||+||+|.++ .+++.||+|.+.... ...++.+|+++|+.+ +|||||+++++|.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 46678999999999999999999885 467899999886432 234678899999998 69999999999876
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
.+ .+|+|||||+||+|.++++ .+++..++.+++||+.||+|||++| |+||||||+|||++.+.|.+||+|||+
T Consensus 92 ~~--~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 92 ND--HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp TT--EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CC--EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 54 7999999999999999984 5999999999999999999999999 999999999999985558999999999
Q ss_pred hhhccCC------------------------------CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcC
Q 006777 178 AIVMQQP------------------------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCE 225 (631)
Q Consensus 178 A~~~~~~------------------------------~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~ 225 (631)
|+..... ...+.+|||.|||||++.+ .|+.++||||+||++|||+||+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 9643321 1234589999999998754 4899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcC----------------------------------------C------------CCCCCCCC
Q 006777 226 YPYNECKNPAQIYKKVTSG----------------------------------------I------------KPASLSKV 253 (631)
Q Consensus 226 ~Pf~~~~~~~~~~~~i~~~----------------------------------------~------------~p~~l~~~ 253 (631)
.||....+.......|... . ........
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 9997766654443333210 0 00011234
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.++++++||.+||+ ||.+|+||.|+|+||||+..
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 67899999999998 99999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=435.42 Aligned_cols=246 Identities=29% Similarity=0.437 Sum_probs=208.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.+++.+.||+|+||+||+|... ..||||+++... .+....++|.+|+.+|++|+|||||++++++.+ ..+
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~ 106 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNL 106 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeE
Confidence 457789999999999999999854 359999987543 356677889999999999999999999997643 247
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++|||||+||+|.+++... +++++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+...
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLH-EGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEE-TTEEEEECCCSSCBC--
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEEC-CCCcEEEeeccCceecc
Confidence 8999999999999999765 57999999999999999999999998 99999999999998 78999999999997654
Q ss_pred CC----CCccccCCCCCCCcccccc----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Q 006777 183 QP----TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLS 251 (631)
Q Consensus 183 ~~----~~~~~~GTp~y~APE~l~~----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~---~l~ 251 (631)
.. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..+...+...+..+..++ .++
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 263 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY 263 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence 22 2346789999999998842 489999999999999999999999998777777877777765443 344
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+++++++||.+||+ +|.+|||+.|++.
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 5678999999999998 8999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=434.95 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=213.4
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
.+++|.+.+.||+|+||+||+|.+. .+|..||||+++.. +....++|.+|+++|++|+|||||++|+++.+
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 3578999999999999999999874 46889999998743 35667889999999999999999999999876
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH-------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN 164 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~-------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~ 164 (631)
.+ .+++|||||++|+|.+++.++ ..+++..+..|+.||+.||.|||+++ ||||||||+|||++
T Consensus 87 ~~--~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~ 162 (299)
T 4asz_A 87 GD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG 162 (299)
T ss_dssp SS--SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred CC--EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEEC
Confidence 54 689999999999999999764 36999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHH
Q 006777 165 GNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 238 (631)
Q Consensus 165 ~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~ 238 (631)
.++.+||+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++.
T Consensus 163 -~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~ 240 (299)
T 4asz_A 163 -ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVI 240 (299)
T ss_dssp -GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHH
T ss_pred -CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHH
Confidence 78999999999998654322 23457999999999885 569999999999999999999 8999987 5677788
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
..+..+..+. .+..+++++++||.+||+ +|.+|||+.+++ +||+
T Consensus 241 ~~i~~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 241 ECITQGRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp HHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred HHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 8888775543 456678999999999998 999999999984 4554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=433.19 Aligned_cols=248 Identities=20% Similarity=0.311 Sum_probs=207.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
....|.+.++||+|+||+||+|.+. .+|..||||+++.. +....++|.+|+++|++|+|||||++++++.+
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 3568999999999999999999864 46899999998743 45667889999999999999999999999865
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceE
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH---------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 162 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~---------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NIL 162 (631)
.. .+++|||||++|+|.+++.++ +++++.++..|+.||+.||.|||+++ ||||||||+|||
T Consensus 115 ~~--~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NIL 190 (329)
T 4aoj_A 115 GR--PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCL 190 (329)
T ss_dssp SS--SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred CC--EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEE
Confidence 44 689999999999999999764 35899999999999999999999998 999999999999
Q ss_pred EeCCCCcEEEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHH
Q 006777 163 VNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 236 (631)
Q Consensus 163 l~~~~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~ 236 (631)
++ .++.+||+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+ .+..+
T Consensus 191 l~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~ 268 (329)
T 4aoj_A 191 VG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTE 268 (329)
T ss_dssp EE-TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHH
T ss_pred EC-CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHH
Confidence 98 7899999999999865432 2235689999999998764 69999999999999999999 8999987 45677
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 237 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 237 ~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+...+..+..+. .+..+++++++||.+||. +|.+|||+.|++.+
T Consensus 269 ~~~~i~~g~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 269 AIDCITQGRELE-RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHTCCCC-CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCCCC-CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 777887775443 456678999999999998 99999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=464.03 Aligned_cols=258 Identities=23% Similarity=0.339 Sum_probs=225.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
+-++|.+.+.||+|+||.||+|.++.+|+.||+|++.... ....+.+.+|+++|+.|+|||||+++++|.+. ..
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 228 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NE 228 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CE
Confidence 3468999999999999999999999999999999997543 44567789999999999999999999998765 47
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC-CCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKI~DFGlA~~ 180 (631)
+|||||||+||+|.+++.+ ++.+++..++.|++||+.||.|||+++ |+||||||+|||++. ..|.+||+|||+|+.
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 9999999999999999864 467999999999999999999999999 999999999999973 248999999999987
Q ss_pred ccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCcH
Q 006777 181 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDP 256 (631)
Q Consensus 181 ~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l~~~~~~ 256 (631)
+... .....+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+ .+..+.+..+..+.. +......+++
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 6543 3456799999999998865 599999999999999999999999987 566677777766533 3334456789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
++++||.+||+ +|.+|||+.|+|+||||+..++
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99999999998 9999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=427.85 Aligned_cols=248 Identities=21% Similarity=0.244 Sum_probs=210.6
Q ss_pred CCcEEEEEEEeecCCeEEEEEEE-----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d-----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
...+++.+.||+|+||+||+|.. ..+++.||||+++... .....++|.+|+.+|++|+|||||++++++.+.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 45789999999999999999985 3578899999987442 233456799999999999999999999988654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceE
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 162 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NIL 162 (631)
. .+++|||||++|+|.+++..+ ..+++..+..++.||+.||+|||+++ ||||||||+|||
T Consensus 102 ~--~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NIL 177 (308)
T 4gt4_A 102 Q--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVL 177 (308)
T ss_dssp S--SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred C--EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceE
Confidence 3 689999999999999999653 35899999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHH
Q 006777 163 VNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 236 (631)
Q Consensus 163 l~~~~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~ 236 (631)
++ .++.+||+|||+|+..... .....+||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..+
T Consensus 178 l~-~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~~ 255 (308)
T 4gt4_A 178 VY-DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQD 255 (308)
T ss_dssp EC-GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHHH
T ss_pred EC-CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCHHH
Confidence 98 7899999999999765332 234568999999999875 569999999999999999998 8999987 56677
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 237 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 237 ~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+...+..+..++ .+..+++.+.+||.+||. +|.+|||+.||+.+
T Consensus 256 ~~~~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 256 VVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 788888775543 455678999999999998 89999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=431.72 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=215.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCC-----CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCcceeeeEEEc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVD 97 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~-----g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~f~~ 97 (631)
.++|++.+.||+|+||+||+|.+... ++.||+|.++... .....+.+.+|+.+|+++.| ||||++++++..
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 56899999999999999999987643 4689999987542 34566789999999999965 999999998865
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCce
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NI 161 (631)
.. ..+++|||||++|+|.+++++. ..+++..+..|+.||+.||+|||+++ ||||||||+||
T Consensus 140 ~~-~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NI 216 (353)
T 4ase_A 140 PG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNI 216 (353)
T ss_dssp TT-SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred cC-CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccce
Confidence 43 4689999999999999999763 34899999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHH
Q 006777 162 FVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPA 235 (631)
Q Consensus 162 Ll~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~ 235 (631)
|++ .++.+||+|||+|+...... ....+||+.|||||++. +.|+.++|||||||++|||+| |..||.+.....
T Consensus 217 Ll~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 217 LLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeC-CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 998 78999999999998654322 23567999999999875 569999999999999999998 899999877677
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 236 ~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+.+.+..+..+. .+...++++++||.+||. +|.+|||+.+|++|
T Consensus 296 ~~~~~i~~g~~~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 296 EFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 7888888776544 455678999999999998 99999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=401.83 Aligned_cols=266 Identities=48% Similarity=0.890 Sum_probs=240.0
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC-
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD- 98 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~- 98 (631)
....+..|.+.+.||+|+||+||+|.+..++..||+|.+..... .....+.+.+|+.+|++++||||++++++|...
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 34456789999999999999999999999999999999986543 456678899999999999999999999988653
Q ss_pred -CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 99 -TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 -~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
....+++||||+++|+|.+++...+.+++..++.|+.||+.||.|||+++++|+||||||+|||++..++.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred CCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 3457899999999999999999988999999999999999999999999888999999999999975788999999999
Q ss_pred hhhccCCCCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 178 AIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 178 A~~~~~~~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
+............||+.|+|||++.+.++.++|||||||++|+|++|..||.+..+.......+..+..+..++...+++
T Consensus 179 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 179 ATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp GGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred cccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 98766666667789999999999988899999999999999999999999999888889988888887777777778899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+++||.+||. +|.+|||+.++|+||||+..
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 9999999998 89999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=406.40 Aligned_cols=256 Identities=23% Similarity=0.431 Sum_probs=226.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+++.+|+++|+.++||||+++++++.+. ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~ 88 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--KT 88 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CE
Confidence 34689999999999999999999999999999999986543 456678899999999999999999999988654 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+|+||||+++|+|.+++..++.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLD-ADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTCCGGGS
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEc-CCCCEEEeeccCceecC
Confidence 9999999999999999998899999999999999999999999999 99999999999998 78999999999997654
Q ss_pred CC-CCccccCCCCCCCccccccc-c-CccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 183 QP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 ~~-~~~~~~GTp~y~APE~l~~~-y-~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
.. .....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+ .+...+...+..+... ++...++.++
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 242 (328)
T 3fe3_A 166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCE 242 (328)
T ss_dssp SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHH
Confidence 33 34567899999999988653 4 5899999999999999999999987 5677777777776432 3445789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+||.+||. +|.+|||+.|+|+||||+...
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999998 999999999999999998643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=412.87 Aligned_cols=268 Identities=21% Similarity=0.372 Sum_probs=231.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
-++|.+.++||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|+.+|+.++||||++++++|.+.. .+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~~ 80 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--EE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC--EE
Confidence 35899999999999999999999999999999999765321 1233567889999999999999999999987654 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc-
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ- 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~- 182 (631)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++...
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEEC-CCCCEEEeeccchhhccc
Confidence 999999999999999998889999999999999999999999999 99999999999998 78999999999997532
Q ss_pred -CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 183 -QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 183 -~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+...++..+.... ..++...++++++
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~ 234 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKS 234 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHH
Confidence 233456789999999998864 589999999999999999999999987 56666777766542 2355667899999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHhcCCCccCCCCCccccCCCCCC
Q 006777 261 FIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 261 lI~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~~~l~~p 300 (631)
||.+||. +|.+|| ++.++++||||...+|..+....+..|
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp 280 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCC
Confidence 9999998 999999 899999999999998887665544443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=418.17 Aligned_cols=271 Identities=20% Similarity=0.325 Sum_probs=227.5
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~ 100 (631)
...++|++.++||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|+.+|+.+ +||||++++++|.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~- 97 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD- 97 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC-
Confidence 3457899999999999999999999999999999999865321 123456688899999988 7999999999987654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.
T Consensus 98 -~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 98 -RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKE 173 (353)
T ss_dssp -EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBC
T ss_pred -EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEEC-CCCCEEEccccceee
Confidence 79999999999999999999899999999999999999999999999 99999999999998 789999999999975
Q ss_pred cc--CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 181 MQ--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~--~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
.. .......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+...++..+..+.. .++...++.
T Consensus 174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~ 250 (353)
T 3txo_A 174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLHED 250 (353)
T ss_dssp SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHH
T ss_pred cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHH
Confidence 32 223456789999999998865 599999999999999999999999987 567777777776533 344567899
Q ss_pred HHHHHHHhcC-CCCCCCCH------HHHhcCCCccCCCCCccccCCCCCCC
Q 006777 258 VKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVCDPLRLPN 301 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta------~elL~hpff~~~~~~~~~~~~l~~p~ 301 (631)
+++||.+||. +|.+||++ .++++||||+..+|..+....+..|.
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~ 301 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPF 301 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred HHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCc
Confidence 9999999998 89999998 89999999999988776555454443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=407.88 Aligned_cols=249 Identities=25% Similarity=0.334 Sum_probs=195.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC--c
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--R 101 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~--~ 101 (631)
..+|.+.++||+|+||+||+|.+ +|+.||||+++... ........|+..+.+|+|||||++++++.+++. .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 45799999999999999999986 59999999986432 122223457777788999999999999886543 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~------~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
.+|+|||||++|+|.++++++ .+++..+..++.|++.||.|||++ .++||||||||+|||++ .+|.+||+||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DF 152 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADL 152 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCC
T ss_pred EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeC
Confidence 689999999999999999875 589999999999999999999987 23499999999999998 7899999999
Q ss_pred cchhhccCCC------CccccCCCCCCCcccccc-------ccCccceEeehhhHHHHHhhcCCCCCCC-----------
Q 006777 176 GLAIVMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNEC----------- 231 (631)
Q Consensus 176 GlA~~~~~~~------~~~~~GTp~y~APE~l~~-------~y~~~sDIwSLG~il~emltG~~Pf~~~----------- 231 (631)
|+|+...... ....+||+.|||||++.+ .|+.++|||||||++|||+||..||...
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 9997654322 234689999999998854 3788999999999999999997665321
Q ss_pred ---CCHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 232 ---KNPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 232 ---~~~~~~~~~i~~~~~p~~l~~~-----~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.....+.+.+......+.++.. ..+.+.+||.+||. +|.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1234444555444332233322 23468899999998 99999999998863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=405.64 Aligned_cols=269 Identities=26% Similarity=0.385 Sum_probs=231.6
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|.+.+.||+|+||.||+|.++.+|+.||+|+++...... ....+.+.+|+.+|+.++||||++++++|.+. ..+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 81 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQI 81 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CEE
Confidence 468999999999999999999999999999999997653211 12346678899999999999999999998764 479
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSS
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEc-CCCCEEEeecCcceecCC
Confidence 999999999999999999889999999999999999999999999 99999999999997 789999999999976543
Q ss_pred CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006777 184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 184 ~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI 262 (631)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+....+..+..+. ..++...++++++||
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li 234 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAE--LRFPPFFNEDVKDLL 234 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHH
Confidence 3456789999999998764 589999999999999999999999987 45666666666553 234556789999999
Q ss_pred HHhcC-CCCCCC-----CHHHHhcCCCccCCCCCccccCCCCCCCC
Q 006777 263 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPNL 302 (631)
Q Consensus 263 ~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~~~l~~p~~ 302 (631)
.+||. +|.+|| ++.++++||||+..+|..+....+..|..
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~ 280 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYE 280 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCC
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCC
Confidence 99998 999999 89999999999998887766555544443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=417.10 Aligned_cols=271 Identities=17% Similarity=0.291 Sum_probs=228.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
...+|.+.++||+|+||+||+|.++.+|+.||+|+++.... ......+.+.+|..+|+++ +|||||+++++|.+. .
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~-~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~ 126 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--S 126 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT-C----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--S
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--C
Confidence 35689999999999999999999999999999999987643 2334456688899999887 899999999998765 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+..
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEC-CCCCEEEeecceeeec
Confidence 79999999999999999999889999999999999999999999999 99999999999998 7899999999999753
Q ss_pred c--CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCC--------CCHHHHHHHHHcCCCCCCC
Q 006777 182 Q--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 182 ~--~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~--------~~~~~~~~~i~~~~~p~~l 250 (631)
. .....+.+||+.|+|||++.+ .|+.++|||||||++|||++|..||... .....+++.+... ...+
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~ 281 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRI 281 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--CCCC
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--ccCC
Confidence 2 234567899999999998765 5999999999999999999999999642 2234455566554 2345
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCH------HHHhcCCCccCCCCCccccCCCCCCC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVCDPLRLPN 301 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta------~elL~hpff~~~~~~~~~~~~l~~p~ 301 (631)
+...++++++||.+||+ +|.+||++ .++++||||+..+|..+....+..|.
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~ 339 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF 339 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSC
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCC
Confidence 56678999999999998 99999995 79999999999988876555444443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=398.02 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=221.7
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
....+|++.+.||+|+||+||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||++++++|.+..
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 90 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD-- 90 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC--
Confidence 345789999999999999999999999999999999986543 22456889999999999999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+++||||+.+|+|.+++.+. .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQI 166 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEC-CCCCEEEeeCCCceec
Confidence 789999999999999999875 5999999999999999999999999 99999999999997 7899999999998765
Q ss_pred cCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 182 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.............+......+...++.+
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T 3fxz_A 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (297)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHH
T ss_pred CCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHH
Confidence 433 2345689999999998754 5899999999999999999999999875544444444444444444556678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
++||.+||. +|.+|||+.|+|+||||+...
T Consensus 247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 999999998 999999999999999998654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=404.81 Aligned_cols=266 Identities=17% Similarity=0.299 Sum_probs=228.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCce
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~ 102 (631)
..+|.+.+.||+|+||.||+|.++.+|+.||+|++..... ......+.+.+|+.+++++ +||||++++++|.+. ..
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~ 84 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR 84 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CE
Confidence 4689999999999999999999999999999999987653 3456677889999999988 899999999998765 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCGGGCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEEecccccccc
Confidence 9999999999999999998889999999999999999999999999 99999999999998 78999999999997532
Q ss_pred --CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCC--------CCHHHHHHHHHcCCCCCCCC
Q 006777 183 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 183 --~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~--------~~~~~~~~~i~~~~~p~~l~ 251 (631)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|..||... .....++..+.... ..++
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCC
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCC
Confidence 233456789999999998764 6899999999999999999999999642 23344555565542 2355
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCH------HHHhcCCCccCCCCCccccCCC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPA------LELLKDPFLVTDNPKDLVCDPL 297 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta------~elL~hpff~~~~~~~~~~~~l 297 (631)
...++.+++||.+||. +|.+||++ .++++||||+..+|..+....+
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~ 292 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQV 292 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCC
Confidence 6678999999999998 99999995 7999999999988876544333
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=408.84 Aligned_cols=271 Identities=21% Similarity=0.337 Sum_probs=234.7
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
....++|.+.+.||+|+||.||+|.++.+|+.||+|++....... ....+.+.+|+.+|+.++||||++++++|.+.
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 113 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-- 113 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--
Confidence 345679999999999999999999999999999999997653211 12356788999999999999999999998764
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKR 190 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEE
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEEC-CCCCEEEccccccee
Confidence 479999999999999999999889999999999999999999999999 99999999999997 789999999999976
Q ss_pred ccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 181 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 181 ~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
.... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+.. .++...++.++
T Consensus 191 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~ 266 (350)
T 1rdq_E 191 VKGR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLK 266 (350)
T ss_dssp CSSC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHH
T ss_pred ccCC-cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHH
Confidence 5443 346789999999998754 689999999999999999999999987 567777777777632 34556789999
Q ss_pred HHHHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCccccCCCCCCC
Q 006777 260 QFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPN 301 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~~~l~~p~ 301 (631)
+||.+||. +|.+||+ +.++++||||...+|..+....+..|.
T Consensus 267 ~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~ 314 (350)
T 1rdq_E 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPF 314 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred HHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCC
Confidence 99999998 9999998 999999999999888776555454443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=409.74 Aligned_cols=263 Identities=24% Similarity=0.376 Sum_probs=226.5
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC--HHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
..+.++|.+.+.||+|+||+||+|.++.+|..||+|++........ ....+.+.+|+.+|++++||||++++++|.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 4567899999999999999999999999999999999987653221 11346788999999999999999999998654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC----cEEEcc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGD 174 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKI~D 174 (631)
..+++||||++||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++ .+||+|
T Consensus 88 --~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~~~~vkl~D 162 (361)
T 2yab_A 88 --TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLL-DKNIPIPHIKLID 162 (361)
T ss_dssp --SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CTTSSSCCEEECC
T ss_pred --CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-CCCCCccCEEEEe
Confidence 479999999999999999998889999999999999999999999999 99999999999997 444 799999
Q ss_pred ccchhhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCC
Q 006777 175 LGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASL 250 (631)
Q Consensus 175 FGlA~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p--~~l 250 (631)
||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+....+..+..+... ...
T Consensus 163 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 241 (361)
T 2yab_A 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEF 241 (361)
T ss_dssp CSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHH
T ss_pred cCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchh
Confidence 9999765443 3456789999999998865 699999999999999999999999987 5666777777665432 222
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
....++.+++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 34568899999999998 9999999999999999986554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=410.29 Aligned_cols=269 Identities=22% Similarity=0.367 Sum_probs=230.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
..++|.+.++||+|+||.||+|.++.+|+.||+|+++...... ....+.+..|..+|+.+ +||||++++++|.+..
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~-- 91 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-- 91 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC--
Confidence 4578999999999999999999999999999999998653211 12345677899999876 9999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++..
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEEC-CCCCEEEeEChhhhhc
Confidence 79999999999999999998889999999999999999999999999 99999999999998 7899999999999754
Q ss_pred c--CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 182 Q--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~--~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
. .......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+. ..++...++++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~ 245 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN--PFYPRWLEKEA 245 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCC--CCCCcccCHHH
Confidence 2 233556789999999998764 589999999999999999999999987 56677777776653 23455678999
Q ss_pred HHHHHHhcC-CCCCCCCHH-HHhcCCCccCCCCCccccCCCCCC
Q 006777 259 KQFIEKCIV-PASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~-elL~hpff~~~~~~~~~~~~l~~p 300 (631)
++||.+||. +|.+||++. ++++||||+..+|..+....+..|
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~~p 289 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPP 289 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC-
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCCCC
Confidence 999999998 999999998 999999999988877655444444
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=407.35 Aligned_cols=271 Identities=20% Similarity=0.282 Sum_probs=231.8
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~ 100 (631)
....+|.+.++||+|+||.||+|.++.+|+.||+|+++...... ....+.+..|..+|+.+ +||||++++++|.+.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-- 93 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-- 93 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--
Confidence 34578999999999999999999999999999999998653211 12346688899999988 899999999998765
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKE 170 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEc-CCCcEEEEeCCcccc
Confidence 479999999999999999998889999999999999999999999999 99999999999998 789999999999975
Q ss_pred cc--CCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 181 MQ--QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~--~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
.. .......+||+.|+|||++. ..|+.++|||||||++|||++|..||.+ .+...++..+..... .++...+++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~ 247 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKE 247 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHH
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHH
Confidence 32 23455678999999999876 4699999999999999999999999987 567777777776532 345667899
Q ss_pred HHHHHHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCccccCCCCCCC
Q 006777 258 VKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLPN 301 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~~~l~~p~ 301 (631)
+++||.+||. +|.+||+ +.++++||||+..+|..+....+..|.
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~ 297 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPY 297 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCc
Confidence 9999999998 9999994 699999999999888776555554443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=398.11 Aligned_cols=270 Identities=22% Similarity=0.287 Sum_probs=218.4
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEc---CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~---~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
.....+|.+.+.||+|+||.||+|.+. .+|+.||+|+++.............+.+|+.+|+.++||||++++++|.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 344578999999999999999999985 68999999999866543334455678899999999999999999998876
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
.. .+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 93 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~ 167 (327)
T 3a62_A 93 GG--KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGL 167 (327)
T ss_dssp SS--CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTSCEEECCCSC
T ss_pred CC--EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEEC-CCCcEEEEeCCc
Confidence 44 78999999999999999998889999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccC--CCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006777 178 AIVMQQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 178 A~~~~~--~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~ 254 (631)
+..... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+.......+..... .++...
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~ 244 (327)
T 3a62_A 168 CKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL--NLPPYL 244 (327)
T ss_dssp C----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCC--CCCTTS
T ss_pred ccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC--CCCCCC
Confidence 975432 2345678999999999875 4589999999999999999999999987 455666666665432 344567
Q ss_pred cHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCccCCCCCccccCCCC
Q 006777 255 DPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLR 298 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~~~l~ 298 (631)
++.+++||.+||. +|.+|| ++.++++||||+..+|..+......
T Consensus 245 ~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~ 294 (327)
T 3a62_A 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVE 294 (327)
T ss_dssp CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSC
T ss_pred CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCC
Confidence 8999999999998 899999 8899999999998887765544333
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=415.07 Aligned_cols=271 Identities=18% Similarity=0.285 Sum_probs=225.4
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|.+.++||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.+|+.++|||||+++++|.+. ..
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~ 143 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RY 143 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CE
Confidence 3568999999999999999999999999999999997532211 11123477899999999999999999998764 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+|+||||++||+|.+++.+. .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeEC-CCCCEEEeccceeEeec
Confidence 99999999999999999764 6999999999999999999999999 99999999999998 78999999999997654
Q ss_pred CCC---CccccCCCCCCCccccccc-----cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCC
Q 006777 183 QPT---ARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSK 252 (631)
Q Consensus 183 ~~~---~~~~~GTp~y~APE~l~~~-----y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~--l~~ 252 (631)
... ..+.+||+.|+|||++.+. |+.++|||||||++|||++|..||.+ .+....+..+..+..... ...
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTC
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcc
Confidence 432 3467899999999987532 78999999999999999999999987 566777777765421111 223
Q ss_pred CCcHHHHHHHHHhcC-CCCC--CCCHHHHhcCCCccCCCCCccccCCCCCCC
Q 006777 253 VTDPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPKDLVCDPLRLPN 301 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~--Rpta~elL~hpff~~~~~~~~~~~~l~~p~ 301 (631)
..++++++||.+||. +|.+ |+++.|+++||||+..+|..+....+..|.
T Consensus 299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~ 350 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPV 350 (410)
T ss_dssp CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSC
T ss_pred cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCC
Confidence 578999999999998 6777 999999999999999888765444444443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=386.82 Aligned_cols=256 Identities=21% Similarity=0.349 Sum_probs=214.2
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.++++++||||++++++|.+.. .++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC--EEE
Confidence 579999999999999999999999999999999986643 3345567889999999999999999999987654 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||+.++.+..+....+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCSC
T ss_pred EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecCCc
Confidence 99999986444444455678999999999999999999999999 99999999999998 7899999999999765432
Q ss_pred --CCccccCCCCCCCcccccc-c-cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--C-CCC---------
Q 006777 185 --TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I-KPA--------- 248 (631)
Q Consensus 185 --~~~~~~GTp~y~APE~l~~-~-y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~--~-~p~--------- 248 (631)
......||+.|+|||++.+ . ++.++|||||||++|+|++|..||....+.......+... . .+.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 2345688999999998754 3 8999999999999999999999977667766666555331 0 000
Q ss_pred ---------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 249 ---------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 ---------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
......++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1122467899999999998 99999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=411.20 Aligned_cols=274 Identities=19% Similarity=0.333 Sum_probs=232.9
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
....++|.+.+.||+|+||.||+|.+..+|+.||+|++....... ......+.+|+.+|+.++|||||+++++|.+..
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~- 88 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE- 88 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-
Confidence 334578999999999999999999999999999999997654211 223567889999999999999999999987654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+|+||||+.||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..
T Consensus 89 -~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 89 -DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAM 164 (384)
T ss_dssp -EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEE
T ss_pred -EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEC-CCCCEEEeccceeee
Confidence 79999999999999999999889999999999999999999999999 99999999999998 789999999999976
Q ss_pred ccCC-CCccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCC--CCHHHHHHHHHcCCCCCCCCCC
Q 006777 181 MQQP-TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 181 ~~~~-~~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~--~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
.... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....+...+... ...++..
T Consensus 165 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~p~~ 242 (384)
T 4fr4_A 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--VVTYPSA 242 (384)
T ss_dssp CCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--CCCCCTT
T ss_pred ccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--ccCCCCc
Confidence 5433 346778999999999885 24899999999999999999999999743 3445555555544 2334556
Q ss_pred CcHHHHHHHHHhcC-CCCCCCC-HHHHhcCCCccCCCCCccccCCCCCCCC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLP-ALELLKDPFLVTDNPKDLVCDPLRLPNL 302 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpt-a~elL~hpff~~~~~~~~~~~~l~~p~~ 302 (631)
+++.+++||.+||. +|.+||+ +.++++||||...+|..+....+..|..
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p~~~ 293 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFI 293 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCCCCC
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCCCCC
Confidence 78999999999998 9999998 8999999999999988776555544433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=389.89 Aligned_cols=258 Identities=21% Similarity=0.385 Sum_probs=214.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC----------------------HHHHHHHHHHHHHH
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS----------------------PDQLERLYSEVHLL 80 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~----------------------~~~~~~~~~Ei~iL 80 (631)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++........ ....+.+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 35689999999999999999999999999999999976543211 12246688999999
Q ss_pred HhCCCCCcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCc
Q 006777 81 KSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160 (631)
Q Consensus 81 ~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~N 160 (631)
++++||||+++++++.+.....+++||||+++|+|.+++. .+.+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHH
Confidence 9999999999999998766678999999999999988654 457999999999999999999999999 9999999999
Q ss_pred eEEeCCCCcEEEccccchhhccCCC--CccccCCCCCCCccccccc----cCccceEeehhhHHHHHhhcCCCCCCCCCH
Q 006777 161 IFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNP 234 (631)
Q Consensus 161 ILl~~~~g~vKI~DFGlA~~~~~~~--~~~~~GTp~y~APE~l~~~----y~~~sDIwSLG~il~emltG~~Pf~~~~~~ 234 (631)
||++ .+|.+||+|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+ .+.
T Consensus 168 il~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~ 245 (298)
T 2zv2_A 168 LLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERI 245 (298)
T ss_dssp EEEC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSH
T ss_pred EEEC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccH
Confidence 9997 78999999999997654332 3456899999999988643 47889999999999999999999987 455
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 235 ~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
......+.....+.......++.+++||.+||. +|.+|||+.|+|+||||+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 566666665544333344578999999999998 999999999999999995
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=412.74 Aligned_cols=259 Identities=23% Similarity=0.390 Sum_probs=224.3
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
....++|.+.+.||+|+||+||+|.+..+|..||+|++..... .....+.+.+|+.+|+.|+|||||+++++|.+.
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-- 82 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEE-- 82 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS--
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC--
Confidence 3456789999999999999999999999999999999986643 345567789999999999999999999988654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEEccccch
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI~DFGlA 178 (631)
..+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++. .++.+||+|||++
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 479999999999999999999999999999999999999999999999 999999999999973 3578999999999
Q ss_pred hhccCCC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCC
Q 006777 179 IVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKV 253 (631)
Q Consensus 179 ~~~~~~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l~~~ 253 (631)
....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+.. +......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 239 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDT 239 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCcccccc
Confidence 7655432 345789999999998865 599999999999999999999999987 566777777776643 2233346
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 240 ~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 240 VTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 78999999999998 9999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=415.57 Aligned_cols=269 Identities=21% Similarity=0.351 Sum_probs=221.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|.+.++||+|+||.||+|.+..+|+.||+|++..... .......++.+|+.+|+.++||||++++++|.+.. .
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~ 222 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--R 222 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEETT--E
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC--E
Confidence 35789999999999999999999999999999999986532 23345567889999999999999999999987654 7
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+++||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+ +| |+||||||+|||++ .+|.+||+|||+|...
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEEC-SSSCEEECCCCCCCTT
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEEC-CCCCEEEccCCCceec
Confidence 99999999999999999998899999999999999999999998 88 99999999999998 7899999999999754
Q ss_pred cC--CCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 182 QQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~~--~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.. ......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+...+...+..... .++...++++
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~ 376 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLGPEA 376 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHH
Confidence 32 2345678999999999875 4699999999999999999999999987 456666666655432 3455678999
Q ss_pred HHHHHHhcC-CCCCCC-----CHHHHhcCCCccCCCCCccccCCCCCC
Q 006777 259 KQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~~~l~~p 300 (631)
++||.+||. +|.+|| ++.|+|+||||...+|..+....+..|
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp 424 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 424 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCC
Confidence 999999998 999999 999999999999988877655444433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=405.61 Aligned_cols=270 Identities=23% Similarity=0.357 Sum_probs=224.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHH-HHhCCCCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHL-LKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIV~l~~~f~~~~~~ 101 (631)
..++|.+.++||+|+||.||+|.++.+|+.||+|+++...... ......+.+|..+ ++.++||||++++++|.+..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~-- 112 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-- 112 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSS--
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC--
Confidence 4578999999999999999999999999999999998765432 3344566777776 57789999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+++..
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCBCGGG
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEeeCcccccc
Confidence 79999999999999999999889999999999999999999999999 99999999999998 7899999999999754
Q ss_pred c--CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 182 Q--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~--~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
. .......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+..+++..+... +..++...++.+
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~ 266 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK--PLQLKPNITNSA 266 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHS--CCCCCSSSCHHH
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhc--ccCCCCCCCHHH
Confidence 3 234567789999999998765 589999999999999999999999987 5677777777665 334556678999
Q ss_pred HHHHHHhcC-CCCCCCCH----HHHhcCCCccCCCCCccccCCCCCCC
Q 006777 259 KQFIEKCIV-PASLRLPA----LELLKDPFLVTDNPKDLVCDPLRLPN 301 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta----~elL~hpff~~~~~~~~~~~~l~~p~ 301 (631)
++||.+||+ +|.+||++ .++++||||+..+|..+....+..|.
T Consensus 267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~ 314 (373)
T 2r5t_A 267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPF 314 (373)
T ss_dssp HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred HHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCC
Confidence 999999998 99999997 69999999999999887655554443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=393.71 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=222.4
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
..+.++|.+.+.||+|+||.||+|.++.+|..||+|++......... ...+.+.+|+.+|+.++||||++++++|.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34567899999999999999999999999999999999875432211 1356788999999999999999999998654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC----cEEEcc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGD 174 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKI~D 174 (631)
..+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+|
T Consensus 87 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~-~~~~~~~~~kl~D 161 (326)
T 2y0a_A 87 --TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL-DRNVPKPRIKIID 161 (326)
T ss_dssp --SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEES-CSSSSSCCEEECC
T ss_pred --CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEe-cCCCCCCCEEEEE
Confidence 479999999999999999998889999999999999999999999999 99999999999997 555 799999
Q ss_pred ccchhhccC-CCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCC
Q 006777 175 LGLAIVMQQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASL 250 (631)
Q Consensus 175 FGlA~~~~~-~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p--~~l 250 (631)
||++..... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+.......+...... ...
T Consensus 162 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~ 240 (326)
T 2y0a_A 162 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEY 240 (326)
T ss_dssp CTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHTCCCCCHHH
T ss_pred CCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHhcCCCcCccc
Confidence 999976543 2345678999999999886 4689999999999999999999999987 4455555555543221 122
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
....++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 24567899999999998 999999999999999998654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=395.00 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=218.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 79 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NI 79 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC--Ce
Confidence 45789999999999999999999999999999999976542 23345688999999999999999999988654 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+++||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECE
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEe-CCCCEEEEEeeccceec
Confidence 8999999999999999988888999999999999999999999999 99999999999998 78999999999997543
Q ss_pred CC----CCccccCCCCCCCcccccc-c-cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 183 QP----TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 183 ~~----~~~~~~GTp~y~APE~l~~-~-y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
.. .....+||+.|+|||++.+ . ++.++|||||||++|+|++|..||.........+................++
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCH
Confidence 22 2345689999999998864 3 4789999999999999999999998766554555555554433333455789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
.+++||.+||. +|.+|||+.|+|+||||+....
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999998 9999999999999999986543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=400.00 Aligned_cols=259 Identities=22% Similarity=0.403 Sum_probs=224.7
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..+.++|.+.+.||+|+||.||+|.++.+|..||+|++..... .....+.+.+|+.+|+.|+||||++++++|.+.
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-- 100 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE-- 100 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--
Confidence 3456789999999999999999999999999999999986643 455677899999999999999999999988754
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEEccccch
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI~DFGlA 178 (631)
..+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||++
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 478999999999999999998889999999999999999999999999 999999999999973 2356999999999
Q ss_pred hhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCC
Q 006777 179 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVT 254 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p--~~l~~~~ 254 (631)
...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+... .......
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (362)
T 2bdw_A 179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTV 257 (362)
T ss_dssp BCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGS
T ss_pred eEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCC
Confidence 765543 2345789999999998865 599999999999999999999999987 4566677777665432 2222456
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
++++++||.+||. +|.+||++.++|+||||..
T Consensus 258 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 258 TPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 8999999999998 9999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=416.12 Aligned_cols=264 Identities=17% Similarity=0.294 Sum_probs=222.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|.+.++||+|+||+||+|.++.+|+.||+|++....... ......+.+|+.+|+.++||||++++++|.+.. .
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~--~ 148 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDDN--N 148 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS--E
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--E
Confidence 3578999999999999999999999999999999997543211 112234778999999999999999999987654 7
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+|+||||+.||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+..
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~-~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEc-CCCCEEEcchhhhhhc
Confidence 9999999999999999987 468999999999999999999999999 99999999999998 7899999999999755
Q ss_pred cCCC---CccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC---CCCC
Q 006777 182 QQPT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPAS 249 (631)
Q Consensus 182 ~~~~---~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~---~p~~ 249 (631)
.... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+ .+..+.+..+.... ..+.
T Consensus 226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCS
T ss_pred ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCCc
Confidence 4332 23468999999999875 3589999999999999999999999987 56666666665421 2222
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCC--CCCHHHHhcCCCccCCCCCccc
Q 006777 250 LSKVTDPQVKQFIEKCIV-PASL--RLPALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 250 l~~~~~~~lk~lI~kcL~-~p~~--Rpta~elL~hpff~~~~~~~~~ 293 (631)
.....++++++||.+||. +|.+ |+++.|+++||||+..+|..+.
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~ 351 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR 351 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence 223478999999999997 5655 8999999999999999998763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=395.35 Aligned_cols=256 Identities=19% Similarity=0.294 Sum_probs=220.5
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.+.++|.+.+.||+|+||+||+|.+..+|..||+|.+... ....+.+.+|+.+|+.++||||++++++|.+..
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 74 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESME-- 74 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC--
Confidence 4567999999999999999999999999999999998743 234567889999999999999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC-CCcEEEccccchh
Q 006777 102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~-~g~vKI~DFGlA~ 179 (631)
.+++||||++||+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.. ++.+||+|||++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 7999999999999999998754 7999999999999999999999999 9999999999999732 7899999999997
Q ss_pred hccCC-CCccccCCCCCCCccccccc-cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCc
Q 006777 180 VMQQP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTD 255 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~y~APE~l~~~-y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~--l~~~~~ 255 (631)
..... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+ .+.......+..+..... .....+
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T 1tki_A 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCC
Confidence 66443 23456799999999988654 79999999999999999999999987 455666666665533221 223568
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 232 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 899999999998 99999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=411.26 Aligned_cols=264 Identities=18% Similarity=0.307 Sum_probs=222.4
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|.+.++||+|+||.||+|.++.+|+.||+|+++..... .....+.+.+|+.+|..++||||++++++|.+.. .
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~--~ 135 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN--Y 135 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS--E
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC--E
Confidence 357899999999999999999999999999999999754321 1123345788999999999999999999987654 7
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+++..
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld-~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeec-CCCCEEEeechhheec
Confidence 999999999999999998754 7999999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCCC---CccccCCCCCCCccccc--------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC---CCC
Q 006777 182 QQPT---ARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKP 247 (631)
Q Consensus 182 ~~~~---~~~~~GTp~y~APE~l~--------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~---~~p 247 (631)
.... ....+||+.|+|||++. +.|+.++|||||||++|||++|+.||.+ .+..+.+..+... ...
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCC
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCC
Confidence 4332 23568999999999875 3589999999999999999999999987 5566666666542 122
Q ss_pred CCCCCCCcHHHHHHHHHhcCCCCCC---CCHHHHhcCCCccCCCCCccc
Q 006777 248 ASLSKVTDPQVKQFIEKCIVPASLR---LPALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~~p~~R---pta~elL~hpff~~~~~~~~~ 293 (631)
+.+....++++++||.+||.+|.+| |++.|+++||||+..+|..+.
T Consensus 292 p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp C----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred CccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 2234567899999999999988776 699999999999999988763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=376.08 Aligned_cols=262 Identities=23% Similarity=0.408 Sum_probs=225.2
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
....++|.+.+.||+|+||.||+|.+..+|..||+|++..... .....+++.+|+.++++++||||+++++++.+.
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 77 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE-- 77 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--
Confidence 3467899999999999999999999999999999999986643 456677899999999999999999999988654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEEccccch
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI~DFGlA 178 (631)
...++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++. ..+.+||+|||++
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 478999999999999999998889999999999999999999999999 999999999999972 2345999999999
Q ss_pred hhccCCC-CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCC
Q 006777 179 IVMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVT 254 (631)
Q Consensus 179 ~~~~~~~-~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l~~~~ 254 (631)
....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+ .+.......+..+.. +.......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T 3kk8_A 156 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTV 234 (284)
T ss_dssp EECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred EEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhccc
Confidence 7654432 345689999999998765 589999999999999999999999987 456666666665533 33333467
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
++++++||.+||. +|.+|||+.++|+||||+....
T Consensus 235 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 235 TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 8999999999998 9999999999999999987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=382.89 Aligned_cols=259 Identities=22% Similarity=0.361 Sum_probs=215.6
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
..++.++|.+.+.||+|+||+||+|.+..+|..||+|.+..... ....+.+.+|+++|++++||||+++++++.+.
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 92 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY- 92 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHheecC-
Confidence 44677899999999999999999999999999999999986542 22356788999999999999999999988654
Q ss_pred CceEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEEc
Q 006777 100 NRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIG 173 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI~ 173 (631)
..+++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++. .++.+||+
T Consensus 93 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 93 -HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp -SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred -CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEE
Confidence 478999999999999998854 367999999999999999999999999 999999999999952 45789999
Q ss_pred cccchhhccCC-CCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCC
Q 006777 174 DLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLS 251 (631)
Q Consensus 174 DFGlA~~~~~~-~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p-~~l~ 251 (631)
|||++...... ......||+.|+|||++.+.++.++|||||||++|+|++|..||.+ .+.......+...... ....
T Consensus 170 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~ 248 (285)
T 3is5_A 170 DFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKEPNYAVEC 248 (285)
T ss_dssp CCCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCC--
T ss_pred eeecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhhccCCccccccc
Confidence 99999765433 3445679999999999988899999999999999999999999987 4455555555443322 2222
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
...++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 3467899999999998 9999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=389.39 Aligned_cols=262 Identities=23% Similarity=0.364 Sum_probs=212.0
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
....+.++|++.+.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+|++++||||+++++++.+.
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 45667889999999999999999999995 699999999976532 233456788999999999999999999988654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
..+++||||+. |+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 92 --~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~ 165 (311)
T 3niz_A 92 --RCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGL 165 (311)
T ss_dssp --SCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTT
T ss_pred --CEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEEC-CCCCEEEccCcC
Confidence 47899999998 5788877665 45999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHH--cCCCCCCC-
Q 006777 178 AIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SGIKPASL- 250 (631)
Q Consensus 178 A~~~~~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~--~~~~p~~l- 250 (631)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..... ....+..+
T Consensus 166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 9765432 2344678999999998754 589999999999999999999999987554444333222 11111111
Q ss_pred ------------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 251 ------------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 251 ------------------------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
....++++++||.+||+ +|.+|||+.|+|+||||+..++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 12356789999999998 9999999999999999987654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=396.56 Aligned_cols=261 Identities=20% Similarity=0.375 Sum_probs=216.1
Q ss_pred cCCCcEEEEEEEeec--CCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 22 SVSYFWISWVVVLNC--TFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G--~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...++|++.++||+| +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+|+.++|||||+++++|.+..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 346789999999999 999999999999999999999987643 4566778899999999999999999999987654
Q ss_pred CceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 100 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
.+++||||+++|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~dfg~ 174 (389)
T 3gni_B 100 --ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRS 174 (389)
T ss_dssp --EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCGGG
T ss_pred --EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEccccc
Confidence 799999999999999999876 67999999999999999999999999 99999999999998 789999999998
Q ss_pred hhhccC---------CCCccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006777 178 AIVMQQ---------PTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 245 (631)
Q Consensus 178 A~~~~~---------~~~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~ 245 (631)
+..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+..........+....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 853321 12234579999999998865 589999999999999999999999987555444433222110
Q ss_pred C-------------------------------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 246 K-------------------------------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 246 ~-------------------------------------------p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
. ...++...++.+++||.+||+ +|.+|||+.|+|+|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 111334567899999999998 99999999999999
Q ss_pred CCccCCCC
Q 006777 282 PFLVTDNP 289 (631)
Q Consensus 282 pff~~~~~ 289 (631)
|||+....
T Consensus 335 p~f~~~~~ 342 (389)
T 3gni_B 335 SFFKQIKR 342 (389)
T ss_dssp GGGGGC--
T ss_pred HHHHHHhh
Confidence 99987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=381.27 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=206.7
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||+||+|.+ .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.. .++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC--eEE
Confidence 5799999999999999999998 6899999999976532 1222356789999999999999999999987653 789
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+.+ +|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGI 152 (288)
T ss_dssp EEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC
T ss_pred EEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEeECccccccCc
Confidence 99999985 999998864 67999999999999999999999999 99999999999998 789999999999976643
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCCCC---------
Q 006777 184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPA--------- 248 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--~~~p~--------- 248 (631)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+............. .....
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 2 2344578999999998754 4899999999999999999999999875444433332221 00000
Q ss_pred ---------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 249 ---------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 ---------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.+....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1123467899999999998 99999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=389.83 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=209.0
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
......++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+|++++||||+++++++.+.
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 355567799999999999999999999999999999999976532 233456678999999999999999999998765
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe----CCCCcEEEcc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKIGD 174 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~----~~~g~vKI~D 174 (631)
. .+++||||+. |+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ...+.+||+|
T Consensus 106 ~--~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 106 H--RLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp T--EEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred C--EEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECc
Confidence 4 7999999998 599999999999999999999999999999999999 99999999999995 2445699999
Q ss_pred ccchhhccCC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC-CC
Q 006777 175 LGLAIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-PA 248 (631)
Q Consensus 175 FGlA~~~~~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-~~~-p~ 248 (631)
||++...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+.. +.. ..
T Consensus 181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 9999866433 2345678999999998864 4899999999999999999999999875544444433322 111 11
Q ss_pred CCC-------------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCC
Q 006777 249 SLS-------------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 249 ~l~-------------------------~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~ 290 (631)
.++ ...++++++||.+||. +|.+|||+.|+|+||||+..++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 110 1156899999999998 99999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=400.66 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=216.9
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
....++|.+.+.||+|+||+||+|.+..+|+.||+|++...... ......++.+|+.+|+.++||||+++++++.+..
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 82 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT- 82 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 34457899999999999999999999999999999998754321 1122356889999999999999999999887654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+++||||+ +|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++..
T Consensus 83 -~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 83 -DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNI 157 (336)
T ss_dssp -EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEEC-TTCCEEECCSSCTBT
T ss_pred -EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEc-CCCCEEEEEecccee
Confidence 799999999 7899999988889999999999999999999999999 99999999999998 789999999999976
Q ss_pred ccCC-CCccccCCCCCCCccccccc-c-CccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 181 MQQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~~-~~~~~~GTp~y~APE~l~~~-y-~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
.... .....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+... ..+...+..+ ...++...++.
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~~~--~~~~p~~~s~~ 234 (336)
T 3h4j_B 158 MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-PNLFKKVNSC--VYVMPDFLSPG 234 (336)
T ss_dssp TTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS-TTCBCCCCSS--CCCCCTTSCHH
T ss_pred ccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH-HHHHHHHHcC--CCCCcccCCHH
Confidence 5443 34567899999999998754 3 7899999999999999999999976322 2222222221 22345567899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
+++||.+||. +|.+|||+.|+++||||+...+
T Consensus 235 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 9999999998 9999999999999999986543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=393.02 Aligned_cols=257 Identities=22% Similarity=0.340 Sum_probs=218.1
Q ss_pred ccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEE
Q 006777 18 PISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV 96 (631)
Q Consensus 18 ~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~ 96 (631)
.....+.+.|.+.+.||+|+||+||+|.++.+|+.||+|++..... ...+|+.+|.++ +||||++++++|.
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 15 RNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp ----CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 3344567899999999999999999999999999999999976532 134688888887 7999999999986
Q ss_pred cCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCC---CcEEEc
Q 006777 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIG 173 (631)
Q Consensus 97 ~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~---g~vKI~ 173 (631)
+. ..+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||+...+ +.+||+
T Consensus 87 ~~--~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 87 DG--KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp CS--SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred cC--CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEE
Confidence 54 479999999999999999999889999999999999999999999999 99999999999995333 359999
Q ss_pred cccchhhccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCC--CCHHHHHHHHHcCCCC-
Q 006777 174 DLGLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKP- 247 (631)
Q Consensus 174 DFGlA~~~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~--~~~~~~~~~i~~~~~p- 247 (631)
|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+. .+..++...+..+..+
T Consensus 163 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 242 (342)
T 2qr7_A 163 DFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242 (342)
T ss_dssp CCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC
T ss_pred ECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc
Confidence 99999765432 3456789999999998865 4899999999999999999999999763 4567777777776443
Q ss_pred -CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 248 -ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 248 -~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
...+...++++++||.+||. +|.+||++.++|+||||..
T Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 22345678999999999998 9999999999999999964
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=376.93 Aligned_cols=256 Identities=21% Similarity=0.355 Sum_probs=221.6
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.+.++|++.+.||+|+||.||+|.+..++..||+|.+..... ...+++.+|+.++++++||||++++++|.+. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 79 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN--T 79 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--S
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecC--C
Confidence 456789999999999999999999999999999999876532 2346788999999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe--CCCCcEEEccccchh
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKI~DFGlA~ 179 (631)
.+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||++. ..++.+||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 78999999999999999998889999999999999999999999999 99999999999992 267899999999997
Q ss_pred hccCC-CCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCCcH
Q 006777 180 VMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDP 256 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~--l~~~~~~ 256 (631)
..... ......||+.|+|||++.+.++.++||||||+++|+|++|..||.. .+.......+..+..+.. .....++
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 158 RFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred eccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 65433 3456689999999999988899999999999999999999999987 455556666665533221 1124678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 99999999998 9999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=392.69 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=206.9
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
....++|.+.+.||+|+||+||+|.+..+|+.||+|++..... ..+.+.+|+.+++.++||||++++++|.+..
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 89 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLRHPNIVRFKEVILTPT- 89 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-
Confidence 3456899999999999999999999999999999999975432 1245779999999999999999999987654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC--cEEEccccch
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g--~vKI~DFGlA 178 (631)
.+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++ .+||+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~-~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 90 -HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLD-GSPAPRLKICDFGYS 165 (361)
T ss_dssp -EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEEC-SSSSCCEEECCCCCC
T ss_pred -EEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCceEEEeecCcc
Confidence 79999999999999999998889999999999999999999999999 99999999999997 444 4999999999
Q ss_pred hhccC-CCCccccCCCCCCCcccccc-ccCc-cceEeehhhHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCC
Q 006777 179 IVMQQ-PTARSVIGTPEFMAPELYEE-EYNE-LVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 179 ~~~~~-~~~~~~~GTp~y~APE~l~~-~y~~-~sDIwSLG~il~emltG~~Pf~~~~~---~~~~~~~i~~~~~p~~l~~ 252 (631)
+.... ......+||+.|+|||++.+ .++. ++|||||||++|+|++|..||.+... .......+...........
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (361)
T 3uc3_A 166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI 245 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTS
T ss_pred ccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcC
Confidence 74332 23455689999999998754 4544 48999999999999999999976433 2344444544433322333
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
..++.+++||.+||+ +|.+|||+.|+|+||||....+
T Consensus 246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 246 RISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp CCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 568999999999998 9999999999999999976543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=397.83 Aligned_cols=260 Identities=21% Similarity=0.324 Sum_probs=207.7
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDT 99 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~ 99 (631)
..+..+|++.+.||+|+||.||+|.+..+|+.||+|++... .......+++.+|+.+|+.+. ||||++++++|...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc--ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 34567899999999999999999999999999999998643 234566788899999999997 999999999998776
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
...+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLN-AECHVKVADFGLSR 157 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEc-CCCCEEecCCcccc
Confidence 678999999997 699999876 46999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccC-----------------------CCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCH
Q 006777 180 VMQQ-----------------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNP 234 (631)
Q Consensus 180 ~~~~-----------------------~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~ 234 (631)
.... ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5422 11234689999999998754 5899999999999999999999999875444
Q ss_pred HHHHHHHHcCCCCC--------------------------------------------CCCCCCcHHHHHHHHHhcC-CC
Q 006777 235 AQIYKKVTSGIKPA--------------------------------------------SLSKVTDPQVKQFIEKCIV-PA 269 (631)
Q Consensus 235 ~~~~~~i~~~~~p~--------------------------------------------~l~~~~~~~lk~lI~kcL~-~p 269 (631)
.++...+.....|. ......++++++||.+||+ +|
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 43332221100010 0112457899999999998 99
Q ss_pred CCCCCHHHHhcCCCccCC
Q 006777 270 SLRLPALELLKDPFLVTD 287 (631)
Q Consensus 270 ~~Rpta~elL~hpff~~~ 287 (631)
.+|||+.|+|+||||+..
T Consensus 318 ~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 318 NKRISANDALKHPFVSIF 335 (388)
T ss_dssp GGSCCHHHHTTSTTTTTT
T ss_pred ccCCCHHHHhCCHHHHHh
Confidence 999999999999999763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=412.39 Aligned_cols=263 Identities=28% Similarity=0.422 Sum_probs=229.1
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...+.++|++.++||+|+||.||+|.+..+|+.||+|++...... .....+.+.+|+.+|++++||||++++++|.+.
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 98 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK- 98 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-
T ss_pred CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-
Confidence 345667999999999999999999999999999999999766432 223456789999999999999999999998654
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe--CCCCcEEEccccc
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGL 177 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKI~DFGl 177 (631)
..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..++.+||+|||+
T Consensus 99 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 99 -GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp -SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred -CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 479999999999999999999899999999999999999999999999 99999999999995 2578999999999
Q ss_pred hhhccCC-CCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCC
Q 006777 178 AIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVT 254 (631)
Q Consensus 178 A~~~~~~-~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l--~~~~ 254 (631)
+...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+...+...+..+...... ....
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 176 STHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp HHHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred eEEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccC
Confidence 9876543 3345689999999999988999999999999999999999999987 5667777777776543322 2457
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
++.+++||.+||+ +|.+|||+.++|+||||+...
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 8999999999998 999999999999999998644
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=391.35 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=208.7
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..+.++|.+.+.||+|+||+||+|.+..+++.||+|++.... ..+.+.+|+.+|+.++||||++++++|.+.
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 120 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-- 120 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECS--
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecC--
Confidence 345678999999999999999999999999999999987432 235577899999999999999999998654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEEccccch
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI~DFGlA 178 (631)
..+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 479999999999999999998888999999999999999999999999 999999999999962 3789999999999
Q ss_pred hhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCC
Q 006777 179 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVT 254 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l~~~~ 254 (631)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.......+..+..... +..+....
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 199 KIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred cccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 765433 2345789999999998865 5899999999999999999999999887776667777766533 22334567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
++.+++||.+||. +|.+|||+.++|+||||....
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 8999999999998 999999999999999998643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=379.14 Aligned_cols=256 Identities=21% Similarity=0.354 Sum_probs=217.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|.+.+.||+|+||+||+|.+..++..||+|++...... .......+.+|+.+++.++||||++++++|.+. ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 84 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRV 84 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEE
Confidence 46899999999999999999999999999999998754321 112245688999999999999999999998654 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEEC-TTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEc-CCCCEEEEeccccccCCc
Confidence 999999999999999998889999999999999999999999999 99999999999997 789999999999976555
Q ss_pred CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006777 184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 184 ~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI 262 (631)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..... .++...++.+++||
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 238 (279)
T 3fdn_A 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLI 238 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHH
T ss_pred ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCC--CCCCcCCHHHHHHH
Confidence 55566789999999998765 478899999999999999999999986 556666666665422 34456789999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 263 EKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 263 ~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.+||. +|.+|||+.|+|+||||+...
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHhccChhhCCCHHHHhhCccccCCc
Confidence 99998 899999999999999997643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=393.82 Aligned_cols=261 Identities=23% Similarity=0.388 Sum_probs=217.2
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC-HHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
...+.+.|++.+.||+|+||+||+|.++.+|+.||+|++........ ....+.+.+|+.+|+.++||||++++++|.+.
T Consensus 19 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp -CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34456789999999999999999999999999999999976532211 11346788999999999999999999998765
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEE
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKI 172 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI 172 (631)
..+|+||||++||+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||
T Consensus 99 --~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 99 --GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp --TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEE
T ss_pred --CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEE
Confidence 4799999999999998887643 35899999999999999999999999 999999999999972 2335999
Q ss_pred ccccchhhccCCC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006777 173 GDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249 (631)
Q Consensus 173 ~DFGlA~~~~~~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~ 249 (631)
+|||++....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ ........+..+.....
T Consensus 175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~ 252 (351)
T 3c0i_A 175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMN 252 (351)
T ss_dssp CCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCC
T ss_pred ecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCC
Confidence 9999997654432 345689999999998864 589999999999999999999999986 34556666655533221
Q ss_pred --CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 250 --LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 250 --l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.....++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 253 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 123567899999999998 9999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=382.97 Aligned_cols=266 Identities=25% Similarity=0.353 Sum_probs=207.2
Q ss_pred ccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC-HHHHHHHHHHHHHHHhC---CCCCcceeee
Q 006777 18 PISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSL---KHENIIKFYN 93 (631)
Q Consensus 18 ~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~-~~~~~~~~~Ei~iL~~L---~HpnIV~l~~ 93 (631)
|++....++|++.+.||+|+||+||+|.+..+|+.||+|++........ ......+.+|+.+++.+ +||||+++++
T Consensus 2 p~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp --------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred CCCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 3456678899999999999999999999999999999999976432111 11123455677666665 5999999999
Q ss_pred EEEcCCC---ceEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC
Q 006777 94 SWVDDTN---RTINMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 94 ~f~~~~~---~~l~lV~Ey~~gGsL~~~l~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
++..... ..+++||||+. |+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~-~~~ 157 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGG 157 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEEC-TTS
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCC
Confidence 9876543 26899999997 699999988654 999999999999999999999999 99999999999997 789
Q ss_pred cEEEccccchhhccCC-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--
Q 006777 169 EVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-- 244 (631)
Q Consensus 169 ~vKI~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~-- 244 (631)
.+||+|||++...... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.. .......+...
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~ 236 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-EADQLGKIFDLIG 236 (308)
T ss_dssp CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-HHHHHHHHHHHHC
T ss_pred CEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhC
Confidence 9999999999765533 345678999999999875 568999999999999999999999998744 44443333221
Q ss_pred CC-CCCC----------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 245 IK-PASL----------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 245 ~~-p~~l----------------------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.. ...+ ....++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 11 1111 12457899999999998 999999999999999998743
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=387.55 Aligned_cols=257 Identities=23% Similarity=0.376 Sum_probs=219.0
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCcceeeeEEEcC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDD 98 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~~f~~~ 98 (631)
...+.+|++.+.||+|+||+||+|.+ .+|..||+|++..... .....+.+.+|+.+|+.++| |||+++++++.+.
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc--chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 34577899999999999999999998 4689999999986642 45667889999999999976 9999999988754
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+++|||+ .+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ +|.+||+|||++
T Consensus 82 --~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~--~~~~kl~DFG~a 154 (343)
T 3dbq_A 82 --QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIA 154 (343)
T ss_dssp --SEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSS
T ss_pred --CEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE--CCcEEEeecccc
Confidence 479999994 57899999999999999999999999999999999999 99999999999997 589999999999
Q ss_pred hhccCCC----CccccCCCCCCCccccc------------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006777 179 IVMQQPT----ARSVIGTPEFMAPELYE------------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 179 ~~~~~~~----~~~~~GTp~y~APE~l~------------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~ 242 (631)
....... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+..+.......+.
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 7654332 23568999999999874 4588999999999999999999999988666666666666
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.......++...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 6555666677778899999999998 99999999999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=409.86 Aligned_cols=262 Identities=27% Similarity=0.401 Sum_probs=223.4
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC---------HHHHHHHHHHHHHHHhCCCCCcce
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS---------PDQLERLYSEVHLLKSLKHENIIK 90 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~---------~~~~~~~~~Ei~iL~~L~HpnIV~ 90 (631)
...+.++|.+.++||+|+||+||+|.++.+|..||+|++........ ....+.+.+|+.+|++|+||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 44567899999999999999999999999999999999986543211 123567889999999999999999
Q ss_pred eeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC--
Q 006777 91 FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-- 168 (631)
Q Consensus 91 l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g-- 168 (631)
++++|.+. ..+++|||||+||+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ .++
T Consensus 111 ~~~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~ 185 (504)
T 3q5i_A 111 LFDVFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLE-NKNSL 185 (504)
T ss_dssp EEEEEECS--SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES-STTCC
T ss_pred EEEEEEcC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEe-cCCCC
Confidence 99998654 479999999999999999998889999999999999999999999999 99999999999997 344
Q ss_pred -cEEEccccchhhccCC-CCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006777 169 -EVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246 (631)
Q Consensus 169 -~vKI~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~ 246 (631)
.+||+|||++...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+...+...+..+..
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKY 264 (504)
T ss_dssp SSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC
T ss_pred ccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC
Confidence 6999999999766543 3456789999999999988899999999999999999999999987 566777777777644
Q ss_pred CCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 247 PAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 p~~--l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
... .....++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 322 124568999999999998 99999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=409.94 Aligned_cols=260 Identities=28% Similarity=0.445 Sum_probs=224.9
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.+.++|.+.++||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.+|++++||||+++++++.+. .
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~ 94 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDS--S 94 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC--C
Confidence 46789999999999999999999999999999999997543321 2346788999999999999999999988654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe--CCCCcEEEccccchh
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKI~DFGlA~ 179 (631)
.+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ +.++.+||+|||++.
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 79999999999999999988889999999999999999999999999 99999999999995 245689999999997
Q ss_pred hccCC-CCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCCcH
Q 006777 180 VMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDP 256 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l--~~~~~~ 256 (631)
..... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+...+...+..+..+... ....++
T Consensus 173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence 66443 3456689999999999998999999999999999999999999987 5666777777766543332 245689
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
++++||.+||. +|.+|||+.++|+||||+...
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99999999998 999999999999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=409.85 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=220.4
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..+..+|.+.+.||+|+||+||+|.++.+|..||+|++...... ......+.+|+.+|+.++|||||+++++|.+.
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 108 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-- 108 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--
Confidence 34556899999999999999999999999999999999865432 22346788999999999999999999998654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEEccccch
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI~DFGlA 178 (631)
..+|+|||||.+|+|.+++.....+++..++.+++||+.||.|||++| |+||||||+|||++. .++.+||+|||++
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 479999999999999999998889999999999999999999999999 999999999999963 2456999999999
Q ss_pred hhccCC-CCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCc
Q 006777 179 IVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTD 255 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~--~l~~~~~ 255 (631)
...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++...+..+..+. ......+
T Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 265 (494)
T 3lij_A 187 AVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVS 265 (494)
T ss_dssp EECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred eECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCC
Confidence 765543 3456789999999999988899999999999999999999999987 56677777777664432 2234578
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+.+++||.+||+ +|.+|||+.++|+||||+..
T Consensus 266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999998 99999999999999999763
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=383.06 Aligned_cols=264 Identities=20% Similarity=0.314 Sum_probs=213.3
Q ss_pred CccCccCCCcEEEE-EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeE
Q 006777 17 EPISSSVSYFWISW-VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (631)
Q Consensus 17 ~~~~~~i~~~Y~i~-e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~ 94 (631)
........+.|.+. ++||+|+||+||+|.+..+|+.||+|++.... ....+++.+|+.+|+++ +||||++++++
T Consensus 4 ~~~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~ 79 (316)
T 2ac3_A 4 DSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEF 79 (316)
T ss_dssp CSSCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CccCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 34455677899995 78999999999999999999999999997543 23346788999999985 79999999999
Q ss_pred EEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc---EE
Q 006777 95 WVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE---VK 171 (631)
Q Consensus 95 f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~---vK 171 (631)
|.+.. .+++||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +|
T Consensus 80 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~~~k 154 (316)
T 2ac3_A 80 FEEED--RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCE-HPNQVSPVK 154 (316)
T ss_dssp EEETT--EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEES-CSSSSCSEE
T ss_pred EeeCC--EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEc-cCCCcCceE
Confidence 87654 79999999999999999998889999999999999999999999999 99999999999997 4444 99
Q ss_pred EccccchhhccCC---------CCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCC---
Q 006777 172 IGDLGLAIVMQQP---------TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKN--- 233 (631)
Q Consensus 172 I~DFGlA~~~~~~---------~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~--- 233 (631)
|+|||++...... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+...
T Consensus 155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 234 (316)
T 2ac3_A 155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234 (316)
T ss_dssp ECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS
T ss_pred EEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc
Confidence 9999998654311 123456999999999875 3489999999999999999999999976432
Q ss_pred -----------HHHHHHHHHcCCCCCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 234 -----------PAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 234 -----------~~~~~~~i~~~~~p~~--l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
...+...+..+..... .....++.+++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp CC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred cccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 2345555655533211 113467899999999998 9999999999999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=395.90 Aligned_cols=255 Identities=22% Similarity=0.379 Sum_probs=219.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC--CCCcceeeeEEEcCCC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDTN 100 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~~f~~~~~ 100 (631)
.+..|.+.+.||+|+||+||+|.+.. |..||+|++..... .....+.+.+|+.+|+.|. ||||+++++++....
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~- 129 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ- 129 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-
Confidence 45679999999999999999999864 99999999987643 4566788999999999996 599999999887654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+|+||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++..
T Consensus 130 -~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~--~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 130 -YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQ 203 (390)
T ss_dssp -EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES--SSCEEECCCSSSCC
T ss_pred -EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE--CCeEEEEecCcccc
Confidence 6999999 567899999999889999999999999999999999999 99999999999995 58999999999976
Q ss_pred ccCCC----CccccCCCCCCCcccccc------------ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006777 181 MQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 181 ~~~~~----~~~~~GTp~y~APE~l~~------------~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~ 244 (631)
..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||....+.......+...
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 54322 345689999999998753 58999999999999999999999998766666666666665
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.....++...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 55555666678899999999998 99999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=380.07 Aligned_cols=260 Identities=20% Similarity=0.333 Sum_probs=210.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
-++|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 77 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR--RL 77 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecCC--eE
Confidence 368999999999999999999999999999999987553 34455677889999999999999999999987654 78
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++||||+++++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC-
T ss_pred EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEc-CCCCEEEeeCCCchhccC
Confidence 999999999999999988888999999999999999999999999 99999999999997 789999999999976543
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--C-------------
Q 006777 184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--G------------- 244 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--~------------- 244 (631)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+............. .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 2345689999999998754 5899999999999999999999999875444333222110 0
Q ss_pred ----CC---CCCC------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCC
Q 006777 245 ----IK---PASL------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 245 ----~~---p~~l------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~ 290 (631)
.. +... ....++.+.+||.+||. +|.+|||+.++|+||||+.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 00 0000 12467889999999998 99999999999999999875443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=396.20 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=211.4
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC-
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~- 100 (631)
.+.++|.+.++||+|+||.||+|.+..+|+.||+|++... .......+++.+|+.+|+.++||||+++++++.....
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST--TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch--hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 4578999999999999999999999999999999998743 2345667889999999999999999999998876532
Q ss_pred --ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 101 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+|+||||+. |+|.++++....+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~~kL~DFGla 176 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLA 176 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred cCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEEC-CCCCEEEccCCCc
Confidence 47999999996 699999998888999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCC------------------------CCccccCCCCCCCcccc-c-cccCccceEeehhhHHHHHhhcCCC-----
Q 006777 179 IVMQQP------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTCEYP----- 227 (631)
Q Consensus 179 ~~~~~~------------------------~~~~~~GTp~y~APE~l-~-~~y~~~sDIwSLG~il~emltG~~P----- 227 (631)
+..... .....+||+.|+|||++ . ..|+.++|||||||++|||++|..|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 755322 12567899999999975 3 4599999999999999999984333
Q ss_pred ------CCCCCC-----------------HHHH-----------------------HHHHHcCCC--CCC---CCCCCcH
Q 006777 228 ------YNECKN-----------------PAQI-----------------------YKKVTSGIK--PAS---LSKVTDP 256 (631)
Q Consensus 228 ------f~~~~~-----------------~~~~-----------------------~~~i~~~~~--p~~---l~~~~~~ 256 (631)
|.+... ..++ ...+..... +.. .....++
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 333110 1111 111111100 000 1134689
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~ 291 (631)
++++||.+||+ +|.+|||+.|+|+||||+...+..
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 99999999998 999999999999999999865543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=416.68 Aligned_cols=271 Identities=21% Similarity=0.325 Sum_probs=230.2
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
...++|.+.++||+|+||.||+|.++.+|+.||+|++....... ......+.+|+.+|+.++|||||+++++|.+. .
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETK--D 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--C
Confidence 44678999999999999999999999999999999997654311 12345678999999999999999999998764 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 102 TINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld-~~g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEe-CCCCeEEEecccce
Confidence 7999999999999999998754 3999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCC
Q 006777 180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~---~~~~~~~~i~~~~~p~~l~~~~ 254 (631)
..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.... ....+...+... +..++...
T Consensus 335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~ 412 (576)
T 2acx_A 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERF 412 (576)
T ss_dssp ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTS
T ss_pred ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccC
Confidence 65433 3345789999999998865 69999999999999999999999998643 345566666554 34455678
Q ss_pred cHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCccCCCCCccccCCCCCC
Q 006777 255 DPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~~~l~~p 300 (631)
++++++||.+||. +|.+|| ++.|+++||||+..+|..+....+..|
T Consensus 413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp 464 (576)
T 2acx_A 413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPP 464 (576)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCC
Confidence 8999999999998 999999 799999999999988877654444333
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=382.24 Aligned_cols=263 Identities=24% Similarity=0.381 Sum_probs=223.6
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
...+.++|.+.+.||+|+||.||+|.++.+|..||+|++......... ...+.+.+|+.+|++++||||++++++|.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 345678999999999999999999999999999999999875432211 135678899999999999999999998865
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC----cEEEc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIG 173 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKI~ 173 (631)
. ..+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++ .+||+
T Consensus 87 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~-~~~~~~~~~kl~ 161 (321)
T 2a2a_A 87 R--TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLL-DKNIPIPHIKLI 161 (321)
T ss_dssp S--SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CTTSSSCCEEEC
T ss_pred C--CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEe-cCCCCcCCEEEc
Confidence 4 479999999999999999998888999999999999999999999999 99999999999997 555 79999
Q ss_pred cccchhhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CC
Q 006777 174 DLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--AS 249 (631)
Q Consensus 174 DFGlA~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p--~~ 249 (631)
|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......+...... ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~ 240 (321)
T 2a2a_A 162 DFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEE 240 (321)
T ss_dssp CCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHH
T ss_pred cCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccChh
Confidence 99999765443 3345679999999998764 589999999999999999999999987 4555666666654332 12
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 250 l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+....++.+++||.+||. +|.+|||+.++|+||||....
T Consensus 241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 234567899999999998 999999999999999997644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=382.70 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=209.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
..++|++.++||+|+||+||+|.+..+|+.||+|++.... .......+...|+..+..+ +||||++++++|.+. .
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~ 130 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--G 130 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC--CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--T
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc--cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--C
Confidence 3478999999999999999999999999999999876543 2334445555666555554 999999999998754 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+++||||+ +|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLG-PRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-GGGCEEECCCTTCEE
T ss_pred EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEccceeeee
Confidence 799999999 67998888764 46999999999999999999999999 99999999999997 789999999999876
Q ss_pred ccCC-CCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 181 MQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 181 ~~~~-~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
.... ......||+.|+|||++.+.++.++|||||||++|+|++|..||.+ ......+..+..+..++...+++++
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~ 282 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELR 282 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHH
T ss_pred cccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHH
Confidence 5433 2345679999999999988999999999999999999999777754 2334455555555555566789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
+||.+||. +|.+|||+.++|+||||+.
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999998 8999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=393.20 Aligned_cols=262 Identities=28% Similarity=0.395 Sum_probs=212.7
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
....+..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+++.+|+.+|+.++||||+++++++...
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 96 (367)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred ceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence 34456789999999999999999999999999999999986542 3455677899999999999999999999998654
Q ss_pred CC----ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 99 TN----RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 99 ~~----~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
.. ..+|+||||+ +++|.++++. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~D 171 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILD 171 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECC
T ss_pred CccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEc-CCCCEEEEe
Confidence 32 3579999999 7899999887 56999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCC----
Q 006777 175 LGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP---- 247 (631)
Q Consensus 175 FGlA~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-~~~p---- 247 (631)
||+++..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.. +..+
T Consensus 172 fg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 172 FGLARQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CTTCEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eecccccccc-cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9999765432 445689999999998754 6899999999999999999999999875444333322211 1100
Q ss_pred -----------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 248 -----------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 248 -----------------------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
..+....++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 11223468899999999998 999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=390.09 Aligned_cols=262 Identities=24% Similarity=0.406 Sum_probs=221.9
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
.+....++|.+.+.||+|+||+||+|.+..+|..||+|++.... .....+.+.+|+.+|+.++||||++++++|.+.
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 34556789999999999999999999999999999999988652 356667899999999999999999999998765
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
. .+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+. + |+||||||+|||++ .+|.+||+|||+
T Consensus 104 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 104 G--EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGV 178 (360)
T ss_dssp T--EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCC
T ss_pred C--EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEEC-CCCCEEEEECCC
Confidence 4 7999999999999999999988999999999999999999999995 8 99999999999998 789999999999
Q ss_pred hhhccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHH-------------------
Q 006777 178 AIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI------------------- 237 (631)
Q Consensus 178 A~~~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~------------------- 237 (631)
+............||+.|+|||++.+ .++.++|||||||++|+|++|..||... +....
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 179 SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp CHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC-CHHHHHHHHC--------------
T ss_pred CcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccCCCCCCCc
Confidence 97665545556789999999998765 5899999999999999999999999763 22222
Q ss_pred -----------------------HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 238 -----------------------YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 238 -----------------------~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
...+.....+.......++++++||.+||. +|.+|||+.++|+||||+...+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 222333333333444578899999999998 9999999999999999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=372.23 Aligned_cols=256 Identities=24% Similarity=0.355 Sum_probs=219.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEE
Confidence 4689999999999999999999999999999999986542 24557788999999999999999999988764 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++||||+++|+|.+++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEc-cCCCEEEeeCCCccccCC
Confidence 999999999999999988888999999999999999999999999 99999999999998 789999999999975432
Q ss_pred C----CCccccCCCCCCCcccccc-c-cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 184 P----TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 184 ~----~~~~~~GTp~y~APE~l~~-~-y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
. ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||.........+..+.............++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 237 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHH
Confidence 2 2345679999999998865 3 47899999999999999999999987655545555555443333333457889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+++||.+||. +|.+|||+.++++||||+..
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 9999999998 99999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=378.69 Aligned_cols=258 Identities=22% Similarity=0.351 Sum_probs=221.2
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENEIAVLKKIKHENIVTLEDIYEST-- 78 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchHHHHHHHHHHHhCCCCCeeehhhhcccC--
Confidence 3456799999999999999999999999999999999985432 2335688999999999999999999988654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe--CCCCcEEEccccch
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKI~DFGlA 178 (631)
..+++||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||++. ..++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 478999999999999999988889999999999999999999999999 99999999999992 26789999999999
Q ss_pred hhccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCc
Q 006777 179 IVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD 255 (631)
Q Consensus 179 ~~~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l~~~~~ 255 (631)
............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...+...+..+.. +.......+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 157 KMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp CCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSC
T ss_pred eecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCC
Confidence 7665554556679999999998864 589999999999999999999999987 456666677766543 233445678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+.+++||.+||. +|.+|||+.++|+||||...
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 236 ESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 999999999998 99999999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=392.95 Aligned_cols=259 Identities=21% Similarity=0.336 Sum_probs=221.3
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..+.++|.+.+.||+|+||.||+|.++.+|+.||+|++.... ......+.+|+.+|+.|+||||++++++|.+.
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-- 120 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-- 120 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--
Confidence 445678999999999999999999999999999999987542 34556788999999999999999999998654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC-CCCcEEEccccch
Q 006777 101 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLA 178 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKI~DFGlA 178 (631)
..+++||||+.||+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccc
Confidence 47999999999999999987654 6999999999999999999999999 999999999999973 3578999999999
Q ss_pred hhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCC
Q 006777 179 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVT 254 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l~~~~ 254 (631)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......+..... +.......
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 277 (387)
T 1kob_A 199 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSV 277 (387)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTS
T ss_pred eecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCccccccC
Confidence 766543 2345689999999998864 589999999999999999999999987 455555555555432 23334457
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 278 s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 8999999999998 999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=380.88 Aligned_cols=253 Identities=28% Similarity=0.518 Sum_probs=218.0
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
..|...+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||++++++|.... .++
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~ 118 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE--ELW 118 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEE
Confidence 468999999999999999999999999999999975532 33456889999999999999999999987654 789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+||||+++|+|.+++.+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCcEEEeeeeeeeecccC
Confidence 99999999999999875 46999999999999999999999999 99999999999998 7899999999998765433
Q ss_pred --CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CCCCCCcHHHHH
Q 006777 185 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQ 260 (631)
Q Consensus 185 --~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~-~l~~~~~~~lk~ 260 (631)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+....+.....+. ......++.+++
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 273 (321)
T 2c30_A 195 VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRD 273 (321)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCHHHHH
T ss_pred ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCHHHHH
Confidence 2345689999999998764 589999999999999999999999987 45666666666554432 223346789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
||.+||. +|.+|||+.++|+||||....
T Consensus 274 li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 274 FLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 9999998 999999999999999998644
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=387.20 Aligned_cols=256 Identities=28% Similarity=0.449 Sum_probs=219.3
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|.+.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+|++++||||++++++|.+.. .+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~ 129 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TA 129 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--eE
Confidence 4569999999999999999999999999999999986532 23445678999999999999999999999987654 78
Q ss_pred EEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~-~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++||||+. |+|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSS
T ss_pred EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEeeccCceecC
Confidence 99999997 68888775 4567999999999999999999999999 99999999999998 78999999999997654
Q ss_pred CCCCccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 183 QPTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
. ....+||+.|+|||++. +.++.++|||||||++|+|++|..||.+... ......+..+..+......+++.+
T Consensus 206 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l 282 (348)
T 1u5q_A 206 P--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPALQSGHWSEYF 282 (348)
T ss_dssp S--BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred C--CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCCCCHHH
Confidence 3 34568999999999873 4689999999999999999999999987544 444444555545555556678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
++||.+||. +|.+|||+.++|+||||....+
T Consensus 283 ~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 999999998 8999999999999999976543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=424.65 Aligned_cols=270 Identities=20% Similarity=0.287 Sum_probs=233.9
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCce
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~ 102 (631)
..+|.+.++||+|+||.||+|.++.+|+.||+|+++...... ....+.+..|..+|..+ +||||++++++|.+. ..
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--~~ 416 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR 416 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--SE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--CE
Confidence 467999999999999999999999999999999998643211 23346678899999988 799999999988654 47
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+||||||++||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEEC-SSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEc-CCCcEEEeecceeeccc
Confidence 9999999999999999999889999999999999999999999999 99999999999998 78999999999997532
Q ss_pred --CCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 183 --QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 183 --~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
.....+.+||+.|+|||++. ..|+.++|||||||++|||++|..||.+ .+..+++..|.... ..++...+++++
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~ 570 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN--VAYPKSMSKEAV 570 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSC--CCCCTTSCHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHH
Confidence 23456789999999999876 4699999999999999999999999987 67777888887753 345567889999
Q ss_pred HHHHHhcC-CCCCCCCH-----HHHhcCCCccCCCCCccccCCCCCCCC
Q 006777 260 QFIEKCIV-PASLRLPA-----LELLKDPFLVTDNPKDLVCDPLRLPNL 302 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta-----~elL~hpff~~~~~~~~~~~~l~~p~~ 302 (631)
+||.+||. +|.+||++ .+|++||||+..+|..+....+..|..
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~ 619 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYK 619 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCC
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCC
Confidence 99999998 89999997 999999999999998876655555443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=384.28 Aligned_cols=253 Identities=22% Similarity=0.372 Sum_probs=209.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC---
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--- 100 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~--- 100 (631)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+.+|+.+|++|+||||++++++|.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 457999999999999999999999999999999998653 23456779999999999999999999999876432
Q ss_pred ----------------------------------------------------ceEEEEEeccCCCCHHHHHHhCCC---C
Q 006777 101 ----------------------------------------------------RTINMITELFTSGSLRQYRKKHKN---V 125 (631)
Q Consensus 101 ----------------------------------------------------~~l~lV~Ey~~gGsL~~~l~~~~~---l 125 (631)
.++++||||+++|+|.+++.+... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 248999999999999999988654 5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC--------------CCccccC
Q 006777 126 DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--------------TARSVIG 191 (631)
Q Consensus 126 ~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~--------------~~~~~~G 191 (631)
++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...... .....+|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 66679999999999999999999 99999999999998 7899999999999765432 1234579
Q ss_pred CCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CC
Q 006777 192 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PA 269 (631)
Q Consensus 192 Tp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p 269 (631)
|+.|+|||++.+ .++.++|||||||++|+|++|..|+. ........+.....+.. ....++.+++||.+||. +|
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLL-FTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHHCSSG
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCcc-cccCChhHHHHHHHHccCCC
Confidence 999999998765 68999999999999999999877763 23344444444433322 12235788999999998 89
Q ss_pred CCCCCHHHHhcCCCccC
Q 006777 270 SLRLPALELLKDPFLVT 286 (631)
Q Consensus 270 ~~Rpta~elL~hpff~~ 286 (631)
.+|||+.++|+||||+.
T Consensus 315 ~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 315 TERPEATDIIENAIFEN 331 (332)
T ss_dssp GGSCCHHHHHHSTTCCC
T ss_pred CcCCCHHHHhhchhhhc
Confidence 99999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=404.35 Aligned_cols=264 Identities=20% Similarity=0.313 Sum_probs=201.6
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC--
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-- 99 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~-- 99 (631)
.+.++|.+.++||+|+||+||+|.++.+|+.||+|++... .......+++.+|+.+|+.|+|||||+++++|....
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh--hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence 4568999999999999999999999999999999998643 234566788999999999999999999999886543
Q ss_pred -CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 -NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 -~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
...+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|
T Consensus 128 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla 203 (458)
T 3rp9_A 128 KFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLA 203 (458)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred cCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEEC-CCCCEeecccccc
Confidence 257999999985 799999998889999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCC-----------------------------CCccccCCCCCCCcccc-c-cccCccceEeehhhHHHHHhh----
Q 006777 179 IVMQQP-----------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVT---- 223 (631)
Q Consensus 179 ~~~~~~-----------------------------~~~~~~GTp~y~APE~l-~-~~y~~~sDIwSLG~il~emlt---- 223 (631)
+..... .....+||+.|+|||++ . ..|+.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 765321 12346789999999975 3 459999999999999999999
Q ss_pred -------cCCCCCCCCCH-------------------HHHHHHHHc--CCC---------------------------CC
Q 006777 224 -------CEYPYNECKNP-------------------AQIYKKVTS--GIK---------------------------PA 248 (631)
Q Consensus 224 -------G~~Pf~~~~~~-------------------~~~~~~i~~--~~~---------------------------p~ 248 (631)
|.++|.+.... ......+.. +.+ ..
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 66666553210 011111100 000 00
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCc
Q 006777 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 249 ~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~ 291 (631)
......++++++||.+||+ +|.+|||+.|+|+||||+...+..
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 1123357899999999998 999999999999999999876544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=407.83 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=225.8
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
.+....++|.+.+.||+|+||.||+|.+..+|+.||+|++...... .....+++.+|+.+|+.++||||+++++++.+.
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3445567899999999999999999999999999999999765321 112356788999999999999999999988665
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 89 --~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~-~~~~vkL~DFG~a 163 (476)
T 2y94_A 89 --SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLS 163 (476)
T ss_dssp --SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEC-TTCCEEECCCSSC
T ss_pred --CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEe-cCCCeEEEeccch
Confidence 479999999999999999998889999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCC-CCccccCCCCCCCccccccc-c-CccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 179 IVMQQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~y~APE~l~~~-y-~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
...... .....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+ .+...++..+..+... .+...+
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s 240 (476)
T 2y94_A 164 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFY--TPQYLN 240 (476)
T ss_dssp EECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTCCC--CCTTCC
T ss_pred hhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCcC--CCccCC
Confidence 765443 34567899999999988754 4 7899999999999999999999987 4556667777766432 345578
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+.+++||.+||. +|.+|||+.++++||||+...
T Consensus 241 ~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 241 PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 999999999998 999999999999999998643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=374.44 Aligned_cols=257 Identities=21% Similarity=0.357 Sum_probs=221.8
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
...++|.+.+.||+|+||.||+|.+..++..||+|++....... ....+.+.+|+.+++.++||||+++++++.+. .
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 87 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--K 87 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--S
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--C
Confidence 34578999999999999999999999999999999987543211 12245688999999999999999999998754 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++...
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMG-YKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEc-CCCCEEEecccccccC
Confidence 78999999999999999998889999999999999999999999999 99999999999997 7899999999999766
Q ss_pred cCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 182 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.........||+.|+|||++.+ .++.++||||||+++|+|++|..||... +.......+.... ..++...++.+++
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~ 241 (284)
T 2vgo_A 165 PSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-SHTETHRRIVNVD--LKFPPFLSDGSKD 241 (284)
T ss_dssp SSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTC--CCCCTTSCHHHHH
T ss_pred cccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC-CHhHHHHHHhccc--cCCCCcCCHHHHH
Confidence 5555566789999999998765 5899999999999999999999999864 4455555555432 2344567899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
||.+||. +|.+||++.++++||||+..
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 9999998 99999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=383.63 Aligned_cols=256 Identities=26% Similarity=0.472 Sum_probs=198.6
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
..+|++.+.||+|+||+||+|.++.+|+.||+|+++.... ....+.+.+|+.+|++++||||+++++++.+. ..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIHTE--NKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--CeE
Confidence 4589999999999999999999999999999999986542 22335678899999999999999999988654 479
Q ss_pred EEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 104 NMITELFTSGSLRQYRKKH------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
++||||+. |+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEc-CCCCEEECcCcc
Confidence 99999998 6999998754 35999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCCCC---
Q 006777 178 AIVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPA--- 248 (631)
Q Consensus 178 A~~~~~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--~~~p~--- 248 (631)
+...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. .......+.. +..+.
T Consensus 155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-DEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCSCCTTTC
T ss_pred ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhHh
Confidence 9765432 2345689999999998854 58999999999999999999999998744 4443333322 11000
Q ss_pred ---------------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 249 ---------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 249 ---------------------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
......++++++||.+||+ +|.+|||+.|+|+||||+...+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 0112457899999999998 9999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=410.76 Aligned_cols=271 Identities=23% Similarity=0.356 Sum_probs=229.1
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
...+.|.+.++||+|+||.||+|.++.+|+.||+|++....... ....+.+.+|+.+|+.++||||++++++|.+. .
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~ 258 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--T 258 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--C
Confidence 34578999999999999999999999999999999997654311 12346788999999999999999999998765 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 102 TINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~-~~g~vkL~DFGl 335 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGL 335 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTT
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEe-CCCCEEEeecce
Confidence 799999999999999999764 36999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCCCC
Q 006777 178 AIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 178 A~~~~~~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~---~~~~~~~~i~~~~~p~~l~ 251 (631)
+....... ....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.. ....+...+.... ..++
T Consensus 336 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~--~~~p 413 (543)
T 3c4z_A 336 AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYP 413 (543)
T ss_dssp CEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--CCCC
T ss_pred eeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--cCCC
Confidence 97654432 345689999999998865 59999999999999999999999997643 3466666666542 2345
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCccccCCCCCC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~~~l~~p 300 (631)
...++.+++||.+||. +|.+||+ +.++++||||+..+|..+....+..|
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp 468 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPP 468 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCC
Confidence 6678999999999998 9999996 58999999999988877654444333
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=387.38 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=212.8
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccC-CHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQ-SPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
.+..+|.+.+.||+|+||+||+|.+..++..||+|++....... .....+++.+|+.+|++++||||++++++|.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 100 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE-- 100 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC--
Confidence 34678999999999999999999999999999999997654321 345567899999999999999999999998654
Q ss_pred ceEEEEEeccCCCCHHHHHHhC----------------------------------------CCCCHHHHHHHHHHHHHH
Q 006777 101 RTINMITELFTSGSLRQYRKKH----------------------------------------KNVDMKAIKNWARQILRG 140 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~----------------------------------------~~l~e~~i~~i~~QIl~g 140 (631)
..+++||||++||+|.+++... ..+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 4799999999999999998521 124678899999999999
Q ss_pred HHHHHhCCCCeEecCCCCCceEEeCCCC--cEEEccccchhhccCC------CCccccCCCCCCCccccc---cccCccc
Q 006777 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELYE---EEYNELV 209 (631)
Q Consensus 141 L~yLHs~~~~IiHrDLKp~NILl~~~~g--~vKI~DFGlA~~~~~~------~~~~~~GTp~y~APE~l~---~~y~~~s 209 (631)
|.|||+++ |+||||||+|||++ .++ .+||+|||++...... ......||+.|+|||++. ..++.++
T Consensus 181 l~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG--ICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT--EECCCCCGGGEEES-CSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC--ccccCCChhhEEEe-cCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999997 455 8999999999754321 134567999999999875 4589999
Q ss_pred eEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 210 DIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 210 DIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~--~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
|||||||++|+|++|..||.+.... .....+....... ......++.+++||.+||. +|.+||++.++|+||||+.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~ 336 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence 9999999999999999999875444 4444444433222 2223468899999999998 9999999999999999987
Q ss_pred CC
Q 006777 287 DN 288 (631)
Q Consensus 287 ~~ 288 (631)
..
T Consensus 337 ~~ 338 (345)
T 3hko_A 337 FS 338 (345)
T ss_dssp TS
T ss_pred Ch
Confidence 54
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=370.73 Aligned_cols=260 Identities=25% Similarity=0.436 Sum_probs=222.3
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+.....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 45689999999999999999999999999999999986543 4566778999999999999999999999988766678
Q ss_pred EEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 103 INMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~---~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ .+|+||||||+||+++ .++.+||+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~df 160 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDF 160 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecC
Confidence 99999999999999998764 34999999999999999999999987 3499999999999998 7899999999
Q ss_pred cchhhccCCC--CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 176 GLAIVMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 176 GlA~~~~~~~--~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
|++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+...+..+..+ .++.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~ 238 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPY 238 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-CCCT
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhcccc-cCCc
Confidence 9997654432 234578999999998764 589999999999999999999999987 4566666777766443 3455
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
..++++++||.+||. +|.+||++.++|+|+|+...
T Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 678999999999998 99999999999999999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=370.42 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=224.8
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
......+|.+.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 87 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN- 87 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-
Confidence 34567899999999999999999999999999999999986543 3456678899999999999999999999988654
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++.
T Consensus 88 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 88 -DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLAT 163 (294)
T ss_dssp -SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred -CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEc-CCCCEEEEeccCce
Confidence 479999999999999999998889999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccC--CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 180 VMQQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 180 ~~~~--~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
.... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. ......+..+.... ..++...++
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~--~~~~~~~~~ 240 (294)
T 2rku_A 164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNE--YSIPKHINP 240 (294)
T ss_dssp ECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTC--CCCCTTSCH
T ss_pred ecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhcc--CCCccccCH
Confidence 6542 22345679999999998765 588999999999999999999999987 44555555555542 234456789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.+++||.+||. +|.+|||+.++|+||||...
T Consensus 241 ~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 99999999998 89999999999999999763
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=402.78 Aligned_cols=257 Identities=26% Similarity=0.346 Sum_probs=205.8
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC--
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-- 99 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~-- 99 (631)
.+.++|++.++||+|+||+||+|.+..+|+.||+|++.... ......+++.+|+.+|+.++|||||+++++|....
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 34678999999999999999999999999999999997542 24566788999999999999999999999986543
Q ss_pred --CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 100 --NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 100 --~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
...+|+||||+.+ +|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~-~~~~~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEe-CCCCEEEEEEEe
Confidence 2478999999985 5666664 35999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCC-------
Q 006777 178 AIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP------- 247 (631)
Q Consensus 178 A~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-~~~p------- 247 (631)
|+..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.. +.++
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 9866543 3456789999999998754 6999999999999999999999999885444433332221 1000
Q ss_pred ------------C----C----CCC-----------CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 248 ------------A----S----LSK-----------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 248 ------------~----~----l~~-----------~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
. . ++. ..++++++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 0 0 000 015679999999998 9999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=383.92 Aligned_cols=264 Identities=20% Similarity=0.262 Sum_probs=218.0
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......++.+|+.++++++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 34567899999999999999999999999999999999986543 34566778999999999999999999999887654
Q ss_pred C--ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 100 N--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 100 ~--~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
. ..+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~ 162 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGI 162 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTSCEEECCCSC
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEc-CCCCEEEeeccC
Confidence 3 256999999999999999998889999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC-----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-CC
Q 006777 178 AIVMQQP-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SL 250 (631)
Q Consensus 178 A~~~~~~-----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~-~l 250 (631)
+...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+.....+. ..
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence 9755332 2234679999999998765 589999999999999999999999987544444444444433322 22
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
....++.+++||.+||. +|.+||++.++|.|+|++..
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 34568899999999998 89999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=367.76 Aligned_cols=254 Identities=21% Similarity=0.353 Sum_probs=211.5
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~ 100 (631)
....+|.+.+.||+|+||+||+|.+..+|+.||+|++..... ......++.+|+..+..+ +||||++++++|.+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~- 84 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD- 84 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT-
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence 345789999999999999999999999999999999886532 234567788999999999 9999999999987654
Q ss_pred ceEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC-----------
Q 006777 101 RTINMITELFTSGSLRQYRKKH----KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----------- 165 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~----~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~----------- 165 (631)
.+++||||+++|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 85 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 85 -HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp -EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------
T ss_pred -eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccc
Confidence 789999999999999999865 67999999999999999999999999 999999999999972
Q ss_pred -------CCCcEEEccccchhhccCCCCccccCCCCCCCccccccc--cCccceEeehhhHHHHHhhcCCCCCCCCCHHH
Q 006777 166 -------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 236 (631)
Q Consensus 166 -------~~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~~--y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~ 236 (631)
..+.+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..|+... .
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~ 235 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----D 235 (289)
T ss_dssp --------CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----H
T ss_pred ccccccCCceEEEEcccccccccCCc--cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----h
Confidence 2347999999999765443 345699999999988654 568999999999999999999877542 2
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 237 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 237 ~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
....+..+..+ .++...++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 236 QWHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHHHTTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHHHcCCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 23444444333 3455678999999999998 899999999999999998643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=383.08 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=211.5
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----CCCcceeeeE
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----HENIIKFYNS 94 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-----HpnIV~l~~~ 94 (631)
+..+.++|.+.++||+|+||+||+|.+..+|+.||+|++.. .......+..|+.+++.+. ||||++++++
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 45568899999999999999999999999999999999863 2345566788999999996 9999999999
Q ss_pred EEcCCCceEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC-------
Q 006777 95 WVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------- 165 (631)
Q Consensus 95 f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~------- 165 (631)
|...+ .+++||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 105 ~~~~~--~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 105 FMYYD--HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEETT--EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEE
T ss_pred eeECC--eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccc
Confidence 87654 799999999 899999998764 5999999999999999999999999 999999999999962
Q ss_pred -----------------CCCcEEEccccchhhccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCC
Q 006777 166 -----------------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP 227 (631)
Q Consensus 166 -----------------~~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~P 227 (631)
.++.+||+|||++..... ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 378999999999975443 3346789999999998754 699999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCC------------------------CC--------------------CCCcHHHHHHHH
Q 006777 228 YNECKNPAQIYKKVTSGIKPAS------------------------LS--------------------KVTDPQVKQFIE 263 (631)
Q Consensus 228 f~~~~~~~~~~~~i~~~~~p~~------------------------l~--------------------~~~~~~lk~lI~ 263 (631)
|... +.......+.....+.. ++ ...++.+.+||.
T Consensus 259 f~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 259 FRTH-EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp CCCS-SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCC-cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 9874 34443333332111100 00 112377889999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCcc
Q 006777 264 KCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 264 kcL~-~p~~Rpta~elL~hpff~ 285 (631)
+||+ +|.+|||+.|+|+||||+
T Consensus 338 ~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHhcCChhhCCCHHHHhcCcccC
Confidence 9998 999999999999999995
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=367.80 Aligned_cols=264 Identities=22% Similarity=0.337 Sum_probs=221.6
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC-----HHHHHHHHHHHHHHHhCC-CCCcceeeeE
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS-----PDQLERLYSEVHLLKSLK-HENIIKFYNS 94 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~-----~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~ 94 (631)
....++|.+.+.||+|+||.||+|.++.+|+.||+|++........ ....+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 3457899999999999999999999999999999999986542111 233567889999999995 9999999998
Q ss_pred EEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 95 WVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 95 f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
+.+. ..+++||||+++|+|.+++.....+++..++.++.||+.||.|||++| ++||||||+||+++ .+|.+||+|
T Consensus 93 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~d 167 (298)
T 1phk_A 93 YETN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTD 167 (298)
T ss_dssp EECS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECC
T ss_pred eccC--CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEc-CCCcEEEec
Confidence 8654 479999999999999999998889999999999999999999999999 99999999999997 789999999
Q ss_pred ccchhhccCC-CCccccCCCCCCCccccc-------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006777 175 LGLAIVMQQP-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 246 (631)
Q Consensus 175 FGlA~~~~~~-~~~~~~GTp~y~APE~l~-------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~ 246 (631)
||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.. .+.......+..+..
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNY 246 (298)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC
T ss_pred ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCc
Confidence 9999765433 344567999999999874 3478899999999999999999999987 455555666655533
Q ss_pred CCC--CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCC
Q 006777 247 PAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 247 p~~--l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~ 290 (631)
... .....++.+++||.+||. +|.+|||+.++|+||||+.....
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 222 223467899999999998 99999999999999999875543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=388.51 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=208.0
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC---
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--- 98 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~--- 98 (631)
....+|.+.++||+|+||+||+|.+..+|+.||+|++...... ..+|+.+|+.++|||||+++++|...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 3467899999999999999999999999999999998754321 23699999999999999999998653
Q ss_pred ---------------------------------CCceEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHH
Q 006777 99 ---------------------------------TNRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGL 141 (631)
Q Consensus 99 ---------------------------------~~~~l~lV~Ey~~gGsL~~~l~----~~~~l~e~~i~~i~~QIl~gL 141 (631)
...++++||||++ |+|.+++. ..+.+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 2346899999998 57666654 457899999999999999999
Q ss_pred HHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC-CCccccCCCCCCCcccccc--ccCccceEeehhhHH
Q 006777 142 HYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCI 218 (631)
Q Consensus 142 ~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il 218 (631)
.|||++| |+||||||+|||++..++.+||+|||+|...... ......||+.|+|||++.+ .|+.++|||||||++
T Consensus 155 ~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 155 GFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999999 9999999999999866889999999999765433 3456688999999998754 489999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCC------------------CC--------CCCCCCcHHHHHHHHHhcC-CCCC
Q 006777 219 LEMVTCEYPYNECKNPAQIYKKVTSGIK------------------PA--------SLSKVTDPQVKQFIEKCIV-PASL 271 (631)
Q Consensus 219 ~emltG~~Pf~~~~~~~~~~~~i~~~~~------------------p~--------~l~~~~~~~lk~lI~kcL~-~p~~ 271 (631)
|+|++|+.||.+.....++...+..... |. .++...++++++||.+||+ +|.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999885555544443321000 00 0234467899999999998 9999
Q ss_pred CCCHHHHhcCCCccC
Q 006777 272 RLPALELLKDPFLVT 286 (631)
Q Consensus 272 Rpta~elL~hpff~~ 286 (631)
|||+.|+|+||||+.
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=389.68 Aligned_cols=266 Identities=20% Similarity=0.300 Sum_probs=220.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEc---CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~---~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~ 99 (631)
.++|.+.+.||+|+||+||+|.+. .+|+.||+|+++...........+.+.+|+.+|+.+ +||||++++++|.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 379999999999999999999984 589999999987543322222334567799999999 6999999999887654
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++
T Consensus 133 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 --KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSK 207 (355)
T ss_dssp --EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEE
T ss_pred --eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCcEEEeeCCCCe
Confidence 78999999999999999998889999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCC---CCccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCC---CCHHHHHHHHHcCCCCCCC
Q 006777 180 VMQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 180 ~~~~~---~~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~---~~~~~~~~~i~~~~~p~~l 250 (631)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+...+.... ..+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~ 285 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPY 285 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--CCC
Confidence 54322 2345689999999998864 3789999999999999999999999743 23445555555442 234
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCccCCCCCccccCC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDP 296 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~~~ 296 (631)
+...++.+++||.+||. +|.+|| ++.++++||||+..+|..+....
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~ 337 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK 337 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhcc
Confidence 45678899999999998 999999 99999999999988776654433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=370.69 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=205.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.++...++.++||||+++++++.+.. .
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~--~ 80 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG--D 80 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--S
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC--C
Confidence 35789999999999999999999999999999999875421 2233344555666688899999999999987654 6
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 103 INMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
+++||||++ |+|.+++.. .+.+++..++.++.||+.||.|||++ + |+||||||+||+++ .++.+||+|||+
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 156 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGI 156 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEEC-TTCCEEBCCC--
T ss_pred EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecCC
Confidence 899999997 588777653 56799999999999999999999998 8 99999999999998 789999999999
Q ss_pred hhhccCCC-CccccCCCCCCCccccc-----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006777 178 AIVMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 178 A~~~~~~~-~~~~~GTp~y~APE~l~-----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~ 251 (631)
+....... .....||+.|+|||++. ..++.++|||||||++|+|+||..||..................+....
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 97654433 33457999999999862 3588999999999999999999999987666666666665555555555
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 5678999999999998 89999999999999999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=383.36 Aligned_cols=257 Identities=23% Similarity=0.399 Sum_probs=219.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCH----HHHHHHHHHHHHHHhC-CCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSP----DQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~----~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~ 98 (631)
..+|.+.++||+|+||.||+|.+..+|+.||||++......... ...+.+.+|+.+++++ +||||++++++|...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 46899999999999999999999999999999998765422222 2246688999999999 899999999988654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+++||||+.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++
T Consensus 173 --~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~-~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 173 --SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFS 247 (365)
T ss_dssp --SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTC
T ss_pred --CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEecCcc
Confidence 479999999999999999998888999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCC-CCccccCCCCCCCcccccc-------ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006777 179 IVMQQP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~y~APE~l~~-------~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l 250 (631)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+.......+..+......
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCH
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCC
Confidence 765433 3456789999999998753 478899999999999999999999987 4555666666655432221
Q ss_pred --CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 251 --SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 251 --~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
....++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 13467889999999998 9999999999999999963
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=380.13 Aligned_cols=257 Identities=21% Similarity=0.353 Sum_probs=213.8
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
.....++|++.++||+|+||+||+|.+..+|+.||+|++...... ...+.+.+|+.+|++++||||+++++++....
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 345678999999999999999999999999999999999765432 23456789999999999999999999988777
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEE----eCCCCcEEE
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKI 172 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~---l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl----~~~~g~vKI 172 (631)
...+++||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||+ + .++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL 157 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKL 157 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTT-SCEEEEE
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCC-CCceEEE
Confidence 6689999999999999999987543 999999999999999999999999 9999999999998 4 5678999
Q ss_pred ccccchhhccCC-CCccccCCCCCCCccccc---------cccCccceEeehhhHHHHHhhcCCCCCCCCCH---HHHHH
Q 006777 173 GDLGLAIVMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYK 239 (631)
Q Consensus 173 ~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~---------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~---~~~~~ 239 (631)
+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+||..||...... .....
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred ccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 999999765443 334567999999999874 46899999999999999999999999753332 33334
Q ss_pred HHHcCCCCC-----------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006777 240 KVTSGIKPA-----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 240 ~i~~~~~p~-----------------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hp 282 (631)
.+..+.++. .+....++.+++||.+||+ +|.+|||+.|+|+||
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 443332211 1222345688999999998 999999999999997
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=381.21 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=196.8
Q ss_pred CcEEEE---EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCC
Q 006777 25 YFWISW---VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN 100 (631)
Q Consensus 25 ~~Y~i~---e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~ 100 (631)
.+|.+. +.||+|+||+||+|.+..+|+.||+|++... ....+.+|+.+++.+. ||||++++++|.+.
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-- 78 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ-- 78 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--
Confidence 456665 7899999999999999999999999998643 2345778999999997 99999999998654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC---cEEEccccc
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDLGL 177 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g---~vKI~DFGl 177 (631)
..+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFT-DENDNLEIKIIDFGF 155 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEE-C----CEEEECCCTT
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEe-cCCCcccEEEecccc
Confidence 478999999999999999999999999999999999999999999999 99999999999997 344 899999999
Q ss_pred hhhccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCC------CCHHHHHHHHHcCCCCC
Q 006777 178 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC------KNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 178 A~~~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~------~~~~~~~~~i~~~~~p~ 248 (631)
+...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+. ....++...+..+..+.
T Consensus 156 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 156 ARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp CEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred ceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 9755432 2345678999999998864 5899999999999999999999999753 23456666776654332
Q ss_pred CC--CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 249 SL--SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 249 ~l--~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.. ....++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 21 13468899999999998 99999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=397.71 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=212.9
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccC----CHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQ----SPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
.+.++|.+.+.||+|+||+||+|.+..+|+.||+|++....... .......+.+|+.+|++++||||++++++|..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999999999999999998754321 11223457899999999999999999998743
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEEccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDL 175 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI~DF 175 (631)
. .+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+||
T Consensus 212 ~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 E---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp S---EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred C---ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeec
Confidence 2 57899999999999999988889999999999999999999999999 999999999999962 2346999999
Q ss_pred cchhhccCC-CCccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC--
Q 006777 176 GLAIVMQQP-TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-- 248 (631)
Q Consensus 176 GlA~~~~~~-~~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~-- 248 (631)
|++...... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+......+...+..+..+.
T Consensus 287 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 287 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp STTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred ccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 999866543 345678999999999874 4588999999999999999999999987655555566666554322
Q ss_pred CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 249 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 249 ~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
......++.+++||.+||+ +|.+|||+.++|+||||+...
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 1223467899999999998 999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=377.61 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=224.3
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
.....+|.+.+.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 113 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-- 113 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 3457799999999999999999999999999999999986543 3456678899999999999999999999988754
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATK 190 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEc-CCCCEEEeeccCcee
Confidence 479999999999999999998889999999999999999999999999 99999999999998 789999999999976
Q ss_pred ccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 181 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 181 ~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+..+.. .++...++.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~ 267 (335)
T 2owb_A 191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPV 267 (335)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHH
T ss_pred cccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcCCC--CCCccCCHH
Confidence 5422 2345679999999998764 588999999999999999999999986 445555555555422 344567899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+++||.+||. +|.+||++.++|+||||...
T Consensus 268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 268 AASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 9999999998 99999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=374.42 Aligned_cols=260 Identities=20% Similarity=0.380 Sum_probs=219.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
+.++|.+.+.||+|+||.||+|.+..+|..||+|++............+.+.+|+.+++.++||||+++++++.+.....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 45689999999999999999999999999999999986543333345678999999999999999999999987666668
Q ss_pred EEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+++||||+.+| |.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-CCCcEEeeccccccc
Confidence 99999999876 7777765 356999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCC----CCccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 181 MQQP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 181 ~~~~----~~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+ .+.......+..+.. .++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~ 235 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGD 235 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSS
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCc
Confidence 5321 2235679999999998864 247899999999999999999999986 566667777766533 34556
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
.++.+.+||.+||. +|.+|||+.++++||||+...+
T Consensus 236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 78999999999998 9999999999999999987544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=375.09 Aligned_cols=254 Identities=19% Similarity=0.296 Sum_probs=212.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~ 101 (631)
..++|++.+.||+|+||+||+|.+..+|+.||+|++.... .+.+.+|+.+|++++ ||||+++++++.+....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 4678999999999999999999999999999999987432 356889999999997 99999999999876667
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+++||||+.+++|.++++ .+++..++.++.||+.||.|||++| |+||||||+|||++.+++.+||+|||++...
T Consensus 107 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred ceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 8999999999999999885 3899999999999999999999999 9999999999999844448999999999765
Q ss_pred cCC-CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-------------CC
Q 006777 182 QQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------GI 245 (631)
Q Consensus 182 ~~~-~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-------------~~ 245 (631)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||....+.......+.. ..
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 433 3455689999999998754 5899999999999999999999999665544333222211 10
Q ss_pred C----------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 246 K----------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 246 ~----------------------p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
. +.......++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0 011122268999999999998 999999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=368.10 Aligned_cols=260 Identities=24% Similarity=0.392 Sum_probs=214.8
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
+....++|.+.+.||+|+||.||+|.+..+|+.||+|++...... .....+++.+|+.+++.++||||+++++++.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 83 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP- 83 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-
Confidence 344567999999999999999999999999999999998754321 122346788999999999999999999988654
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.
T Consensus 84 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 84 -TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSN 159 (276)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEEC-TTSCEEECCCCGGG
T ss_pred -CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEEC-CCCCEEEeeccccc
Confidence 479999999999999999998889999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCC-CCccccCCCCCCCccccccc-c-CccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 180 VMQQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~y~APE~l~~~-y-~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
..... ......||+.|+|||++.+. + +.++||||||+++|+|++|..||.. .+.......+..+.. .++...++
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~ 236 (276)
T 2h6d_A 160 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVF--YIPEYLNR 236 (276)
T ss_dssp CCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCH
T ss_pred ccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCcc--cCchhcCH
Confidence 65433 23456789999999988754 3 6899999999999999999999987 456666777766533 23455688
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.+++||.+||. +|.+|||+.++++||||+...
T Consensus 237 ~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 99999999998 999999999999999998654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=371.64 Aligned_cols=257 Identities=24% Similarity=0.429 Sum_probs=194.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
...+|.+.+.||+|+||.||+|.+..+|+.||+|++...... .....+++.+|+.++++++||||+++++++.+. ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 85 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS--NY 85 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--SE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--Ce
Confidence 346799999999999999999999999999999998754321 112246788999999999999999999988654 47
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+++||||+++++|.+++... +.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLT-RNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEEeecceeec
Confidence 99999999999999999875 67999999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 182 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 182 ~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ....+... ...++...++++
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~ 239 (278)
T 3cok_A 163 KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-TLNKVVLA--DYEMPSFLSIEA 239 (278)
T ss_dssp C----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS--CCCCCTTSCHHH
T ss_pred cCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-HHHHHhhc--ccCCccccCHHH
Confidence 432 2335679999999998764 58899999999999999999999997643322 22222111 223455678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 259 KQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
++||.+||. +|.+|||+.++|+||||....
T Consensus 240 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 999999998 999999999999999997643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=372.03 Aligned_cols=260 Identities=25% Similarity=0.427 Sum_probs=214.8
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
.....+|++.+.||+|+||.||+|.+..+|..||+|++.... ....+++.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 89 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG- 89 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-
Confidence 456789999999999999999999999999999999987542 234567889999999999999999999987654
Q ss_pred ceEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++| ++||||||+||+++ .+|.+||+|||++.
T Consensus 90 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 90 -KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSA 165 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTSCEEECCCHHHH
T ss_pred -eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEC-CCCCEEEEECCCCc
Confidence 68999999999999999876 467999999999999999999999999 99999999999997 78999999999985
Q ss_pred hccC--CCCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCC
Q 006777 180 VMQQ--PTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASL 250 (631)
Q Consensus 180 ~~~~--~~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p-~~l 250 (631)
.... .......||+.|+|||++. ..++.++||||||+++|+|++|..||... +.......+.....+ ...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~ 244 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTLLT 244 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSS
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHhccCCcccCC
Confidence 4321 1234567999999999873 45889999999999999999999999874 444444444444333 233
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~ 290 (631)
+..+++.+++||.+||. +|.+|||+.++++||||+...+.
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 45578899999999998 99999999999999999876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=382.18 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=210.7
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC---
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~--- 99 (631)
..++|++.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+|+.++||||+++++++.+..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 457899999999999999999999999999999998765432 223345778999999999999999999987653
Q ss_pred ---CceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 100 ---NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 100 ---~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
...+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+||
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Df 168 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADF 168 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCCEEEccc
Confidence 3578999999985 777766554 67999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccC------CCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc---C
Q 006777 176 GLAIVMQQ------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---G 244 (631)
Q Consensus 176 GlA~~~~~------~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~---~ 244 (631)
|++..... .......||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+. +.......+.. .
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGS 247 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCC
Confidence 99975432 12245678999999998754 4899999999999999999999999874 44433333322 2
Q ss_pred CCCCCCCCC---------------------------CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 245 IKPASLSKV---------------------------TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ~~p~~l~~~---------------------------~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
..+..++.. .++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 222222211 26789999999998 99999999999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=380.83 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=214.9
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc----CCHHHHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~ 96 (631)
..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ........+.+|+.+|++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 44567999999999999999999999999999999998765321 11223455889999999999999999999875
Q ss_pred cCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC---cEEEc
Q 006777 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EVKIG 173 (631)
Q Consensus 97 ~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g---~vKI~ 173 (631)
.. .+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++ .+||+
T Consensus 86 ~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~~~~kl~ 159 (322)
T 2ycf_A 86 AE---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLS-SQEEDCLIKIT 159 (322)
T ss_dssp SS---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-SSSSSCCEEEC
T ss_pred CC---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-cCCCCCeEEEc
Confidence 43 37999999999999999998889999999999999999999999999 99999999999997 333 59999
Q ss_pred cccchhhccCCC-CccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC
Q 006777 174 DLGLAIVMQQPT-ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 248 (631)
Q Consensus 174 DFGlA~~~~~~~-~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~ 248 (631)
|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||........+...+..+..+.
T Consensus 160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239 (322)
T ss_dssp CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence 999997654332 23467999999999863 4588999999999999999999999987655445555555543321
Q ss_pred --CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 249 --SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 249 --~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
......++.+++||.+||. +|.+||++.++|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 1223467899999999998 999999999999999998644
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=374.32 Aligned_cols=260 Identities=24% Similarity=0.369 Sum_probs=214.7
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
++..+.++|++.+.||+|+||.||+|.+..+|..||+|.+..... ......+++.+|+.++++++||||+++++++.+.
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 466678899999999999999999999999999999999876543 3456678899999999999999999999987654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+++||||++||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||++
T Consensus 84 --~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 84 --DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILID-SNKTLKIFDFGIA 158 (294)
T ss_dssp --SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCSSS
T ss_pred --CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEEeCCCc
Confidence 479999999999999999999889999999999999999999999999 99999999999997 7899999999999
Q ss_pred hhccCC---CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCC
Q 006777 179 IVMQQP---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSK 252 (631)
Q Consensus 179 ~~~~~~---~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p--~~l~~ 252 (631)
...... ......||+.|+|||++.+ .++.++||||||+++|+|+||+.||.+........+.+.....+ .....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK 238 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCT
T ss_pred cccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhccc
Confidence 765433 2334679999999998765 58899999999999999999999998754444444444433221 12445
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
..++.+.++|.+||. +|.+||+..+.+.+.|.
T Consensus 239 ~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 239 DIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 678999999999998 89999966666666554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=373.97 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=211.1
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
....+|.+.+.||+|+||+||+|.+ +|..||+|++..... .....+++.+|+.+|++++||||+++++++.+..
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 107 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-- 107 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--
Confidence 3467999999999999999999986 589999999876543 4566778999999999999999999999886544
Q ss_pred eEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 102 TINMITELFTSGSLRQYRKKHKN---VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~---l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
.+++||||+.+|+|.+++.+.+. +++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a 186 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLS 186 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC--
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEECCCCCC
Confidence 68899999999999999987654 9999999999999999999999988899999999999998 7899999999999
Q ss_pred hhccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 179 IVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 179 ~~~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+....+........++...+
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~ 265 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNLN 265 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCccCC
Confidence 754433 2345689999999998865 589999999999999999999999987 456666666655555556677789
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc--CCCcc
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLK--DPFLV 285 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~--hpff~ 285 (631)
+++++||.+||. +|.+|||+.++++ .++++
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999999999998 9999999999987 44443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=374.72 Aligned_cols=259 Identities=28% Similarity=0.463 Sum_probs=215.8
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~ 98 (631)
.....++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ..+.+.+|+.+++++ +||||++++++|...
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34467899999999999999999999999999999999875432 235688999999999 899999999999864
Q ss_pred C----CceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 99 T----NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 99 ~----~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
. ...+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEc-CCCCEEE
Confidence 3 45899999999999999999875 56999999999999999999999999 99999999999997 7899999
Q ss_pred ccccchhhccCC--CCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006777 173 GDLGLAIVMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 173 ~DFGlA~~~~~~--~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~ 244 (631)
+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+. +.......+...
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~ 249 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRN 249 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHS
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcC
Confidence 999999765432 234567999999999874 35889999999999999999999999874 444444555555
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
..+......+++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 55555556678999999999998 99999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=367.82 Aligned_cols=259 Identities=23% Similarity=0.361 Sum_probs=216.7
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
+.++|.+.+.||+|+||.||+|.+..+|+.||+|++......... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 80 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-- 80 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--
Confidence 346899999999999999999999999999999999876432211 1356788999999999999999999988654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC----cEEEcccc
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLG 176 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKI~DFG 176 (631)
..+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++ .+||+|||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLL-DKNVPNPRIKLIDFG 157 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES-CSSSSSCCEEECCCT
T ss_pred CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEe-cCCCCCCceEEEecc
Confidence 478999999999999999998888999999999999999999999999 99999999999997 455 89999999
Q ss_pred chhhccCC-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCC
Q 006777 177 LAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSK 252 (631)
Q Consensus 177 lA~~~~~~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p--~~l~~ 252 (631)
++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+ .+.......+...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T 3bhy_A 158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFS 236 (283)
T ss_dssp TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCCHHHHT
T ss_pred cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCcchhcc
Confidence 99765432 234567999999999886 4589999999999999999999999987 4555555555554322 12224
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
..++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 567899999999998 89999999999999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=380.63 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=203.4
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+|+.+|+.++||||+++++++.+.. .++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK--SLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS--CEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC--EEE
Confidence 579999999999999999999999999999999875432 112223557999999999999999999986554 689
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+. |+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSI 152 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEEC-TTCCEEECSSSEEECC--
T ss_pred EEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEEC-CCCCEEEccCcccccccC
Confidence 9999997 69999887754 5999999999999999999999999 99999999999998 789999999999975543
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc---CCCCCCCC-----
Q 006777 184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPASLS----- 251 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~---~~~p~~l~----- 251 (631)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. +.......+.. ...+..++
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS-TVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 2 2345578999999998754 5899999999999999999999999874 44443333322 11111111
Q ss_pred --------------------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 252 --------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 252 --------------------~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
...++.+++||.+||+ +|.+|||+.|+|+||||.....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 2357889999999998 9999999999999999987543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=387.76 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=209.9
Q ss_pred CCcEEE--EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 24 SYFWIS--WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 24 ~~~Y~i--~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
...|.+ .++||+|+||.||+|.+..+|..||+|+++... ....+.+.+|+.+|++|+||||++++++|.+. .
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~ 159 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESK--N 159 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--C
Confidence 345555 678999999999999999999999999998643 35567899999999999999999999998764 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe-CCCCcEEEccccchh
Q 006777 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~-~~~g~vKI~DFGlA~ 179 (631)
.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ..++.+||+|||++.
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~ 237 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLAR 237 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence 799999999999999988764 46999999999999999999999999 99999999999984 256799999999997
Q ss_pred hccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCc
Q 006777 180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD 255 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l~~~~~ 255 (631)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. +.......+..... +.......+
T Consensus 238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 316 (373)
T 2x4f_A 238 RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-NDAETLNNILACRWDLEDEEFQDIS 316 (373)
T ss_dssp ECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCSCSGGGTTSC
T ss_pred ecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCChhhhccCC
Confidence 65443 2345679999999998764 5899999999999999999999999874 44455555544322 222234568
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+++++||.+||. +|.+|||+.|+|+||||...
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999998 99999999999999999763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=377.95 Aligned_cols=264 Identities=21% Similarity=0.328 Sum_probs=218.1
Q ss_pred cCCCcEEEE-EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCC
Q 006777 22 SVSYFWISW-VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDT 99 (631)
Q Consensus 22 ~i~~~Y~i~-e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~ 99 (631)
.+.++|.+. +.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.+ +||||++++++|.+.
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~- 101 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYENT- 101 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-
Confidence 356788888 899999999999999999999999999986542 223456788999999999 569999999988654
Q ss_pred CceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEEccc
Q 006777 100 NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDL 175 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI~DF 175 (631)
..+++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++. .+|.+||+||
T Consensus 102 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 -SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp -SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred -CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 4799999999999999998653 67999999999999999999999999 999999999999973 2689999999
Q ss_pred cchhhccCC-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--CCCCCC
Q 006777 176 GLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLS 251 (631)
Q Consensus 176 GlA~~~~~~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~--~p~~l~ 251 (631)
|++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+. +.......+.... .+....
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~ 257 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-DNQETYLNISQVNVDYSEETF 257 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTTT
T ss_pred ccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHhcccccCchhh
Confidence 999765433 234568999999999876 45899999999999999999999999874 4444444444432 233344
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCcc
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~~ 292 (631)
...++.+++||.+||+ +|.+|||+.++|+||||+..++..+
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 5678999999999998 9999999999999999998777654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=369.18 Aligned_cols=262 Identities=28% Similarity=0.447 Sum_probs=224.6
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
......+|.+.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 93 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDS- 93 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-
Confidence 344567999999999999999999999999999999999765432 23456788999999999999999999988654
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC--CCcEEEccccc
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGL 177 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKI~DFGl 177 (631)
..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++.. ++.+||+|||+
T Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 94 -SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred -CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCc
Confidence 478999999999999999988888999999999999999999999999 9999999999999732 34799999999
Q ss_pred hhhccCC-CCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCC
Q 006777 178 AIVMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVT 254 (631)
Q Consensus 178 A~~~~~~-~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~--~~~ 254 (631)
+...... ......||+.|+|||++.+.++.++||||||+++|+|++|..||.+ .+.......+..+..+...+ ...
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 2wei_A 171 STCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTI 249 (287)
T ss_dssp GGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTTS
T ss_pred ceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhhc
Confidence 9765443 2345578999999999988899999999999999999999999987 45666667776664433322 456
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 250 ~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 8899999999998 999999999999999997643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=385.72 Aligned_cols=256 Identities=21% Similarity=0.345 Sum_probs=215.8
Q ss_pred ccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCcceeee
Q 006777 18 PISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYN 93 (631)
Q Consensus 18 ~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~~ 93 (631)
.......++|.+.+.||+|+||+||+|.+..+|+.||+|++........ ....+++.+|+.+|++++||||+++++
T Consensus 17 ~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 96 (335)
T 3dls_A 17 ACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD 96 (335)
T ss_dssp HHTTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEE
T ss_pred cCCcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3344567899999999999999999999999999999999987643221 113345778999999999999999999
Q ss_pred EEEcCCCceEEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 94 SWVDDTNRTINMITELFTSG-SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 94 ~f~~~~~~~l~lV~Ey~~gG-sL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
+|.+. ..+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||
T Consensus 97 ~~~~~--~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL 171 (335)
T 3dls_A 97 IFENQ--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIA-EDFTIKL 171 (335)
T ss_dssp EEECS--SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEE
T ss_pred EEeeC--CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEc-CCCcEEE
Confidence 88654 4789999999776 99999999989999999999999999999999999 99999999999998 7899999
Q ss_pred ccccchhhccCC-CCccccCCCCCCCcccccc-cc-CccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006777 173 GDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 249 (631)
Q Consensus 173 ~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~~-~y-~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~ 249 (631)
+|||++...... .....+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... ... ....
T Consensus 172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~--~~~~ 242 (335)
T 3dls_A 172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVE--AAIH 242 (335)
T ss_dssp CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTT--TCCC
T ss_pred eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHh--hccC
Confidence 999999765443 3456789999999998764 34 7899999999999999999999975211 111 1222
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 250 l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.+...++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 344578999999999998 89999999999999999764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=367.04 Aligned_cols=251 Identities=31% Similarity=0.480 Sum_probs=208.4
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEec
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITEL 109 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~Ey 109 (631)
..+||+|+||.||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||++++++|.+.. .+++||||
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~ 100 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--FIKIFMEQ 100 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC--cEEEEEEe
Confidence 349999999999999999999999999987543 244567889999999999999999999987654 78999999
Q ss_pred cCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC--
Q 006777 110 FTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 184 (631)
Q Consensus 110 ~~gGsL~~~l~~~~---~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~-- 184 (631)
+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++..++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999998752 4679999999999999999999999 9999999999999854899999999999765432
Q ss_pred CCccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 185 TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.....................++...++++++|
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHH
Confidence 2345679999999998854 3789999999999999999999999765555443333322223344556678999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 262 IEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
|.+||. +|.+||++.++|.||||+...
T Consensus 259 i~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 259 ILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 999998 899999999999999998644
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=370.66 Aligned_cols=261 Identities=26% Similarity=0.485 Sum_probs=212.2
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
......++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (314)
T 3com_A 23 LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96 (314)
T ss_dssp -------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred hhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 44556789999999999999999999999999999999987543 234678899999999999999999998765
Q ss_pred CCceEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 99 TNRTINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~-~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
. .+++||||+.+|+|.+++. ....+++..++.++.||+.||.|||++| ++||||||+||+++ .+|.+||+|||+
T Consensus 97 ~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~ 171 (314)
T 3com_A 97 T--DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGV 171 (314)
T ss_dssp T--EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTT
T ss_pred C--EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEEC-CCCCEEEeeccc
Confidence 4 7899999999999999987 4567999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Q 006777 178 AIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKV 253 (631)
Q Consensus 178 A~~~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-p~~l~~~ 253 (631)
+...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+..... ....+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T 3com_A 172 AGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-PMRAIFMIPTNPPPTFRKPEL 250 (314)
T ss_dssp CEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSSGGG
T ss_pred chhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCCCcccCCccc
Confidence 9765433 2345679999999998764 58999999999999999999999998744 3333333433322 2223445
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCc
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 291 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~ 291 (631)
+++.+++||.+||. +|.+|||+.++|+||||+......
T Consensus 251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~ 289 (314)
T 3com_A 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289 (314)
T ss_dssp SCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence 68899999999998 999999999999999998765443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=379.26 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=213.6
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC--
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-- 99 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~-- 99 (631)
.++.+|++.+.||+|+||.||+|.+..+|..||+|++... ......+++.+|+.+|++++||||+++++++....
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 3467999999999999999999999999999999998743 23556678999999999999999999999886543
Q ss_pred -CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 -NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 -~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
...+++||||+. |+|.++++. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLA 175 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred ccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEEC-CCCCEEEEeCcce
Confidence 246899999997 699999876 46999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCC-----CCccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--------
Q 006777 179 IVMQQP-----TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------- 243 (631)
Q Consensus 179 ~~~~~~-----~~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-------- 243 (631)
...... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+...+..
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 755432 134568999999999764 34899999999999999999999999875444333222210
Q ss_pred ---------------CCCCC-----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 244 ---------------GIKPA-----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 ---------------~~~p~-----~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
...+. .+....++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00000 0123457899999999998 99999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=372.33 Aligned_cols=265 Identities=25% Similarity=0.434 Sum_probs=194.1
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
.....++|.+.+.||+|+||+||+|.+..+|+.||+|++..... ....+++.+|+.++++++||||+++++++....
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 34457899999999999999999999998999999999875432 334567889999999999999999999987654
Q ss_pred CceEEEEEeccCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEE
Q 006777 100 NRTINMITELFTSGSLRQYRKK--------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~--------~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
.+++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+|
T Consensus 87 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~k 161 (303)
T 2vwi_A 87 --ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQ 161 (303)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEE
T ss_pred --CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEc-CCCCEE
Confidence 68999999999999999874 456999999999999999999999999 99999999999997 789999
Q ss_pred EccccchhhccCC-------CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006777 172 IGDLGLAIVMQQP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 172 I~DFGlA~~~~~~-------~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~ 242 (631)
|+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||............+.
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 241 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ 241 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence 9999999755322 1234679999999998864 589999999999999999999999987554444433333
Q ss_pred cCCC-------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCcc
Q 006777 243 SGIK-------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDL 292 (631)
Q Consensus 243 ~~~~-------p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~~ 292 (631)
.... ........++.+++||.+||. +|.+||++.++++||||+....+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~ 299 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF 299 (303)
T ss_dssp SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--------
T ss_pred cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCcc
Confidence 2211 112234567899999999998 9999999999999999987655443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=386.81 Aligned_cols=255 Identities=18% Similarity=0.283 Sum_probs=202.8
Q ss_pred cCCCcEEEE-EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHH-HhCCCCCcceeeeEEEc--
Q 006777 22 SVSYFWISW-VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVD-- 97 (631)
Q Consensus 22 ~i~~~Y~i~-e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIV~l~~~f~~-- 97 (631)
.+.+.|.+. ++||+|+||+||+|.++.+|+.||+|++... ..+.+|+.++ +.++||||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 344566665 7999999999999999999999999998632 2356788887 45589999999998864
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC--CCcEEEc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIG 173 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKI~ 173 (631)
....++|+||||+.||+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++.. ++.+||+
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEEC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEE
Confidence 33457999999999999999998754 5999999999999999999999999 9999999999999732 6899999
Q ss_pred cccchhhccCC-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHH---HHHHHHHcCCC--
Q 006777 174 DLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIK-- 246 (631)
Q Consensus 174 DFGlA~~~~~~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~---~~~~~i~~~~~-- 246 (631)
|||+++..... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+..... .....+..+..
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp CCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred ecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 99999765432 345678999999999885 469999999999999999999999997643211 13334443322
Q ss_pred CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 247 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+......+++++++||.+||. +|.+|||+.++|+||||...
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 222234578999999999998 99999999999999999763
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=387.71 Aligned_cols=254 Identities=20% Similarity=0.286 Sum_probs=207.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC----
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD---- 98 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~---- 98 (631)
....|.+.++||+|+||.||+|.+..+|+.||||++..... ...+|+++|+.|+|||||+++++|...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 34579999999999999999999999999999999875432 123699999999999999999988642
Q ss_pred CCceEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 99 TNRTINMITELFTSGSLRQYRK----KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~----~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
+..++++||||+.+ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.+||+|
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECC
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEecc
Confidence 23467899999985 6655543 3567999999999999999999999999 999999999999985557899999
Q ss_pred ccchhhccCC-CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--------
Q 006777 175 LGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------- 243 (631)
Q Consensus 175 FGlA~~~~~~-~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-------- 243 (631)
||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++.+.+..
T Consensus 201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9999765432 3446789999999998754 5899999999999999999999999886555544443321
Q ss_pred ------CCCCCC------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 244 ------GIKPAS------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 ------~~~p~~------------l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
...... +....++++++||.+||+ +|.+|||+.|+|+||||...
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 000001 223457899999999998 99999999999999999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=364.84 Aligned_cols=254 Identities=30% Similarity=0.450 Sum_probs=210.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC----
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---- 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~---- 99 (631)
.++|++.+.||+|+||.||+|.+..+|+.||+|++... ....+.+.+|+.++++++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 46899999999999999999999999999999998643 355678899999999999999999999887632
Q ss_pred -------CceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEE
Q 006777 100 -------NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 100 -------~~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
...+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~-~~~~~k 156 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVK 156 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEc-CCCCEE
Confidence 357899999999999999998654 5889999999999999999999999 99999999999997 789999
Q ss_pred EccccchhhccCC----------------CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCC
Q 006777 172 IGDLGLAIVMQQP----------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN 233 (631)
Q Consensus 172 I~DFGlA~~~~~~----------------~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~ 233 (631)
|+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++ ||....+
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 9999999754321 2234579999999998864 58999999999999999998 6754344
Q ss_pred HHHHHHHHHcCC--CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 234 PAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 234 ~~~~~~~i~~~~--~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.......+.... .|..+....++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 455555555432 2445556677889999999998 999999999999999997643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=388.67 Aligned_cols=261 Identities=28% Similarity=0.379 Sum_probs=198.3
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
..-.+..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+++.+|+.+|+.++||||++++++|...
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 23 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100 (367)
T ss_dssp EEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 34456789999999999999999999999999999999986542 3456677899999999999999999999988653
Q ss_pred C----CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 99 T----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 99 ~----~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
. ...+|+|+||+ +++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kL~D 175 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILD 175 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECC
T ss_pred CccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC-CCCCEEEee
Confidence 2 24689999999 6899998876 57999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC-----
Q 006777 175 LGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK----- 246 (631)
Q Consensus 175 FGlA~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-~~~----- 246 (631)
||+++..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+.. +.+
T Consensus 176 FG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 176 FGLARHTADE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccccccccc-CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9999765432 345689999999998754 6899999999999999999999999875443333222211 000
Q ss_pred -------------------CCC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 247 -------------------PAS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 -------------------p~~---l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
... .....++.+++||.+||+ +|.+|||+.++|.||||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 000 112357889999999998 99999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=378.91 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=215.8
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
+.-...++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 44445679999999999999999999999999999999987553 2445567788999999999999999999998765
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++
T Consensus 97 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 97 --KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFA 171 (331)
T ss_dssp --TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCTTC
T ss_pred --CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEc-CCCcEEEEeCCCc
Confidence 478999999999999999888888999999999999999999999999 99999999999997 7899999999999
Q ss_pred hhccCC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-----------
Q 006777 179 IVMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------- 243 (631)
Q Consensus 179 ~~~~~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~----------- 243 (631)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..........+..
T Consensus 172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 765432 2345679999999998865 5899999999999999999999999875554444333211
Q ss_pred --------CCCCCCC---------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 244 --------GIKPASL---------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 244 --------~~~p~~l---------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
+.....+ ....++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 0000000 12357899999999998 999999999999999998643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=377.92 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=204.5
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCH-HHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSP-DQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
...++|.+.+.||+|+||.||+|.+..+|+.||+|++......... ...+.+.+|+.+++.++||||++++++|.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-- 84 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--
Confidence 3467899999999999999999999999999999998764322111 1234678999999999999999999988654
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAK 160 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGS
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEc-CCCCEEEEecccce
Confidence 468899999985 898888765 46999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCC--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCC-CCCC--
Q 006777 180 VMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIK-PASL-- 250 (631)
Q Consensus 180 ~~~~~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--~~~-p~~l-- 250 (631)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... .....+.. +.. +..+
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSS
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhhhh
Confidence 65433 2345689999999998754 4899999999999999999999999875443 33333322 111 1111
Q ss_pred ---------------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 251 ---------------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 251 ---------------------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
....++.+++||.+||. +|.+|||+.|+|+||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13346899999999998 99999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=378.99 Aligned_cols=256 Identities=26% Similarity=0.351 Sum_probs=203.6
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC--
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-- 99 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~-- 99 (631)
.+.++|.+.+.||+|+||+||+|.+..+|+.||+|++.... ......+++.+|+.+++.++||||++++++|....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 45689999999999999999999999999999999997543 24566678899999999999999999999886543
Q ss_pred --CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 100 --NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 100 --~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
...+++||||+. |+|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 100 EEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGL 173 (371)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC
T ss_pred ccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEEEeec
Confidence 237899999997 57888886 45999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC-------
Q 006777 178 AIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA------- 248 (631)
Q Consensus 178 A~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~------- 248 (631)
+...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. ....+..+.......
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHH
Confidence 9765433 2345689999999998764 58999999999999999999999998744 434444443321100
Q ss_pred -------------CC--------------CC------CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 249 -------------SL--------------SK------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 249 -------------~l--------------~~------~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.+ +. ..++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00 00 015689999999998 9999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=385.43 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=209.9
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC------CCCCcceee
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL------KHENIIKFY 92 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L------~HpnIV~l~ 92 (631)
....+.++|++.++||+|+||+||+|.+..+|+.||+|++... ......+.+|+.+++.+ +|+||++++
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 3455678899999999999999999999999999999998743 34456677888888877 677999999
Q ss_pred eEEEcCCCceEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc-
Q 006777 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE- 169 (631)
Q Consensus 93 ~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~- 169 (631)
++|.... .+++||||+. |+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 166 ~~~~~~~--~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~-~~~~~ 239 (429)
T 3kvw_A 166 ENFTFRN--HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLK-QQGRS 239 (429)
T ss_dssp EEEEETT--EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEES-STTSC
T ss_pred eecccCC--eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-cCCCc
Confidence 9887654 7999999996 79999988764 4999999999999999999999999 99999999999998 5666
Q ss_pred -EEEccccchhhccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC
Q 006777 170 -VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK 246 (631)
Q Consensus 170 -vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-~~~ 246 (631)
+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+......+...+.. +.+
T Consensus 240 ~vkL~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQ-RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp CEEECCCTTCEETTC-CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ceEEeecccceecCC-cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999999965443 3446789999999998754 6999999999999999999999999875444333222211 000
Q ss_pred CC-------------------------------------------------------CCCCCCcHHHHHHHHHhcC-CCC
Q 006777 247 PA-------------------------------------------------------SLSKVTDPQVKQFIEKCIV-PAS 270 (631)
Q Consensus 247 p~-------------------------------------------------------~l~~~~~~~lk~lI~kcL~-~p~ 270 (631)
+. .+....++.+++||.+||+ +|.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~ 398 (429)
T 3kvw_A 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398 (429)
T ss_dssp CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence 00 0112347889999999998 999
Q ss_pred CCCCHHHHhcCCCccCCCC
Q 006777 271 LRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 271 ~Rpta~elL~hpff~~~~~ 289 (631)
+|||+.|+|+||||+...+
T Consensus 399 ~Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 399 VRMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp TSCCHHHHHTSTTTC----
T ss_pred hCCCHHHHhCChhhccCCC
Confidence 9999999999999987543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=364.91 Aligned_cols=260 Identities=28% Similarity=0.508 Sum_probs=223.1
Q ss_pred CccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006777 17 EPISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~ 96 (631)
..........|.+.+.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 90 (303)
T 3a7i_A 14 QNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYL 90 (303)
T ss_dssp TTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 33445567789999999999999999999999999999999986643 234567899999999999999999999987
Q ss_pred cCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 97 DDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 97 ~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
+.. .+++||||+++++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||
T Consensus 91 ~~~--~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg 164 (303)
T 3a7i_A 91 KDT--KLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFG 164 (303)
T ss_dssp ETT--EEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCT
T ss_pred cCC--eEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEEC-CCCCEEEeecc
Confidence 654 78999999999999999875 56999999999999999999999999 99999999999997 78999999999
Q ss_pred chhhccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 177 LAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 177 lA~~~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..+.. ..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~ 242 (303)
T 3a7i_A 165 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKNNP-PTLEGN 242 (303)
T ss_dssp TCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCC-CCCCSS
T ss_pred cceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhcCCC-CCCccc
Confidence 99765433 2345679999999998764 588999999999999999999999987 445555555555433 345566
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.++.+++||.+||. +|.+|||+.++|+||||...
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 78999999999998 89999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=371.51 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=214.0
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
+...+.++|.+.+.||+|+||.||+|.+..+|+.||+|++... .......++.+|+.+|+.++||||+++++++...
T Consensus 5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPD 81 (353)
T ss_dssp CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence 4556788999999999999999999999999999999998643 2355667788999999999999999999977543
Q ss_pred C---CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 99 T---NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 99 ~---~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
. ...+++||||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+||
T Consensus 82 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Df 156 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDF 156 (353)
T ss_dssp CSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCC
T ss_pred ccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-CCCcEEEEec
Confidence 2 257899999997 699999876 56999999999999999999999999 99999999999997 7899999999
Q ss_pred cchhhccCC------------CCccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006777 176 GLAIVMQQP------------TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 241 (631)
Q Consensus 176 GlA~~~~~~------------~~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i 241 (631)
|++...... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+...........
T Consensus 157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 236 (353)
T 2b9h_A 157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236 (353)
T ss_dssp TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 999754321 122357899999999764 458999999999999999999999998754333322211
Q ss_pred Hc-CCCC------------------------C----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 242 TS-GIKP------------------------A----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 242 ~~-~~~p------------------------~----~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.. +..+ . ......++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 10 0000 0 0113467899999999998 999999999999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=383.41 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=208.5
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
.+.....+|.+.++||+|+||+||+|.+..++. ||+|.+...... ..+|+.+|+.++||||++++++|...
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEec
Confidence 344456789999999999999999999976665 888887644321 12699999999999999999998653
Q ss_pred C----CceEEEEEeccCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEE
Q 006777 99 T----NRTINMITELFTSGSLRQYR---KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 99 ~----~~~l~lV~Ey~~gGsL~~~l---~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
. ..++++||||+.++.+.... .....+++..++.|+.||+.||.|||++| |+||||||+|||++..+|.+|
T Consensus 105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~k 182 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLK 182 (394)
T ss_dssp SSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEE
T ss_pred CCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEE
Confidence 3 23588999999875444332 33567999999999999999999999999 999999999999986689999
Q ss_pred EccccchhhccC-CCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC----
Q 006777 172 IGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---- 244 (631)
Q Consensus 172 I~DFGlA~~~~~-~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~---- 244 (631)
|+|||+|+.... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++...+...
T Consensus 183 L~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp ECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999976543 33456789999999998754 58999999999999999999999998865544444333210
Q ss_pred --------------CCC----C----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 245 --------------IKP----A----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 245 --------------~~p----~----~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
..+ . .++...++++++||.+||+ +|.+|||+.|+|+||||+...+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 000 0 1233467899999999998 9999999999999999987544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=368.62 Aligned_cols=261 Identities=21% Similarity=0.344 Sum_probs=210.4
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
.+..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+++.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 3566788999999999999999999999999999999998754 356677899999999999999999999987432
Q ss_pred ------------CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC
Q 006777 99 ------------TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN 166 (631)
Q Consensus 99 ------------~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~ 166 (631)
....+++||||+. |+|.+++.+ +.+++..++.++.||+.||.|||++| |+||||||+|||++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTE 156 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC
Confidence 2357899999998 699999875 56999999999999999999999999 9999999999999856
Q ss_pred CCcEEEccccchhhccCC-----CCccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006777 167 NGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 239 (631)
Q Consensus 167 ~g~vKI~DFGlA~~~~~~-----~~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~ 239 (631)
++.+||+|||++...... ......+|+.|+|||++. ..++.++|||||||++|+|++|+.||.+.. ......
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~~~~~ 235 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH-ELEQMQ 235 (320)
T ss_dssp TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHH
T ss_pred CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC-HHHHHH
Confidence 789999999999765321 233456899999999774 468999999999999999999999998754 333333
Q ss_pred HHHcCCCC----------------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 240 KVTSGIKP----------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 240 ~i~~~~~p----------------------------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.+...... ..+....++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 33221110 01123468899999999998 999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=377.39 Aligned_cols=263 Identities=21% Similarity=0.329 Sum_probs=222.2
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCH-------------HHHHHHHHHHHHHHhCCCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSP-------------DQLERLYSEVHLLKSLKHEN 87 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~-------------~~~~~~~~Ei~iL~~L~Hpn 87 (631)
....++|.+.+.||+|+||.||+|.+ +|+.||+|++......... ...+.+.+|+.++++++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34457999999999999999999998 8999999999865432111 11267889999999999999
Q ss_pred cceeeeEEEcCCCceEEEEEeccCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCC
Q 006777 88 IIKFYNSWVDDTNRTINMITELFTSGSLRQY------RKK--HKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKC 158 (631)
Q Consensus 88 IV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~------l~~--~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp 158 (631)
|+++++++.+. ..+++||||+++|+|.++ +.. ...+++..++.++.||+.||.|||+ +| |+||||||
T Consensus 105 i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p 180 (348)
T 2pml_X 105 CLTCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKP 180 (348)
T ss_dssp BCCCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCG
T ss_pred cceEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCCh
Confidence 99999998765 479999999999999998 665 5679999999999999999999999 88 99999999
Q ss_pred CceEEeCCCCcEEEccccchhhccCCCCccccCCCCCCCccccccc--cCc-cceEeehhhHHHHHhhcCCCCCCCCCHH
Q 006777 159 DNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNE-LVDIYSFGMCILEMVTCEYPYNECKNPA 235 (631)
Q Consensus 159 ~NILl~~~~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~~--y~~-~sDIwSLG~il~emltG~~Pf~~~~~~~ 235 (631)
+||+++ .++.+||+|||++............||+.|+|||++.+. ++. ++|||||||++|+|++|..||.......
T Consensus 181 ~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 181 SNILMD-KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp GGEEEC-TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred HhEEEc-CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 999997 789999999999987655555667899999999988654 555 9999999999999999999998866657
Q ss_pred HHHHHHHcCCCCCCC-----------------CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCC
Q 006777 236 QIYKKVTSGIKPASL-----------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 236 ~~~~~i~~~~~p~~l-----------------~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~ 290 (631)
.....+..+..+... ....++.+++||.+||. +|.+|||+.++|+||||+..++.
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~ 332 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHH
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHH
Confidence 777777665332211 14578999999999998 99999999999999999876543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=391.07 Aligned_cols=250 Identities=16% Similarity=0.176 Sum_probs=200.7
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHH---HHHHhCCCCCcceee-------
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEV---HLLKSLKHENIIKFY------- 92 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei---~iL~~L~HpnIV~l~------- 92 (631)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+.+|+ ++|++++|||||+++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc-cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 35789999999999999999999999999999999986543 2344667889999 555666899999998
Q ss_pred eEEEcCCC----------c-----eEEEEEeccCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCCC
Q 006777 93 NSWVDDTN----------R-----TINMITELFTSGSLRQYRKKHKNVDM-------KAIKNWARQILRGLHYLHSHNPP 150 (631)
Q Consensus 93 ~~f~~~~~----------~-----~l~lV~Ey~~gGsL~~~l~~~~~l~e-------~~i~~i~~QIl~gL~yLHs~~~~ 150 (631)
+++.+.+. . ..|+||||+ +|+|.+++.+.+.+++ ..++.|+.||+.||.|||+++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 55443321 1 378999999 6899999987665665 888899999999999999999
Q ss_pred eEecCCCCCceEEeCCCCcEEEccccchhhccCCCCccccCCCCCCCcccccc------------ccCccceEeehhhHH
Q 006777 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCI 218 (631)
Q Consensus 151 IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~------------~y~~~sDIwSLG~il 218 (631)
|+||||||+|||++ .+|.+||+|||+|+.... .....+| +.|+|||++.+ .|+.++|||||||++
T Consensus 227 ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 227 LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp EECSCCCGGGEEEC-TTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEc-CCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 99999999999998 789999999999975433 3345678 99999998754 589999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 219 ~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
|+|++|+.||.+.. .......+.. .....++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 304 ~elltg~~Pf~~~~-~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDA-ALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC-------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccc-cccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999997632 1111111211 123567899999999998 8999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=365.44 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=216.1
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC--CCCcceeeeEEEcCC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDT 99 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~~f~~~~ 99 (631)
..+.+|.+.+.||+|+||.||+|.+. +|..||+|++..... .....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 34678999999999999999999985 589999999986543 4566788999999999997 599999999887644
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+++||| +.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ +|.+||+|||++.
T Consensus 102 --~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~--~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 102 --YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIAN 174 (313)
T ss_dssp --EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSC
T ss_pred --EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE--CCeEEEeeccccc
Confidence 7999999 567899999999889999999999999999999999999 99999999999997 4899999999997
Q ss_pred hccCCC----CccccCCCCCCCcccccc------------ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006777 180 VMQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243 (631)
Q Consensus 180 ~~~~~~----~~~~~GTp~y~APE~l~~------------~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~ 243 (631)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||....+.......+..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 654322 234579999999998753 5888999999999999999999999876666665566655
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 244 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 ~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
......++...++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 545555666678999999999998 99999999999999999763
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=356.65 Aligned_cols=249 Identities=18% Similarity=0.256 Sum_probs=211.7
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|.+.+.||+|+||+||+|.+. |..||+|++.... ......+.+.+|+.++++++||||+++++++.+.....
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 3568999999999999999999984 8999999998653 24566678999999999999999999999987765568
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++++++||||||+||+++ .+|.++|+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFS 162 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCCT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEeccceee
Confidence 899999999999999998865 48999999999999999999999988899999999999998 788999999888754
Q ss_pred ccCCCCccccCCCCCCCccccccc----cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 181 MQQPTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 181 ~~~~~~~~~~GTp~y~APE~l~~~----y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
... ....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.. .......+........++...++
T Consensus 163 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 163 FQS---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp TSC---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-HHHHHHHHHHSCCCCCCCTTCCH
T ss_pred ecc---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-hHHHHHHHHhcCCCCCCCCCCCH
Confidence 322 345789999999988643 3448999999999999999999998754 44444444444344455667889
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+++||.+||. +|.+|||+.++++
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999998 8999999999886
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=378.97 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=206.9
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC--------CCCcce
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK--------HENIIK 90 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~--------HpnIV~ 90 (631)
++..+.++|.+.++||+|+||+||+|.+..+|+.||+|++... ....+.+.+|+.+|+.++ ||||++
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 3555678999999999999999999999999999999998633 345677889999999985 788999
Q ss_pred eeeEEEcC--CCceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCceEEeC
Q 006777 91 FYNSWVDD--TNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 91 l~~~f~~~--~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~ 165 (631)
++++|... ....+++||||+ +|+|.+++.+. +.+++..++.++.||+.||.|||++ | |+||||||+|||++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~- 181 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLS- 181 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEEC-
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEe-
Confidence 99988632 345899999999 56666666544 5699999999999999999999998 8 99999999999997
Q ss_pred CCC-------------------------------------------------cEEEccccchhhccCCCCccccCCCCCC
Q 006777 166 NNG-------------------------------------------------EVKIGDLGLAIVMQQPTARSVIGTPEFM 196 (631)
Q Consensus 166 ~~g-------------------------------------------------~vKI~DFGlA~~~~~~~~~~~~GTp~y~ 196 (631)
.+| .+||+|||++...... ....+||+.|+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~ 260 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYR 260 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCccc
Confidence 444 7999999999765443 34568999999
Q ss_pred Ccccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCC-----HHHHHHHHHc--CCCCC--------------------
Q 006777 197 APELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-----PAQIYKKVTS--GIKPA-------------------- 248 (631)
Q Consensus 197 APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~-----~~~~~~~i~~--~~~p~-------------------- 248 (631)
|||++.+ .|+.++|||||||++|+|+||..||..... .......+.. +..|.
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 9998764 589999999999999999999999976432 1111111111 11000
Q ss_pred ------------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 249 ------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 249 ------------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.++...++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0112234678999999998 9999999999999999963
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=377.75 Aligned_cols=257 Identities=27% Similarity=0.367 Sum_probs=209.1
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.+..+|.+.+.||+|+||+||+|.+..+|+.||+|++.... .......++.+|+.+++.++||||++++++|......
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence 45689999999999999999999999999999999987543 3455677899999999999999999999998765431
Q ss_pred ----eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 102 ----TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 102 ----~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
.+++||||+. |+|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 117 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~ 190 (371)
T 4exu_A 117 RNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGL 190 (371)
T ss_dssp TTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSTTC
T ss_pred ccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEEC-CCCCEEEEecCc
Confidence 3489999997 68988874 45999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--------
Q 006777 178 AIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------- 247 (631)
Q Consensus 178 A~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p-------- 247 (631)
+...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+.....+
T Consensus 191 a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 191 ARHADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp C---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccccccC-cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 9765433 345678999999998764 68999999999999999999999998744333332222110000
Q ss_pred -------------C-------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 248 -------------A-------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 -------------~-------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
. .+....++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 0123457899999999998 99999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=365.24 Aligned_cols=261 Identities=25% Similarity=0.378 Sum_probs=209.9
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEc-CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCcceeeeEEEc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVD 97 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~-~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~f~~ 97 (631)
...++|++.+.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 34578999999999999999999995 678999999997654211 1112345666666655 89999999998862
Q ss_pred ---CCCceEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 98 ---DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 98 ---~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
.....+++||||+. |+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~-~~~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEc-CCCCEEE
Confidence 23457899999998 69999998754 4999999999999999999999999 99999999999997 7899999
Q ss_pred ccccchhhccCC-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CC--
Q 006777 173 GDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IK-- 246 (631)
Q Consensus 173 ~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~--~~-- 246 (631)
+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+...... ...+... ..
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~ 240 (326)
T 1blx_A 162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGE 240 (326)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCG
T ss_pred ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCc
Confidence 999999765432 234567999999999875 4589999999999999999999999987544333 3333210 00
Q ss_pred ---------------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 247 ---------------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 247 ---------------------p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
...+....++.+++||.+||. +|.+|||+.++|+||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 011234568899999999998 9999999999999999987544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=355.81 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=199.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|.+.+.||+|+||+||+|.+. |..||+|++............+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--PN 80 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cc
Confidence 4578999999999999999999974 8999999987654333334457789999999999999999999988654 36
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CeEecCCCCCceEEeC-------CCCcEEEcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVNG-------NNGEVKIGD 174 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~-~IiHrDLKp~NILl~~-------~~g~vKI~D 174 (631)
+++||||+++|+|.+++.. +.+++..++.++.||+.||.|||+++. +|+||||||+||+++. .++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 8999999999999999864 579999999999999999999999983 4889999999999973 267899999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 175 LGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 175 FGlA~~~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
||++............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+. +.......+.........+..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHTSCCCCCCCTT
T ss_pred CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhcCCCCCCCCcc
Confidence 99998766555556789999999998764 5899999999999999999999999874 444444455555445556667
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.++.+++||.+||. +|.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 78999999999998 89999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=369.20 Aligned_cols=244 Identities=26% Similarity=0.374 Sum_probs=204.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|.+.++||+|+||+||+|.+..+|+.||+|.+.. ......+.+.+|+.+|++++||||+++++++.+.. .+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~ 82 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK--RL 82 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC--ee
Confidence 5689999999999999999999999999999998853 24566788999999999999999999999987654 78
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEEC-CCCCEEEeecccceecc
Confidence 999999999999999987 567999999999999999999999999 99999999999998 78999999999997543
Q ss_pred CCCC----------------ccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHH----HHHHH
Q 006777 183 QPTA----------------RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYKKV 241 (631)
Q Consensus 183 ~~~~----------------~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~----~~~~i 241 (631)
.... ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||........ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 2211 15679999999998865 589999999999999999999999865322110 01111
Q ss_pred HcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 242 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 242 ~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
... ..+...++.+.+||.+||. +|.+|||+.++++
T Consensus 240 ~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 240 LDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 1234456789999999998 9999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=356.89 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=213.1
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHH---HHHHHHHHHHHhCCCCCcceeeeEE
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQL---ERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~---~~~~~Ei~iL~~L~HpnIV~l~~~f 95 (631)
+.....++|.+.+.||+|+||+||+|.+..+++.||+|++............ +++.+|+.++++++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 3345578999999999999999999999999999999998765543333222 6789999999999999999999987
Q ss_pred EcCCCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc-----
Q 006777 96 VDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----- 169 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~----- 169 (631)
.+.. ++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++++||+||||||+|||++ .++.
T Consensus 93 ~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~-~~~~~~~~~ 167 (287)
T 4f0f_A 93 HNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ-SLDENAPVC 167 (287)
T ss_dssp TTTT----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES-CCCTTCSCC
T ss_pred cCCC----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe-ccCCCCcee
Confidence 5432 6899999999998888654 479999999999999999999999988899999999999997 5555
Q ss_pred EEEccccchhhccCCCCccccCCCCCCCccccc---cccCccceEeehhhHHHHHhhcCCCCCCCCCHH-HHHHHHHcCC
Q 006777 170 VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSGI 245 (631)
Q Consensus 170 vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~---~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~-~~~~~i~~~~ 245 (631)
+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||....... .....+....
T Consensus 168 ~kl~Dfg~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 168 AKVADFGLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp EEECCCTTCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred EEeCCCCccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 99999999974433 334567999999999883 347899999999999999999999998754433 3344444444
Q ss_pred CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 246 KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 246 ~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+..++...++.+++||.+||. +|.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4555667788999999999998 9999999999886
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=365.27 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=209.6
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEE-cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC------ccee
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFD-EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN------IIKF 91 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d-~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------IV~l 91 (631)
.+..+.++|++.+.||+|+||+||+|.+ ..+|+.||+|+++.. ....+.+.+|+.+++.++|++ |+++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 3566788999999999999999999999 568999999998632 345677889999999987664 9999
Q ss_pred eeEEEcCCCceEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC---
Q 006777 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--- 166 (631)
Q Consensus 92 ~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--- 166 (631)
+++|.+.. .+++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++..
T Consensus 83 ~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 83 LEWFEHHG--HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp EEEEEETT--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEE
T ss_pred ecccccCC--cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccc
Confidence 99886654 799999999 899999998765 6899999999999999999999999 9999999999999732
Q ss_pred ---------------CCcEEEccccchhhccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCC
Q 006777 167 ---------------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNE 230 (631)
Q Consensus 167 ---------------~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~ 230 (631)
++.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCccccccccccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 56899999999975433 3345689999999998764 689999999999999999999999987
Q ss_pred CCCHHHHHHHHHc--CCCCC----------------------------------------CCCCCCcHHHHHHHHHhcC-
Q 006777 231 CKNPAQIYKKVTS--GIKPA----------------------------------------SLSKVTDPQVKQFIEKCIV- 267 (631)
Q Consensus 231 ~~~~~~~~~~i~~--~~~p~----------------------------------------~l~~~~~~~lk~lI~kcL~- 267 (631)
.. .......+.. +..|. ......++.+++||.+||.
T Consensus 237 ~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 237 HD-SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp SC-HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CC-hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 43 3332222211 10010 0111235678999999998
Q ss_pred CCCCCCCHHHHhcCCCccC
Q 006777 268 PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 268 ~p~~Rpta~elL~hpff~~ 286 (631)
+|.+|||+.|+|+||||+.
T Consensus 316 dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 316 DPAKRITLREALKHPFFDL 334 (339)
T ss_dssp STTTSCCHHHHTTSGGGGG
T ss_pred CcccccCHHHHhcCHHHHH
Confidence 9999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=373.30 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=213.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEE-----EcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEE
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV 96 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~-----d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~ 96 (631)
..++|.+.+.||+|+||.||+|. +..+|+.||+|+++... .....+.+.+|+.+|+++ +||||++++++|.
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 46799999999999999999998 55677999999997542 345667899999999999 8999999999886
Q ss_pred cCCCceEEEEEeccCCCCHHHHHHhCCC----------------------------------------------------
Q 006777 97 DDTNRTINMITELFTSGSLRQYRKKHKN---------------------------------------------------- 124 (631)
Q Consensus 97 ~~~~~~l~lV~Ey~~gGsL~~~l~~~~~---------------------------------------------------- 124 (631)
+.. ..+++||||+.+|+|.+++.....
T Consensus 97 ~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 97 KPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp STT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred cCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 644 468899999999999999987543
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC----CC
Q 006777 125 --------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TA 186 (631)
Q Consensus 125 --------------l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~----~~ 186 (631)
+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...... ..
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCcEEEEeccceeeecccccchhc
Confidence 899999999999999999999999 99999999999997 7889999999999755332 12
Q ss_pred ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHH
Q 006777 187 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264 (631)
Q Consensus 187 ~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~k 264 (631)
....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+..........+..+..+ ..+...++++.++|.+
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLD 331 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHH
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 3456899999999875 468999999999999999998 999998876666666666665433 3455678999999999
Q ss_pred hcC-CCCCCCCHHHHhcC
Q 006777 265 CIV-PASLRLPALELLKD 281 (631)
Q Consensus 265 cL~-~p~~Rpta~elL~h 281 (631)
||. +|.+|||+.++++|
T Consensus 332 ~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCCCHHHHHHH
Confidence 998 99999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=370.22 Aligned_cols=256 Identities=27% Similarity=0.370 Sum_probs=209.0
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC-
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN- 100 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~- 100 (631)
.+..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+++.+|+.+++.++||||+++++++.....
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence 35678999999999999999999999999999999987543 345566788999999999999999999998876543
Q ss_pred ---ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 101 ---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 101 ---~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
..+++||||+. |+|.+++. ..+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~ 172 (353)
T 3coi_A 99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGL 172 (353)
T ss_dssp GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTCCEEECSTTC
T ss_pred ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeEC-CCCcEEEeeccc
Confidence 24689999997 68888764 35999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--C---------
Q 006777 178 AIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--G--------- 244 (631)
Q Consensus 178 A~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--~--------- 244 (631)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ......+.. +
T Consensus 173 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 173 ARHADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TTC---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-HHHHHHHHHHHCBCCHHHHTT
T ss_pred ccCCCCC-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHH
Confidence 9765432 345678999999998754 589999999999999999999999987443 332222211 0
Q ss_pred ------------------CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 245 ------------------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 245 ------------------~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.....+....++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00112234568999999999998 99999999999999999764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=371.51 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=204.9
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccc-------cCCHHHHHHHHHHHHHHHhCCCCCcceeee
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDV-------MQSPDQLERLYSEVHLLKSLKHENIIKFYN 93 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~-------~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~ 93 (631)
..+.++|.+.+.||+|+||.||+|.+. +|..||+|++..... .......+++.+|+.+|++++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 345679999999999999999999985 499999999865422 123344578999999999999999999999
Q ss_pred EEEcC---CCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc
Q 006777 94 SWVDD---TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 94 ~f~~~---~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
+|... ....+++||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~ 172 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA-DNND 172 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCC
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc-CCCC
Confidence 98653 3347899999998 6888877654 47999999999999999999999999 99999999999997 7899
Q ss_pred EEEccccchhhccCC-CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC-C
Q 006777 170 VKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-I 245 (631)
Q Consensus 170 vKI~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~-~ 245 (631)
+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. .......+... .
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST-FYNQLNKIVEVVG 251 (362)
T ss_dssp EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHC
T ss_pred EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcC
Confidence 999999999754333 3345679999999998754 58999999999999999999999998744 33333333210 0
Q ss_pred CC-------------------------C----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 246 KP-------------------------A----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 246 ~p-------------------------~----~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.+ . ......++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 00 0 0123457889999999998 99999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=373.45 Aligned_cols=257 Identities=22% Similarity=0.254 Sum_probs=196.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC---
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~--- 99 (631)
..++|.+.+.||+|+||+||+|.+..+|..||+|++..... ...+..++++.++.++||||++++++|....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 35689999999999999999999999999999999865432 1234567888899999999999999986532
Q ss_pred --CceEEEEEeccCCCCHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCeEecCCCCCceEEeCCCCcEE
Q 006777 100 --NRTINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLH--SHNPPIIHRDLKCDNIFVNGNNGEVK 171 (631)
Q Consensus 100 --~~~l~lV~Ey~~gGsL~~~----l~~~~~l~e~~i~~i~~QIl~gL~yLH--s~~~~IiHrDLKp~NILl~~~~g~vK 171 (631)
..++++||||+.++ |... ......+++..++.++.||+.||.||| +++ |+||||||+|||++..++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEE
Confidence 23588999999864 4433 335677999999999999999999999 877 999999999999984489999
Q ss_pred EccccchhhccCC-CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC-CCC
Q 006777 172 IGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKP 247 (631)
Q Consensus 172 I~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~-~~p 247 (631)
|+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..... ....+... ..+
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~ 251 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRVLGCP 251 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHHcCCC
Confidence 9999999766543 3345689999999998743 38999999999999999999999998754433 33333211 000
Q ss_pred -----------------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 248 -----------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 248 -----------------------------~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.......++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 01112246789999999998 999999999999999998743
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=365.80 Aligned_cols=263 Identities=17% Similarity=0.271 Sum_probs=195.9
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~---~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
....+|.+.+.||+|+||+||+|.+..++. .||+|+++.... .....+++.+|+.++++++||||+++++++...
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 346789999999999999999999877765 899999876532 235567899999999999999999999998765
Q ss_pred CCc----eEEEEEeccCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC
Q 006777 99 TNR----TINMITELFTSGSLRQYRKKHK------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 99 ~~~----~l~lV~Ey~~gGsL~~~l~~~~------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
... .+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~-~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA-EDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc-CCC
Confidence 432 2489999999999999986543 5999999999999999999999999 99999999999998 789
Q ss_pred cEEEccccchhhccCCC----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006777 169 EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT 242 (631)
Q Consensus 169 ~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~ 242 (631)
.+||+|||++....... .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+. +.......+.
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~~~ 253 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNYLI 253 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-ChHHHHHHHh
Confidence 99999999997654322 223456889999998764 58999999999999999999 89999874 4555566665
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCC-------HHHHhcCCCccCCCCCc
Q 006777 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-------ALELLKDPFLVTDNPKD 291 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpt-------a~elL~hpff~~~~~~~ 291 (631)
.+..+ ..+...++.+++||.+||. +|.+||| ..+++.|||+.......
T Consensus 254 ~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p 309 (323)
T 3qup_A 254 GGNRL-KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309 (323)
T ss_dssp TTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred cCCCC-CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 55433 2344577899999999998 9999999 77899999998765443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=383.31 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=194.9
Q ss_pred ccCCCcEEE-EEEEeecCCeEEEEEEEc--CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 21 SSVSYFWIS-WVVVLNCTFMCRYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 21 ~~i~~~Y~i-~e~LG~G~fg~VY~A~d~--~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
..+.+.|.+ .++||+|+||+||+|.++ .+++.||+|++..... ...+.+|+.+|+.|+|||||+++++|..
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLS 89 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence 344567777 568999999999999975 5789999999875432 1357789999999999999999999987
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe---C
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH---------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---G 165 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~---------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~---~ 165 (631)
.....+++||||+. |+|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+|||+. .
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~ 166 (405)
T 3rgf_A 90 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGP 166 (405)
T ss_dssp TTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSST
T ss_pred CCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCC
Confidence 77778999999997 5888877532 24999999999999999999999999 99999999999993 2
Q ss_pred CCCcEEEccccchhhccCC-----CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCH----
Q 006777 166 NNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNP---- 234 (631)
Q Consensus 166 ~~g~vKI~DFGlA~~~~~~-----~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~---- 234 (631)
.++.+||+|||+|...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+....
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 246 (405)
T 3rgf_A 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246 (405)
T ss_dssp TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence 5689999999999765432 2345689999999998764 4899999999999999999999999754321
Q ss_pred -----HHHHHHHHc-CCCC-CCCC---------------------------------CCCcHHHHHHHHHhcC-CCCCCC
Q 006777 235 -----AQIYKKVTS-GIKP-ASLS---------------------------------KVTDPQVKQFIEKCIV-PASLRL 273 (631)
Q Consensus 235 -----~~~~~~i~~-~~~p-~~l~---------------------------------~~~~~~lk~lI~kcL~-~p~~Rp 273 (631)
.++...+.. +.++ ..+. ...++.+++||.+||. +|.+||
T Consensus 247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ 326 (405)
T 3rgf_A 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 326 (405)
T ss_dssp CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence 222221111 1111 1110 1126789999999998 999999
Q ss_pred CHHHHhcCCCccCCC
Q 006777 274 PALELLKDPFLVTDN 288 (631)
Q Consensus 274 ta~elL~hpff~~~~ 288 (631)
|+.|+|+||||....
T Consensus 327 ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 327 TSEQAMQDPYFLEDP 341 (405)
T ss_dssp CHHHHHTSGGGTSSS
T ss_pred CHHHHhcChhhccCC
Confidence 999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=372.19 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=211.7
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEc-------CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeE
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNS 94 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~-------~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~ 94 (631)
..++|.+.+.||+|+||.||+|.+. .++..||+|+++... .....+++.+|+.+|+.+ +||||++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4578999999999999999999874 356789999987542 355677899999999999 89999999998
Q ss_pred EEcCCCceEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006777 95 WVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158 (631)
Q Consensus 95 f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp 158 (631)
|.+. ..+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||
T Consensus 156 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 231 (370)
T 2psq_A 156 CTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 231 (370)
T ss_dssp ECSS--SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred EccC--CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 8654 36899999999999999998754 4789999999999999999999999 99999999
Q ss_pred CceEEeCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCC
Q 006777 159 DNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECK 232 (631)
Q Consensus 159 ~NILl~~~~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~ 232 (631)
+|||++ .+|.+||+|||++...... ......+|+.|+|||++. ..|+.++|||||||++|||+| |..||.+ .
T Consensus 232 ~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~ 309 (370)
T 2psq_A 232 RNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-I 309 (370)
T ss_dssp GGEEEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-C
T ss_pred hhEEEC-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-C
Confidence 999997 7899999999999755432 123346788999999875 458999999999999999999 9999987 4
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 233 ~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+..++...+..+..+ ..+...++++++||.+||. +|.+||++.|++++
T Consensus 310 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CGGGHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 556666677666443 3445678899999999998 89999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=364.84 Aligned_cols=260 Identities=18% Similarity=0.264 Sum_probs=209.3
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCC-eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC------ccee
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDG-IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN------IIKF 91 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g-~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------IV~l 91 (631)
++..+.++|.+.+.||+|+||+||+|.+..++ ..||+|+++.. ....+.+.+|+.+++.++|++ |+.+
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-----GKYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-----ccchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 45667889999999999999999999998777 79999998632 345677888999999997766 8999
Q ss_pred eeEEEcCCCceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe-----
Q 006777 92 YNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN----- 164 (631)
Q Consensus 92 ~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~----- 164 (631)
++++.... .+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 88 ~~~~~~~~--~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 88 SDWFNFHG--HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp EEEEEETT--EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEE
T ss_pred eeeeeeCC--eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccc
Confidence 98876544 799999999 56777777665 36999999999999999999999999 99999999999993
Q ss_pred -------------CCCCcEEEccccchhhccCCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCC
Q 006777 165 -------------GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNE 230 (631)
Q Consensus 165 -------------~~~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~ 230 (631)
..++.+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccCCCcEEEeecCccccccc-cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 1578999999999975433 334568999999999875 4689999999999999999999999987
Q ss_pred CCCHHHHHHHHHc--CCCCC----------------------------------------CCCCCCcHHHHHHHHHhcC-
Q 006777 231 CKNPAQIYKKVTS--GIKPA----------------------------------------SLSKVTDPQVKQFIEKCIV- 267 (631)
Q Consensus 231 ~~~~~~~~~~i~~--~~~p~----------------------------------------~l~~~~~~~lk~lI~kcL~- 267 (631)
..... ....+.. +..|. ......++++++||.+||.
T Consensus 242 ~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 242 HENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp SSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 44333 2222211 11110 0011124588999999998
Q ss_pred CCCCCCCHHHHhcCCCccCCCCC
Q 006777 268 PASLRLPALELLKDPFLVTDNPK 290 (631)
Q Consensus 268 ~p~~Rpta~elL~hpff~~~~~~ 290 (631)
+|.+|||+.++|+||||+...+.
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGLTPE 343 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGCCHH
T ss_pred ChhhCcCHHHHhcChhhcCCChh
Confidence 99999999999999999876543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=378.29 Aligned_cols=258 Identities=13% Similarity=0.121 Sum_probs=192.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC--CCCCcceee-------eE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL--KHENIIKFY-------NS 94 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIV~l~-------~~ 94 (631)
...|.+.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+++.| +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 4469999999999999999999999999999999987643 2345566778885544444 699988865 44
Q ss_pred EEcCCC---------------ceEEEEEeccCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCeE
Q 006777 95 WVDDTN---------------RTINMITELFTSGSLRQYRKKH-KNVDMKAI------KNWARQILRGLHYLHSHNPPII 152 (631)
Q Consensus 95 f~~~~~---------------~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i------~~i~~QIl~gL~yLHs~~~~Ii 152 (631)
+..... ..+|+||||++ |+|.+++... ..+++..+ ..++.||+.||.|||+++ |+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--iv 216 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LV 216 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Cc
Confidence 433222 35899999999 8999999874 33455555 577799999999999999 99
Q ss_pred ecCCCCCceEEeCCCCcEEEccccchhhccCCCCccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCC
Q 006777 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYN 229 (631)
Q Consensus 153 HrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~ 229 (631)
||||||+|||++ .+|.+||+|||+|+...... ....+|+.|+|||++.+ .|+.++|||||||++|+|+||+.||.
T Consensus 217 HrDikp~NIll~-~~~~~kL~DFG~a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 217 HGHFTPDNLFIM-PDGRLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp ETTCSGGGEEEC-TTSCEEECCGGGEEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCcCCHHHEEEC-CCCCEEEEecceeeecCCCc-cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999998 78999999999997654332 24567799999998864 58999999999999999999999998
Q ss_pred CCCCHHH-HHHH---HHcCCCCC--CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 230 ECKNPAQ-IYKK---VTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 230 ~~~~~~~-~~~~---i~~~~~p~--~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+...... .+.. ........ ......++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 6422100 0000 00001111 1123568999999999998 99999999999999999763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=358.20 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=213.6
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEE-----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeE
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d-----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~ 94 (631)
......+|.+.+.||+|+||.||+|.+ ..++..||+|++... ......+++.+|+.+|++++||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 344578999999999999999999998 345689999998744 245667889999999999999999999998
Q ss_pred EEcCCCceEEEEEeccCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCC
Q 006777 95 WVDDTNRTINMITELFTSGSLRQYRKKHKN------------------------VDMKAIKNWARQILRGLHYLHSHNPP 150 (631)
Q Consensus 95 f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~------------------------l~e~~i~~i~~QIl~gL~yLHs~~~~ 150 (631)
+.+.. .+++||||+.+|+|.+++...+. +++..++.++.||+.||.|||+++
T Consensus 95 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 170 (314)
T 2ivs_A 95 CSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-- 170 (314)
T ss_dssp ECSSS--SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EecCC--ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 86543 68999999999999999987543 899999999999999999999999
Q ss_pred eEecCCCCCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-c
Q 006777 151 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-C 224 (631)
Q Consensus 151 IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G 224 (631)
|+||||||+||+++ .++.+||+|||++....... .....+|+.|+|||++.+ .++.++|||||||++|+|+| |
T Consensus 171 ivH~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 171 LVHRDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp EECCCCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred CcccccchheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 99999999999998 78999999999997553321 234467889999998754 58999999999999999999 9
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 225 EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 225 ~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..||.+ .+...+...+..+..+ ..+...++.+++||.+||. +|.+||++.+++++
T Consensus 250 ~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 250 GNPYPG-IPPERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCC-CCHHHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999976 4555666666665433 3445678999999999998 89999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=368.77 Aligned_cols=260 Identities=20% Similarity=0.282 Sum_probs=187.9
Q ss_pred CccCccCCCcEEEE-EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEE
Q 006777 17 EPISSSVSYFWISW-VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 17 ~~~~~~i~~~Y~i~-e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f 95 (631)
.+....+.++|.+. ++||+|+||+||+|.++.+|+.||+|++... .... .+....++.+.||||++++++|
T Consensus 20 ~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~---~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKAR---QEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHH---HHHHHHHHHTTSTTBCCEEEEE
T ss_pred CCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHH---HHHHHHHHhcCCCChHHHHHHH
Confidence 44556678899995 4799999999999999999999999998643 2222 2233446778999999999988
Q ss_pred EcC--CCceEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCc
Q 006777 96 VDD--TNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGE 169 (631)
Q Consensus 96 ~~~--~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~ 169 (631)
... ....+++||||++||+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++. .++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCC
T ss_pred hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCce
Confidence 652 2356899999999999999998764 6999999999999999999999999 999999999999972 2456
Q ss_pred EEEccccchhhccCCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHH---HHHHHHcC-
Q 006777 170 VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYKKVTSG- 244 (631)
Q Consensus 170 vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~---~~~~i~~~- 244 (631)
+||+|||++............||+.|+|||++. ..++.++|||||||++|+|++|..||........ ....+..+
T Consensus 170 ~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 170 LKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249 (336)
T ss_dssp EEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred EEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence 999999999876655556678999999999885 4589999999999999999999999976432211 11122211
Q ss_pred -CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 245 -IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 245 -~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
..+.......++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 11222334578999999999998 9999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=363.15 Aligned_cols=249 Identities=20% Similarity=0.295 Sum_probs=209.6
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g---~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
....+|.+.+.||+|+||+||+|.+..+| ..||+|.++... .....+.+.+|+.+|++++||||++++++|.+.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34678999999999999999999997554 469999987542 355667899999999999999999999988654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
..+++||||+++|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 123 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~ 197 (325)
T 3kul_A 123 --RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVD-SNLVCKVSDFGL 197 (325)
T ss_dssp --GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCSS
T ss_pred --CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEC-CCCCEEECCCCc
Confidence 4688999999999999999765 57999999999999999999999999 99999999999997 789999999999
Q ss_pred hhhccCCC-----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006777 178 AIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 178 A~~~~~~~-----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l 250 (631)
+....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .........+..+..+. .
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~~-~ 275 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYRLP-A 275 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCCC-C
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCCCC-C
Confidence 97654321 12234678899999886 468999999999999999999 9999987 45666667776664433 3
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+...++.+.+||.+||. +|.+|||+.++++
T Consensus 276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 45678999999999998 8999999999886
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=368.23 Aligned_cols=256 Identities=19% Similarity=0.310 Sum_probs=215.5
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC--HHHHHHHHHHHHHHHhCC--CCCcceeeeEE
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLK--HENIIKFYNSW 95 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~--~~~~~~~~~Ei~iL~~L~--HpnIV~l~~~f 95 (631)
...+.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ....+++.+|+.+++.++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 45578899999999999999999999999999999999986643210 012244667999999996 59999999988
Q ss_pred EcCCCceEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 96 VDDTNRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~g-GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
... ..+++||||+.+ ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++..++.+||+|
T Consensus 118 ~~~--~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 118 ERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp ECS--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred ecC--CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEee
Confidence 654 478999999986 899999998889999999999999999999999999 999999999999985678999999
Q ss_pred ccchhhccCCCCccccCCCCCCCcccccc-c-cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 175 LGLAIVMQQPTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 175 FGlA~~~~~~~~~~~~GTp~y~APE~l~~-~-y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
||++............||+.|+|||++.+ . ++.++|||||||++|+|++|..||... .. +..+ ...++.
T Consensus 194 fg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---~~----~~~~--~~~~~~ 264 (320)
T 3a99_A 194 FGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---EE----IIRG--QVFFRQ 264 (320)
T ss_dssp CTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HHHC--CCCCSS
T ss_pred CccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh---hh----hhcc--cccccc
Confidence 99998776665566789999999998754 3 478899999999999999999999652 21 2222 122445
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
..++++++||.+||. +|.+|||+.++++||||+...
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 678999999999998 899999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=371.89 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=207.5
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CC-----Ccceeee
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HE-----NIIKFYN 93 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----nIV~l~~ 93 (631)
+....++|.+.+.||+|+||+||+|.+..+|+.||+|+++.. ......+.+|+.+++.++ |+ +|+++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 445678999999999999999999999999999999998743 344566788999988885 55 4999999
Q ss_pred EEEcCCCceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe-CCCCcE
Q 006777 94 SWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEV 170 (631)
Q Consensus 94 ~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~-~~~g~v 170 (631)
+|.... .+++||||+. |+|.+++... +.+++..++.++.||+.||.|||++..+|+||||||+|||++ ..++.+
T Consensus 124 ~~~~~~--~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 124 HFMFRN--HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEEETT--EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCE
T ss_pred eeccCC--ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcE
Confidence 887654 7999999996 6999999875 469999999999999999999996433499999999999995 246789
Q ss_pred EEccccchhhccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CCC
Q 006777 171 KIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP 247 (631)
Q Consensus 171 KI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~--~~p 247 (631)
||+|||++...... ....+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+... ......+... ..+
T Consensus 201 kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR-IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE-VDQMNKIVEVLGIPP 278 (382)
T ss_dssp EECCCTTCEETTCC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCC
T ss_pred EEEeccCceecccc-cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCC
Confidence 99999999765433 345789999999998765 689999999999999999999999987543 3333333221 110
Q ss_pred CC------------------------------------CCC------------------------CCcHHHHHHHHHhcC
Q 006777 248 AS------------------------------------LSK------------------------VTDPQVKQFIEKCIV 267 (631)
Q Consensus 248 ~~------------------------------------l~~------------------------~~~~~lk~lI~kcL~ 267 (631)
.. ... ...+++++||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 00 000 001478999999998
Q ss_pred -CCCCCCCHHHHhcCCCccCC
Q 006777 268 -PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 268 -~p~~Rpta~elL~hpff~~~ 287 (631)
+|.+|||+.|+|+||||+..
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC-
T ss_pred CChhhCCCHHHHhcCcccccC
Confidence 99999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=364.23 Aligned_cols=255 Identities=19% Similarity=0.314 Sum_probs=206.4
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhC----CCCCcceeee
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSL----KHENIIKFYN 93 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~--~~~~~~~~Ei~iL~~L----~HpnIV~l~~ 93 (631)
.....++|++.+.||+|+||.||+|.+..+|+.||+|++......... .....+.+|+.+++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 345678999999999999999999999999999999999765432211 2234466799999998 8999999999
Q ss_pred EEEcCCCceEEEEEec-cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 94 SWVDDTNRTINMITEL-FTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 94 ~f~~~~~~~l~lV~Ey-~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
++.+.. ..++|+|| +.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++..+|.+||
T Consensus 106 ~~~~~~--~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 106 WFETQE--GFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EC-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEE
T ss_pred EEecCC--eEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEE
Confidence 886543 67889999 789999999998888999999999999999999999999 9999999999999856889999
Q ss_pred ccccchhhccCCCCccccCCCCCCCcccccc-cc-CccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006777 173 GDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~-~y-~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l 250 (631)
+|||++............||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||... .. +... ...+
T Consensus 182 ~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~----~~~~--~~~~ 252 (312)
T 2iwi_A 182 IDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---QE----ILEA--ELHF 252 (312)
T ss_dssp CCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HHHT--CCCC
T ss_pred EEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---HH----Hhhh--ccCC
Confidence 9999998776666667789999999998754 34 55899999999999999999999752 22 1121 2234
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+...++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 45678999999999998 99999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=356.72 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=206.4
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEE----EcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEE
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~----d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f 95 (631)
.....++|++.+.||+|+||+||+|. +..+|+.||+|++... .....+.+.+|+.+|++++||||+++++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34457899999999999999999998 6678999999998743 356667899999999999999999999998
Q ss_pred EcCCCceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 96 VDDTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
.......+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~D 157 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGD 157 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEc-CCCeEEEcc
Confidence 7655557899999999999999998765 4999999999999999999999999 99999999999998 689999999
Q ss_pred ccchhhccCCC-----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCH--------------
Q 006777 175 LGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP-------------- 234 (631)
Q Consensus 175 FGlA~~~~~~~-----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~-------------- 234 (631)
||++....... .....+|+.|+|||++. ..++.++||||||+++|+|+||..||......
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 99997654321 22345778899999875 46899999999999999999999998642100
Q ss_pred -HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 235 -AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 235 -~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
......+..+.. ...+...++++.+||.+||. +|.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 238 VFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 012222333322 23455678999999999998 8999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=349.00 Aligned_cols=245 Identities=18% Similarity=0.359 Sum_probs=209.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|++.+.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--API 80 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cce
Confidence 468999999999999999999986 688899999975532 224688999999999999999999988654 368
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++||||+++|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECCTTGGGGBC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEc-CCCCEEecccccccccc
Confidence 9999999999999999764 46899999999999999999999999 99999999999997 68899999999997654
Q ss_pred CC---CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 183 QP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 183 ~~---~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
.. ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+.......+..+..+ ..+...++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTH 235 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHH
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHH
Confidence 32 223455788999999886 568999999999999999999 9999986 5666777777766443 334556899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
++++|.+||. +|.+||++.++++|
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999998 89999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=371.11 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=215.5
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEE-----EcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeE
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNS 94 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~-----d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~ 94 (631)
......+|.+.+.||+|+||+||+|. +..++..||+|++... .......++.+|+.++++++|||||+++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---cChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34456899999999999999999999 5567889999998643 235566778999999999999999999998
Q ss_pred EEcCCCceEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--
Q 006777 95 WVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-- 165 (631)
Q Consensus 95 f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~-------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-- 165 (631)
+.+.. ..++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 143 ~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 143 SLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPG 218 (367)
T ss_dssp ECSSS--SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSS
T ss_pred EecCC--CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCC
Confidence 86544 5789999999999999998653 5899999999999999999999999 999999999999972
Q ss_pred CCCcEEEccccchhhccC----CCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHH
Q 006777 166 NNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 239 (631)
Q Consensus 166 ~~g~vKI~DFGlA~~~~~----~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~ 239 (631)
.+..+||+|||+++.... .......||+.|+|||++. ..++.++|||||||++|||++ |..||.. .+...+..
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~ 297 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLE 297 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHH
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHH
Confidence 233599999999975422 2234467899999999874 569999999999999999998 9999977 56677777
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 240 ~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.+..+..+. .+...++.+.+||.+||. +|.+||++.+++++.++...
T Consensus 298 ~i~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 298 FVTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCC-CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 777665433 345678899999999998 89999999999999877543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=363.16 Aligned_cols=248 Identities=27% Similarity=0.325 Sum_probs=203.0
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC--
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-- 99 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~-- 99 (631)
....+|++.++||+|+||+||+|.+. |+.||+|++.... .......+|+.+|++++||||+++++++.+..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 34679999999999999999999875 8999999987542 33445567999999999999999999987654
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCeEecCCCCCceEEeCCCCc
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH----------NPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~----------~~~IiHrDLKp~NILl~~~~g~ 169 (631)
...+++||||+++|+|.++++.. .+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~-~~~~ 169 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLK-NNLT 169 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEEC-TTCC
T ss_pred CceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEEC-CCCe
Confidence 34689999999999999999874 599999999999999999999998 8 99999999999998 7899
Q ss_pred EEEccccchhhccCCC----CccccCCCCCCCcccccc------ccCccceEeehhhHHHHHhhcCCCCCCCC-------
Q 006777 170 VKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECK------- 232 (631)
Q Consensus 170 vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~~------~y~~~sDIwSLG~il~emltG~~Pf~~~~------- 232 (631)
+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|+||..||.+..
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 9999999997654322 334679999999998864 46788999999999999999999997532
Q ss_pred --------CHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 233 --------NPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 233 --------~~~~~~~~i~~~~~p~~l~~~-----~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
....+...+........+... .++++.+||.+||. +|.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 233344444433333332221 23569999999998 9999999999886
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.59 Aligned_cols=258 Identities=21% Similarity=0.355 Sum_probs=191.6
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHH-HHHhCCCCCcceeeeEEEcCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIV~l~~~f~~~~ 99 (631)
.....+|.+.+.||+|+||.||+|.++.+|+.||+|++.... ......++..|+. +++.++||||+++++++.+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~- 93 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE- 93 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-
Confidence 344678999999999999999999999999999999997542 2344455666666 77888999999999998765
Q ss_pred CceEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCceEEeCCCCcEEEc
Q 006777 100 NRTINMITELFTSGSLRQYRKK-----HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIG 173 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~-----~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKI~ 173 (631)
..+++||||+. |+|.+++.. ...+++..++.++.|++.||.|||++ + |+||||||+|||++ .+|.+||+
T Consensus 94 -~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~-~~~~~kl~ 168 (327)
T 3aln_A 94 -GDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLC 168 (327)
T ss_dssp -SEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEE-TTTEEEEC
T ss_pred -CceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEc-CCCCEEEc
Confidence 47899999998 488887763 56799999999999999999999998 8 99999999999998 78999999
Q ss_pred cccchhhccCCC-CccccCCCCCCCccccc-----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006777 174 DLGLAIVMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 174 DFGlA~~~~~~~-~~~~~GTp~y~APE~l~-----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p 247 (631)
|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+..........+..+..+
T Consensus 169 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3aln_A 169 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248 (327)
T ss_dssp CCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred cCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence 999997654332 23447999999999873 358999999999999999999999998644333333223232222
Q ss_pred C---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 248 A---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 ~---~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
. ......++.+++||.+||. +|.+||++.++++||||...
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 1 1223578999999999998 89999999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=356.76 Aligned_cols=256 Identities=21% Similarity=0.340 Sum_probs=199.3
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+..+..+++.++||||+++++++.+.. .
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~--~ 98 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT--D 98 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--E
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC--c
Confidence 35689999999999999999999999999999999986532 2223344455556788899999999999987654 7
Q ss_pred EEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+++||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ + |+||||||+||+++ .++.+||+|||++..
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEEC-TTSCEEECCCTTC--
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEEC-CCCCEEEEECCCchh
Confidence 99999999 5677766654 56799999999999999999999995 8 99999999999997 789999999999965
Q ss_pred ccCC-CCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC-CCC
Q 006777 181 MQQP-TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSK 252 (631)
Q Consensus 181 ~~~~-~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~-l~~ 252 (631)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|..||............+..+..+.. ...
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM 254 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence 5433 234567999999999874 35889999999999999999999999887677666666666544322 223
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
..++.+++||.+||. +|.+||++.++|+||||+.
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 468999999999998 9999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.27 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=206.9
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
.+.....+|++.+.||+|+||.||+|.+..+|..||+|++..... ......+++.+|+.+++.++||||+++++++.+.
T Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED 104 (310)
T ss_dssp GTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 344456789999999999999999999999999999999986543 3456678899999999999999999999998765
Q ss_pred CCceEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 99 TNRTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
. .+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|
T Consensus 105 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~-~~~~~kl~D 179 (310)
T 2wqm_A 105 N--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGD 179 (310)
T ss_dssp T--EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECC
T ss_pred C--cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEc-CCCCEEEEe
Confidence 4 78999999999999999874 456999999999999999999999999 99999999999998 789999999
Q ss_pred ccchhhccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCC-CHHHHHHHHHcCCCCCCC
Q 006777 175 LGLAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 175 FGlA~~~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~-~~~~~~~~i~~~~~p~~l 250 (631)
||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.. +...+...+.....+...
T Consensus 180 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 259 (310)
T 2wqm_A 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP 259 (310)
T ss_dssp C------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCC
T ss_pred ccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCc
Confidence 9999765432 2345679999999998754 58999999999999999999999997643 445566666666555544
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
....++++++||.+||. +|.+||++.+++.+
T Consensus 260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 56678999999999998 99999999999873
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=360.90 Aligned_cols=251 Identities=18% Similarity=0.224 Sum_probs=213.0
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEE
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f 95 (631)
....++|.+.+.||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+.+++.++||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345689999999999999999999987 456899999987542 355667899999999999999999999988
Q ss_pred EcCCCceEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 006777 96 VDDTNRTINMITELFTSGSLRQYRKKH------------------------KNVDMKAIKNWARQILRGLHYLHSHNPPI 151 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~gGsL~~~l~~~------------------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~I 151 (631)
.+. ..+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |
T Consensus 120 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--i 195 (343)
T 1luf_A 120 AVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--F 195 (343)
T ss_dssp CSS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred ccC--CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 654 4689999999999999999874 56999999999999999999999999 9
Q ss_pred EecCCCCCceEEeCCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cC
Q 006777 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CE 225 (631)
Q Consensus 152 iHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~ 225 (631)
+||||||+|||++ .++.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+| |.
T Consensus 196 vH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 196 VHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ecCCCCcceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 9999999999998 7889999999999755322 223456899999999875 468999999999999999999 99
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 226 YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 226 ~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.||.+ .+.......+..+..+ ..+...++.+.+||.+||. +|.+||++.+++++
T Consensus 275 ~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 275 QPYYG-MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCC-CChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 99987 4566666677666443 3455678999999999998 89999999998864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=366.78 Aligned_cols=257 Identities=23% Similarity=0.314 Sum_probs=205.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----------CCCccee
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----------HENIIKF 91 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIV~l 91 (631)
...+|.+.+.||+|+||+||+|.+..+|+.||+|++... ....+.+.+|+.++++++ ||||+++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 467999999999999999999999999999999998743 344567888999999886 8999999
Q ss_pred eeEEEcCC--CceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCceEEeC-
Q 006777 92 YNSWVDDT--NRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNG- 165 (631)
Q Consensus 92 ~~~f~~~~--~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~-~~~IiHrDLKp~NILl~~- 165 (631)
+++|.... ...+++||||+ +++|.+++... +.+++..++.++.||+.||.|||++ | |+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV 168 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEecc
Confidence 99887543 34789999999 89999999874 4599999999999999999999998 8 999999999999952
Q ss_pred ----CCCcEEEccccchhhccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCC-----HH
Q 006777 166 ----NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN-----PA 235 (631)
Q Consensus 166 ----~~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~-----~~ 235 (631)
..+.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|+||..||.+... ..
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 3348999999999765443 345679999999998765 589999999999999999999999975321 11
Q ss_pred HHHHHHHc--CCCC--------------------------------------CCCCCCCcHHHHHHHHHhcC-CCCCCCC
Q 006777 236 QIYKKVTS--GIKP--------------------------------------ASLSKVTDPQVKQFIEKCIV-PASLRLP 274 (631)
Q Consensus 236 ~~~~~i~~--~~~p--------------------------------------~~l~~~~~~~lk~lI~kcL~-~p~~Rpt 274 (631)
.....+.. +..| ..++...++++++||.+||+ +|.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 11111111 0000 01222345788999999998 9999999
Q ss_pred HHHHhcCCCccCCC
Q 006777 275 ALELLKDPFLVTDN 288 (631)
Q Consensus 275 a~elL~hpff~~~~ 288 (631)
+.|+|+||||+...
T Consensus 328 ~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 328 AGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHTCGGGTTCT
T ss_pred HHHHhhChhhhccc
Confidence 99999999998743
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=374.11 Aligned_cols=256 Identities=20% Similarity=0.337 Sum_probs=211.1
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
.....++|.+.++||+|+||+||+|.+..+|+.||+|++...... ...+.+.+|+.+|++++||||+++++++.+..
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 345678999999999999999999999999999999999765432 23456788999999999999999999998777
Q ss_pred CceEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEE----eCCCCcEEE
Q 006777 100 NRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKI 172 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~---~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl----~~~~g~vKI 172 (631)
...+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||+ + .++.+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL 157 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKL 157 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTT-SCEEEEE
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCC-CceeEEE
Confidence 668899999999999999997653 3999999999999999999999999 9999999999998 4 5667999
Q ss_pred ccccchhhccCC-CCccccCCCCCCCccccc---------cccCccceEeehhhHHHHHhhcCCCCCCCC---CHHHHHH
Q 006777 173 GDLGLAIVMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYK 239 (631)
Q Consensus 173 ~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~---------~~y~~~sDIwSLG~il~emltG~~Pf~~~~---~~~~~~~ 239 (631)
+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.... .......
T Consensus 158 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp CCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred ecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 999999765433 234567999999999875 357889999999999999999999996432 2234444
Q ss_pred HHHcCCCCCC-----------------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 240 KVTSGIKPAS-----------------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 240 ~i~~~~~p~~-----------------------l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+..+.++.. +....++.+++||.+||. +|.+||++.+++.+
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 4444433211 112245688999999998 99999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=360.87 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=209.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEE-----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEE
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV 96 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d-----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~ 96 (631)
...+|.+.+.||+|+||.||+|.+ ..++..||+|++.... .....+.+.+|+.+|+++ +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 357899999999999999999997 3467799999987542 234457789999999999 9999999999886
Q ss_pred cCCCceEEEEEeccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEe
Q 006777 97 DDTNRTINMITELFTSGSLRQYRKKHK-----------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIH 153 (631)
Q Consensus 97 ~~~~~~l~lV~Ey~~gGsL~~~l~~~~-----------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiH 153 (631)
+. ..+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++| |+|
T Consensus 120 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH 195 (344)
T 1rjb_A 120 LS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 195 (344)
T ss_dssp SS--SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred eC--CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 54 36899999999999999998653 3799999999999999999999999 999
Q ss_pred cCCCCCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCC
Q 006777 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYP 227 (631)
Q Consensus 154 rDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~P 227 (631)
|||||+|||++ .++.+||+|||++....... .....||+.|+|||++. +.++.++|||||||++|+|+| |..|
T Consensus 196 ~Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 196 RDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCCChhhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99999999998 78999999999997554332 22346788999999875 568999999999999999998 9999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006777 228 YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 228 f~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hp 282 (631)
|.+..........+..+..+ ..+...++.+.+||.+||. +|.+|||+.++++|-
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 98866666666666665433 3445578999999999998 899999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=351.87 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=206.8
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEE----EcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEE
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~----d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f 95 (631)
......+|++.+.||+|+||.||+|. +..+|+.||+|++.... .....+.+.+|+.+|+.++||||+++++++
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 44456789999999999999999998 57789999999987553 223456788999999999999999999999
Q ss_pred EcCCCceEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 96 VDDTNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
.+.....+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~D 169 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGD 169 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECC
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEc-CCCCEEECc
Confidence 87766679999999999999999955 457999999999999999999999999 99999999999998 688999999
Q ss_pred ccchhhccCCC-----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCC--------------CCCH
Q 006777 175 LGLAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNE--------------CKNP 234 (631)
Q Consensus 175 FGlA~~~~~~~-----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~--------------~~~~ 234 (631)
||++....... .....||+.|+|||++. ..++.++|||||||++|+|+||..|+.. ....
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence 99997654332 23456888999999875 4588999999999999999999987642 1122
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 235 ~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
......+..+.. ...+...++.+.+||.+||. +|.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 250 TRLVNTLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 233334444433 33455678999999999998 9999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=352.23 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=205.7
Q ss_pred CccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEE
Q 006777 17 EPISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96 (631)
Q Consensus 17 ~~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~ 96 (631)
.+......++|++.+.||+|+||+||+|.+. ..||+|+++... ......+.+.+|+.+|++++||||++++++..
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc
Confidence 4556667889999999999999999999854 359999987653 34567788999999999999999999999542
Q ss_pred cCCCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 97 DDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 97 ~~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
. ..+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+||
T Consensus 91 -~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Df 164 (289)
T 3og7_A 91 -A--PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLH-EDNTVKIGDF 164 (289)
T ss_dssp -S--SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEEECCC
T ss_pred -C--CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEEEccc
Confidence 2 3578999999999999999654 56999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccC----CCCccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006777 176 GLAIVMQQ----PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247 (631)
Q Consensus 176 GlA~~~~~----~~~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p 247 (631)
|++..... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+..+...+...+..+..+
T Consensus 165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (289)
T 3og7_A 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244 (289)
T ss_dssp C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC
T ss_pred eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC
Confidence 99975432 1234567999999999874 357889999999999999999999999888888887777776544
Q ss_pred CC---CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 248 AS---LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 248 ~~---l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.. +....++.+++||.+||. +|.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 33 334578999999999998 8999999999886
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=355.83 Aligned_cols=255 Identities=18% Similarity=0.177 Sum_probs=204.5
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
......++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID 106 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence 445556889999999999999999999999999999999876532 3345567899999999999999999999988764
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
. .+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 107 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 107 G--QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVS-ADDFAYLVDFGIA 181 (309)
T ss_dssp T--EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSCCC-
T ss_pred C--eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEc-CCCCEEEecCccC
Confidence 4 78999999999999999998889999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCCC---CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Q 006777 179 IVMQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKV 253 (631)
Q Consensus 179 ~~~~~~~---~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-p~~l~~~ 253 (631)
....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+. +.......+..... +...+..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQAIPRPSTVRPG 260 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-HHHHHHHHHHSCCCCGGGTSTT
T ss_pred ccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-hHHHHHHHhccCCCCccccCCC
Confidence 7654332 235679999999998754 5889999999999999999999999863 34444444544432 3345566
Q ss_pred CcHHHHHHHHHhcC-CCCCCC-CHHHHhc
Q 006777 254 TDPQVKQFIEKCIV-PASLRL-PALELLK 280 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rp-ta~elL~ 280 (631)
.++.++++|.+||. +|.+|| ++.+++.
T Consensus 261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 261 IPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 78899999999998 899999 7887765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.33 Aligned_cols=246 Identities=20% Similarity=0.338 Sum_probs=207.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+. ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 77 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE--YP 77 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEccC--Cc
Confidence 4578999999999999999999875 678899999875432 235688999999999999999999988544 46
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD-RDLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEEC-TTCCEEECCTTCEEEC
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEEC-CCCCEEEccCccceec
Confidence 899999999999999998754 5999999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCCCC---ccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 182 QQPTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~~~---~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
..... ....+|+.|+|||++.+ .++.++||||||+++|+|+| |..||.. .+.......+..+..+ ..+...++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-YTNSEVVLKVSQGHRL-YRPHLASD 232 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTSCH
T ss_pred chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc-cChHHHHHHHHcCCCC-CCCCcChH
Confidence 44322 23456778999998865 68999999999999999999 9999986 4555555566555332 33445688
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+.+||.+||. +|.+|||+.+++++
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999998 89999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=365.31 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=214.5
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcC-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceee
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFY 92 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~-------~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~ 92 (631)
....++|.+.+.||+|+||+||+|.+.. .+..||+|+++.. .......++.+|+.+++++ +||||++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 3456899999999999999999999753 3468999998754 2456678899999999999 999999999
Q ss_pred eEEEcCCCceEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC
Q 006777 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156 (631)
Q Consensus 93 ~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDL 156 (631)
+++.+.. .+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||
T Consensus 142 ~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dl 217 (382)
T 3tt0_A 142 GACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDL 217 (382)
T ss_dssp EEECSSS--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eeeccCC--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCC
Confidence 9886543 6899999999999999998754 4999999999999999999999999 999999
Q ss_pred CCCceEEeCCCCcEEEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCC
Q 006777 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNE 230 (631)
Q Consensus 157 Kp~NILl~~~~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~ 230 (631)
||+|||++ .++.+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+
T Consensus 218 kp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 218 AARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp CGGGEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CcceEEEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998 7899999999999765432 2234567899999998754 58999999999999999999 9999976
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 231 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 231 ~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+..++...+..+..+. .+...++++++||.+||. +|.+|||+.+++++
T Consensus 297 -~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 297 -VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp -CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56777777777765443 345678999999999998 89999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=357.49 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=189.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEc----
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVD---- 97 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~---- 97 (631)
...+|++.++||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 366999999999999999999999999999999998643 3456677899999999996 9999999998852
Q ss_pred --CCCceEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 98 --DTNRTINMITELFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 98 --~~~~~l~lV~Ey~~gGsL~~~l~~---~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
.....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~~kl 179 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKL 179 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSCEEB
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-CCCCEEE
Confidence 33457899999996 799998865 4679999999999999999999999988899999999999998 7889999
Q ss_pred ccccchhhccCCC--------------CccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCH
Q 006777 173 GDLGLAIVMQQPT--------------ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNP 234 (631)
Q Consensus 173 ~DFGlA~~~~~~~--------------~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~ 234 (631)
+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999997654321 11456899999999873 35789999999999999999999999763221
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006777 235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 235 ~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hp 282 (631)
. +.............++.+++||.+||. +|.+||++.++++|-
T Consensus 260 -~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 260 -R----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred -H----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1 112222222334456789999999998 999999999999873
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=353.93 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=212.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEE-----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEE
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV 96 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d-----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~ 96 (631)
..++|.+.+.||+|+||.||+|.+ ..++..||+|++.... .....+.+.+|+.+|+++ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 467999999999999999999985 4578899999987543 345667899999999999 9999999999886
Q ss_pred cCCCceEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006777 97 DDTNRTINMITELFTSGSLRQYRKKHK------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158 (631)
Q Consensus 97 ~~~~~~l~lV~Ey~~gGsL~~~l~~~~------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp 158 (631)
+.. .+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||
T Consensus 98 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp 173 (313)
T 1t46_A 98 IGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (313)
T ss_dssp SSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred cCC--CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCcc
Confidence 544 6789999999999999998754 4899999999999999999999999 99999999
Q ss_pred CceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCC
Q 006777 159 DNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECK 232 (631)
Q Consensus 159 ~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~ 232 (631)
+||+++ .++.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+..
T Consensus 174 ~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 174 RNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ceEEEc-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999998 78999999999997654432 22345788999999775 468999999999999999999 999998866
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 233 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 233 ~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
........+..+..+. .+...++.+++||.+||. +|.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhccCCCCC-CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 6666666666554432 344578999999999998 89999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=352.53 Aligned_cols=245 Identities=20% Similarity=0.299 Sum_probs=204.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCC-------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEE
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDG-------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g-------~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f 95 (631)
..++|.+.+.||+|+||+||+|.+..+| ..||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 4678999999999999999999998877 579999986542 34456789999999999999999999988
Q ss_pred EcCCCceEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc-----
Q 006777 96 VDDTNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----- 169 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~-l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~----- 169 (631)
.+.. ..++||||+.+|+|.+++.+.+. +++..++.++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 82 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~~~ 156 (289)
T 4fvq_A 82 VCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLI-REEDRKTGN 156 (289)
T ss_dssp CCTT--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-ECCBGGGTB
T ss_pred EeCC--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEe-cCCcccccc
Confidence 6544 57899999999999999988754 999999999999999999999999 99999999999998 5555
Q ss_pred ---EEEccccchhhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006777 170 ---VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 170 ---vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~ 244 (631)
+||+|||++..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..|+....+...........
T Consensus 157 ~~~~kl~Dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLP--KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234 (289)
T ss_dssp CCEEEECCCCSCTTTSC--HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred cceeeeccCcccccccC--ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc
Confidence 99999999865433 234568999999998864 58999999999999999999665555545555555444432
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 245 ~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..++...++++++||.+||. +|.+|||+.++++|
T Consensus 235 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 ---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22333456789999999998 89999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=356.05 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=214.2
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEE-----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEE
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d-----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f 95 (631)
...++|.+.+.||+|+||+||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3467999999999999999999985 4577999999987542 345667899999999999 799999999988
Q ss_pred EcCCCceEEEEEeccCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006777 96 VDDTNRTINMITELFTSGSLRQYRKKHKN----------------VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~----------------l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~ 159 (631)
.... ..+++||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+
T Consensus 101 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~ 177 (316)
T 2xir_A 101 TKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 177 (316)
T ss_dssp CCTT-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred ecCC-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccc
Confidence 6543 468999999999999999987654 899999999999999999999999 999999999
Q ss_pred ceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCC
Q 006777 160 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKN 233 (631)
Q Consensus 160 NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~ 233 (631)
||+++ .+|.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+...
T Consensus 178 Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 178 NILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred eEEEC-CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99997 68899999999997554322 23456789999999875 468999999999999999998 9999988666
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 234 ~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.......+..+..+ ..+...++.++++|.+||. +|.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66666666665433 3445578999999999998 89999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=351.50 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=213.0
Q ss_pred cCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc-
Q 006777 19 ISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD- 97 (631)
Q Consensus 19 ~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~- 97 (631)
.+.....+|.+.+.||+|+||.||+|.+..+|+.||+|.+.... +.+.+|+.+++.++||||++++++|..
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGF 76 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence 34556789999999999999999999999999999999997542 246689999999999999999998754
Q ss_pred -------------CCCceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceE
Q 006777 98 -------------DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 162 (631)
Q Consensus 98 -------------~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NIL 162 (631)
.....+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil 154 (284)
T 2a19_B 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIF 154 (284)
T ss_dssp EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEE
Confidence 1234689999999999999999764 57999999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEccccchhhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006777 163 VNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 240 (631)
Q Consensus 163 l~~~~g~vKI~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~ 240 (631)
++ .++.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .......
T Consensus 155 ~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~ 230 (284)
T 2a19_B 155 LV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTD 230 (284)
T ss_dssp EE-ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHH
T ss_pred Ec-CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHH
Confidence 98 7889999999999765443 3345679999999998764 589999999999999999999998853 3344444
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 241 i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+..+. ++...++.+++||.+||. +|.+||++.++++|.+....
T Consensus 231 ~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 231 LRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred hhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 54443 334567899999999998 89999999999999876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=347.56 Aligned_cols=247 Identities=20% Similarity=0.335 Sum_probs=207.3
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
...++|++.+.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~ 92 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--R 92 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--S
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEEecC--C
Confidence 34678999999999999999999885 788999999975532 125688999999999999999999988554 4
Q ss_pred eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 102 TINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRY 169 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTSCEEECSTTGGGG
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEc-CCCCEEEcccccccc
Confidence 68999999999999999987 467999999999999999999999999 99999999999998 789999999999976
Q ss_pred ccCC---CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 181 MQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~---~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
.... ......+|+.|+|||++. ..++.++||||||+++|+|+| |..||.. .+.......+..+..+ ..+...+
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 247 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLAS 247 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCC
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CCCCcCC
Confidence 5432 123345688999999876 568999999999999999998 9999987 4566666677665433 2345568
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+.+.+||.+||. +|.+|||+.++++|
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 899999999998 89999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.01 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=208.8
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEE--EEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEV--AWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~V--AvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
....++|.+.+.||+|+||.||+|.+..+|..+ |+|.+.... .....+++.+|+.+|+++ +||||+++++++.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 344578999999999999999999999999865 999887432 234556788999999999 99999999999876
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCce
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NI 161 (631)
.. .+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 98 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NI 173 (327)
T 1fvr_A 98 RG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 173 (327)
T ss_dssp TT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred CC--ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceE
Confidence 54 7999999999999999998764 6999999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEccccchhhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHH
Q 006777 162 FVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 238 (631)
Q Consensus 162 Ll~~~~g~vKI~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~ 238 (631)
|++ .++.+||+|||++...... ......+++.|+|||++.+ .++.++|||||||++|+|+| |..||.+ .+.....
T Consensus 174 l~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~ 251 (327)
T 1fvr_A 174 LVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELY 251 (327)
T ss_dssp EEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHH
T ss_pred EEc-CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-CcHHHHH
Confidence 997 7889999999998643322 2233467889999998864 58999999999999999998 9999987 5666777
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..+..+..+. .+...++.+++||.+||. +|.+|||+.+++.+
T Consensus 252 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 252 EKLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHGGGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7777664433 344568999999999998 89999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=355.99 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=213.7
Q ss_pred CccCccCCCcEEEEEEEeecCCeEEEEEEEc-------CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCc
Q 006777 17 EPISSSVSYFWISWVVVLNCTFMCRYKGFDE-------VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENI 88 (631)
Q Consensus 17 ~~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~-------~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnI 88 (631)
.+.-....++|.+.+.||+|+||.||+|.+. .++..||+|++.... .....+++.+|+.+++++ +||||
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCE
Confidence 3334445789999999999999999999985 467899999987542 356677899999999999 99999
Q ss_pred ceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006777 89 IKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPII 152 (631)
Q Consensus 89 V~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~Ii 152 (631)
+++++++.+. ..+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+
T Consensus 104 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iv 179 (334)
T 2pvf_A 104 INLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CI 179 (334)
T ss_dssp CCEEEEECSS--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred eeEEEEEccC--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 9999988654 46899999999999999998754 3899999999999999999999999 99
Q ss_pred ecCCCCCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCC
Q 006777 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEY 226 (631)
Q Consensus 153 HrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~ 226 (631)
||||||+|||++ .+|.+||+|||++....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..
T Consensus 180 H~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 258 (334)
T 2pvf_A 180 HRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258 (334)
T ss_dssp CSCCSGGGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCccceEEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 999999999997 78999999999997554321 23346788999999875 458999999999999999999 999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 227 PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 227 Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
||.+ .+...+...+..+..+ ..+...++.+++||.+||. +|.+||++.+++++
T Consensus 259 p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 259 PYPG-IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp SSTT-CCHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCc-CCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9987 4666777777666443 3445678999999999998 89999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=367.11 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=210.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
..+|.+.+.||+|+||.||+|.+..+|+.||+|.++.. ......+++.+|+.+|++++||||+++++++.+. ..+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CCc
Confidence 56899999999999999999999999999999998743 2345566788999999999999999999988554 368
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++||||+++|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVT-EKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECT
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEc-CCCcEEECcCCCceecC
Confidence 99999999999999998754 6999999999999999999999999 99999999999997 78999999999997543
Q ss_pred CCCC----ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 183 QPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 183 ~~~~----~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
.... ....+++.|+|||++. +.++.++|||||||++|||+| |..||.+ ....+....+..+..+ ..+...++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 342 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-LSNQQTREFVEKGGRL-PCPELCPD 342 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT-SCHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCH
Confidence 3211 1223577899999876 568999999999999999998 9999987 4555666666665433 34456788
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+.+||.+||. +|.+|||+.++++
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999998 9999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.53 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=211.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEE----EcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~----d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
..+|++.+.||+|+||.||+|. +..+|..||+|++... .....+.+.+|+.++++++||||+++++++....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 5799999999999999999998 5778999999998754 3456678999999999999999999999988777
Q ss_pred CceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
...+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEEC-CCCCEEEcccccc
Confidence 77899999999999999999874 56999999999999999999999999 99999999999998 6899999999999
Q ss_pred hhccCCC-----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCC--------------HHHHH
Q 006777 179 IVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--------------PAQIY 238 (631)
Q Consensus 179 ~~~~~~~-----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~--------------~~~~~ 238 (631)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 7654322 234568889999998764 589999999999999999999999864211 12233
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 239 ~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..+..+.. ...+...++.+++||.+||. +|.+|||+.+++++
T Consensus 255 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33444433 33455678999999999998 89999999999754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=358.34 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=201.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEE----EEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~V----AvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
...+|.+.++||+|+||+||+|.+..+|..| |+|.+.... .....+++.+|+.++++++||||+++++++.+.
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 4678999999999999999999998887755 666665322 234456789999999999999999999998764
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
..++|+||+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 90 ---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~ 163 (327)
T 3poz_A 90 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGL 163 (327)
T ss_dssp ---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTH
T ss_pred ---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEEC-CCCCEEEccCcc
Confidence 377899999999999999874 57999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006777 178 AIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 178 A~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~ 251 (631)
++...... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+ .+...+...+..+..+. .+
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~~-~~ 241 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QP 241 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CC
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHcCCCCC-CC
Confidence 98664332 22345688999999875 458999999999999999999 9999986 45555666666554333 34
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
...++.+.++|.+||. +|.+||++.+++.+
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 5567899999999998 89999999999876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=358.22 Aligned_cols=245 Identities=20% Similarity=0.200 Sum_probs=203.3
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
++.+|.+.+.||+|+||+||+|.+..+|+.||+|++...... +.+.+|+.+++.| +||||+++++++.+. .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~ 78 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA------PQLHLEYRFYKQLGSGDGIPQVYYFGPCG--K 78 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS------CCHHHHHHHHHHHCSCTTSCCEEEEEEET--T
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch------HHHHHHHHHHHHhhCCCCCCEEEEEEecC--C
Confidence 467999999999999999999999999999999998755321 2477899999999 999999999988764 4
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc-----EEEccc
Q 006777 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIGDL 175 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~-----vKI~DF 175 (631)
.+++||||+ +|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++. +||+||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~-~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIG-RPGNKTQQVIHIIDF 154 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-CGGGTCTTSEEECCC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-cCCCCCCceEEEEEc
Confidence 789999999 89999999874 67999999999999999999999999 99999999999997 5666 999999
Q ss_pred cchhhccCCC---------CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCC--CHHHHHHHHHc
Q 006777 176 GLAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTS 243 (631)
Q Consensus 176 GlA~~~~~~~---------~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~--~~~~~~~~i~~ 243 (631)
|++....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ...+.+..+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 9997653322 246789999999998765 58999999999999999999999998642 33444444433
Q ss_pred CCCC---CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 244 GIKP---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 244 ~~~p---~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
...+ ..+....+ ++++||..||. +|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2111 11122233 99999999998 9999999988775
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=348.56 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=200.5
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~---g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
....++|++.+.||+|+||.||+|.+..+ +..||+|.+... ......+++.+|+.++++++||||+++++++.+
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc
Confidence 34567999999999999999999998653 567999987643 235567789999999999999999999998732
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
..+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 88 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg 161 (281)
T 1mp8_A 88 ---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFG 161 (281)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC--
T ss_pred ---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEEC-CCCCEEECccc
Confidence 35789999999999999998764 6999999999999999999999999 99999999999998 68999999999
Q ss_pred chhhccCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006777 177 LAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 177 lA~~~~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~ 251 (631)
++....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+. +.......+..+..+ .++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-~~~~~~~~i~~~~~~-~~~ 239 (281)
T 1mp8_A 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-PMP 239 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCC
T ss_pred cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-CHHHHHHHHHcCCCC-CCC
Confidence 997654332 23345788999999886 468999999999999999997 99999874 444555566555333 345
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
...++.+++||.+||. +|.+|||+.+++.+
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5678999999999998 99999999998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=348.11 Aligned_cols=250 Identities=16% Similarity=0.186 Sum_probs=206.2
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~ 98 (631)
+..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 34567899999999999999999999999999999999875432 12467899999999 899999999987654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCc-----EEE
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKI 172 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~-----vKI 172 (631)
...++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|. +||
T Consensus 79 --~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~~~~~~kl 152 (298)
T 1csn_A 79 --LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIG-RPNSKNANMIYV 152 (298)
T ss_dssp --TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-CSSSTTTTCEEE
T ss_pred --ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-cCCCCCCCeEEE
Confidence 4789999999 999999998754 5999999999999999999999999 99999999999997 4554 999
Q ss_pred ccccchhhccCCC---------CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCC--CHHHHHHH
Q 006777 173 GDLGLAIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKK 240 (631)
Q Consensus 173 ~DFGlA~~~~~~~---------~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~--~~~~~~~~ 240 (631)
+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. .....+..
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence 9999997554321 245679999999998765 58999999999999999999999998743 33444444
Q ss_pred HHcCC---CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 241 VTSGI---KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 241 i~~~~---~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+.... ....+....++.+++||.+||. +|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 233 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 43321 1122334567899999999997 99999999998763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.55 Aligned_cols=248 Identities=29% Similarity=0.416 Sum_probs=197.7
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCcceeeeEEEc
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVD 97 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~~~f~~ 97 (631)
...+.++|++.+.||+|+||+||+|.+ +|+.||+|++.... ...+.+|.+++.. ++||||+++++++.+
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-------EKSWFRETELYNTVMLRHENILGFIASDMT 73 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-------chhhHHHHHHHHHhhccCcCeeeEEEeecc
Confidence 356678999999999999999999987 69999999986432 2345566666666 899999999998765
Q ss_pred C--CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEecCCCCCceEEeCCC
Q 006777 98 D--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 98 ~--~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLH--------s~~~~IiHrDLKp~NILl~~~~ 167 (631)
. ....+++||||+++|+|.++++. ..+++..++.++.||+.||.||| +++ |+||||||+|||++ .+
T Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~-~~ 149 (301)
T 3q4u_A 74 SRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVK-KN 149 (301)
T ss_dssp EETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEEC-TT
T ss_pred ccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEc-CC
Confidence 3 23578999999999999999965 56999999999999999999999 888 99999999999998 78
Q ss_pred CcEEEccccchhhccCCC------CccccCCCCCCCcccccc-------ccCccceEeehhhHHHHHhhc----------
Q 006777 168 GEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTC---------- 224 (631)
Q Consensus 168 g~vKI~DFGlA~~~~~~~------~~~~~GTp~y~APE~l~~-------~y~~~sDIwSLG~il~emltG---------- 224 (631)
+.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|||+||
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 999999999996544322 234589999999998864 355799999999999999999
Q ss_pred CCCCCCCC----CHHHHHHHHHcCCCCCCCC-----CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 225 EYPYNECK----NPAQIYKKVTSGIKPASLS-----KVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 225 ~~Pf~~~~----~~~~~~~~i~~~~~p~~l~-----~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..||.+.. ........+........++ ...++.+.+||.+||. +|.+|||+.++++
T Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 88886532 2233333333322222222 1245789999999998 9999999999886
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=347.13 Aligned_cols=248 Identities=19% Similarity=0.276 Sum_probs=208.3
Q ss_pred CCCcEEEEE-EEeecCCeEEEEEEE--cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 23 VSYFWISWV-VVLNCTFMCRYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 23 i~~~Y~i~e-~LG~G~fg~VY~A~d--~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...+|.+.+ .||+|+||+||+|.+ ..++..||+|++.... ......+++.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC--
Confidence 357899998 999999999999954 5678999999987553 234456789999999999999999999998832
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.
T Consensus 90 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 90 -ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSK 165 (291)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCE
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEe-CCCcEEEccCCcce
Confidence 358899999999999999999888999999999999999999999999 99999999999998 68899999999997
Q ss_pred hccCCC-----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 180 VMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 180 ~~~~~~-----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
...... .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+ .+.......+..+..+ ..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 243 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPA 243 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCT
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCC
Confidence 654332 122346789999998754 58999999999999999999 9999987 5566666777665443 3455
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..++.++++|.+||. +|.+||++.++++
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 678999999999998 9999999999876
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=356.38 Aligned_cols=251 Identities=19% Similarity=0.210 Sum_probs=204.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC--CC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--TN 100 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~--~~ 100 (631)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 467999999999999999999999999999999998753 345677899999999999999999999988743 33
Q ss_pred ceEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 101 RTINMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
..+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLG-DEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEc-CCCCEEEEecC
Confidence 578999999999999999876 467999999999999999999999999 99999999999997 78999999999
Q ss_pred chhhccCCC-----------CccccCCCCCCCcccccc----ccCccceEeehhhHHHHHhhcCCCCCCCCC-HHHHHHH
Q 006777 177 LAIVMQQPT-----------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKN-PAQIYKK 240 (631)
Q Consensus 177 lA~~~~~~~-----------~~~~~GTp~y~APE~l~~----~y~~~sDIwSLG~il~emltG~~Pf~~~~~-~~~~~~~ 240 (631)
++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... .......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 886432211 123457999999998753 378999999999999999999999953100 0111222
Q ss_pred HHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 241 VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 241 i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+.... ........++.+++||.+||. +|.+||++.+++++
T Consensus 260 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 VQNQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 22222 222334568899999999998 99999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=353.32 Aligned_cols=251 Identities=21% Similarity=0.331 Sum_probs=211.9
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEE
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f 95 (631)
....++|.+.+.||+|+||.||+|.+. .++..||+|.+.... ......++.+|+.+++.++||||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 445789999999999999999999886 467899999987432 345667799999999999999999999988
Q ss_pred EcCCCceEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC
Q 006777 96 VDDTNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~gGsL~~~l~~~----------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
.+. ..+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++
T Consensus 98 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~- 172 (322)
T 1p4o_A 98 SQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA- 172 (322)
T ss_dssp CSS--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-
T ss_pred ccC--CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEc-
Confidence 554 3688999999999999998753 35799999999999999999999999 99999999999998
Q ss_pred CCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHH
Q 006777 166 NNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 239 (631)
Q Consensus 166 ~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~ 239 (631)
.+|.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .+..+...
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~ 251 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLR 251 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHH
Confidence 78999999999997543321 22346789999999876 458999999999999999999 8899976 45666666
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 240 KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 240 ~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+..+..+ ..+...++.+++||.+||. +|.+|||+.++++|
T Consensus 252 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 252 FVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 66665433 2345678899999999998 89999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=352.46 Aligned_cols=252 Identities=19% Similarity=0.309 Sum_probs=201.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcC---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~---~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN--SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc--cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 36789999999999999999998765 56689999987653 24566778999999999999999999999987655
Q ss_pred Cc---eEEEEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcE
Q 006777 100 NR---TINMITELFTSGSLRQYRKK------HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV 170 (631)
Q Consensus 100 ~~---~l~lV~Ey~~gGsL~~~l~~------~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~v 170 (631)
.. .+++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR-DDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC-TTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcE
Confidence 32 46999999999999999843 356999999999999999999999999 99999999999998 78999
Q ss_pred EEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006777 171 KIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 171 KI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~ 244 (631)
||+|||++...... ......+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+. ........+..+
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~ 265 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHEMYDYLLHG 265 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTT
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHHcC
Confidence 99999999755432 1233467889999998754 58999999999999999999 88899764 455556666665
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 245 ~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..+ ..+...++.+.+||.+||. +|.+||++.+++.+
T Consensus 266 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 HRL-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCC-CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCC-CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 433 3345577899999999998 89999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=340.46 Aligned_cols=245 Identities=19% Similarity=0.367 Sum_probs=209.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 78 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PI 78 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--SC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--Ce
Confidence 468999999999999999999986 688999999876532 1256889999999999999999999886543 68
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++||||+++|+|.+++... +.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-GGGCEEECCTTGGGGBC
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEC-CCCCEEEcccccccccc
Confidence 8999999999999999875 56899999999999999999999999 99999999999997 68899999999997653
Q ss_pred CC---CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 183 QP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 183 ~~---~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
.. ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+.......+..+..+ ..+...++.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~ 233 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTH 233 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHH
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHH
Confidence 32 223446788999999886 468999999999999999999 8999986 5566667777766433 234557899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
++++|.+||. +|.+||++.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999998 89999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.69 Aligned_cols=264 Identities=21% Similarity=0.309 Sum_probs=215.4
Q ss_pred ccCccCccCCCcEEEEEEEeecCCeEEEEEE-----EcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcc
Q 006777 15 SLEPISSSVSYFWISWVVVLNCTFMCRYKGF-----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENII 89 (631)
Q Consensus 15 s~~~~~~~i~~~Y~i~e~LG~G~fg~VY~A~-----d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV 89 (631)
+...+......+|.+.+.||+|+||.||+|. +..+|..||+|++... .......++.+|+.++++++||||+
T Consensus 20 s~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv 96 (327)
T 2yfx_A 20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIV 96 (327)
T ss_dssp CGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred chhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc---cchhhHHHHHHHHHHHhhCCCCCCC
Confidence 3445556678899999999999999999998 5678889999998643 2355667889999999999999999
Q ss_pred eeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceE
Q 006777 90 KFYNSWVDDTNRTINMITELFTSGSLRQYRKKHK-------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 162 (631)
Q Consensus 90 ~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~-------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NIL 162 (631)
++++++.+.. .+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 97 ~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIl 172 (327)
T 2yfx_A 97 RCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCL 172 (327)
T ss_dssp CEEEEECSSS--SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred eEEEEEcCCC--CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEE
Confidence 9999886544 5789999999999999998763 4899999999999999999999999 999999999999
Q ss_pred Ee--CCCCcEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCH
Q 006777 163 VN--GNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNP 234 (631)
Q Consensus 163 l~--~~~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~ 234 (631)
++ +.++.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+| |..||.. .+.
T Consensus 173 i~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~ 251 (327)
T 2yfx_A 173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSN 251 (327)
T ss_dssp ESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCH
T ss_pred EecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCH
Confidence 97 23446999999999754322 223456899999999875 468999999999999999998 9999976 456
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 235 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 235 ~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
......+..+..+ ..+...++.+++||.+||. +|.+||++.++++|.++...
T Consensus 252 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 252 QEVLEFVTSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 6666677665443 3345678999999999998 89999999999999887543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=344.95 Aligned_cols=252 Identities=20% Similarity=0.290 Sum_probs=211.0
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~---~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
.-...|.+.++||+|+||+||+|.+..++. .||+|.+... ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 335578889999999999999999755544 8999988643 3456678899999999999999999999988655
Q ss_pred CCceEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 99 TNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
+ ...++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||+
T Consensus 95 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~ 170 (298)
T 3pls_A 95 E-GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLD-ESFTVKVADFGL 170 (298)
T ss_dssp S-SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECCTTS
T ss_pred C-CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEeCcCCC
Confidence 4 345899999999999999987 456899999999999999999999999 99999999999997 789999999999
Q ss_pred hhhccC------CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006777 178 AIVMQQ------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 178 A~~~~~------~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l 250 (631)
+..... .......+|+.|+|||.+.+ .++.++|||||||++|+|++|..|+....+.......+..+..+. .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~ 249 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP-Q 249 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC-C
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC-C
Confidence 965432 22344578999999998865 589999999999999999997777666677777777777664433 3
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+...++.+.+||.+||. +|.+|||+.+++..
T Consensus 250 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 250 PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 45578899999999998 89999999998863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=343.65 Aligned_cols=250 Identities=21% Similarity=0.221 Sum_probs=203.8
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .+++.+|+.+++.++|++++..+..+... .
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~ 77 (296)
T 3uzp_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-G 77 (296)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-T
T ss_pred ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCC-C
Confidence 3467899999999999999999999999999999999876532 12478899999999999988877665443 3
Q ss_pred ceEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe--CCCCcEEEccccc
Q 006777 101 RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGL 177 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKI~DFGl 177 (631)
..+++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..++.+||+|||+
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 5789999999 8999999984 457999999999999999999999999 99999999999994 3678999999999
Q ss_pred hhhccCCC---------CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH--HHHHHHHHcC-
Q 006777 178 AIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSG- 244 (631)
Q Consensus 178 A~~~~~~~---------~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~--~~~~~~i~~~- 244 (631)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.... .+.+..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 97654332 245689999999998765 5899999999999999999999999764321 1222222211
Q ss_pred --CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 245 --IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 245 --~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.....+....++.+.+||.+||. +|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11112234567899999999998 9999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=343.46 Aligned_cols=249 Identities=17% Similarity=0.297 Sum_probs=209.3
Q ss_pred CCCcEEEEE-EEeecCCeEEEEEEEc--CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 23 VSYFWISWV-VVLNCTFMCRYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 23 i~~~Y~i~e-~LG~G~fg~VY~A~d~--~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
..++|.+.+ .||+|+||.||+|.+. .++..||+|+++.. ......+++.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 81 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-- 81 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC--
Confidence 345677776 9999999999999863 57889999998754 245667889999999999999999999998833
Q ss_pred CceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLS 157 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTC
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEc-CCCCEEECcccce
Confidence 2589999999999999999754 56999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCCC-----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006777 179 IVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 179 ~~~~~~~-----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~ 251 (631)
....... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||... +.......+..+..+ .++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~i~~~~~~-~~~ 235 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECP 235 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCC-CCC
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHhcCCcC-CCC
Confidence 7654321 22345689999999886 468999999999999999998 99999874 445566666665433 345
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hp 282 (631)
...++.++++|.+||. +|.+||++.+++++.
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 5678999999999998 999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=352.47 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=210.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCe-----EEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEE
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGI-----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWV 96 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~-----~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~ 96 (631)
..++|.+.+.||+|+||.||+|.+..+|. .||+|.+.... .....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 36789999999999999999999976664 79999987542 345667899999999999 8999999999886
Q ss_pred cCCCceEEEEEeccCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceE
Q 006777 97 DDTNRTINMITELFTSGSLRQYRKKH--------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIF 162 (631)
Q Consensus 97 ~~~~~~l~lV~Ey~~gGsL~~~l~~~--------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NIL 162 (631)
+. ..+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 121 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 196 (333)
T 2i1m_A 121 HG--GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL 196 (333)
T ss_dssp SS--SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred cC--CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence 54 3689999999999999998753 35899999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHH
Q 006777 163 VNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 236 (631)
Q Consensus 163 l~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~ 236 (631)
++ .++.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||.+......
T Consensus 197 ~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 197 LT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EE-GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EC-CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 98 78899999999997553322 23345788999999875 468999999999999999999 9999988666666
Q ss_pred HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 237 IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 237 ~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
....+..+..+ ..+...++.+.+||.+||. +|.+|||+.+++++
T Consensus 276 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 276 FYKLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 66555555333 3345568999999999998 99999999999873
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=346.79 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=211.4
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
...+|.+.+.||+|+||+||+|.+..++..||+|.+... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 83 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PP 83 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CC
Confidence 467899999999999999999999999999999998743 23457788999999999999999999988554 46
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEEC-GGGCEEECCCCGGGT
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEc-CCCCEEEccCcccee
Confidence 89999999999999999874 45999999999999999999999999 99999999999997 788999999999976
Q ss_pred ccCCCC---ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 181 MQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~~~---~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
...... ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+ .+.......+.....+ ..+...+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 238 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCP 238 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCC
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CCCCCCC
Confidence 654332 2345688999999876 468999999999999999999 9999976 4555666666665443 3345678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+.+++||.+||. +|.+|||+.++++
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 999999999998 8999999999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=344.32 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=206.1
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcC---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~---~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
....++|.+.+.||+|+||+||+|.+.. ++..||+|.+.... .....+++.+|+.+++.++||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 3456789999999999999999998754 34579999987542 35567889999999999999999999998753
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
. ..++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||
T Consensus 85 ~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg 158 (281)
T 3cc6_A 85 E---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVA-SPECVKLGDFG 158 (281)
T ss_dssp S---SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-ETTEEEECCCC
T ss_pred C---CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEC-CCCcEEeCccC
Confidence 3 468999999999999999775 45999999999999999999999999 99999999999998 68899999999
Q ss_pred chhhccCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006777 177 LAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 177 lA~~~~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~ 251 (631)
++....... .....+|+.|+|||++. ..++.++||||||+++|+|+| |..||.... .......+..+..+ ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-~~~~~~~~~~~~~~-~~~ 236 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-NKDVIGVLEKGDRL-PKP 236 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-GGGHHHHHHHTCCC-CCC
T ss_pred CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-hHHHHHHHhcCCCC-CCC
Confidence 997654332 23446788999999886 468999999999999999998 999997643 33444555554332 234
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
...++.++++|.+||. +|.+||++.+++.+
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 5578999999999998 89999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=358.87 Aligned_cols=247 Identities=20% Similarity=0.347 Sum_probs=203.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeE----EEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIE----VAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~----VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
..+|++.+.||+|+||+||+|.+..+|.. ||+|.+..... ....+++.+|+.++++++||||+++++++.+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG---RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-- 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS---CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--
Confidence 57899999999999999999999888875 67776643321 1223456789999999999999999998743
Q ss_pred CceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+++||||+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 87 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a 162 (325)
T 3kex_A 87 -SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVADFGVA 162 (325)
T ss_dssp -SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEES-SSSCEEECSCSGG
T ss_pred -CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEEC-CCCeEEECCCCcc
Confidence 3588999999999999999875 57999999999999999999999999 99999999999997 7899999999999
Q ss_pred hhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 179 IVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 179 ~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
+...... .....||+.|+|||++. +.++.++|||||||++|+|+| |..||.+. ........+..+..+ ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 240 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKGERL-AQPQ 240 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHHHHTTCBC-CCCT
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCCC
Confidence 8654332 23456788999999886 568999999999999999999 99999874 445555556555332 3344
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..++.+.++|.+||. +|.+||++.+++++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 241 ICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred cCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 567789999999998 99999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=354.03 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=202.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEE----EEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEV----AWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~V----AvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
...+|++.++||+|+||+||+|.+..+|..| |+|.+.... .....+++.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 3678999999999999999999998888765 566554322 233456788999999999999999999998764
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
. .++|+||+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 90 ~---~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kL~DfG~ 163 (327)
T 3lzb_A 90 T---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGL 163 (327)
T ss_dssp S---EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTC
T ss_pred C---ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEc-CCCCEEEccCcc
Confidence 3 78899999999999999874 56999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCC----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006777 178 AIVMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 178 A~~~~~~~----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~ 251 (631)
+....... .....||+.|+|||++.+ .|+.++|||||||++|+|++ |..||.+ .+...+...+..+..+. .+
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~ 241 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QP 241 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CC
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CC
Confidence 97654321 223456889999998754 58999999999999999999 9999986 45555666666554333 34
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
...++.+.+||.+||. +|.+||++.+++..
T Consensus 242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 242 PICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5578899999999998 99999999999873
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=367.41 Aligned_cols=242 Identities=20% Similarity=0.348 Sum_probs=205.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|.+.+.||+|+||.||+|.+. |..||+|+++... ..+.+.+|+.+|++++|||||++++++.... ..+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 262 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGL 262 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SCE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-Cce
Confidence 568999999999999999999874 8899999987542 2356889999999999999999999876643 368
Q ss_pred EEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++||||+++|+|.+++...+. +++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++..
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEC-CCCCEEEeeCCCcccc
Confidence 999999999999999987654 799999999999999999999999 99999999999997 7899999999999754
Q ss_pred cCCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 182 QQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
... .....+++.|+|||++. ..++.++|||||||++|||+| |..||.+. +..+....+..+..+ ..+...++.+.
T Consensus 340 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l~ 416 (450)
T 1k9a_A 340 SST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCPPAVY 416 (450)
T ss_dssp C-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-CTTTHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred ccc-ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHH
Confidence 332 23346789999999875 468999999999999999998 99999874 444556667666443 34556789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhc
Q 006777 260 QFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+||.+||. +|.+|||+.+++.
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 99999998 9999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=351.28 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=205.8
Q ss_pred CCCcE-EEEEEEeecCCeEEEEEE----EcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 23 VSYFW-ISWVVVLNCTFMCRYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 23 i~~~Y-~i~e~LG~G~fg~VY~A~----d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
+..+| ++.+.||+|+||+||+|. +..+|+.||+|++... ......+.+.+|+.+|++++||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence 44444 999999999999998774 4558999999998754 245667889999999999999999999999988
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
.....+++||||+++|+|.+++.+.+ +++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGL 180 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGG
T ss_pred CCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEc-CCCCEEECCccc
Confidence 76678999999999999999997754 999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccCCC-----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH--------------HHH
Q 006777 178 AIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--------------AQI 237 (631)
Q Consensus 178 A~~~~~~~-----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~--------------~~~ 237 (631)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|+||..||...... ...
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 97654332 234568889999998865 6889999999999999999999999642111 112
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 238 YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 238 ~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
...+..+. ....+...++.+.+||.+||. +|.+|||+.++++
T Consensus 261 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 261 TELLERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22333332 333455678999999999998 8999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=348.16 Aligned_cols=241 Identities=28% Similarity=0.425 Sum_probs=195.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|.+.+.||+|+||+||+|.+. ++.||+|++... ...+.+.+|+++|++++||||+++++++.+ .+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~ 74 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACLN----PV 74 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TT
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----Cc
Confidence 468999999999999999999874 889999998532 345678999999999999999999997642 36
Q ss_pred EEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCeEecCCCCCceEEeCCCCc-EEEcccc
Q 006777 104 NMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHS---HNPPIIHRDLKCDNIFVNGNNGE-VKIGDLG 176 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~---~l~e~~i~~i~~QIl~gL~yLHs---~~~~IiHrDLKp~NILl~~~~g~-vKI~DFG 176 (631)
++||||+++|+|.+++.... .+++..+..|+.||+.||.|||+ ++ |+||||||+|||++ .+|. +||+|||
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~~kl~Dfg 151 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLV-AGGTVLKICDFG 151 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEE-TTTTEEEECCCC
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEe-CCCCEEEEcccc
Confidence 89999999999999998765 37899999999999999999999 66 99999999999998 5565 8999999
Q ss_pred chhhccCCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCC
Q 006777 177 LAIVMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 177 lA~~~~~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~-~~~~~~i~~~~~p~~l~~~~ 254 (631)
++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ......+..+..+ ......
T Consensus 152 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 229 (307)
T 2eva_A 152 TACDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNL 229 (307)
T ss_dssp C-------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTC
T ss_pred cccccccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-Cccccc
Confidence 99755432 234569999999998865 5899999999999999999999999864333 3344444444333 344567
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
++.+++||.+||. +|.+|||+.+++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 8999999999998 89999999999873
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.91 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=203.7
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~---g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
....+|.+.++||+|+||+||+|.+..+ +..||+|.+... ......+++.+|+.++++++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 3456899999999999999999997543 346899987643 3456678899999999999999999999986554
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
. ...++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|||+
T Consensus 99 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~ 174 (298)
T 3f66_A 99 E-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGL 174 (298)
T ss_dssp S-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSCGG
T ss_pred C-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEC-CCCCEEECcccc
Confidence 3 4678999999999999999764 56899999999999999999999999 99999999999997 789999999999
Q ss_pred hhhccCC------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhc-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 006777 178 AIVMQQP------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 249 (631)
Q Consensus 178 A~~~~~~------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG-~~Pf~~~~~~~~~~~~i~~~~~p~~ 249 (631)
+...... ......||+.|+|||++.+ .++.++||||||+++|+|++| .+||.+ .+.......+..+..+ .
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~-~ 252 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRL-L 252 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTCCC-C
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCCCC-C
Confidence 9755332 1234567889999998754 689999999999999999995 555554 4555555555555433 2
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 250 l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+...++.+.++|.+||. +|.+||++.++++
T Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 253 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 345568899999999998 8999999999886
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=365.44 Aligned_cols=257 Identities=23% Similarity=0.291 Sum_probs=196.8
Q ss_pred ccCccCccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeee
Q 006777 15 SLEPISSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 93 (631)
Q Consensus 15 s~~~~~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~ 93 (631)
++......+.+.|.+.++||+|+||+||.+. ..+|+.||||++.... .+.+.+|+.+|+++ +|||||++++
T Consensus 5 ~~p~~~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~ 76 (434)
T 2rio_A 5 NIPNFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYC 76 (434)
T ss_dssp ---CCSCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred cccchhhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEE
Confidence 3456677788999999999999999998764 4689999999987532 24577899999876 8999999999
Q ss_pred EEEcCCCceEEEEEeccCCCCHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC-
Q 006777 94 SWVDDTNRTINMITELFTSGSLRQYRKKHKNVD-------MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG- 165 (631)
Q Consensus 94 ~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~-------e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~- 165 (631)
++.+. ..+++|||||. |+|.+++...+... +..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 77 ~~~~~--~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~ 151 (434)
T 2rio_A 77 SETTD--RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTS 151 (434)
T ss_dssp EEECS--SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECC
T ss_pred EEecC--CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecC
Confidence 88654 47999999996 69999998765332 3345789999999999999999 999999999999973
Q ss_pred -----------CCCcEEEccccchhhccCCC------CccccCCCCCCCccccc--------cccCccceEeehhhHHHH
Q 006777 166 -----------NNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILE 220 (631)
Q Consensus 166 -----------~~g~vKI~DFGlA~~~~~~~------~~~~~GTp~y~APE~l~--------~~y~~~sDIwSLG~il~e 220 (631)
.++.+||+|||++....... ....+||+.|+|||++. ..++.++|||||||++|+
T Consensus 152 ~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~e 231 (434)
T 2rio_A 152 SRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231 (434)
T ss_dssp HHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHH
T ss_pred cccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHH
Confidence 23589999999997654321 23457999999999875 358899999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC----CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 221 MVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK----VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 221 mlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~----~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
|+| |..||.+..... ...+........+.. ..++++++||.+||. +|.+|||+.++|+||||..
T Consensus 232 llt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 232 ILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 999 999997644332 122222222222211 235789999999998 9999999999999999964
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.64 Aligned_cols=250 Identities=21% Similarity=0.221 Sum_probs=197.9
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... .+.+.+|+.+++.++|++++..+..+... .
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~ 77 (296)
T 4hgt_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-G 77 (296)
T ss_dssp ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-T
T ss_pred cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc------chHHHHHHHHHHHhcCCCCCCeeeeecCC-C
Confidence 4567899999999999999999999999999999998765432 13477899999999999988887766543 3
Q ss_pred ceEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe--CCCCcEEEccccc
Q 006777 101 RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGL 177 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKI~DFGl 177 (631)
...++||||+ +|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..++.+||+|||+
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 5789999999 8999999985 457999999999999999999999999 99999999999992 2678999999999
Q ss_pred hhhccCC---------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH--HHHHHHHHcC-
Q 006777 178 AIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSG- 244 (631)
Q Consensus 178 A~~~~~~---------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~--~~~~~~i~~~- 244 (631)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.... ...+..+...
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 9765432 1235689999999998765 5899999999999999999999999764322 1122222211
Q ss_pred --CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 245 --IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 245 --~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.....+....++.+++||.+||. +|.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11111224467899999999998 9999999999876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=344.21 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=200.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcC-CC--eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEV-DG--IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~-~g--~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...+|++.+.||+|+||+||+|.+.. ++ ..||+|+++.... ......+++.+|+.++++++||||+++++++.+..
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 46799999999999999999998643 33 3799999876533 23456778999999999999999999999886543
Q ss_pred CceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
.++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++
T Consensus 95 ---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 95 ---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLM 168 (291)
T ss_dssp ---CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTC
T ss_pred ---ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEc-CCCCEEEcccccc
Confidence 78999999999999998764 56999999999999999999999999 99999999999998 6889999999999
Q ss_pred hhccCCC-----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006777 179 IVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 179 ~~~~~~~-----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~ 251 (631)
....... .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+ .+.......+.........+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRP 247 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCCCCCCC
Confidence 7654322 223467889999998764 58999999999999999999 9999987 45666666666554444455
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
...++.++++|.+||. +|.+||++.++++
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 6678999999999998 8999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=337.25 Aligned_cols=244 Identities=22% Similarity=0.347 Sum_probs=206.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|.+.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+|+.++||||+++++++.+ ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 81 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EP 81 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-----cHHHHHHHHHHHHhCCCcCcceEEEEEcC---CC
Confidence 4578999999999999999999975 678899999875432 24568899999999999999999998743 24
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++..
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARL 158 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEE
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEc-CCCCEEECCCccccc
Confidence 789999999999999987643 6999999999999999999999999 99999999999998 789999999999976
Q ss_pred ccCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 181 MQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
..... .....+++.|+|||++. +.++.++||||||+++|+|++ |..||.+ .+..+....+..+..+ ..+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 236 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRPDNCP 236 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCC
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCccccc
Confidence 54332 23345788999999886 468999999999999999999 9999987 4556666667665433 3345678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+.+++||.+||. +|.+|||+.+++.
T Consensus 237 ~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 237 EELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999998 8999999999876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=361.36 Aligned_cols=247 Identities=22% Similarity=0.338 Sum_probs=198.8
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEc---CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~---~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..+|.+.+.||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+.+|++++||||+++++++.+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-- 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--
Confidence 468999999999999999999886 567889999987542 355667899999999999999999999988654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+++||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLGR 195 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC----
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEc-CCCCEEECcCcccc
Confidence 46899999999999999998764 6999999999999999999999999 99999999999997 78999999999997
Q ss_pred hccCCC-----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 180 VMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 180 ~~~~~~-----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
...... .....+|+.|+|||++. ..++.++|||||||++|||++ |+.||.+ .+...+...+..+..+. .+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~ 273 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEGYRLP-PPM 273 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTTEECC-CCT
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCc
Confidence 654321 11234578899999876 468999999999999999998 9999987 45566666666654332 234
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..++.+.+||.+||. +|.+||++.++++
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 567899999999998 8999999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=342.24 Aligned_cols=243 Identities=20% Similarity=0.348 Sum_probs=199.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|++.+.||+|+||+||+|.+ +|..||+|+++... ..+++.+|+.++++++||||+++++++.+.. ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 89 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GG 89 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC---C
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-Cc
Confidence 357899999999999999999987 48999999986432 3467889999999999999999999875543 46
Q ss_pred EEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKKHKN--VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~--l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+++||||+++|+|.+++...+. +++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKE 166 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC---
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEe-CCCcEEEeecccccc
Confidence 8999999999999999987643 899999999999999999999999 99999999999998 789999999999875
Q ss_pred ccCCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 181 MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 181 ~~~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.... .....+++.|+|||++. ..++.++||||||+++|+|+| |..||.. .+.......+..+..+ ..+...++.+
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l 243 (278)
T 1byg_A 167 ASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPAV 243 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCC-CCCTTCCHHH
T ss_pred cccc-ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCcccCCHHH
Confidence 5432 23446789999999875 458999999999999999998 9999976 3455566666655433 3455678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 006777 259 KQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+++|.+||. +|.+||++.+++.
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 999999998 8999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=348.11 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=205.0
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g----~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~ 97 (631)
.....|.+.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.++++++||||+++++++.+
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 34678999999999999999999886543 469999987542 34566779999999999999999999998754
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
. ..+++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 118 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg 192 (333)
T 1mqb_A 118 Y--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFG 192 (333)
T ss_dssp S--SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCC
T ss_pred C--CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEEC-CCCcEEECCCC
Confidence 3 4789999999999999999875 57999999999999999999999999 99999999999998 78999999999
Q ss_pred chhhccCCC-----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCC
Q 006777 177 LAIVMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPAS 249 (631)
Q Consensus 177 lA~~~~~~~-----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~ 249 (631)
++....... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+ .+...+...+..+..+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~~- 270 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFRLP- 270 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHCCCcCC-
Confidence 997654321 12234678999999876 468999999999999999999 9999987 45666677777664433
Q ss_pred CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 250 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 250 l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+...++.++++|.+||. +|.+||++.+++++
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 344578999999999998 89999999998874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.27 Aligned_cols=255 Identities=17% Similarity=0.209 Sum_probs=197.7
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcC---CCeEEEEEEeecccccCCH--H-----HHHHHHHHHHHHHhCCCCCcce
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEV---DGIEVAWNQVNIEDVMQSP--D-----QLERLYSEVHLLKSLKHENIIK 90 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~---~g~~VAvK~v~~~~~~~~~--~-----~~~~~~~Ei~iL~~L~HpnIV~ 90 (631)
....++|.+.+.||+|+||.||+|.+.. ++..||+|++......... . ....+.+|+..++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 3456799999999999999999999987 8889999998754310000 0 1133667889999999999999
Q ss_pred eeeEEEcC--CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC
Q 006777 91 FYNSWVDD--TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 91 l~~~f~~~--~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
+++++.+. ....+++||||+ +++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~ 188 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLG-YKN 188 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-SSS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEc-cCC
Confidence 99998763 245899999999 9999999988889999999999999999999999999 99999999999998 455
Q ss_pred --cEEEccccchhhccCC---------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCC-CCHH
Q 006777 169 --EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNEC-KNPA 235 (631)
Q Consensus 169 --~vKI~DFGlA~~~~~~---------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~-~~~~ 235 (631)
.+||+|||+++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+. .+..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999654321 1245679999999998865 4899999999999999999999999543 2222
Q ss_pred HHHHH---HHcCCCCCC-----CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 236 QIYKK---VTSGIKPAS-----LSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 236 ~~~~~---i~~~~~p~~-----l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..... ..... +.. .....++++++||.+||. +|.+||++.++++
T Consensus 269 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 269 AVQTAKTNLLDEL-PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHTT-THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhcccc-cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 22211 11111 110 112567899999999998 9999999999887
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=346.72 Aligned_cols=255 Identities=25% Similarity=0.293 Sum_probs=194.1
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEE---cC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV---DD 98 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~---~~ 98 (631)
...++|++.+.||+|+||+||+|.+ +|+.||+|++..... .......|+..+..++||||+++++.+. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 3467899999999999999999975 689999999875421 1111223444455689999999997553 23
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCeEecCCCCCceEEeCCCCc
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH---------NPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~---------~~~IiHrDLKp~NILl~~~~g~ 169 (631)
....+++||||+++|+|.+++...+ .++..++.++.||+.||.|||++ + |+||||||+|||++ .+|.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK-NDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC-TTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc-CCCc
Confidence 3447899999999999999998755 58999999999999999999999 7 99999999999998 7899
Q ss_pred EEEccccchhhccCC----------CCccccCCCCCCCcccccc--------ccCccceEeehhhHHHHHhhcCCCCCCC
Q 006777 170 VKIGDLGLAIVMQQP----------TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVTCEYPYNEC 231 (631)
Q Consensus 170 vKI~DFGlA~~~~~~----------~~~~~~GTp~y~APE~l~~--------~y~~~sDIwSLG~il~emltG~~Pf~~~ 231 (631)
+||+|||++...... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999754321 1234579999999998864 4678999999999999999998776442
Q ss_pred CC-----------------HHHHHHHHHcCCCCCCCCCC------CcHHHHHHHHHhcC-CCCCCCCHHHH------hcC
Q 006777 232 KN-----------------PAQIYKKVTSGIKPASLSKV------TDPQVKQFIEKCIV-PASLRLPALEL------LKD 281 (631)
Q Consensus 232 ~~-----------------~~~~~~~i~~~~~p~~l~~~------~~~~lk~lI~kcL~-~p~~Rpta~el------L~h 281 (631)
.. .......+........++.. .++.+++||.+||. +|.+|||+.|+ +.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 22 11222222222222222222 34589999999998 99999999999 456
Q ss_pred CCccCC
Q 006777 282 PFLVTD 287 (631)
Q Consensus 282 pff~~~ 287 (631)
+|-+..
T Consensus 319 ~~~~~~ 324 (336)
T 3g2f_A 319 IWERNK 324 (336)
T ss_dssp CCCC--
T ss_pred HHHhcc
Confidence 766654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=346.34 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=195.6
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCcceeeeEEEc
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVD 97 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~~~f~~ 97 (631)
...+.++|++.+.||+|+||.||+|.+. |..||+|++.... .....+|..++.. ++||||+++++++.+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 4455789999999999999999999875 9999999986432 2234455555554 499999999999877
Q ss_pred CCC--ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCeEecCCCCCceEEeCCC
Q 006777 98 DTN--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH--------NPPIIHRDLKCDNIFVNGNN 167 (631)
Q Consensus 98 ~~~--~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~--------~~~IiHrDLKp~NILl~~~~ 167 (631)
... ..+++||||+++|+|.++++.. .+++..++.++.||+.||.|||++ + |+||||||+|||++ .+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~-~~ 178 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK-KN 178 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC-TT
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC-CC
Confidence 643 5799999999999999999765 699999999999999999999998 7 99999999999998 78
Q ss_pred CcEEEccccchhhccCCC------CccccCCCCCCCccccccc-cCc------cceEeehhhHHHHHhhc----------
Q 006777 168 GEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-YNE------LVDIYSFGMCILEMVTC---------- 224 (631)
Q Consensus 168 g~vKI~DFGlA~~~~~~~------~~~~~GTp~y~APE~l~~~-y~~------~sDIwSLG~il~emltG---------- 224 (631)
+.+||+|||++....... ....+||+.|+|||++.+. +.. ++|||||||++|||+||
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999996543322 2356899999999988653 333 48999999999999999
Q ss_pred CCCCCCCCC----HHHHHHHHHcCCCCCCCCC-----CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 225 EYPYNECKN----PAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 225 ~~Pf~~~~~----~~~~~~~i~~~~~p~~l~~-----~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
..||..... .......+........++. ..++++.+||.+||. +|.+|||+.++++|
T Consensus 259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 777765322 2233333322222222222 345679999999998 89999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=363.97 Aligned_cols=244 Identities=21% Similarity=0.329 Sum_probs=207.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
....|.+.+.||+|+||.||+|.+. .+..||+|.++.... ..+.+.+|+.+|++|+|||||++++++. ...
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~ 256 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVVT---KEP 256 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSS
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc-----cHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCc
Confidence 3578999999999999999999985 578899999875432 2567899999999999999999999874 235
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARV 333 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTCCEEECSTTGGGG
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEC-CCCcEEEeeCCCceE
Confidence 89999999999999999754 36899999999999999999999999 99999999999998 789999999999976
Q ss_pred ccCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 181 MQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
..... .....+|+.|+|||++. +.++.++|||||||++|||+| |..||.+ .+..++...+..+..+. .+...+
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~ 411 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRMP-RPENCP 411 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCCCC-CCTTSC
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCC
Confidence 54321 22345678999999886 569999999999999999999 9999987 45666667777664433 345578
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+++.+||.+||. +|.+|||+.+++.
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHH
Confidence 999999999998 9999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=359.16 Aligned_cols=255 Identities=18% Similarity=0.221 Sum_probs=198.3
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCC-----CeEEEEEEeecccccCCHHH--------HHHHHHHHHHHHhCCCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVD-----GIEVAWNQVNIEDVMQSPDQ--------LERLYSEVHLLKSLKHENI 88 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~-----g~~VAvK~v~~~~~~~~~~~--------~~~~~~Ei~iL~~L~HpnI 88 (631)
....+|.+.+.||+|+||+||+|.+..+ ++.||+|++...... ...+ ...+..|+..++.++||||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 3456999999999999999999998764 588999998754310 0001 1223456667788899999
Q ss_pred ceeeeEEEcCCC--ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe-
Q 006777 89 IKFYNSWVDDTN--RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN- 164 (631)
Q Consensus 89 V~l~~~f~~~~~--~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~- 164 (631)
+++++++..... .++++||||+ ||+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence 999999876432 5789999999 99999999876 67999999999999999999999999 99999999999997
Q ss_pred CCCCcEEEccccchhhccCC---------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH
Q 006777 165 GNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP 234 (631)
Q Consensus 165 ~~~g~vKI~DFGlA~~~~~~---------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~ 234 (631)
..++.+||+|||+++..... .....+||+.|+|||++.+ .++.++|||||||++|+|+||..||.+....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 24689999999999654321 1234569999999998865 4899999999999999999999999863332
Q ss_pred HHHHHHHHcCCC--------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 235 AQIYKKVTSGIK--------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 235 ~~~~~~i~~~~~--------p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
............ +.......++++.+||..||. +|.+||++.+|++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 222221111100 000123457899999999998 9999999998876
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=346.72 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=206.5
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEE----EcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEE
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGF----DEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSW 95 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~----d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f 95 (631)
......+|++.+.||+|+||.||+|. +..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 44457789999999999999999998 4678999999998753 345667899999999999999999999988
Q ss_pred EcCCCceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 96 VDDTNRTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
.......+++||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .+|.+||+|
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kL~D 188 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGD 188 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECC
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEc-CCCcEEEec
Confidence 766556789999999999999999876 45999999999999999999999999 99999999999998 689999999
Q ss_pred ccchhhccCCC-----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCH--------------
Q 006777 175 LGLAIVMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNP-------------- 234 (631)
Q Consensus 175 FGlA~~~~~~~-----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~-------------- 234 (631)
||++....... .....+++.|+|||++.+ .++.++|||||||++|+|+||..||......
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 99997654332 223457788999998754 5899999999999999999999998631000
Q ss_pred -HHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 235 -AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 235 -~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+...+..+..+ ..+...++++.+||.+||. +|.+|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 269 VFHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122233333222 3345678999999999998 8999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=354.67 Aligned_cols=244 Identities=16% Similarity=0.238 Sum_probs=199.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcC--------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcce----
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEV--------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK---- 90 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~--------~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~---- 90 (631)
.+++|.+.+.||+|+||.||+|.+.. .|+.||+|++... +.+.+|+.++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhh
Confidence 36899999999999999999999987 4889999998744 24778999999999999998
Q ss_pred -----------eeeEEEcCCCceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCC
Q 006777 91 -----------FYNSWVDDTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157 (631)
Q Consensus 91 -----------l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLK 157 (631)
+++++... ...+++||||+ +|+|.+++... +.+++..++.++.||+.||.|||+++ |+|||||
T Consensus 111 ~~~~~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dik 186 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVT 186 (352)
T ss_dssp HTTCTTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCC
T ss_pred hccCCccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCC
Confidence 55655542 35899999999 99999999986 78999999999999999999999999 9999999
Q ss_pred CCceEEeCCCC--cEEEccccchhhccCC---------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcC
Q 006777 158 CDNIFVNGNNG--EVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCE 225 (631)
Q Consensus 158 p~NILl~~~~g--~vKI~DFGlA~~~~~~---------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~ 225 (631)
|+|||++ .++ .+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus 187 p~NIl~~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 187 AENIFVD-PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp GGGEEEE-TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred HHHEEEc-CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999998 666 8999999999654322 1234589999999998865 6899999999999999999999
Q ss_pred CCCCCCC-CHHHHHHHHH---cCCCCC----CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 226 YPYNECK-NPAQIYKKVT---SGIKPA----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 226 ~Pf~~~~-~~~~~~~~i~---~~~~p~----~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.||.... +...+..... ....+. ......++++++||.+||. +|.+||++.++++
T Consensus 266 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 266 LPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 9998754 4443333322 211110 0112357999999999998 9999999999876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=346.44 Aligned_cols=250 Identities=21% Similarity=0.323 Sum_probs=203.1
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
..|...+.||+|+||+||+|.+ +|..||+|.+............+.+.+|+.++++++||||+++++++.+.. .++
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~ 106 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD--DLC 106 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC--ceE
Confidence 3455569999999999999985 688999999876543334456778999999999999999999999886543 688
Q ss_pred EEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 105 MITELFTSGSLRQYRKK---HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~---~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++...
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD-EAFTAKISDFGLARAS 183 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc-CCCcEEEeeccccccc
Confidence 99999999999999874 346999999999999999999999999 99999999999997 7899999999998755
Q ss_pred cCCC----CccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHH---HHHHHHHcCCC--------
Q 006777 182 QQPT----ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIK-------- 246 (631)
Q Consensus 182 ~~~~----~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~---~~~~~i~~~~~-------- 246 (631)
.... .....||+.|+|||++.+.++.++||||||+++|+|++|..||....... .+...+.....
T Consensus 184 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (307)
T 2nru_A 184 EKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK 263 (307)
T ss_dssp CSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS
T ss_pred ccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc
Confidence 4321 23457999999999998889999999999999999999999997643322 22222222111
Q ss_pred -CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 247 -PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 247 -p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
....+...++.+.++|.+||. +|.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 111222335678999999998 89999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=366.56 Aligned_cols=250 Identities=25% Similarity=0.272 Sum_probs=193.9
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
-..+|.+.++||+|+||+||. ....+|+.||||++..... ..+.+|+++|+.+ +|||||++++++.+..
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-- 91 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDRQ-- 91 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEETT--
T ss_pred ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecCC--
Confidence 356799999999999999764 3346899999999875432 1245799999999 7999999999886544
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CC--CcEEEcccc
Q 006777 102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NN--GEVKIGDLG 176 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~--g~vKI~DFG 176 (631)
.+|+|||||. |+|.+++.... .+.+..++.++.||+.||.|||+++ |+||||||+|||++. .+ ..+||+|||
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 7899999996 69999998764 4666677899999999999999999 999999999999952 12 358899999
Q ss_pred chhhccCC-----CCccccCCCCCCCccccc----cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC
Q 006777 177 LAIVMQQP-----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 246 (631)
Q Consensus 177 lA~~~~~~-----~~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~ 246 (631)
+|...... .....+||+.|+|||++. ..++.++|||||||++|+|+| |..||.... .... ..+.....
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-~~~~-~~~~~~~~ 246 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-QRQA-NILLGACS 246 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-THHH-HHHTTCCC
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-HHHH-HHHhccCC
Confidence 99765432 234567999999999885 346789999999999999999 999996532 2222 22222212
Q ss_pred CC--CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 247 PA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 p~--~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.. ......++.+++||.+||+ +|.+|||+.++|+||||...
T Consensus 247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 11 1223346678999999998 99999999999999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=369.87 Aligned_cols=245 Identities=22% Similarity=0.337 Sum_probs=209.9
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...|.+.+.||+|+||.||+|.++.++..||+|.++.... ..+.+.+|+.+|++++|||||++++++.+. ..+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 291 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPF 291 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-----chHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcE
Confidence 5679999999999999999999999999999999875432 246789999999999999999999988654 368
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG-ENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEECC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEC-CCCcEEEeecccceec
Confidence 9999999999999999874 45899999999999999999999999 99999999999997 7899999999999765
Q ss_pred cCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcH
Q 006777 182 QQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP 256 (631)
Q Consensus 182 ~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~ 256 (631)
.... .....+++.|+|||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..+..+ ..+...++
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 446 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCPE 446 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCH
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCH
Confidence 4332 22345678999999876 468999999999999999999 9999987 4555666667665443 33456789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 257 QVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 257 ~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+++||.+||. +|.+|||+.++++
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHH
Confidence 99999999998 9999999999876
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=340.47 Aligned_cols=236 Identities=17% Similarity=0.269 Sum_probs=188.9
Q ss_pred ccCCCcEEEE-EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHH-HhCCCCCcceeeeEEEc-
Q 006777 21 SSVSYFWISW-VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVD- 97 (631)
Q Consensus 21 ~~i~~~Y~i~-e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIV~l~~~f~~- 97 (631)
..+.++|.+. ++||+|+||.||+|.+..+|+.||+|++... ..+.+|+.++ +.++||||++++++|..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 3445566666 8899999999999999999999999998632 2356788887 66799999999998865
Q ss_pred -CCCceEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC--CCcEEE
Q 006777 98 -DTNRTINMITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKI 172 (631)
Q Consensus 98 -~~~~~l~lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--~g~vKI 172 (631)
.....+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.. ++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEE
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEE
Confidence 33457999999999999999998764 6999999999999999999999999 9999999999999832 688999
Q ss_pred ccccchhhccCCCCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCC
Q 006777 173 GDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASL 250 (631)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p--~~l 250 (631)
+|||++.... ...|+.++|||||||++|+|+||..||.+.... .....+...... ..+
T Consensus 162 ~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 162 TDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKTRIRMGQYEF 221 (299)
T ss_dssp CCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSS
T ss_pred eccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcch-hhhHHHHHHHhhccccC
Confidence 9999885332 144788999999999999999999999763221 111111111111 111
Q ss_pred C----CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 251 S----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 251 ~----~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+ ...++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 1 3468899999999998 99999999999999999764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.48 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=199.0
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
...++|.+.+.||+|+||+||+|.+ .+|..||+|++...... ....++.+|+.+++.++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 100 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-- 100 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS--
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEEEEecCC--
Confidence 3567899999999999999999985 47999999998755321 12235889999999999999999999886544
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCeEecCCCCCceEEeCCCCcEEEcc
Q 006777 102 TINMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSH---NPPIIHRDLKCDNIFVNGNNGEVKIGD 174 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~----~l~e~~i~~i~~QIl~gL~yLHs~---~~~IiHrDLKp~NILl~~~~g~vKI~D 174 (631)
..++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+||+|
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~-~~~~~kl~D 177 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGD 177 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEEC-TTCCEEECC
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEEC-CCCCEEecc
Confidence 5789999999999999998653 499999999999999999999999 8 99999999999998 789999999
Q ss_pred ccchhhccCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCC----CCCHHHHHHHHHcCCC
Q 006777 175 LGLAIVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNE----CKNPAQIYKKVTSGIK 246 (631)
Q Consensus 175 FGlA~~~~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~----~~~~~~~~~~i~~~~~ 246 (631)
||++....... .....||+.|+|||++. ..++.++|||||||++|+|+||..||.. ..........+.....
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99997654322 23456999999999875 4689999999999999999999999952 0111111111111111
Q ss_pred CC------------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006777 247 PA------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 247 p~------------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hp 282 (631)
.. .+....++.+.+||.+||. +|.+|||+.++++|-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 11 1111123678999999998 899999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=356.45 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=202.1
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
...++|.+.+.||+|+||+||+|.+ .+|..||+|++.... ....+.+.+|+.+++.++||||+++++++.+. .
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 108 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPHLVSLIGFCDER--N 108 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT--T
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--C
Confidence 3567899999999999999999996 479999999876542 34567789999999999999999999987544 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 102 TINMITELFTSGSLRQYRKKHK----NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~----~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
.+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLD-ENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEEC-TTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEEC-CCCCEEEeeccc
Confidence 6889999999999999987653 5899999999999999999999999 99999999999997 789999999999
Q ss_pred hhhccCC----CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCH-----HHH-HHHHHcCCC
Q 006777 178 AIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP-----AQI-YKKVTSGIK 246 (631)
Q Consensus 178 A~~~~~~----~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~-----~~~-~~~i~~~~~ 246 (631)
+...... ......||+.|+|||++. +.++.++|||||||++|+|+||+.||.+.... ... ......+..
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 9754322 123456899999999874 56899999999999999999999999753221 111 111111111
Q ss_pred -----C---CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 006777 247 -----P---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP 282 (631)
Q Consensus 247 -----p---~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hp 282 (631)
+ ..+....+..+.++|.+||. +|.+|||+.+++++-
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1 11122235678999999998 999999999999763
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=343.56 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=202.5
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHh--CCCCCcceeeeEEEcCC
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKS--LKHENIIKFYNSWVDDT 99 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~~~f~~~~ 99 (631)
.+.++|.+.+.||+|+||+||+|.+ +|+.||+|++... ....+.+|+.+++. ++||||+++++++....
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3467999999999999999999997 5999999998643 23457788888887 79999999999987654
Q ss_pred C--ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEecCCCCCceEEeCCCCc
Q 006777 100 N--RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNGE 169 (631)
Q Consensus 100 ~--~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLH--------s~~~~IiHrDLKp~NILl~~~~g~ 169 (631)
. ..+++||||+++|+|.+++.+. .+++..++.++.||+.||.||| +++ |+||||||+|||++ .++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~-~~~~ 185 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGT 185 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEEC-TTSC
T ss_pred CccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEEC-CCCC
Confidence 3 3789999999999999999874 5999999999999999999999 777 99999999999997 7899
Q ss_pred EEEccccchhhccCCC------CccccCCCCCCCccccccc-------cCccceEeehhhHHHHHhhc----------CC
Q 006777 170 VKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTC----------EY 226 (631)
Q Consensus 170 vKI~DFGlA~~~~~~~------~~~~~GTp~y~APE~l~~~-------y~~~sDIwSLG~il~emltG----------~~ 226 (631)
+||+|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|+|| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999997654332 2455799999999988653 34789999999999999999 78
Q ss_pred CCCCCC----CHHHHHHHHHcCCCCCCCCC-----CCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 227 PYNECK----NPAQIYKKVTSGIKPASLSK-----VTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 227 Pf~~~~----~~~~~~~~i~~~~~p~~l~~-----~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
||.... ....+...+........++. ...+.+++||.+||. +|.+|||+.++++|
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 987532 23445555544433333332 234578999999998 99999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=352.80 Aligned_cols=239 Identities=19% Similarity=0.260 Sum_probs=190.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEE-----EEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCcceeeeE
Q 006777 23 VSYFWISWVVVLNCTFMCRYKG-----FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNS 94 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A-----~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~ 94 (631)
....|.+.+.||+|+||+||+| .+..+++.||+|++.... ...+.+|+++++.++ |+||++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 3678999999999999999999 467889999999987432 235677888888886 9999999998
Q ss_pred EEcCCCceEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCC---
Q 006777 95 WVDDTNRTINMITELFTSGSLRQYRKK-----HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--- 166 (631)
Q Consensus 95 f~~~~~~~l~lV~Ey~~gGsL~~~l~~-----~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~--- 166 (631)
+...+ ..++||||+++|+|.+++.. .+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .
T Consensus 136 ~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~-~~~~ 210 (365)
T 3e7e_A 136 HLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILG-NGFL 210 (365)
T ss_dssp EECSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-GGGT
T ss_pred eecCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEec-cccc
Confidence 87654 68899999999999999974 457999999999999999999999999 99999999999997 5
Q ss_pred --------CCcEEEccccchhhcc----CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCC
Q 006777 167 --------NGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN 233 (631)
Q Consensus 167 --------~g~vKI~DFGlA~~~~----~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~ 233 (631)
++.+||+|||+|+... .......+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 7899999999996543 122345689999999998865 489999999999999999999999965321
Q ss_pred HHHHHHHHHcCCCCCCCC-CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 234 PAQIYKKVTSGIKPASLS-KVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 234 ~~~~~~~i~~~~~p~~l~-~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
... . ....+. ...++.+.+++.+||. +|..|++..+.|.+
T Consensus 291 ~~~-------~-~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 291 GEC-------K-PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp TEE-------E-ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred Cce-------e-echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 100 0 001111 1236788999999998 78888665444443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=371.73 Aligned_cols=245 Identities=19% Similarity=0.286 Sum_probs=204.7
Q ss_pred cEEE-EEEEeecCCeEEEEEEE--cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 26 FWIS-WVVVLNCTFMCRYKGFD--EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 26 ~Y~i-~e~LG~G~fg~VY~A~d--~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
.+.+ .+.||+|+||.||+|.+ +.+++.||||+++.... .....+++.+|+.+|++|+|||||++++++..+ .
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~ 443 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---S 443 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG--CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 3444 35899999999999955 45678999999876532 344567899999999999999999999987532 4
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCTTHHHHTT
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEe-CCCCEEEEEcCCccccc
Confidence 7899999999999999999889999999999999999999999999 99999999999998 78899999999998654
Q ss_pred CCC-----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 183 QPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 183 ~~~-----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
... .....+|+.|+|||++.+ .|+.++|||||||++|||++ |..||.+ .+..++...+..+..+ ..+...+
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~ 598 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCP 598 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCC
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCC
Confidence 322 223456789999998865 69999999999999999998 9999987 5566777777776543 3445678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+++.+||.+||. +|.+||++.++++
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999998 9999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=358.06 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=202.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
....|.+.+.||+|+||.||+|.+. .+..||+|+++.... ..+.+.+|+.+|++++||||+++++++.+ ..
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~ 252 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EP 252 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC---Cc
Confidence 3578999999999999999999986 457799999875432 23568899999999999999999998754 35
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+++||||+++|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARL 329 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC-
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEC-CCCCEEECCCcccee
Confidence 88999999999999999753 56999999999999999999999999 99999999999997 788999999999976
Q ss_pred ccCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 181 MQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
..... .....+|+.|+|||++. +.++.++|||||||++|||+| |..||.+ ....+....+..+..+. .+...+
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~ 407 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CPPECP 407 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTSC
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCC
Confidence 54322 22345678999999875 568999999999999999999 9999987 45666777777664433 345678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+.+.+||.+||. +|.+|||+.+++.
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 899999999998 9999999999886
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=351.31 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=197.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~---g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
...|.+.++||+|+||+||+|.+..+ +..||+|.++.. ......+++.+|+.+|++++||||+++++++....
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 163 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE- 163 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS-
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 45689999999999999999987543 346899987642 23456788999999999999999999999875443
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
...++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLAR 240 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC----
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEEC-CCCCEEEeeccccc
Confidence 4678999999999999999865 45899999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCCC------CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 006777 180 VMQQPT------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS 251 (631)
Q Consensus 180 ~~~~~~------~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~ 251 (631)
...... .....+|+.|+|||++. ..++.++|||||||++|+|+| |.+||.+. +..+....+..+..+ ..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-~~~~~~~~~~~~~~~-~~p 318 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRL-LQP 318 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CSSCHHHHHHTTCCC-CCC
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-CHHHHHHHHHcCCCC-CCC
Confidence 553221 22345788999999875 468999999999999999999 67777653 344444555555433 234
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
...++.+.++|.+||. +|.+||++.+++++
T Consensus 319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5578899999999998 89999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.22 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=205.1
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
..++|.+.+.||+|+||.||+|.+.. .||+|++..... .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~ 103 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP--H 103 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS--C
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--c
Confidence 46789999999999999999999853 499999876532 2223345778999999999999999999887654 6
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 103 INMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
+++||||+.+++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ +|.+||+|||++...
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC--
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe--CCCEEEeecCCcccc
Confidence 899999999999999998765 6999999999999999999999999 99999999999996 679999999998644
Q ss_pred cC-------CCCccccCCCCCCCcccccc----------ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006777 182 QQ-------PTARSVIGTPEFMAPELYEE----------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 244 (631)
Q Consensus 182 ~~-------~~~~~~~GTp~y~APE~l~~----------~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~ 244 (631)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .........+..+
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTG 258 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTT
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccC
Confidence 21 12234568999999998753 478899999999999999999999986 5566666777777
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 245 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 245 ~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+.......++.++++|.+||. +|.+|||+.++++
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 66655555678899999999998 8999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=367.70 Aligned_cols=246 Identities=17% Similarity=0.306 Sum_probs=202.6
Q ss_pred CCcEEEEE-EEeecCCeEEEEEEEc--CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 24 SYFWISWV-VVLNCTFMCRYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 ~~~Y~i~e-~LG~G~fg~VY~A~d~--~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
...+.+.+ .||+|+||.||+|.+. .++..||||+++... .....+.+.+|+++|++++|||||++++++..+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-- 408 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-- 408 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS--
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC--
Confidence 34556666 8999999999999875 456789999987542 233457789999999999999999999988652
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 409 -~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 409 -ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLV-NRHYAKISDFGLSK 484 (613)
T ss_dssp -SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCSTTT
T ss_pred -CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEc-CCCcEEEeeccCcc
Confidence 489999999999999999754 46999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCCC-----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 180 VMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 180 ~~~~~~-----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
...... .....+|+.|+|||++. +.|+.++|||||||++|||+| |+.||.+. +..++...+..+..+ ..+.
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-~~~~~~~~i~~~~~~-~~p~ 562 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPP 562 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CSHHHHHHHHTTCCC-CCCT
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC-CCCC
Confidence 654321 11234578999999886 569999999999999999998 99999874 445666777776543 3455
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+++++.+||.+||. +|.+||++.+++.
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 678999999999998 9999999998753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.07 Aligned_cols=249 Identities=17% Similarity=0.168 Sum_probs=193.6
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc----CCHHHHHHHHHHHHHHHhCC---------CCCcce
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM----QSPDQLERLYSEVHLLKSLK---------HENIIK 90 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~----~~~~~~~~~~~Ei~iL~~L~---------HpnIV~ 90 (631)
.++|++.+.||+|+||+||+|.+ +|+.||+|++...... ......+.+.+|+.+|+.|+ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 57899999999999999999997 6899999999876421 12233467888999998886 666666
Q ss_pred eeeEEE-----------------cC-----------CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 006777 91 FYNSWV-----------------DD-----------TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLH 142 (631)
Q Consensus 91 l~~~f~-----------------~~-----------~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~ 142 (631)
+++.+. +. ....+|+||||+.+|++.+.+.+ +.+++..++.+++||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 665543 20 14579999999999976666544 56899999999999999999
Q ss_pred HHH-hCCCCeEecCCCCCceEEeCCCC--------------------cEEEccccchhhccCCCCccccCCCCCCCcccc
Q 006777 143 YLH-SHNPPIIHRDLKCDNIFVNGNNG--------------------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY 201 (631)
Q Consensus 143 yLH-s~~~~IiHrDLKp~NILl~~~~g--------------------~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l 201 (631)
||| +++ |+||||||+|||++ .+| .+||+|||+|+..... ..+||+.|+|||++
T Consensus 176 ~lH~~~~--ivHrDlKp~NILl~-~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 176 VAEASLR--FEHRDLHWGNVLLK-KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHC--CBCSCCCGGGEEEE-ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGG
T ss_pred HHHHhCC--EeECCCCHHHEEEe-ccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhh
Confidence 999 899 99999999999998 555 8999999999866542 45899999999999
Q ss_pred ccccCccceEeehhhH-HHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCC----CCCCCcHHHHHHHHHhcCCCCCCCCH
Q 006777 202 EEEYNELVDIYSFGMC-ILEMVTCEYPYNECKNPAQIYKKVTSGIK-PAS----LSKVTDPQVKQFIEKCIVPASLRLPA 275 (631)
Q Consensus 202 ~~~y~~~sDIwSLG~i-l~emltG~~Pf~~~~~~~~~~~~i~~~~~-p~~----l~~~~~~~lk~lI~kcL~~p~~Rpta 275 (631)
.+..+.++||||||++ .+++++|..||.+..........+..... +.. .....++++++||.+||+.+ ||
T Consensus 250 ~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----sa 325 (336)
T 2vuw_A 250 TGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----SA 325 (336)
T ss_dssp CCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----SH
T ss_pred cCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----CH
Confidence 8877999999998777 77899999999531111223333332211 111 12235789999999999833 99
Q ss_pred HHHh-cCCCcc
Q 006777 276 LELL-KDPFLV 285 (631)
Q Consensus 276 ~elL-~hpff~ 285 (631)
.|+| +||||+
T Consensus 326 ~e~l~~Hp~f~ 336 (336)
T 2vuw_A 326 TDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHCGGGC
T ss_pred HHHHhcCCCcC
Confidence 9999 999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=359.44 Aligned_cols=250 Identities=18% Similarity=0.226 Sum_probs=200.8
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..+.++|.+.++||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.|+|++++..+..+.. ..
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~-~~ 75 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGV-EG 75 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEE-ET
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEe-eC
Confidence 34678999999999999999999999999999999988765432 236789999999988655554444433 23
Q ss_pred ceEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe--CCCCcEEEccccc
Q 006777 101 RTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGL 177 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKI~DFGl 177 (631)
...++||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..++.+||+|||+
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 4789999999 8999999986 467999999999999999999999999 99999999999993 2678999999999
Q ss_pred hhhccCCC---------CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCC--HHHHHHHHHcCC
Q 006777 178 AIVMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGI 245 (631)
Q Consensus 178 A~~~~~~~---------~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~--~~~~~~~i~~~~ 245 (631)
++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ..+.+..+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 97654332 225689999999998764 689999999999999999999999987433 333333333221
Q ss_pred C---CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 246 K---PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 246 ~---p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
. ...+...+++++.+||.+||. +|.+||++.+|++
T Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1 111224567899999999998 9999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=360.87 Aligned_cols=245 Identities=22% Similarity=0.320 Sum_probs=207.3
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
....|++.+.||+|+||.||+|.+. .+..||||+++.... ..+.+.+|+.+|++|+|||||++++++.+ ..
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~ 335 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EP 335 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEee---cc
Confidence 3578999999999999999999986 457799999875432 23568899999999999999999998754 35
Q ss_pred EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 103 INMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
+++||||+.+|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARL 412 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCTTSTTT
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEc-CCCcEEEccccccee
Confidence 88999999999999999753 56999999999999999999999999 99999999999997 788999999999976
Q ss_pred ccCC---CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 181 MQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 181 ~~~~---~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
.... ......+++.|+|||++. +.++.++|||||||++|||+| |..||.+ ....++...+..+.... .+..++
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~ 490 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CPPECP 490 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCC
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCC
Confidence 5432 122345678999999775 568999999999999999999 9999987 45666777777664432 345678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+.+.+||.+||. +|.+|||+.+|+..
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 899999999998 99999999998863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=380.80 Aligned_cols=260 Identities=27% Similarity=0.345 Sum_probs=206.8
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEc---
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD--- 97 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~--- 97 (631)
....++|++.+.||+|+||+||+|.+..+|..||+|++... ......+++.+|+.+|+.++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 34457899999999999999999999999999999988653 245667889999999999999999999997644
Q ss_pred -CCCceEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC---cE
Q 006777 98 -DTNRTINMITELFTSGSLRQYRKKHK---NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EV 170 (631)
Q Consensus 98 -~~~~~l~lV~Ey~~gGsL~~~l~~~~---~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g---~v 170 (631)
......++||||++||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++ .+| .+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~-~~g~~~~v 163 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQ-PGPQRLIH 163 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEE-CCSSSCEE
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEee-cCCCceeE
Confidence 12457889999999999999998754 6999999999999999999999999 99999999999998 444 49
Q ss_pred EEccccchhhccCC-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-----
Q 006777 171 KIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----- 243 (631)
Q Consensus 171 KI~DFGlA~~~~~~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~----- 243 (631)
||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+...+..+...+..
T Consensus 164 KL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 164 KIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp EECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred EEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 99999999765443 335568999999999886 46899999999999999999999999764333222111100
Q ss_pred --------C--------CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 244 --------G--------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 244 --------~--------~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
+ ..|..+....++.+.+||.+||. +|.+|||+.++|.||||+.
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 01122333457899999999998 9999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=363.05 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=206.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcC---CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEV---DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~---~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~ 99 (631)
...+|.+.+.||+|+||+||+|.+.. .+..||+|.+... ......+++.+|+.+|++++||||+++++++.+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 462 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-- 462 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 35789999999999999999999864 3568999987643 235566789999999999999999999998743
Q ss_pred CceEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 NRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~~~vkL~DFG~a 538 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLS 538 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCCC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEe-CCCCEEEEecCCC
Confidence 35789999999999999998754 6999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 179 IVMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 179 ~~~~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
....... .....+|+.|+|||++. ..++.++|||||||++|||++ |..||.+ .+.......+..+..+ .++..
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~ 616 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPN 616 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHHTCCC-CCCTT
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCC-CCCcc
Confidence 7654332 22345788999999875 468999999999999999997 9999987 4556666666665433 34556
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.++.+.+||.+||. +|.+||++.+++.
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999998 9999999999876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=352.87 Aligned_cols=249 Identities=17% Similarity=0.194 Sum_probs=190.6
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCcce------------
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIK------------ 90 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~------------ 90 (631)
...|...++||+|+||+||+|.+..+|+.||||++..... ......+.+.+|+.+++.+.| +|+..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 4568999999999999999999999999999999874432 222345778999999999987 32211
Q ss_pred ---------eeeEEEcCC---CceEEEEEeccCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 006777 91 ---------FYNSWVDDT---NRTINMITELFTSGSLRQYRKK-------HKNVDMKAIKNWARQILRGLHYLHSHNPPI 151 (631)
Q Consensus 91 ---------l~~~f~~~~---~~~l~lV~Ey~~gGsL~~~l~~-------~~~l~e~~i~~i~~QIl~gL~yLHs~~~~I 151 (631)
++.++.... ...++++|+++ +++|.++++. .+.+++..+..++.||+.||.|||+++ |
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 232 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 232 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 111111111 12456777776 5899998852 234788899999999999999999999 9
Q ss_pred EecCCCCCceEEeCCCCcEEEccccchhhccCCCCccccCCCCCCCcccc----------cc-ccCccceEeehhhHHHH
Q 006777 152 IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----------EE-EYNELVDIYSFGMCILE 220 (631)
Q Consensus 152 iHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l----------~~-~y~~~sDIwSLG~il~e 220 (631)
+||||||+|||++ .+|.+||+|||+++..... ....+| +.|+|||++ .. .|+.++|||||||++|+
T Consensus 233 iHrDiKp~NILl~-~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 233 VHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp ECSCCCGGGEEEC-TTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEe-cCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999998 7889999999998755433 445678 999999987 22 37889999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 221 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 221 mltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
|+||+.||.... .......+... ....++.+++||.+||. +|.+||++.++|+||||+.
T Consensus 310 lltg~~Pf~~~~-~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 310 IWCADLPNTDDA-ALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHSSCCCCTTG-GGSCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHCCCCCCCcc-hhhhHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 999999997632 22222222111 12457899999999998 9999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=372.54 Aligned_cols=246 Identities=19% Similarity=0.235 Sum_probs=202.7
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcC-CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEV-DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~-~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
+..+.++|++.+.||+|+||+||+|.+.. +|+.||+|++... ......+.+.+|+.+|++++|||||+++++|...
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 34567899999999999999999999976 7999999988643 2355667889999999999999999999998765
Q ss_pred CC---ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 99 TN---RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 99 ~~---~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
.. ..+|+||||++|++|.+++.. .+++..++.|+.||+.||.|||++| |+||||||+|||++ . +.+||+||
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~-~-~~~kl~DF 225 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLT-E-EQLKLIDL 225 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-S-SCEEECCC
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEe-C-CcEEEEec
Confidence 43 137999999999999998765 7999999999999999999999999 99999999999997 3 58999999
Q ss_pred cchhhccCCCCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 176 GLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 176 GlA~~~~~~~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
|++...... ...+||+.|+|||++.+.++.++|||||||++|+|++|..||.+.. .............+
T Consensus 226 G~a~~~~~~--~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~---------~~~~~~~~~~~~~~ 294 (681)
T 2pzi_A 226 GAVSRINSF--GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRY---------VDGLPEDDPVLKTY 294 (681)
T ss_dssp TTCEETTCC--SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEE---------CSSCCTTCHHHHHC
T ss_pred ccchhcccC--CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccc---------cccccccccccccC
Confidence 999765443 4567999999999998888999999999999999999998886521 01111000001124
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
+.+.+||.+||. +|.+||++.+.+.|+|+.
T Consensus 295 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 789999999998 899999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.04 Aligned_cols=227 Identities=14% Similarity=0.127 Sum_probs=186.3
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+++.+|+.++++++||||+++++++.+. .
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~ 104 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--A 104 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--T
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--C
Confidence 567889999999999999999999999999999999986543 3356678899999999999999999999998765 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+|+||||++|++|.+++++. .....+..++.||+.||.|||++| |+||||||+|||++ .+|.+||+++|
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~-~~g~~kl~~~~----- 174 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVS-IDGDVVLAYPA----- 174 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-TTSCEEECSCC-----
T ss_pred cEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEc-CCCCEEEEecc-----
Confidence 799999999999999999643 466678899999999999999999 99999999999998 78999998543
Q ss_pred cCCCCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHH---HHHHHcCCC-CCCCCCCCcHH
Q 006777 182 QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI---YKKVTSGIK-PASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~---~~~i~~~~~-p~~l~~~~~~~ 257 (631)
|++| ++.++|||||||++|+|+||+.||.+......+ .+.+..... +..+....++.
T Consensus 175 -------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 175 -------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp -------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred -------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence 3443 788999999999999999999999874322111 011111111 11233456889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+++||.+||. +|.+| |+.++++.
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHHcccCCccC-CHHHHHHH
Confidence 9999999998 89999 99998873
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=307.48 Aligned_cols=189 Identities=12% Similarity=0.052 Sum_probs=137.6
Q ss_pred EEeecCCeEEEEEEEcCCCeEEEEEEeecccccC------CHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCceEE
Q 006777 32 VVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQ------SPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 32 ~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~------~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~~l~ 104 (631)
.++.|+++.+..+.....|+.||+|++....... .....+++.+|+.+|+++ .|+||+++++++.++. .+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~--~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ--SGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS--EEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC--EEE
Confidence 3567888888888888899999999997653211 233456799999999999 7999999999986554 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
|||||++||+|.+++.+.+++++. .++.||+.||+|||++| ||||||||+|||++ .+|.|||+|||+|+.....
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~-~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVD-ARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEEC-TTSCEEECCCTTEESCC--
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEEC-CCCCEEEeecccCeeCCCC
Confidence 999999999999999999999875 47899999999999999 99999999999998 7899999999999765433
Q ss_pred --CCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCC
Q 006777 185 --TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY 228 (631)
Q Consensus 185 --~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf 228 (631)
...+.+||+.|||||++.+.+..++|+||+|+++++|.++..|+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred CccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence 34567899999999999998899999999999998887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-27 Score=265.26 Aligned_cols=185 Identities=17% Similarity=0.140 Sum_probs=144.9
Q ss_pred EEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC----HHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 28 ISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS----PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 28 ~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
...++||+|+||.||+|. ..+..+++|+......... ....+++.+|+++|++++||||+++..++.+.. ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NK 414 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--cc
Confidence 456799999999999994 5688999998765432211 112466899999999999999995544444444 45
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|+||||++||+|.+++.. +..++.||+.||.|||+++ |+||||||+|||++ . .+||+|||+|+....
T Consensus 415 ~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~-~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFD-K--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEES-S--SEEECCCTTCEECCC
T ss_pred EEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEEC-C--eEEEEECccCEECCC
Confidence 899999999999999876 5689999999999999999 99999999999997 3 999999999986654
Q ss_pred CC---------CccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCC
Q 006777 184 PT---------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYN 229 (631)
Q Consensus 184 ~~---------~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~ 229 (631)
.. ....+||+.|||||++.. .|+..+|+|+..+-.++.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 31 236789999999999864 58889999999999999988888874
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.7e-24 Score=218.21 Aligned_cols=148 Identities=14% Similarity=0.082 Sum_probs=116.9
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc-----CCH---------HHHHHHHHHHHHHHhCCCCCcceee
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM-----QSP---------DQLERLYSEVHLLKSLKHENIIKFY 92 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~-----~~~---------~~~~~~~~Ei~iL~~L~HpnIV~l~ 92 (631)
|.+.+.||+|+||.||+|.+ .+|+.||+|.++..... ... .....+.+|+.+|+.++| ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence 34449999999999999999 88999999998753211 000 235678899999999994 5555
Q ss_pred eEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 93 ~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
+.+.. ...++||||++||+|.+ +. ......++.||+.||.|||++| |+||||||+|||++ +|.+||
T Consensus 168 ~~~~~---~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~~vkl 233 (282)
T 1zar_A 168 KVYAW---EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EEGIWI 233 (282)
T ss_dssp CEEEE---ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TTEEEE
T ss_pred eEEec---cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CCcEEE
Confidence 54422 24689999999999987 32 1335579999999999999999 99999999999997 789999
Q ss_pred ccccchhhccCCCCccccCCCCCCCcccccc
Q 006777 173 GDLGLAIVMQQPTARSVIGTPEFMAPELYEE 203 (631)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~ 203 (631)
+|||+|+ .+..++|||++..
T Consensus 234 ~DFG~a~-----------~~~~~~a~e~l~r 253 (282)
T 1zar_A 234 IDFPQSV-----------EVGEEGWREILER 253 (282)
T ss_dssp CCCTTCE-----------ETTSTTHHHHHHH
T ss_pred EECCCCe-----------ECCCCCHHHHHHH
Confidence 9999985 3566889998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=9.9e-20 Score=185.29 Aligned_cols=144 Identities=16% Similarity=0.161 Sum_probs=111.9
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeE--EEEEEeeccccc-C-------------------CHHHHHHHHHHHHHHH
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIE--VAWNQVNIEDVM-Q-------------------SPDQLERLYSEVHLLK 81 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~--VAvK~v~~~~~~-~-------------------~~~~~~~~~~Ei~iL~ 81 (631)
+..|.+.+.||+|+||.||+|.+..+|.. ||+|+++..... . .......+.+|+.+|+
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 45689999999999999999999778999 999997654210 0 0012246788999999
Q ss_pred hCCCCCc--ceeeeEEEcCCCceEEEEEeccCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEe
Q 006777 82 SLKHENI--IKFYNSWVDDTNRTINMITELFTS-G----SLRQYRKKHKNVDMKAIKNWARQILRGLHYLH-SHNPPIIH 153 (631)
Q Consensus 82 ~L~HpnI--V~l~~~f~~~~~~~l~lV~Ey~~g-G----sL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLH-s~~~~IiH 153 (631)
.|.|++| +.++. .. ..++||||+.+ | +|.++... .++..+..++.||+.||.||| ++| |+|
T Consensus 126 ~l~~~~i~~p~~~~--~~----~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivH 194 (258)
T 1zth_A 126 RAKEAGVSVPQPYT--YM----KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVH 194 (258)
T ss_dssp HHHHTTCCCCCEEE--EE----TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EEC
T ss_pred HHHhCCCCCCeEEE--cC----CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEe
Confidence 9998864 34443 21 35799999942 3 78876543 345678899999999999999 998 999
Q ss_pred cCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 154 rDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
|||||+|||++ . .++|+|||+|...
T Consensus 195 rDlkp~NILl~-~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYI-D--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEES-S--SEEECCCTTCEET
T ss_pred CCCCHHHEEEc-C--cEEEEECcccccC
Confidence 99999999997 3 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.9e-17 Score=175.74 Aligned_cols=144 Identities=15% Similarity=0.087 Sum_probs=102.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc-----------C--CHH---HHHH--HHHHHHHHHhCCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM-----------Q--SPD---QLER--LYSEVHLLKSLKH 85 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~-----------~--~~~---~~~~--~~~Ei~iL~~L~H 85 (631)
+..|.+...||.|+||.||+|.+. +|+.||||+++..... . ... ...+ ..+|..+|.+|.+
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 345999999999999999999984 7999999987643210 0 000 0111 2357777777755
Q ss_pred CCcceeeeEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC
Q 006777 86 ENIIKFYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 86 pnIV~l~~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
.++.-..-+... . .++||||++|++|.++. .......++.||+.+|.|||++| ||||||||.|||++
T Consensus 173 ~gv~vp~p~~~~-~---~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~- 239 (397)
T 4gyi_A 173 EGFPVPEPIAQS-R---HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIR- 239 (397)
T ss_dssp TTCSCCCEEEEE-T---TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-
T ss_pred cCCCCCeeeecc-C---ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe-
Confidence 544322211111 1 26899999999886542 22345678899999999999999 99999999999997
Q ss_pred CCC----------cEEEccccchhhc
Q 006777 166 NNG----------EVKIGDLGLAIVM 181 (631)
Q Consensus 166 ~~g----------~vKI~DFGlA~~~ 181 (631)
++| .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 444 3899999977543
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=5.8e-15 Score=123.28 Aligned_cols=59 Identities=24% Similarity=0.416 Sum_probs=58.0
Q ss_pred ceEEEEEecCCCCCceeeeeeeecCCCCHHHHHHHHHHccCCCcccHHHHHHHHHHHHH
Q 006777 365 TVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIM 423 (631)
Q Consensus 365 ~i~L~Lri~d~~~~~~~i~f~f~~~~Dta~~va~EmV~~~~i~~~d~~~ia~~i~~~i~ 423 (631)
+|+|+||++|++++++||+|+|.+++|||++||+|||.+|+|+..|+.+||++|+++|.
T Consensus 2 pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 2 PISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 68999999999999999999999999999999999999999999999999999999997
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.09 E-value=3.2e-14 Score=120.35 Aligned_cols=63 Identities=30% Similarity=0.393 Sum_probs=58.6
Q ss_pred CCceEEEEEecCCC---CCce---eeeeeeecCCCCHHHHHHHHHHccCCCcccHHHHHHHHHHHHHHh
Q 006777 363 DDTVSLTLRIGDKS---GHVS---NIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 425 (631)
Q Consensus 363 ~~~i~L~Lri~d~~---~~~~---~i~f~f~~~~Dta~~va~EmV~~~~i~~~d~~~ia~~i~~~i~~~ 425 (631)
..+|.|+|||.|++ |+.| +|+|+|++++|||++||+|||++|+|+++|...||++|++-+..+
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~ 91 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLI 91 (98)
Confidence 46899999999994 7888 999999999999999999999999999999999999999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=5.7e-11 Score=119.63 Aligned_cols=141 Identities=14% Similarity=0.024 Sum_probs=107.9
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCceE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~~l 103 (631)
..|.+...++.|+.+.||++.. .|..+++|....... .. ...+.+|+.+|+.|. +.++.++++++.+. +..
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~ 85 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWS 85 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-TS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-CC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecC--Cce
Confidence 4689999999999999999974 378899998864321 11 124778999999884 67788888876543 478
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN----------------------------------- 148 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~----------------------------------- 148 (631)
|+||||++|.+|.+.+. +......++.++..+|..||+..
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999999987631 22234578899999999999821
Q ss_pred ----------------------CCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 149 ----------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 149 ----------------------~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
+.++|+|++|.||+++ .++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-CCcEEEEEEchhcc
Confidence 2389999999999997 44456799999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=1.8e-09 Score=107.39 Aligned_cols=138 Identities=12% Similarity=0.015 Sum_probs=97.0
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--cceeeeEEEcCCC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSWVDDTN 100 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~~~f~~~~~ 100 (631)
....|.+..+.+.|..+.||++.. .+|..+++|...... ...+.+|+.+++.+.+.+ +.+++.++.+.
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-- 87 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA-- 87 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC--
Confidence 344566654445666799999964 567889999865431 134678999999886544 45577765443
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-------------------------------- 148 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~-------------------------------- 148 (631)
+..++||||++|.+|. . ...+ ...++.++...|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp SCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 4688999999998884 1 1122 2356777888888888753
Q ss_pred ------------------------CCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 149 ------------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 149 ------------------------~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
+.++|+|++|.||+++ .++.+.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE-NGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE-CCcEEEEEcchhcc
Confidence 1199999999999997 45556799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.9e-09 Score=112.53 Aligned_cols=144 Identities=14% Similarity=0.132 Sum_probs=103.3
Q ss_pred EEEEEeecCCeEEEEEEEcCCCeEEEEEEee--cccccCCHHHHHHHHHHHHHHHhCC--CCCcceeeeEEEcCCC-ceE
Q 006777 29 SWVVVLNCTFMCRYKGFDEVDGIEVAWNQVN--IEDVMQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVDDTN-RTI 103 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~--~~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~~f~~~~~-~~l 103 (631)
..+.|+.|.+..||+.... +..+++|+.. ..... .....+.+|+.+|+.|. +.++++++.++.+... +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 4688999999999998753 4678888765 32211 12345778999999997 4557888876544321 457
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH------------------------------------ 147 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~------------------------------------ 147 (631)
|+||||++|..+.+. ....+++.....++.+++..|..||+.
T Consensus 117 ~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 899999999877431 123478888899999999999999983
Q ss_pred --------------------CCCeEecCCCCCceEEeCCCC-cEEEccccchh
Q 006777 148 --------------------NPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAI 179 (631)
Q Consensus 148 --------------------~~~IiHrDLKp~NILl~~~~g-~vKI~DFGlA~ 179 (631)
.+.++|+|++++||+++.+.+ .+.|+||+.+.
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 134999999999999984332 36899999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.78 E-value=5.6e-09 Score=107.82 Aligned_cols=185 Identities=18% Similarity=0.142 Sum_probs=121.7
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCC--cceeeeEEEcCC-CceEEE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHEN--IIKFYNSWVDDT-NRTINM 105 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~Hpn--IV~l~~~f~~~~-~~~l~l 105 (631)
.+.++.|.+..||++. ..+++|.... .....++.+|+.+|+.+ .+.. +.+++....... ....|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence 3569999999999873 3488887432 23456788999999888 3433 334443221111 124578
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 006777 106 ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN------------------------------------- 148 (631)
Q Consensus 106 V~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~------------------------------------- 148 (631)
||++++|.+|..... ..++..+...++.|+...|..||+..
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999999988865332 34778888888999999999998621
Q ss_pred -------------------CCeEecCCCCCceEEeCC-CCcEEEccccchhhccCCCCccccCCCCC---CCccccc---
Q 006777 149 -------------------PPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTARSVIGTPEF---MAPELYE--- 202 (631)
Q Consensus 149 -------------------~~IiHrDLKp~NILl~~~-~g~vKI~DFGlA~~~~~~~~~~~~GTp~y---~APE~l~--- 202 (631)
+.++|+|++|.||+++.. .+.+.|+||+.+...... ........+ ..|+...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--NDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HHHHHHHhhccccCHHHHHHHH
Confidence 237999999999999833 456789999988543221 111111111 2333221
Q ss_pred ccc------------CccceEeehhhHHHHHhhcCCCCC
Q 006777 203 EEY------------NELVDIYSFGMCILEMVTCEYPYN 229 (631)
Q Consensus 203 ~~y------------~~~sDIwSLG~il~emltG~~Pf~ 229 (631)
..| ....+.|++|.+++.+.+|..+|.
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 112 123589999999999999988773
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=6e-06 Score=85.45 Aligned_cols=137 Identities=18% Similarity=0.064 Sum_probs=93.4
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC---CcceeeeEEEcCCCceEEEE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE---NIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIV~l~~~f~~~~~~~l~lV 106 (631)
.+.++.|....||+. |..+++|... ......++.+|+.+|+.|.+. .|.+++.+.. ...+..++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v 91 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVG 91 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEE
Confidence 567899999999998 5568888742 234456788999999999753 3455555443 233467899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 006777 107 TELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN-------------------------------------- 148 (631)
Q Consensus 107 ~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~-------------------------------------- 148 (631)
|||++|.+|....- ..++......++.|+...|..||+..
T Consensus 92 ~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 92 YRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp EECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred EeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 99999988865321 22445555555555555555555432
Q ss_pred --------------------CCeEecCCCCCceEEeC--CCCc-EEEccccchhh
Q 006777 149 --------------------PPIIHRDLKCDNIFVNG--NNGE-VKIGDLGLAIV 180 (631)
Q Consensus 149 --------------------~~IiHrDLKp~NILl~~--~~g~-vKI~DFGlA~~ 180 (631)
+.++|+|++|.||+++. .++. +.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 23699999999999973 1345 58999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=1.2e-05 Score=80.77 Aligned_cols=135 Identities=13% Similarity=0.032 Sum_probs=93.7
Q ss_pred EEEeecCCe-EEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCceEEEEEe
Q 006777 31 VVVLNCTFM-CRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 31 e~LG~G~fg-~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~~l~lV~E 108 (631)
+.+..|..+ .||+......+..+++|+-.. .....+.+|...|+.|. +-.|.+++.++.+. +..++|||
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme 100 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTT 100 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEE
Confidence 344455544 799988777788899997552 23445778999998884 33466777766554 46889999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 006777 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN---------------------------------------- 148 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~---------------------------------------- 148 (631)
+++|.++.+..... ......+..++...|.-||+..
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 99998887765432 1223445666666666666431
Q ss_pred ----------------CCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 149 ----------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 149 ----------------~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
+-++|+|+.+.||+++ .++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECcccc
Confidence 0178999999999998 55566799999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=2.8e-05 Score=82.97 Aligned_cols=81 Identities=11% Similarity=0.075 Sum_probs=49.7
Q ss_pred EEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccc-cCC--HHHHHHHHHHHHHHHhCCC--CC-cceeeeEEEcCCCce
Q 006777 29 SWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDV-MQS--PDQLERLYSEVHLLKSLKH--EN-IIKFYNSWVDDTNRT 102 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~-~~~--~~~~~~~~~Ei~iL~~L~H--pn-IV~l~~~f~~~~~~~ 102 (631)
..+.||.|.++.||++.+...+..|++|+...... ... ....+++..|..+|+.+.. |. +.+++.+ +.. .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~--~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE--M 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT--T
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC--c
Confidence 36789999999999997666678899998653211 000 0123456778888887742 33 4455542 333 2
Q ss_pred EEEEEeccCCC
Q 006777 103 INMITELFTSG 113 (631)
Q Consensus 103 l~lV~Ey~~gG 113 (631)
.++||||++|.
T Consensus 110 ~~lvmE~l~g~ 120 (397)
T 2olc_A 110 AVTVMEDLSHL 120 (397)
T ss_dssp TEEEECCCTTS
T ss_pred cEEEEEeCCCc
Confidence 46899999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.0002 Score=73.70 Aligned_cols=42 Identities=24% Similarity=0.288 Sum_probs=31.9
Q ss_pred HHHHHHHHHh-----------CCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 137 ILRGLHYLHS-----------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 137 Il~gL~yLHs-----------~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
+..++.+|+. ..+.++|+|+++.||+++ .++.+.|+||+.+.
T Consensus 199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLG-ENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEEC-GGGCEEECCCTTCE
T ss_pred HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEe-CCCcEEEEehhhcc
Confidence 4446666653 233599999999999996 46789999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0003 Score=73.58 Aligned_cols=85 Identities=6% Similarity=-0.170 Sum_probs=53.6
Q ss_pred EEEEEEE-eecCCeEEEEEEEc--C----CCeEEEEEEeeccc---ccCCHHHHHHHHHHHHHHHhCC-C--CCcceeee
Q 006777 27 WISWVVV-LNCTFMCRYKGFDE--V----DGIEVAWNQVNIED---VMQSPDQLERLYSEVHLLKSLK-H--ENIIKFYN 93 (631)
Q Consensus 27 Y~i~e~L-G~G~fg~VY~A~d~--~----~g~~VAvK~v~~~~---~~~~~~~~~~~~~Ei~iL~~L~-H--pnIV~l~~ 93 (631)
-...+.| +.|....+|+.... . +|..+++|...... ... ...+.+|+.+|+.|. + -.+.+++.
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~----~~~~~~E~~~l~~L~~~~~vpvP~v~~ 97 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP----TYRLDHQFEVIRLVGELTDVPVPRVRW 97 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS----CCCHHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc----hhHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 3446788 88889999988643 1 26788898765432 101 123567888888774 2 35667776
Q ss_pred EEEcCC-CceEEEEEeccCCCCH
Q 006777 94 SWVDDT-NRTINMITELFTSGSL 115 (631)
Q Consensus 94 ~f~~~~-~~~l~lV~Ey~~gGsL 115 (631)
+..+.. .+..++||||++|..+
T Consensus 98 ~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 98 IETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp EECSSTTTSSCEEEEECCCCBCC
T ss_pred EccCCCccCCceEEEEecCCCCh
Confidence 543321 1346789999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0015 Score=70.28 Aligned_cols=77 Identities=8% Similarity=-0.065 Sum_probs=43.9
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccc--cCC-H--HHHHHHHHHHHHHH-hCCCCCcceeeeEEEcCCCceE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDV--MQS-P--DQLERLYSEVHLLK-SLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~--~~~-~--~~~~~~~~Ei~iL~-~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.||.|....||++.. .+..+++|+...... ... . .....+..|+..+. ......+.+++.+. . ...
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~--~~~ 112 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--R--TMA 112 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--T--TTT
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--Ccc
Confidence 67899999999999953 567899995432111 000 0 01122233333222 22334567777643 2 245
Q ss_pred EEEEecc-CC
Q 006777 104 NMITELF-TS 112 (631)
Q Consensus 104 ~lV~Ey~-~g 112 (631)
++||||+ +|
T Consensus 113 ~lv~e~l~~g 122 (420)
T 2pyw_A 113 LIGMRYLEPP 122 (420)
T ss_dssp EEEECCCCTT
T ss_pred EEEEeecCCc
Confidence 7899999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0042 Score=64.54 Aligned_cols=75 Identities=11% Similarity=-0.073 Sum_probs=56.0
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC---CCCcceeeeEEEcCCCceEEEE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK---HENIIKFYNSWVDDTNRTINMI 106 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~f~~~~~~~l~lV 106 (631)
.+.|+.|.+..+|+... .+..+++|+.... ....+..|...|+.|. ...+++++.+.... +..++|
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lv 109 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLL 109 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEE
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEE
Confidence 67899999999999874 4678888876532 2455778988888873 35677787755433 478999
Q ss_pred EeccCCCCH
Q 006777 107 TELFTSGSL 115 (631)
Q Consensus 107 ~Ey~~gGsL 115 (631)
|||++|..+
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.005 Score=62.39 Aligned_cols=79 Identities=11% Similarity=-0.075 Sum_probs=53.7
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC---CCcceeeeEEEcCCCc
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH---ENIIKFYNSWVDDTNR 101 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIV~l~~~f~~~~~~ 101 (631)
....-.+.+|.|....||+... .+|+.|++|+-..... .....+..|...|+.|.- -.+++++.. +.
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--- 84 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP----ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--- 84 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET---
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc----chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC---
Confidence 3455688999999999999986 5799999997553321 112236679988888842 234555542 22
Q ss_pred eEEEEEeccCCCC
Q 006777 102 TINMITELFTSGS 114 (631)
Q Consensus 102 ~l~lV~Ey~~gGs 114 (631)
-++||||+.++.
T Consensus 85 -~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 -RTLAMEWVDERP 96 (288)
T ss_dssp -TEEEEECCCCCC
T ss_pred -ceEEEEeecccC
Confidence 267899998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0037 Score=61.67 Aligned_cols=121 Identities=19% Similarity=0.146 Sum_probs=81.7
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCCCcccc
Q 006777 113 GSLRQYRKKH-KNVDMKAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 190 (631)
Q Consensus 113 GsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yL-Hs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~~~~~~ 190 (631)
-+|.++++.. .+++|+++|.++.|.+.+|.-+ +... -..+=+.|..|++. .+|.|-+.+ +.+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVW-RDGAVTLAP-AADD----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEE-TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEe-cCCceeccc-cccc----------c
Confidence 4799998865 5899999999999999998776 2222 12344456899998 788887764 2111 1
Q ss_pred CCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC
Q 006777 191 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV 267 (631)
Q Consensus 191 GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~ 267 (631)
....|.|||......+.+.-|||||+++|.-+--..|-. -+...++.+..||..|..
T Consensus 99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e~--------------------eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKEN--------------------EERELSPPLEQLIDHMAN 155 (229)
T ss_dssp --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCTT--------------------EEECCCHHHHHHHHHHTT
T ss_pred cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCcc--------------------cchhhCHHHHHHHHHHHh
Confidence 233566888775556678889999999999887544433 233457899999999875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0062 Score=62.11 Aligned_cols=71 Identities=7% Similarity=-0.003 Sum_probs=42.3
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEEEcCCCceEEEEEe
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~f~~~~~~~l~lV~E 108 (631)
.+.|+.|....+|+. ..+++|+...... ......+|+.+++.+..-++ .+++.. +... -++|+|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-----~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~--~~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-----EYINRANEAVAAREAAKAGVSPEVLHV--DPAT--GVMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTT--CCEEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc-----ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCC--CEEEEe
Confidence 688999999999999 3488887653210 01112357777776643233 455542 3332 257899
Q ss_pred cc-CCCCH
Q 006777 109 LF-TSGSL 115 (631)
Q Consensus 109 y~-~gGsL 115 (631)
|+ +|.+|
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0067 Score=62.66 Aligned_cols=30 Identities=23% Similarity=0.277 Sum_probs=25.1
Q ss_pred CeEecCCCCCceEEeCC---CCcEEEccccchh
Q 006777 150 PIIHRDLKCDNIFVNGN---NGEVKIGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~---~g~vKI~DFGlA~ 179 (631)
.++|||+.+.||+++.+ .+.+.|+||+.+.
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 49999999999999732 2679999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.22 E-value=0.017 Score=59.03 Aligned_cols=143 Identities=13% Similarity=0.099 Sum_probs=75.7
Q ss_pred EEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC--cceeeeEE----EcCCCc
Q 006777 28 ISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN--IIKFYNSW----VDDTNR 101 (631)
Q Consensus 28 ~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~~~f----~~~~~~ 101 (631)
.-.+.|+.|....+|+.... +| .+++|...... ..+.+..|+.+++.|...+ +.+++..- .....+
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 34677888998999998753 34 68889876421 1123456777777663212 33333210 000123
Q ss_pred eEEEEEeccCCCCH-----HHH----------HHhCCC--------CCHHHHHHHH---------------HHHHHHHHH
Q 006777 102 TINMITELFTSGSL-----RQY----------RKKHKN--------VDMKAIKNWA---------------RQILRGLHY 143 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL-----~~~----------l~~~~~--------l~e~~i~~i~---------------~QIl~gL~y 143 (631)
..+++++|++|..+ ..+ -..... .........+ ..+...+.+
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 57899999997542 111 111011 1111111100 113344555
Q ss_pred HHhC-----CCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 144 LHSH-----NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 144 LHs~-----~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
++.. .+.++|+|+.++||+++ .++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~-~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFL-GDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEe-CCceEEEecchhcc
Confidence 5532 12489999999999998 44455799999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.16 E-value=0.021 Score=58.59 Aligned_cols=77 Identities=8% Similarity=-0.090 Sum_probs=46.1
Q ss_pred EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCC--CcceeeeE---EEcCCCceEEE
Q 006777 31 VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE--NIIKFYNS---WVDDTNRTINM 105 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~---f~~~~~~~l~l 105 (631)
..|+ |....||+... .+|..+++|....... . ...+..|+.+++.|... .+++++.. ......+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~--~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC--C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 5667 88889998764 3566799998763321 1 23455677777777422 24444432 00001245678
Q ss_pred EEeccCCCC
Q 006777 106 ITELFTSGS 114 (631)
Q Consensus 106 V~Ey~~gGs 114 (631)
++++++|..
T Consensus 105 l~~~i~G~~ 113 (328)
T 1zyl_A 105 VFPSVGGRQ 113 (328)
T ss_dssp EEECCCCEE
T ss_pred EEEecCCCC
Confidence 999998743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.05 E-value=0.017 Score=62.49 Aligned_cols=74 Identities=11% Similarity=0.035 Sum_probs=48.9
Q ss_pred EEEEEeecCCeEEEEEEEcC-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEEEcCCC
Q 006777 29 SWVVVLNCTFMCRYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTN 100 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~-------~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~f~~~~~ 100 (631)
-.+.|+.|....+|++.... .+..|++|+.... .. .+.+.+|..+++.|...++ +++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHLVAESVIFTLLSERHLGPKLYGIF--SG- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT-
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC-
Confidence 46788999999999998642 2578999887321 11 1334578888888853334 5666644 22
Q ss_pred ceEEEEEeccCCCC
Q 006777 101 RTINMITELFTSGS 114 (631)
Q Consensus 101 ~~l~lV~Ey~~gGs 114 (631)
.+|+||++|.+
T Consensus 148 ---g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 ---GRLEEYIPSRP 158 (429)
T ss_dssp ---EEEECCCCEEE
T ss_pred ---CEEEEEeCCcc
Confidence 27899998633
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.88 E-value=0.057 Score=58.98 Aligned_cols=75 Identities=13% Similarity=0.038 Sum_probs=47.6
Q ss_pred EEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEEEcCCCceEEEEE
Q 006777 29 SWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~f~~~~~~~l~lV~ 107 (631)
-.+.|+.|-...+|+......+..+++|+..... ... .+ ..+|..+++.|...++ .+++..+ .+ .+|+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~---id-R~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~ 180 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEI---IN-REREKKISCILYNKNIAKKIYVFF--TN----GRIE 180 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSC---SC-HHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhh---cC-HHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEE
Confidence 3678899999999999875445889998764321 000 00 1478888988865555 5667654 22 2489
Q ss_pred eccCCCC
Q 006777 108 ELFTSGS 114 (631)
Q Consensus 108 Ey~~gGs 114 (631)
||++|.+
T Consensus 181 e~I~G~~ 187 (458)
T 2qg7_A 181 EFMDGYA 187 (458)
T ss_dssp ECCCSEE
T ss_pred EeeCCcc
Confidence 9998744
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.27 E-value=0.033 Score=59.32 Aligned_cols=139 Identities=14% Similarity=0.136 Sum_probs=80.4
Q ss_pred EEEEeecCCeEEEEEEEcC-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCc
Q 006777 30 WVVVLNCTFMCRYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR 101 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~-------~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~ 101 (631)
.+.|..|-...+|+..... ++..|++|+.... . .....+.+|..+++.|. +.-..+++..+ ++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~-- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--L---QGVDSLVLESVMFAILAERSLGPQLYGVF--PE-- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--c---chHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC--
Confidence 4677778888899987632 3578999875321 1 12334558888888874 32235666543 32
Q ss_pred eEEEEEeccCCCCHH-----------HH---HHh-C-------CCC--CHHHHHHHHHHHHH------------------
Q 006777 102 TINMITELFTSGSLR-----------QY---RKK-H-------KNV--DMKAIKNWARQILR------------------ 139 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~-----------~~---l~~-~-------~~l--~e~~i~~i~~QIl~------------------ 139 (631)
.+||||++|.+|. .+ +.+ | +.. -..++..|..|+-.
T Consensus 126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 2799999975542 11 111 1 112 24667777766532
Q ss_pred -HHHHH----HhCC--CCeEecCCCCCceEEeCC---CCcEEEccccchh
Q 006777 140 -GLHYL----HSHN--PPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAI 179 (631)
Q Consensus 140 -gL~yL----Hs~~--~~IiHrDLKp~NILl~~~---~g~vKI~DFGlA~ 179 (631)
.+..| ...+ ..++|+|+.++||+++.. .+.+.|+||..|.
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 12333 2222 238999999999999843 2689999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.23 E-value=0.022 Score=59.78 Aligned_cols=75 Identities=13% Similarity=0.063 Sum_probs=43.1
Q ss_pred EEEEEeecCCeEEEEEEEcC--------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCC-cceeeeEEEcCC
Q 006777 29 SWVVVLNCTFMCRYKGFDEV--------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHEN-IIKFYNSWVDDT 99 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~--------~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~f~~~~ 99 (631)
-.+.|+.|..-.+|+..... .+..+++|+..... ........|..+++.|...+ +.+++..+ ..
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~ 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cceecHHHHHHHHHHHHhcCCCCceEEec--CC
Confidence 35678888888999997643 13678888764321 11111346788887774333 44666543 21
Q ss_pred CceEEEEEeccCCCC
Q 006777 100 NRTINMITELFTSGS 114 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGs 114 (631)
++|+||++|..
T Consensus 110 ----~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 ----GRIEEWLYGDP 120 (369)
T ss_dssp ----EEEEECCCSEE
T ss_pred ----cEEEEEecCCc
Confidence 57899998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.65 E-value=0.15 Score=53.01 Aligned_cols=29 Identities=24% Similarity=0.413 Sum_probs=25.2
Q ss_pred CeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~-~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVG-NEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEEC-GGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEe-CCCeEEEEECCCCe
Confidence 489999999999997 56789999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=90.29 E-value=1.4 Score=47.56 Aligned_cols=138 Identities=10% Similarity=0.106 Sum_probs=81.3
Q ss_pred EEEEEeecCCeEEEEEEEcCC-------CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCC
Q 006777 29 SWVVVLNCTFMCRYKGFDEVD-------GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN 100 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~~-------g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~ 100 (631)
-.+.|..|-.-.+|+...... +..|++|+..... ...-...+|..+++.|. +.-..++++.+ ..
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-----GKFYDSKVELDVFRYLSNINIAPNIIADF--PE- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC-
Confidence 356778888889999986521 5788888754321 00111246778877774 22245566533 22
Q ss_pred ceEEEEEeccCCCCHH-----------HH---HH------h-C-------C--CCCHHHHHHHHHHHHH-----------
Q 006777 101 RTINMITELFTSGSLR-----------QY---RK------K-H-------K--NVDMKAIKNWARQILR----------- 139 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~-----------~~---l~------~-~-------~--~l~e~~i~~i~~QIl~----------- 139 (631)
++|+||++|.+|. .. +. . . . +.-...+..|..++-.
T Consensus 146 ---~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~ 222 (424)
T 3mes_A 146 ---GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDK 222 (424)
T ss_dssp ---EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCH
T ss_pred ---CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhcc
Confidence 5789999985531 11 10 0 0 1 1124556666554322
Q ss_pred --------HHHHHHh----------------------CCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 140 --------GLHYLHS----------------------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 140 --------gL~yLHs----------------------~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+.+|.. ....++|+|+.++||+ + .++.+.|+||..|.
T Consensus 223 ~~~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~-~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 223 ELYSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-Q-TQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-E-CSSCEEECCCTTCE
T ss_pred ccHHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-c-CCCcEEEEecccCC
Confidence 2233321 1123899999999999 5 67899999999874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.44 E-value=2.7 Score=44.41 Aligned_cols=29 Identities=17% Similarity=0.264 Sum_probs=24.0
Q ss_pred eEecCCCCCceEEe-----CCCCcEEEccccchh
Q 006777 151 IIHRDLKCDNIFVN-----GNNGEVKIGDLGLAI 179 (631)
Q Consensus 151 IiHrDLKp~NILl~-----~~~g~vKI~DFGlA~ 179 (631)
++|+|+.+.||++. ..++.+.++||-+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 57999999999994 245679999998874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 631 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-73 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-14 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 1e-73
Identities = 126/246 (51%), Positives = 171/246 (69%), Gaps = 5/246 (2%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD--DT 99
YKG D +EVAW ++ + + + +R E +LK L+H NI++FY+SW
Sbjct: 26 YKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ I ++TEL TSG+L+ Y K+ K + +K +++W RQIL+GL +LH+ PPIIHRDLKCD
Sbjct: 84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 143
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL 219
NIF+ G G VKIGDLGLA + + A++VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+L
Sbjct: 144 NIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCML 203
Query: 220 EMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALEL 278
EM T EYPY+EC+N AQIY++VTSG+KPAS KV P+VK+ IE CI R +L
Sbjct: 204 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
Query: 279 LKDPFL 284
L F
Sbjct: 264 LNHAFF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 9e-57
Identities = 68/254 (26%), Positives = 125/254 (49%), Gaps = 16/254 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
K + DG + W +++ + + + + L SEV+LL+ LKH NI+++Y+ +D TN
Sbjct: 21 QKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78
Query: 102 TINMITELFTSGSLRQY----RKKHKNVDMKAIKNWARQILRGLHYLHSHN---PPIIHR 154
T+ ++ E G L K+ + +D + + Q+ L H + ++HR
Sbjct: 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138
Query: 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDI 211
DLK N+F++G VK+GD GLA ++ T A++ +GTP +M+PE YNE DI
Sbjct: 139 DLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDI 197
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-AS 270
+S G + E+ P+ + ++ K+ G K + ++ + I + +
Sbjct: 198 WSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDY 255
Query: 271 LRLPALELLKDPFL 284
R E+L++P +
Sbjct: 256 HRPSVEEILENPLI 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (484), Expect = 4e-56
Identities = 75/278 (26%), Positives = 128/278 (46%), Gaps = 15/278 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y D + VA +++ QS ++ + + EV L+ L+H N I++ ++ +
Sbjct: 32 YFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT- 89
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
++ E + K + I L+GL YLHSHN +IHRD+K NI
Sbjct: 90 -AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNI 146
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMC 217
++ G VK+GD G A +M A S +GTP +MAPE+ E +Y+ VD++S G+
Sbjct: 147 LLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPAL 276
+E+ + P N + PA S + F++ C+ R +
Sbjct: 204 CIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262
Query: 277 ELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLAHSE 313
LLK F++ + P ++ D + R + V E+ NL + +
Sbjct: 263 VLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRK 300
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-54
Identities = 53/249 (21%), Positives = 112/249 (44%), Gaps = 11/249 (4%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y ++ +A + ++ +L EV + L+H NI++ Y + D T
Sbjct: 23 YLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR- 80
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ +I E G++ + +K D + + ++ L Y HS +IHRD+K +N+
Sbjct: 81 -VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 137
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 220
+ + GE+KI D G ++ ++ GT +++ PE + ++E VD++S G+ E
Sbjct: 138 LLG-SAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 196
Query: 221 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELL 279
+ + P+ E + YK+++ + + I + + S R E+L
Sbjct: 197 FLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
Query: 280 KDPFLVTDN 288
+ P++ ++
Sbjct: 254 EHPWITANS 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-52
Identities = 68/261 (26%), Positives = 123/261 (47%), Gaps = 19/261 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK ++ + A ++ +S ++LE E+ +L S H NI+K +++ + N
Sbjct: 29 YKAQNKETSVLAAAKVID----TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN- 83
Query: 102 TINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ ++ E G++ + + + I+ +Q L L+YLH + IIHRDLK N
Sbjct: 84 -LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGN 140
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY------EEEYNELVDIY 212
I +G++K+ D G++ + R S IGTP +MAPE+ + Y+ D++
Sbjct: 141 ILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199
Query: 213 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASL 271
S G+ ++EM E P++E + K S + K F++KC+
Sbjct: 200 SLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 259
Query: 272 RLPALELLKDPFLVTDNPKDL 292
R +LL+ PF+ D+ K +
Sbjct: 260 RWTTSQLLQHPFVTVDSNKPI 280
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-52
Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 23/270 (8%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y D G EVA Q+N++ + E + +E+ +++ K+ NI+ + +S++
Sbjct: 37 YTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE- 91
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ ++ E GSL + D I R+ L+ L +LHS+ +IHRD+K DNI
Sbjct: 92 -LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 147
Query: 162 FVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 218
+ +G VK+ D G I +Q +++GTP +MAPE + + Y VDI+S G+
Sbjct: 148 LLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALE 277
+EM+ E PY +Y T+G + + F+ +C+ R A E
Sbjct: 207 IEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266
Query: 278 LLKDPFLVTDNPKDLVCDPLRLPNLVPEVM 307
LL+ FL P L +L P +
Sbjct: 267 LLQHQFLKIAKP---------LSSLTPLIA 287
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 4e-51
Identities = 60/256 (23%), Positives = 112/256 (43%), Gaps = 15/256 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ V VA V+++ + P+ +++ E+ + K L HEN++KFY +
Sbjct: 22 QLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNI- 77
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ E + G L + + + + Q++ G+ YLH I HRD+K +N+
Sbjct: 78 -QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 134
Query: 162 FVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFG 215
++ +KI D GLA V ++ + GT ++APEL + + E VD++S G
Sbjct: 135 LLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 193
Query: 216 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+ + M+ E P+++ + Q Y + K D + K +V S R+
Sbjct: 194 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 253
Query: 275 ALELLKDPFLVTDNPK 290
++ KD + K
Sbjct: 254 IPDIKKDRWYNKPLKK 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 5e-51
Identities = 63/293 (21%), Positives = 119/293 (40%), Gaps = 50/293 (17%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+K + G+ +A +++E P ++ E+ +L I+ FY ++ D
Sbjct: 23 FKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE- 78
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
I++ E GSL Q KK + + + + +++GL YL + I+HRD+K NI
Sbjct: 79 -ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNI 136
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 220
VN + GE+K+ D G++ + A S +GT +M+PE L Y+ DI+S G+ ++E
Sbjct: 137 LVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 221 MVTCEYPY-----------------------------------------NECKNPAQIYK 239
M YP ++
Sbjct: 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLD 255
Query: 240 KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
+ + P S V + + F+ KC++ + R +L+ F+ + ++
Sbjct: 256 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 308
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 8e-48
Identities = 73/252 (28%), Positives = 122/252 (48%), Gaps = 24/252 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YKG +VA +N+ +P QL+ +EV +L+ +H NI+ F
Sbjct: 25 YKG---KWHGDVAVKMLNVT--APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-- 77
Query: 102 TINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ ++T+ SL + +M + + ARQ +G+ YLH+ + IIHRDLK +N
Sbjct: 78 -LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNN 134
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYEEE----YNELVDIY 212
IF++ + VKIGD GLA V + + + G+ +MAPE+ + Y+ D+Y
Sbjct: 135 IFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 213 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQVKQFIEKCIVP- 268
+FG+ + E++T + PY+ N QI V G LSKV +K+ + +C+
Sbjct: 194 AFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKK 253
Query: 269 ASLRLPALELLK 280
R ++L
Sbjct: 254 RDERPLFPQILA 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (420), Expect = 1e-46
Identities = 61/285 (21%), Positives = 118/285 (41%), Gaps = 18/285 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
++ + G A V E + E+ + L+H ++ ++++ DD
Sbjct: 43 HRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE- 97
Query: 102 TINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ MI E + G L + +H + + RQ+ +GL ++H +N +H DLK +N
Sbjct: 98 -MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPEN 154
Query: 161 IFVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 217
I + E+K+ D GL + + + + GT EF APE+ E + D++S G+
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 214
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+++ P+ +N + + V S S K FI K ++ + R+
Sbjct: 215 SYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 273
Query: 275 ALELLKDPFLVTDNP--KDLVCDPLRLPNLVPEVMNLAHSEPHPM 317
+ L+ P+L N +D R + + + P P+
Sbjct: 274 IHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPL 318
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-46
Identities = 60/249 (24%), Positives = 111/249 (44%), Gaps = 15/249 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ E A + + +++ + E ++ L H +K Y ++ DD
Sbjct: 25 VLARELATSREYAIKILEKRH-IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK- 82
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ +G L +Y +K + D + + +I+ L YLH IIHRDLK +NI
Sbjct: 83 -LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENI 139
Query: 162 FVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 216
+N + ++I D G A V+ +Q A S +GT ++++PE L E+ + D+++ G
Sbjct: 140 LLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 198
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 275
I ++V P+ N I++K+ + P+ + +EK +V A+ RL
Sbjct: 199 IIYQLVAGLPPFRA-GNEYLIFQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGC 255
Query: 276 LELLKDPFL 284
E+ L
Sbjct: 256 EEMEGYGPL 264
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 164 bits (415), Expect = 6e-46
Identities = 52/255 (20%), Positives = 102/255 (40%), Gaps = 14/255 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
++ ++ G +N P + +E+ ++ L H +I ++++ D
Sbjct: 46 HRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE- 100
Query: 102 TINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ +I E + G L + + + N+ RQ GL ++H H+ I+H D+K +N
Sbjct: 101 -MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPEN 157
Query: 161 IFVNGN-NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 217
I VKI D GLA + + T EF APE+ + E D+++ G+
Sbjct: 158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 217
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIVP-ASLRLPA 275
+++ P+ + + + P+ K FI+ + RL
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
Query: 276 LELLKDPFLVTDNPK 290
+ L+ P+L D+
Sbjct: 278 HDALEHPWLKGDHSN 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 9e-46
Identities = 52/268 (19%), Positives = 108/268 (40%), Gaps = 15/268 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
D+ VA + + + +E E+ +L +KH NI+ + + +
Sbjct: 26 ILAEDKRTQKLVAIKCIAKKALEGKEGSMEN---EIAVLHKIKHPNIVALDDIYESGGH- 81
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ +I +L + G L + + Q+L + YLH I+HRDLK +N+
Sbjct: 82 -LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENL 138
Query: 162 FVN--GNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAP-ELYEEEYNELVDIYSFGMC 217
+ ++ I D GL+ + + + GTP ++AP L ++ Y++ VD +S G+
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 198
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
++ P+ + +N A++++++ + K FI + R
Sbjct: 199 AYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT 257
Query: 275 ALELLKDPFLVTDNPKDLVCDPLRLPNL 302
+ L+ P++ D D +
Sbjct: 258 CEQALQHPWIAGDTALDKNIHQSVSEQI 285
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-43
Identities = 49/250 (19%), Positives = 106/250 (42%), Gaps = 17/250 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
++ + V ++ Q + E+ +L +H NI+ + S+
Sbjct: 22 HRCVETSSKKTYMAKFVKVKGTDQ-----VLVKKEISILNIARHRNILHLHESFESMEE- 75
Query: 102 TINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ MI E + + + ++ + I ++ Q+ L +LHSHN I H D++ +N
Sbjct: 76 -LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPEN 132
Query: 161 IFV-NGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMC 217
I + +KI + G A ++ R + PE+ APE+++ + + D++S G
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+ +++ P+ + QI + + + K + F+++ +V R+
Sbjct: 193 VYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251
Query: 275 ALELLKDPFL 284
A E L+ P+L
Sbjct: 252 ASEALQHPWL 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (395), Expect = 2e-43
Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 18/274 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ +G A + ++++ Q+E E +L + H II+ + ++ D
Sbjct: 21 HLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ- 78
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
I MI + G L +K + K +A ++ L YLHS + II+RDLK +NI
Sbjct: 79 -IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENI 135
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 220
++ NG +KI D G A + T ++ GTP+++APE + + YN+ +D +SFG+ I E
Sbjct: 136 LLD-KNGHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 193
Query: 221 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV------PASLRLP 274
M+ P+ + N + Y+K+ + + VK + + I +L+
Sbjct: 194 MLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 250
Query: 275 ALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
++ P+ + L+ + P P +
Sbjct: 251 TEDVKNHPWFKEVVWEKLLSRNIETP-YEPPIQQ 283
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (392), Expect = 2e-43
Identities = 59/260 (22%), Positives = 111/260 (42%), Gaps = 23/260 (8%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVM-----QSPDQLERLYSEVHLLKSLK-HENIIKFYNSW 95
+ + E A +++ + + E EV +L+ + H NII+ +++
Sbjct: 20 RRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 79
Query: 96 VDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
+T ++ +L G L Y + + K + R +L + LH N I+HRD
Sbjct: 80 ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRD 135
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEE-------YNE 207
LK +NI ++ ++ +K+ D G + + R V GTP ++APE+ E Y +
Sbjct: 136 LKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD--PQVKQFIEKC 265
VD++S G+ + ++ P+ + + + + SG + D VK + +
Sbjct: 195 EVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 253
Query: 266 IVP-ASLRLPALELLKDPFL 284
+V R A E L PF
Sbjct: 254 LVVQPQKRYTAEEALAHPFF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-43
Identities = 63/271 (23%), Positives = 116/271 (42%), Gaps = 15/271 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLYSEVHLLKSLKHENIIKFYNSWVDDT 99
K ++ G++ A + S E + EV +LK ++H N+I + + + T
Sbjct: 27 KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ + +I EL G L + + +++ + + +QIL G++YLHS I H DLK +
Sbjct: 87 D--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPE 142
Query: 160 NIFVNGNN---GEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELYE-EEYNELVDIYSF 214
NI + N +KI D GLA + + GTPEF+APE+ E D++S
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 202
Query: 215 GMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASL 271
G+ +++ P+ + V++ T K FI + +V
Sbjct: 203 GVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKK 261
Query: 272 RLPALELLKDPFLVTDNPKDLVCDPLRLPNL 302
R+ + L+ P++ + + + P
Sbjct: 262 RMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-42
Identities = 45/222 (20%), Positives = 97/222 (43%), Gaps = 10/222 (4%)
Query: 63 VMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITELFTSGSLRQY--RK 120
+++ + +E ++ L+H N+++ V++ + ++TE GSL Y +
Sbjct: 37 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSR 95
Query: 121 KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180
+ + ++ + + YL +N +HRDL N+ V+ + K+ D GL
Sbjct: 96 GRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKE 152
Query: 181 MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 239
T + ++ APE L E++++ D++SFG+ + E+ + +
Sbjct: 153 AS-STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 211
Query: 240 KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
+V G K + P V + ++ C A++R L+L +
Sbjct: 212 RVEKGYKMDAPDGC-PPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 54/274 (19%), Positives = 123/274 (44%), Gaps = 19/274 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
++ G A + ++V+ + D++ +E +L++ +H + ++
Sbjct: 22 ILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR- 79
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ + E G L + + + + + + +I+ L YLHS + +++RD+K +N+
Sbjct: 80 -LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENL 136
Query: 162 FVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 218
++ +G +KI D GL + T ++ GTPE++APE+ E +Y VD + G+ +
Sbjct: 137 MLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 219 LEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV------PASLR 272
EM+ P+ ++ ++++ + + P+ K + +
Sbjct: 196 YEMMCGRLPFYN-QDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 273 LPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
A E+++ F ++ N +D+V L P P+V
Sbjct: 253 SDAKEVMEHRFFLSINWQDVVQKKLLPP-FKPQV 285
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (385), Expect = 2e-42
Identities = 52/253 (20%), Positives = 97/253 (38%), Gaps = 14/253 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ D +VA + D+ + P R E +L H I+ Y++ +T
Sbjct: 24 HLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82
Query: 102 --TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
++ E +LR + K + L++ H + IIHRD+K
Sbjct: 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPA 140
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE-EEYNELVDIYS 213
NI ++ N VK+ D G+A + +VIGT ++++PE + + D+YS
Sbjct: 141 NIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 199
Query: 214 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTDPQVKQFIEKCIVP-ASL 271
G + E++T E P+ + Y+ V P S + + + K +
Sbjct: 200 LGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 259
Query: 272 RLPALELLKDPFL 284
R ++ +
Sbjct: 260 RYQTAAEMRADLV 272
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-41
Identities = 44/250 (17%), Positives = 96/250 (38%), Gaps = 19/250 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDV--MQSPDQLERLYSEVHLLKSLK--HENIIKFYNSWVD 97
Y G D + VA V + + R+ EV LLK + +I+ + +
Sbjct: 21 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80
Query: 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+ + + L + + + + +++ Q+L + + H+ ++HRD+K
Sbjct: 81 PDSFVLIL-ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIK 137
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFG 215
+NI ++ N GE+K+ D G +++ GT + PE + ++S G
Sbjct: 138 DENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 197
Query: 216 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+ + +MV + P+ + + + + + I C+ S R
Sbjct: 198 ILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSECQHLIRWCLALRPSDRPT 248
Query: 275 ALELLKDPFL 284
E+ P++
Sbjct: 249 FEEIQNHPWM 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-41
Identities = 54/256 (21%), Positives = 106/256 (41%), Gaps = 23/256 (8%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ G+ +VA ++ + Q + +E +L+K L+H+ +++ Y +
Sbjct: 30 WMGYYN-GHTKVA-----VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-- 81
Query: 102 TINMITELFTSGSLRQYRKKHKNV--DMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
I +ITE +GSL + K + + + + A QI G+ ++ N IHRDL+
Sbjct: 82 -IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAA 138
Query: 160 NIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTPEFMAP-ELYEEEYNELVDIYSFG 215
NI V+ + KI D GLA ++ + ++ AP + + D++SFG
Sbjct: 139 NILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197
Query: 216 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+ + E+VT ++ + + G + ++ Q + C R
Sbjct: 198 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQLMRLCWKERPEDRPT 256
Query: 275 A---LELLKDPFLVTD 287
+L+D F T+
Sbjct: 257 FDYLRSVLEDFFTATE 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 4e-41
Identities = 63/271 (23%), Positives = 120/271 (44%), Gaps = 16/271 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLL-KSLKHENIIKFYNSWVDDTN 100
+ + A + +DV+ D +E E +L + +H + + ++ N
Sbjct: 19 FLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 77
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
M E G L + + D+ +A +I+ GL +LHS I++RDLK DN
Sbjct: 78 LFFVM--EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDN 133
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 217
I ++ +G +KI D G+ A+ + GTP+++APE L ++YN VD +SFG+
Sbjct: 134 ILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVL 192
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPAL 276
+ EM+ + P+ ++ +++ + + + + K + K V RL
Sbjct: 193 LYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVR 249
Query: 277 -ELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
++ + P N ++L + P P+V
Sbjct: 250 GDIRQHPLFREINWEELERKEID-PPFRPKV 279
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 7e-41
Identities = 46/249 (18%), Positives = 90/249 (36%), Gaps = 16/249 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
G ++ G + + + Q SE ++ H N+I T
Sbjct: 43 CSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP- 101
Query: 102 TINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ +ITE +GSL + R+ + + R I G+ YL N +HRDL N
Sbjct: 102 -VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARN 158
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTARSV-------IGTPEFMAPELYE-EEYNELVDIY 212
I VN +N K+ D GL+ ++ T+ + APE + ++ D++
Sbjct: 159 ILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVW 217
Query: 213 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASL 271
S+G+ + E+++ + + + + Q + C +
Sbjct: 218 SYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNH 276
Query: 272 RLPALELLK 280
R +++
Sbjct: 277 RPKFGQIVN 285
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-40
Identities = 44/245 (17%), Positives = 93/245 (37%), Gaps = 18/245 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ G+ + +VA + + E E ++ L H +++ Y ++
Sbjct: 22 HLGYWL-NKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP- 74
Query: 102 TINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
I ++ E G L Y R + + + + G+ YL +IHRDL N
Sbjct: 75 -ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARN 131
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPE-LYEEEYNELVDIYSFGM 216
V N +K+ D G+ + ++ +PE Y+ D++SFG+
Sbjct: 132 CLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 190
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 275
+ E+ + E ++ +++ + +++G + ++ V Q + C R
Sbjct: 191 LMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHCWKERPEDRPAF 249
Query: 276 LELLK 280
LL+
Sbjct: 250 SRLLR 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 44/254 (17%), Positives = 99/254 (38%), Gaps = 21/254 (8%)
Query: 42 YKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99
KG+ ++ VA + E P + L +E ++++ L + I++ ++
Sbjct: 24 KKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES 81
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
++ E+ G L +Y +++++V K I Q+ G+ YL N +HRDL
Sbjct: 82 ---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAAR 136
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVDIYS 213
N+ + KI D GL+ ++ ++ APE + +++ D++S
Sbjct: 137 NVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 195
Query: 214 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLR 272
FG+ + E + +++ + G + + ++ + C R
Sbjct: 196 FGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDLMNLCWTYDVENR 254
Query: 273 LPA---LELLKDPF 283
L++ +
Sbjct: 255 PGFAAVELRLRNYY 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-40
Identities = 63/290 (21%), Positives = 112/290 (38%), Gaps = 39/290 (13%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQL-ERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100
YK D+ VA ++ + ++ D + E+ LL+ L H NII +++ +N
Sbjct: 15 YKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 74
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
I+++ + + + + IK + L+GL YLH H I+HRDLK +N
Sbjct: 75 --ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNN 130
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY--EEEYNELVDIYSFGM 216
+ ++ NG +K+ D GLA P + T + APEL Y VD+++ G
Sbjct: 131 LLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 189
Query: 217 CILEMVTCEYPY-------------------------NECKNPAQIYKKVTSGIKPASLS 251
+ E++ + C P + K GI +
Sbjct: 190 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249
Query: 252 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 300
+ I+ + R+ A + LK + ++ P +LP
Sbjct: 250 SAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRPGP--TPGCQLP 296
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-40
Identities = 61/273 (22%), Positives = 117/273 (42%), Gaps = 18/273 (6%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ + E I VA ++ SP + + E +++ S+ + ++ + +
Sbjct: 26 YKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLT 82
Query: 98 DTNRTINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
T + +IT+L G L Y ++HK N+ + + NW QI +G++YL ++HRDL
Sbjct: 83 STVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDL 137
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVIGTPEFMAPE-LYEEEYNELVDI 211
N+ V VKI D GLA ++ ++ A ++MA E + Y D+
Sbjct: 138 AARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 196
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-AS 270
+S+G+ + E++T + ++I + G + + V + KC + A
Sbjct: 197 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-PQPPICTIDVYMIMVKCWMIDAD 255
Query: 271 LRLPALELLKDP-FLVTDNPKDLVCDPLRLPNL 302
R EL+ + + D + LV +L
Sbjct: 256 SRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 146 bits (370), Expect = 2e-39
Identities = 53/273 (19%), Positives = 109/273 (39%), Gaps = 20/273 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99
Y G A ++ + + Q + L+ + I+ ++
Sbjct: 21 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80
Query: 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
++ I +L G L + +H ++ +A +I+ GL ++H+ +++RDLK
Sbjct: 81 K--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPA 136
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMC 217
NI ++ +G V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G
Sbjct: 137 NILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV------PASL 271
+ +++ P+ + K + + L P+++ +E + L
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCL 255
Query: 272 RLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 304
A E+ + PF + L + L P
Sbjct: 256 GRGAQEVKESPFF-----RSLDWQMVFLQKYPP 283
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-39
Identities = 39/255 (15%), Positives = 94/255 (36%), Gaps = 23/255 (9%)
Query: 42 YKGFDEV--DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99
+G + I+VA + + E + E ++ L + I++
Sbjct: 26 RQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC---Q 79
Query: 100 NRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKC 158
+ ++ E+ G L ++ K + + + + Q+ G+ YL N +HRDL
Sbjct: 80 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAA 137
Query: 159 DNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIY 212
N+ + N KI D GL+ + + ++ APE + +++ D++
Sbjct: 138 RNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 196
Query: 213 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLR 272
S+G+ + E ++ + ++ + G + P++ + C +
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-ECPPECPPELYALMSDCWIYKWED 255
Query: 273 LP----ALELLKDPF 283
P + ++ +
Sbjct: 256 RPDFLTVEQRMRACY 270
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 2e-38
Identities = 54/246 (21%), Positives = 98/246 (39%), Gaps = 18/246 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y+G + + VA + + ++E E ++K +KH N+++ +
Sbjct: 34 YEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88
Query: 102 TINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
I E T G+L Y + V + A QI + YL N IHRDL
Sbjct: 89 YIIT--EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAAR 144
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT---PEFMAP-ELYEEEYNELVDIYSFG 215
N V N VK+ D GL+ +M T + G ++ AP L +++ D+++FG
Sbjct: 145 NCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203
Query: 216 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+ + E+ T + +Q+Y+ + + +V + + C S R
Sbjct: 204 VLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP-EKVYELMRACWQWNPSDRPS 262
Query: 275 ALELLK 280
E+ +
Sbjct: 263 FAEIHQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-38
Identities = 60/250 (24%), Positives = 99/250 (39%), Gaps = 18/250 (7%)
Query: 42 YKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98
+G + + VA + DV+ P+ ++ EV+ + SL H N+I+ Y +
Sbjct: 25 RRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 83
Query: 99 TNRTINMITELFTSGSLRQYRKKHKN-VDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+ M+TEL GSL +KH+ + + +A Q+ G+ YL S IHRDL
Sbjct: 84 P---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLA 138
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVDI 211
N+ + VKIGD GL + Q + APE L ++ D
Sbjct: 139 ARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 197
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-AS 270
+ FG+ + EM T N +QI K+ + + + + +C
Sbjct: 198 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 257
Query: 271 LRLPALELLK 280
R + L
Sbjct: 258 DRPTFVALRD 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-38
Identities = 52/246 (21%), Positives = 99/246 (40%), Gaps = 13/246 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
++G + S E+ E ++ H +I+K ++
Sbjct: 24 HQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-- 81
Query: 102 TINMITELFTSGSLRQYR-KKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ +I EL T G LR + + ++D+ ++ +A Q+ L YL S +HRD+ N
Sbjct: 82 -VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARN 138
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPE-LYEEEYNELVDIYSFGM 216
+ V+ N VK+GD GL+ M+ T ++MAPE + + D++ FG+
Sbjct: 139 VLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 197
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 275
C+ E++ + + ++ +G + + P + + KC S R
Sbjct: 198 CMWEILMHGVKPFQGVKNNDVIGRIENGERL-PMPPNCPPTLYSLMTKCWAYDPSRRPRF 256
Query: 276 LELLKD 281
EL
Sbjct: 257 TELKAQ 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-38
Identities = 48/246 (19%), Positives = 93/246 (37%), Gaps = 18/246 (7%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
G +VA + + + + E ++ +L HE +++ Y
Sbjct: 21 KYGKWR-GQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP- 73
Query: 102 TINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
I +ITE +G L Y R+ + + + + + YL S +HRDL N
Sbjct: 74 -IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARN 130
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGTPEFMAPELYE-EEYNELVDIYSFGM 216
VN + G VK+ D GL+ + S + PE+ +++ DI++FG+
Sbjct: 131 CLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 189
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA 275
+ E+ + E ++ + + G++ + +V + C A R
Sbjct: 190 LMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMYSCWHEKADERPTF 248
Query: 276 LELLKD 281
LL +
Sbjct: 249 KILLSN 254
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (359), Expect = 3e-38
Identities = 59/274 (21%), Positives = 119/274 (43%), Gaps = 18/274 (6%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ G A ++ + + Q+E +E +L+++ ++K S+ D N
Sbjct: 58 MLVKHKESGNHYAMKILDKQK-VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NS 114
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ M+ E G + + ++ + +A QI+ YLHS + +I+RDLK +N+
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENL 172
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 220
++ G +++ D G A ++ T ++ GTPE +APE + + YN+ VD ++ G+ I E
Sbjct: 173 LID-QQGYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 221 MVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV------PASLRLP 274
M P+ P QIY+K+ SG +K + + +L+
Sbjct: 231 MAAGYPPFF-ADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287
Query: 275 ALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 308
++ + T + + + P +P+
Sbjct: 288 VNDIKNHKWFATTDWIAIYQRKVEAP-FIPKFKG 320
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 8e-38
Identities = 51/258 (19%), Positives = 99/258 (38%), Gaps = 22/258 (8%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+ G VA + + E E ++K L+HE +++ Y +
Sbjct: 34 WMGTWN-GTTRVAIKTLKPGTMSP-----EAFLQEAQVMKKLRHEKLVQLYAVV---SEE 84
Query: 102 TINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
I ++TE + GSL + + K + + + + A QI G+ Y+ N +HRDL+
Sbjct: 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAA 142
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPE-LYEEEYNELVDIYSFG 215
NI V N K+ D GLA +++ + ++ APE + D++SFG
Sbjct: 143 NILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 201
Query: 216 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 274
+ + E+ T ++ +V G + + + + +C R
Sbjct: 202 ILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHDLMCQCWRKEPEERPT 260
Query: 275 ALELLK--DPFLVTDNPK 290
L + + + P+
Sbjct: 261 FEYLQAFLEDYFTSTEPQ 278
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-37
Identities = 60/296 (20%), Positives = 106/296 (35%), Gaps = 50/296 (16%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT-- 99
+K G +VA +V +E+ + E+ +L+ LKHEN++
Sbjct: 27 FKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84
Query: 100 ----NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
+I ++ + + IK + +L GL+Y+H + I+HRD
Sbjct: 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRD 142
Query: 156 LKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPEFMAPE--LYEEEYNE 207
+K N+ + +G +K+ D GLA + + T + PE L E +Y
Sbjct: 143 MKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP 201
Query: 208 LVDIYSFGMCILEMVTCEYPYNECKNPAQIY----------------------------- 238
+D++ G + EM T Q+
Sbjct: 202 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 261
Query: 239 KKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD-NPKDL 292
K +K + V DP I+K +V + R+ + + L F +D P DL
Sbjct: 262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 317
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-37
Identities = 52/251 (20%), Positives = 97/251 (38%), Gaps = 17/251 (6%)
Query: 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVD 97
+ K + VA + + Q E ++ H NII+
Sbjct: 24 YKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80
Query: 98 DTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
I ITE +G+L ++ R+K + + R I G+ YL + N +HRDL
Sbjct: 81 YKPMMI--ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDL 136
Query: 157 KCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVD 210
NI VN +N K+ D GL+ V++ T + APE + ++ D
Sbjct: 137 AARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASD 195
Query: 211 IYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-A 269
++SFG+ + E++T + ++ K + G + + + Q + +C
Sbjct: 196 VWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC-PSAIYQLMMQCWQQER 254
Query: 270 SLRLPALELLK 280
+ R +++
Sbjct: 255 ARRPKFADIVS 265
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 8e-37
Identities = 63/311 (20%), Positives = 117/311 (37%), Gaps = 54/311 (17%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK----FYNSWVD 97
Y+ G VA +V + E+ +++ L H NI++ FY+S
Sbjct: 37 YQAKLCDSGELVAIKKVLQDK--------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88
Query: 98 DTNRTINMITELFTSG---SLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHR 154
+N++ + R Y + + + + +K + Q+ R L Y+HS I HR
Sbjct: 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHR 146
Query: 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELY--EEEYNELVDI 211
D+K N+ ++ + +K+ D G A + + S I + + APEL +Y +D+
Sbjct: 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 212 YSFGMCILEMVTCEYPYNECKNPAQIYKKVT----------------------SGIKPAS 249
+S G + E++ + + Q+ + + IK
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 250 LSKV----TDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL-- 302
+KV T P+ + + + RL LE F +L ++LPN
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-----DELRDPNVKLPNGRD 321
Query: 303 VPEVMNLAHSE 313
P + N E
Sbjct: 322 TPALFNFTTQE 332
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-36
Identities = 45/264 (17%), Positives = 101/264 (38%), Gaps = 28/264 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVH-LLKSLKHENIIKFYNSWVD--D 98
+ F++ + A + + EV ++ + +I++ + + +
Sbjct: 29 LQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRIVDVYENLYA 79
Query: 99 TNRTINMITELFTSGSLRQY--RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDL 156
+ + ++ E G L + + + + I + YLHS N I HRD+
Sbjct: 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDV 137
Query: 157 KCDNIFVN--GNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIY 212
K +N+ N +K+ D G A + + TP ++APE+ E+Y++ D++
Sbjct: 138 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 197
Query: 213 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------PASLSKVTDPQVKQFIEKCI 266
S G+ + ++ P+ + I + + I+ P +VK I +
Sbjct: 198 SLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 256
Query: 267 VP-ASLRLPALELLKDPFLVTDNP 289
+ R+ E + P+++
Sbjct: 257 KTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-36
Identities = 50/248 (20%), Positives = 98/248 (39%), Gaps = 14/248 (5%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y G + + V + + ++ + +E ++K H N++ +
Sbjct: 44 YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 103
Query: 102 TINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ ++ G LR + + + N +K + + Q+ +G+ + +HRDL N
Sbjct: 104 PL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK--FLASKKFVHRDLAARN 160
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTARS------VIGTPEFMAPE-LYEEEYNELVDIYS 213
++ VK+ D GLA M S ++MA E L +++ D++S
Sbjct: 161 CMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 219
Query: 214 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLR 272
FG+ + E++T P N I + G + DP + + + KC P A +R
Sbjct: 220 FGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP-LYEVMLKCWHPKAEMR 278
Query: 273 LPALELLK 280
EL+
Sbjct: 279 PSFSELVS 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-36
Identities = 57/272 (20%), Positives = 100/272 (36%), Gaps = 39/272 (14%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQ--LERLYSEVHLLKSL-KHENIIKFYNSWVDD 98
QV ++ + + D E L SE+ ++ L HENI+ +
Sbjct: 54 MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113
Query: 99 TNRTINMITELFTSGSLRQYRKKHKN-----------------------VDMKAIKNWAR 135
I +I E G L Y + + + + + +A
Sbjct: 114 GP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 171
Query: 136 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIG 191
Q+ +G+ +L + +HRDL N+ V + VKI D GLA + +
Sbjct: 172 QVAKGMEFLEFKS--CVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARL 228
Query: 192 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 249
++MAPE L+E Y D++S+G+ + E+ + PY A YK + +G K
Sbjct: 229 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ 288
Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
T ++ ++ C + R L
Sbjct: 289 PFYAT-EEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 8e-36
Identities = 54/259 (20%), Positives = 96/259 (37%), Gaps = 27/259 (10%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTN 100
K + DG+ + + S D E+ +L L H NII +
Sbjct: 27 LKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85
Query: 101 RTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYL 144
+ + E G+L + +K + + + ++A + RG+ YL
Sbjct: 86 --LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143
Query: 145 HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTPEFMAPE-LYE 202
IHRDL NI V N KI D GL+ + +++ +MA E L
Sbjct: 144 SQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY 200
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262
Y D++S+G+ + E+V+ A++Y+K+ G + D +V +
Sbjct: 201 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC-DDEVYDLM 259
Query: 263 EKCIVP-ASLRLPALELLK 280
+C R ++L
Sbjct: 260 RQCWREKPYERPSFAQILV 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-35
Identities = 60/275 (21%), Positives = 109/275 (39%), Gaps = 39/275 (14%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK +++ G VA ++ ++ ++ E+ LLK L H NI+K + +
Sbjct: 19 YKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK- 75
Query: 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ ++ E + + + IK++ Q+L+GL + HSH ++HRDLK N
Sbjct: 76 -LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQN 132
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY--EEEYNELVDIYSFGM 216
+ +N G +K+ D GLA P + T + APE+ + Y+ VDI+S G
Sbjct: 133 LLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191
Query: 217 CILEMVTCEYPYNECKNPAQIYKKVTSGIKP--------------------------ASL 250
EMVT + Q+++ + P + +
Sbjct: 192 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKV 251
Query: 251 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
D + + + + + R+ A L PF
Sbjct: 252 VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (334), Expect = 2e-35
Identities = 59/274 (21%), Positives = 101/274 (36%), Gaps = 39/274 (14%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
YK + G A ++ +E + E+ +LK LKH NI+K Y+
Sbjct: 19 YKAQNN-YGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR- 74
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
+ ++ E + ++ K++ Q+L G+ Y H ++HRDLK N+
Sbjct: 75 -LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNL 131
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYEEE--YNELVDIYSFGMC 217
+N GE+KI D GLA P + I T + AP++ Y+ +DI+S G
Sbjct: 132 LIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 218 ILEMVTCEYPYNECKNPAQIYK--------------------------KVTSGIKPASLS 251
EMV + Q+ + V + S
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 252 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
K D + K + + R+ A + L+ +
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 55/281 (19%), Positives = 117/281 (41%), Gaps = 24/281 (8%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHE-NIIKFYNSWVDDTN 100
K G A + ++Q E +E +L+ ++ ++ + ++ +T
Sbjct: 44 RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
+ + + G L + + + ++ + +I+ L +LH II+RD+K +N
Sbjct: 104 LHLIL--DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLEN 159
Query: 161 IFVNGNNGEVKIGDLGLAIV---MQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSF 214
I ++ +NG V + D GL+ + A GT E+MAP++ + +++ VD +S
Sbjct: 160 ILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218
Query: 215 GMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV---- 267
G+ + E++T P+ E + A+I +++ P + K I++ ++
Sbjct: 219 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPK 276
Query: 268 --PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 306
A E+ + F N DL + P P +
Sbjct: 277 KRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP-FKPVI 316
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-35
Identities = 55/275 (20%), Positives = 110/275 (40%), Gaps = 39/275 (14%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+K + VA +V ++D E+ LLK LKH+NI++ ++ D
Sbjct: 19 FKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
T+ E + + + ++D + +K++ Q+L+GL + HS N ++HRDLK N+
Sbjct: 77 TLVF--EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNL 132
Query: 162 FVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPELY--EEEYNELVDIYSFGMC 217
+N NGE+K+ + GLA P + T + P++ + Y+ +D++S G
Sbjct: 133 LIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGI---------------------------KPASL 250
E+ P + K++ + ++
Sbjct: 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251
Query: 251 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+ + ++ + R+ A E L+ P+
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 8e-35
Identities = 60/281 (21%), Positives = 103/281 (36%), Gaps = 45/281 (16%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
+D V+ + VA +++ + +R E+ +L +HENII + T
Sbjct: 25 CSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81
Query: 102 TIN--MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
+ + L + K + I + QILRGL Y+HS N ++HRDLK
Sbjct: 82 QMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPS 138
Query: 160 NIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVIGTPEFMAPELYEEE--YNELVDIY 212
N+ +N ++KI D GLA V + T + APE+ Y + +DI+
Sbjct: 139 NLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 197
Query: 213 SFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------------------- 247
S G + EM++ + Q+ + P
Sbjct: 198 SVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 257
Query: 248 ---ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
L D + ++K + R+ + L P+L
Sbjct: 258 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (330), Expect = 9e-35
Identities = 49/263 (18%), Positives = 91/263 (34%), Gaps = 30/263 (11%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
Y G D G EVA ++ + +L+ E + K ++ I W
Sbjct: 24 YLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIR-WCGAEGD 76
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
M+ EL + + +K + A Q++ + Y+HS N IHRD+K DN
Sbjct: 77 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNF 134
Query: 162 FV--NGNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYE-EEYNELV 209
+ V I D GLA + +++ GT + + + E +
Sbjct: 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194
Query: 210 DIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEK 264
D+ S G ++ + + Q Y++++ L K + ++
Sbjct: 195 DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF 254
Query: 265 CIVPASLRLP----ALELLKDPF 283
C P +L ++ F
Sbjct: 255 CRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (330), Expect = 2e-34
Identities = 50/290 (17%), Positives = 111/290 (38%), Gaps = 53/290 (18%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN 100
++ + + +V + P + +++ E+ +L++L+ NII + D +
Sbjct: 52 FEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNIITLADIVKDPVS 104
Query: 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN 160
RT ++ E + +Q ++ + I+ + +IL+ L Y HS I+HRD+K N
Sbjct: 105 RTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHN 159
Query: 161 IFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMC 217
+ ++ + ++++ D GLA + + F PEL + Y+ +D++S G
Sbjct: 160 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 219
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVT----------------------------------- 242
+ M+ + P+ + ++
Sbjct: 220 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW 279
Query: 243 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 291
+ + P+ F++K + RL A E ++ P+ KD
Sbjct: 280 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF-YTVVKD 328
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (324), Expect = 6e-34
Identities = 46/274 (16%), Positives = 84/274 (30%), Gaps = 40/274 (14%)
Query: 38 FMCRYKG-FDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
F R G VA + E S D E L+ + NI+K
Sbjct: 30 FQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCA 86
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKN------------------------VDMKAIKN 132
+ ++ E G L ++ + +
Sbjct: 87 VGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 144
Query: 133 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR----S 188
ARQ+ G+ YL +HRDL N V N VKI D GL+ + +
Sbjct: 145 IARQVAAGMAYLSERK--FVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGN 201
Query: 189 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 247
+M PE ++ Y D++++G+ + E+ + ++ V G
Sbjct: 202 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG-NI 260
Query: 248 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
+ + ++ + C + R + +
Sbjct: 261 LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 8e-34
Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 36/276 (13%)
Query: 42 YKGFD-EVDGIEVAWNQVNIEDVMQS-PDQLERLYSEVHLLKSLKHENIIKFYNSWVD-- 97
+K D + G VA +V ++ + P R + + L++ +H N+++ ++
Sbjct: 24 FKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83
Query: 98 -DTNRTINMITELFTSGSLRQY-RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRD 155
D + ++ E + V + IK+ Q+LRGL +LHSH ++HRD
Sbjct: 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRD 141
Query: 156 LKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYS 213
LK NI V ++G++K+ D GLA I Q SV+ T + APE L + Y VD++S
Sbjct: 142 LKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWS 200
Query: 214 FGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS------------------------ 249
G EM + + + Q+ K + P
Sbjct: 201 VGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 260
Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
D K + KC+ + R+ A L P+
Sbjct: 261 FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 63/280 (22%), Positives = 104/280 (37%), Gaps = 50/280 (17%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
++G G EVA + + ++ +E++ L+HENI+ F + D
Sbjct: 20 WRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 72
Query: 102 TINM--ITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS------HNPPIIH 153
+ +++ GSL Y ++ V ++ + A GL +LH P I H
Sbjct: 73 WTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 131
Query: 154 RDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYEE---- 203
RDLK NI V NG I DLGLA+ T +GT +MAPE+ ++
Sbjct: 132 RDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 204 ---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---------------- 244
E + DIY+ G+ E+ ++ Y +
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 245 ---IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 280
I S + + + +C + RL AL + K
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 70/276 (25%), Positives = 109/276 (39%), Gaps = 39/276 (14%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
D G +VA ++ QS +R Y E+ LLK ++HEN+I + + D
Sbjct: 35 CSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92
Query: 102 TINMITELFTS--GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
L G+ KH+ + I+ Q+L+GL Y+H+ HRDLK
Sbjct: 93 DDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPG 150
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMC 217
N+ VN + E+KI D GLA + T + APE+ Y + VDI+S G
Sbjct: 151 NLAVN-EDCELKILDFGLARQADSEM-TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 208
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------------------------AS 249
+ EM+T + + + Q+ + + P AS
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 284
+ P +EK +V A R+ A E L P+
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 5e-33
Identities = 63/270 (23%), Positives = 112/270 (41%), Gaps = 35/270 (12%)
Query: 38 FMCRYKGFDE---VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYN 93
+ G D+ +VA + + + L L SE+ ++K + KH+NII
Sbjct: 30 VLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLG 86
Query: 94 SWVDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQI 137
+ D + +I E + G+LR+Y + + + K + + A Q+
Sbjct: 87 ACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 144
Query: 138 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTP 193
RG+ YL S IHRDL N+ V + +KI D GLA + +
Sbjct: 145 ARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPV 201
Query: 194 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 252
++MAPE L++ Y D++SFG+ + E+ T +++K + G + S
Sbjct: 202 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN 261
Query: 253 VTDPQVKQFIEKCIVP-ASLRLPALELLKD 281
T ++ + C S R +L++D
Sbjct: 262 CT-NELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 6e-33
Identities = 49/264 (18%), Positives = 100/264 (37%), Gaps = 33/264 (12%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTN 100
Y + VA + + E L SE+ +L L H NI+ +
Sbjct: 45 YGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101
Query: 101 RTINMITELFTSGSLRQYRKKHKN------------------VDMKAIKNWARQILRGLH 142
+ITE G L + ++ ++ +D++ + +++ Q+ +G+
Sbjct: 102 --TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159
Query: 143 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV----IGTPEFMAP 198
+L S N IHRDL NI + + KI D GLA ++ + V ++MAP
Sbjct: 160 FLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
Query: 199 E-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257
E ++ Y D++S+G+ + E+ + + K+ + +
Sbjct: 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE 276
Query: 258 VKQFIEKCIVP-ASLRLPALELLK 280
+ ++ C R ++++
Sbjct: 277 MYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (313), Expect = 2e-32
Identities = 33/243 (13%), Positives = 86/243 (35%), Gaps = 28/243 (11%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
++G + ++ +VA + E QL Y LL + ++
Sbjct: 22 FEGTNLLNNQQVA---IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF----GQEGL 74
Query: 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161
++ +L + +K + A+Q+L + +H + +++RD+K DN
Sbjct: 75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNF 132
Query: 162 FVN----GNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPELYE-EEYNE 207
+ N + + D G+ + P +++ GT +M+ + E +
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192
Query: 208 LVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTSGIKPASLSKVTD---PQVKQFI 262
D+ + G + + + + Q Y+++ + L ++ + +++
Sbjct: 193 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 252
Query: 263 EKC 265
Sbjct: 253 HYA 255
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-31
Identities = 47/257 (18%), Positives = 97/257 (37%), Gaps = 24/257 (9%)
Query: 42 YKGFDEVDGIEVAWNQVNIE--DVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT 99
Y+G + + +V I+ + S + +E ++K ++++
Sbjct: 37 YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96
Query: 100 NRTINMITELFTSGSLRQYRKKHKNV----------DMKAIKNWARQILRGLHYLHSHNP 149
+I EL T G L+ Y + + + + A +I G+ YL+++
Sbjct: 97 P--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK- 153
Query: 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EE 204
+HRDL N V + VKIGD G+ + + + +M+PE +
Sbjct: 154 -FVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 211
Query: 205 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK 264
+ D++SFG+ + E+ T + + Q+ + V G + + +
Sbjct: 212 FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC-PDMLFELMRM 270
Query: 265 CIVP-ASLRLPALELLK 280
C +R LE++
Sbjct: 271 CWQYNPKMRPSFLEIIS 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 6e-31
Identities = 54/267 (20%), Positives = 102/267 (38%), Gaps = 31/267 (11%)
Query: 38 FMCRYKGFDE-VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWV 96
G D+ VA V + + + L SE+ +L + H +
Sbjct: 30 IEADAFGIDKTATCRTVA---VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86
Query: 97 DDTNRTINMITELFTSGSLRQYRKKHKN----------------VDMKAIKNWARQILRG 140
+ +I E G+L Y + +N + ++ + ++ Q+ +G
Sbjct: 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146
Query: 141 LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFM 196
+ +L S IHRDL NI ++ VKI D GLA + + ++M
Sbjct: 147 MEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 203
Query: 197 A-PELYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254
A +++ Y D++SFG+ + E+ + PY K + +++ G + T
Sbjct: 204 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 262
Query: 255 DPQVKQFIEKCIVP-ASLRLPALELLK 280
P++ Q + C S R EL++
Sbjct: 263 TPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 1e-29
Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 41/291 (14%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101
FD G+ VA +++ QS +R Y E+ LLK +KHEN+I + + +
Sbjct: 35 CAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92
Query: 102 TI--NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159
++ G+ K + + ++ QILRGL Y+HS + IIHRDLK
Sbjct: 93 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPS 150
Query: 160 NIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMC 217
N+ VN + E+KI D GLA + T + APE+ YN+ VDI+S G
Sbjct: 151 NLAVN-EDCELKILDFGLARHTDDEM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 208
Query: 218 ILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------------------------AS 249
+ E++T + + Q+ + P A+
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 268
Query: 250 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVT-DNPKDL-VCDPL 297
+ +P +EK +V + R+ A + L + +P D V DP
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY 319
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 2e-28
Identities = 66/313 (21%), Positives = 120/313 (38%), Gaps = 60/313 (19%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--- 98
+D V VA +++ Q+ +R Y E+ L+K + H+NII N +
Sbjct: 34 CAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91
Query: 99 -TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLK 157
+ + ++ EL + + + + D + + Q+L G+ +LHS IHRDLK
Sbjct: 92 EEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAGI--IHRDLK 146
Query: 158 CDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPE-LYEEEYNELVDIYSFG 215
NI V ++ +KI D GLA + + T + APE + Y E VDI+S G
Sbjct: 147 PSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205
Query: 216 MCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---------------------------- 247
+ EMV + + Q K + P
Sbjct: 206 CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 265
Query: 248 -----------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCD 295
+ +K+ Q + + K +V + R+ + L+ P++ ++ D
Sbjct: 266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI------NVWYD 319
Query: 296 PLRLPNLVPEVMN 308
P + P++ +
Sbjct: 320 PAEVEAPPPQIYD 332
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.4 bits (228), Expect = 8e-21
Identities = 56/326 (17%), Positives = 112/326 (34%), Gaps = 77/326 (23%)
Query: 42 YKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIK----------- 90
+ D V+ VA V + V E E+ LL+ + + K
Sbjct: 30 WLAKDMVNNTHVAMKIVRGDKVYT-----EAAEDEIKLLQRVNDADNTKEDSMGANHILK 84
Query: 91 ---FYNSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH 147
+N + + + L + + +H+ + + +K ++Q+L GL Y+H
Sbjct: 85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH-R 143
Query: 148 NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPE-LYE 202
IIH D+K +N+ + + + + +A + + I T E+ +PE L
Sbjct: 144 RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG 203
Query: 203 EEYNELVDIYSFGMCILEMVTCEYPY------NECKNPAQIYKKVTSGIKPAS------- 249
+ DI+S I E++T ++ + + K+ I + + + S
Sbjct: 204 APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 263
Query: 250 --------------------------------LSKVTDPQVKQFIEKCIVP-ASLRLPAL 276
SK ++ F+ + R A
Sbjct: 264 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323
Query: 277 ELLKDPFLVTDNPKD-LVCDPLRLPN 301
L+ P+L KD L + +R+P+
Sbjct: 324 GLVNHPWL-----KDTLGMEEIRVPD 344
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.7 bits (167), Expect = 6e-14
Identities = 27/188 (14%), Positives = 54/188 (28%), Gaps = 22/188 (11%)
Query: 42 YKGFDEVDGIEVA-----WNQVNIEDVMQSPDQLE-RLYSEVHLLKSLKHENIIKFYNSW 95
+ + E E + + V + D + + + K
Sbjct: 17 FNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 75
Query: 96 VD---DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPII 152
V ++ EL K+ V ++ IL + + I+
Sbjct: 76 VPKVYAWEGNA-VLMELI-------DAKELYRVRVENPDEVLDMILEEVAKFYHRG--IV 125
Query: 153 HRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIY 212
H DL N+ V+ + I D ++ + + R ++ + Y DI
Sbjct: 126 HGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEKDIN 183
Query: 213 SFGMCILE 220
S IL+
Sbjct: 184 SAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 631 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.56 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.29 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.82 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.93 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.46 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=482.60 Aligned_cols=261 Identities=49% Similarity=0.892 Sum_probs=238.5
Q ss_pred CCCcE-EEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC--C
Q 006777 23 VSYFW-ISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD--T 99 (631)
Q Consensus 23 i~~~Y-~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~--~ 99 (631)
..++| ++.+.||+|+||+||+|.++.+|+.||+|++..... .....+++.+|+++|++|+|||||++|++|.+. .
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence 33444 788899999999999999999999999999987643 456677899999999999999999999998753 3
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
...+|+|||||++|+|.+++.+.+.+++..++.|+.||+.||+|||+++++|+||||||+|||+++.+|.+||+|||+|+
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 45789999999999999999998999999999999999999999999998899999999999997568999999999998
Q ss_pred hccCCCCccccCCCCCCCccccccccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 180 VMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 180 ~~~~~~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
........+.+|||.|||||++.+.|+.++|||||||++|||++|+.||.+..+..++++.+..+..|..++...+++++
T Consensus 164 ~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 164 LKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243 (270)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred eccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHH
Confidence 77666677889999999999999999999999999999999999999999888899999999998888878888899999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 260 QFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
+||.+||. +|.+|||+.|+|+||||+
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999998 899999999999999996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-57 Score=465.00 Aligned_cols=256 Identities=24% Similarity=0.365 Sum_probs=220.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
-++|++.+.||+|+||+||+|.++.+|+.||+|++..... .+..+++.+|+.+|++|+|||||+++++|.+++ .+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~--~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGN--IQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETT--EE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--ee
Confidence 4579999999999999999999999999999999986542 234467889999999999999999999997754 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|+|||||+||+|.+++.+.+.+++..++.+++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEE
T ss_pred EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEEC-CCCCEEEccchhheeecc
Confidence 999999999999999988889999999999999999999999999 99999999999998 789999999999976532
Q ss_pred C----CCccccCCCCCCCcccccc-cc-CccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 184 P----TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 184 ~----~~~~~~GTp~y~APE~l~~-~y-~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
. .....+||+.|||||++.+ .| +.++|||||||++|+|+||+.||....+....+..+.............+++
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHH
Confidence 2 2456789999999998865 44 6789999999999999999999987666666666666554444444567899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 236 PLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9999999998 89999999999999999753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-57 Score=462.61 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=226.2
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+++|++++|||||+++++|.+++ .+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~ 82 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT--RVY 82 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC--EEE
Confidence 47999999999999999999999999999999997653311 223466889999999999999999999987654 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+|||||++|+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCC
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceec-CCCCEeecccceeeecCCC
Confidence 99999999999999999899999999999999999999999999 99999999999998 7899999999999877666
Q ss_pred CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006777 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~ 263 (631)
.....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+.+..+..+.. .++...++++++||.
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLIS 236 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHH
Confidence 6677899999999999876 489999999999999999999999976 677778887776533 355668899999999
Q ss_pred HhcC-CCCCCCCHHHHhcCCCccC
Q 006777 264 KCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 264 kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
+||+ +|.+|||+.|+|+||||+.
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCC
Confidence 9998 8999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=456.75 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=213.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.|++.+.||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+++|++++|||||+++++|.+.....+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 3679999999999999999999999999999999987643 45667889999999999999999999999987766789
Q ss_pred EEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 104 NMITELFTSGSLRQYRKK----HKNVDMKAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~----~~~l~e~~i~~i~~QIl~gL~yLHs~~---~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
|+|||||++|+|.+++.+ .+.+++..++.|+.||+.||.|||+++ .+|+||||||+|||++ .+|.+||+|||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG 159 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFG 159 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeecc
Confidence 999999999999999864 467999999999999999999999865 2499999999999998 78999999999
Q ss_pred chhhccCC--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 177 LAIVMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 177 lA~~~~~~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
+|+..... .....+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..++...+..+..+ .++..
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~ 237 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYR 237 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTT
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCcc
Confidence 99876543 3456789999999998865 599999999999999999999999986 5677788888776544 35566
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCc
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL 284 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff 284 (631)
.++++++||.+||+ +|.+|||+.|+|+|||+
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 78999999999998 99999999999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-56 Score=461.60 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=223.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
..+|++.+.||+|+||+||+|.++.+|+.||+|++..... ...+.+.+|+.+|++++|||||+++++|.+.+ .+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~ 92 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD--EL 92 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC--EE
Confidence 4589999999999999999999999999999999986543 22466889999999999999999999998765 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|+|||||+||+|.+++.+ +.+++..++.|++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 93 ~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCS
T ss_pred EEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEEC-CCCcEeeccchhheeecc
Confidence 999999999999998876 46999999999999999999999999 99999999999997 789999999999986643
Q ss_pred C--CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 184 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
. .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+......+...+..+..+...+...++++++
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHH
T ss_pred ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHH
Confidence 3 3456789999999998865 589999999999999999999999988655555666666655555556677899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
||.+||. +|.+|||+.|+|+||||+...
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 9999998 899999999999999997543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-56 Score=468.14 Aligned_cols=258 Identities=24% Similarity=0.412 Sum_probs=218.8
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.|++.+.||+|+||+||+|.++.+|+.||+|+++... .....+++.+|+.+|++|+|||||+++++|.++. .+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--EE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EE
Confidence 568999999999999999999999999999999998653 2345578899999999999999999999997654 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
|+|||||+||+|.+++.+++.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||+|+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHH
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeEC-CCCCEEEeeCCCccccC
Confidence 9999999999999999998999999999999999999999997 58 99999999999998 78999999999998776
Q ss_pred CCCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHH-------------------------
Q 006777 183 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ------------------------- 236 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~------------------------- 236 (631)
.....+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+......
T Consensus 157 ~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 666677899999999998865 699999999999999999999999976433211
Q ss_pred ----------------HHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 237 ----------------IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 237 ----------------~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
....+.....|.......++++++||.+||+ +|.+||||.|+|+||||+..++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 1111122222222233467899999999998 9999999999999999986443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-56 Score=458.06 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=227.2
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||+||+|.++.+|+.||||++....... ....+.+.+|+++|++++|||||+++++|.++ ..+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ 84 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLY 84 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC-HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEE
Confidence 57999999999999999999999999999999998654311 23356789999999999999999999998765 4799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+|||||+||+|.+++...+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC--
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccC-CCceEEecccccceecccC
Confidence 99999999999999999999999999999999999999999999 99999999999998 7899999999999865432
Q ss_pred ----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 185 ----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 185 ----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
...+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. .++...+++++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~ 238 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKAR 238 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCCC--CCCccCCHHHH
Confidence 2345789999999998865 599999999999999999999999987 577777788776532 35566789999
Q ss_pred HHHHHhcC-CCCCCCCHHH------HhcCCCccCCCCCcccc
Q 006777 260 QFIEKCIV-PASLRLPALE------LLKDPFLVTDNPKDLVC 294 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~e------lL~hpff~~~~~~~~~~ 294 (631)
+||.+||+ +|.+|||+.| +++||||+..+|..+..
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~ 280 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 280 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence 99999998 8999999987 58999999998877643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=464.35 Aligned_cols=267 Identities=21% Similarity=0.374 Sum_probs=234.5
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+.|.++++||+|+||+||+|+++.+|+.||+|+++...... ....+++.+|+.+|++++|||||+++++|.+.+ .+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~~~ 81 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLC 81 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS--EEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc--ccc
Confidence 47999999999999999999999999999999998654321 234567889999999999999999999997654 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC-
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ- 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~- 183 (631)
+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEec-CCCCEEEeecccccccccC
Confidence 99999999999999999999999999999999999999999999 99999999999998 789999999999986533
Q ss_pred -CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 184 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 184 -~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
......+|||.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+..++++.+..+. ..++...++++++|
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dl 235 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSL 235 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCC--CCCCccCCHHHHHH
Confidence 34556899999999998864 699999999999999999999999987 67777888887764 34566789999999
Q ss_pred HHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCccccCCCCCC
Q 006777 262 IEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 262 I~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~~~l~~p 300 (631)
|.+||+ +|.+|++ +.|+++||||+..+|..+....+..|
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p 280 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred HHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCC
Confidence 999998 9999994 99999999999988877655544433
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=456.34 Aligned_cols=255 Identities=27% Similarity=0.480 Sum_probs=219.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.+.|++++.||+|+||+||+|.++.+|+.||+|+++... ....+++.+|+++|++|+|||||+++++|.+++ .+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~ 84 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NL 84 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--eE
Confidence 357999999999999999999999999999999987542 344567889999999999999999999987654 79
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+...
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNT 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECH
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeEC-CCCCEEEEechhhhccC
Confidence 999999999999999765 467999999999999999999999999 99999999999998 78999999999996543
Q ss_pred CC--CCccccCCCCCCCccccc------cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Q 006777 183 QP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKV 253 (631)
Q Consensus 183 ~~--~~~~~~GTp~y~APE~l~------~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~-p~~l~~~ 253 (631)
.. ...+.+||+.|||||++. ..|+.++|||||||++|+|+||+.||.+. +..+....+..+.. ....+..
T Consensus 162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 240 (288)
T d2jfla1 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSR 240 (288)
T ss_dssp HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHHSCCCCCSSGGG
T ss_pred CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCCCCCcccc
Confidence 22 234678999999999873 34899999999999999999999999875 44445555554433 3344556
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
.++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 241 ~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 78999999999998 899999999999999997643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-55 Score=457.91 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=224.9
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
..|++.+.||+|+||+||+|.++.+|+.||||++..... ......+.+.+|+++|++|+|||||+++++|.+.+ .+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC--EEE
Confidence 469999999999999999999999999999999986543 23455678999999999999999999999987754 799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+|||||.+|+|..++..++++++..++.+++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS-
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEC-CCCCEEEeecccccccCC-
Confidence 99999999999988888889999999999999999999999999 99999999999998 789999999999976543
Q ss_pred CCccccCCCCCCCccccc----cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 185 TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~----~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
....+||+.|||||++. +.|+.++|||||||++|||++|..||.+. +..+....+..+..+...+..+++++++
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 34678999999999874 35899999999999999999999999874 4555555666665555556678899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 261 FIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
||.+||+ +|.+|||+.|+|+||||....
T Consensus 246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 9999998 999999999999999997643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-55 Score=452.72 Aligned_cols=265 Identities=23% Similarity=0.366 Sum_probs=225.4
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC--HHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS--PDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
+.++|.+.+.||+|+||+||+|.++.+|+.||+|+++....... ....+.+.+|+.+|++|+|||||+++++|.+..
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 86 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT- 86 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-
Confidence 56789999999999999999999999999999999986543222 223577899999999999999999999987654
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC----cEEEcccc
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLG 176 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g----~vKI~DFG 176 (631)
.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+| .+||+|||
T Consensus 87 -~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~-~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 87 -DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL-DRNVPKPRIKIIDFG 162 (293)
T ss_dssp -EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CSSSSSCCEEECCCT
T ss_pred -EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEe-cCCCcccceEecchh
Confidence 79999999999999999999889999999999999999999999999 99999999999997 444 59999999
Q ss_pred chhhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--CCCCC
Q 006777 177 LAIVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSK 252 (631)
Q Consensus 177 lA~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p--~~l~~ 252 (631)
+|...... ......||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+.+..+..+... ...+.
T Consensus 163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhcC
Confidence 99766543 3456789999999999875 599999999999999999999999987 5677777777765432 22335
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCCCccc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLV 293 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~~~~~ 293 (631)
..++.+++||.+||. +|.+|||+.|+|+||||+..++...+
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-------
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHhh
Confidence 678999999999998 89999999999999999987665543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-55 Score=456.61 Aligned_cols=258 Identities=20% Similarity=0.328 Sum_probs=209.3
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.+.+.|++.+.||+|+||+||+|.++.+|+.||+|++...... ...+.+.+|+.+|++|+|||||+++++|.++ .
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~ 80 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESG--G 80 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECS--S
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence 4677899999999999999999999999999999999865432 2345688999999999999999999998765 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe--CCCCcEEEccccchh
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKI~DFGlA~ 179 (631)
.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||+. ..+|.+||+|||+|+
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeE
Confidence 79999999999999999999899999999999999999999999999 99999999999995 247899999999998
Q ss_pred hccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCc
Q 006777 180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD 255 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l~~~~~ 255 (631)
..... ...+.+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+ .+..++...+..+.. +.......+
T Consensus 159 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred EccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCCC
Confidence 66433 3456789999999998865 599999999999999999999999987 556667777766543 233445678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999998 89999999999999999763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-54 Score=455.76 Aligned_cols=267 Identities=26% Similarity=0.388 Sum_probs=233.0
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
+.|++.+.||+|+||+||+|.++.+|+.||+|+++..... .....+++.+|+.+|++++|||||+++++|.+. ..+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ 80 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIF 80 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeC--Ceee
Confidence 4699999999999999999999999999999999765321 123356788999999999999999999998765 4899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+|||||.||+|..++.....+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEc-CCCCEEEecCccceEeccc
Confidence 99999999999999999999999999999999999999999999 99999999999998 7899999999999766543
Q ss_pred CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHH
Q 006777 185 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 263 (631)
Q Consensus 185 ~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~ 263 (631)
..+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+.. .++...+++++++|.
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLS 233 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence 456789999999999875 599999999999999999999999987 667777777776633 345567899999999
Q ss_pred HhcC-CCCCCC-----CHHHHhcCCCccCCCCCccccCCCCCCC
Q 006777 264 KCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPN 301 (631)
Q Consensus 264 kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~~~l~~p~ 301 (631)
+||+ +|.+|+ |++++|+||||+..+|..+....+..|.
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~ 277 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPY 277 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSC
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCC
Confidence 9998 899886 8999999999999888776555554443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-54 Score=460.77 Aligned_cols=268 Identities=20% Similarity=0.301 Sum_probs=225.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc--CCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCce
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM--QSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRT 102 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~ 102 (631)
+.|.+.++||+|+||+||+|.++.+|+.||+|++...... .......+...++.+++.++|||||+++++|.+.+ .
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~--~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--K 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--E
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC--E
Confidence 4799999999999999999999999999999999754321 12222333445678888899999999999987654 7
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 103 INMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 103 l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+|+|||||+||+|.+++.+++.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEc-CCCcEEEeeeceeeecC
Confidence 9999999999999999999999999999999999999999999999 99999999999998 78999999999998777
Q ss_pred CCCCccccCCCCCCCccccc-c-ccCccceEeehhhHHHHHhhcCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 183 QPTARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~-~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~--~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.......+||+.|||||++. + .|+.++|||||||++|+|+||+.||.+.... ..+...+. ..+..++...++++
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPEL 236 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS--SCCCCCCSSSCHHH
T ss_pred CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCCCCHHH
Confidence 66667789999999999875 3 4899999999999999999999999764332 22222222 23445566789999
Q ss_pred HHHHHHhcC-CCCCCCC-----HHHHhcCCCccCCCCCccccCCCCC
Q 006777 259 KQFIEKCIV-PASLRLP-----ALELLKDPFLVTDNPKDLVCDPLRL 299 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpt-----a~elL~hpff~~~~~~~~~~~~l~~ 299 (631)
++||.+||+ +|.+||| |+|+|+||||+..+|..+.......
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~ 283 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 283 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCc
Confidence 999999998 9999999 8999999999998887665444433
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-54 Score=459.48 Aligned_cols=268 Identities=22% Similarity=0.340 Sum_probs=233.9
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
-++|++++.||+|+||+||+|.++.+|+.||||++...... .....+++.+|+++|+.++|||||+++++|.+.. .+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS--NL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeeccccccccc--cc
Confidence 47899999999999999999999999999999999765431 1234567889999999999999999999987654 78
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
++||||+.||+|..++.+.+.+++..++.|+.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|+....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSS
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccC-CCCCEEeeeceeeeeccc
Confidence 999999999999999999999999999999999999999999999 99999999999998 789999999999987654
Q ss_pred CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHH
Q 006777 184 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 262 (631)
Q Consensus 184 ~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI 262 (631)
. ..+.+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+...++..+..+.. .++...++++++||
T Consensus 194 ~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 194 R-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLL 269 (350)
T ss_dssp C-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHH
T ss_pred c-cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHH
Confidence 3 456789999999998865 599999999999999999999999986 577777777777643 33456789999999
Q ss_pred HHhcC-CCCCCC-----CHHHHhcCCCccCCCCCccccCCCCCCC
Q 006777 263 EKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPN 301 (631)
Q Consensus 263 ~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~~~l~~p~ 301 (631)
.+||+ +|.+|+ |+.++|+||||+..+|..+....+..|.
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~ 314 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPF 314 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred HHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCc
Confidence 99998 898884 8999999999999888776655555443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-53 Score=453.11 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=224.6
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.+-++|.+.+.||+|+||+||+|.++.+|+.||+|++.... ....+.+.+|+.+|++|+|||||+++++|.+++
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-- 96 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-- 96 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT--
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 34568999999999999999999999999999999987542 455678899999999999999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC-CCCcEEEccccchh
Q 006777 102 TINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~-~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKI~DFGlA~ 179 (631)
.+|+|||||+||+|.+++. ..+.+++..++.|+.||+.||.|||++| |+||||||+|||++. .+|.+||+|||+|+
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA 174 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhe
Confidence 7999999999999999985 4567999999999999999999999999 999999999999963 36899999999998
Q ss_pred hccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCc
Q 006777 180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD 255 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l~~~~~ 255 (631)
..... .....+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..+.+..+..+.. +.......+
T Consensus 175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 253 (350)
T d1koaa2 175 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGIS 253 (350)
T ss_dssp ECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCC
T ss_pred ecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCC
Confidence 76543 3456789999999998865 589999999999999999999999986 566677777765533 223334578
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
+++++||.+||+ +|.+|||+.|+|+||||+..++
T Consensus 254 ~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999999999998 8999999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-53 Score=450.05 Aligned_cols=257 Identities=21% Similarity=0.337 Sum_probs=223.4
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.+.+.|++.+.||+|+||+||+|.++.+|+.||+|+++... ....+.+.+|+.+|++|+|||||+++++|.++ .
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~ 99 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--Y 99 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--S
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence 45578999999999999999999999999999999987543 34456788999999999999999999998765 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC-CCCcEEEccccchh
Q 006777 102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKI~DFGlA~ 179 (631)
.+|+|||||+||+|.+++.+.+ ++++..++.|+.||+.||.|||++| |+||||||+|||++. .+|.+||+|||+|.
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccce
Confidence 7999999999999999876654 6999999999999999999999999 999999999999963 46899999999998
Q ss_pred hccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCc
Q 006777 180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD 255 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l~~~~~ 255 (631)
..... ......||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+.......+..+.. +.......+
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 256 (352)
T d1koba_ 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVS 256 (352)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred ecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCC
Confidence 76544 3456789999999998865 599999999999999999999999987 455666666665533 344455678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 257 ~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999998 89999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=447.03 Aligned_cols=264 Identities=22% Similarity=0.373 Sum_probs=226.9
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHH-hCCCCCcceeeeEEEcCCCceE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~-~L~HpnIV~l~~~f~~~~~~~l 103 (631)
++|+++++||+|+||+||+|.++.+|+.||||+++...... ....+.+..|+.++. .++|||||+++++|.+.. .+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~--~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE--NL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--EE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC--ce
Confidence 57999999999999999999999999999999998653211 123455667777654 789999999999987654 79
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 104 NMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
|+|||||++|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENML 155 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCC
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeec-CCCceeccccchhhhccc
Confidence 999999999999999999999999999999999999999999999 99999999999998 789999999999975543
Q ss_pred --CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 184 --PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 184 --~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
......+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+. ..+++..++++++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~d 232 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN--PFYPRWLEKEAKD 232 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHH
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCccCCHHHHH
Confidence 23445789999999998865 699999999999999999999999987 67778888887653 3456678999999
Q ss_pred HHHHhcC-CCCCCCCHH-HHhcCCCccCCCCCccccCCC
Q 006777 261 FIEKCIV-PASLRLPAL-ELLKDPFLVTDNPKDLVCDPL 297 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~-elL~hpff~~~~~~~~~~~~l 297 (631)
||.+||+ +|.+||++. ++++||||+..++..+....+
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~~~~~ 271 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI 271 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCS
T ss_pred HHHHhcccCCCCCcCHHHHHHhCchhccCCHHHHHhcCC
Confidence 9999998 899999996 899999999877765543333
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-52 Score=430.22 Aligned_cols=257 Identities=22% Similarity=0.352 Sum_probs=223.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCC-----HHHHHHHHHHHHHHHhCC-CCCcceeeeEEEc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQS-----PDQLERLYSEVHLLKSLK-HENIIKFYNSWVD 97 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~-----~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~ 97 (631)
.++|++.+.||+|+||+||+|.++.+|+.||+|++........ ....+++.+|+.+|++|+ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4689999999999999999999999999999999987653322 223457889999999997 9999999999875
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
+ +.+|+|||||+||+|.++++.++++++..++.|+.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+
T Consensus 82 ~--~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 N--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGF 156 (277)
T ss_dssp S--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTT
T ss_pred C--cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-CCCCeEEccchh
Confidence 4 489999999999999999999999999999999999999999999999 99999999999997 789999999999
Q ss_pred hhhccCC-CCccccCCCCCCCcccccc-------ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--C
Q 006777 178 AIVMQQP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 247 (631)
Q Consensus 178 A~~~~~~-~~~~~~GTp~y~APE~l~~-------~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p 247 (631)
++..... .....+||+.|+|||.+.+ .|+.++||||+||++|+|+||+.||.+ .+.......+..+.. +
T Consensus 157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCC
T ss_pred eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCC
Confidence 9765543 3455789999999998742 378899999999999999999999987 556666666666533 2
Q ss_pred CCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 248 ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 248 ~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.......++++++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 22334678999999999998 8999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=440.77 Aligned_cols=256 Identities=19% Similarity=0.292 Sum_probs=221.7
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.+.++|++++.||+|+||+||+|.++.+|+.||+|+++... .....+.+|+++|++++|||||+++++|.+..
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-- 74 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESME-- 74 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--
Confidence 45678999999999999999999999999999999997543 33456889999999999999999999997654
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC-CCCcEEEccccchh
Q 006777 102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAI 179 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~-~~g~vKI~DFGlA~ 179 (631)
.+|+|||||+||+|.+++..++ .+++.+++.|+.||+.||+|||++| |+||||||+|||++. ..+.+||+|||++.
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhh
Confidence 7999999999999999998765 7999999999999999999999999 999999999999973 24589999999997
Q ss_pred hccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCc
Q 006777 180 VMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTD 255 (631)
Q Consensus 180 ~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~--p~~l~~~~~ 255 (631)
..... .....+||+.|+|||.+.+ .|+.++|||||||++|+|++|..||.+ .+..+.+..+..+.. +.......+
T Consensus 153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T d1tkia_ 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCC
Confidence 66443 3456689999999998764 589999999999999999999999987 566777777766533 222234568
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 232 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999998 89999999999999999753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=433.81 Aligned_cols=253 Identities=22% Similarity=0.327 Sum_probs=205.8
Q ss_pred EEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHH-HHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEE
Q 006777 29 SWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPD-QLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~-~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~ 107 (631)
.+++||+|+||+||+|.++.+|+.||+|+++......... ..+++.+|+.+|++++|||||+++++|.+++ .+|+||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ceeehh
Confidence 4689999999999999999999999999997654322221 2356889999999999999999999986654 689999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC--C
Q 006777 108 ELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 185 (631)
Q Consensus 108 Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~--~ 185 (631)
||+.++++..+....+.+++..++.|++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+..... .
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEec-CCCccccccCccccccCCCccc
Confidence 99999888888777788999999999999999999999999 99999999999998 7899999999999765443 3
Q ss_pred CccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--CC-CCC-----------
Q 006777 186 ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IK-PAS----------- 249 (631)
Q Consensus 186 ~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~--~~-p~~----------- 249 (631)
....+||+.|+|||++. ..|+.++|||||||++|||+||..||.+..+.++ ...+... .. ...
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCCChhhccchhccchhh
Confidence 44678999999999875 3489999999999999999999999987544443 3333221 00 000
Q ss_pred ------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 250 ------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 250 ------------l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.....++++++||.+||+ +|.+||||.|+|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 012357899999999998 99999999999999999853
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=430.28 Aligned_cols=252 Identities=19% Similarity=0.319 Sum_probs=215.2
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCH--HHHHHHHHHHHHHHhCC--CCCcceeeeEEEcC
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSP--DQLERLYSEVHLLKSLK--HENIIKFYNSWVDD 98 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~--~~~~~~~~Ei~iL~~L~--HpnIV~l~~~f~~~ 98 (631)
+.++|++.++||+|+||+||+|.++.+|+.||||++......... ....++.+|+.+|++++ |||||+++++|.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 457899999999999999999999999999999999865432111 12234668999999996 89999999998765
Q ss_pred CCceEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 99 TNRTINMITELFTS-GSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 99 ~~~~l~lV~Ey~~g-GsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
+ .+++||||+.+ +++.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+++.+||+|||+
T Consensus 82 ~--~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 82 D--SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp S--EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred C--eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccc
Confidence 4 78999999976 689999998889999999999999999999999999 999999999999985668999999999
Q ss_pred hhhccCCCCccccCCCCCCCcccccc-c-cCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 178 AIVMQQPTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 178 A~~~~~~~~~~~~GTp~y~APE~l~~-~-y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
|+........+.+||+.|+|||++.+ . ++.++|||||||++|+|+||+.||.+. . .+..+ ...++...+
T Consensus 158 a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~----~i~~~--~~~~~~~~s 228 (273)
T d1xwsa_ 158 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---E----EIIRG--QVFFRQRVS 228 (273)
T ss_dssp CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H----HHHHC--CCCCSSCCC
T ss_pred ceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---h----HHhhc--ccCCCCCCC
Confidence 98776666677899999999998864 3 467899999999999999999999752 2 22232 223455678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999998 99999999999999999763
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=422.67 Aligned_cols=256 Identities=24% Similarity=0.374 Sum_probs=208.4
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||+||+|.+..+|+.||+|+++.... .....+++.+|+++|++++|||||+++++|.+.. .+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~--~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEecccccccc--cee
Confidence 589999999999999999999999999999999976532 2233567889999999999999999999997754 799
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+.++.+...... .+.+++..++.++.||+.||.|||++| ||||||||+|||++ .++.+||+|||+|+....
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGV 154 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCC
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeec-ccCcceeccCCcceeccC
Confidence 99999976544444333 457999999999999999999999999 99999999999998 789999999999987654
Q ss_pred C--CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCC----------
Q 006777 184 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---------- 249 (631)
Q Consensus 184 ~--~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~---------- 249 (631)
. .....+||+.|+|||++.. .++.++|||||||++|+|++|+.||.+......+...+.....+..
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 3 3455689999999997653 3688999999999999999999999876555554443322111100
Q ss_pred ----------------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 250 ----------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 250 ----------------l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.....++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 012346889999999998 89999999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.8e-51 Score=419.52 Aligned_cols=261 Identities=20% Similarity=0.254 Sum_probs=213.9
Q ss_pred ccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 21 SSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 21 ~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|+++.... ......+++.+|+++|+.++|||||++++++...+.
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 4567899999999999999999999999999999999986543 345667889999999999999999999999876543
Q ss_pred --ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 101 --RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 101 --~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
..+|+|||||+||+|.+++...+.+++.+++.++.||+.||+|||++| |+||||||+|||++ .++.++|+|||.+
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIA 158 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTC
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccC-ccccceeehhhhh
Confidence 468999999999999999999999999999999999999999999999 99999999999998 7899999999998
Q ss_pred hhccCC-----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-CCCC
Q 006777 179 IVMQQP-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLS 251 (631)
Q Consensus 179 ~~~~~~-----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p-~~l~ 251 (631)
...... .....+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+........+.+.....+ ....
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence 644322 2345689999999998875 59999999999999999999999998754444444555554333 3445
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCcc
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 285 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~ 285 (631)
...++++++||.+||+ +|.+||++.+.|.|+|++
T Consensus 239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 6678999999999998 899999544444566553
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=431.97 Aligned_cols=256 Identities=18% Similarity=0.270 Sum_probs=207.9
Q ss_pred ccCCCcEEEE-EEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHH-hCCCCCcceeeeEEEc-
Q 006777 21 SSVSYFWISW-VVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLK-SLKHENIIKFYNSWVD- 97 (631)
Q Consensus 21 ~~i~~~Y~i~-e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~-~L~HpnIV~l~~~f~~- 97 (631)
..+-++|.+. ++||+|+||+||+|.+..+|+.||+|+++.. ..+.+|+.++. .++|||||+++++|.+
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 3445678876 5799999999999999999999999998632 24668998865 4589999999999865
Q ss_pred -CCCceEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC--CCCcEEE
Q 006777 98 -DTNRTINMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKI 172 (631)
Q Consensus 98 -~~~~~l~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~--~~g~vKI 172 (631)
.....+|+|||||+||+|.+++.++ .++++.+++.|+.||+.||+|||++| |+||||||+|||++. ..+.+||
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEE
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccc
Confidence 3346799999999999999999875 46999999999999999999999999 999999999999973 3568999
Q ss_pred ccccchhhccC-CCCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHH---HHHHHHcCCC-
Q 006777 173 GDLGLAIVMQQ-PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYKKVTSGIK- 246 (631)
Q Consensus 173 ~DFGlA~~~~~-~~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~---~~~~i~~~~~- 246 (631)
+|||+|+.... ......+|||.|||||++.+ .|+.++|||||||++|+|+||+.||.+...... +...+..+..
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred cccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 99999976543 34456789999999999875 599999999999999999999999976433222 1122222211
Q ss_pred -CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 247 -PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 -p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
|.......++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 111112467899999999998 89999999999999999753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-50 Score=417.07 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=209.8
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|.+.++||+|+||+||+|.++ +|+.||||+++.... .....+++.+|+.+|++++|||||+++++|.+.+ .++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~ 76 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLV 76 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--cee
Confidence 58999999999999999999985 889999999976543 2233567889999999999999999999997665 688
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
++|||+.++.+..+....+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|......
T Consensus 77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIP 153 (286)
T ss_dssp EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC-
T ss_pred EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEc-CCCCEEecccccceecccC
Confidence 99999998888888887889999999999999999999999999 99999999999998 7899999999999776543
Q ss_pred C--CccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC-------------
Q 006777 185 T--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK------------- 246 (631)
Q Consensus 185 ~--~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~-~~~------------- 246 (631)
. .....|++.|+|||.+.+ .++.++|||||||++|||++|+.||.+.....++.+.... +..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 2 345579999999998753 4799999999999999999999999875444433332210 000
Q ss_pred ------------CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 247 ------------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 247 ------------p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
...+....++.+++||.+||+ +|.+|||+.|+|+||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 011223457899999999998 9999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=416.83 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=207.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCC-CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC---CCCCcceeeeEEEcC-
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVD-GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL---KHENIIKFYNSWVDD- 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~-g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~f~~~- 98 (631)
.++|++++.||+|+||+||+|.+..+ ++.||+|+++...... .....+.+|+.+|+.| +|||||+++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 46899999999999999999999765 6789999997653221 1122345677666655 899999999998642
Q ss_pred --CCceEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 99 --TNRTINMITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 99 --~~~~l~lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
....++++|||+.+|++...... .+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc-CCCCeeecch
Confidence 34578999999998877655443 456999999999999999999999999 99999999999998 7899999999
Q ss_pred cchhhccCC-CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC--C------
Q 006777 176 GLAIVMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I------ 245 (631)
Q Consensus 176 GlA~~~~~~-~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~--~------ 245 (631)
|++...... .....+||+.|+|||++. ..|+.++|||||||++|||+||..||.+.. .......+... .
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhhCCCchhcc
Confidence 998755432 345678999999999875 569999999999999999999999998754 44433333210 0
Q ss_pred -----------------CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 246 -----------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 246 -----------------~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
....+....++.+++||.+||+ +|.+||||.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 0011234567899999999998 999999999999999998643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=416.90 Aligned_cols=247 Identities=28% Similarity=0.416 Sum_probs=209.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|++.+.||+|+||+||+|... ..||||+++.... .....+.+.+|+.+|++++|||||++++++.+ ..+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~ 78 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQL 78 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEE
Confidence 467899999999999999999743 3599999876543 34567889999999999999999999997533 357
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++|||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+...
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSCC--
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEc-CCCCEEEccccceeecc
Confidence 8999999999999999765 56999999999999999999999998 99999999999998 78999999999997654
Q ss_pred CC----CCccccCCCCCCCcccccc----ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Q 006777 183 QP----TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLS 251 (631)
Q Consensus 183 ~~----~~~~~~GTp~y~APE~l~~----~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~---~l~ 251 (631)
.. ......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..+...+...+..+..++ .++
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 32 2345689999999998742 489999999999999999999999998777778877777765443 345
Q ss_pred CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 252 KVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 252 ~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
...++++++||.+||. +|.+|||+.+++++
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 5678999999999998 89999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=411.31 Aligned_cols=245 Identities=19% Similarity=0.317 Sum_probs=206.5
Q ss_pred EEEeecCCeEEEEEEEc--CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEEEEEe
Q 006777 31 VVVLNCTFMCRYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTINMITE 108 (631)
Q Consensus 31 e~LG~G~fg~VY~A~d~--~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~lV~E 108 (631)
++||+|+||+||+|.+. .+++.||||+++... .++...+++.+|+.+|++|+|||||++++++.++ .+++|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEEEEEE
Confidence 47999999999999864 456889999987543 2345567899999999999999999999988543 4689999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCCC---
Q 006777 109 LFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--- 185 (631)
Q Consensus 109 y~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~~--- 185 (631)
||++|+|.+++.+.+.+++..+..|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+......
T Consensus 88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEE
T ss_pred cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccc-ccCcccccchhhhhhcccccccc
Confidence 9999999999999999999999999999999999999999 99999999999998 78999999999997654322
Q ss_pred --CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 006777 186 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 261 (631)
Q Consensus 186 --~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~l 261 (631)
.....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+. .+..+++++++|
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~~~~~~~~l 242 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAGCPREMYDL 242 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCCHHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccCHHHHHH
Confidence 23457899999999875 468999999999999999998 8999987 56677788888775543 455678999999
Q ss_pred HHHhcC-CCCCCCCHHHH---hcCCCcc
Q 006777 262 IEKCIV-PASLRLPALEL---LKDPFLV 285 (631)
Q Consensus 262 I~kcL~-~p~~Rpta~el---L~hpff~ 285 (631)
|.+||. +|.+|||+.++ |+|+|+.
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 999998 99999999987 5676653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-50 Score=415.75 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=215.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|++.+.||+|+||+||+|.++.+|+.||||+++... ...+++.+|+++|++|+|||||+++++|.+.+ .+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~ 88 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--PF 88 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEeeCC--ee
Confidence 458999999999999999999999999999999987543 23456899999999999999999999986554 68
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++|||||++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+..
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCCTTTC
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEEC-CCCcEEEccccceeec
Confidence 8999999999999999764 56899999999999999999999999 99999999999998 7899999999999876
Q ss_pred cCCCC---ccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 182 QQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~~~---~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
..... ....||+.|+|||++. +.|+.++|||||||++|||++|..||....+..++.+.+..+..+. .+...+++
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 244 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-RPEGCPEK 244 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC-CCccchHH
Confidence 54432 2345789999999875 5699999999999999999998888877788888888887775543 45567899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 258 VKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+++||.+||. +|.+|||+.++++
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999998 9999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-49 Score=416.58 Aligned_cols=255 Identities=19% Similarity=0.309 Sum_probs=213.5
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~~~~ 101 (631)
..++|+++++||+|+||+||+|.++.+|+.||+|+++... .+++.+|+.+|+++. ||||++++++|......
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 4578999999999999999999999999999999986432 356789999999995 99999999999877667
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
.+++|||||.+|+|..+. +.+++..++.+++||+.||.|||++| |+||||||+|||++..++.+||+|||+|...
T Consensus 106 ~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp SEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred ceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceec
Confidence 899999999999997653 56999999999999999999999999 9999999999999855667999999999766
Q ss_pred cCC-CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--------------C
Q 006777 182 QQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------------G 244 (631)
Q Consensus 182 ~~~-~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~--------------~ 244 (631)
... .....+||+.|+|||.+.+ .|+.++|||||||++|+|++|..||....+.......+.. .
T Consensus 181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred cCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 543 4556789999999998754 4899999999999999999999999876654433222210 0
Q ss_pred C---------------------CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCCC
Q 006777 245 I---------------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP 289 (631)
Q Consensus 245 ~---------------------~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~~ 289 (631)
. .+.......++++++||.+||+ +|.+||||+|+|+||||++..+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0 0011112357899999999998 9999999999999999987654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=405.10 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=220.1
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++++.||+|+||+||+|.++.+|+.||||+++.... ......++.+|+.+|+.++|||||+++++|.+.. .++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--cee
Confidence 489999999999999999999999999999999986642 3456678999999999999999999999987655 788
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccCC
Q 006777 105 MITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 184 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~~ 184 (631)
+|++++.+++|..++..++.+++..++.++.|++.||+|||+++ |+||||||+|||++ .++.+||+|||.|......
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSC
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccc-cCCceeeeecchhhcccCC
Confidence 99999999999999999999999999999999999999999999 99999999999998 6889999999999766543
Q ss_pred --CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC---------------
Q 006777 185 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--------------- 245 (631)
Q Consensus 185 --~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~--------------- 245 (631)
......+++.|+|||++.. .++.++|||||||++|||++|..||....+..+....+....
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2334567889999998754 378999999999999999999999877777777666654210
Q ss_pred ------------CCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 246 ------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 246 ------------~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
.........++.+++||.+||+ +|.+||||+|+|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0111223457899999999998 9999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=418.16 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=209.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCC-----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDG-----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g-----~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
.++|++.++||+|+||+||+|.+...+ ..||+|.+.... .......+.+|+.+|+++ +|||||+++++|.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 368999999999999999999986544 379999886542 234456788999999998 89999999999876
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHK-----------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR 154 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~-----------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 154 (631)
.+ .+|+|||||++|+|.++++..+ .+++..++.++.||+.||.|||+++ |+||
T Consensus 113 ~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHR 188 (325)
T d1rjba_ 113 SG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 188 (325)
T ss_dssp SS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred CC--eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 54 6899999999999999997642 4899999999999999999999999 9999
Q ss_pred CCCCCceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCC
Q 006777 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPY 228 (631)
Q Consensus 155 DLKp~NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf 228 (631)
||||+|||++ .+|.+||+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+| |..||
T Consensus 189 DlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 189 DLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred cCchhccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 9999999998 78999999999997654432 23456899999999775 569999999999999999998 89999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 229 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 229 ~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+......+.+.+..+..+ ..+...++++++||.+||+ +|.+|||+.||++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8866666677666666544 3456678999999999998 89999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=409.72 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=214.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|++.+.||+|+||+||+|.++ ++..||||+++.... ..+.+.+|+.+|++++|||||++++++.++ .+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~ 82 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQE---PI 82 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-----CHHHHHHHHHHHHhCCCCCEeEEEeeeccC---Ce
Confidence 468999999999999999999985 688999999875432 235689999999999999999999976432 47
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKKH--KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~--~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+..
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeee-cccceeeccccceEEc
Confidence 8999999999999977543 35999999999999999999999999 99999999999998 7899999999999866
Q ss_pred cCCC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 182 QQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
.... .....||+.|||||++. +.|+.++|||||||++|||+||..|+....+..++...+..+..+. .+...+++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~ 238 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCPEE 238 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccChHH
Confidence 5432 33467899999999876 5699999999999999999997777666678888888888775554 34567899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc--CCCccC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLK--DPFLVT 286 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~--hpff~~ 286 (631)
+++||.+||. +|.+|||+.++++ |+||..
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 9999999998 8999999999988 788753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=418.59 Aligned_cols=258 Identities=28% Similarity=0.382 Sum_probs=209.8
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC---
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT--- 99 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~--- 99 (631)
+.++|++++.||+|+||+||+|.++.+|+.||||+++... ......+++.+|+++|++|+|||||+++++|....
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 6789999999999999999999999999999999997543 34566788999999999999999999999987653
Q ss_pred -CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 100 -NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 100 -~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
...+|+||||+ +++|..+.+. +++++..++.+++||+.||.|||++| |+||||||+|||++ .++.+||+|||+|
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLA 168 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred ccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcc-cccccccccccce
Confidence 23689999999 5788877654 57999999999999999999999999 99999999999998 7899999999999
Q ss_pred hhccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-------------
Q 006777 179 IVMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------- 243 (631)
Q Consensus 179 ~~~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~------------- 243 (631)
+..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+......
T Consensus 169 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 169 RQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp EECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred eccCCc-cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 766543 356789999999998754 4789999999999999999999999875433332222110
Q ss_pred ------------CCC---CCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCCC
Q 006777 244 ------------GIK---PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN 288 (631)
Q Consensus 244 ------------~~~---p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~~ 288 (631)
... ........++.+++||.+||. +|.+||||.|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000 111234468899999999998 999999999999999998643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=409.08 Aligned_cols=251 Identities=17% Similarity=0.319 Sum_probs=213.7
Q ss_pred CCcEEEEEE-EeecCCeEEEEEEEc--CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 24 SYFWISWVV-VLNCTFMCRYKGFDE--VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 ~~~Y~i~e~-LG~G~fg~VY~A~d~--~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
.++|.+.+. ||+|+||+||+|.++ .++..||||+++.. ......+++.+|+++|++++|||||++++++.++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-- 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-- 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--
Confidence 467888885 999999999999775 35668999998754 2456678899999999999999999999987543
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+|+|||||++|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 82 -~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 82 -ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSK 157 (285)
T ss_dssp -SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCE
T ss_pred -eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeec-cCCceeeccchhhh
Confidence 489999999999999998654 57999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCCC-----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 006777 180 VMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSK 252 (631)
Q Consensus 180 ~~~~~~-----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~ 252 (631)
...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+. +..++...+..+..+. .+.
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-~~~~~~~~i~~~~~~~-~p~ 235 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRME-CPP 235 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCCC-CCT
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCC
Confidence 654321 23457899999999876 569999999999999999998 89999874 4566777787776544 455
Q ss_pred CCcHHHHHHHHHhcC-CCCCCCCHHHH---hcCCCcc
Q 006777 253 VTDPQVKQFIEKCIV-PASLRLPALEL---LKDPFLV 285 (631)
Q Consensus 253 ~~~~~lk~lI~kcL~-~p~~Rpta~el---L~hpff~ 285 (631)
.+++++.+||.+||. +|.+|||+.++ |+|+|+.
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 678999999999998 89999999876 6788774
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=405.67 Aligned_cols=245 Identities=18% Similarity=0.321 Sum_probs=202.5
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.+.||+|+||+||+|.+. ++..||||+++.... ..+++.+|+++|++++|||||++++++.+++ .++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~~ 76 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PIC 76 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-----cHHHHHHHHHHHHhcCCCCcccccceeccCC--ceE
Confidence 57999999999999999999985 678899999875432 2356899999999999999999999986654 688
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+....
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC-------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeec-CCCCeEecccchheeccC
Confidence 999999999999998765 56899999999999999999999999 99999999999998 789999999999976543
Q ss_pred CC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 006777 184 PT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVK 259 (631)
Q Consensus 184 ~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk 259 (631)
.. .....||+.|+|||++. +.|+.++|||||||++|||+|+..|+....+..++...+..+..+. .+...++++.
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~ 232 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVY 232 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-CCTTSCHHHH
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC-CccccCHHHH
Confidence 32 23457899999999886 4699999999999999999996556555577888888888775543 3556789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcC
Q 006777 260 QFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 260 ~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+||.+||+ +|.+|||+.++++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999998 89999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-49 Score=410.92 Aligned_cols=248 Identities=21% Similarity=0.315 Sum_probs=201.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCe---EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGI---EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~---~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
.+.|++.++||+|+||+||+|.++.+|. .||+|.+... ......+++.+|+++|++|+|||||++++++.+..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~- 100 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST- 100 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-
Confidence 4689999999999999999999977664 6888887643 24566778999999999999999999999886544
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+++|||||++|+|.+++... +.+++.++..|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+|+
T Consensus 101 -~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 101 -PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSR 176 (299)
T ss_dssp -SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC----
T ss_pred -EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEEC-CCCcEEECCcccce
Confidence 689999999999999988874 56999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCCC-------CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 006777 180 VMQQPT-------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 180 ~~~~~~-------~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l 250 (631)
...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+. .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~-~ 254 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLP-P 254 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-C
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-C
Confidence 654321 11245799999999876 469999999999999999998 8999987 45677777887765543 3
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+...++.+++||.+||. +|.+|||+.+++++
T Consensus 255 ~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 45578999999999998 89999999998864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=416.18 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=206.9
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC----C
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD----T 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~----~ 99 (631)
...|...++||+|+||+||+|.++.+|+.||||++...... ..+|+.+|++|+|||||+++++|... +
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 44799999999999999999999999999999999765421 23699999999999999999998643 3
Q ss_pred CceEEEEEeccCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEcccc
Q 006777 100 NRTINMITELFTSGSLRQY---RKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG 176 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~---l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFG 176 (631)
..++|+|||||++|.+..+ ......+++..++.|++||+.||+|||++| |+||||||+|||++.++..+||+|||
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEeccc
Confidence 4578999999987644333 344567999999999999999999999999 99999999999998444589999999
Q ss_pred chhhccC-CCCccccCCCCCCCccccc--cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc----------
Q 006777 177 LAIVMQQ-PTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---------- 243 (631)
Q Consensus 177 lA~~~~~-~~~~~~~GTp~y~APE~l~--~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~---------- 243 (631)
++..... ....+.+||+.|+|||++. ..|+.++|||||||++|||++|+.||.......++...+..
T Consensus 169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 9976543 3355678999999999764 35899999999999999999999999875544444333211
Q ss_pred ----C----CCCC--------CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 244 ----G----IKPA--------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 244 ----~----~~p~--------~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
. ..+. ......++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0 0000 1123467899999999998 99999999999999999763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=411.55 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=208.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC----
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---- 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~---- 99 (631)
-++|.+.+.||+|+||+||+|.++.+|+.||||++..... ......++.+|+.+|++++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 4799999999999999999999999999999999876643 2234466889999999999999999999886532
Q ss_pred --CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccc
Q 006777 100 --NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL 177 (631)
Q Consensus 100 --~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGl 177 (631)
...+++||||+.++++..+......+++..++.+++||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeec-CCCcEEeeecce
Confidence 3468999999998888777666778999999999999999999999999 99999999999998 789999999999
Q ss_pred hhhccC------CCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc---CCC
Q 006777 178 AIVMQQ------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIK 246 (631)
Q Consensus 178 A~~~~~------~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~---~~~ 246 (631)
+..... ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+. +.......+.. ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSIT 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-CHHHHHHHHHHhcCCCC
Confidence 965432 12345689999999998753 5899999999999999999999999863 44443333322 111
Q ss_pred CCCCCC---------------------------CCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 247 PASLSK---------------------------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 247 p~~l~~---------------------------~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
+..... ..++.+++||.+||+ +|.+||||.|+|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 111110 126788999999998 9999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-50 Score=420.28 Aligned_cols=270 Identities=20% Similarity=0.312 Sum_probs=223.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEE---cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCcceeeeEEEcCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFD---EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDT 99 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d---~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~f~~~~ 99 (631)
-++|.++++||+|+||+||+|.+ +.+|+.||||+++...........+++.+|+.+|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 37799999999999999999998 447899999999765433333334567889999999976 89999999887654
Q ss_pred CceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 100 NRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 100 ~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+++||||+.+|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+||+++ .+|.+||+|||+|+
T Consensus 103 --~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 103 --KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSK 177 (322)
T ss_dssp --EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEE
T ss_pred --ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeec-CCCCEEEeeccchh
Confidence 79999999999999999999999999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCC---CCccccCCCCCCCcccccc---ccCccceEeehhhHHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCCCCC
Q 006777 180 VMQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASL 250 (631)
Q Consensus 180 ~~~~~---~~~~~~GTp~y~APE~l~~---~y~~~sDIwSLG~il~emltG~~Pf~~~~---~~~~~~~~i~~~~~p~~l 250 (631)
..... ...+..|++.|+|||.+.+ .++.++|||||||++|+|+||..||.+.. ....+.+..... ...+
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~--~~~~ 255 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPY 255 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CCCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC--CCCC
Confidence 55332 2345689999999998753 47889999999999999999999997643 223334433333 2334
Q ss_pred CCCCcHHHHHHHHHhcC-CCCCCC-----CHHHHhcCCCccCCCCCccccCCCCCC
Q 006777 251 SKVTDPQVKQFIEKCIV-PASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 300 (631)
Q Consensus 251 ~~~~~~~lk~lI~kcL~-~p~~Rp-----ta~elL~hpff~~~~~~~~~~~~l~~p 300 (631)
+...++++++||.+||. +|.+|| |++|+|+||||+..++..+....++.|
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p 311 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 311 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcC
Confidence 55688999999999998 899999 589999999999888776655544444
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=413.38 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=207.3
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC--
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN-- 100 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~-- 100 (631)
++.+|++++.||+|+||+||+|.++.+|+.||||+++... .....+++.+|+.+|++|+||||+++++++.....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 5678999999999999999999999999999999997543 35566789999999999999999999999865432
Q ss_pred -ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 -RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 -~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+++ ++|+.+|+|.++++.+ ++++..++.++.||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|.
T Consensus 83 ~~~~~l-~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 83 MKDVYL-VTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLAR 157 (345)
T ss_dssp CCCEEE-EEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred cceEEE-EEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEEC-CCCCEEEcccCcee
Confidence 23444 4566789999999764 6999999999999999999999999 99999999999998 78999999999996
Q ss_pred hccCC-----CCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC------
Q 006777 180 VMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------ 246 (631)
Q Consensus 180 ~~~~~-----~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~------ 246 (631)
..... .....+||+.|+|||++.. .|+.++||||+||++|+|++|..||............+.....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 54322 2345689999999998743 4789999999999999999999999875433333222211000
Q ss_pred -------------------CC---CCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 247 -------------------PA---SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 247 -------------------p~---~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
+. ......++++++||.+||+ ||.+||||.|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00 1123457899999999998 99999999999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=397.70 Aligned_cols=247 Identities=21% Similarity=0.312 Sum_probs=206.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCC----eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDG----IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g----~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..|++.++||+|+||+||+|.+..++ ..||||++.... ......++.+|+.+|++|+|||||++++++.+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~- 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK- 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC-
Confidence 46999999999999999999987654 579999986542 3556677999999999999999999999886544
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
.+++||||+.+|+|.+++... +.+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 83 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 83 -PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSR 158 (283)
T ss_dssp -SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC--
T ss_pred -ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEEC-CCCeEEEcccchhh
Confidence 689999999999999987765 67999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCCC-----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 180 VMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 180 ~~~~~~-----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
...... .....||+.|||||++.+ .|+.++|||||||++|||++|..||....+..++++.+..+..+. .+..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~ 237 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-TPMD 237 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-CCTT
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-Cchh
Confidence 654321 223468999999998764 699999999999999999998777777678888888888876654 3456
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.++.+++||.+||. +|.+|||+.|+++
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 78999999999998 8999999999987
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=397.55 Aligned_cols=244 Identities=20% Similarity=0.343 Sum_probs=211.5
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.++||+|+||+||+|.++ ++..||||+++.... ..+.+.+|+.++++++|||||++++++.++ ..++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~ 75 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIF 75 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-----CHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceE
Confidence 47888999999999999999984 788999999986542 235688999999999999999999988654 4699
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhccC
Q 006777 105 MITELFTSGSLRQYRKK-HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ 183 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~-~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~~ 183 (631)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||+++....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSS
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEc-CCCcEEECcchhheeccC
Confidence 99999999999999665 457999999999999999999999999 99999999999998 789999999999976543
Q ss_pred CC---CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHH
Q 006777 184 PT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 258 (631)
Q Consensus 184 ~~---~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~l 258 (631)
.. .....||+.|+|||++. ..|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+ ..+...++++
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l 230 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASEKV 230 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC-CCHHHHHHHHHhCCCC-CCcccccHHH
Confidence 32 23457899999999876 569999999999999999998 8999987 4567778888877544 3556788999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 259 KQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 259 k~lI~kcL~-~p~~Rpta~elL~h 281 (631)
++||.+||+ +|.+|||+.++|+|
T Consensus 231 ~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 231 YTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999998 89999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=398.13 Aligned_cols=251 Identities=21% Similarity=0.302 Sum_probs=210.4
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
.++|++.+.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|+.+|++++|||||++|+++.++ .+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~~ 86 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PI 86 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccC-----CHHHHHHHHHHHHhcccCCEeEEEEEEecC---Ce
Confidence 468999999999999999999986 456799999875432 235689999999999999999999987432 47
Q ss_pred EEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhc
Q 006777 104 NMITELFTSGSLRQYRKK--HKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 181 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~--~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~ 181 (631)
++||||+++|+|..++.. .+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|+..
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLI 163 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC--
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEEC-CCCcEEEcccchhhhc
Confidence 899999999999988754 357999999999999999999999999 99999999999998 7899999999999765
Q ss_pred cCC---CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHH
Q 006777 182 QQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ 257 (631)
Q Consensus 182 ~~~---~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~ 257 (631)
... ......||+.|+|||++. +.++.++|||||||++|||+||..||.......++...+..+..+. .+...+++
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 242 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPES 242 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHH
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCHH
Confidence 432 223467899999999875 5699999999999999999998777777678888888888775544 45667899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc--CCCccCC
Q 006777 258 VKQFIEKCIV-PASLRLPALELLK--DPFLVTD 287 (631)
Q Consensus 258 lk~lI~kcL~-~p~~Rpta~elL~--hpff~~~ 287 (631)
+++||.+||+ +|.+||++.+++. ++||...
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999998 9999999999988 8888653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=395.55 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=201.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCC---CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVD---GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~---g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
.++|++.+.||+|+||.||+|.+..+ +..||+|.++.. ......+.+.+|+.+|++++|||||++++++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 46899999999999999999998654 457888887543 245567789999999999999999999998743
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||+|+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~-~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSR 156 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC-----
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeec-CCCcEEEccchhhe
Confidence 3589999999999999987654 57999999999999999999999999 99999999999998 78999999999997
Q ss_pred hccCC---CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 006777 180 VMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVT 254 (631)
Q Consensus 180 ~~~~~---~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~ 254 (631)
..... ......||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+ .+..+++..+..+..+. ++...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~ 234 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPNC 234 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CCTTC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCC
Confidence 65432 233457899999999886 569999999999999999998 8888876 56667777787775543 45667
Q ss_pred cHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 255 DPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 255 ~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
++.+++||.+||. +|.+|||+.||++|
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 8999999999998 89999999999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=398.61 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=203.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcC-----CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEV-----DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~-----~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
.++|++.+.||+|+||.||+|.+.. +++.||+|+++... .....+.+.+|+.++.++ +|||||.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 4689999999999999999999754 45789999987442 345566788888888776 78999999998765
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCce
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI 161 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NI 161 (631)
.+ ..+++|||||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 89 ~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NI 165 (299)
T d1ywna1 89 PG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNI 165 (299)
T ss_dssp TT-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred CC-CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccce
Confidence 43 4689999999999999999753 24899999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhc-CCCCCCCCCHH
Q 006777 162 FVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTC-EYPYNECKNPA 235 (631)
Q Consensus 162 Ll~~~~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG-~~Pf~~~~~~~ 235 (631)
|++ .+|.+||+|||+|+..... ......||+.|||||++.+ .|+.++|||||||++|||+|| ..||.+.....
T Consensus 166 Ll~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 166 LLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eEC-CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 998 7899999999999765432 2345689999999998764 589999999999999999997 46787766677
Q ss_pred HHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 236 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 236 ~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.+...+..+..+. .+...++++++||.+||. +|.+|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7777777776553 455678999999999998 89999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=400.96 Aligned_cols=246 Identities=25% Similarity=0.407 Sum_probs=204.1
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCe----EEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGI----EVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN 100 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~----~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~ 100 (631)
..|++.++||+|+||+||+|.+..+|+ .||+|.++... +....+++.+|+.+|++++|||||++++++.+.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 469999999999999999999988876 57888775432 234456799999999999999999999998764
Q ss_pred ceEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 101 RTINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
..++++||+.+|+|.+++..+ ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~-~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAK 159 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCCSHHH
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeC-CCCCeEeeccccce
Confidence 367889999999999887764 57999999999999999999999999 99999999999998 78999999999998
Q ss_pred hccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 180 VMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 180 ~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
...... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..+..+. .+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~ 237 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPI 237 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCTT
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcc
Confidence 764322 23456899999999775 569999999999999999999 7888876 55667777787775543 3456
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.++.+++||.+||. +|.+|||+.+++.|
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 78999999999998 99999999999988
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=409.00 Aligned_cols=256 Identities=27% Similarity=0.362 Sum_probs=207.5
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCC---C
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDT---N 100 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~---~ 100 (631)
.++|++.++||+|+||+||+|.++.+|+.||||++.... .+....+++.+|+++|++|+|||||+++++|.... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 468999999999999999999999999999999997543 34566678999999999999999999999886432 2
Q ss_pred ceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 101 RTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
...++|++|+.||+|.+++.. +++++..++.+++||+.||+|||++| |+||||||+|||++ .+|.+|++|||+|..
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARH 170 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----C
T ss_pred CceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccc-ccccccccccchhcc
Confidence 234556777889999999865 56999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCCCCccccCCCCCCCcccccc--ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC-CCC----------
Q 006777 181 MQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKP---------- 247 (631)
Q Consensus 181 ~~~~~~~~~~GTp~y~APE~l~~--~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~-~~p---------- 247 (631)
... ...+..||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. .......+... ..+
T Consensus 171 ~~~-~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 171 TDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp CTG-GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred cCc-ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCChHHhhhccc
Confidence 543 2345689999999997654 36899999999999999999999998743 33333333211 000
Q ss_pred ----------CC--------CCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccCC
Q 006777 248 ----------AS--------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD 287 (631)
Q Consensus 248 ----------~~--------l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~~ 287 (631)
.. .....++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00 112457899999999998 99999999999999999863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=407.80 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=199.6
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC----
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD---- 98 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~---- 98 (631)
+..+|+++++||+|+||+||+|.++.+|+.||||++..... +....+++.+|+.+|++++|||||+++++|...
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 34679999999999999999999999999999999986542 456677899999999999999999999998754
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccch
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA 178 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA 178 (631)
....+|+|||||.++.+. .+ ...+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+|++|||++
T Consensus 93 ~~~~~~iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~~~ 166 (355)
T d2b1pa1 93 EFQDVYLVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 166 (355)
T ss_dssp TCCEEEEEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC-
T ss_pred cCceeEEEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccc-cccceeeechhhh
Confidence 236899999999865554 43 356999999999999999999999999 99999999999998 7899999999998
Q ss_pred hhccCC-CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-------------
Q 006777 179 IVMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------- 243 (631)
Q Consensus 179 ~~~~~~-~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~------------- 243 (631)
+..... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.. ......++..
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHTTS
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC-HHHHHHHHHHhccCCCHHHHHHh
Confidence 765543 3456689999999998764 58999999999999999999999998743 3333222211
Q ss_pred ---------CCCCCC------------CC------CCCcHHHHHHHHHhcC-CCCCCCCHHHHhcCCCccC
Q 006777 244 ---------GIKPAS------------LS------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT 286 (631)
Q Consensus 244 ---------~~~p~~------------l~------~~~~~~lk~lI~kcL~-~p~~Rpta~elL~hpff~~ 286 (631)
...+.. .. ...++++++||.+||. +|.+||||+|+|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 100000 00 0125678999999998 9999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-47 Score=392.54 Aligned_cols=247 Identities=19% Similarity=0.238 Sum_probs=210.2
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
+++|++.+.||+|+||+||+|.++ .++..||||+++... .....+++.+|+.+|++++||||++++++|.+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 458999999999999999999875 356899999987542 355677899999999999999999999988654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHK------------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHR 154 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~------------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHr 154 (631)
. .+++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||
T Consensus 89 ~--~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHr 164 (301)
T d1lufa_ 89 K--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR 164 (301)
T ss_dssp S--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred C--ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEee
Confidence 3 6889999999999999986532 3889999999999999999999999 9999
Q ss_pred CCCCCceEEeCCCCcEEEccccchhhccCC----CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCC-CC
Q 006777 155 DLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEY-PY 228 (631)
Q Consensus 155 DLKp~NILl~~~~g~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~-Pf 228 (631)
||||+|||++ .++.+||+|||+|+..... ...+..||+.|+|||++.+ .|+.++|||||||++|||++|.. ||
T Consensus 165 DlKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 165 DLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EEcccceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999998 6899999999999765432 2235678999999998765 69999999999999999999965 56
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 229 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 229 ~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+ .+..++...+..+..+. .+...++++.+||.+||. +|.+|||+.|+++
T Consensus 244 ~~-~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YG-MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55 67788888888876543 455678999999999998 8999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=395.42 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=207.6
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeE--EEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEcCCCc
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIE--VAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~--VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~~~~~ 101 (631)
++|++.++||+|+||+||+|.++.+|.. ||||.++... .....+.+.+|+.+|+++ +|||||++++++.+.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-- 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-- 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--
Confidence 6899999999999999999999888875 6677665322 234566799999999999 7999999999997654
Q ss_pred eEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC
Q 006777 102 TINMITELFTSGSLRQYRKKH----------------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG 165 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~ 165 (631)
.+++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~- 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG- 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc-
Confidence 799999999999999999754 56999999999999999999999999 99999999999998
Q ss_pred CCCcEEEccccchhhccCCC-CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006777 166 NNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 243 (631)
Q Consensus 166 ~~g~vKI~DFGlA~~~~~~~-~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~ 243 (631)
.++.+||+|||+|+...... .....||+.|+|||.+. +.|+.++|||||||++|||++|..|+....+..+++..+..
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 78899999999997554332 33557899999999875 56999999999999999999976544445788888888888
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 244 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 244 ~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+..+. .+...++++++||.+||. +|.+|||+.|+++|
T Consensus 242 ~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 76554 445678999999999998 89999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=388.72 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=197.3
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcC-C--CeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEV-D--GIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~-~--g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.+|++.+.||+|+||.||+|.... + +..||||+++.... ......+++.+|+.+|++++|||||++|+++.++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---
Confidence 569999999999999999998643 3 34799999876543 3345567899999999999999999999988543
Q ss_pred eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhh
Q 006777 102 TINMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 180 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~ 180 (631)
.+++||||+++|+|.+++..+ +.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~-~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRA 160 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEE
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccc-cccceeeccchhhhh
Confidence 478999999999999877654 57999999999999999999999999 99999999999998 688999999999986
Q ss_pred ccCCC-----CccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 006777 181 MQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKV 253 (631)
Q Consensus 181 ~~~~~-----~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~ 253 (631)
..... .....||+.|+|||++.+ .|+.++|||||||++|||+| |..||.+ .+..+....+.........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCccc
Confidence 54332 234567889999998864 58999999999999999998 8999987 5666666666555443345566
Q ss_pred CcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 254 TDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 254 ~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
+++.+++||.+||. +|.+|||+.+|+.
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999998 9999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=387.18 Aligned_cols=242 Identities=20% Similarity=0.351 Sum_probs=201.0
Q ss_pred CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceEE
Q 006777 25 YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTIN 104 (631)
Q Consensus 25 ~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l~ 104 (631)
++|++.++||+|+||.||+|.+ .|..||+|+++.+. ..+.+.+|+++|++++|||||++++++.+.. ..++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~ 77 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLY 77 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEE
Confidence 4699999999999999999997 48899999986432 3356889999999999999999999886543 3579
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 105 MITELFTSGSLRQYRKKHK--NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 105 lV~Ey~~gGsL~~~l~~~~--~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
+||||+++|+|.+++.+++ .+++..+..|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||+++...
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-----
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheec-CCCCEeecccccceecC
Confidence 9999999999999987643 5899999999999999999999998 99999999999998 78999999999997654
Q ss_pred CCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 006777 183 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 260 (631)
Q Consensus 183 ~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~~~lk~ 260 (631)
.. .....+|+.|+|||++. +.|+.++|||||||++|||+| |.+||.. .+..++...+..+..+. ++...++++++
T Consensus 155 ~~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~ 231 (262)
T d1byga_ 155 ST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYE 231 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHH
T ss_pred CC-CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHH
Confidence 33 34567899999999875 569999999999999999998 6777765 57778888888776655 45567899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcC
Q 006777 261 FIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 261 lI~kcL~-~p~~Rpta~elL~h 281 (631)
||.+||. +|.+|||+.+++++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHH
Confidence 9999998 89999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=385.62 Aligned_cols=247 Identities=21% Similarity=0.312 Sum_probs=205.9
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCC---eEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCceE
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDG---IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g---~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~~l 103 (631)
+.+.++||+|+||+||+|.+..++ ..||||+++.. .+....+++.+|+.+|++|+|||||++++++.+.. ..+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-Cce
Confidence 344789999999999999986543 47999998642 35677788999999999999999999999887644 478
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEEccccchhhcc
Q 006777 104 NMITELFTSGSLRQYRKKH-KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ 182 (631)
Q Consensus 104 ~lV~Ey~~gGsL~~~l~~~-~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~~~~ 182 (631)
++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMY 181 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSSGGGCCTT
T ss_pred EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeEC-CCCCEEEecccchhhcc
Confidence 9999999999999988754 45788899999999999999999999 99999999999998 78999999999997654
Q ss_pred CC------CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCc
Q 006777 183 QP------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 255 (631)
Q Consensus 183 ~~------~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~~~i~~~~~p~~l~~~~~ 255 (631)
.. ......||+.|+|||.+. +.++.++|||||||++|||+||..||....+..++...+..+..+. .+...+
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~p~~~~ 260 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCP 260 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-CCTTCC
T ss_pred ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-CcccCc
Confidence 32 122357899999999875 5699999999999999999999888887677777778888776554 455678
Q ss_pred HHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 256 PQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 256 ~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
+.+.+||.+||. +|.+||++.|+++|
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999998 89999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=385.75 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=207.1
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCC-------eEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEE
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDG-------IEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSW 95 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g-------~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f 95 (631)
.++|++++.||+|+||.||+|.+..++ ..||+|+++... .......+.+|+..+.++ +|||||+++++|
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 579999999999999999999876544 479999987542 345667888999999888 899999999998
Q ss_pred EcCCCceEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006777 96 VDDTNRTINMITELFTSGSLRQYRKKHK----------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159 (631)
Q Consensus 96 ~~~~~~~l~lV~Ey~~gGsL~~~l~~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~ 159 (631)
.++ ..+++|||||++|+|.+++...+ .+++..++.|+.||+.||+|||+++ |+||||||+
T Consensus 89 ~~~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~ 164 (299)
T d1fgka_ 89 TQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 164 (299)
T ss_dssp CSS--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred ccC--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeeccc
Confidence 754 46899999999999999997553 4899999999999999999999999 999999999
Q ss_pred ceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCC
Q 006777 160 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKN 233 (631)
Q Consensus 160 NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~ 233 (631)
|||++ .+|.+||+|||+++...... .....||+.|+|||++. +.|+.++|||||||++|||++ |..||.+ .+
T Consensus 165 NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~ 242 (299)
T d1fgka_ 165 NVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VP 242 (299)
T ss_dssp GEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CC
T ss_pred ceeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-CC
Confidence 99998 78999999999997654332 34467899999999775 579999999999999999998 6777765 67
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 234 ~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+++..+..+..+. .+...++.+++||.+||+ +|.+|||+.|+|+
T Consensus 243 ~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCC-CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 788888888775554 456678999999999998 8999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=384.66 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=209.7
Q ss_pred CCcEEEEEEEeecCCeEEEEEEE-----cCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhC-CCCCcceeeeEEEc
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFD-----EVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSL-KHENIIKFYNSWVD 97 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d-----~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~f~~ 97 (631)
.++|++.++||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+++.+ +|||||++++++.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 47999999999999999999986 3567899999997543 356667899999999999 69999999998865
Q ss_pred CCCceEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006777 98 DTNRTINMITELFTSGSLRQYRKKHK------------------NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCD 159 (631)
Q Consensus 98 ~~~~~l~lV~Ey~~gGsL~~~l~~~~------------------~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~ 159 (631)
.. .+++|||||++|+|.+++.+.. .+++..++.++.||+.||+|||+++ ++||||||+
T Consensus 99 ~~--~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~ 174 (311)
T d1t46a_ 99 GG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174 (311)
T ss_dssp SS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred CC--EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccc
Confidence 54 5899999999999999997643 5899999999999999999999999 999999999
Q ss_pred ceEEeCCCCcEEEccccchhhccCCC----CccccCCCCCCCccccc-cccCccceEeehhhHHHHHhh-cCCCCCCCCC
Q 006777 160 NIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKN 233 (631)
Q Consensus 160 NILl~~~~g~vKI~DFGlA~~~~~~~----~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emlt-G~~Pf~~~~~ 233 (631)
||+++ .++.+||+|||+++...... ....+||+.|+|||++. +.++.++|||||||++|||+| |.+||.....
T Consensus 175 NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 175 NILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99998 78999999999997654322 23467899999999876 568999999999999999999 5555655555
Q ss_pred HHHHHHHHHcCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 234 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 234 ~~~~~~~i~~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
...+.+.+..+..+. .+...++.+++||.+||. +|.+|||+.++|+
T Consensus 254 ~~~~~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 254 DSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 555666666665443 445678999999999998 8999999999886
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=384.56 Aligned_cols=247 Identities=21% Similarity=0.326 Sum_probs=210.3
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEc-----CCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcC
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDE-----VDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDD 98 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~-----~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~ 98 (631)
.++|.+.+.||+|+||+||+|.+. .++..||||+++.. ........+.+|++++++++|||||++++++..+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc---cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 479999999999999999999875 34678999998743 2455667899999999999999999999988654
Q ss_pred CCceEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCC
Q 006777 99 TNRTINMITELFTSGSLRQYRKKH----------KNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG 168 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~----------~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g 168 (631)
. .+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 96 ~--~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld-~~~ 170 (308)
T d1p4oa_ 96 Q--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDF 170 (308)
T ss_dssp S--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTC
T ss_pred C--ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeec-CCc
Confidence 4 689999999999999998643 24789999999999999999999998 99999999999998 789
Q ss_pred cEEEccccchhhccCC----CCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcC-CCCCCCCCHHHHHHHHH
Q 006777 169 EVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE-YPYNECKNPAQIYKKVT 242 (631)
Q Consensus 169 ~vKI~DFGlA~~~~~~----~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~-~Pf~~~~~~~~~~~~i~ 242 (631)
++||+|||+|+..... ......||+.|+|||.+. +.|+.++|||||||++|||+||. .||.+ .+..+.+..+.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~ 249 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVM 249 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 9999999999765432 233457899999999876 45899999999999999999985 56654 77788888887
Q ss_pred cCCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 243 SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 243 ~~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
.+..+. .+...++.++++|.+||+ +|.+|||+.++++
T Consensus 250 ~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 250 EGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 775543 345678999999999998 8999999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-44 Score=372.06 Aligned_cols=254 Identities=20% Similarity=0.226 Sum_probs=198.4
Q ss_pred cCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCCc
Q 006777 22 SVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTNR 101 (631)
Q Consensus 22 ~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~~ 101 (631)
.++++|++.+.||+|+||+||+|.+..+|+.||||++...... +++..|+++++.++|+|+|..+..+... ..
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~ 76 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAE-GD 76 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TT
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEec-CC
Confidence 3567899999999999999999999999999999998765321 2477899999999888776665554433 34
Q ss_pred eEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEe--CCCCcEEEccccch
Q 006777 102 TINMITELFTSGSLRQYRK-KHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA 178 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~-~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~--~~~g~vKI~DFGlA 178 (631)
..++||||+. |+|.+++. ..+.+++..+..++.||+.||+|||++| |+||||||+|||++ +.+..+||+|||+|
T Consensus 77 ~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 77 YNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcc
Confidence 7889999995 56655554 4567999999999999999999999999 99999999999985 23457999999999
Q ss_pred hhccCC---------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCCCHHHHH--HHHHc---
Q 006777 179 IVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY--KKVTS--- 243 (631)
Q Consensus 179 ~~~~~~---------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~~~~~~~--~~i~~--- 243 (631)
+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||..||.......... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 765432 1245689999999998865 59999999999999999999999998644332221 11111
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHH---HHhcCCCcc
Q 006777 244 GIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL---ELLKDPFLV 285 (631)
Q Consensus 244 ~~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~---elL~hpff~ 285 (631)
...+..+....++++.+||.+||. +|.+||++. ++|+|+|.+
T Consensus 234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 112223345578999999999997 999999987 557777654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=373.14 Aligned_cols=249 Identities=25% Similarity=0.331 Sum_probs=193.9
Q ss_pred CCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCcceeeeEEEcCCC--c
Q 006777 24 SYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENIIKFYNSWVDDTN--R 101 (631)
Q Consensus 24 ~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~f~~~~~--~ 101 (631)
...|.+.+.||+|+||+||+|.. +|+.||||+++.+. ........|+..+++++|||||++++++.++.. .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 35799999999999999999985 69999999986442 222223346666678899999999999986553 3
Q ss_pred eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEecCCCCCceEEeCCCCcEEEccc
Q 006777 102 TINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDL 175 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~------~~~IiHrDLKp~NILl~~~~g~vKI~DF 175 (631)
.+++|||||++|+|.+++++. .+++..+..++.|++.||.|||+. .++|+||||||+|||++ .+|.+||+||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DF 152 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADL 152 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCC
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEec
Confidence 689999999999999999875 599999999999999999999974 12499999999999998 7899999999
Q ss_pred cchhhccCC------CCccccCCCCCCCcccccc-------ccCccceEeehhhHHHHHhhcCCCCCCC-----------
Q 006777 176 GLAIVMQQP------TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNEC----------- 231 (631)
Q Consensus 176 GlA~~~~~~------~~~~~~GTp~y~APE~l~~-------~y~~~sDIwSLG~il~emltG~~Pf~~~----------- 231 (631)
|++...... .....+||+.|||||++.+ .++.++|||||||++|||+||..||...
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 999765432 2235689999999998864 2678999999999999999998776321
Q ss_pred ---CCHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006777 232 ---KNPAQIYKKVTSGIKPASLSKV-----TDPQVKQFIEKCIV-PASLRLPALELLKD 281 (631)
Q Consensus 232 ---~~~~~~~~~i~~~~~p~~l~~~-----~~~~lk~lI~kcL~-~p~~Rpta~elL~h 281 (631)
.....+...+......+.++.. ....+.+|+.+||+ +|.+|||+.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1233444444433322222222 12458999999998 89999999998763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.3e-43 Score=360.98 Aligned_cols=247 Identities=16% Similarity=0.197 Sum_probs=201.3
Q ss_pred CCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC-CCcceeeeEEEcCCCc
Q 006777 23 VSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH-ENIIKFYNSWVDDTNR 101 (631)
Q Consensus 23 i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~f~~~~~~ 101 (631)
++.+|++.++||+|+||+||+|.+..+|+.||+|++..... ...+.+|++.++.|.| +||+.+++++.+. .
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~ 74 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--L 74 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--T
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecC--C
Confidence 56799999999999999999999999999999998865432 1236678899999965 8999999987654 4
Q ss_pred eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeC----CCCcEEEcccc
Q 006777 102 TINMITELFTSGSLRQYRKKHK-NVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDLG 176 (631)
Q Consensus 102 ~l~lV~Ey~~gGsL~~~l~~~~-~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~----~~g~vKI~DFG 176 (631)
..++||||+ +|+|.+++...+ .+++..+..++.|++.||+|||++| |+||||||+|||++. ..+.+||+|||
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccc
Confidence 789999999 689999987754 6999999999999999999999999 999999999999962 35789999999
Q ss_pred chhhccCC---------CCccccCCCCCCCcccccc-ccCccceEeehhhHHHHHhhcCCCCCCCC--CHHHHHHHHHcC
Q 006777 177 LAIVMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSG 244 (631)
Q Consensus 177 lA~~~~~~---------~~~~~~GTp~y~APE~l~~-~y~~~sDIwSLG~il~emltG~~Pf~~~~--~~~~~~~~i~~~ 244 (631)
+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||..||.+.. +....+..+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 99765322 2335689999999998865 59999999999999999999999997533 333444443322
Q ss_pred ---CCCCCCCCCCcHHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006777 245 ---IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK 280 (631)
Q Consensus 245 ---~~p~~l~~~~~~~lk~lI~kcL~-~p~~Rpta~elL~ 280 (631)
..+..+.+..++++.+++..|+. +|..||+.+.+.+
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 22223345567899999999997 9999999776543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-42 Score=365.38 Aligned_cols=260 Identities=21% Similarity=0.282 Sum_probs=197.5
Q ss_pred CccCC-CcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-----------CCC
Q 006777 20 SSSVS-YFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-----------HEN 87 (631)
Q Consensus 20 ~~~i~-~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-----------Hpn 87 (631)
+..+. ++|+++++||+|+||+||+|.++.+|+.||||+++.+ ....+.+.+|+++++.++ |||
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 44433 4699999999999999999999999999999999754 234456778999888875 578
Q ss_pred cceeeeEEEcCCCceEEEEEeccCCCCH-HHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCceEE
Q 006777 88 IIKFYNSWVDDTNRTINMITELFTSGSL-RQYR--KKHKNVDMKAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFV 163 (631)
Q Consensus 88 IV~l~~~f~~~~~~~l~lV~Ey~~gGsL-~~~l--~~~~~l~e~~i~~i~~QIl~gL~yLHs-~~~~IiHrDLKp~NILl 163 (631)
||+++++|........+++++++..+.. ..+. .....+++..++.+++||+.||.|||+ +| |+||||||+|||+
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll 159 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLM 159 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeee
Confidence 9999998876655567777777765443 2222 234579999999999999999999998 77 9999999999999
Q ss_pred eCCCC------cEEEccccchhhccCCCCccccCCCCCCCccccc-cccCccceEeehhhHHHHHhhcCCCCCCCCCH--
Q 006777 164 NGNNG------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP-- 234 (631)
Q Consensus 164 ~~~~g------~vKI~DFGlA~~~~~~~~~~~~GTp~y~APE~l~-~~y~~~sDIwSLG~il~emltG~~Pf~~~~~~-- 234 (631)
+ .+| .+||+|||.|..... .....+||+.|+|||++. ..|+.++||||+||++++|++|+.||......
T Consensus 160 ~-~~~~~~~~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 160 E-IVDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp E-EEETTTTEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred e-ccCcccccceeeEeeccccccccc-ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 7 333 499999999975543 345678999999999775 46999999999999999999999999753221
Q ss_pred ----HHHHHHHH--cC-------------------CCC------------------CCCCCCCcHHHHHHHHHhcC-CCC
Q 006777 235 ----AQIYKKVT--SG-------------------IKP------------------ASLSKVTDPQVKQFIEKCIV-PAS 270 (631)
Q Consensus 235 ----~~~~~~i~--~~-------------------~~p------------------~~l~~~~~~~lk~lI~kcL~-~p~ 270 (631)
..+...+. .. ..+ ..+....++++++||.+||. +|.
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence 11111100 00 000 01112235789999999998 999
Q ss_pred CCCCHHHHhcCCCccCCC
Q 006777 271 LRLPALELLKDPFLVTDN 288 (631)
Q Consensus 271 ~Rpta~elL~hpff~~~~ 288 (631)
+||||.|+|+||||+...
T Consensus 318 ~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 318 KRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TCBCHHHHHTCGGGTTCT
T ss_pred HCcCHHHHhcCcccCCCC
Confidence 999999999999998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1e-24 Score=209.79 Aligned_cols=173 Identities=15% Similarity=0.088 Sum_probs=125.4
Q ss_pred EEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc-----C-------C--HHHHHHHHHHHHHHHhCCCCCcceee
Q 006777 27 WISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM-----Q-------S--PDQLERLYSEVHLLKSLKHENIIKFY 92 (631)
Q Consensus 27 Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~-----~-------~--~~~~~~~~~Ei~iL~~L~HpnIV~l~ 92 (631)
|.+.++||+|+||+||+|.+. +|++||+|+++..... . . ........+|+.++.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 578999999999999999984 7999999987642110 0 0 01123455789999999999999988
Q ss_pred eEEEcCCCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCceEEeCCCCcEEE
Q 006777 93 NSWVDDTNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI 172 (631)
Q Consensus 93 ~~f~~~~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~~~IiHrDLKp~NILl~~~~g~vKI 172 (631)
++. . .+++|||++++.+. .++...+..++.||+.||.|||++| |+||||||+|||++ + +.++|
T Consensus 81 ~~~--~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~l 143 (191)
T d1zara2 81 AWE--G----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWI 143 (191)
T ss_dssp EEE--T----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEE
T ss_pred Eec--C----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeee-C-CCEEE
Confidence 742 2 26899999986553 2556667889999999999999999 99999999999998 4 45999
Q ss_pred ccccchhhccCCCCccccCCCCCCCccccccccCccceEeehhhH
Q 006777 173 GDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC 217 (631)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~GTp~y~APE~l~~~y~~~sDIwSLG~i 217 (631)
+|||+|.....+........-.-.-.+.+.+.|+..+|+||+.--
T Consensus 144 iDFG~a~~~~~~~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 999999765444322211000000013345678999999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.04 E-value=5.4e-06 Score=80.41 Aligned_cols=146 Identities=13% Similarity=-0.007 Sum_probs=90.1
Q ss_pred CccCCCcEEEEEEEeecCCeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCC-CCCcceeeeEEEcC
Q 006777 20 SSSVSYFWISWVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLK-HENIIKFYNSWVDD 98 (631)
Q Consensus 20 ~~~i~~~Y~i~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~f~~~ 98 (631)
....-..|++.+..+.++.+.||+.. .++..+++|........ ....+.+|...++.|. +--+.+++.+..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc----chhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 33444566767665556667899885 45666788877643221 1223567888887773 33356666654433
Q ss_pred CCceEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 006777 99 TNRTINMITELFTSGSLRQYRKKHKNVDMKAIKNWARQILRGLHYLHSHN------------------------------ 148 (631)
Q Consensus 99 ~~~~l~lV~Ey~~gGsL~~~l~~~~~l~e~~i~~i~~QIl~gL~yLHs~~------------------------------ 148 (631)
+..++||++++|.++...... ......++.++...|..||+..
T Consensus 83 --~~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 83 --GWSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp --TEEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred --CceEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 478899999999887554311 1112223344444444444321
Q ss_pred ---------------------------CCeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 149 ---------------------------PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 149 ---------------------------~~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
+.++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec-CCceEEEeechhcc
Confidence 1178999999999998 45555699999774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.56 E-value=7.6e-05 Score=77.52 Aligned_cols=81 Identities=11% Similarity=0.050 Sum_probs=49.5
Q ss_pred EEEEeecCCeEEEEEEEcCCCeEEEEEEeeccccc---CCHHHHHHHHHHHHHHHhCC-C--CCcceeeeEEEcCCCceE
Q 006777 30 WVVVLNCTFMCRYKGFDEVDGIEVAWNQVNIEDVM---QSPDQLERLYSEVHLLKSLK-H--ENIIKFYNSWVDDTNRTI 103 (631)
Q Consensus 30 ~e~LG~G~fg~VY~A~d~~~g~~VAvK~v~~~~~~---~~~~~~~~~~~Ei~iL~~L~-H--pnIV~l~~~f~~~~~~~l 103 (631)
.+.||.|..-.||+..+...|+.|++|+-...-.. ..+...++...|...|+.+. + ..++++|. .+... .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~--~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM--A 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT--T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCC--C
Confidence 56789999999999998777889999975432110 11122345667888887662 2 34556664 34432 3
Q ss_pred EEEEeccCCCC
Q 006777 104 NMITELFTSGS 114 (631)
Q Consensus 104 ~lV~Ey~~gGs 114 (631)
++|||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 57999997644
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.29 E-value=0.00029 Score=67.38 Aligned_cols=75 Identities=7% Similarity=-0.127 Sum_probs=48.2
Q ss_pred EEEeecCC-eEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCC--CCcceeeeEEEcCCCceEEEEE
Q 006777 31 VVVLNCTF-MCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKH--ENIIKFYNSWVDDTNRTINMIT 107 (631)
Q Consensus 31 e~LG~G~f-g~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~~f~~~~~~~l~lV~ 107 (631)
+.+..|.. +.||+... ..|..+++|....... ..+..|...|+.|.. -.+.+++.+..+. +..++||
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~ 85 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-------NELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLL 85 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-------SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEE
T ss_pred EEcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-------hHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEE
Confidence 45555554 67898875 4576788887654322 235667777777643 3356667654433 4678999
Q ss_pred eccCCCCH
Q 006777 108 ELFTSGSL 115 (631)
Q Consensus 108 Ey~~gGsL 115 (631)
++++|.++
T Consensus 86 ~~i~G~~~ 93 (255)
T d1nd4a_ 86 GEVPGQDL 93 (255)
T ss_dssp ECCSSEET
T ss_pred Eeeecccc
Confidence 99987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.82 E-value=0.0062 Score=60.69 Aligned_cols=68 Identities=9% Similarity=-0.012 Sum_probs=40.9
Q ss_pred CeEEEEEEEcCCCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc--ceeee----EEEcCCCceEEEEEeccC
Q 006777 38 FMCRYKGFDEVDGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI--IKFYN----SWVDDTNRTINMITELFT 111 (631)
Q Consensus 38 fg~VY~A~d~~~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI--V~l~~----~f~~~~~~~l~lV~Ey~~ 111 (631)
--.||++.. ++|..|++|+...... + .+.+..|+..|..|...+| +.... ... ......+.+++++.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~--s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~-~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL-NHQGFYFAVFPSVG 107 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE-EETTEEEEEEECCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC--C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeee-eeeeEEEEEEeecC
Confidence 347999986 5788999998765421 2 2346678888877743222 11111 111 11246788999987
Q ss_pred C
Q 006777 112 S 112 (631)
Q Consensus 112 g 112 (631)
|
T Consensus 108 G 108 (325)
T d1zyla1 108 G 108 (325)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.93 E-value=0.021 Score=58.24 Aligned_cols=75 Identities=12% Similarity=0.073 Sum_probs=48.1
Q ss_pred EEEEEeecCCeEEEEEEEcC-------CCeEEEEEEeecccccCCHHHHHHHHHHHHHHHhCCCCCc-ceeeeEEEcCCC
Q 006777 29 SWVVVLNCTFMCRYKGFDEV-------DGIEVAWNQVNIEDVMQSPDQLERLYSEVHLLKSLKHENI-IKFYNSWVDDTN 100 (631)
Q Consensus 29 i~e~LG~G~fg~VY~A~d~~-------~g~~VAvK~v~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~f~~~~~ 100 (631)
-++.|+.|-.=.+|++.... .+..|++++.... .. . ....+|..+++.+.-.++ .+++.++ ++
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~--~-idr~~E~~i~~~ls~~gl~Pkll~~~--~~- 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET--E-SHLVAESVIFTLLSERHLGPKLYGIF--SG- 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC--H-HHHHHHHHHHHHHHHTTSSSCEEEEE--TT-
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---ch--h-hHHHHHHHHHHHHHhCCCCCeEEEEc--CC-
Confidence 35788989999999998653 2356777665421 11 1 234578888888843344 5677654 22
Q ss_pred ceEEEEEeccCCCCH
Q 006777 101 RTINMITELFTSGSL 115 (631)
Q Consensus 101 ~~l~lV~Ey~~gGsL 115 (631)
.+|+||++|.+|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 468999987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.46 E-value=0.19 Score=48.71 Aligned_cols=29 Identities=31% Similarity=0.355 Sum_probs=24.5
Q ss_pred CeEecCCCCCceEEeCCCCcEEEccccchh
Q 006777 150 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI 179 (631)
Q Consensus 150 ~IiHrDLKp~NILl~~~~g~vKI~DFGlA~ 179 (631)
++||+|+.++||+++ .++..-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~-~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFL-GDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcc-cccceeEecccccc
Confidence 399999999999998 45556799999874
|